0001607062-23-000168.txt : 20230331 0001607062-23-000168.hdr.sgml : 20230331 20230331170605 ACCESSION NUMBER: 0001607062-23-000168 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 90 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230331 DATE AS OF CHANGE: 20230331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Applied UV, Inc. CENTRAL INDEX KEY: 0001811109 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRIC LIGHTING & WIRING EQUIPMENT [3640] IRS NUMBER: 844373308 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39480 FILM NUMBER: 23789020 BUSINESS ADDRESS: STREET 1: 150 N. MACQUESTEN PKWY CITY: MOUNT VERNON STATE: NY ZIP: 10550 BUSINESS PHONE: 9292073751 MAIL ADDRESS: STREET 1: 150 N. MACQUESTEN PKWY CITY: MOUNT VERNON STATE: NY ZIP: 10550 10-K 1 auvi123122form10k.htm 10-K
0001811109 false 2022 FY 0001811109 2022-01-01 2022-12-31 0001811109 auvi:CommonStockParValue0.0001PerShareMember 2022-01-01 2022-12-31 0001811109 auvi:Sec10.5SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember 2022-01-01 2022-12-31 0001811109 2022-06-30 0001811109 2023-03-31 0001811109 2022-12-31 0001811109 2021-12-31 0001811109 auvi:SeriesXPreferredStockMember 2022-12-31 0001811109 auvi:SeriesXPreferredStockMember 2021-12-31 0001811109 2021-01-01 2021-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2020-12-31 0001811109 auvi:PreferredStockSeriesXMember 2020-12-31 0001811109 us-gaap:CommonStockMember 2020-12-31 0001811109 auvi:TreasuryStocksMember 2020-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001811109 us-gaap:RetainedEarningsMember 2020-12-31 0001811109 2020-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2021-12-31 0001811109 auvi:PreferredStockSeriesXMember 2021-12-31 0001811109 us-gaap:CommonStockMember 2021-12-31 0001811109 auvi:TreasuryStocksMember 2021-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001811109 us-gaap:RetainedEarningsMember 2021-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2021-01-01 2021-12-31 0001811109 auvi:PreferredStockSeriesXMember 2021-01-01 2021-12-31 0001811109 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001811109 auvi:TreasuryStocksMember 2021-01-01 2021-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001811109 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2022-01-01 2022-12-31 0001811109 auvi:PreferredStockSeriesXMember 2022-01-01 2022-12-31 0001811109 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001811109 auvi:TreasuryStocksMember 2022-01-01 2022-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001811109 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2022-12-31 0001811109 auvi:PreferredStockSeriesXMember 2022-12-31 0001811109 us-gaap:CommonStockMember 2022-12-31 0001811109 auvi:TreasuryStocksMember 2022-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001811109 us-gaap:RetainedEarningsMember 2022-12-31 0001811109 auvi:TwoMajorSuppliersMember 2021-01-01 2021-12-31 0001811109 us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001811109 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001811109 us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001811109 us-gaap:OptionMember 2022-01-01 2022-12-31 0001811109 us-gaap:OptionMember 2021-01-01 2021-12-31 0001811109 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001811109 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001811109 us-gaap:TransferredOverTimeMember 2022-01-01 2022-12-31 0001811109 us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0001811109 us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-12-31 0001811109 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31 0001811109 us-gaap:TransferredOverTimeMember 2022-12-31 0001811109 us-gaap:TransferredOverTimeMember 2021-12-31 0001811109 us-gaap:TransferredAtPointInTimeMember 2022-12-31 0001811109 us-gaap:TransferredAtPointInTimeMember 2021-12-31 0001811109 2021-02-08 0001811109 2021-09-28 0001811109 2021-10-13 0001811109 2022-03-25 0001811109 auvi:SteriLumenMember 2021-02-08 0001811109 auvi:SteriLumenMember 2021-09-28 0001811109 auvi:SteriLumenMember 2021-10-13 0001811109 2022-03-31 0001811109 2022-01-01 2022-03-31 0001811109 auvi:SteriLumenMember 2022-03-25 0001811109 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001811109 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001811109 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001811109 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001811109 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001811109 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001811109 us-gaap:CustomerRelationshipsMember 2022-12-31 0001811109 us-gaap:CustomerRelationshipsMember 2021-12-31 0001811109 us-gaap:TradeNamesMember 2022-12-31 0001811109 us-gaap:TradeNamesMember 2021-12-31 0001811109 us-gaap:PatentsMember 2022-12-31 0001811109 us-gaap:PatentsMember 2021-12-31 0001811109 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001811109 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-12-31 0001811109 us-gaap:TradeNamesMember 2022-01-01 2022-12-31 0001811109 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001811109 auvi:SecurityPurchaseAgreementMember 2022-10-01 2022-10-07 0001811109 auvi:SecurityPurchaseAgreementMember 2022-10-07 0001811109 us-gaap:DirectorsAndOfficersLiabilityInsuranceMember 2022-08-28 0001811109 2022-08-01 2022-08-28 0001811109 2022-09-01 2022-09-30 0001811109 auvi:LoanAndSecurityAgreementMember 2022-08-01 2022-08-28 0001811109 auvi:LoanAndSecurityAgreementMember 2022-01-01 2022-12-31 0001811109 srt:MaximumMember 2022-01-01 2022-12-31 0001811109 srt:MinimumMember 2022-01-01 2022-12-31 0001811109 auvi:StreetervilleNoteMember 2022-12-31 0001811109 auvi:FairValueMember 2022-12-31 0001811109 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001811109 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001811109 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001811109 auvi:FairValueMember 2021-12-31 0001811109 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001811109 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001811109 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001811109 auvi:AtTheMarketSalesAgreementMember 2022-06-28 2022-07-02 0001811109 auvi:MaximGroupLLCMember 2022-06-28 2022-07-02 0001811109 auvi:AtTheMarketSalesAgreementMember 2022-01-01 2022-12-31 0001811109 2022-06-28 2022-07-02 0001811109 us-gaap:SubsequentEventMember 2023-03-01 2023-03-31 0001811109 srt:BoardOfDirectorsChairmanMember 2022-07-01 2022-07-11 0001811109 us-gaap:PreferredStockMember 2022-12-31 0001811109 auvi:IncentivePlan2020Member 2020-03-01 2020-03-31 0001811109 auvi:IncentivePlan2020Member 2022-12-31 0001811109 auvi:OptionsMember 2022-01-01 2022-12-31 0001811109 auvi:OptionsMember 2021-01-01 2021-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2022-12-31 0001811109 2021-12-01 2021-12-28 0001811109 2021-12-28 0001811109 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-01-05 0001811109 us-gaap:OverAllotmentOptionMember 2022-01-05 0001811109 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001811109 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001811109 us-gaap:RestrictedStockMember 2022-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2020-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2021-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001811109 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2022-12-31 0001811109 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-12-31 0001811109 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2021-12-31 0001811109 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2021-12-31 0001811109 auvi:DividendYieldMember 2022-01-01 2022-12-31 0001811109 auvi:DividendYieldMember 2021-01-01 2021-12-31 0001811109 us-gaap:MeasurementInputPriceVolatilityMember 2022-01-01 2022-12-31 0001811109 us-gaap:MeasurementInputPriceVolatilityMember 2021-01-01 2021-12-31 0001811109 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-01-01 2022-12-31 0001811109 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-01-01 2021-12-31 0001811109 us-gaap:MeasurementInputExpectedTermMember 2022-01-01 2022-12-31 0001811109 us-gaap:MeasurementInputExpectedTermMember 2021-01-01 2021-12-31 0001811109 us-gaap:WarrantMember 2020-12-31 0001811109 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001811109 us-gaap:WarrantMember 2021-12-31 0001811109 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001811109 us-gaap:WarrantMember 2022-12-31 0001811109 us-gaap:RestrictedStockMember 2020-12-31 0001811109 us-gaap:RestrictedStockMember 2021-12-31 0001811109 auvi:PayrollProtectionPlanLoanCaresActMember 2020-04-30 0001811109 auvi:PayrollProtectionPlanLoanCaresActMember 2020-04-01 2020-04-30 0001811109 auvi:RelatedPartyMember 2021-02-28 0001811109 2021-11-30 0001811109 auvi:HospitalitySegmentMember 2022-12-31 0001811109 auvi:DisinfectantSegmentMember 2022-12-31 0001811109 us-gaap:CorporateMember 2022-12-31 0001811109 auvi:HospitalitySegmentMember 2021-12-31 0001811109 auvi:DisinfectantSegmentMember 2021-12-31 0001811109 us-gaap:CorporateMember 2021-12-31 0001811109 auvi:HospitalitySegmentMember 2022-01-01 2022-12-31 0001811109 auvi:DisinfectantSegmentMember 2022-01-01 2022-12-31 0001811109 us-gaap:CorporateMember 2022-01-01 2022-12-31 0001811109 auvi:HospitalitySegmentMember 2021-01-01 2021-12-31 0001811109 auvi:DisinfectantSegmentMember 2021-01-01 2021-12-31 0001811109 us-gaap:CorporateMember 2021-01-01 2021-12-31 0001811109 auvi:AkidaKESVisionmarkAndSciAirMember 2022-01-01 2022-12-31 0001811109 auvi:AkidaKESVisionmarkAndSciAirMember 2021-01-01 2021-12-31 0001811109 us-gaap:SubsequentEventMember 2023-01-25 0001811109 us-gaap:SubsequentEventMember 2023-01-01 2023-01-25 0001811109 us-gaap:SubsequentEventMember us-gaap:InvestorMember 2023-01-25 0001811109 us-gaap:SubsequentEventMember 2023-07-25 0001811109 us-gaap:SubsequentEventMember 2023-01-01 2023-01-26 0001811109 2022-02-01 2022-02-25 0001811109 us-gaap:SubsequentEventMember 2023-01-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Fiscal Year Ended December 31, 2022

Or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

 Commission File Number: 001-39480

 

APPLIED UV, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 84-4373308
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

 

150 N. Macquesten Parkway

Mount Vernon, NY 10550

(914) 665-6100

(Address, including zip code, of registrant’s principal executive offices and

telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   AUVI   The Nasdaq Stock Market LLC
10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share   AUVIP   The Nasdaq Stock Market LLC

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes: ☐  No: ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes: ☐  No: ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes: ☒  No: ☐

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes: ☒  No: ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company, in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
Emerging Growth Company ☒  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Act).

Yes: ☐  No: ☒

The aggregate market value of the voting and non-voting common stock held by non-affiliates of the registrant as of June 30, 2022 was approximately $17,200,000.

At March 31, 2023, the registrant had 19,237,273 shares of common stock, par value $0.0001 per share, outstanding.

 1 

 

Table of Contents

    Page
PART I    
Item 1. Business  6
Item 1A. Risk Factors  9
Item 1B. Unresolved Staff Comments 32
Item 2. Properties 32
Item 3. Legal Proceedings 32
Item 4. Mine Safety Disclosures 32
     
PART II    
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 33
Item 6. [Reserved] 34
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 40
Item 8. Financial Statements and Supplementary Data 41
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 76
Item 9A. Controls and Procedures 76
Item 9B. Other Information 77
Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 77
     

PART III

    
Item 10. Directors, Executive Officers and Corporate Governance  78
Item 11. Executive Compensation  82
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters  85
Item 13. Certain Relationships and Related Transactions, and Director Independence  86
Item 14. Principal Accounting Fees and Services  86
     
PART IV    
Item 15. Exhibits, Financial Statement Schedules  87
Item 16. Form 10-K Summary  87

 2 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements. The forward-looking statements are contained principally in the sections entitled “Business,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “would,” and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. You should read these factors and the other cautionary statements made in this report and in the documents we incorporate by reference into this report as being applicable to all related forward-looking statements wherever they appear in this report or the documents we incorporate by reference into this report. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements.

Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements include, among other things, statements relating to:

•   our ability to continue as a going concern;

•   our ability to successfully integrate our recent acquisitions into our overall business;

•   our ability to secure sufficient funding and alternative source of funding to support our current and proposed operations, which could be more difficult in light of the negative impact of the COVID-19 pandemic on investor sentiment and investing ability;
•   our anticipated growth strategies and our ability to manage the expansion of our business operations effectively;
•   our ability to maintain or increase our market share in the competitive markets in which we do business;
•   our ability to grow net revenue and increase our gross profit margin;
•   our ability to keep up with rapidly changing technologies and evolving industry standards, including our ability to achieve technological advances;
•   our dependence on the growth in demand for our products;
•   our ability to compete with larger companies with far greater resources than we have;
•   our continued ability to obtain raw materials and other supplies for our products at competitive prices and on a timely basis, particularly in light of the potential impact of the COVID-19 pandemic on our suppliers and supply chain;
•   our ability to diversify our product offerings and capture new market opportunities;
•   our ability to source our needs for skilled labor, machinery, parts, and raw materials economically;
•   our ability to retain key members of our senior management;
•   our ability to continue to operate safely and effectively during the COVID-19 pandemic; and
•   our ability to maintain our listing on The Nasdaq Capital Markets.

Also, forward-looking statements represent our estimates and assumptions only as of the date of this report. You should read this report and the documents that we reference and file as exhibits to this report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

 3 

 

Use of Certain Defined Terms

Except where the context otherwise requires and for the purposes of this report only:

•   the “Company,” “Applied UV,” “we,” “us,” and “our” refer to the combined business of Applied UV, Inc., a Delaware corporation and its wholly-owned subsidiaries, SteriLumen, Inc., a New York corporation (“SteriLumen”) and Munn Works, LLC, a New York limited liability company (“MunnWorks”).
•   “Exchange Act” refers the Securities Exchange Act of 1934, as amended;
•   “SEC” refers to the Securities and Exchange Commission; and
•   “Securities Act” refers to the Securities Act of 1933, as amended.

SUMMARY OF RISK FACTORS

Our business is subject to a number of risks. You should be aware of these risks before making an investment decision. These risks are discussed more fully in Item 1A Risk Factors in this Annual Report. These risks include, among others, that:

•   We operate through SteriLumen and MunnWorks and our only current source of revenue is distributions from our subsidiaries. SteriLumen has incurred losses since its inception and we anticipate it will continue to incur significant losses for the foreseeable future and revenue from MunnWorks may not be sufficient to offset those loses;
•   We could need to raise additional capital in the future, and if we are unable to secure adequate funds on terms acceptable to us, we could be unable to execute our business plan;
•   Our suppliers may not supply us with a sufficient amount or adequate quality of materials;
•   Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed;
•   We could be subject to significant warranty obligations if our products are defective;
•   Product liability claims against us could be costly and could harm our reputation;
•   If we lose our key management personnel, or are unable to attract or retain qualified personnel, it could adversely affect our ability to execute our growth strategy;
•   Climate change initiatives could materially and adversely affect our business, financial condition, and results of operations;
•   Our financial controls and procedures may not be sufficient to ensure timely and reliable reporting of financial information, which, as a public company, could materially harm our stock price;
•   The air purification market is fragmented and competitive and we may not be able to compete successfully with our existing competitors or new entrants into the markets we serve;
•   If we are unable to execute our plan to distribute SteriLumen’s Airocide products, we may not be able to generate revenues and your investment could be materially adversely affected;
•   We are subject to significant regulatory oversight and changes in applicable regulatory requirements could adversely affect our business;

 

 4 

 

 

•   SteriLumen’s Scientific Air business is highly dependent on a sole distributor and any disruption in their operations could have a material adverse effect on our business, results of operations and financial condition;
•   SteriLumen’s business is highly dependent on market perceptions of it and the safety and quality of its products;
•   Rapidly changing standards and competing technologies could harm demand for our products;
•   We could be unable to effectively manage and implement our growth strategies, which could have a material adverse effect on our business, financial condition, and results of operations;
•   International sales may comprise a significant portion of SteriLumen’s revenues and will be subject to risks associated with operating in domestic and international markets;
•   SteriLumen’s collaborations with outside scientists and consultants may be subject to restriction and change;
•   The custom design decorative framed mirror supply market is highly competitive;
•   MunnWorks’ possible failure to develop new products or respond to changing consumer preferences and purchasing practices could have a material adverse effect;
•   MunnWorks’ business is highly dependent on market perceptions of it and the quality of its products;
•   If the patents that we own or license, or our other intellectual property rights, do not adequately protect our technologies, we could lose market share to our competitors and be unable to operate our business profitably;
•   Changes in U.S. patent law could diminish the value of patents in general;
•   Our directors and officers beneficially will own more than 50% of the voting power of our voting stock and will be able to exert a controlling influence over our business affairs and matters submitted to stockholders for approval;
•   We have not paid dividends on our Common Stock in the past and do not expect to pay dividends on our Common Stock in the future, and any return on investment may be limited to the value of our stock; and
•   Provisions of our Amended and Restated Certificate of Incorporation could delay or prevent the acquisition or sale of our business.
•   We expect that we will need to raise additional capital, and raising additional funds by issuing additional equity securities or with additional debt financing may cause dilution to shareholders or restrict our operations;
•   The Series A Preferred Stock ranks junior to all of our indebtedness and other liabilities;
•   The Series A Preferred Stock will be effectively subordinated to the obligations of our subsidiaries;
•   A holder of Series A Preferred Stock has essentially no voting rights;
•   If we are not paying full dividends on any future dividend parity stock, we will not be able to pay full dividends on the Series A Preferred Stock;

 5 

 

PART I

Item 1. Business

Corporate History

Applied UV, Inc. (“AUVI”) is a leading sales and marketing company that develops, acquires, markets and sells proprietary surface and air disinfection technology focused on Improving Indoor Air Quality (IAQ), specialty LED lighting and luxury mirrors and commercial furnishings, all of which serves clients globally in the healthcare, commercial & public venue, hospitality, food preservation, cannabis, education, and winery vertical markets.

With its established strategic manufacturing partnerships and alliances including Canon, Acuity, Johnson Controls, USHIO, Siemens, Grainger, and a global network of 89 dealers and distributors in 52 countries, 47 manufacturing representatives, and 19 US based internal sales representatives, AUVI offers a complete suite of products through its two wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and Munn Works, LLC (“MunnWorks”).

SteriLumen owns, brands, and markets a portfolio of research backed and clinically proven products utilizing advanced UVC Carbon, Broad Spectrum UVC LED’s, and Photo-catalytic oxidation (PCO) pathogen elimination technology, branded as Airocide ™, Scientific Air™, Airoclean™ 420, Lumicide™, PUROAir, PUROHealth, PURONet, and LED Supply Company.   Sterilumen’s proprietary platform suite of patented surface and air technologies offers one of the most complete pathogen disinfection platforms including mobile, fixed, and HVAC systems and software solutions interconnecting its entire portfolio suite into the IoT, allowing customers to implement, manage and monitor IAQ measures recommended by the EPA across any enterprise. Additionally, the Lumicide™ platform applies the power of ultraviolet light (UVC) to destroy pathogens automatically, addressing the challenge of healthcare-acquired infections (“HAI’s) in several patented designs for infection control in healthcare. LED Supply Company is a full-service, wholesale distributor of LED lighting and controls throughout North America. MunnWorks manufactures and sells custom luxury and backlit mirrors, conference room and living spaces furnishings.

Our global list of Fortune 100 end users including Kaiser Permanente, NY Health+Hospitals, MERCY Healthcare, University of Chicago Medical, Baptist Health South Florida, New York City Transit, Samsung, JB Hunt, Boston Red Sox’s Fenway Park, JetBlue Park, France’s Palace of Versailles, Whole Foods, Del Monte Foods, U.S. Department of Veterans Affairs, Marriott, Hilton, Four Seasons and Hyatt, and more. For information on Applied UV, Inc., and its subsidiaries, please visit https://www.applieduvinc.com

Air Disinfection Solutions & LED Lighting: Airocide, Scientific Air, PURO and LED Supply Co.

In February of 2021, the Company acquired all the assets and assumed certain liabilities of Akida Holdings, LLC (“Akida”). At the time of the acquisition, Akida owned the Airocide™ system of air purification technologies, originally developed for NASA with assistance from the University of Wisconsin at Madison, that uses a combination of UVC and a proprietary, titanium dioxide based photocatalyst that has helped to accelerate the reopening of the global economy with applications in the hospitality, hotel, healthcare, nursing home, grocer, wine, commercial building and retail sectors. The Airocide™ system has been used by brands such as NASA, Whole Foods, Dole, Chiquita, Opus One, Sub-Zero Refrigerators and Robert Mondavi Wines. Akida had contracted KES Science & Technology, Inc. (“KES”) to manufacture, warehouse and distribute the Airocide™ system and Akida’s contractual relationship with KES was assigned to and assumed by the Company as part of the acquisition.

On September 28, 2021, the Company acquired all the assets and assumed certain liabilities of KES. At the time of the acquisition, KES was principally engaged in the manufacturing and distribution of the Airocide™ system of air purification technologies and misting systems. KES also had the exclusive right to the sale and distribution of the Airocide™ system in certain markets. This acquisition consolidated all of manufacturing, sale and distribution of the Airocide™ system under the SteriLumen brand and expanded the Company’s market presence in food distribution, post-harvest produce, wineries, and retail sectors. The Company sells its products throughout the United States, Canada, and Europe.

 6 

 

The Airocide™ system of air purification technologies, originally developed for the National Aeronautics and Space Administration (“NASA”) with assistance from the University of Wisconsin at Madison, uses a combination of UVC and a proprietary, titanium dioxide based photocatalyst to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds and many odors. The core Airocide™ technology has been in use on the International Space Station and is based on photo-catalytic oxidation (PCO), a bioconversion process that continuously converts damaging molds, microorganisms, dangerous pathogens, destructive volatile organic chemicals (VOCs) and biological gasses into harmless water vapor. Unlike other air purification systems that provide “active” air cleaning, ozone producing systems, ionization or “photo-electrochemical oxidation”, Airocide’s™ nanocoating technology permanently bonds titanium dioxide to the surface of the catalytic bed. This permits the perpetual generation of surface-bound (OH-) radicals over the large surface area created by their advanced geometric design and prevents the generation and release of ozone and other harmful byproducts. The proprietary formulation and methods for creating the catalyst are the basis of Airocide’s™ competitive advantage, making it the only consistently robust, highly effective, ozone free PCO technology on the market. Airocide™ has been tested over the past 12 years by governmental agencies such as NASA, the National Renewable Energy Laboratory, independent universities including the University of Wisconsin, Texas Tech University, and Texas A&M, as well as air quality science laboratories. Airocide™ technology is listed as a FDA Class II Medical Device, making it a suitable for providing medical grade air purification in critical hospital use cases. Airocide™ Product lines include APS (consumer units), the GCS and HD lines (commercial units that will include the Sterilumen App to bring connectivity, reporting and asset management to our suite of products). The APS series provides true choice, low maintenance filter-less PCO or a filtered PCO air purification option ideal for restaurants, conference rooms, residential and small business or home office spaces. The GCS series is suitable for larger public spaces and enclosed rooms that may have high occupancy such as offices, waiting rooms and hotel lobbies, and airport gate areas. The HD series is the most powerful, providing two-stage purification for fast sanitization of larger or industrial spaces such as sporting venues and locker rooms, airports, museums, winery cellars, warehouses, and food-processing facilities. All Airocide™ products also extend the life of any perishables like fruit, produce or flowers.

On October 13, 2021, we acquired substantially all of the assets of Old SAM Partners, LLC F/K/A Scientific Air Management, LLC (“Old SAM”), which owned a line of air purification technologies (“Scientific Air”). The Scientific Air product line uses a combination of UVC and a proprietary, patented system to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products. Scientific Air’s products are well suited for larger spaces within a facility due to the higher air flow of these units. The units are also mobile with industrial grade casters, allowing for movement throughout a facility to address increased bio burden from larger meetings or increased human traffic. Both of these key items extend our Airocide line, creating a comprehensive air disinfection portfolio that spans from small to large spaces and mobile applications. Scientific Air’s products are currently sold predominantly in North America and into the healthcare market.

PURO Lighting

On January 26, 2023 we acquired PURO Lighting LLC (“PURO”) and its operating subsidiaries (the “PURO Acquisition”) pursuant to an agreement and plan of merger dated December 19, 2022 (the “PURO Merger Agreement”) for (i) $4,056,789 in the obligations to pay certain PURO debt and transaction costs, (ii) 2,497,220 shares of our common stock, (iii) 251,108 shares of our 5% Series C Cumulative Perpetual Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”) and (iv) the payment to PURO former equity interest holders of earnout payments on the terms and conditions described in the PURO Merger Agreement.

PURO Lighting was founded in 2019 with the goal of using light technology to promote health and wellness within spaces. Today PURO provides a suite of UV disinfection systems that have the ability to disinfect air and surfaces in commercial and industrial spaces. They focus their sales efforts in three primary verticals: Education, Government, and Healthcare.  The acquisition of Puro Lighting, LLC adds PUROHealth and PURONet - a powerful suite of products used in education, government, and healthcare that incorporates UV Lighting and a HVAC monitoring software platform. With its UL listed and patented portfolio of independently tested (Resonova Labs) synergistic surface and air disinfection technologies that help facility managers protect against multiple pathogens; PURO opens new opportunities for cross marketing sales to existing distribution channels. Additionally, the potential to inter-connect our entire portfolio of disinfection technology solutions into the IoT will provide our customers with both products and smart tools to manage and monitor indoor air quality (IAQ) across any enterprise. Applied UV’s proprietary platform suite of patented technologies offers the most complete pathogen disinfection platform including mobile, fixed and HVAC systems and solutions allowing companies to implement the IAQ measures recommended by the EPA.  PURO boast a strong domestic sales network with reps in 43 states, and distribution in all 50 states.  Their product offerings encompass a range of innovative solutions, including UVC systems for air handling, in-room continuous disinfection using cutting-edge Far-UVC technology, and specialized surface disinfection solutions designed specifically for the healthcare industry.

The Puro Acquisition further positions the Company to address a growing air disinfection market trend that aligns with the White House “Clean Air Initiatives” implemented during the height of the COVID 19 Pandemic designed to protect consumers and businesses against existing and future airborne pathogens allowing economies globally to remain open. The merged entities have proven applications that can now be included in improving indoor air quality (IAQ) at the facility level including HVAV systems in public, government, municipal, retail spaces and buildings. The Puro Acquisition positions Applied UV to be one of the only companies in the world to offer a complete air and surface disinfection platform that includes consumer, fixed and mobile, and commercial applications that are research backed, clinically tested and that are used by global Fortune 100 end users in multiple verticals.

 7 

 

LED Supply Company

On January 26, 2023 we acquired LED Supply Co. LLC (“LED”) and its operating subsidiaries (the “LED Acquisition”) pursuant to an agreement and plan of merger dated December 19, 2022 (the “LED Merger Agreement”) for (i) $2,364,657 in the obligations to pay certain LED debt and transaction costs, (ii) 1,377,777 shares of our common stock, (iii) 148,888 shares of our 5% Series C Cumulative Perpetual Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”) and (iv) the payment to LED former equity interest holders of earnout payments on the terms and conditions described in the LED Merger Agreement.

Founded in 2009, LED Supply Company is a national, Colorado-based company that provides design, distribution, and implementation services for lighting, controls and smart building technologies. LED Supply Co continues to expand its market reach with a focus on new types of energy efficiency and sustainable technologies. Along with its robust e-commerce component, LED Supply Company has recently taken the next step in revenue growth by repositioning itself as a preferred supplier for not only the latest in LED technologies, but the source for emerging technologies and product categories that the construction and retrofit market need; from electric vehicle charging to smart home technology, emergency and safety equipment, and much more.

We see synergies across our entire air and surface disinfection portfolio. First, we look to leverage Airocide’s global distribution capabilities to facilitate the sale of Scientific Air’s and PURO’s offerings internationally. Second, we look to leverage PURO’s strength in healthcare to pull through existing Airocide™ units, creating a broad healthcare product line, from small clinics, patient rooms and doctor’s offices to larger spaces such as nursing stations, waiting rooms and cafeterias. Third, we look to leverage the national MunnWorks hospitality reach with leading luxury hotel chain operators to pull through our entire air and surface disinfection portfolio (Airocide™ and Lumicide™) as well as PURO’s offerings into future hotel, condo and other renovation, upgrade and remodeling projects. Fourth, the Company will look to work with Canon Virginias’ (CVI) extensive field support team to promote the sale of the Companys’ products as well as service capabilities.  Finally, we look to incorporate the PUROAir, PUROHealth and PURONet  (a powerful suite of products used in healthcare that incorporates UV Lighting and a HVAC monitoring software platform) into our IoT integration plans via the Sterilumen App across our entire platform connecting all our units, thereby creating a leading smart asset management, reporting, and control system tool that can be incorporated across all enterprises.

Market Opportunity

According to Research and Markets, the UV Disinfection market is expected to reach $9 billion by 2027 as technology continues to improve and the focus on stopping the spread of contagious diseases increases. The Center for Disease Control states that 1 in 25 patients have at least one Hospital Associated Infection (HAI) annually and that 3 million serious infections occur every year in long-term care facilities. Losses from contagious infections, pathogens, and viruses cost the U.S. economy more than $270B every year as per the CDC: $28B lost through HAI’s; $225B in lost productivity due to absenteeism; and $25B in losses due to Student/Teacher absenteeism. Scientists globally have been advocating improving air quality post pandemic, significantly boosting global adoption to control airborne pathogen transmission.  Governments globally mandating health agencies to address improving indoor air quality (IAQ) via grants and mechanisms to ease visitation and protect facilities against future pathogens (Centers for Medicare and Medicaid Services – CMS, February 2022 Long-term Care Initiative April 2022 WH Clean Air Initiatives).

Indoor air quality (IAQ) has become an even more important issue as world economies transition beyond the COVID 19 pandemic. In 2021, 39 scientists reiterated the need for a “paradigm shift” and called for improvements in, “how we view and address the transmission of respiratory infections to protect against unnecessary suffering and economic losses.”  In mid 2022 we began to see this seismic shift from pandemic related mobile apparatuses to complete systems within systems for facilities designed to monitor, improve, and report on a more permanent basis.  While there are opportunities for mobile systems, our emphasis will be on this growing market trend.  

In addition to this, the global air purifier market size is set to grow exponentially. It was valued at $9.24 billion in 2021 and is predicted to grow to approximately $22.84 billion by 2030. According to Precedence Research, the immense demand for air purification and sterilization in the US will be driven by the commercial sector.  

Sterilumen’s product portfolio is one of the only research-backed, clinically proven pure-play air and surface disinfection technology companies with international distribution and globally recognized end users, with product developed for NASA.  In addition to the numerous recognized research institutions and globally recognized names who published the reports that were completed by the acquired companies, Airocide was independently proven to kill SARS, MERSA and Anthrax.  Sterilumen’s air purification (Airocide, Scientific Air & PURO Lighting) and surface disinfection (Lumicide) were independently tested and proven to kill both Candida Auris (Resinnova Laboratories) and SARS CoV-2 (COVID-19) (MRIGlobal), MRSA (Resinnova Laboratories), Salmonella enterica (Resonnova Laboratories) and Escherichia coli (Resinnova Laboratories).  

Our goal is to build a company that successfully designs, develops, and markets our air and surface disinfection solutions that will enable US and global economies to implement “Clean Air” initiatives aimed at improving indoor air quality (IAQ) as recommended by the US Government’s EPA. We will seek to achieve this goal by having our products actively involved in the following activities:  

Focus on key target verticals that have proven business use cases including:

•Food Preservation
•Healthcare
•Winery
•Hospitality
•Schools
•Cannabis
•Correctional Facilities
•Dental and Long-Term Care

In addition to further developing Airocide, Scientific Air, PURO, Lumicide and LED Supply specific sales efforts, we intend to leverage the Company’s hospitality business (MunnWorks) for cross-selling opportunities of our air purification and surface disinfectant solutions and products. Our initial research indicates that the key stakeholders in this market value the asset management and reporting capabilities of our platform and provide key points of differentiation.

•Expand our global distributor channels into new markets not currently served.
•Continue scientific validation through lab testing and data from real world deployments; publish case studies in peer reviewed journals.

Manufacturing

In an effort to improve operationally, after analyzing each of the points in our supply chain to tighten integration to optimize inventory, improve quality control, and mitigate against supply chain disruptions that were witnessed globally throughout the pandemic, on December 18th, 2022, Applied UV announced that it has signed a strategic manufacturing and related services agreement with Canon Virginia, Inc., (“CVI”) a global manufacturing, engineering and technical operation for the Canon family and a wholly owned subsidiary of Canon U.S.A, Inc. The agreement establishes CVI’s status as the primary manufacturer, assembler, and logistical authority for Applied UV’s entire suite of air purification solutions. The Manufacturing Agreement, the first of a series of anticipated agreements, enables the Company to leverage the resources of CVI’s two million-square-foot state-of-the-art engineering, manufacturing, and distribution facility.  Applied UV plans to leverage CVI’s almost 40 years of innovative and efficient production methods to manufacture the Company’s patented, FDA Class II Listed Airocide PCO commercial and consumer devices, as well as the patented advanced Activated Carbon UVC and HEPA Mobile disinfection Scientific Air portfolio.  From an R&D perspective, working closely with Canon, we are also beginning to formulate our new product roadmap and making substantial improvements to our entire line of mobile and fixed air purification products, further differentiating our patented PCO and UVC Carbon based solutions from that of our competition.  Applied UV also plans to collaborate with Canon Financial Services, Inc. to enable better cash flow management in regard to its growing supply chain requirements. Further, the Company will look to work with CVI’s extensive field support team to promote the sale of the Company’s products, as well as service capabilities.

Employees

As of December 31, 2022, we had 115 employees.

Corporate Information

Our principal executive offices are located at 150 N. Macquesten Parkway, Mount Vernon, NY 10550. Our website address is www.applieduvinc.com.

 8 

 

Item 1a. Risk Factors.

Investing in our common stock is highly speculative and involves a significant degree of risk. Before you invest in our securities, you should give careful consideration to the following risk factors, in addition to the other information included in this Annual Report on Form 10-K, including our financial statements and related notes, before deciding whether to invest in our securities. The occurrence of any of the adverse developments described in the following risk factors could materially and adversely harm our business, financial condition, results of operations or prospects. In that case, the trading price of our common stock could decline, and you may lose all or part of your investment.

Risks Related to Our Business and Operations

The Company operates through its subsidiaries and its only material assets are its equity interests in those subsidiaries. As a result, our only current source of revenue is distributions from our subsidiaries, and all of its subsidiaries have been incurring losses and may continue to incur losses in the future.

The Company is a holding company for SteriLumen, MunnWorks, Puro, and LED Supply, and has no material assets other than its equity interests in those subsidiaries. Therefore, the only current revenue source is future distributions from its subsidiaries. SteriLumen is an early-stage designer and marketer of disinfection systems with limited operating history spanning from December 2016. We expect negative cash flows from SteriLumen’s operations for the foreseeable future. Our cash expenses will be highly dependent on the product development programs that SteriLumen chooses to pursue, the progress of these product development programs, the results of SteriLumen’s validation/marketing studies, the terms and conditions of SteriLumen’s contracts with service providers and manufacturing contractors, and the terms of recruitment of facilities in our validation/marketing studies. In addition, the continuation of SteriLumen’s validation/marketing studies. Failure to raise capital as and when needed, on favorable terms or at all, would have a negative impact on our financial condition and SteriLumen’s ability to develop its product candidates.

SteriLumen has devoted substantially all of its financial resources to develop its product candidates. SteriLumen has financed its operations primarily through the contributions of its founders. The amount of SteriLumen’s future net losses will depend, in part, on the development of adequate distribution channels for the Disinfecting System, the demand for the Disinfecting System, the rate of its future expenditures and our ability to obtain funding through the issuance of our securities, strategic collaborations or grants. Disinfection product development is a highly speculative undertaking and involves a substantial degree of risk. Its future revenue will depend upon its ability to achieve sufficient market acceptance, pricing, the performance of its independent sales representatives and its manufacturing and distribution suppliers.

We anticipate that SteriLumen’s expenses will increase substantially if and as SteriLumen:

   • continues the research and development of the Disinfecting System and other disinfecting products;
     
   • expands the scope of its testing for the Disinfecting System and other disinfecting products;
     
   • establishes a sales, marketing, and distribution infrastructure to commercialize its product candidates;
     
   • seeks to maintain, protect, and expand its intellectual property portfolio;
     
   • seeks to attract and retain skilled personnel; and
     
  • creates additional infrastructure to support its product candidate development and planned future commercialization efforts.

Furthermore, any additional fundraising efforts may divert our management from our subsidiaries’ day-to-day activities, which may adversely affect our ability to develop and commercialize their product candidates. In addition, we cannot guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of holders of our securities and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our shares to decline. The incurrence of indebtedness could result in increased fixed payment obligations, and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely affect our ability to conduct our business. We could also be required to seek funds through arrangements with collaborative partners or otherwise at an earlier stage than otherwise would be desirable, and we may be required to relinquish rights to some of our technologies or product candidates or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results, and prospects. Even if we believe that we have sufficient funds for our current or future operating plans, we may seek additional capital if market conditions are favorable or if we have specific strategic considerations.

 9 

 

If we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our research or development programs or the commercialization of any product candidates or be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations.

The pandemic caused by the spread of the Coronavirus could have an adverse impact on our financial condition and results of operations and other aspects of our business.

In December 2019, a novel strain of Coronavirus was reported to have surfaced in Wuhan, China. The virus has since spread to over 150 countries and every state in the United States. On January 30, 2020, the World Health Organization declared the outbreak of Coronavirus a “Public Health Emergency of International Concern”. On March 11, 2020, the World Health Organization declared the outbreak a pandemic, and on March 13, 2020, the United States declared a national emergency.

The spread of the virus in many countries continues to adversely impact global economic activity and has contributed to significant volatility and negative pressure in financial markets and supply chains. The pandemic has had, and could have a significantly greater, material adverse effect on the U.S. economy where we conduct a majority of our business. The pandemic has resulted, and may continue to result for an extended period, in significant disruption of global financial markets, which may reduce our ability to access capital in the future, which could negatively affect our liquidity.

Most states and cities have reacted by instituting quarantines, restrictions on travel, “stay at home” and “social distancing” rules and restrictions on the types of businesses that may continue to operate, as well as guidance in response to the pandemic and the need to contain it.

We have taken steps to take care of our employees, including providing the ability for employees to work remotely and implementing strategies to support appropriate social distancing techniques for those employees who are not able to work remotely. We have also taken precautions with regard to employee, facility, and office hygiene as well as implementing significant travel restrictions. We are also assessing our business continuity plans for all business units in the context of the pandemic. This is a rapidly evolving situation, and we will continue to monitor and mitigate developments affecting our workforce, our suppliers, our customers, and the public at large to the extent we are able to do so. We have and will continue to carefully review all rules, regulations, and orders and responding accordingly. We are dependent upon suppliers to provide us with all of the raw materials for products that we manufacture and sell and we currently manufacture the majority of our products in China. The pandemic has impacted and may continue to impact suppliers of materials and the manufacturing locations for our products. As a result, we have faced and may continue to face delays or difficulty manufacturing certain products, which could negatively affect our business and financial results. Even if we are able to find alternate sources for materials and manufacturing, they may cost more, which could adversely impact our profitability and financial condition.

We are vulnerable to continued global economic uncertainty and volatility in financial markets.

Our business is highly sensitive to changes in general economic conditions as a seller of goods and services. Financial markets inside the United States and internationally have experienced extreme disruption in recent times, including, among other things, extreme volatility in security prices, severely diminished liquidity and credit availability, and declining valuations of investments. We believe these disruptions are likely to have an ongoing adverse effect on the world economy. A continuing economic downturn and financial market disruptions could have a material adverse effect on our business, financial condition, and results of operations, including by:

  • reducing demand for our products and services, increasing order cancellations and resulting in longer sales cycles and slower adoption of new technologies;
  • increasing the difficulty of collecting accounts receivable and the risk of excess and obsolete inventories;
  • increasing price competition in our served markets; and
  • resulting in supply interruptions, which could disrupt our ability to produce our products.

 10 

 

We could need to raise additional capital in the future, and if we are unable to secure adequate funds on terms acceptable to us, we could be unable to execute our business plan.

To remain competitive, we must continue to make significant investments in the development of our products, the expansion of our sales and marketing activities, and the expansion of our operating and management infrastructure as we increase sales domestically and internationally. If cash generated from our operations is insufficient to fund such growth, we could be required to raise additional funds through the issuance of equity or debt securities in the public or private markets, or through a collaborative arrangement or sale of assets. Additional financing opportunities may not be available to us, or if available, may not be on favorable terms. The availability of financing opportunities will depend, in part, on market conditions, and the outlook for our business. Any future issuance of equity securities or securities convertible into equity securities could result in substantial dilution to our stockholders, and the securities issued in such a financing could have rights, preferences or privileges senior to those of our Common Stock. In addition, if we raise additional funds through debt financing, we could be subject to debt covenants that place limitations on our operations. We could not be able to raise additional capital on reasonable terms, or at all, or we could use capital more rapidly than anticipated. If we cannot raise the required capital when needed, we may not be able to satisfy the demands of existing and prospective customers, we could lose revenue and market share and we may have to curtail our capital expenditures.

The following factors, among others, could affect our ability to obtain additional financing on favorable terms, or at all:

  • our results of operations;
  • general economic conditions and conditions in the sanitation and disinfection industries and performance of sanitation devices as opposed to sanitation and disinfection substances;
  • the perception of our business in the capital markets;
  • making capital improvements to improve our infrastructure;
  • hiring qualified management and key employees;
  • responding to competitive pressures;
  • complying with regulatory requirements, if any;
  • our ratio of debt to equity;
  • our financial condition;
  • our business prospects; and
  • interest rates.

If we are unable to obtain sufficient capital in the future, we could have to curtail our capital expenditures. Any curtailment of our capital expenditures could result in a reduction in net revenue, reduced quality of our products, increased manufacturing costs for our products, harm to our reputation, or reduced manufacturing efficiencies and could have a material adverse effect on our business, financial condition, and results of operations.

Raising additional capital may cause dilution to our existing stockholders and restrict our operations or require us to relinquish certain intellectual property rights.

We may seek additional capital through a combination of public and private equity offerings, debt financings, strategic partnerships and alliances, licensing arrangements, and grants. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our existing stockholders may be diluted, and the terms may include liquidation or other preferences that adversely affect the rights of our stockholders. Debt and receivables financings may be coupled with an equity component, such as warrants to purchase shares, which could also result in dilution of our existing stockholders’ ownership. The incurrence of indebtedness would result in increased fixed payment obligations and could also result in certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we raise additional funds through strategic partnerships and alliances and licensing arrangements with third parties, we may have to relinquish valuable rights to our or our subsidiaries’ products or grant licenses on terms that are not favorable to us. A failure to obtain adequate funds may cause us to curtail certain operational activities, including research and development, validation/marketing studies, sales and marketing, and manufacturing operations, in order to reduce costs and sustain the business, and would have a material adverse effect on our business and financial condition.

 11 

 

Our success depends, in part, on our relationships with, and the efforts of, third-party manufacturers, distributors, and other third parties that perform various tasks for us. If these third parties do not successfully carry out their contractual duties or meet expected, we may not be able to commercialize our product candidates and our business could be substantially harmed.

While we internally manufacture all of MunnWorks’ products that are manufactured domestically, currently approximately 75% of MunnWorks’ products and all of SteriLumen’s products are manufactured overseas in China by third party manufacturers. We do not currently have the infrastructure or capability internally to manufacture all of the components of our products and systems, and we lack the resources and the capability to manufacture and distribute the Disinfecting System on a commercial scale. We plan to rely on third parties for such operations. There are a limited number of manufacturers who have the ability to produce our products, and there may be a need to identify alternate manufacturers to prevent a possible disruption of our manufacturing and distribution process. Switching manufacturers or distributors, if necessary, may involve substantial costs and is likely to result in a delay in our desired commercial timelines, which could harm our business and results of operations.

Our suppliers may not supply us with a sufficient amount or adequate quality of materials, which could have a material adverse effect on our business, financial condition, and results of operations.

Our business depends on our ability to obtain timely deliveries of materials, components, and subassemblies of acceptable quality and in acceptable quantities from third-party suppliers. We generally purchase components and subassemblies from a limited group of suppliers through purchase orders, rather than written supply contracts. Consequently, many of our suppliers have no obligation to continue to supply us on a long-term basis. In addition, our suppliers manufacture products for a range of customers, and fluctuations in demand for the products those suppliers manufacture for others could affect their ability to deliver components for us in a timely manner. Moreover, our suppliers could encounter financial hardships, be acquired, or experience other business events unrelated to our demand for components, which could inhibit or prevent their ability to fulfill our orders and satisfy our requirements.

If any of our suppliers cease to provide us with sufficient quantities of our components in a timely manner or on terms acceptable to us, or ceases to manufacture components of acceptable quality, we could incur manufacturing delays and sales disruptions while we locate and engage alternative qualified suppliers, and we might be unable to engage acceptable alternative suppliers on favorable terms. In addition, we could need to reengineer our components, which could significantly delay production. Any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive procedures. We are continually in the process of identifying and qualifying alternate source suppliers for our key components. There can be no assurance, however, that we will successfully identify and qualify an alternate source supplier for any of our key components or that we could enter into an agreement with any such alternate source supplier on terms acceptable to us, or at all.

Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.

Because we rely on third parties to develop and manufacture our products, we must, at times, share trade secrets with them. We seek to protect our proprietary technology in part by entering into confidentiality agreements and, if applicable, material transfer agreements, collaborative research agreements, consulting agreements or other similar agreements with our collaborators, advisors, employees and consultants prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, such as trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor’s discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may have a material adverse effect on our business.

We may engage in future acquisitions or strategic transactions which may require us to seek additional financing or financial commitments, increase our expenses and/or present significant distractions to our management.

We may make acquisitions in the future. In the event we engage in an acquisition or strategic transaction, we may need to acquire additional financing. Obtaining financing through the issuance or sale of additional equity and/or debt securities, if possible, may not be at favorable terms and may result in additional dilution to our current stockholders. Any future acquisition by us or one of our subsidiaries may require us to incur non-recurring or other charges, may increase our near and long-term expenditures, and may pose significant integration challenges or disrupt our management or business, which could adversely affect our operations and financial results. For example, an acquisition or strategic transaction such as the acquisition may entail numerous operational and financial risks, including the risks outlined above and additionally:

  • exposure to unknown liabilities;
  • disruption of our business and diversion of our management’s time and attention in order to develop acquired products or technologies higher than expected acquisition and integration costs;
  • write-downs of assets or goodwill or impairment charges;
  • increased amortization expenses;
  • difficulty and cost in combining the operations and personnel of any acquired businesses with our operations and personnel;
  • impairment of relationships with key suppliers or customers of any acquired businesses due to changes in management and ownership; and
  • inability to retain key employees of any acquired businesses.

 12 

 

Accordingly, although there can be no assurance that we will undertake or successfully complete any transactions of the nature described above, and any transactions that we do complete could have a material adverse effect on our business, results of operations, financial condition and prospects.

 Recent U.S. tax legislation may materially affect our financial condition, results of operations and cash flows.

The recently enacted Tax Cuts and Jobs Act (the “Tax Act”) has significantly changed the U.S. federal income taxation of U.S. businesses, including by reducing the U.S. corporate income tax rate, limiting interest deductions, permitting immediate expensing of certain capital expenditures, modifying or repealing many business deductions and credits.

The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) modifies certain provisions of the Tax Act, including increasing the amount of interest expense that may be deducted.

The Tax Act as modified by the CARES Act is unclear in many respects and could be subject to potential amendments and technical corrections, as well as interpretations and implementing regulations by the Treasury and IRS, any of which could lessen or increase certain adverse impacts of the legislation. In addition, it is unclear how these U.S. federal income tax changes will affect state and local taxation, which often uses federal taxable income as a starting point for computing state and local tax liabilities. Our analysis and interpretation of this legislation is preliminary and ongoing and there may be material adverse effects resulting from the legislation that we have not yet identified. While some of the changes made by the tax legislation may adversely affect us, other changes may be beneficial. We continue to work with our tax advisors and auditors to determine the full impact that the recent tax legislation as a whole will have on us. We urge our investors to consult with their legal and tax advisors with respect to such legislation and its potential effect on an investment in our common stock.

Our operating results are affected by many factors and may fluctuate significantly on a quarterly basis.

Our operating results may vary substantially from quarter to quarter and may be greater or less than those achieved in the immediately preceding period or in the comparable period of the prior year. Factors that may cause quarterly results to vary include, but are not limited to, the following:

  • the number of new product introductions by our subsidiaries;
  • losses related to inventory write-offs;
  • marketing exclusivity, if any, which may be obtained on certain new products;
  • the level of competition in the marketplace for certain products;
  • our subsidiaries’ ability to create demand in the marketplace for their products;
  • availability of raw materials and finished products from suppliers;
  • our subsidiaries’ ability to contract manufacturers to make their products;
  • Our dependence on a small number of products for a significant portion of net revenue or income;
  • price erosion and customer consolidation; and
  • uncertainty of future import tariffs.

The profitability of our subsidiaries’ product sales is also dependent upon the prices they are able to charge for their products, the costs to purchase products from third parties, and their ability to manufacture their products in a cost-effective manner. If their revenues decline or do not grow as anticipated, they may not be able to reduce their operating expenses to offset such declines. Failure to achieve anticipated levels of revenues could, therefore, significantly harm our operating results for a particular fiscal period.

We could be subject to significant warranty obligations if our products are defective, which could have a material adverse effect on our business, financial condition, and results of operations.

In manufacturing our products, we depend upon third parties for the supply of various components. Many of these components require a significant degree of technical expertise to design and produce. If we fail to adequately design, or if our suppliers fail to produce components to specification, or if the suppliers, or we, use defective materials or workmanship in the manufacturing process, the reliability and performance of our products will be compromised. Our products could contain defects that cannot be repaired easily and inexpensively that can result some or all of the following:

  • loss of customer orders and delay in order fulfillment;
  • damage to our brand reputation;
  • increased cost of our warranty program due to product repair or replacement;
  • inability to attract new customers;
  • diversion of resources from our manufacturing and engineering and development departments into our service department; and
  • legal action.

 13 

 

We are increasingly dependent on information technology, and our systems and infrastructure face certain risks, including cybersecurity and data leakage risks.

Significant disruptions to our information technology systems or breaches of information security could adversely affect our business. In the ordinary course of business, we collect, store and transmit large amounts of confidential information, and it is critical that we do so in a secure manner to maintain the confidentiality and integrity of such information. We have also outsourced significant elements of our information technology infrastructure; as a result, we manage independent vendor relationships with third parties who are responsible for maintaining significant elements of our information technology systems and infrastructure and who may or could have access to our confidential information. The size and complexity of our information technology systems, and those of our third-party vendors, make such systems potentially vulnerable to service interruptions and security breaches from inadvertent or intentional actions by our employees, partners or vendors. These systems are also vulnerable to attacks by malicious third parties and may be susceptible to intentional or accidental physical damage to the infrastructure maintained by us or by third parties. Maintaining the secrecy of confidential, proprietary, and/or trade secret information is important to our competitive business position. While we have taken steps to protect such information and have invested in systems and infrastructures to do so, there can be no guarantee that our efforts will prevent service interruptions or security breaches in our systems or the unauthorized or inadvertent wrongful use or disclosure of confidential information that could adversely affect our business operations or result in the loss, dissemination, or misuse of critical or sensitive information. A breach our security measures or the accidental loss, inadvertent disclosure, unapproved dissemination, misappropriation or misuse of trade secrets, proprietary information, or other confidential information, whether as a result of theft, hacking, fraud, trickery or other forms of deception, or for any other cause, could enable others to produce competing products, use our proprietary technology or information, and/or adversely affect our business position. Further, any such interruption, security breach, loss or disclosure of confidential information could result in financial, legal, business, and reputational harm to us and could have a material adverse effect on our business, financial position, results of operations and/or cash flow.

Product liability claims against us could be costly and could harm our reputation.

The sale of our products involves the risk of product liability claims against us. Claims could exceed our product liability insurance coverage limits. Our insurance policies are subject to various standard coverage exclusions, including damage to the product itself, losses from recall of our product, and losses covered by other forms of insurance such as workers compensation. We cannot be certain that we will be able to successfully defend any claims against us, nor can we be certain that our insurance will cover all liabilities resulting from such claims. In addition, we cannot provide assurance that we will be able to obtain such insurance in the future on terms acceptable to us, or at all. Regardless of merit or eventual outcome, any product liability claim brought against us could result in harm to our reputation, decreased demand for our products, costs related to litigation, product recalls, loss of revenue, an increase in our product liability insurance rates, or the inability to secure coverage in the future, and could have a material adverse effect on our business by reducing cash collections from customers and limiting our ability to meet our operating cash flow requirements.

Litigation against us could be costly and time-consuming to defend and could materially and adversely affect our business, financial condition, and results of operations.

We are from time to time involved in various claims, litigation matters and regulatory proceedings incidental to our business, including claims for damages arising out of the use of our products or services and claims relating to intellectual property matters, employment matters, commercial disputes, competition, sales and trading practices, environmental matters, personal injury, and insurance coverage. Some of these lawsuits include claims for punitive as well as compensatory damages. The defense of these lawsuits could divert our management’s attention, and we could incur significant expenses in defending these lawsuits. In addition, we could be required to pay damage awards or settlements or become subject to unfavorable equitable remedies. Moreover, any insurance or indemnification rights that we could have may be insufficient or unavailable to protect us against potential loss exposures.

If we lose our key management personnel, or are unable to attract or retain qualified personnel, it could adversely affect our ability to execute our growth strategy.

Our success is dependent, in part, upon our ability to hire and retain management, engineers, marketing and sales personnel, and technical, research and other personnel who are in high demand and are often subject to competing employment opportunities. Our success will depend on our ability to retain our current personnel and to attract and retain qualified like personnel in the future. Competition for senior management, engineers, marketing and sales personnel, and other specialized technicians is intense and we may not be able to retain our personnel. If we lose the services of any executive officers or key employees, our ability to achieve our business objectives could be harmed or delayed, which could have a material adverse effect on our daily operations, operating cash flows, results of operations, and ultimately share price. In general, our officers could terminate their employment at any time without notice for any reason.

 14 

 

Climate change initiatives could materially and adversely affect our business, financial condition, and results of operations.

Both domestic and international legislation to address climate change by reducing greenhouse gas emissions and establishing a price on carbon could create increases in energy costs and price volatility. Considerable international attention is now focused on development of an international policy framework to address climate change. Proposed and existing legislative efforts to control or limit greenhouse gas emissions could increase the cost of raw materials derived from sources that generate greenhouse gas emissions. If our suppliers are unable to obtain energy at a reasonable cost in the future, the cost of our raw materials could be negatively impacted which could result in increased manufacturing costs.

As a “controlled company” under the Nasdaq Marketplace Rules, we may choose to exempt our Company from certain corporate governance requirements that could have an adverse effect on our public stockholders.

Max Munn of Chief Executive Officer holds [*]% of our voting power. Under Rule 4350(c) of the Nasdaq Marketplace Rules, a company of which more than 50% of the voting power is held by an individual, group or another company is a “controlled company” and may elect not to comply with certain corporate governance requirements, including the requirement that a majority of our directors be independent, as defined in Nasdaq rules and the requirement that our compensation and nominating and corporate governance committees consist entirely of independent directors. Although we have not relied nor do we intend to rely on the “controlled company” exemption under Nasdaq rules, we could elect to rely on this exemption in the future. If we elect to rely on the “controlled company” exemption, a majority of the members of our Board might not be independent directors and our nominating and corporate governance and compensation committees might not consist entirely of independent directors. Accordingly, during any time while we remain a controlled company relying on the exemption and during any transition period following a time when we are no longer a controlled company, you would not have the same protections afforded to shareholders of companies that are subject to all of the Nasdaq corporate governance requirements. Our status as a controlled company could cause our common stock to look less attractive to certain investors or otherwise harm our trading price.

Our failure to maintain effective internal controls over financial reporting could have an adverse impact on us.

We are required to establish and maintain appropriate internal controls over financial reporting. Failure to establish those controls, or any failure of those controls once established, could adversely impact our public disclosures regarding our business, financial condition or results of operations. In addition, management’s assessment of internal controls over financial reporting may identify weaknesses and conditions that need to be addressed in our internal controls over financial reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses and conditions that need to be addressed in our internal control over financial reporting, disclosure of management’s assessment of our internal controls over financial reporting or disclosure of our public accounting firm’s attestation to or report on management’s assessment of our internal controls over financial reporting may have an adverse impact on the price of our common stock.

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints and the benefit of controls must be relative to their costs. Because of the inherent limitations in all control systems, no system of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Further, controls can be circumvented by individual acts of some persons, by collusion of two or more persons, or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, a control may become inadequate because of changes in conditions or the degree of compliance with policies or procedures may deteriorate. Because of inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.

At present, we believe that we have effective internal controls in place. However, our management, including our Chief Executive Officer, cannot guarantee that our internal controls and disclosure controls that we have in place will prevent all possible errors, mistakes or all fraud. 

Our financial controls and procedures may not be sufficient to ensure timely and reliable reporting of financial information, which, as a public company, could materially harm our stock price.

We require significant financial resources to maintain our public reporting status. We cannot assure you we will be able to maintain adequate resources to ensure that we will not have any future material weakness in our system of internal controls. The effectiveness of our controls and procedures may in the future be limited by a variety of factors including:

  • faulty human judgment and simple errors, omissions or mistakes;
  • fraudulent action of an individual or collusion of two or more people;
  • inappropriate management override of procedures; and
  • the possibility that any enhancements to controls and procedures may still not be adequate to assure timely and accurate financial information.

 15 

 

Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Despite these controls, because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. Furthermore, smaller reporting companies like us face additional limitations. Smaller reporting companies employ fewer individuals and can find it difficult to employ resources for complicated transactions and effective risk management. Additionally, smaller reporting companies tend to utilize general accounting software packages that lack a rigorous set of software controls.

If we fail to have effective controls and procedures for financial reporting in place, we could be unable to provide timely and accurate financial information and be subject to investigation by the Securities and Exchange Commission and civil or criminal sanctions.

We are an “emerging growth company” under the JOBS Act of 2012 and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.

We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933 (the “Securities Act”) for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We are choosing to take advantage of the extended transition period for complying with new or revised accounting standards.

We will remain an “emerging growth company” until December 31, 2025, the last day of the fiscal year following the fifth anniversary of August 31, 2020, the date of the first sale of our Common Stock pursuant to an effective registration statement under the Securities Act, although we will lose that status sooner if our revenues exceed $1.07 billion, if we issue more than $1 billion in non-convertible debt in a three year period, or if the market value of our Common Stock that is held by non-affiliates exceeds $700 million as of the last day of our most recently completed second fiscal quarter.

 16 

 

Our status as an “emerging growth company” under the JOBS Act may make it more difficult to raise capital as and when we need it.

Because of the exemptions from various reporting requirements provided to us as an “emerging growth company” and because we will have an extended transition period for complying with new or revised financial accounting standards, we may be less attractive to investors and it may be difficult for us to raise additional capital as and when we need it. Investors may be unable to compare our business with other companies in our industry if they believe that our financial accounting is not as transparent as other companies in our industry. If we are unable to raise additional capital as and when we need it, our financial condition and results of operations may be materially and adversely affected.

There may be limitations on the effectiveness of our internal controls, and a failure of our control systems to prevent error or fraud may materially harm our company. If we fail to remediate a material weakness, or if we experience material weaknesses in the future or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect investor confidence in us and, as a result, the value of our common stock and Warrants.

Prior to the completion of our initial public offering in August 2020, we had been a private company with limited accounting personnel to adequately execute our accounting processes and limited supervisory resources with which to address our internal control over financial reporting. As a newly public company, we have designed a control environment as required of public companies under the rules and regulations of the SEC.

Proper systems of internal controls over financial accounting and disclosure controls and procedures are critical to the operation of a public company. We may be unable to effectively establish such systems, especially in light of the fact that we expect to operate as a publicly reporting company. This would leave us without the ability to reliably assimilate and compile financial information about our company and significantly impair our ability to prevent error and detect fraud, all of which would have a negative impact on our company from many perspectives.

Moreover, we do not expect that disclosure controls or internal control over financial reporting, even if established, will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Failure of our control systems to prevent error or fraud could materially adversely impact us.

Geopolitical conditions, including trade disputes and direct or indirect acts of war or terrorism, could have an adverse effect on our operations and financial results.

Recently, Russia initiated significant military action against Ukraine. In response, the U.S. and certain other countries imposed significant sanctions and export controls against Russia, Belarus and certain individuals and entities connected to Russian or Belarusian political, business, and financial organizations, and the U.S. and certain other countries could impose further sanctions, trade restrictions, and other retaliatory actions should the conflict continue or worsen. It is not possible to predict the broader consequences of the conflict, including related geopolitical tensions, and the measures and retaliatory actions taken by the U.S. and other countries in respect thereof as well as any counter measures or retaliatory actions by Russia or Belarus in response, including, for example, potential cyberattacks or the disruption of energy exports, is likely to cause regional instability, geopolitical shifts, and could materially adversely affect regional economies and the global economy. The situation remains uncertain, and while it is difficult to predict the impact of any of the foregoing, the conflict and actions taken in response to the conflict could increase our costs, disrupt our supply chain, reduce our sales and earnings, impair our ability to raise additional capital when needed on acceptable terms, if at all, or otherwise adversely affect our business, financial condition, and results of operations.

If we sustain a cyber-attack or suffer privacy or data security breaches that disrupt our information systems or operations, or result in the dissemination of sensitive personal or confidential information, we could suffer increased costs, exposure to significant liability, reputational harm, loss of business, and other serious negative consequences.

Our information technology systems and safety control systems are subject to a growing number of threats from computer programmers, hackers, and other adversaries that may be able to penetrate our network security and misappropriate our confidential information or that of third parties, create system disruptions, or cause damage, security issues, or shutdowns. They also may be able to develop and deploy viruses, worms, and other malicious software programs that attack our systems or otherwise exploit security vulnerabilities. Because the techniques used to circumvent, gain access to, or sabotage security systems, can be highly sophisticated and change frequently, they often are not recognized until launched against a target, and may originate from less regulated and remote areas around the world. We may be unable to anticipate these techniques or implement adequate preventive measures, resulting in potential data loss and damage to our systems. Our systems are also subject to compromise from internal threats such as improper action by employees, including malicious insiders, or by vendors, counterparties, and other third parties with otherwise legitimate access to our systems. Our policies, employee training (including phishing prevention training), procedures, and technical safeguards may not prevent all improper access to our network or proprietary or confidential information by employees, vendors, counterparties, or other third parties. Our facilities may also be vulnerable to security incidents or security attacks, acts of vandalism or theft, misplaced or lost data, human errors, or other similar events that could negatively affect our systems, and our and our members’, data. Additionally, our third-party service providers who process information on our behalf may cause security breaches for which we are responsible.

 17 

 

Moreover, we face the ongoing challenge of managing access controls in a complex environment. The process of enhancing our protective measures can itself create a risk of systems disruptions and security issues. Given the breadth of our operations and the increasing sophistication of cyber-attacks, a particular incident could occur and persist for an extended period of time before being detected. The extent of a particular cyber-attack and the steps that we may need to take to investigate the attack may take a significant amount of time before such an investigation could be completed and full and reliable information about the incident is known. During such time, the extent of any harm or how best to remediate it might not be known, which could further increase the risks, costs, and consequences of a data security incident. In addition, our systems must be routinely updated, patched, and upgraded to protect against known vulnerabilities. The volume of new software vulnerabilities has increased substantially, as has the importance of patches and other remedial measures. In addition to remediating newly identified vulnerabilities, previously identified vulnerabilities must also be updated. We are at risk that cyber-attackers exploit these known vulnerabilities before they have been addressed. The complexity of our systems and platforms, the increased frequency at which vendors are issuing security patches to their products, our need to test patches, and, in some instances, coordinate with third-parties before they can be deployed, all could further increase our risks.

Any compromise or perceived compromise of the security of our systems or the systems of one or more of our vendors or service providers could damage our reputation and brand, cause the termination of relationships with our members, result in disruption or interruption to our business operations, marketing partners and carriers, reduce demand for our services, and subject us to significant liability and expense, which would harm our business, operating results, and financial condition.

Risks Related to SteriLumen’s Business

Certain ResInnova testing limitations.

Our claims on the effectiveness of the Disinfecting System against certain pathogens are supported by the analysis of the Disinfecting System performed in ResInnova’s laboratory. The environment in ResInnova’s laboratory is controlled and does not account for all real-world variables, which may impact the effectiveness of ultraviolet light in killing microorganisms. Such variables include humidity, air temperature, and the presence of organic soils that differ from those used in the laboratory tests. If any one of these un-accounted for variables proves to be significant in the evaluation of the effectiveness of the Disinfecting System, the laboratory results obtained by ResInnova could be significantly more favorable than the results experienced by our customers. Furthermore, in accordance with CDC guidelines only laboratories with a biosafety level 3 or 4 may test against SARS-CoV-2, the virus that causes COVID-19. ResInnova is a biosafety level 2 laboratory and cannot test against SARS-CoV-2 and therefore in its place tested against OC43, which, according to ResInnova is a common surrogate for SARS-CoV-2 as both are of the Beta genre of coronaviruses. If the results from testing the Disinfecting System against OC43 are different from the results that would have occurred from testing against SARS-CoV-2, ResInnova’s testing results could be materially more favorable than the results experienced by our customers with respect to SARS-CoV-2. If the Disinfecting System is not effective against SARS-CoV-2, this could have a material adverse effect on the Company’s, which would have a material adverse effect on our business prospects and financial condition.

The complete and final assembly of the Disinfecting System has not yet received safety certification from a nationally recognized testing laboratory.

All of the component parts of the Disinfecting System have been certified by ETL. The ETL listings for ETL Listing numbers: SLR-1 = E519669 for the ribbon unit and SLD-1 = E519957 for the drain unit is new for such a UVC device for the UL and due to incomplete standards does not guarantee successful deployment and installation at scale in the US. If we are unable or significantly delayed in obtaining confidence for installations within the marketplace with above certifications, our business and financial prospects will be materially adversely affected.

In accordance with an August 24, 1993 Interpretation Letter from OSHA, all electrical equipment must be accepted, certified, labeled, listed, or otherwise determined that such equipment is safe by a NRTL or by another Federal agency or by a State, municipal, or other local authority responsible for enforcing occupational safety provisions of the National Electric Safety Code.

 18 

 

If SteriLumen is unable to develop a successful marketing approach, our business will suffer.

If SteriLumen fails to develop a successful marketing approach or to manage its growth effectively, our business and financial results will be materially harmed. Healthcare facilities operate in a highly regulated and dynamic market with changing regulations, codes, standards and guidelines and as a result are very loyal to vendors they trust. Achieving market acceptance will require extensive customer education and product validation. Some of the ways in which SteriLumen intends on achieving market acceptance is through working with professional trade organizations, having articles published in industry trade publications, conducting validation/marketing studies at well-known hospitals and lab testing. However, there is no assurance that SteriLumen will be successful in organizing these efforts or if the results from them will be positive. SteriLumen has sought and may also seek in the future to expand its business through complementary or strategic acquisitions of other businesses, products or assets such as its recent acquisition of the Airocide product line, or through joint ventures, strategic partnerships or other arrangements with established and trusted disinfection companies. Any such acquisitions, joint ventures or other business combinations may involve significant integration challenges, operational complexities and time consumption and require substantial resources and effort. It may also disrupt SteriLumen’s ongoing businesses, which may adversely affect its relationships with customers, employees and others with whom it has business or other dealings. Further, if SteriLumen is unable to realize synergies or other benefits expected to result from any acquisitions, joint ventures or other business combinations, or to generate additional revenue to offset any unanticipated inability to realize these expected synergies or benefits, its growth and ability to compete may be impaired, which would require it and us to focus additional resources on the integration of operations rather than other profitable areas of its business, and may otherwise cause a material adverse effect on our business, results of operations and financial condition. However, failure to acquire or partner with established and trusted disinfection companies would prevent SteriLumen’s products from being part of a bundle of disinfection products that could be sold all at once, which could have a material adverse effect on the financial results of our business.

The air purification market is fragmented and competitive and we may not be able to compete successfully with our existing competitors or new entrants into the markets we serve.

The air purification market is fragmented and competitive. SteriLumen’s competition varies by product line, customer classification and geographic market. The principal competitive factors in our industry are quality of product, pricing, service and delivery capabilities and availability of product. We will compete with many local, regional and national air purification distributors and dealers. In addition, some air purification suppliers might sell and distribute their products directly to our customers, and the volume of such direct sales could increase in the future. Additionally, distributors of products similar to those distributed by us may elect to sell and distribute to our customers in the future or enter into exclusive supplier arrangements with other distributors. Some of our competitors have greater financial resources and may be able to withstand sales or price decreases more effectively than we can. We also expect to continue to face competition from new market entrants. We may be unable to continue to compete effectively with these existing or new competitors, which could have a material adverse effect on our financial condition and results of operations.

If we are unable to execute our plan to distribute SteriLumen’s Airocide products, we may not be able to generate revenues and your investment could be materially adversely affected.

We acquired the rights to manufacture and sell our Airocide products in February of 2021 and have not yet fully scaled to execute our plan to sell and distribute SteriLumen’s Airocide products. The success of the Airocide business will depend on the execution of our plan and the acceptance of Airocide products by the consumer and commercial markets. Achieving such acceptance will require significant marketing investment. Once we execute our plan to sell and distribute the Airocide products, it may not be accepted by consumers at sufficient levels to support our operations and build our business. If SteriLumen’s Airocide products are not accepted at sufficient levels, our business could fail.

We are subject to significant regulatory oversight and changes in applicable regulatory requirements could adversely affect our business.

We may become subject to significant government regulation, by the EPA and, to a certain extent, by Congress, other federal agencies and foreign, state and local authorities. Depending upon the circumstances, noncompliance with legislation or regulations promulgated by these entities could result in the suspension or revocation of our licenses or registrations, the termination or loss of contracts or the imposition of contractual damages, civil fines or criminal penalties any of which could have a material adverse effect on our business, financial condition and results of operations. Furthermore, the adoption or modification of laws or regulations relating to UVC or air purification or other areas of our business could limit or otherwise adversely affect the manner in which we currently conduct our business. If we are required to comply with new regulations or legislation or new interpretations of existing regulations. This compliance could cause us to incur additional expenses or alter our business model.

 19 

 

SteriLumen’s Disinfecting System business is highly dependent on its suppliers’ and any disruption in their operations could have a material adverse effect on our business, results of operations and financial condition.

SteriLumen’s Disinfecting System business will be dependent upon the continued ability of its suppliers to deliver systems, components, raw materials, and finished disinfection products. Its UVC LEDs are manufactured in South Korea and then shipped to China or the United States for assembly with all other components, which if manufactured in China, the finished products are shipped to Long Beach, California for warehousing and distribution, otherwise the units are shipped from Mount Vernon. Any number of factors, including labor disruptions, catastrophic weather events, contractual or other disputes with suppliers, and supplier financial difficulties or solvency problems could disrupt its suppliers’ operations and lead to uncertainty in its supply chain or cause supply disruptions, which could, in turn, disrupt its operations. If SteriLumen experiences supply disruptions, it may not be able to develop alternate sourcing quickly. Any disruption of its production schedule caused by an unexpected shortage of systems, components, raw materials or parts even for a relatively short period of time could cause it to alter production schedules or suspend production entirely. If any such disruptions occur it could have a material adverse effect on our business, results of operations and financial condition.

SteriLumen’s business is highly dependent on market perceptions of it and the safety and quality of its products.

Market perceptions of SteriLumen’s business are very important to us, especially market perceptions of the safety and quality of SteriLumen’s products. If any of its products or similar products that other companies distribute are subject to market withdrawal or recall or are proven to be, or are claimed to be, harmful to end users, then this could have a material adverse effect on our business, results of operations and financial condition. Also, because SteriLumen’s business is dependent on market perceptions, negative publicity associated or perceived to be associated with its business, products or product pricing could have a material adverse impact on our business, results of operations and financial condition.

Customers may be hesitant in adopting UV light-based technologies, and our inability to overcome this hesitation could limit the market acceptance of our products and our market share.

Our UV light disinfection systems represent relatively new technologies in the market. Only a small percentage of professional medical institutions or hospitality providers are immediately willing to conduct sanitation using our systems. Our future success will depend on our ability to increase demand for our products by demonstrating to a broad spectrum of medical professional, dentists, hospitality industry, their patients and customers, the potential performance advantages of our UV light systems over traditional methods of disinfection over competitive UV light systems, and our inability to do so could have a material adverse effect on our business, financial condition, and results of operations.

Conventional germicidal UV light was historically considered as a human health hazard if improperly used and can lead to skin cancer and cataracts. We may experience long sales cycles because healthcare facilities and hotels and other facilities may be slow to adopt new technologies on a widespread basis and admit that such technologies can sanitize public space without damaging public health. As a result, we generally are required to invest a significant amount of time and resources to educate general public about the benefits of our products in comparison to competing products and technologies before completing a sale, if any. Factors that could inhibit adoption of UV technologies by healthcare facilities or hospitality companies include the initial cost and concerns about the safety, efficacy, and reliability of our UV systems. In addition, economic pressure, caused, for example, by an economic slowdown as a result of Coronavirus, changes in health care reimbursement or by competitive factors in a specific market, could make businesses reluctant to purchase substantial capital equipment or invest in new technologies. Customer acceptance will depend on the recommendations of governmental authorities, as well as other factors, including the relative effectiveness, safety, reliability, and comfort of our systems as compared to other instruments and methods for performing disinfecting procedures.

If future data proves to be inconsistent with our research results or if competitors’ products present more favorable results our revenues could decline and our business, financial condition, and results of operations could be materially and adversely affected.

Even though our disinfecting devices are protected with patents, if new studies or comparative studies generate results that are not as favorable as our research results, our revenues could decline. Additionally, if future studies indicate that our competitors’ products are more effective or safer than ours, our revenues could decline. Furthermore, hospitals and businesses could choose not to purchase our UV light sanitation systems until they receive additional published long-term clinical evidence and recommendations from prominent hospitals and businesses that indicate our UV light sanitation systems are effective for disinfecting applications.

 20 

 

We may face competition from other companies, many of which have substantially greater resources than we do. If we do not successfully develop and commercialize enhanced or new products that remain competitive with products or alternative technologies developed by others, we could lose revenue opportunities and customers and our ability to grow our business would be impaired.

A number of competitors have substantially greater capital resources, larger customer bases, larger technical, sales and marketing forces and stronger reputations with target customers than ours. We compete with a number of domestic and foreign companies that market traditional chemical sanitation products, as well as companies that market UV technologies. The marketplace is highly fragmented and very competitive. We expect that the rapid technological changes occurring in the health care industry could lead to the entry of new competitors, particularly if UV disinfecting increases market acceptance. If we do not compete successfully, our revenue and market share could decline, which would impact our ability to meet our operating cash flow requirements and our business, financial condition, and results of operations could be adversely affected.

Our long-term success depends upon our ability to (i) distinguish our products through improving our product performance and pricing, protecting our intellectual property, improving our customer support, accurately timing the introduction of new products, and developing sustainable distribution channels worldwide; and (ii) develop and successfully commercialize new products, new or improved technologies, and additional applications for our UV light sanitation systems. We may not be able to distinguish our products and commercialize any new products, new or improved technologies, or additional applications for our UV light disinfecting systems.

We could incur problems in manufacturing our products.

In order to grow our business, we must expand our manufacturing capabilities to produce the systems and accessories necessary to meet any demand we may experience. We could encounter difficulties in increasing the production of our products, including problems involving production capacity and yields, quality control and assurance, component supply, and shortages of qualified personnel. In addition, before we can begin commercial manufacture of our products, we must ensure our manufacturing facilities, processes, and quality systems, and the manufacture of our UV light sanitation systems, quality control, and documentation policies and procedures. From time to time, we could expend significant resources in obtaining, maintaining, and addressing our compliance with various federal and requirements that may be subject to changes. Our success will depend in part upon our ability to manufacture our products without FDA approval or compliance with and other regulatory requirements.

We have not experienced significant quality issues with components of our products supplied by third parties, however, we could in the future. Our future success depends on our ability to manufacture our products on a timely basis with acceptable manufacturing costs, while at the same time maintaining good quality control and complying with applicable regulatory requirements, and an inability to do so could have a material adverse effect on our product sales, cash collections from customers, and our ability to meet operating cash flow requirements, which could have a material adverse effect on our business, financial condition, and results of operations.

Adverse publicity regarding our technology or products could negatively impact us.

Adverse publicity regarding any of our products or similar products marketed or sold by others could negatively affect us. If any studies raise or substantiate concerns regarding the efficacy or safety of our products or other concerns, our reputation could be harmed and demand for our products could diminish, which could have a material adverse effect on growth in new customers and sales of our products, leading to a decline in revenues, cash collections, and ultimately our ability to meet operating cash flow requirements.

Rapidly changing standards and competing technologies could harm demand for our products, result in significant additional costs, and have a material adverse effect on our business, financial condition, and results of operations.

The markets in which our products compete are subject to rapid technological change, evolving industry standards, changes in the regulatory environment, and frequent introductions of new devices and evolving sanitizing solutions and practices, specifically catalyzed by the impact of the Coronavirus pandemic. Competing products could emerge that render our products uncompetitive or obsolete. We cannot guarantee that we will successfully identify new product opportunities, identify new and innovative applications of our technology, or be financially or otherwise capable of completing the research and development required to bring new products to market in a timely manner. An inability to expand our product offerings or the application of our technology could limit our growth. In addition, we could incur higher manufacturing costs if manufacturing processes or standards change, and we could need to replace, modify, design, or build and install equipment, all of which would require additional capital expenditures.

 21 

 

We could be unable to effectively manage and implement our growth strategies, which could have a material adverse effect on our business, financial condition, and results of operations.

 Our growth strategy includes expanding our product line and applications by developing enhancements and transformational innovations, including new solutions for various fields and industries. Expansion of our existing product line and entry into new applications divert the use of our resources and systems, require additional resources that might not be available (or available on acceptable terms), may require regulatory approvals, result in new or increasing competition, could require longer implementation times or greater start-up expenditures than anticipated, and could otherwise fail to achieve the desired results in a timely fashion, if at all. These efforts could also require that we successfully commercialize new technologies in a timely manner, price them competitively and cost-effectively, and manufacture and deliver sufficient volumes of new products of appropriate quality on time. We could be unable to increase our sales and earnings by expanding our product offerings in a cost-effective manner, and we could fail to accurately predict future customer needs and preferences or to produce viable technologies. In addition, we could invest heavily in research and development of products that do not lead to significant revenue. Even if we successfully innovate and develop new products and product enhancements, we could incur substantial costs in doing so. In addition, promising new products could fail to reach the market or realize only limited commercial success because of efficacy or safety concerns, failure to achieve positive clinical outcomes, or uncertainty over third-party reimbursement.

International sales may comprise a significant portion of SteriLumen’s revenues and will be subject to risks associated with operating in domestic and international markets.

International sales may comprise a significant portion of SteriLumen’s revenue, and we intend to continue to pursue and expand our international business activities. Political and economic conditions outside the United States could make it difficult for us to increase our international revenue or to operate abroad. International operations are subject to many inherent risks, which could have a material adverse effect on our revenues and operating cash flow, including among others:

  • adverse changes in tariffs and trade restrictions;
  • political, social, and economic instability and increased security concerns;
  • fluctuations in foreign currency exchange rates;
  • longer collection periods and difficulties in collecting receivables from foreign entities;
  • exposure to different legal standards;
  • transportation delays and difficulties of managing international distribution channels;
  • reduced protection for our intellectual property in some countries;
  • difficulties in obtaining domestic and foreign export, import, and other governmental approvals, permits, and licenses, and compliance with foreign laws;
  • the imposition of governmental controls;
  • unexpected changes in regulatory or certification requirements;
  • difficulties in staffing and managing foreign operations; and
  • potentially adverse tax consequences and the complexities of foreign value-added tax systems.

We believe that international sales may represent a significant portion of SteriLumen’s revenue, and we intend to expand its international operations. In international markets where our sales are denominated in U.S. dollars, an increase in the relative value of the dollar against the currency in such markets could indirectly increase the price of our products in those markets and result in a decrease in sales. We do not currently engage in any transactions as a hedge against risks of loss due to foreign currency fluctuations. However, we could do so in the future.

SteriLumen’s collaborations with outside scientists and consultants may be subject to restriction and change.

SteriLumen works with scientists at academic and other institutions, and consultants who assist it in its research, development, and design efforts. These scientists and consultants have provided, and we expect that they will continue to provide, valuable advice on SteriLumen’s programs. These scientists and consultants are not our or SteriLumen’s employees, may have other commitments that would limit their future availability to SteriLumen and typically will not enter into non-compete agreements with SteriLumen. If a conflict of interest arises between their work for SteriLumen and their work for another entity, SteriLumen may lose their services. In addition, SteriLumen will be unable to prevent them from establishing competing businesses or developing competing products. For example, if a key scientist acting as a principal investigator in any of SteriLumen’s clinical trials identifies a potential product or compound that is more scientifically interesting to his or her professional interests, his or her availability to remain involved in its clinical trials could be restricted or eliminated.

SteriLumen has entered into or intends to enter into non-competition agreements with certain of SteriLumen’s employees. These agreements prohibit its employees, if they cease working for it, from competing directly against it or working for its competitors for a limited period. However, under current law, SteriLumen may be unable to enforce these agreements against certain of its employees and it may be difficult for it to restrict their competitors from gaining the expertise its former employees gained while working for it. If SteriLumen cannot enforce its employees’ non-compete agreements, it may be unable to prevent its competitors from benefiting from the expertise of its former employees.

 22 

 

Risks Related to MunnWorks’ Business

The custom design decorative framed mirror supply market is highly competitive, and we may not be able to compete successfully.

MunnWorks operates within the highly competitive custom design decorative framed mirror supply market, which is characterized by competition from a number of other manufacturers. Competition is further intensified during economic downturns. MunnWorks competes with numerous large national and regional companies for, among other things, customers, raw materials and skilled management and labor resources. Purchase volumes have fluctuated substantially from time to time in the past, and we expect such fluctuations to occur from time to time in the future. Some of its competitors have greater financial, marketing and other resources than it does and, therefore, may be able to adapt to changes in customer preferences more quickly, devote more resources to the marketing and sale of their products, generate greater national brand recognition or adopt more aggressive pricing policies than MunnWorks can.

In addition, some of our competitors may resort to price competition to sustain or gain market share and manufacturing capacity utilization, and MunnWorks may have to adjust the prices on some of its products to stay competitive, which could reduce its revenues. MunnWorks may not ultimately succeed in competing with other manufacturers and distributors in its market, which may have a material adverse effect on our business, financial condition or results of operations.

MunnWorks’ possible failure to develop new products or respond to changing consumer preferences and purchasing practices could have a material adverse effect on our business, financial condition or results of operations.

The custom design decorative framed mirror supply market is subject to changing consumer trends, demands and preferences. The uncertainties associated with developing and introducing new products, such as gauging changing consumer preferences and successfully developing, manufacturing, marketing and selling new products, could lead to, among other things, rejection of a new product line, reduced demand and price reductions for our products. If MunnWorks’ products do not keep up with consumer trends, demands and preference, it could lose market share, which could have a material adverse effect on our business, financial condition or results of operations.

Changes to the buying strategies of MunnWorks’ customers could also affect its ability to compete. Further, the volatile and challenging economic environment of recent years has caused shifts in trends, demands, preferences and purchasing practices and changes in the business models and strategies of its customers. Shifts in consumer preferences, which may or may not be long-term, have altered the quantity, type and prices of products demanded by the end-consumer and MunnWorks’ customers. If it does not timely and effectively identify and respond to these changing consumer preferences and purchasing practices, its relationships with our customers could be harmed, the demand for its products could be reduced and its market share could be negatively affected.

MunnWorks’ independent sales force may not be effective.

MunnWorks hires independent sales representatives who have primary responsibility for contacting existing and potential customers and are paid on a commission basis. While this sales model has proven successful in the past, to continue to be effective, sales representatives will need to continue to be extremely knowledgeable about MunnWorks’ products. However, these independent sales representatives may be selling products from different non-competitive sellers, which could prevent them from focusing on MunnWorks’ products and providing the required information to the customers, which could have a material adverse effect on our business, results of operations and financial condition.

MunnWorks’ business is highly dependent on its suppliers’ and any disruption in their operations could have a material adverse effect on our business, results of operations and financial condition.

MunnWorks’ operations will be dependent upon the continued ability of its suppliers to deliver components, raw materials, and finished products. Although many of its products are manufactured at our corporate headquarters in New York, many of its products are manufactured overseas. Any number of factors, including labor disruptions, catastrophic weather events, contractual or other disputes with suppliers, and supplier financial difficulties or solvency problems could disrupt its suppliers’ operations and lead to uncertainty in its supply chain or cause supply disruptions, which could, in turn, disrupt its operations. If MunnWorks experiences supply disruptions, it may not be able to develop alternate sourcing quickly. Any disruption of its production schedule caused by an unexpected shortage of systems, components, raw materials or parts even for a relatively short period of time could cause it to alter production schedules or suspend production entirely. If any such disruptions occur it could have a material adverse effect on our business, results of operations and financial condition.

 23 

 

MunnWorks’ business is highly dependent on market perceptions of it and the quality of its products.

Market perceptions of MunnWorks’ business are very important to us, especially market perceptions of the quality of MunnWorks’ products. Because MunnWorks’ business is dependent on market perceptions, negative publicity associated or perceived to be associated with its business, products or product pricing could have a material adverse impact on our business, results of operations and financial condition.

Risks Related to Our Intellectual Property

If the patents that we own or license, or our other intellectual property rights, do not adequately protect our technologies, we could lose market share to our competitors and be unable to operate our business profitably.

Our future success depends, in part, on our ability to obtain and maintain patent protection for our products and technology, to preserve our trade secrets and to operate without infringing the intellectual property of others. We rely on patents to establish and maintain proprietary rights in our technology and products. We currently possess a number of issued patents and patent applications with respect to our products and technology. However, we cannot ensure that any additional patents will be issued, that the scope of any patent protection will be effective in helping us address our competition, or that any of our patents will be held valid if subsequently challenged. It is also possible that our competitors could independently develop similar or more desirable products, duplicate our products, or design products that circumvent our patents. The laws of foreign countries may not protect our products or intellectual property rights to the same extent as the laws of the United States. In addition, there have been recent changes in the patent laws and rules of the U.S. Patent and Trademark Office (“USPTO”), and there could be future proposed changes that, if enacted, have a significant impact on our ability to protect our technology and enforce our intellectual property rights. If we fail to protect our intellectual property rights adequately, our competitive position could be adversely affected, and there could be a material adverse effect on sales, cash collections, and our ability to meet operating cash flow requirements.

If third parties claim that we infringe their intellectual property rights, we could incur liabilities and costs and have to redesign or discontinue selling certain products, which could have a material adverse effect on our business, financial condition, and results of operations.

We face substantial uncertainty regarding the impact that other parties’ intellectual property positions will have on UV light applications. From time to time, we expect to continue to receive, notices of claims of infringement, misappropriation, or misuse of other parties’ proprietary rights. Some of these claims could lead to litigation. We may not prevail in any future intellectual property infringement litigation given the complex technical issues and inherent uncertainties in litigation. Any claims, with or without merit, could be time-consuming and distracting to management, result in costly litigation, or cause product shipment delays. Adverse determinations in litigation could subject us to significant liability and could result in the loss of proprietary rights. A successful lawsuit against us could also force us to cease selling or redesign products that incorporate the infringed intellectual property. Additionally, we could be required to seek a license from the holder of the intellectual property to use the infringed technology, and we may not be able to obtain a license on acceptable terms, or at all.

Patent terms are limited and we may not be able to effectively protect our products and business.

Patents have a limited lifespan. In the U.S., the natural expiration of a patent is generally 20 years after it is filed. Although various extensions may be available, the life of a patent, and the protection it affords, is limited. In addition, upon issuance in the U.S., the patent term may be extended based on certain delays caused by the applicant(s) or the USPTO. Even if we obtain effective patent rights for all our current patent applications, we may not have sufficient patent terms or regulatory exclusivity to protect our products, and our business and results of operations would be adversely affected.

We may be subject to claims challenging the inventorship of our patents and other intellectual property.

We may be subject to claims that former employees, collaborators or other third parties have an interest in or right to compensation with respect to our patents or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations of consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or claiming the right to compensation. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. To the extent that our employees have not effectively waived the right to compensation with respect to inventions that they helped create, they may be able to assert claims for compensation with respect to our future revenue may be successful. As a result, we may receive less revenue from future products if such claims are successful which in turn could impact our future profitability.

 24 

 

Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our products.

As is the case with other equipment manufacturing companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biotechnology industry involves both technological and legal complexity. Therefore, obtaining and enforcing patents is costly, time-consuming, and inherently uncertain. In addition, the U.S. has recently enacted and is currently implementing wide-ranging patent reform legislation. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future.

We may not be able to protect our intellectual property rights throughout the world.

Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the U.S. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and may also export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the U.S. These products may compete with our products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.

Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.

Risks Relating to Ownership of Our Securities

The public price of our Common Stock may be volatile, and could, following a sale decline significantly and rapidly.

The offering price for the shares will be determined by negotiations between us and the underwriters and may not be indicative of prices that will prevail in the open market following this offering. The market price of our common stock may decline below the initial offering price, and you may not be able to sell your shares of our common stock at or above the price you paid in the offering, or at all. Following this Offering, the public price of our common stock in the secondary market will be determined by private buy and sell transaction orders collected from broker-dealers.

We may not be able to maintain a listing of our Common Stock.

In order for our common stock to continue to be listed on Nasdaq, we must meet certain financial and liquidity criteria to maintain such listing. If we violate the maintenance requirements for continued listing of our common stock, our common stock may be delisted. In addition, our board may determine that the cost of maintaining our listing on a national securities exchange outweighs the benefits of such listing. A delisting of our common stock from Nasdaq may materially impair our stockholders’ ability to buy and sell our common stock and could have an adverse effect on the market price of, and the efficiency of the trading market for, our common stock. In addition, the delisting of our common stock could significantly impair our ability to raise capital.

Our directors and officers beneficially own more than 50% of the voting power of our voting stock as of December 31, 2022, and will be able to exert a controlling influence over our business affairs and matters submitted to stockholders for approval.

Our directors and officers have voting control over more than 50% of our voting stock (which excludes 265,253 shares underlying options and warrants issued to the directors and officers, but does include 10,000 shares of the Company’s Super Voting Preferred Stock beneficially owned by Max Munn, our Chief Executive Officer, President and director , which is entitled to 1,000 votes per share (10,000,000 votes in aggregate) and votes with the common stock as a single class. As a result, our directors and officers will have control over all matters submitted to our stockholders for approval, including the election of directors, amendments to our certificate of incorporation and bylaws, the approval of any business combination and any other significant corporate transaction. These actions may be taken even if they are opposed by other stockholders. This concentration of ownership may also have the effect of delaying or preventing a change of control of our company or discouraging others from making tender offers for our shares, which could prevent our stockholders from receiving a premium for their shares.

 25 

 

Our directors and officers may have interests different from yours.

We have not paid dividends on our Common Stock in the past and do not expect to pay dividends on our Common Stock in the future, and any return on investment may be limited to the value of our stock.

We have never paid cash dividends on our Common Stock and do not anticipate paying cash dividends on our Common Stock in the foreseeable future. We currently intend to retain any future earnings to support the development of our business and do not anticipate paying cash dividends in the foreseeable future. Our payment of any future dividends will be at the discretion of our board of directors after taking into account various factors, including, but not limited to, our financial condition, operating results, cash needs, growth plans and the terms of any credit agreements that we may be a party to at the time. In addition, our ability to pay dividends on our Common Stock is limited by the terms of our Series A Perpetual Preferred Stock and may be limited by Delaware state law. Accordingly, investors must rely on sales of their Common Stock after price appreciation, which may never occur, as the only way to realize a return on their investment.

The elimination of personal liability against our directors and officers under Delaware law and the existence of indemnification rights held by our directors, officers and employees may result in substantial expenses.

Our Amended and Restated Certificate of Incorporation and our Bylaws eliminate the personal liability of our directors and officers to us and our stockholders for damages for breach of fiduciary duty as a director or officer to the extent permissible under Delaware law. Further, our amended and restated certificate of incorporation and our Bylaws and individual indemnification agreements we have entered with each of our directors and executive officers provide that we are obligated to indemnify each of our directors or officers to the fullest extent authorized by the Delaware law and, subject to certain conditions, advance the expenses incurred by any director or officer in defending any action, suit or proceeding prior to its final disposition. Those indemnification obligations could expose us to substantial expenditures to cover the cost of settlement or damage awards against our directors or officers, which we may be unable to afford. Further, those provisions and resulting costs may discourage us or our stockholders from bringing a lawsuit against any of our current or former directors or officers for breaches of their fiduciary duties, even if such actions might otherwise benefit our stockholders, indemnification rights held by our directors, officers and employees may result in substantial expenses.

Our certificate of incorporation will designate the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us.

Our amended and restated certificate of incorporation specifies that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for: (a) any derivative action or proceeding brought on behalf of the Company, (b) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, employee or agent of the Company to the Company or the Company’s stockholders, (c) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, the Company’s Certificate of Incorporation or the Bylaws, or (d) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of and to have consented to the provisions of our amended and restated certificate of incorporation described above.

We believe these provisions benefit us by providing increased consistency in the application of Delaware law by chancellors particularly experienced in resolving corporate disputes, efficient administration of cases on a more expedited schedule relative to other forums and protection against the burdens of multi-forum litigation. However, the provision may have the effect of discouraging lawsuits against our directors, officers, employees and agents as it may limit any stockholder’s ability to bring a claim in a judicial forum that such stockholder finds favorable for disputes with us or our directors, officers, employees or agents. The enforceability of similar choice of forum provisions in other companies’ certificates of incorporation has been challenged in legal proceedings, and it is possible that, in connection with any applicable action brought against us, a court could find the choice of forum provisions contained in our restated certificate of incorporation to be inapplicable or unenforceable in such action. If a court were to find the choice of forum provision contained in our restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business, financial condition or results of operations.

 26 

 

Our revenues, operating results and cash flows may fluctuate in future periods and we may fail to meet investor expectations, which may cause the price of our Common Stock to decline.

Variations in our quarterly and year-end operating results are difficult to predict and our income and cash flows may fluctuate significantly from period to period, which may impact our board of directors’ willingness or legal ability to declare a monthly dividend. If our operating results fall below the expectations of investors or securities analysts, the price of our Common Stock could decline substantially. Specific factors that may cause fluctuations in our operating results include:

  • demand and pricing for our products and services;
  • introduction of competing products;
  • our operating expenses which fluctuate due to growth of our business; and
  • variable sales cycle and implementation periods for content and services.

The market price of our securities could be substantially affected by various factors.

The market price of our Common Stock could be subject to wide fluctuations in response to numerous factors. The price of the our Common Stock that will prevail in the market after this offering may be higher or lower than the offering price depending on many factors, some of which are beyond our control and may not be directly related to our operating performance.

These factors include, but are not limited to, the following:

  • trading prices of securities generally;
  • general economic and financial market conditions;
  • government action or regulation;
  • the financial condition, performance and prospects of us and our competitors;
  • changes in financial estimates or recommendations by securities analysts with respect to us or our competitors in our industry;
  • our issuance of preferred equity or debt securities; and
  • actual or anticipated variations in quarterly operating results of us and our competitors.

As a result of these and other factors, investors who purchase the Common Stock in this offering may experience a decrease, which could be substantial and rapid, in the market price of the Common Stock, including decreases unrelated to our operating performance or prospects.

You should consult your own independent tax advisor regarding any tax matters arising with respect to the securities offered in connection with this offering.

Participation in this offering could result in various tax-related consequences for investors. All prospective purchasers of the resold securities are advised to consult their own independent tax advisors regarding the U.S. federal, state, local and non-U.S. tax consequences relevant to the purchase, ownership and disposition of the resold securities in their particular situations.

We have not paid dividends on our common stock in the past and do not expect to pay dividends on our common stock in the future, and any return on investment may be limited to the value of our stock.

We have never paid cash dividends on our common stock and do not anticipate paying cash dividends on our common stock in the foreseeable future. We currently intend to use any future earnings to pay dividends on our Series A Preferred Stock and to support the development of our business and do not anticipate paying cash dividends on our common stock in the foreseeable future. Our payment of any future dividends will be at the discretion of our board of directors after taking into account various factors, including, but not limited to, our financial condition, operating results, cash needs, growth plans and the terms of any credit agreements that we may be a party to at the time. In addition, our ability to pay dividends on our common stock may be limited by Delaware state law. Accordingly, investors must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize a return on their investment. Investors seeking cash dividends should not purchase our common stock.

We will have broad discretion in using the proceeds of this offering and we may not effectively spend the proceeds.

We will use the net proceeds of this offering for general corporate purposes, including investments and acquisitions. We have not allocated any specific portion of the net proceeds to any particular purpose, and our management will have the discretion to allocate the proceeds as it determines. We will have significant flexibility and broad discretion in applying the net proceeds of this offering, and we may not apply these proceeds effectively. Our management might not be able to yield a significant return, if any, on any investment of these net proceeds, and you will not have the opportunity to influence our decisions on how to use our net proceeds from this offering.

 27 

 

Provisions of our Amended and Restated Certificate of Incorporation could delay or prevent the acquisition or sale of our business.

Our Amended and Restated Certificate of Incorporation permits our Board of Directors to designate new series of preferred stock and issue those shares without any vote or action by our stockholders. Such newly authorized and issued shares of preferred stock could contain terms that grant special voting rights to the holders of such shares that make it more difficult to obtain stockholder approval for an acquisition of our business or increase the cost of any such acquisition.

We expect that we will need to raise additional capital, and raising additional funds by issuing additional equity securities or with additional debt financing may cause dilution to shareholders or restrict our operations.

We expect that we will need to raise additional capital in the future. We may raise additional funds through public or private equity or debt offerings or other financings, as well as borrowings from banks or through the issuance of debt securities.

Any new debt financing we enter into may involve covenants that restrict our operations more than our current outstanding debt. These restrictive covenants could include limitations on additional borrowings and specific restrictions on the use of our assets, as well as prohibitions or limitations on our ability to create liens, pay dividends, receive distributions from our subsidiaries, redeem or repurchase our stock or make investments. These factors could hinder our access to capital markets and limit or delay our ability to carry out our capital expenditure plan or pursue other opportunities beyond the current capital expenditure plan. Further, we may incur substantial costs in pursuing any capital-raising transactions, including investment banking, legal and accounting fees. On the other hand, if we are unable to obtain capital when needed, on reasonable terms and in amounts sufficient to fund our obligations, expenses, capital expenditure plan and other strategic initiatives, we could be forced to suspend, delay or curtail these plans or initiatives or could default on our contractual commitments. Any such outcome could negatively affect our business, performance, liquidity and prospects.

The Series A Preferred Stock ranks junior to all of our indebtedness and other liabilities.

In the event of our bankruptcy, liquidation, dissolution or winding-up of our affairs, our assets will be available to pay obligations on the Series A Preferred Stock only after all of our indebtedness and other liabilities have been paid. The rights of holders of the Series A Preferred Stock to participate in the distribution of our assets will rank junior to the prior claims of our current and future creditors and any future series or class of preferred stock we may issue that ranks senior to the Series A Preferred Stock. Also, the Series A Preferred Stock effectively ranks junior to all existing and future indebtedness and to the indebtedness and other liabilities of any future subsidiaries. Our existing subsidiaries are, and future subsidiaries would be, separate legal entities and have no legal obligation to pay any amounts to us in respect of dividends due on the Series A Preferred Stock.

We have incurred and may in the future incur substantial amounts of debt and other obligations that will rank senior to the Series A Preferred Stock. If we are forced to liquidate our assets to pay our creditors, we may not have sufficient assets to pay amounts due on any or all of the Series A Preferred Stock then outstanding.

The Company’s ability to pay dividends and to meet its debt obligations largely depends on the performance of its subsidiaries and the ability to utilize the cash flows from those subsidiaries.

The Company is a holding company for SteriLumen and MunnWorks and has no material assets other than its equity interests in those subsidiaries. Therefore, the only current revenue source for future dividends on the Series A Preferred Stock is from its subsidiaries. SteriLumen is an early-stage designer and marketer of disinfection systems with limited operating history spanning from December 2016. As a result of the acquisition of the Akida assets, we expect that SteriLumen will have positive cash flow, but this cash flow combined with cash flows from MunnWorks may not be sufficient to pay dividends on the Series A Preferred Stock. Our utilization of cash has been and will continue to be highly dependent on SteriLumen’s product development programs and cash flow from Airocide and MunnWorks’ operations. Our cash expenses will be highly dependent on the product development programs SteriLumen chooses to pursue, the progress of these product development programs, the results of SteriLumen’s validation/marketing studies, the terms and conditions of SteriLumen’s contracts with service providers and manufacturing contractors, and the terms of recruitment of facilities in our validation/marketing studies.

In addition, the subsidiaries and any joint ventures or other entities accounted for as equity method investments are separate and distinct legal entities that are not obligated to pay dividends or make loans or distributions to the Company, whether to enable us to pay principal and interest on our debt, our other obligations or dividends on our Common Stock or preferred stock (including the Series A Preferred Stock offered hereby), and could be precluded from paying any such dividends or making any such loans or distributions under certain circumstances, including, without limitation, as a result of legislation, regulation, court order, contractual restrictions or in times of financial distress. The inability to access capital from our subsidiaries and entities accounted for as equity method investments as well from the capital markets could have a material adverse effect on the Company’s cash flows and financial condition and, on our ability, to pay dividends on the Series A Preferred Stock.

 28 

 

The Series A Preferred Stock will be effectively subordinated to the obligations of our subsidiaries.

We are a holding company and conduct substantially all of our operations through our subsidiaries. Our right to receive any assets of any of our subsidiaries upon their liquidation, reorganization or otherwise, and thus the ability of a holder of our Series A Preferred Stock to benefit indirectly from such distribution, will be subject to the prior claims of the subsidiaries’ creditors. Even if we were a creditor of any of our subsidiaries, our rights as a creditor would be subordinate to any security interest in the assets of those subsidiaries and any indebtedness of those subsidiaries senior to that held by us.

We must adhere to prescribed legal requirements and we must also have sufficient cash in order to be able to pay dividends on the Preferred Stock.

In accordance with Section 170 of the Delaware General Corporation Law (“DGCL”), we may only declare and pay cash dividends on the Series A Preferred Stock if we have either net profits during the fiscal year in which the dividend is declared and/or the preceding fiscal year, or a “surplus”, meaning the excess, if any, of our net assets (total assets less total liabilities) over our capital. If the capital of the Company, computed in accordance with Sections 154 and 244 of the DGCL, shall have been diminished by depreciation in the value of its property, or by losses, or otherwise, to an amount less than the aggregate amount of the capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets, the directors of the Company cannot declare and pay out of such net profits any dividends upon any shares of any classes of its capital stock until the deficiency in the amount of capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets shall have been repaired. We can provide no assurance that we will satisfy such requirements in any given year. Further, even if we have the legal ability to declare a dividend, we may not have sufficient cash to pay dividends on the Series A Preferred Stock. Our ability to pay dividends may be impaired if any of the risks described in this prospectus actually occur. Also, payment of our dividends depend upon our financial condition and other factors as our board of directors may deem relevant from time to time. We cannot assure you that our businesses will generate sufficient cash flow from operations or that future borrowings will be available to us in an amount sufficient to enable us to pay dividends on the Series A Preferred Stock.

The Series A Preferred Stock represents perpetual equity interests in us, and investors should not expect us to redeem the Series A Preferred Stock on any such date that the Series A Preferred Stock becomes redeemable by us or on any particular date afterwards.

The Series A Preferred Stock represents perpetual equity interests in us, and it has no maturity or mandatory redemption, is not redeemable at the option of investors under any circumstances. As a result, unlike our indebtedness, the Series A Preferred Stock will not give rise to a claim for payment of a principal amount at a particular date. As a result, holders of the Series A Preferred Stock may be required to bear the financial risks of an investment in the Series A Preferred Stock for an indefinite period of time.

We may redeem the Series A Preferred Stock on a date or dates determined in our sole discretion and the investor may not find a new investment with a comparable dividend or interest rate.

The Series A Preferred Stock will be a perpetual equity security. This means that it will have no maturity or mandatory redemption date and will not be redeemable at the option of the holders. We may, at our option, after July 16, 2022, redeem the Series A Preferred Stock, in whole or in part, at any time or from time to time as we may determine in our sole discretion, for cash at a redemption price equal to $27.50 until July 16, 2026 and $25.00 thereafter. We may have an incentive to redeem the Series A Preferred Stock voluntarily if we can do so without paying the premium or if market conditions allow us to issue other preferred stock or debt securities at a rate that is lower than the dividend rate on the Series A Preferred Stock. If we redeem the Series A Preferred Stock, then from and after the redemption date, dividends will cease to accrue on shares of Series A Preferred Stock, the shares of Series A Preferred Stock shall no longer be deemed outstanding and all rights as a holder of those shares will terminate, except the right to receive the redemption price plus accumulated and unpaid dividends, if any, payable upon redemption. If we choose to redeem the Series A Preferred Stock, you may not be able to reinvest the redemption proceeds in a comparable security at an effective dividend or interest rate as high as the dividend payable on the Series A Preferred Stock.

 29 

 

The conversion feature may not adequately compensate you, and the conversion and redemption features of the Series A Preferred Stock may make it more difficult for a party to take over our company and may discourage a party from taking over our company.

Upon the occurrence of a Delisting Event or Change of Control, holders of the Series A Preferred Stock will have the right (unless, prior to the Delisting Event Conversion Date or Change of Control Conversion Date, as applicable, we have provided or provide notice of our election to redeem the Series A Preferred Stock) to direct the depositary to convert some or all of the Series A Preferred Stock into our common stock (or equivalent value of alternative consideration), and under these circumstances we will also have a special optional redemption right to redeem the Series A Preferred Stock. See “Description of Series A Preferred—Conversion Rights” and “—Special Optional Redemption.” Upon such a conversion, the holders will be limited to a maximum number of shares of our common stock equal to the Share Cap multiplied by the number of shares of Series A Preferred Stock converted. If the Common Stock Price is less than $4.67 (which is approximately 50% of the closing sale price per share of our common stock on July 12, 2021), subject to adjustment, the holders will receive a maximum of 5.353319 shares of our common stock per share of Series A Preferred Stock, which may result in a holder receiving value that is less than the liquidation preference of the Series A Preferred Stock. In addition, those features of the Series A Preferred Stock may have the effect of inhibiting a third party from making an acquisition proposal for our company or of delaying, deferring or preventing a change of control of our company under circumstances that otherwise could provide the holders of our common stock and Series A Preferred Stock with the opportunity to realize a premium over the then-current market price or that stockholders may otherwise believe is in their best interests.

The Series A Preferred Stock has not been rated.

We have not sought to obtain a rating for the Series A Preferred Stock, and the Series A Preferred Stock may never be rated. It is possible, however, that one or more rating agencies might independently determine to assign a rating to the Series A Preferred Stock or that we may elect to obtain a rating of the Series A Preferred Stock in the future. In addition, we may elect to issue other securities for which we may seek to obtain a rating. If any ratings are assigned to the Series A Preferred Stock in the future or if we issue other securities with a rating, such ratings, if they are lower than market expectations or are subsequently lowered or withdrawn, could adversely affect the market for or the market value of the Series A Preferred Stock. Ratings only reflect the views of the issuing rating agency or agencies and such ratings could at any time be revised downward or withdrawn entirely at the discretion of the issuing rating agency. A rating is not a recommendation to purchase, sell or hold any particular security, including the Series A Preferred Stock. Ratings do not reflect market prices or suitability of a security for a particular investor and any future rating of the Series A Preferred Stock may not reflect all risks related to us and our business, or the structure or market value of the Series A Preferred Stock.

If Nasdaq delists the Series A Preferred Stock, investors’ ability to make trades in the Series A Preferred Stock could be limited.

Our Series A Preferred Stock is traded on the Nasdaq Capital Market under the symbol “AUVIP.” In order to continue to be listed on the Nasdaq Capital Market, we must meet and maintain certain financial, distribution, and share price levels. Generally, this means having a minimum number of publicly held shares of Series A Preferred Stock (generally 1,000,000 shares), a minimum market value (generally $5,000,000), a minimum net income from continuing operations (generally $750,000) and a minimum number of holders (generally 300 public holders). If we are also unable to meet the listing standards for the Nasdaq Capital Market, we may apply to have our Series A Preferred Stock quoted by OTC Markets. If we are unable to maintain listing for the Series A Preferred Stock on the Nasdaq Capital Market, the ability to transfer or sell shares of the Series A Preferred Stock will be limited and the market value of the Series A Preferred Stock will likely be materially adversely affected. Moreover, since the Series A Preferred Stock has no stated maturity date, investors may be forced to hold shares of the Series A Preferred Stock indefinitely while receiving stated dividends thereon when, as and if authorized by our board of directors and paid by us with no assurance as to ever receiving the liquidation value thereof.

The market for our Series A Preferred Stock may not provide investors with adequate liquidity.

Liquidity of the market for the Series A Preferred Stock depends on a number of factors, including prevailing interest rates, our financial condition and operating results, the number of holders of the Series A Preferred Stock, the market for similar securities and the interest of securities dealers in making a market in the Series A Preferred Stock. We cannot predict the extent to which investor interest in our Company will maintain a trading market in our Series A Preferred Stock, or how liquid that market will be. If an active market is not maintained, investors may have difficulty selling shares of our Series A Preferred Stock.

We are allowed to issue shares of other series of preferred stock that rank above or equal to the Series A Preferred Stock as to dividend payments and rights upon our liquidation, dissolution or winding up of our affairs without first obtaining the approval of the holders of our Series A Preferred Stock. The issuance of additional shares of Series A Preferred Stock and/or additional series of preferred stock could have the effect of reducing the amounts available to the Series A Preferred Stock upon our liquidation or dissolution or the winding up of our affairs. It also may reduce dividend payments on the Series A Preferred Stock if we do not have sufficient funds to pay dividends on all Series A Preferred Stock outstanding and other classes or series of stock with equal or senior priority with respect to dividends. Future issuances and sales of senior or pari passu preferred stock, or the perception that such issuances and sales could occur, may cause prevailing market prices for the Series A Preferred Stock and our Common Stock to decline and may adversely affect our ability to raise additional capital in the financial markets at times and prices favorable to us.

 30 

 

Market interest rates may materially and adversely affect the value of the Series A Preferred Stock.

One of the factors that will influence the price of the Series A Preferred Stock is the dividend yield on the Series A Preferred Stock (as a percentage of the market price of the Series A Preferred Stock) relative to market interest rates. Continued increase in market interest rates may lead prospective purchasers of the Series A Preferred Stock to expect a higher dividend yield (and higher interest rates would likely increase our borrowing costs and potentially decrease funds available for dividend payments). Thus, higher market interest rates could cause the market price of the Series A Preferred Stock to materially decrease.

Holders of the Series A Preferred Stock may be unable to use the dividends-received deduction and may not be eligible for the preferential tax rates applicable to “qualified dividend income.”

Distributions paid to corporate U.S. holders of the Series A Preferred Stock may be eligible for the dividends-received deduction, and distributions paid to non-corporate U.S. holders of the Series A Preferred Stock may be subject to tax at the preferential tax rates applicable to “qualified dividend income,” only if we have current or accumulated earnings and profits, as determined for U.S. federal income tax purposes. Additionally, we may not have sufficient current earnings and profits during future fiscal years for the distributions on the Series A Preferred Stock to qualify as dividends for U.S. federal income tax purposes. If the distributions fail to qualify as dividends, U.S. holders would be unable to use the dividends-received deduction and may not be eligible for the preferential tax rates applicable to “qualified dividend income.”  If any distributions on the Series A Preferred Stock with respect to any fiscal year are not eligible for the dividends-received deduction or preferential tax rates applicable to “qualified dividend income” because of insufficient current or accumulated earnings and profits, it is possible that the market value of the Series A Preferred Stock might decline. 

A holder of Series A Preferred Stock has essentially no voting rights.

The holders of Series A Preferred Stock will not be entitled to vote on any matter that comes before our stockholders for a vote unless such vote is required by the DGCL. This means that, unless it is required by Delaware law, you will not have the right to participate in any decisions regarding or affecting our Company or your investment, including the election of directors or any extraordinary events, such as a merger, acquisition or other similar transaction. Decisions on those matters could be made in a manner that materially and adversely affects your interests. Our shares of the Super Voting Preferred Stock and our Common Stock are the only classes of our securities that carry full voting rights. See “Description of the Securities--Series A Preferred Stock—Voting Rights.”

Future issuances of preferred stock may reduce the value of the Series A Preferred Stock.

We may sell additional shares of preferred stock on terms that may differ from those of the Series A Preferred Stock. Such shares could rank on parity with or senior to the Series A Preferred Stock offered hereby as to dividends, voting or rights upon liquidation, winding up or dissolution. The creation and subsequent issuance of additional classes of preferred stock on parity with the Series A Preferred Stock, could dilute the interests of the holders of Series A Preferred Stock offered hereby. Any issuance of preferred stock that is senior to the Series A Preferred Stock would not only dilute the interests of the holders of Series A Preferred Stock offered hereby, but also could affect our ability to pay distributions on, redeem or pay the liquidation preference on the Series A Preferred Stock.

We have issued 1,250,000 shares of another series of preferred stock that ranks on parity with the Series A Preferred Stock and such issuance could impact our ability to pay dividends upon the Series A Preferred Stock and will dilute the payment of any liquidation proceeds to the Series A Preferred Stock.

We have issued 1,250,000 shares of 2% Series B Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”), which has a liquidation preference of $6.00 per share and ranks on parity with the Series A Preferred Stock. As long as any dividend payments on the Series B Preferred Stock that are due are not made, we will not be able make dividend payments on the Series A Preferred Stock. Additionally, because the Series B Preferred Stock rank on parity with the Series A Preferred Stock, upon a liquidation of the Company, holders of the Series A Preferred Stock and Holders of Series B Preferred Stock will be entitled to receive their pro rata portion of the liquidation proceeds available to the aggregate outstanding amount of Series A Preferred Stock and Series B Preferred Stock, which could result in the holders of the Sries A Preferred Stock receiving less liquidation proceeds than it otherwise be entitled to.

 31 

 

If we are not paying full dividends on any future dividend parity stock, we will not be able to pay full dividends on the Series A Preferred Stock.

When dividends are not paid in full on outstanding shares of any class or series of our stock that ranks on a parity with the Series A Preferred Stock in the payment of dividends (“dividend parity stock”) for a dividend period, all dividends declared with respect to shares of Series A Preferred Stock and all shares of outstanding dividend parity stock for such dividend period shall be declared pro rata so that the respective amounts of such dividends declared bear the same ratio to each other as all accrued but unpaid dividends per share on the shares of Series A Preferred Stock and all shares of outstanding dividend parity stock for such dividend period bear to each other. Therefore, if we are not paying full dividends on any outstanding shares of dividend parity stock, we will not be able to pay full dividends on the Series A Preferred Stock.

Item 1B. Unresolved Staff Comments

None. 

Item 2. Properties.

We lease and maintain our primary offices and manufacturing facility at 150 N. Macquesten Parkway, Mount Vernon, NY 10550, 185 Randolph Street, Brooklyn, NY 11237, and at 3625 Kennesaw North Industrial Pkwy NW, Kennesaw, GA. 30144. We do not currently own any real estate.

Item 3. Legal Proceedings

On February 25, 2022, James Doyle, a former Chief Operating Officer of the Company filed an arbitration claim against the Company for approximately $1.5 million plus attorneys’ fees and other costs with the American Arbitration Association in the State of New York for severance pay and other claims after being terminated by the Company for cause. The arbitration proceeding was initiated pursuant to the arbitration provision in Mr. Doyle’s employment agreement with the Company. The evidentiary hearing was conducted at the American Arbitration Association’s midtown offices on November 7 - 10, 2022.  Afterwards, the parties submitted post-hearing briefs.  On January 24, 2023, the arbitration panel issued a Partial Final Award, whereby the Panel denied five of the seven counts asserted by Doyle, and awarded him only $100,000 in severance pay plus $21,154 in unused vacation time plus 6,379 additional shares in the Company pursuant to the terms of his Employment Agreement.  Because Mr. Doyle was determined to be the prevailing party, the Panel awarded him his reasonable attorneys’ fees and expenses, which amounts are currently the subject of post-hearing briefing. The respective amounts have been recorded in the Company’s financial statements in S,G&A, interest expense, and accrued expenses.

From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. We may in the future receive claims from third parties asserting, among other things, infringement of their intellectual property rights. Future litigation may be necessary to defend ourselves, our partners and our customers by determining the scope, enforceability and validity of third-party proprietary rights, or to establish our proprietary rights. The results of any future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors. To date, we have not been made aware of any actual, pending or threatened litigation against the Company.

Item 4. Mine Safety Disclosures

Not applicable.

 32 

 

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

Our common stock has been traded on the Nasdaq Capital Market under the symbol AUVI. 

Holders

As of March 31, 2023, there were 24 stockholders of record of our common stock. Because many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, this number is not representative of the total number of beneficial owners of our stock.

Dividends

We have never paid cash dividends on our Common Stock and do not anticipate paying cash dividends on our Common Stock in the foreseeable future. We currently intend to retain any future earnings to support the development of our business and do not anticipate paying cash dividends in the foreseeable future. Our payment of any future dividends will be at the discretion of our board of directors after taking into account various factors, including, but not limited to, our financial condition, operating results, cash needs, growth plans and the terms of any credit agreements that we may be a party to at the time. In addition, our ability to pay dividends on our Common Stock is limited by the terms of our Series A Perpetual Preferred Stock and may be limited by Delaware state law. Accordingly, investors must rely on sales of their Common Stock after price appreciation, which may never occur, as the only way to realize a return on their investment.

Recent Sales of Unregistered Securities 

During the fiscal year ended December 31, 2022 we made the following unregistered sales of our securities:

On January 1, 2022 the Company issued in the aggregate 62,500 unvested shares of its Common Stock to its independent directors, which vest on January 1, 2023.

On January 1, 2022, the Company issued 50,000 shares of its Common Stock to Michael Riccio, Chief Financial Officer, pursuant to his employment agreement.

On March 31, 2022, there was a settlement of a dispute between the Company and the members of Old SAM Partners, LLC (SAM), formerly known as Scientific Air Management, LLC, regarding certain representations and warranties in the purchase agreement which resulted in a settlement and mutual release agreement whereby the seller agreed to relinquish any right, title, and interest in the previously issued 400,000 shares.

On April 11, 2022 the Company issued 75,000 shares of its Common Stock to John Andrews, Chief Executive Officer, pursuant to his employment agreement. Mr. Andrews resigned from the Company as of December 19, 2022, resulting in the cancellation of 59,035 of his unvested shares.

On May 17, 2022, the Company issued 10,000 shares of its Common to Stock to Joseph Luhukay, who was elected to the board of directors by the stockholders on May 17, 2022.

On May 17, 2022, the Company issued 10,000 shares of its Common to Stock to Monica Woo, who was elected to the board of directors by the stockholders on May 17, 2022.

On May 17, 2022, the Company cancelled 17,500 unvested shares of its Common Stock held by Joel Kanter, former Chairman of the Board, who was not re-elected by the stockholders.

On May 17, 2022, the Company cancelled 17,500 unvested shares of its Common Stock held by Alastair Clemow, former director, who resigned from the board as of May 17, 2022.

On May 17, 2022, the Company cancelled 17,500 unvested shares of its Common Stock held by Eugene Bauer, former director, who resigned from the board as of May 17, 2022.

 33 

 

The foregoing issuances were exempt from registration under Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder.

Securities Authorized for Issuance under Equity Compensation Plans

The following table sets forth information concerning grants of option awards pursuant to employees, directors, consultants and other independent contractors during the year ended December 31, 2022:

Plan category  Number of securities to be
issued upon exercise of
outstanding options,
warrants and rights		  Weighted-average
exercise price of
outstanding options,
warrants and rights		  Number of securities remaining available
for future issuance under equity
compensation plans
Equity compensation plans approved by security holders(1)   895,000   $3.12    1,605,000 
Equity compensation plans not approved by security holders(2)   105,028    7.75    —   
Total   1,000,028   $3.61    —   

 

(1) The Applied UV, Inc. 2020 Omnibus Incentive Plan (the “Plan”) permits grants of equity awards to employees, directors, consultants and other independent contractors. Our board of directors and shareholders have approved a total reserve of 2,500,000 shares for issuance under the Plan.
   
(2) Includes 103,278 options granted to Max Munn pursuant his employment contract.

Transfer Agent

The transfer agent for the common stock is Vstock Transfer LLC, 18 Lafayette Place, Woodmere, New York, telephone (212) 828-8436.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

Item 6. [Reserved].

 34 

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Overview

Applied UV, Inc. (“AUVI”) is a leading sales and marketing company that develops, acquires, markets and sells proprietary surface and air disinfection technology focused on Improving Indoor Air Quality (IAQ), specialty LED lighting and luxury mirrors and commercial furnishings, all of which serves clients globally in the healthcare, commercial & public venue, hospitality, food preservation, cannabis, education, and winery vertical markets.

With its established strategic manufacturing partnerships and alliances including Canon, Acuity, Johnson Controls, USHIO, Siemens, Grainger, and a global network of 89 dealers and distributors in 52 countries, 47 manufacturing representatives, and 10 US based internal sales representatives, AUVI offers a complete suite of products through its two wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and Munn Works, LLC (“MunnWorks”).

SteriLumen, AUVI’s subsidiary, owns, brands, and markets a portfolio of research backed and clinically proven products utilizing advanced UVC Carbon, Broad Spectrum UVC LED’s, and Photo-catalytic oxidation (PCO) pathogen elimination technology, branded as Airocide ™, Scientific Air™, Airoclean™ 420, Lumicide™, PUROAir, PUROHealth, PURONet, and LED Supply Company.   Sterilumen’s proprietary platform suite of patented surface and air technologies offers one of the most complete pathogen disinfection platforms including mobile, fixed, and HVAC systems and software solutions interconnecting its entire portfolio suite into the IoT, allowing customers to implement, manage and monitor IAQ measures recommended by the EPA across any enterprise. Additionally, the Lumicide™ platform applies the power of ultraviolet light (UVC) to destroy pathogens automatically, addressing the challenge of healthcare-acquired infections (“HAI’s) in several patented designs for infection control in healthcare. LED Supply Company is a full-service, wholesale distributor of LED lighting and controls throughout North America. MunnWorks manufactures and sells custom luxury and electrified mirrors and superior furnishings for the hospitality industry.

Our global list of Fortune 100 end users including Kaiser Permanente, NY Health+Hospitals, MERCY Healthcare, University of Chicago Medical, Baptist Health South Florida, New York City Transit, Samsung, JB Hunt, Boston Red Sox’s Fenway Park, JetBlue Park, France’s Palace of Versailles, Whole Foods, Del Monte Foods, U.S. Department of Veterans Affairs, Marriott, Hilton, Four Seasons and Hyatt, and more. For information on Applied UV, Inc., and its subsidiaries, please visit https://www.applieduvinc.com

Air Disinfection Solutions & LED Lighting: Airocide, Scientific Air, PURO and LED Supply Co.

In February of 2021, the Company acquired all the assets and assumed certain liabilities of Akida Holdings, LLC (“Akida”). At the time of the acquisition, Akida owned the Airocide™ system of air purification technologies, originally developed for NASA with assistance from the University of Wisconsin at Madison, that uses a combination of UVC and a proprietary, titanium dioxide based photocatalyst that has helped to accelerate the reopening of the global economy with applications in the hospitality, hotel, healthcare, nursing home, grocer, wine, commercial building and retail sectors. The Airocide™ system has been used by brands such as NASA, Whole Foods, Dole, Chiquita, Opus One, Sub-Zero Refrigerators and Robert Mondavi Wines. Akida had contracted KES Science & Technology, Inc. (“KES”) to manufacture, warehouse and distribute the Airocide™ system and Akida’s contractual relationship with KES was assigned to and assumed by the Company as part of the acquisition.

On September 28, 2021, the Company acquired all the assets and assumed certain liabilities of KES. At the time of the acquisition, KES was principally engaged in the manufacturing and distribution of the Airocide™ system of air purification technologies and misting systems. KES also had the exclusive right to the sale and distribution of the Airocide™ system in certain markets. This acquisition consolidated all of manufacturing, sale and distribution of the Airocide™ system under the SteriLumen brand and expanded the Company’s market presence in food distribution, post-harvest produce, wineries, and retail sectors. The Company sells its products throughout the United States, Canada, and Europe.

 35 

 

The Airocide™ system of air purification technologies, originally developed for the National Aeronautics and Space Administration (“NASA”) with assistance from the University of Wisconsin at Madison, uses a combination of UVC and a proprietary, titanium dioxide based photocatalyst to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds and many odors. The core Airocide™ technology has been in use on the International Space Station and is based on photo-catalytic oxidation (PCO), a bioconversion process that continuously converts damaging molds, microorganisms, dangerous pathogens, destructive volatile organic chemicals (VOCs) and biological gasses into harmless water vapor. Unlike other air purification systems that provide “active” air cleaning, ozone producing systems, ionization or “photo-electrochemical oxidation”, Airocide’s™ nanocoating technology permanently bonds titanium dioxide to the surface of the catalytic bed. This permits the perpetual generation of surface-bound (OH-) radicals over the large surface area created by their advanced geometric design and prevents the generation and release of ozone and other harmful byproducts. The proprietary formulation and methods for creating the catalyst are the basis of Airocide’s™ competitive advantage, making it the only consistently robust, highly effective, ozone free PCO technology on the market. Airocide™ has been tested over the past 12 years by governmental agencies such as NASA, the National Renewable Energy Laboratory, independent universities including the University of Wisconsin, Texas Tech University, and Texas A&M, as well as air quality science laboratories. Airocide™ technology is listed as a FDA Class II Medical Device, making it a suitable for providing medical grade air purification in critical hospital use cases. Airocide™ Product lines include APS (consumer units), the GCS and HD lines (commercial units that will include the Sterilumen App to bring connectivity, reporting and asset management to our suite of products). The APS series provides true choice, low maintenance filter-less PCO or a filtered PCO air purification option ideal for restaurants, conference rooms, residential and small business or home office spaces. The GCS series is suitable for larger public spaces and enclosed rooms that may have high occupancy such as offices, waiting rooms and hotel lobbies, and airport gate areas. The HD series is the most powerful, providing two-stage purification for fast sanitization of larger or industrial spaces such as sporting venues and locker rooms, airports, museums, winery cellars, warehouses, and food-processing facilities. All Airocide™ products also extend the life of any perishables like fruit, produce or flowers.

On October 13, 2021, we acquired substantially all of the assets of Old SAM Partners, LLC F/K/A Scientific Air Management, LLC (“Old SAM”), which owned a line of air purification technologies (“Scientific Air”). The Scientific Air product line uses a combination of UVC and a proprietary, patented system to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products. Scientific Air’s products are well suited for larger spaces within a facility due to the higher air flow of these units. The units are also mobile with industrial grade casters, allowing for movement throughout a facility to address increased bio burden from larger meetings or increased human traffic. Both of these key items extend our Airocide™ line, creating a comprehensive air disinfection portfolio that spans from small to large spaces and mobile applications. Scientific Air’s products are currently sold predominantly in North America and into the healthcare market.

PURO Lighting

On January 26, 2023 we closed on the merger agreement with PURO Lighting LLC and LED Supply Co. LLC along with its operating subsidiaries (“PURO merger”). PURO and LED Supply Co. own a powerful suite of products used in education, government, and healthcare that incorporates UV Lighting and a HVAC monitoring software platform; LED Supply Co. provides design, distribution, and implementation services for lighting, controls and smart building technologies.

PURO Lighting was founded in 2019 with the goal of using light technology to promote health and wellness within spaces. Today PURO provides a suite of UV disinfection systems that have the ability to disinfect air and surfaces in commercial and industrial spaces. They focus their sales efforts in three primary verticals: Education, Government, and Healthcare.  The acquisition of Puro Lighting, LLC adds PUROHealth and PURONet - a powerful suite of products used in healthcare that incorporates UV Lighting and a HVAC monitoring software platform. With their UL listed and patented portfolio of independently tested (Resonova Labs) synergistic surface and air disinfection technologies that help facility managers protect against multiple pathogens, PURO opens new opportunities for cross marketing sales to existing distribution channels. Additionally, the potential to inter-connect our entire portfolio of disinfection technology solutions into the IoT will provide our customers with both products and smart tools to manage and monitor indoor air quality (IAQ) across any enterprise. Applied UV’s proprietary platform suite of patented technologies offers the most complete pathogen disinfection platform including mobile, fixed and HVAC systems and solutions allowing companies to implement the IAQ measures recommended by the EPA.  PURO boast a strong domestic sales network with reps in 43 states, and distribution in all 50 states.  Their product offerings encompass a range of innovative solutions, including UVC systems for air handling, in-room continuous disinfection using cutting-edge Far-UVC technology, and specialized surface disinfection solutions designed specifically for the healthcare industry.

The Puro merger further positions the Company to address a growing air disinfection market trend that aligns with the White House “Clean Air Initiatives” implemented during the height of the COVID 19 Pandemic designed to protect consumers and businesses against existing and future airborne pathogens allowing economies globally to remain open. The merged entities have proven applications that can now be included in improving indoor air quality (IAQ) at the facility level including HVAV systems in public, government, municipal, retail spaces and buildings. The Puro merger positions Applied UV to be one of the only companies in the world to offer a complete air and surface disinfection platform that includes consumer, fixed and mobile, and commercial applications that are research backed, clinically tested and that are used by global Fortune 100 end users in multiple verticals.

 36 

 

LED Supply Company

Founded in 2009, LED Supply Company is a national, Colorado-based company that provides design, distribution, and implementation services for lighting, controls and smart building technologies. LED Supply Co continues to expand their market reach with a focus on new types of energy efficiency and sustainable technologies. Along with its robust e-commerce component, LED Supply Company has recently taken the next step in revenue growth by repositioning itself as a preferred supplier for not only the latest in LED technologies, but the source for emerging technologies and product categories that the construction and retrofit market need; from electric vehicle charging to smart home technology, emergency and safety equipment, and much more.

We see a number of bidirectional synergies across our entire air and surface disinfection portfolio. First, we look to leverage Airocide’s global distribution capabilities to facilitate the sale of Scientific Air’s and PURO Lightings’ offerings internationally. Second, we look to leverage PURO Lightings’ strength in healthcare to pull through existing Airocide™ units, creating a broad healthcare product line, from small clinics, patient rooms and doctor’s offices to larger spaces such as nursing stations, waiting rooms and cafeterias. Third, we look to leverage the national MunnWorks hospitality reach with leading luxury hotel chain operators to pull through our entire air and surface disinfection portfolio (Airocide™ and Lumicide™) as well as PURO Lightings’ offerings into future hotel, condo and other renovation, upgrade and remodeling projects. Fourth, the Company will look to work with Canon Virginias’ (CVI) extensive field support team to promote the sale of the Companys’ products as well as service capabilities.  Finally, we look to incorporate the PUROAir, PUROHealth and PURONet  (a powerful suite of products used in healthcare that incorporates UV Lighting and a HVAC monitoring software platform) into our IoT integration plans via the Sterilumen App across our entire platform connecting all our units, thereby creating a leading smart asset management, reporting, and control system tool that can be incorporated across all enterprises.

Principal Factors Affecting Our Financial Performance

Our operating results are primarily affected by the following factors:

•   our ability to acquire new customers or retain existing customers;
•   our ability to offer competitive product pricing;
•   our ability to broaden product offerings;
•   industry demand and competition; and
•   market conditions and our market positions

Results of Operations

Year Ended December 31, 2022 Compared to the Year Ended December 31, 2021

   Year Ended December 31, 2022  Year Ended December 31, 2021
   Hospitality  Disinfection  Corporate  Total  Hospitality  Disinfection  Corporate  Total
Net Sales  $13,639,370   $6,500,479   $—     $20,139,849   $5,943,664   $5,723,915   $—     $11,667,579 
Cost of Goods Sold   12,375,645    3,725,910    —      16,101,555    4,488,652    3,080,541    —      7,569,193 
Gross Profit   1,263,725    2,774,569    —      4,038,294    1,455,012    2,643,374    —      4,098,386 
Research and development   —      319,167    —      319,167    —      53,408    —      53,408 
Loss on impairment of goodwill   —      6,993,075    —      6,993,075    —      —      —      —   
Selling, General and Administrative   4,351,932    7,680,551    2,771,585    14,804,068    2,281,460    6,110,206    2,950,046    11,341,712 
Total Operating expenses   4,351,932    14,992,793    2,771,585    22,116,310    2,281,460    6,163,614    2,950,046    11,395,120 
Operating Loss   (3,088,207)   (12,218,224)   (2,771,585)   (18,078,016)   (826,448)   (3,520,240)   (2,950,046)   (7,296,734)
Other Income                                        
Change in Fair Market Value of Warrant Liability   —      —      58,276    58,276    —      —      66,862    66,862 
Interest expense   —      —      (290,341)   (290,341)   —      —      —      —   
Gain on settlement of contingent consideration   —      —      1,700,000    1,700,000    —      —      —      —   
Loss on change in contingent consideration   —      —      (240,000)   (240,000)   —      —      (574,000)   (574,000)
Forgiveness of paycheck protection program loan   —      —      —      —      —      —      296,827    296,827 
Other income   —      —      274,764    274,764    —      —      24,871    24,871 
Total Other Income (Expense)   —      —      1,502,699    1,502,699    —      —      (185,440)   (185,440)
Loss Before Provision for Income Taxes   (3,088,207)   (12,218,224)   (1,268,886)   (16,575,317)   (826,448)   (3,520,240)   (3,135,486)   (7,482,174)
Provision for Income Taxes   —      —      —      —      —      —      (91,819)   (91,819)
Net Loss  $(3,088,207)  $(12,218,224)  $(1,268,886)  $(16,575,317)  $(826,448)  $(3,520,240)  $(3,043,667)  $(7,390,355)
Non-GAAP Financial Measures                                        
Adjusted EBITDA                                        
Operating Loss  $(3,088,207)  $(12,218,224)  $(2,771,585)  $(18,078,016)  $(826,448)  $(3,520,240)  $(2,950,046)  $(7,296,734)
Depreciation and Amortization   321,973    1,815,868    77,600    2,215,441    31,205    915,539    —      946,744 
Loss on impairment of goodwill   —      6,993,075    —      6,993,075    —      —      —      —   
Stock based compensation   194,458    133,012    392,932    720,402    290,706    229,898    1,029,183    1,549,787 
Adjusted EBITDA  $(2,571,776)  $(3,276,269)  $(2,301,053)  $(8,149,098)  $(504,537)  $(2,374,803)  $(1,920,863)  $(4,800,203)

 37 

 

Adjusted EBITDA

The Company utilizes Adjusted EBITDA, a non-GAAP financial measure, to assist in analyzing our segment operating performance by removing the impact of certain key items that management believes do not directly reflect our underlying operations. In addition, we consider certain non-GAAP (or “adjusted”) measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity, and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenues, operating income, net income (loss), earnings (loss) per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP.  Adjusted EBITDA is defined as Operating Profit (Loss), excluding Depreciation and Amortization, and excluding Stock Based Compensation and Loss on Impairment of Goodwill/Intangible Assets. Adjusted EBITDA was a loss of $8.1 million for the year ended December 31, 2022, which was an increase of $3.3 million as compared to the year ended December 31, 2021. By segment, Hospitality decreased $2.1 million primarily due to lower gross profit on the completion of projects that were in process when the Company acquired the assets of VisionMark; Disinfection decreased $0.9 million primarily due to the increase in S,G&A from the asset acquisitions of KES and SciAir in late Q3/early Q4 2021; and Corporate decreased $0.3 million primarily due to an increase in professional fees.

Segments

The Company has three reportable segments: the design, manufacture, assembly and distribution of a suite of air (fixed and mobile) and surface disinfecting systems for use in healthcare, hospitality, food preservation, education, and winery vertical markets (Disinfection segment); the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries (Hospitality segment); and the Corporate segment, which includes expenses primarily related to corporate governance, such as board fees, legal expenses, audit fees, executive management, and listing costs. See NOTE 14 – Segment Reporting.

Net Sales

Net sales of $20.1 million represented an increase of $8.5 million, or 72.6% for the year ended December 31, 2022 as compared to net sales of $11.6 million for the year ended December 31, 2021. This increase was primarily attributable to the Hospitality segment, with sales of $13.6 million, representing an increase of $7.7 million or 129.5% as compared to 2021. This was largely due to the VisionMark asset acquisition, accounting for $6.0 million of the increase, plus the increase in sales in the base MunnWorks business of $1.7 million, or 28.5%. The Hospitality segment is currently experiencing a rebound in the markets it serves due to hotels resuming their scheduled upgrade, remodel and repair and maintenance activities that were postponed due to the Covid-19 pandemic and subsequent closing of the US economy. The Disinfection segment had sales of $6.5 million in 2022, which represented a 13.6% increase over 2021. The rate of growth was lower than expected as the Disinfection markets have not yet rebounded from the initial “buy-in” during the early stages of the Covid-19 pandemic. Additionally, due to macro market shifts, the Company saw major global trends towards end-to-end systems across entire facilities that include software monitoring capabilities. This allows facilities to implement standards included in the current Environmental Protection Administration’s (EPA) “Clean The Air” initiatives and guidelines announced in early 2022. These guidelines set the standards that are focused on improving Indoor Air Quality (IAQ), including indoor air ventilation and HVAC systems in all public spaces. With these shifting macro trends the Company altered its marketing, merger and acquisition, and research and development activities to address these changes. Additionally, the Company accelerated its Internet of Things (IoT) development, manufacturing processes, and next generation product development roadmap. The PURO merger, coupled with the strategic manufacturing partnership with Canon, further addresses this shift in focus.

Gross Profit

Gross profit was $4.0 million, which was 20.1% of sales for the year ended December 31, 2022 as compared to $4.1 million, which is 35.1% of sales for the year ended December 31, 2021. Gross profit as a percentage of sales decreased primarily due to the higher sales mix of the Hospitality segment. The Hospitality segment’s sales for the year ended December 31, 2022 were 67.7% of AUVI’s total as compared to 50.9% for the year ended December 31, 2021. Additionally, the Hospitality segment’s gross profit as a percentage of sales decreased from 24.5% for the year ended December 31, 2021 to 9.3% for the year ended December 31, 2022, largely as a result of the lower gross profit on the completion of projects that were in process when the Company acquired the assets of VisionMark, which was a non-recurring event. The Company is focused on streamlining both manufacturing and distribution operations across both segments.

 38 

 

Operating Expenses

Selling, General, and Administrative – S,G&A costs were $14.8 million for the year ended December 31, 2022, which represented an increase of $3.5 million as compared to the year ended December 31, 2021. This increase was driven primarily by the asset acquisitions of VisionMark in the Hospitality segment in Q1 2022 and the asset acquisitions of KES and SciAir in the Disinfection segment at the end of Q3/beginning of Q4 2021: payroll and sales commission costs increased $1.5 million; amortization costs increased $1.0 million; marketing increased $0.4 million; professional fees increased $0.3 million; rent increased $0.3 million. The Company anticipates efficiency gains in the coming year as all three acquisitions have been fully integrated and synergies are being leveraged.

Loss on Impairment of Goodwill and Intangibles – The Company determined that a triggering event had occurred as a result of a settlement agreement with Scientific Air. A quantitative impairment test on the goodwill determined that the fair value was below the carrying value and as a result the Company recorded a full non-cash goodwill impairment charge of $1.1 million on the Consolidated Statements of Operations for the year ended December 31, 2022. Subsequently, as of December 31, 2022, we evaluated potential triggering events that might be indicators that other Scientific Air intangibles were impaired. We saw a significant decrease in the number of orders and demand of our Scientific Air product lines. As a result of this impact due to the shifting market trends described above in the Net Sales commentary, an additional non-cash impairment on intangibles of $5.9 million was also recorded in the Consolidated Statements of Operations for the year ended December 31, 2022.

Other Income (Expense)

On March 31, 2022, there was a dispute between the Company and Scientific Air (“Old SAM Partners”) regarding certain representations and warranties in the purchase agreement which resulted in a settlement and mutual release agreement where Old SAM Partners agreed to relinquish such Partner’s right, title, and interest in the previously issued 400,000 shares of AUVI common stock that were part of the consideration in the original asset acquisition. The Company recorded a loss on change in fair market value of contingent consideration of $0.24 million, and as a result of the settlement, the Company recorded a gain on settlement of $1.7 million during the year ended December 31, 2022. The company had previously recorded a loss on contingent consideration of $0.57 million for the year ended December 31, 2021 as a result of the decrease in our stock price from the date of acquisition of SciAir and the reporting date.

Other Income includes $0.2 million in the year ended December 31, 2022 for the Employee Retention Tax Credit and $0.3 million in the year ended December 31, 2021 for the Paycheck Protection Program loan forgiveness.

Net Loss

The Company recorded a net loss of $16.6 million for the year ended December 31, 2022, compared to a net loss of $7.4 million for the year ended December 31, 2021. The increase of $9.2 million in the net loss was mainly due to the non-cash Loss on Impairment of Goodwill/Intangibles of $7.0 million and an increase in S,G&A costs of $3.5 million as explained above.

Liquidity and Capital Resources

Year Ended December 31, 2022 Compared to the Year Ended December 31, 2021

Net cash used in operating activities  $(8,736,350)  $(6,997,970)
Net cash used in investing activities   (176,280)   (14,589,362)
Net cash provided by financing activities   2,878,959    18,597,558 
Net decrease in cash and cash equivalents   (6,033,671)   (2,989,774)
Cash and cash equivalents at beginning of year   8,768,156    11,757,930 
Cash, restricted cash, and cash equivalents at end of year   2,734,485    8,768,156 

In the year ended December 31, 2022, net cash used in operating activities was $8.7 million, as compared to $7.0 million in the year ended December 31, 2021. The increase in net cash used of $1.7 million was due mainly to the increase in the net loss of $2.7 million, after adjusting for non-cash items, plus an increase in inventory of $3.7 million, offset by an increase in deferred revenue of $3.9 million and a decrease in vendor deposits of $0.9 million. The increase in inventory is mainly due to the increase in VisionMark inventory of $1.4 million and an increase in Airocide inventory of $1.6 million, partly due to the increase in Consumer units in anticipation of planned marketing programs, and partly due to the securing of product in advance to mitigate any risks associated with the transition to Canon manufacturing.

 39 

 

In the year ended December 31, 2022, net cash used in investing activities was $0.2 million as compared to $14.6 million in the year ended December 31, 2021. The decrease of $14.2 million was due primarily to the acquisitions made during 2021: Akida $0.76 million, KES $4.3 million, and Scientific Air $9.5 million, for a total of $14.56 million, as compared to the VisionMark acquisition in March 2022, which only required a payment of ten dollars ($10), in addition to assuming certain liabilities.

In the year ended December 31, 2022, cash provided by financing activities was $2.9 million as compared to $18.6 million in the year ended December 31, 2021. The major financing activities that provided cash for the year ended December 31, 2022 was cash received from the net proceeds of the common stock over-allotment on January 5, 2022 of $1.1 million, plus net proceeds of $0.9 million from the issuance of shares under the ATM (At the Market) sales agreement with Maxim Group. In the year ended December 31, 2021, the Company received net proceeds of $12.3 million from the July 2021 preferred stock offering and $7.0 million form the December, 2021 common stock offering.

The Company believes our sources of liquidity and capital will be sufficient to finance our continued operations and growth strategies. On July 1, 2022, the Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission to register and aggregate $50.0 million of securities which may be issued in the form of common stock, preferred stock, warrants, debt securities, rights or units.  Such securities will be offered pursuant to the base prospectus contained in the shelf registration statement and a prospectus supplement that will be prepared and filed at the time of any offering.  Also, included in the registration statement was a second prospectus which provides for the issuance of $9.0 million of the Company’s common stock in At-The-Market (ATM) transactions pursuant to an equity distribution agreement dated July 1, 2022 between the Company and Maxim Group LLC, as sales agent. As of December 31, 2022, 804,811 shares have been sold via the ATM for gross proceeds of $0.9 million. As of March 31, 2023, and additional 1,764,311 shares have been sold for gross proceeds of $2.3 million, leaving a balance of $5.7 million on the ATM facility. The shelf registration statement will expire on July 12, 2025.

In December 2022, the Company entered into a Loan and Security Agreement, or (the “Loan Agreement”), with Pinnacle Bank, which provides for a $5,000,000 secured revolving credit facility (the “Loan Facility”). The loan is subject to a maximum advance rate of up to 85% of net face amount of eligible accounts, plus the lessor a) of the sum of 20% of the aggregate eligible inventory value of raw materials and 35% of the aggregate eligible inventory value of finished goods, b) $1 million, c) 80% of the net orderly liquidation value of raw materials and finished goods, or d) 100% of the aggregate outstanding principal amount of advances. In no event shall the aggregate amount of the outstanding advances under the Loan Facility be greater than $5 million. The loan matures on December 9, 2024. The principal amount of outstanding revolving loan, together with accrued and unpaid interest, is due on the maturity date.

The loan accrues interest at a 1.50% margin above the greater of the prime rate or 4.00%. The interest margin is increased to 2.00% in respect to the advances against eligible inventory. If the Company fails to perform any covenant, term or provision of the Loan Agreement, then interest shall accrue at the rate of 6.0% above the interest rate. If after the occurrence of an event of default and the loan is not paid in full by the maturity date, the loan shall bear interest at the rate of 18.0% above the interest rate.

Obligations under the Loan Agreement are secured by all of the Company’s assets. On the effective date the Company paid a loan fee of 2% of the amount of the Loan Facility and will be required to pay a loan fee of 1.5% of the amount of the Loan Facility annually thereafter.

The Loan Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and the Subsidiaries, including, without limitation, restrictions on liens, indebtedness, fundamental changes, capital expenditures, consignments of inventory and distributions.

The Loan Agreement contains customary events of default, including, without limitation, payment defaults, covenant defaults, breaches of certain representations and warranties, certain events of bankruptcy and insolvency, certain events under ERISA and judgments. If an event of default occurs and is not cured within any applicable grace period or is not waived, the Lender is entitled to take various actions, including, without limitation, the acceleration of amounts due thereunder and termination of commitments under the Loan Facility.

There were no borrowings outstanding under the Loan Facility as of December 31, 2022.

On January 25, 2023, (the “Execution Date”) the Company executed a Redeemable Promissory Note with Streeterville Capital, LLC (the “Investor”) in the amount of $2,807,500 (the “Note”). The Note matures eighteen (18) months from its issuance date of January 25, 2023 and bears interest at 8% per annum on the outstanding principal balance of the Note. The original principal balance of the Note is $2,500,000, plus debt issuance costs of $345,000. Beginning on July 25, 2023, the Investor shall have the right in any month to cause the Company to redeem up to $247,500 of the principal amount of the Note in such month. The Company may elect, in its sole discretion, to redeem such portions of the Note in cash or in its common stock or in any combination thereof. If redemptions are made by the Company with its common stock, such stock will be valued at 87.5% of the Nasdaq Minimum Price. The Company may not redeem the Note with its common stock if at the time of such redemption there is an Equity Condition Failure. It is the intention of the Company to make all Note redemption payments in cash and not in stock. Beginning on July 25, 2023, all cash redemptions will be subject to a ten percent (10%) redemption premium. The Company may pay all or any portion of the outstanding balance on or before one hundred five (105) days from the Execution Date without a prepayment penalty; if paid after one hundred five (105) days, the Company will be subject to a 10% prepayment premium.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

The Company is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information required under this item.

 40 

 

Item 8. Financial Statements and Supplementary Data.

 

Applied UV, Inc. and Subsidiaries

Index to the Consolidated Financial Statements

December 31, 2022 and 2021

Independent Auditors Reports (Mazars USA LLP, Fort Washington, PA, PCAOB ID 339) 42
Financial Statements  
Consolidated Balance Sheets 43
Consolidated Statements of Operations 44
Consolidated Statements of Changes in Stockholders' Equity 45
Consolidated Statements of Cash Flows 46
Notes to the Consolidated Financial Statements 47

 41 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of Applied UV, Inc.

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Applied UV, Inc. and Subsidiaries (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2022 and 2021, and the consolidated results of its operations and its cash flows for each of the two years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provides a reasonable basis for our opinion.

 

/s/ Mazars USA LLP 

We have served as the Company’s auditor since 2021.

Fort Washington, PA

March 31, 2023

 42 

 

 

Applied UV, Inc. and Subsidiaries

Consolidated Balance Sheets

As of December 31, 2022 and 2021

 

           
   2022  2021
Assets      
Current Assets          
Cash and cash equivalents  $2,734,485   $7,922,906 
Restricted cash   —      845,250 
Accounts receivable, net of allowance for doubtful accounts   1,508,239    986,253 
Costs and estimated earnings in excess of billings   1,306,762    —   
Inventory, net   5,508,086    1,646,238 
Vendor deposits   75,548    992,042 
Prepaid expense and other current assets   1,187,223    419,710 
Total Current Assets   12,320,343    12,812,399 
           
Property and equipment, net of accumulated depreciation   1,133,468    196,611 
Goodwill   3,722,077    4,809,811 
Other intangible assets, net of accumulated amortization   11,354,430    18,976,556 
Other assets   153,000    —   
Right of use assets   4,044,109    1,730,615 
Total Assets  $32,727,427   $38,525,992 
           
Liabilities and Stockholders’ Equity          
           
Current Liabilities          
Accounts payable and accrued expenses  $2,982,760   $1,642,108 
Contingent Consideration   —      1,460,000 
Deferred revenue   4,730,299    788,776 
Due to landlord (Note 2)   229,234    —   
Warrant liability   9,987    68,263 
Financing lease obligations   33,712    7,671 
Operating lease liability   1,437,308    389,486 
Notes payable   2,098,685    97,500 
Total Current Liabilities   11,521,985    4,453,804 
Long-term Liabilities          
Due to landlord-less current portion (Note 2)   393,230    —   
Notes payable- less current portion   765,144    60,000 
Financing lease obligations-less current portion   158,070    —   
Operating lease liability-less current portion   2,655,103    1,346,428 
Total Long-Term Liabilities   3,971,547    1,406,428 
Total Liabilities   15,493,532    5,860,232 
           
Stockholders’ Equity          
Preferred stock, Series A Cumulative Perpetual, $0.0001 par value, 19,990,000 shares authorized, 552,000 shares issued and outstanding as of both December 31, 2022 and 2021   55    55 
Preferred stock, Series X, $0.0001 par value, 10,000 shares authorized, 10,000 shares issued and outstanding as of December 31, 2022 and 2,000 shares issued and outstanding as of December 31, 2021   1    1 
Common stock $.0001 par value, 150,000,000 shares authorized; 13,676,450 shares issued and outstanding as of December 31, 2022 and 12,775,674 shares issued and outstanding as of December 31, 2021   1,368    1,278 
Additional paid-in capital   45,619,670    42,877,622 
Treasury stock at cost, 113,485 and 0 shares, respectively   (149,686)   —   
Accumulated deficit   (28,237,513)   (10,213,196)
Total Stockholders’ Equity   17,233,895    32,665,760 
Total Liabilities and Stockholders’ Equity  $32,727,427   $38,525,992 
           
The accompanying notes are an integral part of these audited consolidated financial statements.

 43 

 

Applied UV, Inc. and Subsidiaries

Consolidated Statements of Operations

For the Years Ended December 31, 2022 and 2021

 

           
   2022  2021
Net Sales  $20,139,849   $11,667,579 
Cost of Goods Sold   16,101,555    7,569,193 
Gross Profit   4,038,294    4,098,386 
           
Operating Expenses          
Research and development   319,167    53,408 
Selling general and administrative   14,804,068    11,341,712 
Loss on impairment of goodwill and intangible assets   6,993,075    —   
Total Operating Expenses   22,116,310    11,395,120 
           
Operating Loss   (18,078,016)   (7,296,734)
           
Other Income (Expense)          
Change in Fair Market Value of Warrant Liability   58,276    66,862 
Interest expense   (290,341)   —   
Loss on change in Fair Market Value of Contingent Consideration   (240,000)   (574,000)
Gain on Settlement of Contingent Consideration (Note 2)   1,700,000    —   
Other Income   274,764    24,871 
Forgiveness of paycheck protection program loan   —      296,827 
Total Other Income (Expense)   1,502,699    (185,440)
           
Loss Before Provision for Income Taxes   (16,575,317)   (7,482,174)
           
Benefit from Income Taxes   —      (91,819)
           
Net Loss  $(16,575,317)  $(7,390,355)
           
Net Loss attributable to common stockholders:          
Dividends to preferred shareholders   (1,449,000)   (603,750)
Net Loss attributable to common stockholders   (18,024,317)   (7,994,105)
           
Basic and Diluted Loss Per Common Share  $(1.41)  $(0.86)
Weighted Average Shares Outstanding - basic and diluted   12,754,979    9,273,257 
           
The accompanying notes are an integral part of these audited consolidated financial statements.

 44 

 

 

Applied UV, Inc. and Subsidiaries

Statements of Changes in Stockholders’ Equity

For the Years Ended December 31, 2022 and 2021

 

 

                                                        
    

Preferred Stock Series A Cumulative

    

Preferred Stock Series X

    

Common Stock

    

Treasury Stock

    

Additional Paid-In Capital

    

Accumulated Deficit

    

Total Stockholders Equity

 
Balance, January 1, 2021   —     $—      2,000   $1    7,945,034   $795    —     $—     $11,973,051   $(2,219,091)  $9,754,756 
Shares granted to settle previously recorded liability   —      —      —      —      3,000    —      —      —      21,420    —      21,420 
Warrant liability recognized in connection with initial issuance of November offering (See Note 7)   —      —      —      —      —      —      —      —      (135,125)   —      (135,125)
Exercise of warrants   —      —      —      —      17,852    2    —      —      1,155    —      1,157 
Common stock issued for acquisition   —      —      —      —      2,075,000    208    —      —      10,195,293    —      10,195,501 
Stock-based compensation   —      —      —      —      74,500    7    —      —      1,549,781    —      1,549,788 
Common stock issued in public offering, net of costs   —      —      —      —      2,666,667    267    —      —      6,999,661    —      6,999,928 
Preferred stock issued in public offering, net of costs   552,000    55    —      —      —      —      —      —      12,272,385    —      12,272,440 
Dividends paid to preferred shareholders   —      —      —      —      —      —      —      —      —      (603,750)   (603,750)
Cancellation of restricted stock   —      —      —      —      (6,379)   (1)   —      —      1    —      —   
Net loss   —      —      —      —      —      —      —      —      —      (7,390,355)   (7,390,355)
Balance, December 31, 2021   552,000   $55    2,000   $1    12,775,674   $1,278    —     $—     $42,877,622   $(10,213,196)  $32,665,760 
Common stock issued in public offering (over-allotment), net of costs   —      —      —      —      400,000    40    —      —      1,091,960    —      1,092,000 
Common stock issued in public offering (ATM), net of costs   —      —      —      —      804,811    80    —      —      929,656    —      929,736 
Cancellation of restricted shares   —      —      —      —      (111,535)   (11)   —      —      11    —      —   
Settlement of stock in connection with prior acquisition                       (400,000)   (40)             40    —      —   
Common shares repurchased   —      —      —      —      —      —      113,485    (149,686)   —      —      (149,686)
Reissuance of preferred stock   —      —      8,000    —      —      —      —      —      —      —      —   
Stock-based compensation   —      —      —      —      207,500    21    —      —      720,381    —      720,402 
Dividends paid to preferred shareholder   —      —      —      —      —      —      —      —      —      (1,449,000)   (1,449,000)
Net Loss   —      —      —      —      —      —      —      —      —      (16,575,317)   (16,575,317)
Balance, December 31, 2022   552,000   $55    10,000   $1    13,676,450   $1,368    113,485   $(149,686)  $45,619,670   $(28,237,513)  $17,233,895 
                                                        
The accompanying notes are an integral part of these audited consolidated financial statements.

 45 

 

 

Applied UV, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

For the Years Ended December 31, 2022 and 2021

 

           
   2022  2021
Cash flows from Operating Activities          
Net Loss  $(16,575,317)  $(7,390,355)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities          
Stock based compensation   720,402    1,549,788 
Bad debt expense (recovery)   94,714    (71,003)
Forgiveness of paycheck protection program loan   —      (296,827)
Change in fair market value of warrant liability   (58,276)   (66,862)
Gain on settlement of loan payable   —      (20,000)
Loss on change in fair market value of contingent consideration (Note 2)   240,000    —   
Gain on settlement of contingent consideration   (1,700,000)   574,000 
Loss on impairment of goodwill and intangible assets   6,993,075    —   
Change in reserve for Obsolescence inventory   (52,208)   (140,000)
Amortization of right-of-use asset   1,213,949    635,540 
Depreciation and amortization   1,991,798    946,744 
Amortization of debt discount   223,643    —   
Changes in operating assets and liabilities, net of effects of acquisitions:          
Accounts receivable   19,850    73,189 
Cost and estimated earnings excess of billings   (1,125,610)   —   
Inventory   (3,633,057)   (166,126)
Vendor deposits   916,494    (951,242)
Prepaid expenses and other current assets   (448,680)   35,273 
Income taxes payable   —      (173,716)
Accounts payable and accrued expenses   1,340,655    (361,569)
Billings in excess of costs and earnings on uncompleted contracts   (1,388,838)   —   
Deferred revenue   3,941,523    (544,563)
Due to landlord   (279,518)   —   
Operating lease payments   (1,170,949)   (630,241)
Net Cash Used in Operating Activities   (8,736,350)   (6,997,970)
           
Cash Flows From Investing Activities          
Cash paid for patent costs   (682)   (14,434)
Purchase of machinery and equipment   (23,017)   (14,735)
Acquisitions, net of cash acquired (Note 2)   (10)   (14,560,193)
Payments on note payable   (152,571)   —   
Net Cash Used in Investing Activities   (176,280)   (14,589,362)
           
Cash Flows From Financing Activities          
Payments on financing leases   (6,591)   (7,217)
Proceeds from warrant exercise   —      1,157 
Shares repurchased   (149,686)   —   
Dividends to preferred shareholders   (1,449,000)   (603,750)
Payments on loan payable   —      (65,000)
Proceeds from equity raises, net   2,021,736    19,272,368 
Proceeds from note payable, net   2,462,500    —   
Net Cash Provided by Financing Activities   2,878,959    18,597,558 
           
Net Decrease in Cash and equivalents   (6,033,671)   (2,989,774)
Cash, restricted cash, and cash equivalents at January 1,   8,768,156    11,757,930 
Cash, restricted cash, and cash equivalents at December 31,  $2,734,485   $8,768,156 
           
Supplemental Disclosures of Cash Flow Information:          
Cash paid during the year for:          
Interest  $57,534   $1,022 
Income taxes  $—     $16,246 
Supplemental Schedule of Non-Cash Financing and Investing Activities:          
Initial recognition of warrant liability  $—     $135,125 
Property and equipment obtained in exchange for financing lease liabilities  $190,702    —   
Reclassification from liability to be settled in stock to additional paid in capital  $—     $21,420 
Common stock issued in connection with acquisitions  $—     $10,195,501 
Initial recognition of contingent consideration liability  $—     $886,000 
Recognition of right of use asset - operating lease  $3,527,443   $1,884,730 
Issuance of Note Payable for payment of prepaid expense  $318,833   $—   
           
The accompanying notes are an integral part of these audited consolidated financial statements.

 46 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business

Applied UV, Inc. (the “Parent”) was formed and incorporated in the State of Delaware for the intended purpose of holding the equity of SteriLumen, Inc. (“SteriLumen”) and MunnWorks, LLC (“MunnWorks”), together “the Subsidiaries”, and other companies acquired or created by the Parent in the future. The Parent acquired the Subsidiaries pursuant to share exchanges whereby the equity holders of the Subsidiaries exchanged all of their equity interests in the Subsidiaries for shares of voting stock of the Parent. As a result of the share exchanges, each Subsidiary became a wholly-owned subsidiary of the Parent. The Parent and each Subsidiary are collectively referred to herein as (the “Company”).

SteriLumen is engaged in the design, manufacture, assembly and distribution of (i) automated disinfecting mirror systems for use in hospitals and other healthcare facilities and (ii) air purification systems through its purchase of substantially all of the assets and certain liabilities of Akida Holdings, LLC, KES Science & Technology, and Scientific Air Management LLC, as described below. MunnWorks, LLC is engaged in the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries.

In February of 2021, the Company acquired all the assets and assumed certain liabilities of Akida Holdings, LLC (“Akida”). At the time of this acquisition, Akida owned the Airocide™ system of air purification technologies, originally developed for NASA, with assistance from the University of Wisconsin at Madison, that uses a combination of UVC and a proprietary, titanium dioxide based photocatalyst (“PCO”) to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products, with applications in the hospitality, hotel, healthcare, nursing homes, grocer, wine, commercial buildings and retail sectors. The Airocide™ system has been used by brands and organizations such as NASA, Whole Foods, Dole, Chiquita, Opus One, Sub-Zero Refrigerators and Robert Mondavi Wines. Akida contracted KES Science & Technology, Inc. (“KES”) to manufacture, warehouse and distribute the Airocide™ system and Akida’s contractual relationship with KES was assigned to and assumed by the Company as part of the acquisition.

On September 28, 2021, the Company acquired all the assets and assumed certain liabilities of KES. At the time of the acquisition, KES was principally engaged in the manufacturing and distribution of the Airocide™ system of air purification technologies and misting systems. KES also had the exclusive right to the sale and distribution of the Airocide™ system in certain markets. This acquisition consolidates all of manufacturing, sale and distribution of the Airocide™ system under the SteriLumen brand and expands the Company’s market presence in food distribution, post-harvest produce, wineries, and retail sectors. The Company sells its products throughout the United States, Canada, and Europe.

On October 13, 2021, the Company acquired all the assets and assumed certain liabilities of Scientific Air Management LLC, (“SciAir”). SciAir is a provider of whole-room, aerosol chamber and laboratory certified air disinfection machines that use a combination of UVC and a proprietary, patented system to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products. The units are well suited for larger spaces within a facility and are mobile with industrial grade casters allowing for movement throughout a facility to address increased bio burden from larger meetings or increased human traffic.

On March 25, 2022, the Company acquired the assets and assumed certain liabilities of VisionMark, LLC, (“Visionmark”). Visionmark is engaged in the business of manufacturing customized furniture using wood and metal components for the hospitality and retail industries.

 47 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Principles of Consolidation

The consolidated financial statements include the accounts of Applied UV, Inc., Munnworks, LLC and SteriLumen, Inc. All significant intercompany transactions and balances are eliminated in consolidation. 

Concentration of Credit and Business Risk

At times throughout the year, the Company maintains cash balances at various institutions, which may exceed the Federal Deposit Insurance Corporation limit. As of December 31, 2022, the Company was approximately $2,473,000 in excess of FDIC insured limits.

The Company provides credit in the normal course of business. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends and other information.

For the year ended December 31, 2022, the Company had no major suppliers that accounted for over 10% of supplies and materials used by the Company. For the year ended December 31, 2021, the Company had two major suppliers that accounted for approximately 25.4% of supplies and materials used by the Company. The amounts have been recorded as costs of sales in the consolidated statements of operations.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, as of the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation and accounting for equity awards related to warrants and stock-based compensation, determination of fair value for derivative instruments, the accounting for business combinations and allocating purchase price and estimating the useful life of intangible assets.

Cash, Restricted Cash and Cash Equivalents

Cash and equivalents include highly liquid investments that have original maturities less than 90 days at the time of their purchase. These investments are carried at cost, which approximates market value because of their short maturities. As of December 31, 2022 and 2021, the Company had approximately $27,000 and $1,077,000, respectively, in cash equivalents.

Accounts receivable

An allowance for uncollectible accounts receivable is recorded when management believes the collectability of the accounts receivable is confirmed. Subsequent recoveries, if any, are credited to the allowance. The allowance is determined based on management’s review of the debtor’s ability to repay and repayment history, aging history, and estimated value of collateral, if any. The Company had an allowance for doubtful accounts approximating $35,000 and $9,000 as of December 31, 2022 and 2021 respectively.

 48 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Inventory

Inventories consist of raw materials, work-in-process, and finished goods. Raw materials and finished goods are valued at the lower of cost or net realizable value, using the first-in, first-out (“FIFO”) valuation method. Work-in-process and finished goods includes the cost of materials, freight and duty, direct labor and overhead. The Company writes down inventory for estimated obsolescence equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. The company had a reserve for inventory approximating $88,000 and $140,000 as of December 31, 2022 and 2021, respectively.

Property and Equipment

Property and equipment are recorded at cost. Depreciation of furniture and fixtures is provided using the straight-line method, generally over the terms of the lease. Repairs and maintenance expenditures, which do not extend the useful lives of the related assets, are expensed as incurred. Depreciation of machinery and equipment is based on the estimated useful lives of the assets.

Schedule of estimated useful lives   
Machinery and equipment  5 to 7 years
Leasehold improvements  Lesser of term of lease or useful life
Furniture and fixtures  5 to 7 years

Business Acquisition Accounting

The Company applies the acquisition method of accounting for those that meet the criteria of a business combination. The Company allocates the purchase price of its business acquisitions based on the fair value of identifiable tangible and intangible assets. The difference between the total cost of the acquisition and the sum of the fair values of acquired tangible and identifiable intangible assets less liabilities is recorded as goodwill. Transaction costs are expensed as incurred in general and administrative expenses.

Goodwill and Intangible Assets

The Company has recorded intangible assets, including goodwill, in connection with business combinations. Estimated useful lives of amortizable intangible assets are determined by management based on an assessment of the period over which the asset is expected to contribute to future cash flows.

In accordance with U.S. GAAP for goodwill and other indefinite-lived intangibles, the Company tests these assets for impairment annually and whenever events or circumstances make it more likely than not that impairment may have occurred. For the purposes of that assessment, the Company has determined to assign assets acquired in business combinations to a single reporting unit including all goodwill and indefinite-lived intangible assets acquired in business combinations. During the year ended December 31, 2022, we evaluated potential triggering events that might be indicators that our goodwill and definite lived intangibles were impaired. As a result of our evaluation, we determined that the fair value of our goodwill and certain intangible assets were less than the carrying amount as of December 31, 2022. This resulted in a total impairment charge of $6,993,075. See note 2 for further information related to the impairment.

Income Taxes

The Company files income tax returns using the cash basis of accounting. Income taxes are accounted for under the asset and liability method. Current income taxes are based on the year’s income taxable for federal and state tax reporting purposes. Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable income will be available to allow all or part of the asset to be recovered.

 49 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Derivative Instruments

The Company evaluates its warrants to determine if those contracts or embedded components of those contracts qualify as derivatives. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company has concluded that there are no such reclassifications required to be made as of and for the periods ended December 31, 2022 and 2021.

The Company utilizes the Black-Scholes valuation model to value the derivative warrants as stipulated in the agreement for the warrant holders to receive cash based on that value.

Fair Value of Financial Instruments

The carrying amounts reported in the consolidated balance sheets for loans payable approximate fair value because of the immediate or short-term maturity of the financial instruments. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy.

Loss Per Share

Basic loss per share is computed by dividing net loss attributable to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential shares outstanding would be anti-dilutive.

The following table sets forth the number of potential shares of common stock that have been excluded from diluted net loss per share because their effect was anti-dilutive:

          
   As of December 31,
   2022  2021
Common stock options   1,000,028    644,314 
Common stock warrants   192,419    192,419 
Total   1,192,447    836,733 

Stock-Based Compensation

The Company accounts for its stock-based compensation awards in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 718 (“ASC”), Compensation-Stock Compensation (“ASC 718"). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock and modifications to existing stock options, to be recognized in the statements of operations based on their fair values over the requisite service period.

 50 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Research and Development

The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10"). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, research and development costs are expensed as incurred.

Revenue Recognition

The Company recognizes revenue when the performance obligations in the client contract has been achieved. A performance obligation is a contractual promise to transfer product to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as, the customer receives the benefit of the performance obligation. Under ASC 606, revenue is recognized when a customer obtains control of goods in an amount that reflects the consideration the Company expects to receive in exchange for those goods. To achieve this core principle, the Company applies the following five steps:

1) Identify the contract with a customer.
2) Identify the performance obligations in the contract.
3) Determine the transaction price.
4) Allocate the transaction price to performance obligations in the contract.
5) Recognize revenue when or as the Company satisfies a performance obligation.

MunnWorks projects, including those from the VisionMark acquisition, are completed within the Company’s facilities. For these projects, the company designs, manufactures and sells custom mirrors and furniture for the hospitality and retail industries through contractual agreements. These sales require the company to deliver the products within three to nine months from commencement of order acceptance. Revenue is recognized using the input method of accounting. Deferred revenue represents amounts billed in excess of revenues recognized. Revenues recognized in excess of amounts billed typically does not occur as the Company will not perform any work in excess of the amount the company bills to its customers. If work is performed in excess of amounts billed, the Company will record an unbilled receivable.

The company applied the five-step model to the sales of Akida’s and KES’s Airocide™ and misting system products, and SciAir’s whole-room aerosol chamber and laboratory certified air disinfection machines. At contract inception and once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company sells Airocide™ air sterilization units, misting systems, and whole-room aerosol chamber and laboratory certified disinfection machines to both consumer and commercial customers. These products are sold both domestically and internationally. The cycle from contract inception to shipment of products is typically one day to three months. The Company’s contracts for both its consumer and commercial customers each contain a single performance obligation (delivery of Airocide™, KES, and SciAir products), as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts and, therefore, not distinct. As a result, the entire transaction price is allocated to this single performance obligation. The Company recognizes revenues at a point in time when the customer obtains control of the Company’s product, which typically occurs upon shipment of the product by the Company or upon customer pick-up via third party common carrier.

 51 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Revenue Recognition (Continued)

Revenue recognized over time and revenue recognized at a point in time for the years ended:

Schedule of revenue:

          
   December 31,
   2022  2021
Recognized over time  $9,419,117   $1,606,950 
Recognized at a point in time   10,720,732    10,060,629 
   $20,139,849   $11,667,579 

Deferred revenue was comprised of the following as of:

   December 31,  December 31,
   2022  2021
Recognized over time  $3,581,195   $94,867 
Recognized at a point in time   1,149,104    693,908 
   $4,730,299   $788,775 

Deferred revenue amounting to $788,775 as of December 31, 2021 was recognized as revenue during the year ended December 31, 2022.

Shipping and Handling Charges

The Company reports shipping and handling fees charged to customers as part of net sales and the associated expense as part of cost of sales. Shipping charges amounted to $821,448 and $963,385 for the years ended December 31, 2022 and 2021, respectively.

Advertising

Advertising costs consist primarily of online search advertising and placement, trade shows, advertising fees, and other promotional expenses. Advertising costs are expensed as incurred and are included in sales and marketing on the consolidated statements of operations. Advertising expense for the years ended December 31, 2022 and 2021 was $1,109,207 and $799,799, respectively.

Vendor deposits

Vendor payments to third manufactures are capitalized until completion of the project and are recorded as vendor deposits. As of December 31, 2022 and 2021, the vendor deposit balance was $75,548 and $992,042, respectively.

 52 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Patent Costs

The Company capitalizes costs consisting principally of outside legal costs and filing fees related to obtaining and maintaining patents. The Company amortizes patent costs over the useful life of the patent which is typically 20 years, beginning with the date the patent is filed with the U.S. Patent and Trademark Office, or foreign equivalent. As of December 31, 2022 and 2021, capitalized patent costs net of accumulated amortization was $1,593,741 and $1,693,124, respectively. For the years ended December 31, 2022 and 2021, the Company recorded $100,065 and $32,398, respectively, of amortization expense for these patents.

Recently adopted accounting standards:

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (eTopic 326): Measurement of Credit Losses on Financial Instruments. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards replace the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measure at amortized cost to be presented at the net amount expected to be collected. The Company determined that this change does not have a material impact to the consolidated financial statements.

NOTE 2 – BUSINESS ACQUISITION

The Company accounted for the acquisitions as a business combinations using the purchase method of accounting as prescribed in Accounting Standards Codification 805, Business Combinations (“ASC 805") and ASC 820 – Fair Value Measurements and Disclosures (“ASC 820"). In accordance with ASC 805 and ASC 820, the Company used its best estimates and assumptions to accurately assign fair value to the tangible assets acquired, identifiable intangible assets and liabilities assumed as of the acquisition dates. Goodwill as of the acquisition date is measured as the excess of purchase consideration over the fair value of tangible and identifiable intangible assets acquired and liabilities assumed. The results of operations of the acquired businesses since the date of acquisition are included in the consolidated financial statements of the Company years ended December 31, 2022 and 2021. The total purchase consideration was allocated to the assets acquired and liabilities assumed at their estimated fair values as of the date of acquisition, as determined by management. The excess of the purchase price over the amounts allocated to assets acquired and liabilities assumed has been recorded as goodwill. The value of the goodwill from the acquisitions described below can be attributed to a number of business factors including, but not limited to, cost synergies expected to be realized and a trained technical workforce.

 53 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 2 – BUSINESS ACQUISITION (CONTINUED)

In conjunction with acquisitions noted below, we used various valuation techniques to determine fair value of the assets acquired, with the primary techniques being discounted cash flow analysis, relief-from-royalty, a form of the multi-period excess earnings and the with-and-without valuation approaches, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Inputs to these valuation approaches require significant judgment including: (i) forecasted sales, growth rates and customer attrition rates, (ii) forecasted operating margins, (iii) royalty rates and discount rates used to present value future cash flows, (iv) the amount of synergies expected from the acquisition, (v) the economic useful life of assets and (vi) the evaluation of historical tax positions. In certain acquisitions, historical data is limited, therefore, we base our estimates and assumptions on budgets, business plans, economic projections, anticipated future cash flows and marketplace data.

Akida Holdings LLC

On February 8, 2021 Applied UV, Inc. (the “Company”), entered into an asset purchase agreement (the “APA”) by and among the Company, SteriLumen, Inc., a New York corporation and wholly-owned subsidiary of the Company (the “Purchaser”) and Akida Holdings LLC, a Florida limited liability company (the “Seller”) pursuant to which the Purchaser acquired substantially all of the assets of the Seller and assumed certain of its current liabilities and contract obligations, as set forth in the APA (the “Acquisition”). In the Acquisition, the Purchaser acquired all the Seller’s assets and was assigned its contracts related to the manufacture and sale of the Airocide™ system, originally developed for NASA with assistance from the University of Wisconsin at Madison, that uses a combination of UV-C and a proprietary, titanium dioxide-based photocatalyst that has applications in the hospitality, hotel, healthcare, nursing homes, grocer, wine, commercial buildings, and retail sectors.

The purchase price and purchase price allocation as of the acquisition completion date follows.

     
Purchase Price:   
Cash  $760,293 
Fair market value of common stock issued (1,375,000 shares)   7,122,500 
Total Purchase Price, Net of Cash Acquired   7,882,793 
      
Assets Acquired:     
Accounts receivable   233,241 
Inventory   211,105 
Prepaid expenses   285,490 
Machinery and equipment   168,721 
Customer relationships   539,000 
Trade names   1,156,000 
Technology and know how   3,468,000 
Total Assets Acquired:   6,061,557 
      
Liabilities Assumed:     
Accounts payable   (415,341)
Deferred revenue   (491,702)
Total Liabilities Assumed   (907,043)
Net Assets Acquired   5,154,514 
Excess Purchase Price “Goodwill”  $2,728,279 

 

 54 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 2 – BUSINESS ACQUISITION (CONTINUED)

The excess purchase price has been recorded as goodwill in the amount of approximately $2,728,279. The estimated useful life of the identifiable intangible assets (see note 5) is seven to ten years. The goodwill is amortizable for tax purposes.

KES Science & Technology, Inc.

On September 28, 2021, SteriLumen, Inc. completed an Asset Purchase Agreement with KES Science & Technology, Inc. (“KES”), a Georgia corporation.

The purchase price and purchase price allocation as of the acquisition completion date follows.

Purchase Price:   
Cash  $4,299,900 
Fair market value of common stock issued (300,000 shares)   1,959,001 
Total Purchase Price, Net of Cash Acquired   6,258,901 
      
Assets Acquired:     
Accounts receivable   392,367 
Inventory   602,746 
Prepaid expenses   10,995 
Machinery and equipment   36,146 
Customer relationships   —   
Trade names   914,000 
Technology and know how   3,656,000 
Total Assets Acquired:   5,612,254 
      
Liabilities Assumed:     
Accounts payable   (296,681)
Capital lease obligations   —   
Total Liabilities Assumed   (296,681)
Net Assets Acquired   5,315,573 
Excess Purchase Price “Goodwill”  $943,328 

The excess purchase price has been recorded as goodwill in the amount of $943,328. The estimated useful life of the identifiable intangible assets is ten years (see note 5). The goodwill is amortizable for tax purposes.

Old SAM Partners (Scientific Air)

On October 13, 2021, the Company entered into an asset purchase agreement by and among the Company, SteriLumen, Inc., a New York corporation and wholly-owned subsidiary of the Company (the “Purchaser”) and Old SAM Partners, LLC, a Florida limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller, including the assignment of an exclusive distribution agreement. On October 13, 2021 the Seller received, as consideration for the Acquisition (i) $9,500,000 in cash; and (ii) 200,000 shares of the Company’s common stock and (iii) 200,000 unvested shares of the Company’s common stock, which are subject to cancellation if the earnout is not met. On the date of acquisition, the fair market value of the 200,000 vested shares was $5.57 for a total value of $1,114,000. An additional liability was recorded for $886,000 as a result of the agreement calling for additional cash consideration to the extent the share price is below $10 on the free trading date, as defined in the agreement. On December 31, 2021, the share price of our common stock was $2.70 per share and a loss on contingent consideration of  $574,000 was recorded in the consolidated statements of operations and increased the liability to $1,460,000.

 55 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 2 – BUSINESS ACQUISITION (CONTINUED)

The purchase price and purchase price allocation as of the acquisition completion date follows.

Purchase Price:   
Cash  $9,500,000 
Fair market value of common stock issued   1,114,000 
Contingent consideration based on stock price   886,000 
Total Purchase Price, net of cash acquired   11,500,000 
      
Assets Acquired:     
Accounts receivable   129,845 
Inventory   369,970 
Machinery and equipment   1,982 
Customer relationships   6,784,000 
Patents   1,533,000 
Technology and know how   1,217,000 
Trade names   326,000 
Total Assets Acquired:   10,361,797 
Assets Acquired   10,361,797 
Excess Purchase Price “Goodwill”  $1,138,203 

The excess purchase price has been recorded as goodwill in the amount of approximately $1,138,203. The estimated useful life of the identifiable intangible assets (see note 5) is ten years. The goodwill is amortizable for tax purposes.

On March 31, 2022, there was a settlement of a dispute that arose during the first quarter of 2022 between both parties regarding certain representations and warranties in the purchase agreement which resulted in a settlement and mutual release agreement where the seller agreed to relinquish any right, title, and interest in the previously issued 400,000 shares. During the three months ended March 31, 2022, the company recorded a loss on change in fair market value of contingent consideration of $240,000 and, as a result of the settlement agreement, the company recorded a gain on settlement of contingent consideration of $1,700,000. The Company also determined that a triggering event had occurred as a result of the settlement agreement. A quantitative impairment test on the goodwill and intangible assets determined that the fair value was below the carrying value and as a result the Company recorded a full goodwill impairment charge of $1,138,203 in the first quarter of 2022. Subsequently, as of December 31, 2022, we evaluated potential triggering events that might be indicators that our definite lived intangibles were impaired. We saw a significant decrease in the number of orders and demand of certain product lines within our disinfectant business segment.

As a result of our evaluation, we determined that the fair value of certain intangible assets were less than the carrying amount as of December 31, 2022. The Company recorded an impairment on intangibles of $5,854,872 in the Consolidated Statements of Operations during the year ended December 31, 2022.

On March 25, 2022, the Company entered into an asset purchase agreement by and among the Company, Munnworks, LLC., a New York Limited Liability Company and wholly-owned subsidiary of the Company (the “Purchaser”) and VisionMark LLC, a New York limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller in exchange for the assumption of obligations of buyer under the sublease and sublease guarantee.

 56 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 2 – BUSINESS ACQUISITION (CONTINUED)

The purchase price and purchase price allocation as of the acquisition completion date follows.

Purchase Price:   
Cash paid at closing  $10 
Due to landlord   755,906 
Total Purchase Price, net of cash acquired   755,916 
      
Assets Acquired:     
Accounts receivable, net   636,550 
Inventory   176,583 
Costs and estimated earnings in excess of billings   181,152 
Machinery and equipment   1,100,000 
Total Assets Acquired:   2,094,285 
      
Liabilities Assumed:     
Billings in excess of costs and earnings on uncompleted contracts   (1,388,838)
Total Liabilities Assumed   (1,388,838)
Net Assets Acquired   705,447 
Excess Purchase Price “Goodwill”  $50,469 

The excess purchase price has been recorded as goodwill in the amount of approximately $50,469. The goodwill is amortizable for tax purposes.

In connection with the VisionMark LLC acquisition, the Company is obligated to repay $31,057 of past due lease payments per month for the next 36 months commencing on April 1, 2022. The Company recognized a discount and related liability equal to the present value of the past due lease liability, and amortizes the difference between such present value and the liability through interest expense using a rate of 38.7% as per the effective interest rate method over the repayment period. Amortization of discount included in interest expenses was $146,073 for the year ended December 31, 2022.

As of December 31, 2022, the future maturity of the lease liability as of December 31, is as follows:

     
Years Ended December 31,   
2023  $372,684 
2024   372,684 
2025   93,174 
Total   838,542 
Less: Unamortized discount   (216,078)
Total amount due to landlord   622,464 
Less: current portion of amount due to landlord, net of discount   (229,235)
Total long-term portion of amount due to landlord  $393,230 

 

 57 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 3 – INVENTORY

Inventory consists of the following as of:

          
   December 31,  December 31,
   2022  2021
Raw materials  $3,485,040   $356,759 
Finished goods   2,110,838    1,429,479 
Inventory at cost   5,595,878    1,786,238 
Less: Reserve   (87,792)   (140,000)
Inventory  $5,508,086   $1,646,238 

NOTE 4 – PROPERTY AND EQUIPMENT

Property and equipment (including machinery and equipment under capital leases) are summarized by major classifications as follows:

          
   December 31,  December 31,
   2022  2021
Machinery and Equipment  $1,266,189   $254,685 
Leasehold improvements   67,549    67,549 
Furniture and Fixtures   203,256    54,041 
    1,536,994    376,275 
Less: Accumulated Depreciation   (403,526)   (179,664)
   $1,133,468   $196,611 

Depreciation expense, including amortization of assets under financing leases, for the year ended December 31, 2022 and 2021 was $223,862 and $137,777, respectively.

NOTE 5 – INTANGIBLE ASSETS

Intangible assets as of December 31, 2022 and 2021 consist of the following:

          
   December 31,  December 31,
   2022  2021
Intangible assets subject to amortization          
Customer Relationship (Note 2)  $1,655,598   $7,323,000 
Trade Names   2,208,530    2,396,000 
Patents   1,730,771    1,730,089 
Technology and Know How   8,341,000    8,341,000 
    13,935,899    19,790,089 
Less: Accumulated Amortization   (2,581,469)   (813,533)
   $11,354,430   $18,976,556 

 

 58 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 5 – INTANGIBLE ASSETS (CONTINUED)

As described in Note 2 of the financial statements, a quantitative impairment test on the goodwill and intangible assets determined that the fair value was below the carrying value and as a result the Company recorded a full goodwill impairment charge of $1,138,203 in the first quarter of 2022. Subsequently, as of December 31, 2022, we evaluated potential triggering events that might be indicators that our definite lived intangibles were impaired. We saw a significant decrease in the number of orders and demand of certain product lines within our disinfectant business segment. As a result of our assessment, the Company recorded an additional impairment on trade name and customer relationship intangible assets of $187,470 and $5,667,402, respectively, in the Consolidated Statements of Operations during the year ended December 31, 2022.

During the years ended December 31, 2022 and 2021, the Company recorded total amortization expense related to intangible assets of $1,767,936 and $808,967, respectively. The useful lives of tradenames ranges from 5 to 10 years, technology is 10 years, customer relationships ranges from 7 to 14 years, and patents range from 17 to 20 years.

Future amortization of intangible assets is as follows:

      
For the years ending December 31,   
2023   $1,256,948 
2024    1,256,948 
2025    1,256,948 
2026    1,242,192 
2027    1,197,925 
Thereafter    5,143,468 
Total    $11,354,430 

NOTE 6 – FINANCING LEASE OBLIGATION

The Company’s future minimum principal and interest payments under a financing lease for machinery and equipment are as follows:

      
For the years ending December 31,   
2023   $51,716 
2024    48,145 
2025    48,145 
2026    48,145 
2027    36,109 
Total lease payments    232,261 
Less: Amount representing interest    (40,479)
Present value of future minimum lease payments    191,782 
Less: current portion    (33,712)
Financing lease obligations, net of current    158,070 

NOTE 7 – NOTES PAYABLE

The Company entered into a loan agreement in April of 2019 where the company was required to pay $157,500 in five payments in the amount of $30,000 per year, with an additional $7,500, representing interest, in year two to a loan holder. As of December 31, 2022, the company has an outstanding balance of $157,500, and no payments have been made as of year end.

Minimum obligations under this loan agreement are as follows:

      
For the year ending December 31,   
2023   $127,500 
2024    30,000 
Total    $157,500 

 59 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

Streeterville Note

On October 7, 2022, the Company entered into a Security Purchase Agreement with Streeterville Capital, LLC whereby the Company issued an 8% unsecured redeemable note in the principal amount of $2,807,500. The Company received net proceeds of $2,462,500, after the deduction of debt issuance costs of $345,000. These fees were recorded as debt discounts, net of the carrying value of the debt, and are being amortized over the life of the loan using the effective interest rate method. The note has a maturity date of April 7, 2024. At any time following the occurrence of any event of default, interest shall accrue on the outstanding balance beginning on the date the applicable event of default occurred at an interest rate equal to the lesser of 18% per annum or the maximum rate permitted under applicable law.

The following table presents the balance of the Streeterville Note, net of discount at December 31, 2022.

     
   December 31,
   2022
Principle outstanding  $2,807,500 
Debt discount   (345,000)
Total   2,462,500 
      
Accumulated amortization of debt discount   77,600 
Streeterville note, net of related discount  $2,540,100 

 

 60 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 7 – NOTES PAYABLE (continued)

Minimum obligations under this loan agreement are as follows:

      
For the years sending December 31,   
2023   $2,072,500 
2024    735,000 
Total    $2,807,500 

The lender has the right at any time 6 months after the effective date, at its election, to redeem all or part of the maximum redemption amount as set forth in the promissory note. Payments of each redemption amount may be made (a) in cash, or (b) in common stock per the following formula: the portion of the applicable Redemption amount being paid in common stock divided by the common stock redemption price, or (c) by any combination of the foregoing. Whereas common stock redemption price means 87.5% multiplied by the Nasdaq minimum price. Whereas Nasdaq minimum price means the lower of: (i) the closing price on the trading day immediately preceding the date the common stock redemption price is measured; or (ii) the average closing price of the common stock for the five trading days immediately preceding the date the common stock redemption price is measured.

The principal amount of the Note may be prepaid in full, or any portion of the outstanding balance earlier than it is due; provided that in the event borrower elects to prepay all or any portion of the outstanding balance it shall pay to lender 120% of the portion of the outstanding balance borrower elects to prepay. The prepayment premium will not apply if borrower repays the Note in full on the anniversary date, which is one year from the purchase price date.

If prior to the anniversary date all redemption amounts are paid as common stock redemptions, then each time after the anniversary date that borrower makes a common stock redemption, $8,333 of the monitoring fee will be deducted from the outstanding balance, not to exceed $50,000. No interest will accrue on the monitoring fee.

For the year ended December 31, 2022, the Company recognized $345,000 as a debt discount relating to the fee and will be amortized using the effective interest method over the term of the note. The effective interest rate of the note is 22.23%. The Company recorded $77,600 due to debt discount amortization to interest expense in the accompanying Statement of Operations and as a result, at December 31, 2022, the remaining unamortized balance was $267,400.

Interest expense recorded in the accompanying Statements of Operations by the Company was $53,031 for the year ended December 31, 2022.

Directors and Officers Liability Insurance Agreement

On August 28, 2022, the Company entered into a one-year Directors and Officers Liability Insurance agreement for $318,833. Under the terms of the agreement, the Company made a down payment of $41,730, with the remaining balance financed over the remaining term at an annual percentage rate of 5.05%. Beginning in September 2022, the Company is making 10 monthly payments of $27,710, with the last payment expected to be made in June 2023. At December 31, 2022, the outstanding balance on the note payable was $166,262. The interest expense for the year ended December 31, 2022 was immaterial to the consolidated financial statements.

Pinnacle Note

In December 2022, the Company entered into a Loan and Security Agreement, or (the “Loan Agreement”), with Pinnacle Bank, which provides for a $5,000,000 secured revolving credit facility (the “Loan Facility”). The loan is subject to a maximum advance rate of up to 85% of net face amount of eligible accounts, plus the lessor a) of the sum of 20% of the aggregate eligible inventory value of raw materials and 35% of the aggregate eligible inventory value of finished goods, b) $1 million, c) 80% of the net orderly liquidation value of raw materials and finished goods, or d) 100% of the aggregate outstanding principal amount of advances. In no event shall the aggregate amount of the outstanding advances under the Loan Facility be greater than $5 million. The loan matures on December 9, 2024. The principal amount of outstanding revolving loan, together with accrued and unpaid interest, is due on the maturity date.

 61 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

The loan accrues interest at a 1.50% margin above the greater of the prime rate or 4.00%. The interest margin is increased to 2.00% in respect to the advances against eligible inventory. If the Company fails to perform any covenant, term or provision of the Loan Agreement, then interest shall accrue at the rate of 6.0% above the interest rate. If after the occurrence of an event of default and the loan is not paid in full by the maturity date, the loan shall bear interest at the rate of 18.0% above the interest rate.

Obligations under the Loan Agreement are secured by all of the Company’s assets. On the effective date the Company paid a loan fee of 2% of the amount of the Loan Facility and will be required to pay a loan fee of 1.5% of the amount of the Loan Facility annually thereafter.

The Loan Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and the Subsidiaries, including, without limitation, restrictions on liens, indebtedness, fundamental changes, capital expenditures, consignments of inventory and distributions.

The Loan Agreement contains customary events of default, including, without limitation, payment defaults, covenant defaults, breaches of certain representations and warranties, certain events of bankruptcy and insolvency, certain events under ERISA and judgments. If an event of default occurs and is not cured within any applicable grace period or is not waived, the Lender is entitled to take various actions, including, without limitation, the acceleration of amounts due thereunder and termination of commitments under the Loan Facility.

There were no borrowings outstanding under the Loan Facility as of December 31, 2022.

NOTE 8 – FAIR VALUE MEASUREMENTS

Accounting guidance on fair value measurements requires that financial assets and liabilities be classified and disclosed in one of the following categories of the fair value hierarchy:

Level 1 – Based on unadjusted quoted prices for identical assets or liabilities in an active market.

Level 2 – Based on observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3– Based on unobservable inputs that reflect the entity’s own assumptions about the assumptions that a market participant would use in pricing the asset or liability.

 62 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 8 – FAIR VALUE MEASUREMENTS (continued)

We did not have any transfers between levels during the periods presented.

The following table presents assets and liabilities that were measured at fair value in the Consolidated Balance Sheets on a recurring basis as of December 31, 2022 and 2021:

                         
   Carrying Amount  Fair Value  Quoted Priced active markets (Level 1)  Significant other observable inputs (Level 2)  Significant unobservable inputs (Level 3)
   As of December 31, 2022
Assets               
Money market funds  $26,828   $26,828   $26,828   $—     $—   
Total assets  $26,828   $26,828   $26,828   $—     $—   
Liabilities                         
Contingent consideration  $—     $—     $—     $—     $—   
Warrant liability   9,987    9,987    —      —      9,987 
Total liabilities  $9,987   $9,987   $—     $—     $9,987 
                          
    As of December 31, 2021
Assets                         
Money market funds  $1,076,664   $1,076,664   $1,076,664   $—     $—   
Total assets  $1,076,664   $1,076,664   $1,076,664   $—     $—   
Liabilities                         
Contingent consideration  $1,460,000   $1,460,000   $1,460,000   $—     $—   
Warrant liability   68,263    68,263    —      —      68,263 
Total liabilities  $1,528,263   $1,528,263   $1,460,000   $—     $68,263 

The carrying amounts of accounts receivable, accounts payable and short-term debt approximated fair values as of December 31, 2022 and 2021 because of the relatively short maturity of these instruments. There were no other level 3 or level 1 assets or liabilities as if December 31, 2022.

Money market funds – Cash equivalents of $26,828 and $1,076,664 as of December 31, 2022 and 2021, respectively, consisted of money market funds. Money market funds are classified as Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets.

Contingent consideration – The fair value of the contingent consideration is derived through the quoted market price of our stock, which represents a Level 1 measurement within the fair value hierarchy.

Warrant liability – The fair value of the warrant liability is derived through the Black scholes method and is based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.

Other Fair Value Measurements

In addition to assets and liabilities that are recorded at fair value on a recurring basis, GAAP requires that, under certain circumstances, we also record assets and liabilities at fair value on a nonrecurring basis.

In connection with the acquisitions of SciAir, KES, and Akida during 2021, and VisionMark in 2022, as discussed in Note 2, we used various valuation techniques to determine fair value, with the primary techniques being discounted cash flow analysis and the relief-from-royalty, a form of the multi-period excess earnings, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy.

 63 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

NOTE 9 – STOCKHOLDERS’ EQUITY 

At the Market Sales Agreement

On July 1, 2022, the Company filed a $50,000,000 mixed use shelf registration (Form S-3) and entered into an At The Market sales agreement (ATM) with Maxim Group, LLC, for a total of $9,000,000, as a readily available source of funding if needed. During the year ended December 31, 2022 the Company sold 804,811 ATM shares through the sales agent with gross proceeds of $964,083. In connection with the sale of these ATM Shares, the compensation paid by the Company to the Sales Agent was $28,922. As of March 31, 2023, an additional 1,764,311 shares have been sold for gross proceeds of $2,314,860, leaving a balance of $5,721,057 on the ATM facility. The shelf registration statement will expire on July 12, 2025.

Amendment of the Certificate of Designation

On June 17, 2021, the Company filed an amendment of the certificate of designation of Series A Preferred Stock. The Board of Directors, by unanimous written consent, duly adopted resolutions to amend the Series A Preferred Stock Certificate of Designations and changed the name from “Series A Preferred Stock” to “Series X Super Voting Preferred Stock”. All dividend, liquidation preference, voting, conversion, and redemption rights, did not change from the originally filed Certificate of Designation of Series A Preferred Stock. On July 11, 2022, the Board of Directors approved the reissuance of 8,000 shares of the Company’s Series X Super Voting Preferred Shares, which represent the remainder of the designated but unissued shares of Super Voting Preferred Stock.

On March 9, 2022, the Board of Directors approved a resolution that authorized the senior management of the Company to purchase up to and limited to one million shares of common stock between March 10, 2022 and September 30, 2022. As of December 31, 2022, the Company has a total 113,485 of treasury shares, all of which have been purchased as of December 31, 2022.

Pursuant to the Company’s amended and restated certificate of incorporation, as amended, the Company is authorized to designate and issue up to 20,000,000 shares of preferred stock, par value $0.0001 per share, in one or more classes or series. During the year ended December 31, 2022, the Company had 10,000 preferred shares designated as Series X Preferred Stock and 19,990,000 shares of preferred stock designated as 10.5% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). Upon certain events, the Company may, subject to certain conditions, at the Company’s option, redeem the Series A Preferred Stock. See below for a further description of the Series A Preferred Stock:

Dividends: Holders are entitled to receive cumulative cash dividends at the annual rate of 10.5% on $25.00 liquidation preference per share of the Series A Perpetual Preferred Stock. Dividends accrue and are payable in arrears beginning August 15, 2021, regardless of whether declared or there are sufficient earnings or funds available for payment. Sufficient net proceeds from the offering must be set aside to pay dividends for the first twelve months from issuance. The company has classified $0 and $845,250 as restricted cash as of December 31, 2022 and 2021, respectively, as a reserve to pay the remaining required dividends for the first year.

Redemption: Company has an optional redemption right beginning July 16, 2022, which redemption price declines annually. The initial redemption price after year 1 is $30 and decreases annually over 5 years to $25 per share. The Company also has a special optional redemption right upon the occurrence of a Delisting Event or Change of Control, as defined, at $25 per share plus accrued and unpaid dividends.

Voting Rights: The holders have no voting rights, except for voting on certain corporate decisions, or upon default in payment of dividends for any twelve periods, in which case the holders would have voting rights to elect two additional directors to serve on the Board of Directors.

Conversion Rights: Such shares are not convertible unless and until the occurrence of a Delisting Event or Change of Control and when the Company has not exercised its special optional redemption right. The conversion price would be the lesser of the amount converted based on the $25.00 liquidation preference plus accrued dividends divided by the common stock price of the Delisting Event or Change of Control (as defined) or $5.353319 (Share Cap). Effectively, the Share Cap limits the common stock price to no lower than $4.67.

 64 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 9 – STOCKHOLDERS’ EQUITY (continued)

2020 Incentive Plan

On March 31, 2020, the Company adopted the Applied UV, Inc. 2020 Omnibus Incentive Plan (the “Plan”) with 600,000 shares of common stock available for issuance under the terms of the Plan. On May 17, 2022, the shareholders of the Company approved an amendment to the Plan, increasing the shares available for issuance to 2,500,000. The Plan permits the granting of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units and Other Awards. The objectives of the Plan are to optimize the profitability and growth of the Company through incentives that are consistent with the Company’s goals and that link the personal interests of Participants to those of the Company’s stockholders. The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract and retain the services of Participants who make or are expected to make significant contributions to the Company’s success and to allow Participants to share in the success of the Company. From time to time, the Company may issue Incentive Awards pursuant to the Plan. Each of the awards will be evidenced by and issued under a written agreement.

If an incentive award granted under the Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered to the company in connection with an incentive award, the shares subject to such award and the surrendered shares will become available for future awards under the Plan. The number of shares subject to the Plan, and the number of shares and terms of any Incentive Award may be adjusted in the event of any change in our outstanding common stock by reason of any stock dividend, spin-off, stock split, reverse stock split, recapitalization, reclassification, merger, consolidation, liquidation, business combination or exchange of shares, or similar transaction. There are 1,605,000 shares available for future grants under the plan.

A summary of the Company’s option activity and related information follows:

                         
   Number of Options  Weighted-Average Exercise Price  Weighted-Average Grant Date Fair Value  Weighted-Average Remaining Contractual Life (in years)  Aggregate intrinsic value
Balances, January 1, 2021   136,750   $4.96   $2.27    9.95   $—   
Options granted   602,564    7.81    5.43    10.00    —   
Options forfeited   (95,000)   4.96    3.73    —      —   
Options exercised   —      —      —      —      —   
Balances, December 31, 2021   644,314   $7.11   $5.03    8.47   $—   
Options granted   639,000    1.66    1.06    10.00    —   
Options forfeited   (283,286)   7.02    —      —      —   
Options exercised   —      —      —      —      —   
Balances, December 31, 2022   1,000,028   $3.61   $—      9.03   $—   
Vested   320,109   $5.69             $—   

Share-based compensation expense for options totaling $567,194 and $721,783 was recognized for the years ended December 31, 2022 and 2021, respectively, based on requisite service periods.

The valuation methodology used to determine the fair value of the options issued during the year was the Black-Scholes option-pricing model. The Black-Scholes model requires the use of a number of assumptions including volatility of the stock price, the average risk-free interest rate, and the weighted average expected life of the options.

 65 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 9 – STOCKHOLDERS’ EQUITY (continued)

The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options.

Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of the award. The Company’s calculation of estimated volatility is based on historical stock prices of peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price.

As of December 31, 2022 there was $1,090,364 of total unrecognized compensation expense related to unvested employee options granted under the Company’s share-based compensation plans that is expected to be recognized over a weighted average period of approximately 2.19 years.

The weighted average fair value of options granted, and the assumptions used in the Black-Scholes model during the years ended December 31, 2022 and 2021 are set forth in the table below.

          
   2022  2021
Stock Price   $0.90 - $2.70    $4.16 - $9.79 
Exercise Price   $1.07 - $2.70    $4.16 - $9.79 
Dividend Yield   0%   0%
Volatility   78.95% - 92.96%    75.04% - 89.96% 
Risk-Free Rate   1.26% - 3.46%    1.02% - 1.40% 
Expected Life (in years)   5.31 - 6.08    5.36 - 6.25 

Common Stock Warrants

A summary of the Company’s warrant activity and related information follows:

           

 

 

  Number of Shares  Weighted-Average Exercise Price
Balances, January 1, 2021    235,095   $5.89 
Granted    —      —   
Exercised    (42,676)   —   
Balances, December 31, 2021    192,419   $5.84 
Granted    —      —   
Exercised    —      —   
Balances, December 31, 2022    192,419   $5.84 
Vested    192,419   $5.84 

For the years ended December 31, 2022 and 2021, the Company recorded a gain on the change in fair value of warrant liability in the amount of $58,276 and $66,862, respectively. The Company valued the warrant using the Black-Scholes option pricing model with the following terms on December 31, 2022: (a) exercise price of $6.56, (b) volatility rate of 94.55%, (c) risk free rate of 4.22%, (d) term of 2.86 years, and (e) dividend rate of 0%. The Company valued the warrant using the Black-Scholes option pricing model with the following terms on December 31, 2021: (a) exercise price of $6.56, (b) volatility rate of 82.08%, (c) risk free rate of 0.98%, (d) term of 3.86 years, and (e) dividend rate of 0%.

 66 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 9 – STOCKHOLDERS’ EQUITY (continued)

Preferred Stock Offering

On July 13, 2021, Applied UV, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Ladenburg Thalmann & Co. Inc. as representative (“Representative”) of the underwriters (“Underwriters”), related to the offering of 480,000 shares (the “Shares”) of the Company’s 10.5% Series A Cumulative Perpetual Preferred Stock [non-convertible], par value $0.0001 per share (“Series A Preferred Stock”), at a public offering price of $25.00 per share, which excludes 72,000 shares of Series A Cumulative Perpetual Preferred Stock that may be purchased by the Underwriters pursuant to their overallotment option granted to the Underwriters under the terms of the Underwriting Agreement. The Shares were offered and sold by the Company pursuant to the terms of the Underwriting Agreement and registered pursuant to the Company’s registration statement on (i) Form S-1 (File No. 333-257197), as amended, which was filed with the SEC and declared effective by the Commission on July 12, 2021 and (ii) the Company’s registration statement on Form S-1 (File No. 333-257862), which was filed with the Commission on July 13, 2021 and declared effective upon filing. The closing of the offering for the Shares took place on July 16, 2021 and were approved for listing on Nasdaq under the trading symbol “AUVIP”. On July 29, 2021, in connection with its offering of its 10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share, the Company closed the exercise of the underwriter’s overallotment option of 72,000 shares at $25.00 per share. Aggregate gross proceeds including the exercise of the underwriter’s overallotment option was $12,272,440 after deducting underwriting discounts and commissions and fees and other offering expenses.

Common Stock Offering

On December 28, 2021, the Company closed a common stock offering in which it issued 2,666,667 common shares at a public offering price of $3.00 per share. In connection with the Offering, the Company (i) received $8,000,000 less underwriting fees of $560,000 and offering Costs in the amount of $440,073, resulting in net proceeds of $6,999,928.

On January 5, 2022, the underwriters fully exercised their over-allotment option to purchase an additional 400,000 shares of common stock at the public offering price of $3.00 per share. The Company received gross proceeds of $1,200,000 for the over-allotment, which resulted in net proceeds to us of $1,092,000, after deducting underwriting discounts and commissions of $108,000.

 67 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 9 – STOCKHOLDERS’ EQUITY (continued)

Restricted Stock Awards

The Company records compensation expense for restricted stock awards based on the quoted market price of our stock at the grant date and the expense is amortized over the vesting period. These restricted stock awards are subject to time-based vesting conditions based on the continued service of the restricted stock award holder.

The following table presents the restricted stock units activity for the years ended December 31, 2021 and 2022:

          
   Number of Shares  Weighted-Average Fair Market Value
Unvested shares at January 1, 2021   187,555   $5.00 
Granted and unvested   274,500    5.16 
Vested   (163,176)   5.24 
Forfeited/Cancelled   (6,379)   5.00 
Unvested shares, December 31, 2021   292,500    4.71 
Granted and unvested   207,500    2.10 
Vested   (100,966)   3.88 
Forfeited/Cancelled   (311,535)   4.45 
Unvested shares, December 31, 2022   87,499   $2.38 
Vested as of December 31, 2022   306,670   $4.76 

Upon vesting, the restricted stock units are converted to common shares. Based on the terms of the restricted share and restricted stock unit grants, all forfeited shares revert back to the Company.

In connection with the grant of restricted shares, the Company recognized $153,208 and $550,138 of compensation expense within its statements of operations for the years ended December 31, 2022 and 2021, respectively.

The unvested shares as of December 31, 2022 represent $149,438 in unrecognized stock based compensation which will be recognized over a weighted average period of 2.10 years.

 68 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 10 - LEASING ARRANGEMENTS

The Company determines whether an arrangement qualifies as a lease under ASC 842 at inception. The Company has operating leases for office space and office equipment. The Company’s leases have remaining lease terms of one year to seven years, some of which include options to extend the lease term for up to five years. The Company considered these options to extend in determining the lease term used to establish the Company’s right-of use assets and lease liabilities once reasonably certain of exercise. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the lease term. The operating lease ROU asset also includes any lease payments made in advance of lease commencement and excludes lease incentives. The lease terms used in the calculations of the operating ROU assets and operating lease liabilities include options to extend or terminate the lease when the Company is reasonably certain that it will exercise those options. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

As the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate of 7.6% based on the information available at commencement date in determining the present value of lease payments.

Munnworks, LLC entered into a lease agreement in Mount Vernon, New York for a term that commenced on April 1, 2019 and will expire on the 31st day of March 2024 at a monthly rate of $13,400. In March of 2021, the Company obtained additional lease space and the agreement was amended to increase rent expense to $15,000 per month. On July 1, 2021, the Company again obtained additional lease space and rent expense was increased to $27,500 per month through July 1, 2024 and $29,150 per month from July 1, 2024 through July 1, 2026.

On September 28, 2021, the Company entered into a lease agreement in Kennesaw, Georgia for office and production space for a term that commenced on September 29, 2021 and will expire on October 1, 2024, with a rate ranging from $14,729 to $15,626 per month.

On April 1, 2022, the Company entered into a lease agreement in Brooklyn, New York for office and production space that commenced on April 1, 2022 and will expire on June 1, 2023, with a rate ranging from $94,529 to $97,365 per month. On December 31, 2022, the Company exercised its option to renew the first renewal term, commencing on July 1, 2023 and ending on June 30, 2025. As a result of the extension of the lease, the Company recorded an additional $2,146,785 of ROU asset and liability on the balance sheet on December 31, 2022.

Rent expense for the years ended December 31, 2022 and 2021 was $1,375,848 and $249,100 respectively.

Schedule maturities of operating lease liabilities outstanding as of December 31, 2022 are as follows:

      
2023   $1,699,318 
2024    1,702,014 
2025    969,567 
2026    174,900 
Total lease payments    4,545,799 
Less: Imputed Interest    (453,388)
Present value of future minimum lease payments   $4,092,411 

Consistent with ASC 842-20-50-4, the Company calculated its total lease cost based solely on its monthly rent obligation. The Company had no cash flows arising from its lease, no finance lease cost, short term lease cost, or variable lease costs. The Company’s lease does not produce any sublease income, or any net gain or loss recognized from sale and leaseback transactions. As a result, the Company did not need to segregate amounts between finance and operating leases for cash paid for amounts included in the measurement of lease liabilities, segregated between operating and financing cash flows; supplemental non-cash information on lease liabilities arising from obtaining right-of-use assets; weighted-average calculations for the remaining lease term; or the weighted-average discount rate.

 69 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 11 – PAYROLL PROTECTION PROGRAM

In April of 2020, the Company submitted a Paycheck Protection Program (“PPP”) application to Chase Bank for a loan amount equal to $296,827. The amount was approved, and the Company has received the funds. The PPP Loan, which is in the form of a PPP promissory note and agreement, matures in April of 2025 and bears interest at a rate of 1.00% per annum. The Lender will have 90 days to review borrower’s forgiveness application and the SBA will have an additional 60 days to review the Lender’s decision as to whether the borrower’s loan may be forgiven. Under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, covered utilities, and certain covered mortgage interest payments during the twenty-four-week period beginning on the date of first disbursement of the PPP Loan. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee earning more than $100,000, prorated annually. Not more than 40% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. The loan was forgiven in July of 2021 and in accordance with ASC 470, the amount was recorded as other income.

Under the CARES Act, further economic relief was provided through the Employee Retention Tax Credit (ERTC). In the year ended December 31, 2022, the Company recorded non-operating income of $205,052 related to the ERTC as a component of Other Income.

NOTE 12 - NOTE RECEIVABLE- RELATED PARTY

The company contemplated an acquisition with an entity where certain board members of the Company were also board members of the potential acquiree. In February of 2021, the Company entered into a non-interest bearing note receivable agreement whereby the Company loaned $500,000 to the entity. The note receivable was recorded at cost basis which approximates fair value because of the short-term maturity of the instrument. The loan matures on the earlier of (i) 180 days from the issuance date or (ii) the closing of the transactions set forth in a definitive acquisition entered into between the lender and the borrower. In the event the loan is paid in full on or before the maturity date, there shall be no interest accrued or payable on the outstanding principal amount. If an acquisition occurs, the $500,000 will be applied against the total acquisition price. If the company decides not to execute a definitive agreement within 180 days from the issuance date, the maturity date shall be the one-year anniversary of the issuance date. The maturity date has since been extended to November 30, 2021. The acquisition did not occur and the full amount of $500,000 was repaid on November 30, 2021.

NOTE 13 - INCOME TAXES

The provision for federal and state income taxes for the years ended is as follows:

          
   2022  2021
Current provision:          
Federal  $—     $(110,234)
State   —      18,415 
Deferred provision (benefit):          
Federal  $—     $—   
State   —      —   
Total Deferred   —      —   
Total provision for income taxes  $—     $(91,819)

Realization of future tax benefits related to the deferred tax assets is dependent on many factors, including the Company’s ability to generate taxable income within the net operating loss carryforward period. Management has considered these factors in reaching conclusion as to the valuation allowance for financial reporting purposes and has recorded a full valuation allowance against the deferred tax asset.

The income tax effect of temporary differences comprising the deferred tax assets and deferred tax liabilities is a result of the following at December 31:

 70 

 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 
          
   2022  2021
Deferred tax assets:          
Net operating loss  $3,170,457   $1,732,422 
Fixed assets   (51,573)   14,493 
Lease   52,340    1,201 
Loss on contingency   (193,398)   130,765 
Intangible assets   1,663,044    1,707 
Research and development   64,189    0 
Stock based compensation   95,908    284,468 
Accrual to cash conversion   1,099,403    216,068 
Total  $5,900,370   $2,381,124 
Valuation allowance  $(5,900,370)  $(2,381,124)
Net  $—     $—   

The income tax provision differs from the expense that would result from applying federal statutory rates to income before income taxes because the Company is subject to state income taxes, deferred income taxes are based on average tax rates and a portion of gifts and meals and entertainment are not tax deductible. A valuation allowance has been provided to reduce deferred tax assets to an amount that is more likely than not to be realized.

Prior to the share exchange, Munn Works, LLC was taxed as a single member Limited Liability Company for federal and state income tax purposes. As such, the Company will not pay income taxes for earnings prior to the share exchange, as any income or loss will be included in the tax returns of the individual member. Accordingly, no provision is made for income taxes in the financial statements prior to the share exchange.

Effective tax rates differ from the federal statutory rate of 21% applied to income before provision for income taxes due to the following:

          
   2022  2021
Federal statutory rate times financial statement income  $(3,551,627)  $(1,552,673)
Permanent tax basis differences   (2,268)   (72,997)
Deferred true up   159,849    13,911 
State taxable income, net   (158,480)   (86,700)
Change in Valuation allowance   3,519,246    1,524,637 
Rate change   —      154,179 
True up   —      (91,819)
Other   33,280    19,643 
           
Total provision for income taxes  $—     $(91,819)

The Company has available net operating loss approximately $16,757,643 for tax purposes to offset future taxable income. Pursuant to the Tax Reform Act of 1986, annual utilization of the Company’s net operating loss and contribution carryforwards may be limited if a cumulative change in ownership of more than 50% is deemed to occur within any three-year period. The tax years 2018 through 2021 remain open to examination by federal agencies and other jurisdictions in which it operates.

NOTE 14 - SEGMENT REPORTING

FASB Codification Topic 280, Segment Reporting, establishes standards for reporting financial and descriptive information about an enterprise’s reportable segments. The Company has three reportable segments: the design, manufacture, assembly and distribution of a suite of air (fixed and mobile) and surface disinfecting systems for use in healthcare, hospitality, food, wine, and commercial municipal and residential markets (Disinfection segment); the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries (Hospitality segment); and the Corporate segment, which includes expenses primarily related to corporate governance, such as board fees, legal expenses, audit fees, executive management, and listing costs. The segments are determined based on several factors, including the nature of products and services, the nature of production processes, customer base, delivery channels and similar economic characteristics.

An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net sales less cost of sales, segment selling, general and administrative expenses, research and development costs and stock-based compensation. It does not include other charges (income), or interest.

 71 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 14 - SEGMENT REPORTING (continued)
                     
   Hospitality  Disinfectant  Corporate  Total
Balance sheet at December 31, 2022                     
Assets   $9,638,828   $19,831,097   $3,257,502   $32,727,427 
Liabilities    10,666,643    1,545,217    3,281,672    15,493,532 
Balance sheet at December 31, 2021                     
Assets   $2,158,789   $27,851,691   $8,515,512   $38,525,992 
Liabilities    2,481,186    1,528,706    1,850,340    5,860,232 

 

   Hospitality  Disinfectant  Corporate  Total
Income Statement for the year ended December 31, 2022                    
Net Sales  $13,639,370   $6,500,479   $—     $20,139,849 
Cost of Goods Sold   12,375,645    3,725,910    —      16,101,555 
Research and development   —      319,167    —      319,167 
Loss on impairment of goodwill   —      6,993,075    —      6,993,075 
Selling, General and Administrative expenses   4,351,932    7,680,551    2,771,585    14,804,068 
Income Statement for the year ended December 31, 2021                    
Net Sales  $5,943,664   $5,723,915   $—     $11,667,579 
Cost of Goods Sold   4,488,652    3,080,541    —      7,569,193 
Research and development   —      53,408    —      53,408 
Selling, General and Administrative expenses   2,281,460    6,110,206    2,950,046    11,341,712 

 

 72 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

NOTE 15 – PROFORMA FINANCIAL STATEMENTS (UNAUDITED)

Unaudited Supplemental Pro Forma Data

Unaudited pro forma results of operations for the years ended December 31, 2022 and 2021 as though the company acquired Akida, KES, Visionmark, and SciAir (the “Acquired Companies”) on January 1, 2021 is set forth below.

          
   Year Ended December 31,  Year Ended December 31,
   2022  2021
Net Sales  $22,248,183   $22,072,379 
Net Loss   (16,580,044)   (9,046,424)
           
Net Loss attributable to common stockholders:          
Dividends to preferred shareholders   (1,449,000)   603,750 
Net Loss attributable to common stockholders   (18,031,480)   (9,650,174)
Basic and Diluted Loss Per Common Share  $(1.41)  $(0.98)
Weighted Average Shares Outstanding - basic and diluted   12,754,979    9,799,627 

NOTE 16 – SUBSEQUENT EVENTS

Streeterville Capital

On January 25, 2023, (the “Execution Date”) the Company executed a Redeemable Promissory Note with Streeterville Capital, LLC (the “Investor”) in the amount of $2,807,500 (the “Note”). The Note matures eighteen (18) months from its issuance date of January 25, 2023 and bears interest at 8% per annum on the outstanding principal balance of the Note. The original principal balance of the Note is $2,500,000, plus debt issuance costs of $345,000. Beginning on July 25, 2023, the Investor shall have the right in any month to cause the Company to redeem up to $247,500 of the principal amount of the Note in such month. The Company may elect, in its sole discretion, to redeem such portions of the Note in cash or in its common stock or in any combination thereof. If redemptions are made by the Company with its common stock, such stock will be valued at 87.5% of the Nasdaq Minimum Price. The Company may not redeem the Note with its common stock if at the time of such redemption there is an Equity Condition Failure. It is the intention of the Company to make all Note redemption payments in cash and not in stock. Beginning on July 25, 2023, all cash redemptions will be subject to a ten percent (10%) redemption premium. The Company may pay all or any portion of the outstanding balance on or before one hundred five (105) days from the Execution Date without a prepayment penalty; if paid after one hundred five (105) days, the Company will be subject to a 10% prepayment premium.

 73 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

The Acquisitions

The PURO Acquisition

On January 26, 2023 (the “Closing Date”), prior to the effective time of the Puro Mergers (as defined below), the Company paid or issued, as applicable (i) 2,497,220 shares of the Company’s common (based on a value of $2.00 per share), (ii) 251,108 shares of the Company’s 5% Series C Cumulative Perpetual Preferred Stock, par value $0.0001 per share (“Series C Preferred Stock”) (iii) $1,335,114 of PURO’s indebtedness to various creditors, (iv) $221,675 of the PURO’s transaction expenses and (v) $2,500,000 and 1,250,000 shares of the Company’s 2% Series B Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”) in repayment of a $5 million note issued by PURO and held by one of its vendor’s. As a result of these issuances and payments the Company and PURO agreed that the acquisition of PURO by the Company (the “PURO Acquisition”) was closed and the PURO Mergers could be affected as soon as possible. The Company financed the payments described above through a $2,807,500 Redeemable Promissory Note from Streeterville Capital, LLC (the “Redeemable Note”) and a $1,537,938 draw on a line of credit from Pinnacle Bank (the “Line of Credit Draw”). The shares described in clauses (i) and (ii) above are collectively referred to herein as the “PURO Equity Consideration”.

 On January 27, 2023 in connection with the prior closing of the PURO Acquisition, the Company caused a two-step merger to occur as follows: (i) a merger between PURO Lighting, LLC, a Colorado limited liability company (“Old PURO”) and PURO Acquisition Sub I, Inc., a Colorado corporation (“PURO Sub I”) and wholly owned subsidiary of the Company became effective (the “First PURO Merger), whereby PURO Sub I was the surviving entity of the merger and then (ii) a merger between PURO Sub I and PURO Acquisition Sub II, LLC, a Delaware limited liability corporation (“PURO Sub II”) and wholly owned subsidiary of the Company became effective (the “Second PURO Merger” and together with the First PURO Merger, the “PURO Mergers”), in each case, pursuant to a previously executed Agreement and Plan of Merger dated as of December 19, 2022, as amended on January 26, 2023 (the “PURO Merger Agreement”), by and between the Company, PURO Acquisition Sub I, PURO Acquisition Sub II, PURO, Brian Stern and Andrew Lawrence. In connection with the PURO Mergers, PURO Sub II was renamed Puro Lighting, LLC (“New PURO”) and New PURO is a wholly-owned subsidiary of the Company.

At the effective time of the First Puro Merger (i) all of the capital stock of PURO Merger Sub I that was outstanding immediately prior to the effective time of the First PURO Merger was converted into and became (i) 100% of the membership interests of Old PURO (and the membership interests of Old PURO into which the membership interests of PURO Merger Sub I were converted became the only outstanding membership interests of Old PURO) and (ii) the right of each holder of a membership interest or profit interest in Old PURO immediately prior to the effective time of the First PURO Merger to receive from the Company their ownership percentage of the following:

(1)The PURO Equity Consideration; and
(2)The right to receive earnout payments subject to certain conditions, including achieving certain revenue targets and gross profit margins and payable as set forth in the PURO Merger Agreement and Schedule II thereto.

The LED Supply Acquisition

On the Closing Date, prior to the effective time of the Puro Mergers, the Company paid or issued, as applicable (i) 1,377,777 shares of the Company’s common stock; (ii) 148,888 shares of Series C Preferred Stock; (iii) $364,316 of Old LED Supply’s indebtedness to various creditors; and (iv) $221,674 of Old LED Supply’s transaction expenses. Part of Old LED Supply’s indebtedness on the Closing Date was $1,778,667 outstanding principal and interest on a line of credit from JP Morgan Chase Bank, N.A. (the “Chase Loan”). The Company has agreed to repay the Chase Loan 14 calendar days from the Closing Date As a result of these issuances, agreements and payments the Company and Old LED Supply agreed that the acquisition of Old LED Supply by the Company (the “LED Supply Acquisition”) was closed and the LED Supply Mergers could be effected as soon as possible. The Company financed the payments described above through the Line of Credit Draw. The shares described in clauses (i) and (ii) above are collectively referred to herein as the “LED Supply Equity Consideration”.

On January 27, 2023 in connection with the prior closing of the LED Supply Acquisition, the Company caused a two-step merger to occur as follows: (i) a merger between LED Supply Co. LLC, a Colorado limited liability company (“Old LED Supply”) and LED Supply Acquisition Sub I, Inc., a Colorado corporation (“LED Supply Sub I”) and wholly owned subsidiary of the Company became effective (the “First LED Supply Merger”), whereby LED Supply Acquisition Sub I was the surviving entity in the merger and then (ii) a merger between LED Supply Sub I and LED Supply Acquisition Sub II, LLC, a Delaware limited liability corporation (“LED Supply Sub II”) and wholly owned subsidiary of the Company became effective (the “Second LED Supply Merger” and together with the First LED Supply Merger, the “LED Supply Mergers”), pursuant to the previously executed Agreement and Plan of Merger dated as of December 19, 2022, as amended on January 26, 2023 (the “LED Supply Merger Agreement”), by and between the Company, LED Supply Acquisition Sub I, LED Supply Acquisition Sub II, LED Supply, Brian Stern and Andrew Lawrence. In connection with the LED Supply Mergers, LED Supply Sub II was renamed Led Supply Co. LLC (“New LED Supply”) and New LED Supply is a wholly-owned subsidiary of the Company.

 74 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

At the effective time of the First LED Supply Merger (i) all of the capital stock of LED Supply Merger Sub I that was outstanding immediately prior to the effective time of the First LED Supply Merger was converted into and became (i) 100% of the membership interests of Old LED Supply (and the membership interests of Old LED Supply into which the membership interests of LED Supply Merger Sub I were converted became the only outstanding membership interests of Old LED Supply) and (ii) the right of each holder of a membership interest or profit interest in Old LED Supply immediately prior to the effective time of the First LED Supply Merger to receive from the Company their ownership percentage of the following:

(1)The LED Supply Equity Consideration; and
(2)The right to receive earnout payments subject to certain conditions, including achieving certain revenue targets and gross profit margins and payable as set forth in the LED Supply Merger Agreement and Schedule II thereto.

 

The foregoing descriptions of the transactions consummated by the Merger Agreements (as amended) are not intended to be complete and is qualified in its entirety by reference to the full text of the Merger Agreements previously filed as Exhibits 10.1 and 10.2 to the Form 8-K filed on December 20, 2022, and the Amendments to the Merger Agreements filed hereto as Exhibits 10.1 and 10.2including its amendments, and the Note Cancellation Agreement, copies of which are filed herewith as Exhibits 10.1, 10.2, 10.3, 10.4 and 10.5, respectively, and incorporated by reference herein.

Legal Settlement

On February 25, 2022, James Doyle, a former Chief Operating Officer of the Company filed an arbitration claim against the Company for approximately $1.5 million plus attorneys’ fees and other costs with the American Arbitration Association in the State of New York for severance pay and other claims after being terminated by the Company for cause. The arbitration proceeding was initiated pursuant to the arbitration provision in Mr. Doyle’s employment agreement with the Company. The evidentiary hearing was conducted at the American Arbitration Association’s midtown offices on November 7, 8, 9, and 10, 2022.  Afterwards, the parties submitted post-hearing briefs.  On January 24, 2023, the arbitration panel issued a Partial Final Award, whereby the Panel denied five of the seven counts asserted by Doyle, and awarded him only $100,000 in severance pay plus $21,153.84 in unused vacation time plus 6,379 additional shares in the Company pursuant to the terms of his Employment Agreement.  Because Mr. Doyle was determined to be the prevailing party, the Panel awarded him his reasonable attorneys’ fees and expenses, which amounts are currently the subject of post-hearing briefing.  The Company estimated additional legal fees of $10,000. The Company accrued a total of $131,153.83 in S,G&A expense to cover severance pay, unused vacation time, and the legal fee estimate. An additional $5,000 was accrued for interest expense as per the Partial Final Award.

Unregistered Sales of Equity Securities.

The issuance of the PURO Equity Consideration, the LED Supply Equity Consideration and the Series B Preferred Stock are exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”).

 75 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

Material Modification to Rights of Security Holders.

Series B Preferred Stock

On January 25, 2023, the Company filed the Certificate of Designations, Rights, and Preferences for the Series B Preferred Stock with the Secretary of State of the State of Delaware, which became effective upon acceptance for record. On January 26, 2023, the Company filed the Amendment to the Series B Certificate of Designation (together with the Certificate of Designations, Rights, and Preferences for the Series B Preferred Stock, the “Series B Certificate of Designation”), which became effective upon acceptance for record. The Series B Certificate of Designation classified a total of 1,250,000 shares of the Company’s authorized shares of preferred stock, $0.0001 par value per share, as Series B Preferred Stock.

As set forth in the Series B Certificate of Designation, the Series B Preferred Stock ranks, as to dividend rights and rights upon the Company’s liquidation, dissolution or winding up: (i) senior to all classes or series of Common Stock and to all other equity securities issued by the Company expressly designated as ranking junior to the Series B Preferred Stock; (ii) on parity with the Company’s 10.5% Series A Cumulative Perpetual Preferred Stock; (iii) at least on parity with any future class or series of the Company’s equity securities designated on or after January 25, 2023, including the Company’s 5% Series C Cumulative Perpetual Preferred Stock; and (iv) effectively junior to all the Company’s existing and future indebtedness (including indebtedness convertible into Common Stock or preferred stock) and to the indebtedness and other liabilities of the Company’s existing or future subsidiaries.

Holders of Series B Preferred Stock, when and as authorized by the Company’s Board of Directors, are entitled to cumulative cash dividends at the rate of 2% of the $6 per share liquidation preference per year (equivalent to $0.12 per share per year). Dividends will be payable quarterly in arrears, on or about the 15th day after the end of a quarterly period, beginning on April 15, 2023.

The holders of Series B Preferred Stock, at his, her, or its option, can require the Company to redeem all or a portion of the Series B Preferred Stock at any time and from time to time held by such holder after 30 months from the original issue date at a redemption price of $2.00 per share, plus any accrued and unpaid dividends (whether or not authorized or declared), up to but not including the date fixed for redemption, without interest, to the extent the Company has funds legally available therefor; provided that if a holder requires the Company to redeem all or a portion of the Series B Preferred Stock at any time and from time to time held by such holder on or after the five (5) year anniversary of the original issue date, the redemption price will be $6.00 per share, plus any accrued and unpaid dividends (whether or not authorized or declared), up to but not including the date fixed for redemption, without interest, to the extent the Company has funds legally available therefor.

The Series B Certificate of Designation provides for a special optional redemption by the Company upon a change of control, in whole or in part, for $6.00 per share, plus accrued but unpaid dividends to, but not including the redemption date.

The holders of Series B Preferred Stock neither have voting nor preemptive rights. Each share of Series B Preferred Stock is convertible, at any time and from time to time from and after the original issue date, at the option of the holder, into one share of Common Stock. The Series B Preferred Stock has no stated maturity and will not be subject to any sinking fund for the payment of the redemption price or mandatory redemption.

Series C Preferred Stock

On January 25, 2023, the Company filed the Certificate of Designations, Rights, and Preferences for the Series C Preferred Stock with the Secretary of State of the State of Delaware, which became effective upon acceptance for record. On January 26, 2023, the Company filed the Amendment to the Series C Certificate of Designation (together with the Certificate of Designations, Rights, and Preferences for the Series C Preferred Stock, the “Series C Certificate of Designation”), which became effective upon acceptance for record. The Series C Certificate of Designation classified a total of 2,500,000 shares of the Company’s authorized shares of preferred stock, $0.0001 par value per share, as Series C Preferred Stock.

 76 

 

Applied UV, Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

 

As set forth in the Series C Certificate of Designation, the Series C Preferred Stock will rank, as to dividend rights and rights upon the Company’s liquidation, dissolution or winding up: (i) senior to all classes or series of Common Stock and to all other equity securities issued by the Company expressly designated as ranking junior to the Series C Preferred Stock; (ii) on parity with any future class or series of the Company’s equity securities expressly designated as ranking on parity with the Series C Preferred Stock; (iii) junior to all equity securities issued by the Company with terms specifically providing that those equity securities rank senior to the Series C Preferred Stock with respect to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up; and (iv) effectively junior to all the Company’s existing and future indebtedness (including indebtedness convertible into Common Stock or preferred stock) and to the indebtedness and other liabilities of the Company’s existing or future subsidiaries.

Holders of Series C Preferred Stock, when and as authorized by the Company’s Board of Directors, are entitled to cumulative cash dividends at the rate of 5% of the $5.00 per share liquidation preference per year (equivalent to $0.25 per share per year). Dividends will be payable quarterly in arrears, on or about the 15th day after the end of a quarterly period, beginning on April 15, 2023.

The Company, to the extent it has legally available funds, must redeem all shares of Series C Preferred Stock on the date that is three years from January 26, 2023. The Series C Certificate of Designation provides for a special optional redemption by the Company upon a change of control, in whole or in part, for $5.00 per share, plus accrued but unpaid dividends to, but not including the redemption date.

The holders of Series C Preferred Stock neither have voting nor preemptive rights. Each share of Series C Preferred Stock will be convertible, at any time and from time to time from and after January 26, 2023, at the option of the holder, into one share of Common Stock. The Series C Preferred Stock has no stated maturity and will not be subject to any sinking fund for the payment of the redemption price or mandatory redemption.

 

 77 

 

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosures  

None.

Item 9A. Controls and Procedures

Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of December 31, 2022. Based on that evaluation, the Company’s Chief Executive Officer and the Company’s Chief Financial Officer have concluded that as of December 31, 2022, due to the existence of the material weakness in the Company’s internal control over financial reporting described below, the Company’s disclosure controls and procedures were not effective.

Evaluation of Disclosure Controls and Procedures

Our Chief Financial Officer is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, our principal executive and principal financial officers, or persons performing similar functions, and effected by our Board, senior management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We continue to review our internal control over financial reporting and may from time to time make changes aimed at enhancing their effectiveness and to ensure that our systems evolve with our business.

 78 

 

Under the supervision and with the participation of management, including the interim Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in “Internal Control — Integrated Framework (2013)” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on the control deficiencies identified during this evaluation and set forth below, our senior management has concluded that we did not maintain effective internal control over financial reporting as of December 31, 2022 due to the existence of a material weakness in internal control over financial reporting as described below.

As set forth below, management will continue to take steps to remediate the control deficiencies identified below. Notwithstanding the control deficiencies described below, we have performed additional analyses and other procedures to enable management to conclude that our consolidated financial statements included in this Form 10-K fairly present, in all material respects, our financial condition and results of operations as of and for the year ended December 31, 2022.

A material weakness is a deficiency, or a combination of deficiencies, in internal controls over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

While preparing its annual report for the year ended December 31, 2020 the Company identified an error in the timing of recognizing certain revenues that effected the previously filed consolidated financial statements as of and for the years ended December 31, 2019 and 2018. The error also impacted the previously reported financial statements for the quarters ended September 30, 2020, June 30, 2020 and March 31, 2020. The impact in those periods has been disclosed in the September 30, 2021, June 30, 2021 and March 31, 2021 10-Q filings.

In connection with the preparation of the consolidated financial statements for the three months ended March 31, 2021, the Company recognized an error relating to the recognition of the initial warrant liability in November of 2020. The error caused additional paid in capital to be overstated by approximately $135,000, warrant liability to be understated by approximately $110,000, and net loss to be overstated by approximately $25,000 as of and for the year ended December 31, 2020. The Company concluded the impact on the interim and year ended December 31, 2020 financial statements was immaterial and corrected the balances as of March 31, 2021,

As part of such process, our management and audit committee determined that our disclosure controls and procedures for the Affected Periods were not effective and that the foregoing arose as a result of a material weakness in our internal control over financial reporting.

The Company’s management has developed a remediation plan to address the material weakness and as of January 1, 2021 began using a new cloud-based software which tracks the progress of jobs and more accurately reflects the percentage of job completeness ensure such revenue is recognized in the appropriate period. In addition, the Company intends to further remediate the deficiency by performing the following:

•   design and implement additional internal controls and policies to ensure that we routinely review and document our application of established significant accounting policies; and
•   implement additional systems and technologies to enhance the timeliness and reliability of financial data within the organization.
•   continue to engage third-party subject matter experts to aid in identifying and applying US GAAP rules related to complex financial instruments as well as to enhance the financial reporting function.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures and internal control over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. 

Changes in Internal Controls over Financial Reporting

No change in the Company’s internal controls over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information.

None.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 

Not applicable. 

 79 

 

PART III

Item 10. Directors, Executive Officers and Corporate Governance

The following are our executive officers and directors and their respective ages and positions as of March 31, 2023.

Name   Age    Position
Max Munn   78   President, Chief Executive Officer and Director
Michael Riccio   64   Chief Financial Officer
Eugene E. Burleson   82   Chairman
Dallas C. Hack   70   Director
Joseph Luhukay   76   Director
Brian Stern   38   Director

Max Munn is the President, Chief Executive Officer and a director of the Company and is also the Chief Executive Officer of Munn Works, LLC, our subsidiary focused on the hospitality market. Mr. Munn has held this position at Munn Works for over 20 years. Mr. Munn is also Co-chairman of Dieu Donne Inc., a not-for-profit and a leading, world recognized atelier wherein dimensional, handmade paper is utilized in the making of art. Mr. Munn attended MIT from 1961-1966, majored in chemistry and architecture; and received a Bachelor of Architecture degree. Mr. Munn also attended Columbia University for post graduate studies from 1966-1968, working toward a Ph.D. in architectural history.

Michael Riccio is our Chief Financial Officer. Mr. Riccio joins Applied UV with more than 25 years of broad experience in leadership roles in corporate and operational finance, including corporate merger and acquisition planning and integration. From September 1986 to March 2021 Mr. Riccio was Chief Financial Officer and Treasurer of Panasonic Corporation of North America. At Panasonic Mr. Riccio lead the finance organization that supports the principal North American subsidiary of Osaka, Japan-based Panasonic Corporation. Prior to Panasonic, Mr. Riccio was the Corporate Accounting Manager for Sealed Air Corporation (SEE on NYSE), and prior to Sealed Air he began his career at CohnReznick, where he was a Senior Auditor. Mr. Riccio is a Certified Public Accountant (CPA) and holds a B.A. in accounting from Rutgers University and an MBA in finance from Rutgers Business School. Mr. Riccio is a member of the American Institute of Certified Public Accountants and the New Jersey Society of Certified Public Accountants.

Eugene E. Burleson is a Director of the Company. He is a private investor, currently a director and Chairman of the Compensation Committee of Sunlink Health Systems, Inc. (NYSE American: SSY), an investor in healthcare facilities and related businesses located in the Southeast, and a director and the Chairman of the Compensation Committee of HealthNow New York, a private health insurance company. He was Chairman of PET DRx Corporation from June 2005 to July 1, 2010, and its Chief Executive Officer from October 2008 until its acquisition by VCA Antech in July 2010. Mr. Burleson was a director of HealthMont Inc. from September 2000 until its acquisition by SunLink in October 2003. Mr. Burleson served as Chairman of the Board of Directors of Mariner Post-Acute Network, Inc. from January 2000 to June 2002. Mr. Burleson also served as Chairman of the Board of Directors of Alterra Healthcare Inc. a developer and operator of assisted living facilities and is on the Board of Deckers Outdoor Corporation Inc. Mr. Burleson served as Chairman of the Board and Chief Executive Officer of GranCare Inc. from October 1988 to November 2000. Additionally, Mr. Burleson served as President and Chief Executive Officer of GranCare Inc. from December 1990 to February 1997. Upon completion of the merger of GranCare’s pharmacy operations with Vitalink Pharmacy Services Inc. in February 1997, he became Chief Executive Officer and a Director of Vitalink Pharmacy Services Inc. Mr. Burleson resigned as Chief Executive Officer and Director of Vitalink Pharmacy Services in August 1997. From June 1986 to March 1989, Mr. Burleson served as President, Chief Operating Officer and a Director of American Medical International Inc. ("AMI"), an owner and operator of acute care hospitals. Based in London from May 1981 to June 1986, Mr. Burleson served as Managing Director of AMI’s international operations. Mr. Burleson received his early management training at Eastman Kodak from 1963 to 1974. He graduated from East Tennessee State University with a Bachelor of Science Degree in accounting and earned an MBA degree in 1972.

 80 

 

Dallas C. Hack, M.D., M.P.H. is a Director of the Company. He is board certified in General Preventive Medicine and Public Health and a Fellow in the American College of Military Public Health. Since July 2018, he has been the Chief Medical Officer of Virtech Bio, Inc., a private company that sells a ready-to-use oxygen-carrying plasma expander to restore circulatory system parameters and since 2015 has been a consultant to numerous biotech and non-profit companies to advance medical research and transition the progress to improved clinical practice. From June 2018 to March 2020, he was a director, member of the Audit and Product Development Committees and the interim Chief Executive Officer and Chief Financial Officer of CVR Medical Corp. (OTC: CRRVF), a publicly traded med-tech company dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. He directed trauma research for the military from 2008 to 2014, with responsibility for more than $2 billion in grant funding. He held numerous military medical leadership positions including Commander of the NATO Headquarters Healthcare Facility, and Command Surgeon at the strategic level during Operations Enduring Freedom and Iraqi Freedom. COL.(R) Hack, who served for 28 years, received numerous military awards including the Bronze Star, two Legion of Merit awards, and was inducted as a Distinguished Member of the Military Order of Medical Merit. He has a BA from Andrews University (1972), an MPH from Johns Hopkins University (1995), a MD from Loma Linda University (1976), an MSS from the US Army War College (2004), and a CPE from the Certifying Commission in Medical Management (1997). He was recognized as the Distinguished Alumnus of the Year by Loma Linda University in May 2015. Dr. Hack has an appointment from the School of Medicine, University of Pittsburgh as Adjunct Professor of Neurosurgery and from Virginia Commonwealth University as an Associate Clinical Professor, Department of Physical Medicine and Rehabilitation.

Joseph (Jos) Luhukay is a seasoned international banking Executive with over 40 years of experience leading many of Indonesia’s leading financial institutions and a former Ernst and Young Partner who led the business advisory and risk consulting practice which provided services in corporate governance, risk management, information systems audit and advisory, internal audit and policy and operational process development. Jos Luhukay’s distinguished career brings Applied UV a strong track record in delivering profitable growth for internationally recognized bank and investment banking companies including: Chief Operating Officer of Bank Niaga, Bahana Pembinaan Usaha Indonesia, a main Indonesian Government-owned investment Bank, Chief Operating Officer & Executive Director of the Jakarta Initiative Task Force (set up by the Ministry of Finance) where he managed a $65B portfolio and restructured over 20% of it in less than 2 years, President Director of Bank Lippo, where he was awarded “CEO of the Year” in 2006 by SWA Magazine (the largest business magazine in Indonesia), Deputy President of Temasek-owned Bank Danamon and his most recent role as President Director of Rabobank International Indonesia, a 30 year old Dutch owned Commercial Bank in Indonesia. Jos Luhukay holds an engineering degree in electrical engineering from the University of Indonesia, a Master’s and PhD in Computer Science from the University of Illinois at Urbana-Champaign.

Brian A. Stern is a Director of the Company. He currently serves as President of PURO Lighting, a division of Applied UV Inc. Mr. Stern co-founded LED Supply Co LLC in 2009, and co-founded PURO Lighting LLC in 2019. He served as the CEO of both LED Supply Co LLC and PURO Lighting LLC until the acquisition by Applied UV Inc in January of 2023. He graduated from University of Denver with a Bachelor of Science in business management in 2007.

Board of Directors

Our business and affairs are managed under the direction of our Board. Our Board consists of five (5) directors, three (3) of whom qualify as “independent” under the listing standards of Nasdaq.

Directors serve until the next annual meeting and until their successors are elected and qualified. Officers are appointed to serve for one year until the meeting of the Board following the annual meeting of shareholders and until their successors have been elected and qualified.

 81 

 

Board Leadership Structure and Risk Oversight

The Board oversees our business and considers the risks associated with our business strategy and decisions. The Board currently implements its risk oversight function as a whole. Each of the Board committees, as set forth below, will also provide risk oversight in respect of its areas of concentration and reports material risks to the board for further consideration.

Director Independence

Our board of directors are composed of a majority of “independent directors” as defined under the rules of Nasdaq. Nasdaq Listing Rule 5605(a)(2) provides that an “independent director” is a person other than an officer or employee of the company or any other individual having a relationship which, in the opinion of the Company’s Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.

Under such definition, our Board has undertaken a review of the independence of each director. Based on information provided by each director concerning his or her background, employment and affiliations, our Board has determined that Eugene Burleson, Dr. Dallas Hack, and Joseph Luhukay are all independent directors of the Company.

Board Committees

Our board of directors has established three standing committees: audit committee, compensation committee and nominating and corporate governance committee, each of which operate under a charter that has been approved by our board of directors. We have appointed persons to the board of directors and committees of the board of directors as required meeting the corporate governance requirements of the Nasdaq Listing Rules.

Audit Committee

We have established an audit committee consisting of Eugene Burleson, Joseph Luhukay, and Dallas Hack. Eugene Burleson is the Chairman of the audit committee. In addition, our Board has determined that Eugene Burleson is an audit committee financial expert within the meaning of Item 407(d) of Regulation S-K under the Securities Act of 1933, as amended, or the Securities Act. The audit committee’s duties, which are specified in our Audit Committee Charter, include, but are not limited to:

•   reviewing and discussing with management and the independent auditor the annual audited financial statements, and recommending to the board whether the audited financial statements should be included in our annual disclosure report;
•   discussing with management and the independent auditor significant financial reporting issues and judgments made in connection with the preparation of our financial statements;
•   discussing with management major risk assessment and risk management policies;
•   monitoring the independence of the independent auditor;
•   verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law;
•   reviewing and approving all related-party transactions;
•   inquiring and discussing with management our compliance with applicable laws and regulations;
•   pre-approving all audit services and permitted non-audit services to be performed by our independent auditor, including the fees and terms of the services to be performed;
•   appointing or replacing the independent auditor;
•   determining the compensation and oversight of the work of the independent auditor (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work;
•   establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; and
•   approving reimbursement of expenses incurred by our management team in identifying potential target businesses.

 82 

 

The audit committee is composed exclusively of “independent directors” who are “financially literate” as defined under the Nasdaq listing standards. The Nasdaq listing standards define “financially literate” as being able to read and understand fundamental financial statements, including a company’s balance sheet, income statement and cash flow statement.

Compensation Committee

We have established a compensation committee of the board of directors to consist of Dallas Hack, Joseph Luhukay, and Eugene Burleson, each of whom is an independent director. Dallas Hack is Chairman of the compensation committee. Each member of our compensation committee is also a non-employee director, as defined under Rule 16b-3 promulgated under the Exchange Act, and an outside director, as defined pursuant to Section 162(m) of the Code. The compensation committee’s duties, which are specified in our Compensation Committee Charter, include, but are not limited to:

•   reviews, approves and determines, or makes recommendations to our board of directors regarding, the compensation of our executive officers;
•   administers our equity compensation plans;
•   reviews and approves, or makes recommendations to our board of directors, regarding incentive compensation and equity compensation plans; and
•   establishes and reviews general policies relating to compensation and benefits of our employees.

Nominating and Corporate Governance Committee

We have established a nominating and corporate governance committee consisting of Eugene Burleson, Joseph Luhukay, and Dallas Hack. Joseph Luhukay is Chairman of the nominating and corporate governance committee. The nominating and corporate governance committee’s duties, which are specified in our Nominating and Corporate Governance Audit Committee Charter, include, but are not limited to:

•   identifying, reviewing and evaluating candidates to serve on our board of directors consistent with criteria approved by our board of directors;
•   evaluating director performance on our board of directors and applicable committees of our board of directors and determining whether continued service on our board of directors is appropriate
•   evaluating nominations by stockholders of candidates for election to our board of directors; and
•   corporate governance matters

Code of Ethics

Our Board has adopted a written code of business conduct and ethics ("Code") that applies to our directors, officers and employees, including our principal executive officer, principal financial officer and principal accounting officer or controller, or persons performing similar functions. The Code is applicable to all of our directors, officers and employees and is available on our corporate website, www.applieduvinc.com. We intend to disclose any amendments to our code of business conduct and ethics, or waivers of its requirements, on our website or in filings under the Exchange Act to the extent required by applicable rules and exchange requirements.

 83 

 

Family Relationships

There are no family relationships among the officers and directors, nor are there any arrangements or understanding between any of the Directors or Officers of our Company or any other person pursuant to which any Officer or Director was or is to be selected as an officer or director.

Involvement in Certain Legal Proceedings

On June 25, 2018, MunnWorks filed a voluntary petition for reorganization pursuant to Chapter 11 of the Bankruptcy Code in order to (i) pursue its appeal of a $1.4 million New York State court judgment arising out of an employment and business dispute with a former employer of Mr. Munn (of which Mr. Munn’s family-owned 50% of the equity) and (ii) preserve its ongoing operations from collection efforts with respect to such judgment. MunnWorks settled the dispute by making a $400,000 cash payment and on June 28, 2019, concluded its Chapter 11 proceedings.

None of our other directors, executive officers, significant employees or control persons have been involved in any legal proceeding listed in Item 401(f) of Regulation S-K in the past 10 years. 

Item 11. Executive Compensation

Summary Compensation Table

The following summary compensation table provides information regarding the compensation paid during our fiscal years ended December 31, 2022 and 2021 for our Chief Executive Officer (principal executive officer) and President, and our Chief Financial Officer. We refer to these individuals as our “named executive officers.”:

Name and Principal Position  Fiscal Year Ended  Salary ($)  Stock Awards ($)  Option Awards ($)(1)  All Other Compensation ($)  Total ($)
Max Munn   2022   $297,692    —     $27,827(3)   30,612(4)  $356,131 
President and Chief Executive Officer, President and Director(2)   2021    310,357    —     $1,567,449   $25,510   $1,903,316 
Michael Riccio   2022   $298,077    135,000(5)  $149,404(6)   100,000(7)  $682,481 
Senior Vice President and Chief Financial Officer   2021    146,154    —      297,711    —      443,865 
John Andrews   2022    276,530    106,500(9)   183,089(10)        566,119 
Former Chief Executive Officer(8)   2021    —      —      —      —      —   

(1)See Footnote 9 in the Notes to the Consolidated Financial Statements for a description of all of the assumptions made in the valuation of these options.
(2)Mr. Munn became the acting Chief Executive Officer upon the resignation of Mr. John Andrews as of December 19, 2022, and was appointed Chief Executive Officer by the board om March 3, 2023.
(3)Mr.Munn received options to purchase 50,000 shares of common stock at an exercise price of $2.00 per share. These options vest at the end of each quarter for 4 quarters beginning March 31, 2023.
(4)Auto lease and auto insurance payments the Company provided to Mr. Munn.
(5)Mr. Riccio received 50,000 shares of restricted common stock on January 1, 2022 valued at $2.70 per share, which was the fair market value on the grant date. These shares vest quarterly over 3 years.
(6)Mr. Riccio received options on January 1, 2022 to purchase 70,000 shares of common stock at an exercise price of $2.70, and also received options on June 3, 2022 to purchase 30,000 shares of common stock at an exercise price of $1.07. These options vest quarterly over 3 years.
(7)Mr. Riccio received a bonus of $100,000 in January 2022, pursuant to his employment agreement dated January 1, 2022.
(8)Mr. Andrews resigned as of December 19, 2022.
(9)Mr. Andrews received 75,000 shares of restricted common stock on April 11, 2022, valued at $1.42 per share, which was the fair market value on the grant date. These shares vest quarterly over 3 years. As of his resignation date of December 19, 2022, 59,035 unvested shares were cancelled.
(10)Mr. Andrews received options on April 11, 2022 to purchase 175,000 shares of common stock at an exercise price of $1.42. These options were cancelled as of March 19, 2023, which is 90 days after his resignation date.
 84 

 

Employment Agreements

Max Munn. On April 18, 2022, Applied UV, Inc. (the “Company”) and its wholly-owned subsidiary Munn Works LLC, entered into an amended and restated employment agreement (the “Employment Agreement”) with Mr. Max Munn, pursuant to which Mr. Munn will continue to serve as the President of the Company and the Manager and Chief Executive Officer of Munn Works LLC. The Employment Agreement amends and restates Mr. Munn’s prior employment agreement dated March 4, 2021 (the “Original Agreement”). The Employment Agreement is effective as of March 1, 2022 and terminates on February 28, 2024 (the “Term”) and will automatically renew for successive one-year terms unless terminated by the parties as provided under the Employment Agreement. The Employment Agreement amends the terms of the Original Agreement by providing Mr. Munn with a cash annual base salary of $360,000 and cancels 206,557 of the 309,835 options granted to Mr. Munn under the Original Agreement. Also, all the Original Agreement terminated on March 4, 2024 while the Employment Agreement terminates on February 28, 2024. All of the other terms of the Original Agreement remain the same.

Michael Riccio. The Company has entered into an Employment Agreement (the “Employment Agreement”) dated January 1, 2022 with Michael Riccio, its current Chief Financial Officer. The Employment Agreement has a two year term and automatically renews for additional two year terms unless 90 days prior to the prior to the end of the current term the Company or Mr. Riccio provides notice to the other that the term will not be extended or the Employment Agreement is sooner terminated by the Company with or without cause or by Mr. Riccio with good reason or for no reason, in each case as set forth in the Employment Agreement. The Employment Agreement provides Mr. Riccio with a base salary of $300,000, annual performance bonus of up to 100% of base salary based on periodic assessments of Mr. Riccio’s performance as well as the achievement of specific individual and corporate objectives as determined by the CEO in consultation with Mr. Riccio; and equity awards of 50,000 shares of the Company’s common stock and a 10 year option to purchase 70,000 shares of the Company’s common stock at an exercise price of $2.70 per share. Each equity award vests quarterly over a three year period commencing on January 1, 2022 with the first vesting to occur on April 1, 2022. Mr Riccio is also entitled to in the participate the Company-funded healthcare insurance plan and in all other benefits, perquisites, vacation days, benefit plans or programs of the Company which are available generally to office employees and other employees of the Company in accordance with the terms of such plans, benefits or programs.

Severance Agreement

On December 19, 2022, Mr. John Andrews resigned as a member of the Board of Directors of Applied UV, Inc. (the “Company”) and the Chief Executive Officer of the Company. Mr. Andrews tendered his resignations, in connection with the anticipated closing of the acquisitions of PURO Lighting, LLC (“PURO”) and LED Supply Co. LLC (together with PURO, the “Acquired Companies”) by the Company to allow the executives that will be retained from the Acquired Companies to assume a leadership position with the Company. Mr. Andrews agreed to remain as a consultant (subject to his availability) for 10 months if asked by the Company.

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth information concerning outstanding equity awards held by the certain executives of the Company as of December 31, 2022:

   Option Awards  Stock Awards
   Number of Securities Underlying Unexercised Options               
Name  Exercisable  Unexercisable  Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Options  Option Exercise Price  Option Expiration Date  Number of Shares or Units of Stock That Have Not Vested  Market Value of Shares or Units of Stock That Have Not Vested
Max
Munn		   104,278    50,000    —     $(1)   (1)   —      —   
Michael Riccio   80,976    89,024    —     $(2)   (2)   33,333   $90,000 
John Andrews   29,167    —      —     $1.42    (3)   (4)   (4)

 

(1)Mr. Munn’s options are as follows: 500 exercisable with an exercise price of $5.00 expiring April 1, 2030; 500 exercisable with an exercise price of $5.00 expiring July 1, 2030; 103,278 exercisable with an exercise price of 7.80 expiring March 4, 2031; 50,000 unexercisable options with an exercise price of $2.00 expiring December 31, 2032.
(2)Mr. Riccio’s options are as follows: 52,643 exercisable with an exercise price od $6.53 expiring September 28, 2031; 23,333 exercisable with an exercise price of $2.70 expiring January 1, 2032; 5,000 exercisable with an exercise price of $1.07 expiring June 3, 2032.
(3)Mr. Andrews resigned as of December 19, 2022 and his exercisable options expired on March 19, 2023.
(4)Mr. Andrews had 15,965 shares vested after his resignation from the Company at a market value of $22,670.

Option Exercises: No stock options were exercised by the above named individuals in 2021.

 

 85 

 

Director Compensation

The annual compensation for each non-employee Director is summarized in the table below.

2022 Director Compensation Table

Name  Fees earned or paid in cash
($)(1)		  Stock
Awards
($)		  Option
Awards
($)		  Total
($)
Joel Kanter (2)  $6,250   $0   $0   $6,250 
Alastair J. Clemow (3)  $6,250   $0   $0   $6,250 
Eugene A. Bauer (4)  $6,250   $0   $0   $6,250 
Eugene Burleson (5)  $25,000   $33,750   $0   $58,750 
Dallas C Hack (6)  $25,000   $20,250   $0   $45,250 
Joseph Luhukay(7)  $12,500   $13,000   $0   $25,500 
Monica Woo(8)  $12,500   $13,000   $0   $25,500 
(1)Directorsare paid $6,250 per quarter.
(2)On May 17, 2022, Mr. Kanter, the Company’s former Chairman, was not re-elected by the stockholders. He was paid his fee for the first quarter, but his 7,500 shares of restricted common stock granted January 1, 2022, that vest one year from the date of grant for his service as a director and his 10,000 shares of restricted common stock granted January 1, 2022 that vest one year from the date of grant for his service as the Chairman of the Board were cancelled as of May 17, 2022.
(3)On May 17, 2022, Mr. Clemow resigned from the board of directors of the Company. He was paid his fee for the first quarter, but his 7,500 shares of restricted common stock granted January 1, 2022 that vest one year from the date of grant for his service as a director and his 5,000 shares of restricted common stock granted January 1, 2022 that vest one year from the date of grant for his service as the Chairman of the Compensation Committee were cancelled as of May 17, 2022.
(4)On May 17, 2022, Mr. Bauer resigned from the board of directors of the Company. He was paid his fee for the first quarter, but his 7,500 shares of restricted common stock granted January 1, 2022 that vest one year from the date of grant for his service as a director and 5,000 shares of restricted common stock granted January 1, 2022 that vest one year from the date of grant for his service as the Chairman of the Nominating and Corporate Governance Committee were cancelled as of May 17, 2022.
(5)On January 1, 2022, Mr. Burleson was awarded 7,500 shares of restricted common stock that vest one year from the date of grant for his service as a director and 5,000 shares of restricted common stock that vest one year from the date of grant for his service as the Chairman of the Audit Committee.
(6)On January 1, 2022, Dr. Hack was awarded 7,500 shares of restricted common stock that vest one year from the date of grant for his service as a director.
(7)Mr. Luhukay was elected to the board by the shareholders on May 17, 2022. He was awarded 10,000 shares on May 17, 2022 upon his appointment to the board which vest equally over four years beginning January 1, 2023.
(8)Ms. Woo was elected to the board by the shareholders on May 17, 2022. She was awarded 10,000 shares on May 17, 2022 upon her appointment to the board which vest equally over four years beginning January 1, 2023. Ms. Woo resigned from the board as of February 27, 2023, and her 10,000 share stock award was cancelled.

 86 

 

Item 12. Security ownership Certain Beneficial Owners and Management and Related Stockholder Matters

The table below sets forth information regarding the beneficial ownership of the common stock by (i) our directors and named executive officers; (ii) all the named executives and directors as a group and (iii) any other person or group that to our knowledge beneficially owns more than five percent of our outstanding shares of common stock.

We have determined beneficial ownership in accordance with the rules and regulations of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting thereof, or to dispose or direct the disposition thereof or has the right to acquire such powers within 60 days. Shares of common stock subject to options that are currently exercisable or exercisable within 60 days of March 31, 2023, are deemed to be outstanding and beneficially owned by the person holding the options. Shares issuable pursuant to stock options or warrants are deemed outstanding for computing the percentage ownership of the person holding such options or warrants but are not deemed outstanding for computing the percentage ownership of any other person. Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons and entities named in the table below will have sole voting and investment power with respect to all shares of common stock that they will beneficially own, subject to applicable community property laws. The percentage of beneficial ownership is based on 19,237,273 shares of common stock outstanding on March 31, 2023.

   Number of Shares
Beneficially Owned		  Beneficial Ownership Percentages
Name and Address of Beneficial Owner(1)  Common
Stock		  Series X Super Voting Preferred
Stock(2)		  Percent of
Common
Stock		  Percent of Series X Super Voting Preferred
Stock		  Percent of
Voting
Stock(3)
Officers and Directors                         
Max Munn, Chief Executive Officer , President and Director   5,237,611(4)   10,000(5)   27.2%   100%   52.1%
Michael Riccio, Chief Financial Officer   143,529    —      *    —      * 
Brian Stern, Director(6)   1,825,526    —      9.5%   —      6.2%
Eugene Burleson, Director   60,000    —      *    —      * 
Dallas Hack, Director   40,000    —      *    —      * 
Joseph Luhukay, Director   17,500    —      *    —      * 
                          
 Officers and Directors as a Group   7,324,166    10,000    38.1%   100%   59.3%
5% Stockholders                         
The Munn Family 2020 Irrevocable Trust   5,000,000    10,000    26.0%   100%   51.3%
Brian Stern, Director   1,825,526         9.5%        6.2%
Andrew Lawrence   1,549,971    —      8.1%   N/A    5.3%
                          
(1)The principal address of the named officers, directors and 5% stockholders of the Company is c/o Applied UV, Inc. 150 N. Macquesten Parkway Mount Vernon, New York 10550.
(2)Entitles the holder to 1,000 votes per share and votes with the common as a single class.
(3)Represents total ownership percentage with respect to all shares of common stock and Series X Super Voting Preferred Stock, as a single class.
(4)Includes (i) 5,000,000 shares which are held in the name of The Munn Family 2020 Irrevocable Trust, for which the spouse of Max Munn is the trustee; (ii) 20,000 shares owned by Mr. Munn directly (iii) 80,000 shares underlying a warrant issued to Mr. Munn, which is exercisable at $5.00 per share; (iv) 1,000 vested shares underlying an option granted to Mr. Munn as director compensation, which are exercisable at $5.00 per share; (v) 103,278 vested shares underlying an option granted to Mr. Munn pursuant to his employment agreement, which are exercisable at $7.80 per share; (vi) 12,500 vested shares underlying an option granted to Mr. Munn on December 31, 2022; and (vii) 20,833 vested shares underlying an option granted to Mr. Munn on January 10, 2023. Mr. Munn is a guarantor of a $1,500,000 loan to The Munn Family Trust pursuant to which 5,000,000 shares of Common Stock held by the Munn Family Trust are pledged as collateral.
(5)Held by The Munn Family 2020 Irrevocable Trust.
(6)Mr. Stern was appointed to the board of directors on February 1, 2023.

 87 

 

Item 13. Certain Relationships and Related party Transactions, and Director Independence

In February of 2019, the Company engaged Carmel, Milazzo & Feil LLP (the “Firm”) to represent and assist the company with all general corporate legal matters including the preparation and filing with the Securities and Exchange Commission of a registration statement on Form S-1 in connection with the Company’s initial public offering. Ross Carmel, a former member of the Company’s Board of Directors, who resigned on May 1, 2020, is a partner at the Firm. The Firm performed legal services in exchange for 161,794 shares of the Company’s common stock

Item 14. Principal Accounting Fees and Services

Fees For Audit Services: The following table sets forth the aggregate fees for services we have paid to Mazars USA LLP (“Mazars”) our independent registered public accounting firms for the fiscal years ended December 31, 2022 and 2021:

Years  Audit Fees  Audit Related Fees  Tax Fees  All other Fees
2022(1)  $371,370    —      —      —   
2021(1)  $99,225    —      —      —   

 

(1)Audit fees consist of fees billed for professional services rendered for the audit of our consolidated annual financial statements, review of the interim consolidated financial statements, the issuance of consent and comfort letters in connection with registration statement filings with the SEC and all services that are normally provided by the accounting firm in connection with statutory and regulatory filings or engagements.

 88 

 

PART IV

Item 15. Exhibits, Financial Statement Schedules.

(a)  The following documents are filed as part of this Annual Report:

(1) The financial statements are filed as part of this Annual Report under “Item 8. Financial Statements and Supplementary Data.”

(2) The financial statement schedules are omitted because they are either not applicable or the information required is presented in the financial statements and notes thereto under “Item 8. Financial Statements and Supplementary Data.”

(3) The exhibits listed in the following Exhibit Index are filed, furnished or incorporated by reference as part of this Annual Report.

(b) Exhibits

See the Exhibit Index immediately preceding the signature page of this Annual Report.

Item 16. Form 10-K Summary

None.

 89 

 

EXHIBIT INDEX

No.   Exhibit No.
3.1 Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
3.2 Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.2 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
3.3 Bylaws of the Registrant (incorporated by reference to Exhibit 3.3 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
3.4 Certificate of Designation, Preferences and Rights of Series A Preferred Stock (incorporated by reference to Exhibit 3.4 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
3.5 Certificate of Amendment of Certificate of Incorporation filed on June 17, 2020 (incorporated by reference to Exhibit 3.5 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
3.6 Certificate of Amendment of Certificate of Incorporation filed on June 23, 2020 (incorporated by reference to Exhibit 3.6 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
3.7 Certificate of Amendment of Certificate of Incorporation filed July 14, 2020 (incorporated by reference to Exhibit 3.7 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
3.8 Certificate of Amendment to Certificate of Designation of Series A Preferred Stock, filed on June 17, 2021 (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K, filed on July 19, 2021).
3.9 Certificate of Designation, Preferences and Rights of 10.5% Series A Cumulative Perpetual Preferred Stock (incorporated by reference to Exhibit 3.9 of the Company’s Registration Statement on Form S-1 (File No. 333-257197) filed with the SEC as of June 25, 2021).
3.10 Certificate of Amendment to the Amended and Restated Certificate of Incorporation, filed on October 7, 2021
3.11 Certificate of Amendment to the Certificate of Designation of Series A Preferred Stock, filed on December 8, 2021
3.12 Certificate of Designations, Rights, and Preferences of 2% Series B Cumulative Perpetual Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 1, 2023)
3.13 Certificate of Designations, Rights, and Preferences of 5% Series C Cumulative Perpetual Preferred Stock (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the SEC on February 1, 2023)
10.1 Warrant, dated April 1, 2020 issued to Max Munn (incorporated by reference to Exhibit 10.4 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
10.2 The Company’s 2020 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.5 of the Company’s Registration Statement on Form S-1 (333-239892) filed with the SEC as of July 16, 2020).
10.3 Form of Option Agreement and Grant issued under February 18, 2020 Board Approval (incorporated by reference to Exhibit 10.6 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
10.4 Agreement, dated April 20, 2020 between Icahn School of Medicine at Mount Sinai and SteriLumen, Inc. (incorporated by reference to Exhibit 10.7 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
10.5 Common Stock Purchase Warrant, dated July 1, 2020 (incorporated by reference to Exhibit 10.10 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
10.6 Common Stock Purchase Warrant, dated July 1, 2020 (incorporated by reference to Exhibit 10.11 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
10.7 Form of Option issued to Medical Advisory Board members (incorporated by reference to Exhibit 10.12 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
10.8 Employment Agreement, dated June 30, 2020 between the Company and Max Munn (incorporated by reference to Exhibit 10.9 of the Company’s Registration Statement on Form S-1 (File No. 333-239892) filed with the SEC as of July 16, 2020).
10.9 Employment Agreement, dated January 1, 2022 between the Company and Michael Ricco (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on January 3, 2022)
10.10 Agreement and Plan of Merger dated as of December 19, 2022, by and among the Company, PURO Acquisition Sub I, Inc., PURO Acquisition Sub II, LLC, PURO Lighting, LLC, Brian Stern, Andrew Lawrence, and the Member Representative (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on February 1, 2023)
10.11 Agreement and Plan of Merger dated as of December 19, 2022, by and among the Company, LED Supply Acquisition Sub I, Inc., LED Supply Acquisition Sub II, LLC, LED Supply Co. LLC, Brian Stern, Andrew Lawrence, and the Member Representative (incorporated by reference Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on February 1, 2023)
10.12 Amendment to Agreement and Plan of Merger dated as of January 26, 2023, by and among the Company, PURO Acquisition Sub I, Inc., PURO Acquisition Sub II, LLC, PURO Lighting, LLC, Brian Stern, Andrew Lawrence, and the Member Representative (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on February 1, 2023)
10.13 Amendment to Agreement and Plan of Merger dated as of January 26, 2023, by and among the Company, LED Supply Acquisition Sub I, Inc., LED Supply Acquisition Sub II, LLC, LED Supply Co. LLC, Brian Stern, Andrew Lawrence, and the Member Representative (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on February 1, 2023)
10.14 Securities Purchase Agreement dated October 7, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 14, 2022)
10.15 Note dated October 7, 2022 in the principal amount of $2,807,500 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on October 14, 2022)
10.16 Loan and Security Agreement dated as of December 9, 2022, by and between the Company, SteriLumen, Inc., Munn Works, LLC and Pinnacle Bank (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 15, 2022)
10.17 First Modification to Loan and Security Agreement and Loan Documents dated as of December 9, 2022, by and between the Company, SteriLumen, Inc., Munn Works, LLC and Pinnacle Bank (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on December 15, 2022)
10.18 Note Purchase and Cancellation Agreement dated as of January 5, 2023, by and between the Company, PURO Lighting, LLC, and Acuity Brands Lighting, Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on January 11, 2023)
10.19 Securities Purchase Agreement dated January 25, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on January 31, 2023)
10.20 Amendment to Securities Purchase Agreement dated January 25, 2023 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on January 31, 2023)
10.21 Note dated January 25, 2023 in the principal amount of $2,807,500 (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on January 31, 2023)
21.1*   List of Subsidiaries of the Registrant
31.1* Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2* Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1** Certification by the Chief Executive Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2** Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

* Filed herewith

** Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

 90 

 

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 31, 2023 APPLIED UV, INC.
   
  By: /s/ Max Munn
    Max Munn
    Chief Executive Officer

POWER OF ATTORNEY

Each individual person whose signature appears below hereby appoints Max Munn as attorneys-in-fact with full power of substitution, severally, to execute in the name and on behalf of each such person, individually and in each capacity stated below, one or more amendments to this annual report which amendments may make such changes in the report as the attorney-in-fact acting in the premises deems appropriate, to file any such amendment to the report with the SEC, and to take all other actions either of them deem necessary or advisable to enable the Company to comply with the rules, regulations and requirements of the SEC.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature   Title   Date
         
         
/s/ Max Munn   Chief Executive Officer, President and Director   March 31, 2023
Max Munn        
         
/s/ Michael Riccio   Chief Financial Officer   March 31, 2023
Michael Riccio   (principal financial and accounting officer)    
         
/s/ Eugene Burleson   Director   March 31, 2023
Eugene Burleson        
         
/s/ Dr. Dallas C. Hack   Director   March 31, 2023
Dr. Dallas C. Hack        
         
/s/ Joseph Luhukay   Director   March 31, 2023
Joseph Luhukay        
         
         
/s/ Brian Stern   Director   March 31, 2023
Brian Stern        

 91 

 

 

 EX-21.1 2 ex21_1.htm EXHIBIT 21.1

Subsidiaries of the Registrant

 

Legal Name of Subsidiary

   Jurisdiction
of Organization
Munn Works, LLC   New York
SteriLuman, Inc.   New York
PURO Lighting, LLC   Colorado
LED Supply Co. LLC.   Colorado
 EX-31.1 3 ex31_1.htm EXHIBIT 31.1

Exhibit 31.1

CHIEF EXECUTIVE OFFICER CERTIFICATION
PURSUANT TO SECTION 302

I, Max Munn, certify that:

  1.   I have reviewed this Annual Report on Form 10-K of Applied UV, Inc. (the “Registrant”);

       

  2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

       

  3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

       

  4.   The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

  a)   designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

       

  b)   designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

       

  c)   evaluated the effectiveness of the Registrant’s disclosure controls and procedures presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

       

  d)   disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

  5.   The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):

 

  a)   all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

       

  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

Date: March 31, 2023

 

/s/ Max Munn

Max Munn

Chief Executive Officer
(Principal Executive Officer)   

               

 EX-31.2 4 ex31_2.htm EXHIBIT 31.2

Exhibit 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION
PURSUANT TO SECTION 302

I, Michael Riccio, certify that:

  1.   I have reviewed this Annual Report on Form 10-K of Applied UV, Inc. (the “Registrant”);

       

  2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

       

  3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

       

  4.   The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

  a)   designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

       

  b)   designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

       

  c)   evaluated the effectiveness of the Registrant’s disclosure controls and procedures presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

       

  d)   disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

  5.   The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):

 

  a)   all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

       

  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

Date: March 31, 2023

 

/s/ Michael Riccio

Michael Riccio

Chief Financial Officer
(Principal Financial Officer) 

 EX-32.1 5 ex32_1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the accompanying Annual Report of Applied UV, Inc. (the “Company”) on Form 10-K for the twelve months ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Max Munn, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

     (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fully presents, in all material respects, the financial condition and results of operations of the Company.

 
/s/ Max Munn
Max Munn
Principal Executive Officer 

 

March 31, 2023

 EX-32.2 6 ex32_2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the accompanying Annual Report of Applied UV, Inc. (the “Company”) on Form 10-K for the twelve months ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Riccio, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

     (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fully presents, in all material respects, the financial condition and results of operations of the Company.

/s/Michael Riccio  
Michael Riccio  
Principal Financial Officer   

 

March 31, 2023

 EX-101.SCH 7 auvi-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - BUSINESS ACQUISITION link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - FINANCING LEASE OBLIGATION link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - LEASING ARRANGEMENTS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - PAYROLL PROTECTION PROGRAM link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - NOTE RECEIVABLE- RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - PROFORMA FINANCIAL STATEMENTS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - BUSINESS ACQUISITION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - FINANCING LEASE OBLIGATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - LEASING ARRANGEMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - PROFORMA FINANCIAL STATEMENTS (UNAUDITED) (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-dilutive shares) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - BUSINESS ACQUISITION - Recognized Identified Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - BUSINESS ACQUISITION - Future Maturity of lease Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - BUSINESS ACQUISITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - INTANGIBLE ASSETS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - FINANCING LEASE OBLIGATION - Future minimum principal and interest payments under capital lease arrangements (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - NOTES PAYABLE - Minimum obligations under this loan agreement (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - NOTES PAYABLE - net of discount (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - NOTES PAYABLE - Minimum obligations (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - STOCKHOLDERS' EQUITY (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - STOCKHOLDERS' EQUITY (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - STOCKHOLDERS' EQUITY (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - LEASING ARRANGEMENTS - Maturities of Operating lease laibilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - LEASING ARRANGEMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - PAYROLL PROTECTION PROGRAM (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - NOTE RECEIVABLE- RELATED PARTY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - INCOME TAXES - Federal and State Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - INCOME TAXES - Deferred Tax Assets and Deferred Tax Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - INCOME TAXES - Income Before Provision For Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SEGMENT REPORTING (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - PROFORMA FINANCIAL STATEMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 auvi-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 auvi-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 10 auvi-20221231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.0001 per share 10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share Series X Preferred Stock [Member] Equity Components [Axis] Preferred Stock Series A Cumulative [Member] Preferred Stock Series X [Member] Common Stock [Member] Treasury Stocks [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Customer [Axis] Two Major Suppliers [Member] Long-Lived Tangible Asset [Axis] Machinery and Equipment [Member] Leasehold Improvements [Member] Furniture and Fixtures [Member] Antidilutive Securities [Axis] Options Held [Member] Warrant [Member] Timing of Transfer of Good or Service [Axis] Transferred over Time [Member] Transferred at Point in Time [Member] Business Acquisition [Axis] Steri Lumen [Member] Finite-Lived Intangible Assets by Major Class [Axis] Customer Relationships [Member] Trade Names [Member] Patents [Member] Technology-Based Intangible Assets [Member] Transaction Type [Axis] Security Purchase Agreement [Member] Title of Individual [Axis] Directors and Officers Liability Insurance [Member] Loan And Security Agreement [Member] Statistical Measurement [Axis] Maximum [Member] Minimum [Member] Short-Term Debt, Type [Axis] Streeterville Note [Member] Debt Instrument [Axis] Fair Value [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] At The Market Sales Agreement [Member] Maxim Group L L C [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Board of Directors Chairman [Member] Preferred Stock [Member] Plan Name [Axis] Incentive Plan 2020 [Member] Award Type [Axis] Options [Member] Share-Based Payment Arrangement, Option [Member] Sale of Stock [Axis] Over-Allotment Option [Member] Restricted Stock [Member] Measurement Input Type [Axis] Dividend Yield [Member] Measurement Input, Price Volatility [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Term [Member] Class of Warrant or Right [Axis] Payroll Protection Plan Loan Cares Act [Member] Related Party [Axis] Related Party [Member] Segments [Axis] Hospitality Segment [Member] Disinfectant Segment [Member] Corporate Segment [Member] Akida K E S Visionmark And Sci Air [Member] Investor [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Name Auditor Location Auditor Firm ID Assets Current Assets Cash and cash equivalents Restricted cash Accounts receivable, net of allowance for doubtful accounts Costs and estimated earnings in excess of billings Inventory, net Vendor deposits Prepaid expense and other current assets Total Current Assets Property and equipment, net of accumulated depreciation Goodwill Other intangible assets, net of accumulated amortization Other assets Right of use assets Total Assets Liabilities and Stockholders’ Equity Current Liabilities Accounts payable and accrued expenses Contingent Consideration Deferred revenue Due to landlord (Note 2) Warrant liability Financing lease obligations Operating lease liability Notes payable Total Current Liabilities Long-term Liabilities Due to landlord-less current portion (Note 2) Notes payable- less current portion Financing lease obligations-less current portion Operating lease liability-less current portion Total Long-Term Liabilities Total Liabilities Stockholders’ Equity Preferred stock value Common stock $.0001 par value, 150,000,000 shares authorized; 13,676,450 shares issued and outstanding as of December 31, 2022 and 12,775,674 shares issued and outstanding as of December 31, 2021 Additional paid-in capital Treasury stock at cost, 113,485 and 0 shares, respectively Accumulated deficit Total Stockholders’ Equity Total Liabilities and Stockholders’ Equity Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Treasury Stock, Shares Income Statement [Abstract] Net Sales Cost of Goods Sold Gross Profit Operating Expenses Research and development Selling general and administrative Loss on impairment of goodwill and intangible assets Total Operating Expenses Operating Loss Other Income (Expense) Change in Fair Market Value of Warrant Liability Interest expense Loss on change in Fair Market Value of Contingent Consideration Gain on Settlement of Contingent Consideration (Note 2) Other Income Forgiveness of paycheck protection program loan Total Other Income (Expense) Loss Before Provision for Income Taxes Benefit from Income Taxes Net Loss Net Loss attributable to common stockholders: Dividends to preferred shareholders Net Loss attributable to common stockholders Basic and Diluted Loss Per Common Share Weighted Average Shares Outstanding - basic and diluted Beginning balance, value Beginning balance, shares Common stock issued in public offering (over-allotment), net of costs Common stock issued in public offering (over-allotment), net of costs, shares Common stock issued in public offering (ATM), net of costs Common stock issued in public offering (ATM), net of costs, shares Cancellation of restricted shares Cancellation of restricted shares , shares Settlement of stock in connection with prior acquisition Settlement of stock in connection with prior acquisition, shares Common shares repurchased Common shares repurchased, shares Reissuance of preferred stock Reissuance of preferred stock, shares Shares granted to settle previously recorded liability Shares granted to settle previously recorded liability , shares Warrant liability recognized in connection with initial issuance of November offering (See Note 7) Exercise of warrants Exercise of warrants , shares Common stock issued for acquisition Common stock issued for acquisition , shares Stock-based compensation Stock-based compensation , shares Common stock issued in public offering, net of costs Common stock issued in public offering net of costs, shares Preferred stock issued in public offering, net of costs Preferred stock issued in public offering, net of costs, shares Dividends paid to preferred shareholder Cancellation of restricted stock Cancellation of Restricted Stock, shares Net Loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from Operating Activities Net Loss Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities Stock based compensation Bad debt expense (recovery) Forgiveness of paycheck protection program loan Change in fair market value of warrant liability Gain on settlement of loan payable Loss on change in fair market value of contingent consideration (Note 2) Gain on settlement of contingent consideration Change in reserve for Obsolescence inventory Amortization of right-of-use asset Depreciation and amortization Amortization of debt discount Changes in operating assets and liabilities, net of effects of acquisitions: Accounts receivable Cost and estimated earnings excess of billings Inventory Vendor deposits Prepaid expenses and other current assets Income taxes payable Accounts payable and accrued expenses Billings in excess of costs and earnings on uncompleted contracts Deferred revenue Due to landlord Operating lease payments Net Cash Used in Operating Activities Cash Flows From Investing Activities Cash paid for patent costs Purchase of machinery and equipment Acquisitions, net of cash acquired (Note 2) Payments on note payable Net Cash Used in Investing Activities Cash Flows From Financing Activities Payments on financing leases Proceeds from warrant exercise Shares repurchased Dividends to preferred shareholders Payments on loan payable Proceeds from equity raises, net Proceeds from note payable, net Net Cash Provided by Financing Activities Net Decrease in Cash and equivalents Cash, restricted cash, and cash equivalents at January 1, Cash, restricted cash, and cash equivalents at December 31, Supplemental Disclosures of Cash Flow Information: Cash paid during the year for: Interest Income taxes Supplemental Schedule of Non-Cash Financing and Investing Activities: Initial recognition of warrant liability Property and equipment obtained in exchange for financing lease liabilities Reclassification from liability to be settled in stock to additional paid in capital Common stock issued in connection with acquisitions Initial recognition of contingent consideration liability Recognition of right of use asset - operating lease Issuance of Note Payable for payment of prepaid expense Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business Combination and Asset Acquisition [Abstract] BUSINESS ACQUISITION Inventory Disclosure [Abstract] INVENTORY Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Financing Lease Obligation FINANCING LEASE OBLIGATION Notes Payable NOTES PAYABLE Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Equity [Abstract] STOCKHOLDERS’ EQUITY Leasing Arrangements LEASING ARRANGEMENTS Debt Disclosure [Abstract] PAYROLL PROTECTION PROGRAM Note Receivable- Related Party NOTE RECEIVABLE- RELATED PARTY Income Tax Disclosure [Abstract] INCOME TAXES Segment Reporting [Abstract] SEGMENT REPORTING Proforma Financial Statements PROFORMA FINANCIAL STATEMENTS (UNAUDITED) Subsequent Events [Abstract] SUBSEQUENT EVENTS Nature of Business Principles of Consolidation Concentration of Credit and Business Risk Use of Estimates Cash, Restricted Cash and Cash Equivalents Accounts receivable Inventory Property and Equipment Business Acquisition Accounting Goodwill and Intangible Assets Income Taxes Derivative Instruments Fair Value of Financial Instruments Loss Per Share Stock-Based Compensation Research and Development Revenue Recognition Shipping and Handling Charges Advertising Vendor deposits Patent Costs Recently adopted accounting standards Schedule of estimated useful lives Schedule of anti dilutive securities excluded from computation of earnings per share Schedule of revenue Schedule of recognized identified assets acquired and liabilities assumed Schedule of future maturity of the lease liability Schedule of Inventory Schedule of property and equipment Schedule of Intangible Assets Future amortization of intangible assets Schedule of future minimum principal and interest payments under capital lease arrangements Schedule of minimum obligations under loan agreement Schedule of note payable net of discount Schedule of minimum obligations Fair Value, Assets Measured on Recurring Basis Schedule of the Company's option activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of the Company's warrant activity Schedule of Unvested Restricted Stock Units Activity Schedule of maturities of operating lease liabilities Schedule of federal and state income Schedule of deferred tax assets and deferred tax liabilities Schedule of income before provision for income taxes Schedule of segment reporting Proforma Financial Statements Unaudited Business Acquisition, Pro Forma Information Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated useful lives Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Revenues Deferred revenue Cash, FDIC Insured Amount Concentration Risk, Percentage Cash Equivalents, at Carrying Value Accounts Receivable, Allowance for Credit Loss Inventory, LIFO Reserve Impairment charges Deferred revenue Shipping charges Advertising Expense Deposits assets current Patent cost Amortization Cash paid at closing Fair market value of common stock issued Total Purchase Price, net of cash acquired Accounts receivable, net Inventory Prepaid expenses Machinery and equipment Customer relationships Trade names Technology and know how Total Assets Acquired: Accounts payable Deferred revenue Total Liabilities Assumed Net Assets Acquired Excess Purchase Price "Goodwill" Contingent consideration based on stock price Patents Technology and know how Due to landlord Billings in excess of costs and earnings on uncompleted contracts 2023 2024 2025 Total Less: Unamortized discount Total amount due to landlord Less: current portion of amount due to landlord, net of discount Total long-term portion of amount due to landlord Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Excess purchase price Shares, Issued Change in fair market value Contingent consideration Asset Impairment Charge Impairment on intangibles Operating Lease, Payments Interest expense rate Amortization of discount in interest expenses Raw materials Finished goods Inventory at cost Less: Reserve Inventory Property and equipment, gross Less: Accumulated Depreciation Property and equipment, net Depreciation Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Intangible assets gross Less: Accumulated Depreciation Intangible assets net 2023 2024 2025 2026 2027 Thereafter Total  Asset Impairment Charges Intangible assets Amortization of Intangible Assets Financing Lease Obligation - Future Minimum Principal And Interest Payments Under Capital Lease Arrangements 2023 2024 2025 2026 2027 Total lease payments Less: Amount representing interest Present value of future minimum lease payments Less: current portion Financing lease obligations, net of current Notes Payable - Minimum Obligations Under This Loan Agreement 2023 2024 Total  Notes Payable - Net Of Discount Principle outstanding Debt discount Total Accumulated amortization of debt discount Streeterville note, net of related discount Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Offsetting Assets [Table] Offsetting Assets [Line Items] Long term debt Down payment Debt instrument additional amount Repayments of debt Annual percentage rate Face amount Proceeds from notes payable Debt issuance costs Maturity date Redemption price Monitoring fee Outstanding balance Debt discount fee Effective interest rate Debt discount amortization to interest expense Remaining unamortized balance Interest expense Note payable Secured credit facility Debt instrument description Loan fee percentage Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Money market funds Total assets Contingent consideration Warrant liability Other liablities Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of Option Outstanding, beginning Weighted average exercise price, beginning Weighted average grant date fair value, beginning Weighted average remaining contractual life in years Options granted Weighted average exercise price, granted Weighted average grant date fair value, granted Weighted average remaining contractual life, granted Options forfeited/cancelled Weighted average exercise price, forfeited Weighted average grant date fair value, forfeited Option exercised Weighted average exercise price, exercised Number of Option Outstanding, ending Weighted average exercise price, ending Weighted average remaining contractual life in years Vested and Exercisable Vested and Exercisable Stock Price Exercise Price Dividend yield Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Options outstanding at the beginning Granted Weighted average exercise price, Granted Exercised Weighted average exercise price, Exercised Exercised Options outstanding at the ending Vested and Exercisable Weighted average exercise price,Vested and Exercisable Number of unvested shares outstanding, at beginning Weighted average fair market value outstanding, at beginning Granted and unvested Weighted average fair market value, granted and unvested Vested Weighted average fair market value, vested Forfeited/Cancelled Weighted average fair market value, forfeited/Cancelled Number of unvested shares outstanding, at ending Weighted average fair market value outstanding, at ending Vested Vested Schedule of Stock by Class [Table] Class of Stock [Line Items] Stock holders equity Sale of stock Proceeds from sale of stock Compensation paid Gross proceeds Expiration date Treasury stock reissued Treasury stock, shares Number of share issued Number of shares available for grant Share-Based Payment Arrangement, Expense Unrecognized stock based compensation Fair value of warrant liability Offering price Underwriting fees Offering cost Net proceeds Offering price Underwriting discount Leasing Arrangements - Maturities Of Operating Lease Laibilities 2023 2024 2025 2026 Total lease payments Less: Imputed Interest Present value of future minimum lease payments Operating Lease, Weighted Average Discount Rate, Percent Rent expense Accrued payroll cost Long term debt, Description Non-operating income Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Acquisition price Note receivable, related party Current provision: Federal State Deferred provision (benefit): Federal State Total Deferred Total provision for income taxes Deferred tax assets: Net operating loss Fixed assets Lease Loss on contingency Intangible assets Research and development Stock based compensation Accrual to cash conversion Total Valuation allowance Net Federal statutory rate times financial statement income Permanent tax basis differences Deferred true up State taxable income, net Change in Valuation allowance Rate change True up Other Total provision for income taxes Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Operating Loss Carryforwards Effective Income Tax Rate Reconciliation, Deduction, Percent Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Total Assets Total Liabilities Loss on impairment of goodwill Selling, General and Administrative Expenses Schedule of Restructuring and Related Costs [Table] Restructuring Cost and Reserve [Line Items] Net Sales Net Loss attributable to common stockholders: Dividends to preferred shareholders Net Loss attributable to common stockholders Basic and Diluted Loss Per Common Share Weighted Average Shares Outstanding - basic and diluted Subsequent Event [Table] Subsequent Event [Line Items] Principal amount Bears interest rate Debt issuance costs Acquisition descrption Attorneys fees Arbitration panel issued amount Legal fees Accrued interest expense Shares authorized Preferred stock, par value Dividends rate percentage Per share liquidation preference Dividends per share Represents information pertaining to Steri Lumen. Amount of additional amount payable in year two under the debt instrument. The amount of underwriting fees incurred. Payroll Protection Plan Loan, CARES ACT [Member] Assets, Current Assets [Default Label] Liabilities, Current Liabilities, Noncurrent Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses [Default Label] Operating Income (Loss) Interest Expense LossOnChangeInFairMarketValueOfContingentConsideration Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net Income (Loss) Attributable to Parent Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Stock Repurchased During Period, Value Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments GainOnSettlementOfLoanPayable GainOnSettlementOfContingentConsiderations Increase (Decrease) in Accounts Receivable CostAndEstimatedEarningsExcessOfBillings Increase (Decrease) in Inventories Increase (Decrease) in Deposit Assets Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable and Accrued Liabilities BillingsInExcessOfCostsAndEarningOnUncompletedContract Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Operating Activities Payments to Acquire Intangible Assets Payments to Acquire Machinery and Equipment Business Combination, Consideration Transferred Repayments of Notes Payable Net Cash Provided by (Used in) Investing Activities Finance Lease, Principal Payments Payments for Repurchase of Equity Payments of Dividends Repayments of Construction Loans Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Deposit Contracts, Policy [Policy Text Block] Deferred Revenue, Current Deferred Revenue, Noncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities TechnologyAndKnowHow BillingsInExcessOfCostsAndEarningsOnUncompletedContracts LessUnamortizedDiscount LessCurrentPortionOfAmountDueToLandlordNetOfDiscount Inventory Valuation Reserves Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Asset, Expected Amortization, Year One Finite-Lived Intangible Asset, Expected Amortization, Year Two Finite-Lived Intangible Asset, Expected Amortization, Year Three Finance Lease, Liability, to be Paid, Year One Finance Lease, Liability, to be Paid, Year Two Finance Lease, Liability, to be Paid, Year Three Finance Lease, Liability, to be Paid, Year Four Finance Lease, Liability, to be Paid, Year Five Finance Lease, Liability, Undiscounted Excess Amount Finance Lease, Liability Long-Term Debt, Maturity, Year One Long-Term Debt, Maturity, Year Two Other Notes Payable [custom:WarrantLiability-0] Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term VestedAndExerciables Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Operating Lease, Liability Deferred Federal Income Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Deferred Tax Assets, in Process Research and Development Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Deferred Tax Assets, Gross Deferred Tax Assets, Valuation Allowance EarningPerShareBasicAndDiluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted Amortization of Debt Issuance Costs EX-101.PRE 11 auvi-20221231_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 31, 2023
Jun. 30, 2022
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 001-39480    
Entity Registrant Name APPLIED UV, INC.    
Entity Central Index Key 0001811109    
Entity Tax Identification Number 84-4373308    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 150 N. Macquesten Parkway    
Entity Address, City or Town Mount Vernon    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10550    
City Area Code (914)    
Local Phone Number 665-6100    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 17,200,000
Entity Common Stock, Shares Outstanding   19,237,273  
Auditor Name Mazars USA LLP    
Auditor Location Fort Washington, PA    
Auditor Firm ID 339    
Common Stock, par value $0.0001 per share      
Title of 12(b) Security Common Stock, par value $0.0001 per share    
Trading Symbol AUVI    
Security Exchange Name NASDAQ    
10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share      
Title of 12(b) Security 10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share    
Trading Symbol AUVIP    
Security Exchange Name NASDAQ    
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 2,734,485 $ 7,922,906
Restricted cash 0 845,250
Accounts receivable, net of allowance for doubtful accounts 1,508,239 986,253
Costs and estimated earnings in excess of billings 1,306,762 0
Inventory, net 5,508,086 1,646,238
Vendor deposits 75,548 992,042
Prepaid expense and other current assets 1,187,223 419,710
Total Current Assets 12,320,343 12,812,399
Property and equipment, net of accumulated depreciation 1,133,468 196,611
Goodwill 3,722,077 4,809,811
Other intangible assets, net of accumulated amortization 11,354,430 18,976,556
Other assets 153,000 0
Right of use assets 4,044,109 1,730,615
Total Assets 32,727,427 38,525,992
Current Liabilities    
Accounts payable and accrued expenses 2,982,760 1,642,108
Contingent Consideration 0 1,460,000
Deferred revenue 4,730,299 788,776
Due to landlord (Note 2) 229,234 0
Warrant liability 9,987 68,263
Financing lease obligations 33,712 7,671
Operating lease liability 1,437,308 389,486
Notes payable 2,098,685 97,500
Total Current Liabilities 11,521,985 4,453,804
Long-term Liabilities    
Due to landlord-less current portion (Note 2) 393,230 0
Notes payable- less current portion 765,144 60,000
Financing lease obligations-less current portion 158,070 0
Operating lease liability-less current portion 2,655,103 1,346,428
Total Long-Term Liabilities 3,971,547 1,406,428
Total Liabilities 15,493,532 5,860,232
Stockholders’ Equity    
Preferred stock value 55 55
Common stock $.0001 par value, 150,000,000 shares authorized; 13,676,450 shares issued and outstanding as of December 31, 2022 and 12,775,674 shares issued and outstanding as of December 31, 2021 1,368 1,278
Additional paid-in capital 45,619,670 42,877,622
Treasury stock at cost, 113,485 and 0 shares, respectively (149,686) 0
Accumulated deficit (28,237,513) (10,213,196)
Total Stockholders’ Equity 17,233,895 32,665,760
Total Liabilities and Stockholders’ Equity 32,727,427 38,525,992
Series X Preferred Stock [Member]    
Stockholders’ Equity    
Preferred stock value $ 1 $ 1
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized 19,990,000 19,990,000
Preferred Stock, Shares Issued 552,000 552,000
Preferred Stock, Shares Outstanding 552,000 552,000
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Shares Authorized 150,000,000 150,000,000
Common Stock, Shares, Issued 13,676,450 12,775,674
Common Stock, Shares, Outstanding 13,676,450 12,775,674
Treasury Stock, Shares 113,485 0
Series X Preferred Stock [Member]    
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized 10,000 10,000
Preferred Stock, Shares Issued 10,000 2,000
Preferred Stock, Shares Outstanding 10,000 2,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Net Sales $ 20,139,849 $ 11,667,579
Cost of Goods Sold 16,101,555 7,569,193
Gross Profit 4,038,294 4,098,386
Operating Expenses    
Research and development 319,167 53,408
Selling general and administrative 14,804,068 11,341,712
Loss on impairment of goodwill and intangible assets 6,993,075 0
Total Operating Expenses 22,116,310 11,395,120
Operating Loss (18,078,016) (7,296,734)
Other Income (Expense)    
Change in Fair Market Value of Warrant Liability 58,276 66,862
Interest expense (290,341) 0
Loss on change in Fair Market Value of Contingent Consideration (240,000) (574,000)
Gain on Settlement of Contingent Consideration (Note 2) 1,700,000 0
Other Income 274,764 24,871
Forgiveness of paycheck protection program loan 0 296,827
Total Other Income (Expense) 1,502,699 (185,440)
Loss Before Provision for Income Taxes (16,575,317) (7,482,174)
Benefit from Income Taxes 0 (91,819)
Net Loss (16,575,317) (7,390,355)
Net Loss attributable to common stockholders:    
Dividends to preferred shareholders (1,449,000) (603,750)
Net Loss attributable to common stockholders $ (18,024,317) $ (7,994,105)
Basic and Diluted Loss Per Common Share $ (1.41) $ (0.86)
Weighted Average Shares Outstanding - basic and diluted 12,754,979 9,273,257
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Changes in Stockholders' Equity - USD ($)
Preferred Stock Series A Cumulative [Member]
Preferred Stock Series X [Member]
Common Stock [Member]
Treasury Stocks [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 1 $ 795 $ 11,973,051 $ (2,219,091) $ 9,754,756
Beginning balance, shares at Dec. 31, 2020 2,000 7,945,034      
Shares granted to settle previously recorded liability 21,420 21,420
Shares granted to settle previously recorded liability , shares     3,000        
Warrant liability recognized in connection with initial issuance of November offering (See Note 7) (135,125) (135,125)
Exercise of warrants $ 2 1,155 1,157
Exercise of warrants , shares     17,852        
Common stock issued for acquisition $ 208 10,195,293 10,195,501
Common stock issued for acquisition , shares     2,075,000        
Stock-based compensation $ 7 1,549,781 1,549,788
Stock-based compensation , shares     74,500        
Common stock issued in public offering, net of costs $ 267 6,999,661 6,999,928
Common stock issued in public offering net of costs, shares     2,666,667        
Preferred stock issued in public offering, net of costs $ 55 12,272,385 12,272,440
Preferred stock issued in public offering, net of costs, shares 552,000            
Dividends paid to preferred shareholder (603,750) (603,750)
Cancellation of restricted stock $ (1) 1
Cancellation of Restricted Stock, shares     (6,379)        
Net Loss (7,390,355) (7,390,355)
Ending balance, value at Dec. 31, 2021 $ 55 $ 1 $ 1,278 42,877,622 (10,213,196) 32,665,760
Ending balance, shares at Dec. 31, 2021 552,000 2,000 12,775,674      
Common stock issued in public offering (over-allotment), net of costs $ 40 1,091,960 1,092,000
Common stock issued in public offering (over-allotment), net of costs, shares     400,000        
Common stock issued in public offering (ATM), net of costs $ 80 929,656 929,736
Common stock issued in public offering (ATM), net of costs, shares     804,811        
Cancellation of restricted shares $ (11) 11
Cancellation of restricted shares , shares     (111,535)        
Settlement of stock in connection with prior acquisition     $ (40)   40
Settlement of stock in connection with prior acquisition, shares     (400,000)        
Common shares repurchased $ (149,686) (149,686)
Common shares repurchased, shares       113,485      
Reissuance of preferred stock
Reissuance of preferred stock, shares   8,000          
Stock-based compensation $ 21 720,381 720,402
Stock-based compensation , shares     207,500        
Dividends paid to preferred shareholder (1,449,000) (1,449,000)
Net Loss (16,575,317) (16,575,317)
Ending balance, value at Dec. 31, 2022 $ 55 $ 1 $ 1,368 $ (149,686) $ 45,619,670 $ (28,237,513) $ 17,233,895
Ending balance, shares at Dec. 31, 2022 552,000 10,000 13,676,450 113,485      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from Operating Activities    
Net Loss $ (16,575,317) $ (7,390,355)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities    
Stock based compensation 720,402 1,549,788
Bad debt expense (recovery) 94,714 (71,003)
Forgiveness of paycheck protection program loan 0 (296,827)
Change in fair market value of warrant liability (58,276) (66,862)
Gain on settlement of loan payable 0 (20,000)
Loss on change in fair market value of contingent consideration (Note 2) 240,000 0
Gain on settlement of contingent consideration (1,700,000) 574,000
Loss on impairment of goodwill and intangible assets 6,993,075 0
Change in reserve for Obsolescence inventory (52,208) (140,000)
Amortization of right-of-use asset 1,213,949 635,540
Depreciation and amortization 1,991,798 946,744
Amortization of debt discount 223,643 0
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable 19,850 73,189
Cost and estimated earnings excess of billings (1,125,610) 0
Inventory (3,633,057) (166,126)
Vendor deposits 916,494 (951,242)
Prepaid expenses and other current assets (448,680) 35,273
Income taxes payable 0 (173,716)
Accounts payable and accrued expenses 1,340,655 (361,569)
Billings in excess of costs and earnings on uncompleted contracts (1,388,838) 0
Deferred revenue 3,941,523 (544,563)
Due to landlord (279,518) 0
Operating lease payments (1,170,949) (630,241)
Net Cash Used in Operating Activities (8,736,350) (6,997,970)
Cash Flows From Investing Activities    
Cash paid for patent costs (682) (14,434)
Purchase of machinery and equipment (23,017) (14,735)
Acquisitions, net of cash acquired (Note 2) (10) (14,560,193)
Payments on note payable (152,571) 0
Net Cash Used in Investing Activities (176,280) (14,589,362)
Cash Flows From Financing Activities    
Payments on financing leases (6,591) (7,217)
Proceeds from warrant exercise 0 1,157
Shares repurchased (149,686) 0
Dividends to preferred shareholders (1,449,000) (603,750)
Payments on loan payable 0 (65,000)
Proceeds from equity raises, net 2,021,736 19,272,368
Proceeds from note payable, net 2,462,500 0
Net Cash Provided by Financing Activities 2,878,959 18,597,558
Net Decrease in Cash and equivalents (6,033,671) (2,989,774)
Cash, restricted cash, and cash equivalents at January 1, 8,768,156 11,757,930
Cash, restricted cash, and cash equivalents at December 31, 2,734,485 8,768,156
Cash paid during the year for:    
Interest 57,534 1,022
Income taxes 0 16,246
Supplemental Schedule of Non-Cash Financing and Investing Activities:    
Initial recognition of warrant liability 0 135,125
Property and equipment obtained in exchange for financing lease liabilities 190,702 0
Reclassification from liability to be settled in stock to additional paid in capital 0 21,420
Common stock issued in connection with acquisitions 0 10,195,501
Initial recognition of contingent consideration liability 0 886,000
Recognition of right of use asset - operating lease 3,527,443 1,884,730
Issuance of Note Payable for payment of prepaid expense $ 318,833 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business

Applied UV, Inc. (the “Parent”) was formed and incorporated in the State of Delaware for the intended purpose of holding the equity of SteriLumen, Inc. (“SteriLumen”) and MunnWorks, LLC (“MunnWorks”), together “the Subsidiaries”, and other companies acquired or created by the Parent in the future. The Parent acquired the Subsidiaries pursuant to share exchanges whereby the equity holders of the Subsidiaries exchanged all of their equity interests in the Subsidiaries for shares of voting stock of the Parent. As a result of the share exchanges, each Subsidiary became a wholly-owned subsidiary of the Parent. The Parent and each Subsidiary are collectively referred to herein as (the “Company”).

SteriLumen is engaged in the design, manufacture, assembly and distribution of (i) automated disinfecting mirror systems for use in hospitals and other healthcare facilities and (ii) air purification systems through its purchase of substantially all of the assets and certain liabilities of Akida Holdings, LLC, KES Science & Technology, and Scientific Air Management LLC, as described below. MunnWorks, LLC is engaged in the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries.

In February of 2021, the Company acquired all the assets and assumed certain liabilities of Akida Holdings, LLC (“Akida”). At the time of this acquisition, Akida owned the Airocide™ system of air purification technologies, originally developed for NASA, with assistance from the University of Wisconsin at Madison, that uses a combination of UVC and a proprietary, titanium dioxide based photocatalyst (“PCO”) to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products, with applications in the hospitality, hotel, healthcare, nursing homes, grocer, wine, commercial buildings and retail sectors. The Airocide™ system has been used by brands and organizations such as NASA, Whole Foods, Dole, Chiquita, Opus One, Sub-Zero Refrigerators and Robert Mondavi Wines. Akida contracted KES Science & Technology, Inc. (“KES”) to manufacture, warehouse and distribute the Airocide™ system and Akida’s contractual relationship with KES was assigned to and assumed by the Company as part of the acquisition.

On September 28, 2021, the Company acquired all the assets and assumed certain liabilities of KES. At the time of the acquisition, KES was principally engaged in the manufacturing and distribution of the Airocide™ system of air purification technologies and misting systems. KES also had the exclusive right to the sale and distribution of the Airocide™ system in certain markets. This acquisition consolidates all of manufacturing, sale and distribution of the Airocide™ system under the SteriLumen brand and expands the Company’s market presence in food distribution, post-harvest produce, wineries, and retail sectors. The Company sells its products throughout the United States, Canada, and Europe.

On October 13, 2021, the Company acquired all the assets and assumed certain liabilities of Scientific Air Management LLC, (“SciAir”). SciAir is a provider of whole-room, aerosol chamber and laboratory certified air disinfection machines that use a combination of UVC and a proprietary, patented system to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products. The units are well suited for larger spaces within a facility and are mobile with industrial grade casters allowing for movement throughout a facility to address increased bio burden from larger meetings or increased human traffic.

On March 25, 2022, the Company acquired the assets and assumed certain liabilities of VisionMark, LLC, (“Visionmark”). Visionmark is engaged in the business of manufacturing customized furniture using wood and metal components for the hospitality and retail industries.

Principles of Consolidation

The consolidated financial statements include the accounts of Applied UV, Inc., Munnworks, LLC and SteriLumen, Inc. All significant intercompany transactions and balances are eliminated in consolidation. 

Concentration of Credit and Business Risk

At times throughout the year, the Company maintains cash balances at various institutions, which may exceed the Federal Deposit Insurance Corporation limit. As of December 31, 2022, the Company was approximately $2,473,000 in excess of FDIC insured limits.

The Company provides credit in the normal course of business. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends and other information.

For the year ended December 31, 2022, the Company had no major suppliers that accounted for over 10% of supplies and materials used by the Company. For the year ended December 31, 2021, the Company had two major suppliers that accounted for approximately 25.4% of supplies and materials used by the Company. The amounts have been recorded as costs of sales in the consolidated statements of operations.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, as of the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation and accounting for equity awards related to warrants and stock-based compensation, determination of fair value for derivative instruments, the accounting for business combinations and allocating purchase price and estimating the useful life of intangible assets.

Cash, Restricted Cash and Cash Equivalents

Cash and equivalents include highly liquid investments that have original maturities less than 90 days at the time of their purchase. These investments are carried at cost, which approximates market value because of their short maturities. As of December 31, 2022 and 2021, the Company had approximately $27,000 and $1,077,000, respectively, in cash equivalents.

Accounts receivable

An allowance for uncollectible accounts receivable is recorded when management believes the collectability of the accounts receivable is confirmed. Subsequent recoveries, if any, are credited to the allowance. The allowance is determined based on management’s review of the debtor’s ability to repay and repayment history, aging history, and estimated value of collateral, if any. The Company had an allowance for doubtful accounts approximating $35,000 and $9,000 as of December 31, 2022 and 2021 respectively.

Inventory

Inventories consist of raw materials, work-in-process, and finished goods. Raw materials and finished goods are valued at the lower of cost or net realizable value, using the first-in, first-out (“FIFO”) valuation method. Work-in-process and finished goods includes the cost of materials, freight and duty, direct labor and overhead. The Company writes down inventory for estimated obsolescence equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. The company had a reserve for inventory approximating $88,000 and $140,000 as of December 31, 2022 and 2021, respectively.

Property and Equipment

Property and equipment are recorded at cost. Depreciation of furniture and fixtures is provided using the straight-line method, generally over the terms of the lease. Repairs and maintenance expenditures, which do not extend the useful lives of the related assets, are expensed as incurred. Depreciation of machinery and equipment is based on the estimated useful lives of the assets.

Schedule of estimated useful lives   
Machinery and equipment  5 to 7 years
Leasehold improvements  Lesser of term of lease or useful life
Furniture and fixtures  5 to 7 years

Business Acquisition Accounting

The Company applies the acquisition method of accounting for those that meet the criteria of a business combination. The Company allocates the purchase price of its business acquisitions based on the fair value of identifiable tangible and intangible assets. The difference between the total cost of the acquisition and the sum of the fair values of acquired tangible and identifiable intangible assets less liabilities is recorded as goodwill. Transaction costs are expensed as incurred in general and administrative expenses.

Goodwill and Intangible Assets

The Company has recorded intangible assets, including goodwill, in connection with business combinations. Estimated useful lives of amortizable intangible assets are determined by management based on an assessment of the period over which the asset is expected to contribute to future cash flows.

In accordance with U.S. GAAP for goodwill and other indefinite-lived intangibles, the Company tests these assets for impairment annually and whenever events or circumstances make it more likely than not that impairment may have occurred. For the purposes of that assessment, the Company has determined to assign assets acquired in business combinations to a single reporting unit including all goodwill and indefinite-lived intangible assets acquired in business combinations. During the year ended December 31, 2022, we evaluated potential triggering events that might be indicators that our goodwill and definite lived intangibles were impaired. As a result of our evaluation, we determined that the fair value of our goodwill and certain intangible assets were less than the carrying amount as of December 31, 2022. This resulted in a total impairment charge of $6,993,075. See note 2 for further information related to the impairment.

Income Taxes

The Company files income tax returns using the cash basis of accounting. Income taxes are accounted for under the asset and liability method. Current income taxes are based on the year’s income taxable for federal and state tax reporting purposes. Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable income will be available to allow all or part of the asset to be recovered.

Derivative Instruments

The Company evaluates its warrants to determine if those contracts or embedded components of those contracts qualify as derivatives. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company has concluded that there are no such reclassifications required to be made as of and for the periods ended December 31, 2022 and 2021.

The Company utilizes the Black-Scholes valuation model to value the derivative warrants as stipulated in the agreement for the warrant holders to receive cash based on that value.

Fair Value of Financial Instruments

The carrying amounts reported in the consolidated balance sheets for loans payable approximate fair value because of the immediate or short-term maturity of the financial instruments. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy.

Loss Per Share

Basic loss per share is computed by dividing net loss attributable to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential shares outstanding would be anti-dilutive.

The following table sets forth the number of potential shares of common stock that have been excluded from diluted net loss per share because their effect was anti-dilutive:

          
   As of December 31,
   2022  2021
Common stock options   1,000,028    644,314 
Common stock warrants   192,419    192,419 
Total   1,192,447    836,733 

Stock-Based Compensation

The Company accounts for its stock-based compensation awards in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 718 (“ASC”), Compensation-Stock Compensation (“ASC 718"). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock and modifications to existing stock options, to be recognized in the statements of operations based on their fair values over the requisite service period.

Research and Development

The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10"). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, research and development costs are expensed as incurred.

Revenue Recognition

The Company recognizes revenue when the performance obligations in the client contract has been achieved. A performance obligation is a contractual promise to transfer product to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as, the customer receives the benefit of the performance obligation. Under ASC 606, revenue is recognized when a customer obtains control of goods in an amount that reflects the consideration the Company expects to receive in exchange for those goods. To achieve this core principle, the Company applies the following five steps:

1) Identify the contract with a customer.
2) Identify the performance obligations in the contract.
3) Determine the transaction price.
4) Allocate the transaction price to performance obligations in the contract.
5) Recognize revenue when or as the Company satisfies a performance obligation.

MunnWorks projects, including those from the VisionMark acquisition, are completed within the Company’s facilities. For these projects, the company designs, manufactures and sells custom mirrors and furniture for the hospitality and retail industries through contractual agreements. These sales require the company to deliver the products within three to nine months from commencement of order acceptance. Revenue is recognized using the input method of accounting. Deferred revenue represents amounts billed in excess of revenues recognized. Revenues recognized in excess of amounts billed typically does not occur as the Company will not perform any work in excess of the amount the company bills to its customers. If work is performed in excess of amounts billed, the Company will record an unbilled receivable.

The company applied the five-step model to the sales of Akida’s and KES’s Airocide™ and misting system products, and SciAir’s whole-room aerosol chamber and laboratory certified air disinfection machines. At contract inception and once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company sells Airocide™ air sterilization units, misting systems, and whole-room aerosol chamber and laboratory certified disinfection machines to both consumer and commercial customers. These products are sold both domestically and internationally. The cycle from contract inception to shipment of products is typically one day to three months. The Company’s contracts for both its consumer and commercial customers each contain a single performance obligation (delivery of Airocide™, KES, and SciAir products), as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts and, therefore, not distinct. As a result, the entire transaction price is allocated to this single performance obligation. The Company recognizes revenues at a point in time when the customer obtains control of the Company’s product, which typically occurs upon shipment of the product by the Company or upon customer pick-up via third party common carrier.

Revenue recognized over time and revenue recognized at a point in time for the years ended:

Schedule of revenue:

          
   December 31,
   2022  2021
Recognized over time  $9,419,117   $1,606,950 
Recognized at a point in time   10,720,732    10,060,629 
   $20,139,849   $11,667,579 

Deferred revenue was comprised of the following as of:

   December 31,  December 31,
   2022  2021
Recognized over time  $3,581,195   $94,867 
Recognized at a point in time   1,149,104    693,908 
   $4,730,299   $788,775 

Deferred revenue amounting to $788,775 as of December 31, 2021 was recognized as revenue during the year ended December 31, 2022.

Shipping and Handling Charges

The Company reports shipping and handling fees charged to customers as part of net sales and the associated expense as part of cost of sales. Shipping charges amounted to $821,448 and $963,385 for the years ended December 31, 2022 and 2021, respectively.

Advertising

Advertising costs consist primarily of online search advertising and placement, trade shows, advertising fees, and other promotional expenses. Advertising costs are expensed as incurred and are included in sales and marketing on the consolidated statements of operations. Advertising expense for the years ended December 31, 2022 and 2021 was $1,109,207 and $799,799, respectively.

Vendor deposits

Vendor payments to third manufactures are capitalized until completion of the project and are recorded as vendor deposits. As of December 31, 2022 and 2021, the vendor deposit balance was $75,548 and $992,042, respectively.

Patent Costs

The Company capitalizes costs consisting principally of outside legal costs and filing fees related to obtaining and maintaining patents. The Company amortizes patent costs over the useful life of the patent which is typically 20 years, beginning with the date the patent is filed with the U.S. Patent and Trademark Office, or foreign equivalent. As of December 31, 2022 and 2021, capitalized patent costs net of accumulated amortization was $1,593,741 and $1,693,124, respectively. For the years ended December 31, 2022 and 2021, the Company recorded $100,065 and $32,398, respectively, of amortization expense for these patents.

Recently adopted accounting standards:

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (eTopic 326): Measurement of Credit Losses on Financial Instruments. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards replace the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measure at amortized cost to be presented at the net amount expected to be collected. The Company determined that this change does not have a material impact to the consolidated financial statements.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS ACQUISITION
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
BUSINESS ACQUISITION

NOTE 2 – BUSINESS ACQUISITION

The Company accounted for the acquisitions as a business combinations using the purchase method of accounting as prescribed in Accounting Standards Codification 805, Business Combinations (“ASC 805") and ASC 820 – Fair Value Measurements and Disclosures (“ASC 820"). In accordance with ASC 805 and ASC 820, the Company used its best estimates and assumptions to accurately assign fair value to the tangible assets acquired, identifiable intangible assets and liabilities assumed as of the acquisition dates. Goodwill as of the acquisition date is measured as the excess of purchase consideration over the fair value of tangible and identifiable intangible assets acquired and liabilities assumed. The results of operations of the acquired businesses since the date of acquisition are included in the consolidated financial statements of the Company years ended December 31, 2022 and 2021. The total purchase consideration was allocated to the assets acquired and liabilities assumed at their estimated fair values as of the date of acquisition, as determined by management. The excess of the purchase price over the amounts allocated to assets acquired and liabilities assumed has been recorded as goodwill. The value of the goodwill from the acquisitions described below can be attributed to a number of business factors including, but not limited to, cost synergies expected to be realized and a trained technical workforce.

In conjunction with acquisitions noted below, we used various valuation techniques to determine fair value of the assets acquired, with the primary techniques being discounted cash flow analysis, relief-from-royalty, a form of the multi-period excess earnings and the with-and-without valuation approaches, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Inputs to these valuation approaches require significant judgment including: (i) forecasted sales, growth rates and customer attrition rates, (ii) forecasted operating margins, (iii) royalty rates and discount rates used to present value future cash flows, (iv) the amount of synergies expected from the acquisition, (v) the economic useful life of assets and (vi) the evaluation of historical tax positions. In certain acquisitions, historical data is limited, therefore, we base our estimates and assumptions on budgets, business plans, economic projections, anticipated future cash flows and marketplace data.

Akida Holdings LLC

On February 8, 2021 Applied UV, Inc. (the “Company”), entered into an asset purchase agreement (the “APA”) by and among the Company, SteriLumen, Inc., a New York corporation and wholly-owned subsidiary of the Company (the “Purchaser”) and Akida Holdings LLC, a Florida limited liability company (the “Seller”) pursuant to which the Purchaser acquired substantially all of the assets of the Seller and assumed certain of its current liabilities and contract obligations, as set forth in the APA (the “Acquisition”). In the Acquisition, the Purchaser acquired all the Seller’s assets and was assigned its contracts related to the manufacture and sale of the Airocide™ system, originally developed for NASA with assistance from the University of Wisconsin at Madison, that uses a combination of UV-C and a proprietary, titanium dioxide-based photocatalyst that has applications in the hospitality, hotel, healthcare, nursing homes, grocer, wine, commercial buildings, and retail sectors.

The purchase price and purchase price allocation as of the acquisition completion date follows.

     
Purchase Price:   
Cash  $760,293 
Fair market value of common stock issued (1,375,000 shares)   7,122,500 
Total Purchase Price, Net of Cash Acquired   7,882,793 
      
Assets Acquired:     
Accounts receivable   233,241 
Inventory   211,105 
Prepaid expenses   285,490 
Machinery and equipment   168,721 
Customer relationships   539,000 
Trade names   1,156,000 
Technology and know how   3,468,000 
Total Assets Acquired:   6,061,557 
      
Liabilities Assumed:     
Accounts payable   (415,341)
Deferred revenue   (491,702)
Total Liabilities Assumed   (907,043)
Net Assets Acquired   5,154,514 
Excess Purchase Price “Goodwill”  $2,728,279 

 

The excess purchase price has been recorded as goodwill in the amount of approximately $2,728,279. The estimated useful life of the identifiable intangible assets (see note 5) is seven to ten years. The goodwill is amortizable for tax purposes.

KES Science & Technology, Inc.

On September 28, 2021, SteriLumen, Inc. completed an Asset Purchase Agreement with KES Science & Technology, Inc. (“KES”), a Georgia corporation.

The purchase price and purchase price allocation as of the acquisition completion date follows.

Purchase Price:   
Cash  $4,299,900 
Fair market value of common stock issued (300,000 shares)   1,959,001 
Total Purchase Price, Net of Cash Acquired   6,258,901 
      
Assets Acquired:     
Accounts receivable   392,367 
Inventory   602,746 
Prepaid expenses   10,995 
Machinery and equipment   36,146 
Customer relationships   —   
Trade names   914,000 
Technology and know how   3,656,000 
Total Assets Acquired:   5,612,254 
      
Liabilities Assumed:     
Accounts payable   (296,681)
Capital lease obligations   —   
Total Liabilities Assumed   (296,681)
Net Assets Acquired   5,315,573 
Excess Purchase Price “Goodwill”  $943,328 

The excess purchase price has been recorded as goodwill in the amount of $943,328. The estimated useful life of the identifiable intangible assets is ten years (see note 5). The goodwill is amortizable for tax purposes.

Old SAM Partners (Scientific Air)

On October 13, 2021, the Company entered into an asset purchase agreement by and among the Company, SteriLumen, Inc., a New York corporation and wholly-owned subsidiary of the Company (the “Purchaser”) and Old SAM Partners, LLC, a Florida limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller, including the assignment of an exclusive distribution agreement. On October 13, 2021 the Seller received, as consideration for the Acquisition (i) $9,500,000 in cash; and (ii) 200,000 shares of the Company’s common stock and (iii) 200,000 unvested shares of the Company’s common stock, which are subject to cancellation if the earnout is not met. On the date of acquisition, the fair market value of the 200,000 vested shares was $5.57 for a total value of $1,114,000. An additional liability was recorded for $886,000 as a result of the agreement calling for additional cash consideration to the extent the share price is below $10 on the free trading date, as defined in the agreement. On December 31, 2021, the share price of our common stock was $2.70 per share and a loss on contingent consideration of  $574,000 was recorded in the consolidated statements of operations and increased the liability to $1,460,000.

The purchase price and purchase price allocation as of the acquisition completion date follows.

Purchase Price:   
Cash  $9,500,000 
Fair market value of common stock issued   1,114,000 
Contingent consideration based on stock price   886,000 
Total Purchase Price, net of cash acquired   11,500,000 
      
Assets Acquired:     
Accounts receivable   129,845 
Inventory   369,970 
Machinery and equipment   1,982 
Customer relationships   6,784,000 
Patents   1,533,000 
Technology and know how   1,217,000 
Trade names   326,000 
Total Assets Acquired:   10,361,797 
Assets Acquired   10,361,797 
Excess Purchase Price “Goodwill”  $1,138,203 

The excess purchase price has been recorded as goodwill in the amount of approximately $1,138,203. The estimated useful life of the identifiable intangible assets (see note 5) is ten years. The goodwill is amortizable for tax purposes.

On March 31, 2022, there was a settlement of a dispute that arose during the first quarter of 2022 between both parties regarding certain representations and warranties in the purchase agreement which resulted in a settlement and mutual release agreement where the seller agreed to relinquish any right, title, and interest in the previously issued 400,000 shares. During the three months ended March 31, 2022, the company recorded a loss on change in fair market value of contingent consideration of $240,000 and, as a result of the settlement agreement, the company recorded a gain on settlement of contingent consideration of $1,700,000. The Company also determined that a triggering event had occurred as a result of the settlement agreement. A quantitative impairment test on the goodwill and intangible assets determined that the fair value was below the carrying value and as a result the Company recorded a full goodwill impairment charge of $1,138,203 in the first quarter of 2022. Subsequently, as of December 31, 2022, we evaluated potential triggering events that might be indicators that our definite lived intangibles were impaired. We saw a significant decrease in the number of orders and demand of certain product lines within our disinfectant business segment.

As a result of our evaluation, we determined that the fair value of certain intangible assets were less than the carrying amount as of December 31, 2022. The Company recorded an impairment on intangibles of $5,854,872 in the Consolidated Statements of Operations during the year ended December 31, 2022.

On March 25, 2022, the Company entered into an asset purchase agreement by and among the Company, Munnworks, LLC., a New York Limited Liability Company and wholly-owned subsidiary of the Company (the “Purchaser”) and VisionMark LLC, a New York limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller in exchange for the assumption of obligations of buyer under the sublease and sublease guarantee.

The purchase price and purchase price allocation as of the acquisition completion date follows.

Purchase Price:   
Cash paid at closing  $10 
Due to landlord   755,906 
Total Purchase Price, net of cash acquired   755,916 
      
Assets Acquired:     
Accounts receivable, net   636,550 
Inventory   176,583 
Costs and estimated earnings in excess of billings   181,152 
Machinery and equipment   1,100,000 
Total Assets Acquired:   2,094,285 
      
Liabilities Assumed:     
Billings in excess of costs and earnings on uncompleted contracts   (1,388,838)
Total Liabilities Assumed   (1,388,838)
Net Assets Acquired   705,447 
Excess Purchase Price “Goodwill”  $50,469 

The excess purchase price has been recorded as goodwill in the amount of approximately $50,469. The goodwill is amortizable for tax purposes.

In connection with the VisionMark LLC acquisition, the Company is obligated to repay $31,057 of past due lease payments per month for the next 36 months commencing on April 1, 2022. The Company recognized a discount and related liability equal to the present value of the past due lease liability, and amortizes the difference between such present value and the liability through interest expense using a rate of 38.7% as per the effective interest rate method over the repayment period. Amortization of discount included in interest expenses was $146,073 for the year ended December 31, 2022.

As of December 31, 2022, the future maturity of the lease liability as of December 31, is as follows:

     
Years Ended December 31,   
2023  $372,684 
2024   372,684 
2025   93,174 
Total   838,542 
Less: Unamortized discount   (216,078)
Total amount due to landlord   622,464 
Less: current portion of amount due to landlord, net of discount   (229,235)
Total long-term portion of amount due to landlord  $393,230 

 
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
INVENTORY

NOTE 3 – INVENTORY

Inventory consists of the following as of:

          
   December 31,  December 31,
   2022  2021
Raw materials  $3,485,040   $356,759 
Finished goods   2,110,838    1,429,479 
Inventory at cost   5,595,878    1,786,238 
Less: Reserve   (87,792)   (140,000)
Inventory  $5,508,086   $1,646,238 
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

NOTE 4 – PROPERTY AND EQUIPMENT

Property and equipment (including machinery and equipment under capital leases) are summarized by major classifications as follows:

          
   December 31,  December 31,
   2022  2021
Machinery and Equipment  $1,266,189   $254,685 
Leasehold improvements   67,549    67,549 
Furniture and Fixtures   203,256    54,041 
    1,536,994    376,275 
Less: Accumulated Depreciation   (403,526)   (179,664)
   $1,133,468   $196,611 

Depreciation expense, including amortization of assets under financing leases, for the year ended December 31, 2022 and 2021 was $223,862 and $137,777, respectively.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 5 – INTANGIBLE ASSETS

Intangible assets as of December 31, 2022 and 2021 consist of the following:

          
   December 31,  December 31,
   2022  2021
Intangible assets subject to amortization          
Customer Relationship (Note 2)  $1,655,598   $7,323,000 
Trade Names   2,208,530    2,396,000 
Patents   1,730,771    1,730,089 
Technology and Know How   8,341,000    8,341,000 
    13,935,899    19,790,089 
Less: Accumulated Amortization   (2,581,469)   (813,533)
   $11,354,430   $18,976,556 

 

As described in Note 2 of the financial statements, a quantitative impairment test on the goodwill and intangible assets determined that the fair value was below the carrying value and as a result the Company recorded a full goodwill impairment charge of $1,138,203 in the first quarter of 2022. Subsequently, as of December 31, 2022, we evaluated potential triggering events that might be indicators that our definite lived intangibles were impaired. We saw a significant decrease in the number of orders and demand of certain product lines within our disinfectant business segment. As a result of our assessment, the Company recorded an additional impairment on trade name and customer relationship intangible assets of $187,470 and $5,667,402, respectively, in the Consolidated Statements of Operations during the year ended December 31, 2022.

During the years ended December 31, 2022 and 2021, the Company recorded total amortization expense related to intangible assets of $1,767,936 and $808,967, respectively. The useful lives of tradenames ranges from 5 to 10 years, technology is 10 years, customer relationships ranges from 7 to 14 years, and patents range from 17 to 20 years.

Future amortization of intangible assets is as follows:

      
For the years ending December 31,   
2023   $1,256,948 
2024    1,256,948 
2025    1,256,948 
2026    1,242,192 
2027    1,197,925 
Thereafter    5,143,468 
Total    $11,354,430 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCING LEASE OBLIGATION
 12 Months Ended
Dec. 31, 2022
Financing Lease Obligation  
FINANCING LEASE OBLIGATION

NOTE 6 – FINANCING LEASE OBLIGATION

The Company’s future minimum principal and interest payments under a financing lease for machinery and equipment are as follows:

      
For the years ending December 31,   
2023   $51,716 
2024    48,145 
2025    48,145 
2026    48,145 
2027    36,109 
Total lease payments    232,261 
Less: Amount representing interest    (40,479)
Present value of future minimum lease payments    191,782 
Less: current portion    (33,712)
Financing lease obligations, net of current    158,070 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE
 12 Months Ended
Dec. 31, 2022
Notes Payable  
NOTES PAYABLE

NOTE 7 – NOTES PAYABLE

The Company entered into a loan agreement in April of 2019 where the company was required to pay $157,500 in five payments in the amount of $30,000 per year, with an additional $7,500, representing interest, in year two to a loan holder. As of December 31, 2022, the company has an outstanding balance of $157,500, and no payments have been made as of year end.

Minimum obligations under this loan agreement are as follows:

      
For the year ending December 31,   
2023   $127,500 
2024    30,000 
Total    $157,500 

Applied UV, Inc. and Subsidiaries

Streeterville Note

On October 7, 2022, the Company entered into a Security Purchase Agreement with Streeterville Capital, LLC whereby the Company issued an 8% unsecured redeemable note in the principal amount of $2,807,500. The Company received net proceeds of $2,462,500, after the deduction of debt issuance costs of $345,000. These fees were recorded as debt discounts, net of the carrying value of the debt, and are being amortized over the life of the loan using the effective interest rate method. The note has a maturity date of April 7, 2024. At any time following the occurrence of any event of default, interest shall accrue on the outstanding balance beginning on the date the applicable event of default occurred at an interest rate equal to the lesser of 18% per annum or the maximum rate permitted under applicable law.

The following table presents the balance of the Streeterville Note, net of discount at December 31, 2022.

     
   December 31,
   2022
Principle outstanding  $2,807,500 
Debt discount   (345,000)
Total   2,462,500 
      
Accumulated amortization of debt discount   77,600 
Streeterville note, net of related discount  $2,540,100 

 

Minimum obligations under this loan agreement are as follows:

      
For the years sending December 31,   
2023   $2,072,500 
2024    735,000 
Total    $2,807,500 

The lender has the right at any time 6 months after the effective date, at its election, to redeem all or part of the maximum redemption amount as set forth in the promissory note. Payments of each redemption amount may be made (a) in cash, or (b) in common stock per the following formula: the portion of the applicable Redemption amount being paid in common stock divided by the common stock redemption price, or (c) by any combination of the foregoing. Whereas common stock redemption price means 87.5% multiplied by the Nasdaq minimum price. Whereas Nasdaq minimum price means the lower of: (i) the closing price on the trading day immediately preceding the date the common stock redemption price is measured; or (ii) the average closing price of the common stock for the five trading days immediately preceding the date the common stock redemption price is measured.

The principal amount of the Note may be prepaid in full, or any portion of the outstanding balance earlier than it is due; provided that in the event borrower elects to prepay all or any portion of the outstanding balance it shall pay to lender 120% of the portion of the outstanding balance borrower elects to prepay. The prepayment premium will not apply if borrower repays the Note in full on the anniversary date, which is one year from the purchase price date.

If prior to the anniversary date all redemption amounts are paid as common stock redemptions, then each time after the anniversary date that borrower makes a common stock redemption, $8,333 of the monitoring fee will be deducted from the outstanding balance, not to exceed $50,000. No interest will accrue on the monitoring fee.

For the year ended December 31, 2022, the Company recognized $345,000 as a debt discount relating to the fee and will be amortized using the effective interest method over the term of the note. The effective interest rate of the note is 22.23%. The Company recorded $77,600 due to debt discount amortization to interest expense in the accompanying Statement of Operations and as a result, at December 31, 2022, the remaining unamortized balance was $267,400.

Interest expense recorded in the accompanying Statements of Operations by the Company was $53,031 for the year ended December 31, 2022.

Directors and Officers Liability Insurance Agreement

On August 28, 2022, the Company entered into a one-year Directors and Officers Liability Insurance agreement for $318,833. Under the terms of the agreement, the Company made a down payment of $41,730, with the remaining balance financed over the remaining term at an annual percentage rate of 5.05%. Beginning in September 2022, the Company is making 10 monthly payments of $27,710, with the last payment expected to be made in June 2023. At December 31, 2022, the outstanding balance on the note payable was $166,262. The interest expense for the year ended December 31, 2022 was immaterial to the consolidated financial statements.

Pinnacle Note

In December 2022, the Company entered into a Loan and Security Agreement, or (the “Loan Agreement”), with Pinnacle Bank, which provides for a $5,000,000 secured revolving credit facility (the “Loan Facility”). The loan is subject to a maximum advance rate of up to 85% of net face amount of eligible accounts, plus the lessor a) of the sum of 20% of the aggregate eligible inventory value of raw materials and 35% of the aggregate eligible inventory value of finished goods, b) $1 million, c) 80% of the net orderly liquidation value of raw materials and finished goods, or d) 100% of the aggregate outstanding principal amount of advances. In no event shall the aggregate amount of the outstanding advances under the Loan Facility be greater than $5 million. The loan matures on December 9, 2024. The principal amount of outstanding revolving loan, together with accrued and unpaid interest, is due on the maturity date.

The loan accrues interest at a 1.50% margin above the greater of the prime rate or 4.00%. The interest margin is increased to 2.00% in respect to the advances against eligible inventory. If the Company fails to perform any covenant, term or provision of the Loan Agreement, then interest shall accrue at the rate of 6.0% above the interest rate. If after the occurrence of an event of default and the loan is not paid in full by the maturity date, the loan shall bear interest at the rate of 18.0% above the interest rate.

Obligations under the Loan Agreement are secured by all of the Company’s assets. On the effective date the Company paid a loan fee of 2% of the amount of the Loan Facility and will be required to pay a loan fee of 1.5% of the amount of the Loan Facility annually thereafter.

The Loan Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and the Subsidiaries, including, without limitation, restrictions on liens, indebtedness, fundamental changes, capital expenditures, consignments of inventory and distributions.

The Loan Agreement contains customary events of default, including, without limitation, payment defaults, covenant defaults, breaches of certain representations and warranties, certain events of bankruptcy and insolvency, certain events under ERISA and judgments. If an event of default occurs and is not cured within any applicable grace period or is not waived, the Lender is entitled to take various actions, including, without limitation, the acceleration of amounts due thereunder and termination of commitments under the Loan Facility.

There were no borrowings outstanding under the Loan Facility as of December 31, 2022.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 8 – FAIR VALUE MEASUREMENTS

Accounting guidance on fair value measurements requires that financial assets and liabilities be classified and disclosed in one of the following categories of the fair value hierarchy:

Level 1 – Based on unadjusted quoted prices for identical assets or liabilities in an active market.

Level 2 – Based on observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3– Based on unobservable inputs that reflect the entity’s own assumptions about the assumptions that a market participant would use in pricing the asset or liability.

We did not have any transfers between levels during the periods presented.

The following table presents assets and liabilities that were measured at fair value in the Consolidated Balance Sheets on a recurring basis as of December 31, 2022 and 2021:

                         
   Carrying Amount  Fair Value  Quoted Priced active markets (Level 1)  Significant other observable inputs (Level 2)  Significant unobservable inputs (Level 3)
   As of December 31, 2022
Assets               
Money market funds  $26,828   $26,828   $26,828   $—     $—   
Total assets  $26,828   $26,828   $26,828   $—     $—   
Liabilities                         
Contingent consideration  $—     $—     $—     $—     $—   
Warrant liability   9,987    9,987    —      —      9,987 
Total liabilities  $9,987   $9,987   $—     $—     $9,987 
                          
    As of December 31, 2021
Assets                         
Money market funds  $1,076,664   $1,076,664   $1,076,664   $—     $—   
Total assets  $1,076,664   $1,076,664   $1,076,664   $—     $—   
Liabilities                         
Contingent consideration  $1,460,000   $1,460,000   $1,460,000   $—     $—   
Warrant liability   68,263    68,263    —      —      68,263 
Total liabilities  $1,528,263   $1,528,263   $1,460,000   $—     $68,263 

The carrying amounts of accounts receivable, accounts payable and short-term debt approximated fair values as of December 31, 2022 and 2021 because of the relatively short maturity of these instruments. There were no other level 3 or level 1 assets or liabilities as if December 31, 2022.

Money market funds – Cash equivalents of $26,828 and $1,076,664 as of December 31, 2022 and 2021, respectively, consisted of money market funds. Money market funds are classified as Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets.

Contingent consideration – The fair value of the contingent consideration is derived through the quoted market price of our stock, which represents a Level 1 measurement within the fair value hierarchy.

Warrant liability – The fair value of the warrant liability is derived through the Black scholes method and is based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.

Other Fair Value Measurements

In addition to assets and liabilities that are recorded at fair value on a recurring basis, GAAP requires that, under certain circumstances, we also record assets and liabilities at fair value on a nonrecurring basis.

In connection with the acquisitions of SciAir, KES, and Akida during 2021, and VisionMark in 2022, as discussed in Note 2, we used various valuation techniques to determine fair value, with the primary techniques being discounted cash flow analysis and the relief-from-royalty, a form of the multi-period excess earnings, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 9 – STOCKHOLDERS’ EQUITY 

At the Market Sales Agreement

On July 1, 2022, the Company filed a $50,000,000 mixed use shelf registration (Form S-3) and entered into an At The Market sales agreement (ATM) with Maxim Group, LLC, for a total of $9,000,000, as a readily available source of funding if needed. During the year ended December 31, 2022 the Company sold 804,811 ATM shares through the sales agent with gross proceeds of $964,083. In connection with the sale of these ATM Shares, the compensation paid by the Company to the Sales Agent was $28,922. As of March 31, 2023, an additional 1,764,311 shares have been sold for gross proceeds of $2,314,860, leaving a balance of $5,721,057 on the ATM facility. The shelf registration statement will expire on July 12, 2025.

Amendment of the Certificate of Designation

On June 17, 2021, the Company filed an amendment of the certificate of designation of Series A Preferred Stock. The Board of Directors, by unanimous written consent, duly adopted resolutions to amend the Series A Preferred Stock Certificate of Designations and changed the name from “Series A Preferred Stock” to “Series X Super Voting Preferred Stock”. All dividend, liquidation preference, voting, conversion, and redemption rights, did not change from the originally filed Certificate of Designation of Series A Preferred Stock. On July 11, 2022, the Board of Directors approved the reissuance of 8,000 shares of the Company’s Series X Super Voting Preferred Shares, which represent the remainder of the designated but unissued shares of Super Voting Preferred Stock.

On March 9, 2022, the Board of Directors approved a resolution that authorized the senior management of the Company to purchase up to and limited to one million shares of common stock between March 10, 2022 and September 30, 2022. As of December 31, 2022, the Company has a total 113,485 of treasury shares, all of which have been purchased as of December 31, 2022.

Pursuant to the Company’s amended and restated certificate of incorporation, as amended, the Company is authorized to designate and issue up to 20,000,000 shares of preferred stock, par value $0.0001 per share, in one or more classes or series. During the year ended December 31, 2022, the Company had 10,000 preferred shares designated as Series X Preferred Stock and 19,990,000 shares of preferred stock designated as 10.5% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). Upon certain events, the Company may, subject to certain conditions, at the Company’s option, redeem the Series A Preferred Stock. See below for a further description of the Series A Preferred Stock:

Dividends: Holders are entitled to receive cumulative cash dividends at the annual rate of 10.5% on $25.00 liquidation preference per share of the Series A Perpetual Preferred Stock. Dividends accrue and are payable in arrears beginning August 15, 2021, regardless of whether declared or there are sufficient earnings or funds available for payment. Sufficient net proceeds from the offering must be set aside to pay dividends for the first twelve months from issuance. The company has classified $0 and $845,250 as restricted cash as of December 31, 2022 and 2021, respectively, as a reserve to pay the remaining required dividends for the first year.

Redemption: Company has an optional redemption right beginning July 16, 2022, which redemption price declines annually. The initial redemption price after year 1 is $30 and decreases annually over 5 years to $25 per share. The Company also has a special optional redemption right upon the occurrence of a Delisting Event or Change of Control, as defined, at $25 per share plus accrued and unpaid dividends.

Voting Rights: The holders have no voting rights, except for voting on certain corporate decisions, or upon default in payment of dividends for any twelve periods, in which case the holders would have voting rights to elect two additional directors to serve on the Board of Directors.

Conversion Rights: Such shares are not convertible unless and until the occurrence of a Delisting Event or Change of Control and when the Company has not exercised its special optional redemption right. The conversion price would be the lesser of the amount converted based on the $25.00 liquidation preference plus accrued dividends divided by the common stock price of the Delisting Event or Change of Control (as defined) or $5.353319 (Share Cap). Effectively, the Share Cap limits the common stock price to no lower than $4.67.

2020 Incentive Plan

On March 31, 2020, the Company adopted the Applied UV, Inc. 2020 Omnibus Incentive Plan (the “Plan”) with 600,000 shares of common stock available for issuance under the terms of the Plan. On May 17, 2022, the shareholders of the Company approved an amendment to the Plan, increasing the shares available for issuance to 2,500,000. The Plan permits the granting of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units and Other Awards. The objectives of the Plan are to optimize the profitability and growth of the Company through incentives that are consistent with the Company’s goals and that link the personal interests of Participants to those of the Company’s stockholders. The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract and retain the services of Participants who make or are expected to make significant contributions to the Company’s success and to allow Participants to share in the success of the Company. From time to time, the Company may issue Incentive Awards pursuant to the Plan. Each of the awards will be evidenced by and issued under a written agreement.

If an incentive award granted under the Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered to the company in connection with an incentive award, the shares subject to such award and the surrendered shares will become available for future awards under the Plan. The number of shares subject to the Plan, and the number of shares and terms of any Incentive Award may be adjusted in the event of any change in our outstanding common stock by reason of any stock dividend, spin-off, stock split, reverse stock split, recapitalization, reclassification, merger, consolidation, liquidation, business combination or exchange of shares, or similar transaction. There are 1,605,000 shares available for future grants under the plan.

A summary of the Company’s option activity and related information follows:

                         
   Number of Options  Weighted-Average Exercise Price  Weighted-Average Grant Date Fair Value  Weighted-Average Remaining Contractual Life (in years)  Aggregate intrinsic value
Balances, January 1, 2021   136,750   $4.96   $2.27    9.95   $—   
Options granted   602,564    7.81    5.43    10.00    —   
Options forfeited   (95,000)   4.96    3.73    —      —   
Options exercised   —      —      —      —      —   
Balances, December 31, 2021   644,314   $7.11   $5.03    8.47   $—   
Options granted   639,000    1.66    1.06    10.00    —   
Options forfeited   (283,286)   7.02    —      —      —   
Options exercised   —      —      —      —      —   
Balances, December 31, 2022   1,000,028   $3.61   $—      9.03   $—   
Vested   320,109   $5.69             $—   

Share-based compensation expense for options totaling $567,194 and $721,783 was recognized for the years ended December 31, 2022 and 2021, respectively, based on requisite service periods.

The valuation methodology used to determine the fair value of the options issued during the year was the Black-Scholes option-pricing model. The Black-Scholes model requires the use of a number of assumptions including volatility of the stock price, the average risk-free interest rate, and the weighted average expected life of the options.

The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options.

Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of the award. The Company’s calculation of estimated volatility is based on historical stock prices of peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price.

As of December 31, 2022 there was $1,090,364 of total unrecognized compensation expense related to unvested employee options granted under the Company’s share-based compensation plans that is expected to be recognized over a weighted average period of approximately 2.19 years.

The weighted average fair value of options granted, and the assumptions used in the Black-Scholes model during the years ended December 31, 2022 and 2021 are set forth in the table below.

          
   2022  2021
Stock Price   $0.90 - $2.70    $4.16 - $9.79 
Exercise Price   $1.07 - $2.70    $4.16 - $9.79 
Dividend Yield   0%   0%
Volatility   78.95% - 92.96%    75.04% - 89.96% 
Risk-Free Rate   1.26% - 3.46%    1.02% - 1.40% 
Expected Life (in years)   5.31 - 6.08    5.36 - 6.25 

Common Stock Warrants

A summary of the Company’s warrant activity and related information follows:

           

 

 

  Number of Shares  Weighted-Average Exercise Price
Balances, January 1, 2021    235,095   $5.89 
Granted    —      —   
Exercised    (42,676)   —   
Balances, December 31, 2021    192,419   $5.84 
Granted    —      —   
Exercised    —      —   
Balances, December 31, 2022    192,419   $5.84 
Vested    192,419   $5.84 

For the years ended December 31, 2022 and 2021, the Company recorded a gain on the change in fair value of warrant liability in the amount of $58,276 and $66,862, respectively. The Company valued the warrant using the Black-Scholes option pricing model with the following terms on December 31, 2022: (a) exercise price of $6.56, (b) volatility rate of 94.55%, (c) risk free rate of 4.22%, (d) term of 2.86 years, and (e) dividend rate of 0%. The Company valued the warrant using the Black-Scholes option pricing model with the following terms on December 31, 2021: (a) exercise price of $6.56, (b) volatility rate of 82.08%, (c) risk free rate of 0.98%, (d) term of 3.86 years, and (e) dividend rate of 0%.

Preferred Stock Offering

On July 13, 2021, Applied UV, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Ladenburg Thalmann & Co. Inc. as representative (“Representative”) of the underwriters (“Underwriters”), related to the offering of 480,000 shares (the “Shares”) of the Company’s 10.5% Series A Cumulative Perpetual Preferred Stock [non-convertible], par value $0.0001 per share (“Series A Preferred Stock”), at a public offering price of $25.00 per share, which excludes 72,000 shares of Series A Cumulative Perpetual Preferred Stock that may be purchased by the Underwriters pursuant to their overallotment option granted to the Underwriters under the terms of the Underwriting Agreement. The Shares were offered and sold by the Company pursuant to the terms of the Underwriting Agreement and registered pursuant to the Company’s registration statement on (i) Form S-1 (File No. 333-257197), as amended, which was filed with the SEC and declared effective by the Commission on July 12, 2021 and (ii) the Company’s registration statement on Form S-1 (File No. 333-257862), which was filed with the Commission on July 13, 2021 and declared effective upon filing. The closing of the offering for the Shares took place on July 16, 2021 and were approved for listing on Nasdaq under the trading symbol “AUVIP”. On July 29, 2021, in connection with its offering of its 10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share, the Company closed the exercise of the underwriter’s overallotment option of 72,000 shares at $25.00 per share. Aggregate gross proceeds including the exercise of the underwriter’s overallotment option was $12,272,440 after deducting underwriting discounts and commissions and fees and other offering expenses.

Common Stock Offering

On December 28, 2021, the Company closed a common stock offering in which it issued 2,666,667 common shares at a public offering price of $3.00 per share. In connection with the Offering, the Company (i) received $8,000,000 less underwriting fees of $560,000 and offering Costs in the amount of $440,073, resulting in net proceeds of $6,999,928.

On January 5, 2022, the underwriters fully exercised their over-allotment option to purchase an additional 400,000 shares of common stock at the public offering price of $3.00 per share. The Company received gross proceeds of $1,200,000 for the over-allotment, which resulted in net proceeds to us of $1,092,000, after deducting underwriting discounts and commissions of $108,000.

Restricted Stock Awards

The Company records compensation expense for restricted stock awards based on the quoted market price of our stock at the grant date and the expense is amortized over the vesting period. These restricted stock awards are subject to time-based vesting conditions based on the continued service of the restricted stock award holder.

The following table presents the restricted stock units activity for the years ended December 31, 2021 and 2022:

          
   Number of Shares  Weighted-Average Fair Market Value
Unvested shares at January 1, 2021   187,555   $5.00 
Granted and unvested   274,500    5.16 
Vested   (163,176)   5.24 
Forfeited/Cancelled   (6,379)   5.00 
Unvested shares, December 31, 2021   292,500    4.71 
Granted and unvested   207,500    2.10 
Vested   (100,966)   3.88 
Forfeited/Cancelled   (311,535)   4.45 
Unvested shares, December 31, 2022   87,499   $2.38 
Vested as of December 31, 2022   306,670   $4.76 

Upon vesting, the restricted stock units are converted to common shares. Based on the terms of the restricted share and restricted stock unit grants, all forfeited shares revert back to the Company.

In connection with the grant of restricted shares, the Company recognized $153,208 and $550,138 of compensation expense within its statements of operations for the years ended December 31, 2022 and 2021, respectively.

The unvested shares as of December 31, 2022 represent $149,438 in unrecognized stock based compensation which will be recognized over a weighted average period of 2.10 years.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
LEASING ARRANGEMENTS
 12 Months Ended
Dec. 31, 2022
Leasing Arrangements  
LEASING ARRANGEMENTS

NOTE 10 - LEASING ARRANGEMENTS

The Company determines whether an arrangement qualifies as a lease under ASC 842 at inception. The Company has operating leases for office space and office equipment. The Company’s leases have remaining lease terms of one year to seven years, some of which include options to extend the lease term for up to five years. The Company considered these options to extend in determining the lease term used to establish the Company’s right-of use assets and lease liabilities once reasonably certain of exercise. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the lease term. The operating lease ROU asset also includes any lease payments made in advance of lease commencement and excludes lease incentives. The lease terms used in the calculations of the operating ROU assets and operating lease liabilities include options to extend or terminate the lease when the Company is reasonably certain that it will exercise those options. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

As the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate of 7.6% based on the information available at commencement date in determining the present value of lease payments.

Munnworks, LLC entered into a lease agreement in Mount Vernon, New York for a term that commenced on April 1, 2019 and will expire on the 31st day of March 2024 at a monthly rate of $13,400. In March of 2021, the Company obtained additional lease space and the agreement was amended to increase rent expense to $15,000 per month. On July 1, 2021, the Company again obtained additional lease space and rent expense was increased to $27,500 per month through July 1, 2024 and $29,150 per month from July 1, 2024 through July 1, 2026.

On September 28, 2021, the Company entered into a lease agreement in Kennesaw, Georgia for office and production space for a term that commenced on September 29, 2021 and will expire on October 1, 2024, with a rate ranging from $14,729 to $15,626 per month.

On April 1, 2022, the Company entered into a lease agreement in Brooklyn, New York for office and production space that commenced on April 1, 2022 and will expire on June 1, 2023, with a rate ranging from $94,529 to $97,365 per month. On December 31, 2022, the Company exercised its option to renew the first renewal term, commencing on July 1, 2023 and ending on June 30, 2025. As a result of the extension of the lease, the Company recorded an additional $2,146,785 of ROU asset and liability on the balance sheet on December 31, 2022.

Rent expense for the years ended December 31, 2022 and 2021 was $1,375,848 and $249,100 respectively.

Schedule maturities of operating lease liabilities outstanding as of December 31, 2022 are as follows:

      
2023   $1,699,318 
2024    1,702,014 
2025    969,567 
2026    174,900 
Total lease payments    4,545,799 
Less: Imputed Interest    (453,388)
Present value of future minimum lease payments   $4,092,411 

Consistent with ASC 842-20-50-4, the Company calculated its total lease cost based solely on its monthly rent obligation. The Company had no cash flows arising from its lease, no finance lease cost, short term lease cost, or variable lease costs. The Company’s lease does not produce any sublease income, or any net gain or loss recognized from sale and leaseback transactions. As a result, the Company did not need to segregate amounts between finance and operating leases for cash paid for amounts included in the measurement of lease liabilities, segregated between operating and financing cash flows; supplemental non-cash information on lease liabilities arising from obtaining right-of-use assets; weighted-average calculations for the remaining lease term; or the weighted-average discount rate.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
PAYROLL PROTECTION PROGRAM
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
PAYROLL PROTECTION PROGRAM

NOTE 11 – PAYROLL PROTECTION PROGRAM

In April of 2020, the Company submitted a Paycheck Protection Program (“PPP”) application to Chase Bank for a loan amount equal to $296,827. The amount was approved, and the Company has received the funds. The PPP Loan, which is in the form of a PPP promissory note and agreement, matures in April of 2025 and bears interest at a rate of 1.00% per annum. The Lender will have 90 days to review borrower’s forgiveness application and the SBA will have an additional 60 days to review the Lender’s decision as to whether the borrower’s loan may be forgiven. Under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, covered utilities, and certain covered mortgage interest payments during the twenty-four-week period beginning on the date of first disbursement of the PPP Loan. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee earning more than $100,000, prorated annually. Not more than 40% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. The loan was forgiven in July of 2021 and in accordance with ASC 470, the amount was recorded as other income.

Under the CARES Act, further economic relief was provided through the Employee Retention Tax Credit (ERTC). In the year ended December 31, 2022, the Company recorded non-operating income of $205,052 related to the ERTC as a component of Other Income.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
NOTE RECEIVABLE- RELATED PARTY
 12 Months Ended
Dec. 31, 2022
Note Receivable- Related Party  
NOTE RECEIVABLE- RELATED PARTY

NOTE 12 - NOTE RECEIVABLE- RELATED PARTY

The company contemplated an acquisition with an entity where certain board members of the Company were also board members of the potential acquiree. In February of 2021, the Company entered into a non-interest bearing note receivable agreement whereby the Company loaned $500,000 to the entity. The note receivable was recorded at cost basis which approximates fair value because of the short-term maturity of the instrument. The loan matures on the earlier of (i) 180 days from the issuance date or (ii) the closing of the transactions set forth in a definitive acquisition entered into between the lender and the borrower. In the event the loan is paid in full on or before the maturity date, there shall be no interest accrued or payable on the outstanding principal amount. If an acquisition occurs, the $500,000 will be applied against the total acquisition price. If the company decides not to execute a definitive agreement within 180 days from the issuance date, the maturity date shall be the one-year anniversary of the issuance date. The maturity date has since been extended to November 30, 2021. The acquisition did not occur and the full amount of $500,000 was repaid on November 30, 2021.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 13 - INCOME TAXES

The provision for federal and state income taxes for the years ended is as follows:

          
   2022  2021
Current provision:          
Federal  $—     $(110,234)
State   —      18,415 
Deferred provision (benefit):          
Federal  $—     $—   
State   —      —   
Total Deferred   —      —   
Total provision for income taxes  $—     $(91,819)

Realization of future tax benefits related to the deferred tax assets is dependent on many factors, including the Company’s ability to generate taxable income within the net operating loss carryforward period. Management has considered these factors in reaching conclusion as to the valuation allowance for financial reporting purposes and has recorded a full valuation allowance against the deferred tax asset.

The income tax effect of temporary differences comprising the deferred tax assets and deferred tax liabilities is a result of the following at December 31:

          
   2022  2021
Deferred tax assets:          
Net operating loss  $3,170,457   $1,732,422 
Fixed assets   (51,573)   14,493 
Lease   52,340    1,201 
Loss on contingency   (193,398)   130,765 
Intangible assets   1,663,044    1,707 
Research and development   64,189    0 
Stock based compensation   95,908    284,468 
Accrual to cash conversion   1,099,403    216,068 
Total  $5,900,370   $2,381,124 
Valuation allowance  $(5,900,370)  $(2,381,124)
Net  $—     $—   

The income tax provision differs from the expense that would result from applying federal statutory rates to income before income taxes because the Company is subject to state income taxes, deferred income taxes are based on average tax rates and a portion of gifts and meals and entertainment are not tax deductible. A valuation allowance has been provided to reduce deferred tax assets to an amount that is more likely than not to be realized.

Prior to the share exchange, Munn Works, LLC was taxed as a single member Limited Liability Company for federal and state income tax purposes. As such, the Company will not pay income taxes for earnings prior to the share exchange, as any income or loss will be included in the tax returns of the individual member. Accordingly, no provision is made for income taxes in the financial statements prior to the share exchange.

Effective tax rates differ from the federal statutory rate of 21% applied to income before provision for income taxes due to the following:

          
   2022  2021
Federal statutory rate times financial statement income  $(3,551,627)  $(1,552,673)
Permanent tax basis differences   (2,268)   (72,997)
Deferred true up   159,849    13,911 
State taxable income, net   (158,480)   (86,700)
Change in Valuation allowance   3,519,246    1,524,637 
Rate change   —      154,179 
True up   —      (91,819)
Other   33,280    19,643 
           
Total provision for income taxes  $—     $(91,819)

The Company has available net operating loss approximately $16,757,643 for tax purposes to offset future taxable income. Pursuant to the Tax Reform Act of 1986, annual utilization of the Company’s net operating loss and contribution carryforwards may be limited if a cumulative change in ownership of more than 50% is deemed to occur within any three-year period. The tax years 2018 through 2021 remain open to examination by federal agencies and other jurisdictions in which it operates.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT REPORTING
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 14 - SEGMENT REPORTING

FASB Codification Topic 280, Segment Reporting, establishes standards for reporting financial and descriptive information about an enterprise’s reportable segments. The Company has three reportable segments: the design, manufacture, assembly and distribution of a suite of air (fixed and mobile) and surface disinfecting systems for use in healthcare, hospitality, food, wine, and commercial municipal and residential markets (Disinfection segment); the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries (Hospitality segment); and the Corporate segment, which includes expenses primarily related to corporate governance, such as board fees, legal expenses, audit fees, executive management, and listing costs. The segments are determined based on several factors, including the nature of products and services, the nature of production processes, customer base, delivery channels and similar economic characteristics.

An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net sales less cost of sales, segment selling, general and administrative expenses, research and development costs and stock-based compensation. It does not include other charges (income), or interest.

                     
   Hospitality  Disinfectant  Corporate  Total
Balance sheet at December 31, 2022                     
Assets   $9,638,828   $19,831,097   $3,257,502   $32,727,427 
Liabilities    10,666,643    1,545,217    3,281,672    15,493,532 
Balance sheet at December 31, 2021                     
Assets   $2,158,789   $27,851,691   $8,515,512   $38,525,992 
Liabilities    2,481,186    1,528,706    1,850,340    5,860,232 

 

   Hospitality  Disinfectant  Corporate  Total
Income Statement for the year ended December 31, 2022                    
Net Sales  $13,639,370   $6,500,479   $—     $20,139,849 
Cost of Goods Sold   12,375,645    3,725,910    —      16,101,555 
Research and development   —      319,167    —      319,167 
Loss on impairment of goodwill   —      6,993,075    —      6,993,075 
Selling, General and Administrative expenses   4,351,932    7,680,551    2,771,585    14,804,068 
Income Statement for the year ended December 31, 2021                    
Net Sales  $5,943,664   $5,723,915   $—     $11,667,579 
Cost of Goods Sold   4,488,652    3,080,541    —      7,569,193 
Research and development   —      53,408    —      53,408 
Selling, General and Administrative expenses   2,281,460    6,110,206    2,950,046    11,341,712 

 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.1
PROFORMA FINANCIAL STATEMENTS (UNAUDITED)
 12 Months Ended
Dec. 31, 2022
Proforma Financial Statements  
PROFORMA FINANCIAL STATEMENTS (UNAUDITED)

NOTE 15 – PROFORMA FINANCIAL STATEMENTS (UNAUDITED)

Unaudited Supplemental Pro Forma Data

Unaudited pro forma results of operations for the years ended December 31, 2022 and 2021 as though the company acquired Akida, KES, Visionmark, and SciAir (the “Acquired Companies”) on January 1, 2021 is set forth below.

          
   Year Ended December 31,  Year Ended December 31,
   2022  2021
Net Sales  $22,248,183   $22,072,379 
Net Loss   (16,580,044)   (9,046,424)
           
Net Loss attributable to common stockholders:          
Dividends to preferred shareholders   (1,449,000)   603,750 
Net Loss attributable to common stockholders   (18,031,480)   (9,650,174)
Basic and Diluted Loss Per Common Share  $(1.41)  $(0.98)
Weighted Average Shares Outstanding - basic and diluted   12,754,979    9,799,627 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 16 – SUBSEQUENT EVENTS

Streeterville Capital

On January 25, 2023, (the “Execution Date”) the Company executed a Redeemable Promissory Note with Streeterville Capital, LLC (the “Investor”) in the amount of $2,807,500 (the “Note”). The Note matures eighteen (18) months from its issuance date of January 25, 2023 and bears interest at 8% per annum on the outstanding principal balance of the Note. The original principal balance of the Note is $2,500,000, plus debt issuance costs of $345,000. Beginning on July 25, 2023, the Investor shall have the right in any month to cause the Company to redeem up to $247,500 of the principal amount of the Note in such month. The Company may elect, in its sole discretion, to redeem such portions of the Note in cash or in its common stock or in any combination thereof. If redemptions are made by the Company with its common stock, such stock will be valued at 87.5% of the Nasdaq Minimum Price. The Company may not redeem the Note with its common stock if at the time of such redemption there is an Equity Condition Failure. It is the intention of the Company to make all Note redemption payments in cash and not in stock. Beginning on July 25, 2023, all cash redemptions will be subject to a ten percent (10%) redemption premium. The Company may pay all or any portion of the outstanding balance on or before one hundred five (105) days from the Execution Date without a prepayment penalty; if paid after one hundred five (105) days, the Company will be subject to a 10% prepayment premium.

The Acquisitions

The PURO Acquisition

On January 26, 2023 (the “Closing Date”), prior to the effective time of the Puro Mergers (as defined below), the Company paid or issued, as applicable (i) 2,497,220 shares of the Company’s common (based on a value of $2.00 per share), (ii) 251,108 shares of the Company’s 5% Series C Cumulative Perpetual Preferred Stock, par value $0.0001 per share (“Series C Preferred Stock”) (iii) $1,335,114 of PURO’s indebtedness to various creditors, (iv) $221,675 of the PURO’s transaction expenses and (v) $2,500,000 and 1,250,000 shares of the Company’s 2% Series B Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”) in repayment of a $5 million note issued by PURO and held by one of its vendor’s. As a result of these issuances and payments the Company and PURO agreed that the acquisition of PURO by the Company (the “PURO Acquisition”) was closed and the PURO Mergers could be affected as soon as possible. The Company financed the payments described above through a $2,807,500 Redeemable Promissory Note from Streeterville Capital, LLC (the “Redeemable Note”) and a $1,537,938 draw on a line of credit from Pinnacle Bank (the “Line of Credit Draw”). The shares described in clauses (i) and (ii) above are collectively referred to herein as the “PURO Equity Consideration”.

 On January 27, 2023 in connection with the prior closing of the PURO Acquisition, the Company caused a two-step merger to occur as follows: (i) a merger between PURO Lighting, LLC, a Colorado limited liability company (“Old PURO”) and PURO Acquisition Sub I, Inc., a Colorado corporation (“PURO Sub I”) and wholly owned subsidiary of the Company became effective (the “First PURO Merger), whereby PURO Sub I was the surviving entity of the merger and then (ii) a merger between PURO Sub I and PURO Acquisition Sub II, LLC, a Delaware limited liability corporation (“PURO Sub II”) and wholly owned subsidiary of the Company became effective (the “Second PURO Merger” and together with the First PURO Merger, the “PURO Mergers”), in each case, pursuant to a previously executed Agreement and Plan of Merger dated as of December 19, 2022, as amended on January 26, 2023 (the “PURO Merger Agreement”), by and between the Company, PURO Acquisition Sub I, PURO Acquisition Sub II, PURO, Brian Stern and Andrew Lawrence. In connection with the PURO Mergers, PURO Sub II was renamed Puro Lighting, LLC (“New PURO”) and New PURO is a wholly-owned subsidiary of the Company.

At the effective time of the First Puro Merger (i) all of the capital stock of PURO Merger Sub I that was outstanding immediately prior to the effective time of the First PURO Merger was converted into and became (i) 100% of the membership interests of Old PURO (and the membership interests of Old PURO into which the membership interests of PURO Merger Sub I were converted became the only outstanding membership interests of Old PURO) and (ii) the right of each holder of a membership interest or profit interest in Old PURO immediately prior to the effective time of the First PURO Merger to receive from the Company their ownership percentage of the following:

(1)The PURO Equity Consideration; and
(2)The right to receive earnout payments subject to certain conditions, including achieving certain revenue targets and gross profit margins and payable as set forth in the PURO Merger Agreement and Schedule II thereto.

The LED Supply Acquisition

On the Closing Date, prior to the effective time of the Puro Mergers, the Company paid or issued, as applicable (i) 1,377,777 shares of the Company’s common stock; (ii) 148,888 shares of Series C Preferred Stock; (iii) $364,316 of Old LED Supply’s indebtedness to various creditors; and (iv) $221,674 of Old LED Supply’s transaction expenses. Part of Old LED Supply’s indebtedness on the Closing Date was $1,778,667 outstanding principal and interest on a line of credit from JP Morgan Chase Bank, N.A. (the “Chase Loan”). The Company has agreed to repay the Chase Loan 14 calendar days from the Closing Date As a result of these issuances, agreements and payments the Company and Old LED Supply agreed that the acquisition of Old LED Supply by the Company (the “LED Supply Acquisition”) was closed and the LED Supply Mergers could be effected as soon as possible. The Company financed the payments described above through the Line of Credit Draw. The shares described in clauses (i) and (ii) above are collectively referred to herein as the “LED Supply Equity Consideration”.

On January 27, 2023 in connection with the prior closing of the LED Supply Acquisition, the Company caused a two-step merger to occur as follows: (i) a merger between LED Supply Co. LLC, a Colorado limited liability company (“Old LED Supply”) and LED Supply Acquisition Sub I, Inc., a Colorado corporation (“LED Supply Sub I”) and wholly owned subsidiary of the Company became effective (the “First LED Supply Merger”), whereby LED Supply Acquisition Sub I was the surviving entity in the merger and then (ii) a merger between LED Supply Sub I and LED Supply Acquisition Sub II, LLC, a Delaware limited liability corporation (“LED Supply Sub II”) and wholly owned subsidiary of the Company became effective (the “Second LED Supply Merger” and together with the First LED Supply Merger, the “LED Supply Mergers”), pursuant to the previously executed Agreement and Plan of Merger dated as of December 19, 2022, as amended on January 26, 2023 (the “LED Supply Merger Agreement”), by and between the Company, LED Supply Acquisition Sub I, LED Supply Acquisition Sub II, LED Supply, Brian Stern and Andrew Lawrence. In connection with the LED Supply Mergers, LED Supply Sub II was renamed Led Supply Co. LLC (“New LED Supply”) and New LED Supply is a wholly-owned subsidiary of the Company.

At the effective time of the First LED Supply Merger (i) all of the capital stock of LED Supply Merger Sub I that was outstanding immediately prior to the effective time of the First LED Supply Merger was converted into and became (i) 100% of the membership interests of Old LED Supply (and the membership interests of Old LED Supply into which the membership interests of LED Supply Merger Sub I were converted became the only outstanding membership interests of Old LED Supply) and (ii) the right of each holder of a membership interest or profit interest in Old LED Supply immediately prior to the effective time of the First LED Supply Merger to receive from the Company their ownership percentage of the following:

(1)The LED Supply Equity Consideration; and
(2)The right to receive earnout payments subject to certain conditions, including achieving certain revenue targets and gross profit margins and payable as set forth in the LED Supply Merger Agreement and Schedule II thereto.

 

The foregoing descriptions of the transactions consummated by the Merger Agreements (as amended) are not intended to be complete and is qualified in its entirety by reference to the full text of the Merger Agreements previously filed as Exhibits 10.1 and 10.2 to the Form 8-K filed on December 20, 2022, and the Amendments to the Merger Agreements filed hereto as Exhibits 10.1 and 10.2including its amendments, and the Note Cancellation Agreement, copies of which are filed herewith as Exhibits 10.1, 10.2, 10.3, 10.4 and 10.5, respectively, and incorporated by reference herein.

Legal Settlement

On February 25, 2022, James Doyle, a former Chief Operating Officer of the Company filed an arbitration claim against the Company for approximately $1.5 million plus attorneys’ fees and other costs with the American Arbitration Association in the State of New York for severance pay and other claims after being terminated by the Company for cause. The arbitration proceeding was initiated pursuant to the arbitration provision in Mr. Doyle’s employment agreement with the Company. The evidentiary hearing was conducted at the American Arbitration Association’s midtown offices on November 7, 8, 9, and 10, 2022.  Afterwards, the parties submitted post-hearing briefs.  On January 24, 2023, the arbitration panel issued a Partial Final Award, whereby the Panel denied five of the seven counts asserted by Doyle, and awarded him only $100,000 in severance pay plus $21,153.84 in unused vacation time plus 6,379 additional shares in the Company pursuant to the terms of his Employment Agreement.  Because Mr. Doyle was determined to be the prevailing party, the Panel awarded him his reasonable attorneys’ fees and expenses, which amounts are currently the subject of post-hearing briefing.  The Company estimated additional legal fees of $10,000. The Company accrued a total of $131,153.83 in S,G&A expense to cover severance pay, unused vacation time, and the legal fee estimate. An additional $5,000 was accrued for interest expense as per the Partial Final Award.

Unregistered Sales of Equity Securities.

The issuance of the PURO Equity Consideration, the LED Supply Equity Consideration and the Series B Preferred Stock are exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”).

Material Modification to Rights of Security Holders.

Series B Preferred Stock

On January 25, 2023, the Company filed the Certificate of Designations, Rights, and Preferences for the Series B Preferred Stock with the Secretary of State of the State of Delaware, which became effective upon acceptance for record. On January 26, 2023, the Company filed the Amendment to the Series B Certificate of Designation (together with the Certificate of Designations, Rights, and Preferences for the Series B Preferred Stock, the “Series B Certificate of Designation”), which became effective upon acceptance for record. The Series B Certificate of Designation classified a total of 1,250,000 shares of the Company’s authorized shares of preferred stock, $0.0001 par value per share, as Series B Preferred Stock.

As set forth in the Series B Certificate of Designation, the Series B Preferred Stock ranks, as to dividend rights and rights upon the Company’s liquidation, dissolution or winding up: (i) senior to all classes or series of Common Stock and to all other equity securities issued by the Company expressly designated as ranking junior to the Series B Preferred Stock; (ii) on parity with the Company’s 10.5% Series A Cumulative Perpetual Preferred Stock; (iii) at least on parity with any future class or series of the Company’s equity securities designated on or after January 25, 2023, including the Company’s 5% Series C Cumulative Perpetual Preferred Stock; and (iv) effectively junior to all the Company’s existing and future indebtedness (including indebtedness convertible into Common Stock or preferred stock) and to the indebtedness and other liabilities of the Company’s existing or future subsidiaries.

Holders of Series B Preferred Stock, when and as authorized by the Company’s Board of Directors, are entitled to cumulative cash dividends at the rate of 2% of the $6 per share liquidation preference per year (equivalent to $0.12 per share per year). Dividends will be payable quarterly in arrears, on or about the 15th day after the end of a quarterly period, beginning on April 15, 2023.

The holders of Series B Preferred Stock, at his, her, or its option, can require the Company to redeem all or a portion of the Series B Preferred Stock at any time and from time to time held by such holder after 30 months from the original issue date at a redemption price of $2.00 per share, plus any accrued and unpaid dividends (whether or not authorized or declared), up to but not including the date fixed for redemption, without interest, to the extent the Company has funds legally available therefor; provided that if a holder requires the Company to redeem all or a portion of the Series B Preferred Stock at any time and from time to time held by such holder on or after the five (5) year anniversary of the original issue date, the redemption price will be $6.00 per share, plus any accrued and unpaid dividends (whether or not authorized or declared), up to but not including the date fixed for redemption, without interest, to the extent the Company has funds legally available therefor.

The Series B Certificate of Designation provides for a special optional redemption by the Company upon a change of control, in whole or in part, for $6.00 per share, plus accrued but unpaid dividends to, but not including the redemption date.

The holders of Series B Preferred Stock neither have voting nor preemptive rights. Each share of Series B Preferred Stock is convertible, at any time and from time to time from and after the original issue date, at the option of the holder, into one share of Common Stock. The Series B Preferred Stock has no stated maturity and will not be subject to any sinking fund for the payment of the redemption price or mandatory redemption.

Series C Preferred Stock

On January 25, 2023, the Company filed the Certificate of Designations, Rights, and Preferences for the Series C Preferred Stock with the Secretary of State of the State of Delaware, which became effective upon acceptance for record. On January 26, 2023, the Company filed the Amendment to the Series C Certificate of Designation (together with the Certificate of Designations, Rights, and Preferences for the Series C Preferred Stock, the “Series C Certificate of Designation”), which became effective upon acceptance for record. The Series C Certificate of Designation classified a total of 2,500,000 shares of the Company’s authorized shares of preferred stock, $0.0001 par value per share, as Series C Preferred Stock.

As set forth in the Series C Certificate of Designation, the Series C Preferred Stock will rank, as to dividend rights and rights upon the Company’s liquidation, dissolution or winding up: (i) senior to all classes or series of Common Stock and to all other equity securities issued by the Company expressly designated as ranking junior to the Series C Preferred Stock; (ii) on parity with any future class or series of the Company’s equity securities expressly designated as ranking on parity with the Series C Preferred Stock; (iii) junior to all equity securities issued by the Company with terms specifically providing that those equity securities rank senior to the Series C Preferred Stock with respect to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up; and (iv) effectively junior to all the Company’s existing and future indebtedness (including indebtedness convertible into Common Stock or preferred stock) and to the indebtedness and other liabilities of the Company’s existing or future subsidiaries.

Holders of Series C Preferred Stock, when and as authorized by the Company’s Board of Directors, are entitled to cumulative cash dividends at the rate of 5% of the $5.00 per share liquidation preference per year (equivalent to $0.25 per share per year). Dividends will be payable quarterly in arrears, on or about the 15th day after the end of a quarterly period, beginning on April 15, 2023.

The Company, to the extent it has legally available funds, must redeem all shares of Series C Preferred Stock on the date that is three years from January 26, 2023. The Series C Certificate of Designation provides for a special optional redemption by the Company upon a change of control, in whole or in part, for $5.00 per share, plus accrued but unpaid dividends to, but not including the redemption date.

The holders of Series C Preferred Stock neither have voting nor preemptive rights. Each share of Series C Preferred Stock will be convertible, at any time and from time to time from and after January 26, 2023, at the option of the holder, into one share of Common Stock. The Series C Preferred Stock has no stated maturity and will not be subject to any sinking fund for the payment of the redemption price or mandatory redemption.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Nature of Business

Nature of Business

Applied UV, Inc. (the “Parent”) was formed and incorporated in the State of Delaware for the intended purpose of holding the equity of SteriLumen, Inc. (“SteriLumen”) and MunnWorks, LLC (“MunnWorks”), together “the Subsidiaries”, and other companies acquired or created by the Parent in the future. The Parent acquired the Subsidiaries pursuant to share exchanges whereby the equity holders of the Subsidiaries exchanged all of their equity interests in the Subsidiaries for shares of voting stock of the Parent. As a result of the share exchanges, each Subsidiary became a wholly-owned subsidiary of the Parent. The Parent and each Subsidiary are collectively referred to herein as (the “Company”).

SteriLumen is engaged in the design, manufacture, assembly and distribution of (i) automated disinfecting mirror systems for use in hospitals and other healthcare facilities and (ii) air purification systems through its purchase of substantially all of the assets and certain liabilities of Akida Holdings, LLC, KES Science & Technology, and Scientific Air Management LLC, as described below. MunnWorks, LLC is engaged in the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries.

In February of 2021, the Company acquired all the assets and assumed certain liabilities of Akida Holdings, LLC (“Akida”). At the time of this acquisition, Akida owned the Airocide™ system of air purification technologies, originally developed for NASA, with assistance from the University of Wisconsin at Madison, that uses a combination of UVC and a proprietary, titanium dioxide based photocatalyst (“PCO”) to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products, with applications in the hospitality, hotel, healthcare, nursing homes, grocer, wine, commercial buildings and retail sectors. The Airocide™ system has been used by brands and organizations such as NASA, Whole Foods, Dole, Chiquita, Opus One, Sub-Zero Refrigerators and Robert Mondavi Wines. Akida contracted KES Science & Technology, Inc. (“KES”) to manufacture, warehouse and distribute the Airocide™ system and Akida’s contractual relationship with KES was assigned to and assumed by the Company as part of the acquisition.

On September 28, 2021, the Company acquired all the assets and assumed certain liabilities of KES. At the time of the acquisition, KES was principally engaged in the manufacturing and distribution of the Airocide™ system of air purification technologies and misting systems. KES also had the exclusive right to the sale and distribution of the Airocide™ system in certain markets. This acquisition consolidates all of manufacturing, sale and distribution of the Airocide™ system under the SteriLumen brand and expands the Company’s market presence in food distribution, post-harvest produce, wineries, and retail sectors. The Company sells its products throughout the United States, Canada, and Europe.

On October 13, 2021, the Company acquired all the assets and assumed certain liabilities of Scientific Air Management LLC, (“SciAir”). SciAir is a provider of whole-room, aerosol chamber and laboratory certified air disinfection machines that use a combination of UVC and a proprietary, patented system to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products. The units are well suited for larger spaces within a facility and are mobile with industrial grade casters allowing for movement throughout a facility to address increased bio burden from larger meetings or increased human traffic.

On March 25, 2022, the Company acquired the assets and assumed certain liabilities of VisionMark, LLC, (“Visionmark”). Visionmark is engaged in the business of manufacturing customized furniture using wood and metal components for the hospitality and retail industries.
Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of Applied UV, Inc., Munnworks, LLC and SteriLumen, Inc. All significant intercompany transactions and balances are eliminated in consolidation. 
Concentration of Credit and Business Risk

Concentration of Credit and Business Risk

At times throughout the year, the Company maintains cash balances at various institutions, which may exceed the Federal Deposit Insurance Corporation limit. As of December 31, 2022, the Company was approximately $2,473,000 in excess of FDIC insured limits.

The Company provides credit in the normal course of business. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends and other information.

For the year ended December 31, 2022, the Company had no major suppliers that accounted for over 10% of supplies and materials used by the Company. For the year ended December 31, 2021, the Company had two major suppliers that accounted for approximately 25.4% of supplies and materials used by the Company. The amounts have been recorded as costs of sales in the consolidated statements of operations.
Use of Estimates

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, as of the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation and accounting for equity awards related to warrants and stock-based compensation, determination of fair value for derivative instruments, the accounting for business combinations and allocating purchase price and estimating the useful life of intangible assets.
Cash, Restricted Cash and Cash Equivalents

Cash, Restricted Cash and Cash Equivalents

Cash and equivalents include highly liquid investments that have original maturities less than 90 days at the time of their purchase. These investments are carried at cost, which approximates market value because of their short maturities. As of December 31, 2022 and 2021, the Company had approximately $27,000 and $1,077,000, respectively, in cash equivalents.
Accounts receivable

Accounts receivable

An allowance for uncollectible accounts receivable is recorded when management believes the collectability of the accounts receivable is confirmed. Subsequent recoveries, if any, are credited to the allowance. The allowance is determined based on management’s review of the debtor’s ability to repay and repayment history, aging history, and estimated value of collateral, if any. The Company had an allowance for doubtful accounts approximating $35,000 and $9,000 as of December 31, 2022 and 2021 respectively.
Inventory

Inventory

Inventories consist of raw materials, work-in-process, and finished goods. Raw materials and finished goods are valued at the lower of cost or net realizable value, using the first-in, first-out (“FIFO”) valuation method. Work-in-process and finished goods includes the cost of materials, freight and duty, direct labor and overhead. The Company writes down inventory for estimated obsolescence equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. The company had a reserve for inventory approximating $88,000 and $140,000 as of December 31, 2022 and 2021, respectively.
Property and Equipment

Property and Equipment

Property and equipment are recorded at cost. Depreciation of furniture and fixtures is provided using the straight-line method, generally over the terms of the lease. Repairs and maintenance expenditures, which do not extend the useful lives of the related assets, are expensed as incurred. Depreciation of machinery and equipment is based on the estimated useful lives of the assets.

Schedule of estimated useful lives   
Machinery and equipment  5 to 7 years
Leasehold improvements  Lesser of term of lease or useful life
Furniture and fixtures  5 to 7 years
Business Acquisition Accounting

Business Acquisition Accounting

The Company applies the acquisition method of accounting for those that meet the criteria of a business combination. The Company allocates the purchase price of its business acquisitions based on the fair value of identifiable tangible and intangible assets. The difference between the total cost of the acquisition and the sum of the fair values of acquired tangible and identifiable intangible assets less liabilities is recorded as goodwill. Transaction costs are expensed as incurred in general and administrative expenses.
Goodwill and Intangible Assets

Goodwill and Intangible Assets

The Company has recorded intangible assets, including goodwill, in connection with business combinations. Estimated useful lives of amortizable intangible assets are determined by management based on an assessment of the period over which the asset is expected to contribute to future cash flows.

In accordance with U.S. GAAP for goodwill and other indefinite-lived intangibles, the Company tests these assets for impairment annually and whenever events or circumstances make it more likely than not that impairment may have occurred. For the purposes of that assessment, the Company has determined to assign assets acquired in business combinations to a single reporting unit including all goodwill and indefinite-lived intangible assets acquired in business combinations. During the year ended December 31, 2022, we evaluated potential triggering events that might be indicators that our goodwill and definite lived intangibles were impaired. As a result of our evaluation, we determined that the fair value of our goodwill and certain intangible assets were less than the carrying amount as of December 31, 2022. This resulted in a total impairment charge of $6,993,075. See note 2 for further information related to the impairment.
Income Taxes

Income Taxes

The Company files income tax returns using the cash basis of accounting. Income taxes are accounted for under the asset and liability method. Current income taxes are based on the year’s income taxable for federal and state tax reporting purposes. Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable income will be available to allow all or part of the asset to be recovered.
Derivative Instruments

Derivative Instruments

The Company evaluates its warrants to determine if those contracts or embedded components of those contracts qualify as derivatives. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company has concluded that there are no such reclassifications required to be made as of and for the periods ended December 31, 2022 and 2021.

The Company utilizes the Black-Scholes valuation model to value the derivative warrants as stipulated in the agreement for the warrant holders to receive cash based on that value.
Fair Value of Financial Instruments

Fair Value of Financial Instruments

The carrying amounts reported in the consolidated balance sheets for loans payable approximate fair value because of the immediate or short-term maturity of the financial instruments. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy.
Loss Per Share

Loss Per Share

Basic loss per share is computed by dividing net loss attributable to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential shares outstanding would be anti-dilutive.

The following table sets forth the number of potential shares of common stock that have been excluded from diluted net loss per share because their effect was anti-dilutive:

          
   As of December 31,
   2022  2021
Common stock options   1,000,028    644,314 
Common stock warrants   192,419    192,419 
Total   1,192,447    836,733 
Stock-Based Compensation

Stock-Based Compensation

The Company accounts for its stock-based compensation awards in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 718 (“ASC”), Compensation-Stock Compensation (“ASC 718"). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock and modifications to existing stock options, to be recognized in the statements of operations based on their fair values over the requisite service period.
Research and Development

Research and Development

The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10"). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, research and development costs are expensed as incurred.
Revenue Recognition

Revenue Recognition

The Company recognizes revenue when the performance obligations in the client contract has been achieved. A performance obligation is a contractual promise to transfer product to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as, the customer receives the benefit of the performance obligation. Under ASC 606, revenue is recognized when a customer obtains control of goods in an amount that reflects the consideration the Company expects to receive in exchange for those goods. To achieve this core principle, the Company applies the following five steps:

1) Identify the contract with a customer.
2) Identify the performance obligations in the contract.
3) Determine the transaction price.
4) Allocate the transaction price to performance obligations in the contract.
5) Recognize revenue when or as the Company satisfies a performance obligation.

MunnWorks projects, including those from the VisionMark acquisition, are completed within the Company’s facilities. For these projects, the company designs, manufactures and sells custom mirrors and furniture for the hospitality and retail industries through contractual agreements. These sales require the company to deliver the products within three to nine months from commencement of order acceptance. Revenue is recognized using the input method of accounting. Deferred revenue represents amounts billed in excess of revenues recognized. Revenues recognized in excess of amounts billed typically does not occur as the Company will not perform any work in excess of the amount the company bills to its customers. If work is performed in excess of amounts billed, the Company will record an unbilled receivable.

The company applied the five-step model to the sales of Akida’s and KES’s Airocide™ and misting system products, and SciAir’s whole-room aerosol chamber and laboratory certified air disinfection machines. At contract inception and once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company sells Airocide™ air sterilization units, misting systems, and whole-room aerosol chamber and laboratory certified disinfection machines to both consumer and commercial customers. These products are sold both domestically and internationally. The cycle from contract inception to shipment of products is typically one day to three months. The Company’s contracts for both its consumer and commercial customers each contain a single performance obligation (delivery of Airocide™, KES, and SciAir products), as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts and, therefore, not distinct. As a result, the entire transaction price is allocated to this single performance obligation. The Company recognizes revenues at a point in time when the customer obtains control of the Company’s product, which typically occurs upon shipment of the product by the Company or upon customer pick-up via third party common carrier.

Revenue recognized over time and revenue recognized at a point in time for the years ended:

Schedule of revenue:

          
   December 31,
   2022  2021
Recognized over time  $9,419,117   $1,606,950 
Recognized at a point in time   10,720,732    10,060,629 
   $20,139,849   $11,667,579 

Deferred revenue was comprised of the following as of:

   December 31,  December 31,
   2022  2021
Recognized over time  $3,581,195   $94,867 
Recognized at a point in time   1,149,104    693,908 
   $4,730,299   $788,775 

Deferred revenue amounting to $788,775 as of December 31, 2021 was recognized as revenue during the year ended December 31, 2022.
Shipping and Handling Charges

Shipping and Handling Charges

The Company reports shipping and handling fees charged to customers as part of net sales and the associated expense as part of cost of sales. Shipping charges amounted to $821,448 and $963,385 for the years ended December 31, 2022 and 2021, respectively.
Advertising

Advertising

Advertising costs consist primarily of online search advertising and placement, trade shows, advertising fees, and other promotional expenses. Advertising costs are expensed as incurred and are included in sales and marketing on the consolidated statements of operations. Advertising expense for the years ended December 31, 2022 and 2021 was $1,109,207 and $799,799, respectively.
Vendor deposits

Vendor deposits

Vendor payments to third manufactures are capitalized until completion of the project and are recorded as vendor deposits. As of December 31, 2022 and 2021, the vendor deposit balance was $75,548 and $992,042, respectively.
Patent Costs

Patent Costs

The Company capitalizes costs consisting principally of outside legal costs and filing fees related to obtaining and maintaining patents. The Company amortizes patent costs over the useful life of the patent which is typically 20 years, beginning with the date the patent is filed with the U.S. Patent and Trademark Office, or foreign equivalent. As of December 31, 2022 and 2021, capitalized patent costs net of accumulated amortization was $1,593,741 and $1,693,124, respectively. For the years ended December 31, 2022 and 2021, the Company recorded $100,065 and $32,398, respectively, of amortization expense for these patents.
Recently adopted accounting standards

Recently adopted accounting standards:

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (eTopic 326): Measurement of Credit Losses on Financial Instruments. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards replace the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measure at amortized cost to be presented at the net amount expected to be collected. The Company determined that this change does not have a material impact to the consolidated financial statements.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of estimated useful lives
Schedule of estimated useful lives   
Machinery and equipment  5 to 7 years
Leasehold improvements  Lesser of term of lease or useful life
Furniture and fixtures  5 to 7 years
Schedule of anti dilutive securities excluded from computation of earnings per share
          
   As of December 31,
   2022  2021
Common stock options   1,000,028    644,314 
Common stock warrants   192,419    192,419 
Total   1,192,447    836,733 
Schedule of revenue
          
   December 31,
   2022  2021
Recognized over time  $9,419,117   $1,606,950 
Recognized at a point in time   10,720,732    10,060,629 
   $20,139,849   $11,667,579 

Deferred revenue was comprised of the following as of:

   December 31,  December 31,
   2022  2021
Recognized over time  $3,581,195   $94,867 
Recognized at a point in time   1,149,104    693,908 
   $4,730,299   $788,775 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS ACQUISITION (Tables)
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of recognized identified assets acquired and liabilities assumed
     
Purchase Price:   
Cash  $760,293 
Fair market value of common stock issued (1,375,000 shares)   7,122,500 
Total Purchase Price, Net of Cash Acquired   7,882,793 
      
Assets Acquired:     
Accounts receivable   233,241 
Inventory   211,105 
Prepaid expenses   285,490 
Machinery and equipment   168,721 
Customer relationships   539,000 
Trade names   1,156,000 
Technology and know how   3,468,000 
Total Assets Acquired:   6,061,557 
      
Liabilities Assumed:     
Accounts payable   (415,341)
Deferred revenue   (491,702)
Total Liabilities Assumed   (907,043)
Net Assets Acquired   5,154,514 
Excess Purchase Price “Goodwill”  $2,728,279 

 

The excess purchase price has been recorded as goodwill in the amount of approximately $2,728,279. The estimated useful life of the identifiable intangible assets (see note 5) is seven to ten years. The goodwill is amortizable for tax purposes.

KES Science & Technology, Inc.

On September 28, 2021, SteriLumen, Inc. completed an Asset Purchase Agreement with KES Science & Technology, Inc. (“KES”), a Georgia corporation.

The purchase price and purchase price allocation as of the acquisition completion date follows.

Purchase Price:   
Cash  $4,299,900 
Fair market value of common stock issued (300,000 shares)   1,959,001 
Total Purchase Price, Net of Cash Acquired   6,258,901 
      
Assets Acquired:     
Accounts receivable   392,367 
Inventory   602,746 
Prepaid expenses   10,995 
Machinery and equipment   36,146 
Customer relationships   —   
Trade names   914,000 
Technology and know how   3,656,000 
Total Assets Acquired:   5,612,254 
      
Liabilities Assumed:     
Accounts payable   (296,681)
Capital lease obligations   —   
Total Liabilities Assumed   (296,681)
Net Assets Acquired   5,315,573 
Excess Purchase Price “Goodwill”  $943,328 

The excess purchase price has been recorded as goodwill in the amount of $943,328. The estimated useful life of the identifiable intangible assets is ten years (see note 5). The goodwill is amortizable for tax purposes.

Old SAM Partners (Scientific Air)

On October 13, 2021, the Company entered into an asset purchase agreement by and among the Company, SteriLumen, Inc., a New York corporation and wholly-owned subsidiary of the Company (the “Purchaser”) and Old SAM Partners, LLC, a Florida limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller, including the assignment of an exclusive distribution agreement. On October 13, 2021 the Seller received, as consideration for the Acquisition (i) $9,500,000 in cash; and (ii) 200,000 shares of the Company’s common stock and (iii) 200,000 unvested shares of the Company’s common stock, which are subject to cancellation if the earnout is not met. On the date of acquisition, the fair market value of the 200,000 vested shares was $5.57 for a total value of $1,114,000. An additional liability was recorded for $886,000 as a result of the agreement calling for additional cash consideration to the extent the share price is below $10 on the free trading date, as defined in the agreement. On December 31, 2021, the share price of our common stock was $2.70 per share and a loss on contingent consideration of  $574,000 was recorded in the consolidated statements of operations and increased the liability to $1,460,000.

The purchase price and purchase price allocation as of the acquisition completion date follows.

Purchase Price:   
Cash  $9,500,000 
Fair market value of common stock issued   1,114,000 
Contingent consideration based on stock price   886,000 
Total Purchase Price, net of cash acquired   11,500,000 
      
Assets Acquired:     
Accounts receivable   129,845 
Inventory   369,970 
Machinery and equipment   1,982 
Customer relationships   6,784,000 
Patents   1,533,000 
Technology and know how   1,217,000 
Trade names   326,000 
Total Assets Acquired:   10,361,797 
Assets Acquired   10,361,797 
Excess Purchase Price “Goodwill”  $1,138,203 

The excess purchase price has been recorded as goodwill in the amount of approximately $1,138,203. The estimated useful life of the identifiable intangible assets (see note 5) is ten years. The goodwill is amortizable for tax purposes.

On March 31, 2022, there was a settlement of a dispute that arose during the first quarter of 2022 between both parties regarding certain representations and warranties in the purchase agreement which resulted in a settlement and mutual release agreement where the seller agreed to relinquish any right, title, and interest in the previously issued 400,000 shares. During the three months ended March 31, 2022, the company recorded a loss on change in fair market value of contingent consideration of $240,000 and, as a result of the settlement agreement, the company recorded a gain on settlement of contingent consideration of $1,700,000. The Company also determined that a triggering event had occurred as a result of the settlement agreement. A quantitative impairment test on the goodwill and intangible assets determined that the fair value was below the carrying value and as a result the Company recorded a full goodwill impairment charge of $1,138,203 in the first quarter of 2022. Subsequently, as of December 31, 2022, we evaluated potential triggering events that might be indicators that our definite lived intangibles were impaired. We saw a significant decrease in the number of orders and demand of certain product lines within our disinfectant business segment.

As a result of our evaluation, we determined that the fair value of certain intangible assets were less than the carrying amount as of December 31, 2022. The Company recorded an impairment on intangibles of $5,854,872 in the Consolidated Statements of Operations during the year ended December 31, 2022.

On March 25, 2022, the Company entered into an asset purchase agreement by and among the Company, Munnworks, LLC., a New York Limited Liability Company and wholly-owned subsidiary of the Company (the “Purchaser”) and VisionMark LLC, a New York limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller in exchange for the assumption of obligations of buyer under the sublease and sublease guarantee.

The purchase price and purchase price allocation as of the acquisition completion date follows.

Purchase Price:   
Cash paid at closing  $10 
Due to landlord   755,906 
Total Purchase Price, net of cash acquired   755,916 
      
Assets Acquired:     
Accounts receivable, net   636,550 
Inventory   176,583 
Costs and estimated earnings in excess of billings   181,152 
Machinery and equipment   1,100,000 
Total Assets Acquired:   2,094,285 
      
Liabilities Assumed:     
Billings in excess of costs and earnings on uncompleted contracts   (1,388,838)
Total Liabilities Assumed   (1,388,838)
Net Assets Acquired   705,447 
Excess Purchase Price “Goodwill”  $50,469 
Schedule of future maturity of the lease liability
     
Years Ended December 31,   
2023  $372,684 
2024   372,684 
2025   93,174 
Total   838,542 
Less: Unamortized discount   (216,078)
Total amount due to landlord   622,464 
Less: current portion of amount due to landlord, net of discount   (229,235)
Total long-term portion of amount due to landlord  $393,230 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY (Tables)
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventory
          
   December 31,  December 31,
   2022  2021
Raw materials  $3,485,040   $356,759 
Finished goods   2,110,838    1,429,479 
Inventory at cost   5,595,878    1,786,238 
Less: Reserve   (87,792)   (140,000)
Inventory  $5,508,086   $1,646,238 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
          
   December 31,  December 31,
   2022  2021
Machinery and Equipment  $1,266,189   $254,685 
Leasehold improvements   67,549    67,549 
Furniture and Fixtures   203,256    54,041 
    1,536,994    376,275 
Less: Accumulated Depreciation   (403,526)   (179,664)
   $1,133,468   $196,611 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets
          
   December 31,  December 31,
   2022  2021
Intangible assets subject to amortization          
Customer Relationship (Note 2)  $1,655,598   $7,323,000 
Trade Names   2,208,530    2,396,000 
Patents   1,730,771    1,730,089 
Technology and Know How   8,341,000    8,341,000 
    13,935,899    19,790,089 
Less: Accumulated Amortization   (2,581,469)   (813,533)
   $11,354,430   $18,976,556 
Future amortization of intangible assets
      
For the years ending December 31,   
2023   $1,256,948 
2024    1,256,948 
2025    1,256,948 
2026    1,242,192 
2027    1,197,925 
Thereafter    5,143,468 
Total    $11,354,430 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCING LEASE OBLIGATION (Tables)
 12 Months Ended
Dec. 31, 2022
Financing Lease Obligation  
Schedule of future minimum principal and interest payments under capital lease arrangements
      
For the years ending December 31,   
2023   $51,716 
2024    48,145 
2025    48,145 
2026    48,145 
2027    36,109 
Total lease payments    232,261 
Less: Amount representing interest    (40,479)
Present value of future minimum lease payments    191,782 
Less: current portion    (33,712)
Financing lease obligations, net of current    158,070 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE (Tables)
 12 Months Ended
Dec. 31, 2022
Notes Payable  
Schedule of minimum obligations under loan agreement
      
For the year ending December 31,   
2023   $127,500 
2024    30,000 
Total    $157,500 
Schedule of note payable net of discount
     
   December 31,
   2022
Principle outstanding  $2,807,500 
Debt discount   (345,000)
Total   2,462,500 
      
Accumulated amortization of debt discount   77,600 
Streeterville note, net of related discount  $2,540,100 
Schedule of minimum obligations
      
For the years sending December 31,   
2023   $2,072,500 
2024    735,000 
Total    $2,807,500 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis
                         
   Carrying Amount  Fair Value  Quoted Priced active markets (Level 1)  Significant other observable inputs (Level 2)  Significant unobservable inputs (Level 3)
   As of December 31, 2022
Assets               
Money market funds  $26,828   $26,828   $26,828   $—     $—   
Total assets  $26,828   $26,828   $26,828   $—     $—   
Liabilities                         
Contingent consideration  $—     $—     $—     $—     $—   
Warrant liability   9,987    9,987    —      —      9,987 
Total liabilities  $9,987   $9,987   $—     $—     $9,987 
                          
    As of December 31, 2021
Assets                         
Money market funds  $1,076,664   $1,076,664   $1,076,664   $—     $—   
Total assets  $1,076,664   $1,076,664   $1,076,664   $—     $—   
Liabilities                         
Contingent consideration  $1,460,000   $1,460,000   $1,460,000   $—     $—   
Warrant liability   68,263    68,263    —      —      68,263 
Total liabilities  $1,528,263   $1,528,263   $1,460,000   $—     $68,263 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of the Company's option activity
                         
   Number of Options  Weighted-Average Exercise Price  Weighted-Average Grant Date Fair Value  Weighted-Average Remaining Contractual Life (in years)  Aggregate intrinsic value
Balances, January 1, 2021   136,750   $4.96   $2.27    9.95   $—   
Options granted   602,564    7.81    5.43    10.00    —   
Options forfeited   (95,000)   4.96    3.73    —      —   
Options exercised   —      —      —      —      —   
Balances, December 31, 2021   644,314   $7.11   $5.03    8.47   $—   
Options granted   639,000    1.66    1.06    10.00    —   
Options forfeited   (283,286)   7.02    —      —      —   
Options exercised   —      —      —      —      —   
Balances, December 31, 2022   1,000,028   $3.61   $—      9.03   $—   
Vested   320,109   $5.69             $—   
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
          
   2022  2021
Stock Price   $0.90 - $2.70    $4.16 - $9.79 
Exercise Price   $1.07 - $2.70    $4.16 - $9.79 
Dividend Yield   0%   0%
Volatility   78.95% - 92.96%    75.04% - 89.96% 
Risk-Free Rate   1.26% - 3.46%    1.02% - 1.40% 
Expected Life (in years)   5.31 - 6.08    5.36 - 6.25 
Schedule of the Company's warrant activity
           

 

 

  Number of Shares  Weighted-Average Exercise Price
Balances, January 1, 2021    235,095   $5.89 
Granted    —      —   
Exercised    (42,676)   —   
Balances, December 31, 2021    192,419   $5.84 
Granted    —      —   
Exercised    —      —   
Balances, December 31, 2022    192,419   $5.84 
Vested    192,419   $5.84 
Schedule of Unvested Restricted Stock Units Activity
          
   Number of Shares  Weighted-Average Fair Market Value
Unvested shares at January 1, 2021   187,555   $5.00 
Granted and unvested   274,500    5.16 
Vested   (163,176)   5.24 
Forfeited/Cancelled   (6,379)   5.00 
Unvested shares, December 31, 2021   292,500    4.71 
Granted and unvested   207,500    2.10 
Vested   (100,966)   3.88 
Forfeited/Cancelled   (311,535)   4.45 
Unvested shares, December 31, 2022   87,499   $2.38 
Vested as of December 31, 2022   306,670   $4.76 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
LEASING ARRANGEMENTS (Tables)
 12 Months Ended
Dec. 31, 2022
Leasing Arrangements  
Schedule of maturities of operating lease liabilities
      
2023   $1,699,318 
2024    1,702,014 
2025    969,567 
2026    174,900 
Total lease payments    4,545,799 
Less: Imputed Interest    (453,388)
Present value of future minimum lease payments   $4,092,411 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of federal and state income
          
   2022  2021
Current provision:          
Federal  $—     $(110,234)
State   —      18,415 
Deferred provision (benefit):          
Federal  $—     $—   
State   —      —   
Total Deferred   —      —   
Total provision for income taxes  $—     $(91,819)
Schedule of deferred tax assets and deferred tax liabilities
          
   2022  2021
Deferred tax assets:          
Net operating loss  $3,170,457   $1,732,422 
Fixed assets   (51,573)   14,493 
Lease   52,340    1,201 
Loss on contingency   (193,398)   130,765 
Intangible assets   1,663,044    1,707 
Research and development   64,189    0 
Stock based compensation   95,908    284,468 
Accrual to cash conversion   1,099,403    216,068 
Total  $5,900,370   $2,381,124 
Valuation allowance  $(5,900,370)  $(2,381,124)
Net  $—     $—   
Schedule of income before provision for income taxes
          
   2022  2021
Federal statutory rate times financial statement income  $(3,551,627)  $(1,552,673)
Permanent tax basis differences   (2,268)   (72,997)
Deferred true up   159,849    13,911 
State taxable income, net   (158,480)   (86,700)
Change in Valuation allowance   3,519,246    1,524,637 
Rate change   —      154,179 
True up   —      (91,819)
Other   33,280    19,643 
           
Total provision for income taxes  $—     $(91,819)
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT REPORTING (Tables)
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of segment reporting
                     
   Hospitality  Disinfectant  Corporate  Total
Balance sheet at December 31, 2022                     
Assets   $9,638,828   $19,831,097   $3,257,502   $32,727,427 
Liabilities    10,666,643    1,545,217    3,281,672    15,493,532 
Balance sheet at December 31, 2021                     
Assets   $2,158,789   $27,851,691   $8,515,512   $38,525,992 
Liabilities    2,481,186    1,528,706    1,850,340    5,860,232 

 

   Hospitality  Disinfectant  Corporate  Total
Income Statement for the year ended December 31, 2022                    
Net Sales  $13,639,370   $6,500,479   $—     $20,139,849 
Cost of Goods Sold   12,375,645    3,725,910    —      16,101,555 
Research and development   —      319,167    —      319,167 
Loss on impairment of goodwill   —      6,993,075    —      6,993,075 
Selling, General and Administrative expenses   4,351,932    7,680,551    2,771,585    14,804,068 
Income Statement for the year ended December 31, 2021                    
Net Sales  $5,943,664   $5,723,915   $—     $11,667,579 
Cost of Goods Sold   4,488,652    3,080,541    —      7,569,193 
Research and development   —      53,408    —      53,408 
Selling, General and Administrative expenses   2,281,460    6,110,206    2,950,046    11,341,712 
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
PROFORMA FINANCIAL STATEMENTS (UNAUDITED) (Tables)
 12 Months Ended
Dec. 31, 2022
Proforma Financial Statements  
Business Acquisition, Pro Forma Information
          
   Year Ended December 31,  Year Ended December 31,
   2022  2021
Net Sales  $22,248,183   $22,072,379 
Net Loss   (16,580,044)   (9,046,424)
           
Net Loss attributable to common stockholders:          
Dividends to preferred shareholders   (1,449,000)   603,750 
Net Loss attributable to common stockholders   (18,031,480)   (9,650,174)
Basic and Diluted Loss Per Common Share  $(1.41)  $(0.98)
Weighted Average Shares Outstanding - basic and diluted   12,754,979    9,799,627 
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
 12 Months Ended
Dec. 31, 2022
Machinery and Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 5 to 7 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives Lesser of term of lease or useful life
Furniture and Fixtures [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 5 to 7 years
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-dilutive shares) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 1,192,447 836,733
Options Held [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 1,000,028 644,314
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 192,419 192,419
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]    
Revenues $ 20,139,849 $ 11,667,579
Deferred revenue 4,730,299 788,775
Transferred over Time [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 9,419,117 1,606,950
Deferred revenue 3,581,195 94,867
Transferred at Point in Time [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 10,720,732 10,060,629
Deferred revenue $ 1,149,104 $ 693,908
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash, FDIC Insured Amount   $ 2,473,000  
Cash Equivalents, at Carrying Value   27,000 $ 1,077,000
Accounts Receivable, Allowance for Credit Loss   35,000 9,000
Inventory, LIFO Reserve   88,000 140,000
Impairment charges $ 1,138,203 6,993,075  
Deferred revenue     788,775
Shipping charges   821,448 963,385
Advertising Expense   1,109,207 799,799
Deposits assets current   75,548 992,042
Patent cost   1,593,741 1,693,124
Amortization   $ 100,065 $ 32,398
Two Major Suppliers [Member]      
Concentration Risk, Percentage     25.40%
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS ACQUISITION - Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)
Dec. 31, 2022
Mar. 25, 2022
Dec. 31, 2021
Oct. 13, 2021
Sep. 28, 2021
Feb. 08, 2021
Business Combination and Asset Acquisition [Abstract]            
Cash paid at closing   $ 10   $ 9,500,000 $ 4,299,900 $ 760,293
Fair market value of common stock issued       1,114,000 1,959,001 7,122,500
Total Purchase Price, net of cash acquired   755,916   11,500,000 6,258,901 7,882,793
Accounts receivable, net   636,550   129,845 392,367 233,241
Inventory   176,583   369,970 602,746 211,105
Prepaid expenses         10,995 285,490
Machinery and equipment   1,100,000   1,982 36,146 168,721
Customer relationships       6,784,000 0 539,000
Trade names       326,000 914,000 1,156,000
Technology and know how         3,656,000 3,468,000
Total Assets Acquired:   2,094,285   10,361,797 5,612,254 6,061,557
Accounts payable         (296,681) (415,341)
Deferred revenue         0 (491,702)
Total Liabilities Assumed   (1,388,838)     (296,681) (907,043)
Net Assets Acquired   705,447   10,361,797 5,315,573 5,154,514
Excess Purchase Price "Goodwill"   50,469   1,138,203 $ 943,328 $ 2,728,279
Contingent consideration based on stock price       886,000    
Patents       1,533,000    
Technology and know how       $ 1,217,000    
Due to landlord $ 229,234 755,906 $ 0      
Costs and estimated earnings in excess of billings $ 1,306,762 181,152 $ 0      
Billings in excess of costs and earnings on uncompleted contracts   $ (1,388,838)        
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS ACQUISITION - Future Maturity of lease Liability (Details)
Dec. 31, 2022
USD ($)
Business Combination and Asset Acquisition [Abstract]  
2023 $ 372,684
2024 372,684
2025 93,174
Total 838,542
Less: Unamortized discount (216,078)
Total amount due to landlord 622,464
Less: current portion of amount due to landlord, net of discount (229,235)
Total long-term portion of amount due to landlord $ 393,230
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS ACQUISITION (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2022
Mar. 25, 2022
Oct. 13, 2021
Sep. 28, 2021
Feb. 08, 2021
Business Acquisition [Line Items]            
Excess purchase price     $ 50,469 $ 1,138,203 $ 943,328 $ 2,728,279
Shares, Issued 400,000          
Change in fair market value $ 240,000          
Contingent consideration 1,700,000          
Asset Impairment Charge $ 1,138,203          
Impairment on intangibles   $ 5,854,872        
Operating Lease, Payments   $ 31,057        
Interest expense rate   38.70%        
Amortization of discount in interest expenses   $ 146,073        
Steri Lumen [Member]            
Business Acquisition [Line Items]            
Excess purchase price     $ 50,469 $ 1,138,203 $ 943,328 $ 2,728,279
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Raw materials $ 3,485,040 $ 356,759
Finished goods 2,110,838 1,429,479
Inventory at cost 5,595,878 1,786,238
Less: Reserve (87,792) (140,000)
Inventory $ 5,508,086 $ 1,646,238
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 1,536,994 $ 376,275
Less: Accumulated Depreciation (403,526) (179,664)
Property and equipment, net 1,133,468 196,611
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 1,266,189 254,685
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 67,549 67,549
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 203,256 $ 54,041
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Abstract]    
Depreciation $ 223,862 $ 137,777
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Intangible assets gross $ 13,935,899 $ 19,790,089
Less: Accumulated Depreciation (2,581,469) (813,533)
Intangible assets net 11,354,430 18,976,556
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets gross 1,655,598 7,323,000
Trade Names [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets gross 2,208,530 2,396,000
Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets gross 1,730,771 1,730,089
Technology-Based Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets gross $ 8,341,000 $ 8,341,000
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
2023 $ 1,256,948  
2024 1,256,948  
2025 1,256,948  
2026 1,242,192  
2027 1,197,925  
Thereafter 5,143,468  
Total  $ 11,354,430 $ 18,976,556
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]      
Asset Impairment Charges $ 1,138,203 $ 6,993,075  
Intangible assets   5,854,872  
Amortization of Intangible Assets   1,767,936 $ 808,967
Trade Names [Member]      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets   187,470  
Customer Relationships [Member]      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets   $ 5,667,402  
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCING LEASE OBLIGATION - Future minimum principal and interest payments under capital lease arrangements (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Financing Lease Obligation    
2023 $ 51,716  
2024 48,145  
2025 48,145  
2026 48,145  
2027 36,109  
Total lease payments 232,261  
Less: Amount representing interest (40,479)  
Present value of future minimum lease payments 191,782  
Less: current portion (33,712)  
Financing lease obligations, net of current $ 158,070 $ 0
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE - Minimum obligations under this loan agreement (Details)
Dec. 31, 2022
USD ($)
Notes Payable  
2023 $ 127,500
2024 30,000
Total  $ 157,500
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE - net of discount (Details)
Dec. 31, 2022
USD ($)
Notes Payable  
Principle outstanding $ 2,807,500
Debt discount (345,000)
Total 2,462,500
Accumulated amortization of debt discount 77,600
Streeterville note, net of related discount $ 2,540,100
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE - Minimum obligations (Details)
Dec. 31, 2022
USD ($)
Short-Term Debt [Line Items]  
2023 $ 127,500
2024 30,000
Total  157,500
Streeterville Note [Member]  
Short-Term Debt [Line Items]  
2023 2,072,500
2024 735,000
Total  $ 2,807,500
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Oct. 07, 2022
Sep. 30, 2022
Aug. 28, 2022
Dec. 31, 2022
Dec. 31, 2021
Offsetting Assets [Line Items]          
Long term debt       $ 157,500  
Down payment   $ 27,710 $ 41,730 30,000  
Debt instrument additional amount       7,500  
Repayments of debt       $ 157,500  
Annual percentage rate     5.05% 18.00%  
Face amount       $ 2,807,500  
Proceeds from notes payable       2,462,500 $ 0
Debt issuance costs       $ 345,000  
Maturity date       Apr. 07, 2024  
Redemption price       87.50%  
Monitoring fee       $ 8,333  
Outstanding balance       50,000  
Debt discount fee       $ 345,000  
Effective interest rate       22.23%  
Debt discount amortization to interest expense       $ 77,600  
Remaining unamortized balance       267,400  
Interest expense       53,031  
Note payable       $ 166,262  
Debt instrument description       The loan accrues interest at a 1.50% margin above the greater of the prime rate or 4.00%. The interest margin is increased to 2.00% in respect to the advances against eligible inventory. If the Company fails to perform any covenant, term or provision of the Loan Agreement, then interest shall accrue at the rate of 6.0% above the interest rate. If after the occurrence of an event of default and the loan is not paid in full by the maturity date, the loan shall bear interest at the rate of 18.0% above the interest rate.  
Maximum [Member]          
Offsetting Assets [Line Items]          
Loan fee percentage       2.00%  
Minimum [Member]          
Offsetting Assets [Line Items]          
Loan fee percentage       1.50%  
Directors and Officers Liability Insurance [Member]          
Offsetting Assets [Line Items]          
Face amount     $ 318,833    
Loan And Security Agreement [Member]          
Offsetting Assets [Line Items]          
Secured credit facility     $ 5,000,000    
Debt instrument description       The loan is subject to a maximum advance rate of up to 85% of net face amount of eligible accounts, plus the lessor a) of the sum of 20% of the aggregate eligible inventory value of raw materials and 35% of the aggregate eligible inventory value of finished goods, b) $1 million, c) 80% of the net orderly liquidation value of raw materials and finished goods, or d) 100% of the aggregate outstanding principal amount of advances. In no event shall the aggregate amount of the outstanding advances under the Loan Facility be greater than $5 million. The loan matures on December 9, 2024.  
Security Purchase Agreement [Member]          
Offsetting Assets [Line Items]          
Annual percentage rate 8.00%        
Face amount $ 2,807,500        
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds $ 26,828 $ 1,076,664
Total assets 26,828 1,076,664
Contingent consideration 0 1,460,000
Warrant liability 9,987 68,263
Other liablities 9,987 1,528,263
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds 26,828 1,076,664
Total assets 26,828 1,076,664
Contingent consideration 0 1,460,000
Warrant liability 0
Other liablities 0 1,460,000
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds 0 0
Total assets 0 0
Contingent consideration 0 0
Warrant liability 0 0
Other liablities 0 0
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds 0 0
Total assets 0 0
Contingent consideration 0 0
Warrant liability 9,987 68,263
Other liablities 9,987 68,263
Fair Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds 26,828 1,076,664
Total assets 26,828 1,076,664
Contingent consideration 0 1,460,000
Warrant liability 9,987 68,263
Other liablities $ 9,987 $ 1,528,263
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Fair Value Disclosures [Abstract]    
Money market funds $ 26,828 $ 1,076,664
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Option Outstanding, beginning 644,314 136,750
Weighted average exercise price, beginning $ 7.11 $ 4.96
Weighted average grant date fair value, beginning $ 5.03 $ 2.27
Weighted average remaining contractual life in years 8 years 5 months 19 days 9 years 11 months 12 days
Options granted 639,000 602,564
Weighted average exercise price, granted $ 1.66 $ 7.81
Weighted average grant date fair value, granted $ 1.06 $ 5.43
Weighted average remaining contractual life, granted 10 years 10 years
Options forfeited/cancelled (283,286) (95,000)
Weighted average exercise price, forfeited $ 7.02 $ 4.96
Weighted average grant date fair value, forfeited $ 3.73
Option exercised 0 0
Weighted average exercise price, exercised $ 0 $ 0
Number of Option Outstanding, ending 1,000,028 644,314
Weighted average exercise price, ending $ 3.61 $ 7.11
Weighted average remaining contractual life in years 9 years 10 days  
Vested and Exercisable 320,109  
Vested and Exercisable $ 5.69  
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY (Details 1) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dividend Yield [Member]      
Dividend yield 0 0  
Measurement Input, Price Volatility [Member]      
Dividend yield 78.95% - 92.96% 75.04% - 89.96%  
Measurement Input, Risk Free Interest Rate [Member]      
Dividend yield 1.26% - 3.46% 1.02% - 1.40%  
Measurement Input, Expected Term [Member]      
Dividend yield 5.31 - 6.08 5.36 - 6.25  
Share-Based Payment Arrangement, Option [Member]      
Exercise Price $ 3.61 $ 7.11 $ 4.96
Minimum [Member] | Share-Based Payment Arrangement, Option [Member]      
Stock Price 0.90 4.16  
Exercise Price 1.07 4.16  
Maximum [Member] | Share-Based Payment Arrangement, Option [Member]      
Stock Price 2.70 9.79  
Exercise Price $ 2.70 $ 9.79  
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY (Details 2) - Warrant [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Class of Warrant or Right [Line Items]    
Options outstanding at the beginning 192,419 235,095
Weighted average exercise price, beginning $ 5.84 $ 5.89
Granted 0 0
Weighted average exercise price, Granted $ 0 $ 0
Exercised 0 (42,676)
Weighted average exercise price, Exercised $ 0 $ 0
Exercised 0 42,676
Options outstanding at the ending 192,419 192,419
Weighted average exercise price, ending $ 5.84 $ 5.84
Vested and Exercisable 192,419  
Weighted average exercise price,Vested and Exercisable $ 5.84  
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY (Details 3) - Restricted Stock [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of unvested shares outstanding, at beginning 292,500 187,555
Weighted average fair market value outstanding, at beginning $ 4.71 $ 5.00
Granted and unvested 207,500 274,500
Weighted average fair market value, granted and unvested $ 2.10 $ 5.16
Vested (100,966) (163,176)
Weighted average fair market value, vested $ 3.88 $ 5.24
Forfeited/Cancelled (311,535) (6,379)
Weighted average fair market value, forfeited/Cancelled $ 4.45 $ 5.00
Number of unvested shares outstanding, at ending 87,499 292,500
Weighted average fair market value outstanding, at ending $ 2.38 $ 4.71
Vested 306,670  
Vested $ 4.76  
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jul. 11, 2022
Jul. 02, 2022
Jan. 05, 2022
Mar. 31, 2023
Dec. 28, 2021
Mar. 31, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Class of Stock [Line Items]                  
Compensation paid   $ 28,922              
Gross proceeds         $ 8,000,000        
Expiration date   Jul. 12, 2025              
Treasury stock, shares             113,485    
Preferred Stock, Shares Authorized             19,990,000 19,990,000  
Preferred Stock, Par or Stated Value Per Share             $ 0.0001 $ 0.0001  
Restricted cash             $ 0 $ 845,250  
Number of share issued         2,666,667        
Fair value of warrant liability             58,276 66,862  
Offering price         $ 3.00        
Underwriting fees         $ 560,000        
Offering cost         440,073        
Net proceeds         $ 6,999,928        
Over-Allotment Option [Member]                  
Class of Stock [Line Items]                  
Gross proceeds     $ 1,200,000            
Number of share issued     400,000            
Net proceeds     $ 1,092,000            
Offering price     $ 3.00            
Underwriting discount     $ 108,000            
Options [Member]                  
Class of Stock [Line Items]                  
Share-Based Payment Arrangement, Expense             $ 567,194 $ 721,783  
Share-Based Payment Arrangement, Option [Member]                  
Class of Stock [Line Items]                  
Number of shares available for grant             1,000,028 644,314 136,750
Unrecognized stock based compensation             $ 1,090,364    
Restricted Stock [Member]                  
Class of Stock [Line Items]                  
Share-Based Payment Arrangement, Expense             153,208 $ 550,138  
Unrecognized stock based compensation             $ 149,438    
Incentive Plan 2020 [Member]                  
Class of Stock [Line Items]                  
Number of share issued           600,000      
Number of shares available for grant             1,605,000    
Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred Stock, Shares Authorized             20,000,000    
Preferred Stock, Par or Stated Value Per Share             $ 0.0001    
Series X Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred Stock, Shares Authorized             10,000 10,000  
Preferred Stock, Par or Stated Value Per Share             $ 0.0001 $ 0.0001  
Board of Directors Chairman [Member]                  
Class of Stock [Line Items]                  
Treasury stock reissued 8,000                
Subsequent Event [Member]                  
Class of Stock [Line Items]                  
Sale of stock       1,764,311          
Proceeds from sale of stock       $ 2,314,860          
Gross proceeds       $ 5,721,057          
At The Market Sales Agreement [Member]                  
Class of Stock [Line Items]                  
Stock holders equity   $ 50,000,000              
Sale of stock             804,811    
Proceeds from sale of stock             $ 964,083    
Maxim Group L L C [Member]                  
Class of Stock [Line Items]                  
Stock holders equity   $ 9,000,000              
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.23.1
LEASING ARRANGEMENTS - Maturities of Operating lease laibilities (Details)
Dec. 31, 2022
USD ($)
Leasing Arrangements  
2023 $ 1,699,318
2024 1,702,014
2025 969,567
2026 174,900
Total lease payments 4,545,799
Less: Imputed Interest (453,388)
Present value of future minimum lease payments $ 4,092,411
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.23.1
LEASING ARRANGEMENTS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Leasing Arrangements    
Operating Lease, Weighted Average Discount Rate, Percent 7.60%  
Rent expense $ 1,375,848 $ 249,100
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.23.1
PAYROLL PROTECTION PROGRAM (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Apr. 30, 2020
Dec. 31, 2022
Short-Term Debt [Line Items]    
Face amount   $ 2,807,500
Non-operating income   $ 205,052
Payroll Protection Plan Loan Cares Act [Member]    
Short-Term Debt [Line Items]    
Face amount $ 296,827  
Accrued payroll cost $ 100,000  
Long term debt, Description Not more than 40% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. The loan was forgiven in July of 2021 and in accordance with ASC 470, the amount was recorded as other income.  
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.23.1
NOTE RECEIVABLE- RELATED PARTY (Details Narrative) - USD ($)
Dec. 31, 2022
Nov. 30, 2021
Feb. 28, 2021
Defined Benefit Plan Disclosure [Line Items]      
Face amount $ 2,807,500    
Note receivable, related party   $ 500,000  
Related Party [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Face amount     $ 500,000
Acquisition price     $ 500,000
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES - Federal and State Income Taxes (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Current provision:    
Federal $ 0 $ (110,234)
State 0 18,415
Deferred provision (benefit):    
Federal 0 0
State 0 0
Total Deferred 0 0
Total provision for income taxes $ 0 $ (91,819)
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES - Deferred Tax Assets and Deferred Tax Liabilities (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:    
Net operating loss $ 3,170,457 $ 1,732,422
Fixed assets (51,573) 14,493
Lease 52,340 1,201
Loss on contingency (193,398) 130,765
Intangible assets 1,663,044 1,707
Research and development 64,189 0
Stock based compensation 95,908 284,468
Accrual to cash conversion 1,099,403 216,068
Total 5,900,370 2,381,124
Valuation allowance (5,900,370) (2,381,124)
Net $ 0 $ 0
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES - Income Before Provision For Income Taxes (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Federal statutory rate times financial statement income $ (3,551,627) $ (1,552,673)
Permanent tax basis differences (2,268) (72,997)
Deferred true up 159,849 13,911
State taxable income, net $ (158,480) $ (86,700)
Change in Valuation allowance 3,519,246 1,524,637
Rate change $ 0 $ 154,179
True up 0 (91,819)
Other 33,280 19,643
Total provision for income taxes $ 0 $ (91,819)
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details Narrative)
 12 Months Ended
Dec. 31, 2022
USD ($)
Income Tax Disclosure [Abstract]  
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00%
Operating Loss Carryforwards $ 16,757,643
Effective Income Tax Rate Reconciliation, Deduction, Percent 50.00%
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT REPORTING (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Total Assets $ 32,727,427 $ 38,525,992
Total Liabilities 15,493,532 5,860,232
Net Sales 20,139,849 11,667,579
Cost of Goods Sold 16,101,555 7,569,193
Research and development 319,167 53,408
Loss on impairment of goodwill 6,993,075  
Selling, General and Administrative Expenses 14,804,068 11,341,712
Hospitality Segment [Member]    
Segment Reporting Information [Line Items]    
Total Assets 9,638,828 2,158,789
Total Liabilities 10,666,643 2,481,186
Net Sales 13,639,370 5,943,664
Cost of Goods Sold 12,375,645 4,488,652
Research and development 0 0
Loss on impairment of goodwill 0  
Selling, General and Administrative Expenses 4,351,932 2,281,460
Disinfectant Segment [Member]    
Segment Reporting Information [Line Items]    
Total Assets 19,831,097 27,851,691
Total Liabilities 1,545,217 1,528,706
Net Sales 6,500,479 5,723,915
Cost of Goods Sold 3,725,910 3,080,541
Research and development 319,167 53,408
Loss on impairment of goodwill 6,993,075  
Selling, General and Administrative Expenses 7,680,551 6,110,206
Corporate Segment [Member]    
Segment Reporting Information [Line Items]    
Total Assets 3,257,502 8,515,512
Total Liabilities 3,281,672 1,850,340
Net Sales 0 0
Cost of Goods Sold 0 0
Research and development 0 0
Loss on impairment of goodwill 0  
Selling, General and Administrative Expenses $ 2,771,585 $ 2,950,046
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.23.1
PROFORMA FINANCIAL STATEMENTS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]    
Net Sales $ 20,139,849 $ 11,667,579
Net Loss (16,575,317) (7,390,355)
Net Loss attributable to common stockholders:    
Net Loss attributable to common stockholders 1,449,000 603,750
Akida K E S Visionmark And Sci Air [Member]    
Restructuring Cost and Reserve [Line Items]    
Net Sales 22,248,183 22,072,379
Net Loss (16,580,044) (9,046,424)
Net Loss attributable to common stockholders:    
Dividends to preferred shareholders (1,449,000) 603,750
Net Loss attributable to common stockholders $ (18,031,480) $ (9,650,174)
Basic and Diluted Loss Per Common Share $ (1.41) $ (0.98)
Weighted Average Shares Outstanding - basic and diluted 12,754,979 9,799,627
XML 83 R72.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jan. 26, 2023
Jan. 25, 2023
Feb. 25, 2022
Dec. 31, 2022
Jul. 25, 2023
Subsequent Event [Line Items]          
Principal amount       $ 2,807,500  
Acquisition descrption       (i) 1,377,777 shares of the Company’s common stock; (ii) 148,888 shares of Series C Preferred Stock; (iii) $364,316 of Old LED Supply’s indebtedness to various creditors; and (iv) $221,674 of Old LED Supply’s transaction expenses. Part of Old LED Supply’s indebtedness on the Closing Date was $1,778,667 outstanding principal and interest on a line of credit from JP Morgan Chase Bank, N.A. (the “Chase Loan”). The Company has agreed to repay the Chase Loan 14 calendar days from the Closing Date As a result of these issuances, agreements and payments the Company and Old LED Supply agreed that the acquisition of Old LED Supply by the Company (the “LED Supply Acquisition”) was closed and the LED Supply Mergers could be effected as soon as possible. The Company financed the payments described above through the Line of Credit Draw. The shares described in clauses (i) and (ii) above are collectively referred to herein as the “LED Supply Equity Consideration”.  
Attorneys fees     $ 1,500,000    
Arbitration panel issued amount     100,000    
Legal fees     10,000    
Accrued interest expense     $ 5,000    
Dividends rate percentage       5.00%  
Per share liquidation preference       $ 5.00  
Dividends per share       $ 0.25  
Subsequent Event [Member]          
Subsequent Event [Line Items]          
Principal amount   $ 2,807,500     $ 247,500
Bears interest rate   8.00%      
Debt issuance costs   $ 345,000      
Acquisition descrption (i) 2,497,220 shares of the Company’s common (based on a value of $2.00 per share), (ii) 251,108 shares of the Company’s 5% Series C Cumulative Perpetual Preferred Stock, par value $0.0001 per share (“Series C Preferred Stock”) (iii) $1,335,114 of PURO’s indebtedness to various creditors, (iv) $221,675 of the PURO’s transaction expenses and (v) $2,500,000 and 1,250,000 shares of the Company’s 2% Series B Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”) in repayment of a $5 million note issued by PURO and held by one of its vendor’s. As a result of these issuances and payments the Company and PURO agreed that the acquisition of PURO by the Company (the “PURO Acquisition”) was closed and the PURO Mergers could be affected as soon as possible. The Company financed the payments described above through a $2,807,500 Redeemable Promissory Note from Streeterville Capital, LLC (the “Redeemable Note”) and a $1,537,938 draw on a line of credit from Pinnacle Bank (the “Line of Credit Draw”). The shares described in clauses (i) and (ii) above are collectively referred to herein as the “PURO Equity Consideration”.        
Shares authorized   1,250,000      
Preferred stock, par value   $ 0.0001      
Per share liquidation preference $ 5.00        
Subsequent Event [Member] | Investor [Member]          
Subsequent Event [Line Items]          
Principal amount   $ 2,500,000      
XML 84 auvi123122form10k_htm.xml IDEA: XBRL DOCUMENT 0001811109 2022-01-01 2022-12-31 0001811109 auvi:CommonStockParValue0.0001PerShareMember 2022-01-01 2022-12-31 0001811109 auvi:Sec10.5SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember 2022-01-01 2022-12-31 0001811109 2022-06-30 0001811109 2023-03-31 0001811109 2022-12-31 0001811109 2021-12-31 0001811109 auvi:SeriesXPreferredStockMember 2022-12-31 0001811109 auvi:SeriesXPreferredStockMember 2021-12-31 0001811109 2021-01-01 2021-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2020-12-31 0001811109 auvi:PreferredStockSeriesXMember 2020-12-31 0001811109 us-gaap:CommonStockMember 2020-12-31 0001811109 auvi:TreasuryStocksMember 2020-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001811109 us-gaap:RetainedEarningsMember 2020-12-31 0001811109 2020-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2021-12-31 0001811109 auvi:PreferredStockSeriesXMember 2021-12-31 0001811109 us-gaap:CommonStockMember 2021-12-31 0001811109 auvi:TreasuryStocksMember 2021-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001811109 us-gaap:RetainedEarningsMember 2021-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2021-01-01 2021-12-31 0001811109 auvi:PreferredStockSeriesXMember 2021-01-01 2021-12-31 0001811109 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001811109 auvi:TreasuryStocksMember 2021-01-01 2021-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001811109 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2022-01-01 2022-12-31 0001811109 auvi:PreferredStockSeriesXMember 2022-01-01 2022-12-31 0001811109 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001811109 auvi:TreasuryStocksMember 2022-01-01 2022-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001811109 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001811109 auvi:PreferredStockSeriesACumulativeMember 2022-12-31 0001811109 auvi:PreferredStockSeriesXMember 2022-12-31 0001811109 us-gaap:CommonStockMember 2022-12-31 0001811109 auvi:TreasuryStocksMember 2022-12-31 0001811109 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001811109 us-gaap:RetainedEarningsMember 2022-12-31 0001811109 auvi:TwoMajorSuppliersMember 2021-01-01 2021-12-31 0001811109 us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001811109 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001811109 us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001811109 us-gaap:OptionMember 2022-01-01 2022-12-31 0001811109 us-gaap:OptionMember 2021-01-01 2021-12-31 0001811109 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001811109 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001811109 us-gaap:TransferredOverTimeMember 2022-01-01 2022-12-31 0001811109 us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0001811109 us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-12-31 0001811109 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31 0001811109 us-gaap:TransferredOverTimeMember 2022-12-31 0001811109 us-gaap:TransferredOverTimeMember 2021-12-31 0001811109 us-gaap:TransferredAtPointInTimeMember 2022-12-31 0001811109 us-gaap:TransferredAtPointInTimeMember 2021-12-31 0001811109 2021-02-08 0001811109 2021-09-28 0001811109 2021-10-13 0001811109 2022-03-25 0001811109 auvi:SteriLumenMember 2021-02-08 0001811109 auvi:SteriLumenMember 2021-09-28 0001811109 auvi:SteriLumenMember 2021-10-13 0001811109 2022-03-31 0001811109 2022-01-01 2022-03-31 0001811109 auvi:SteriLumenMember 2022-03-25 0001811109 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001811109 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001811109 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001811109 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001811109 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001811109 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001811109 us-gaap:CustomerRelationshipsMember 2022-12-31 0001811109 us-gaap:CustomerRelationshipsMember 2021-12-31 0001811109 us-gaap:TradeNamesMember 2022-12-31 0001811109 us-gaap:TradeNamesMember 2021-12-31 0001811109 us-gaap:PatentsMember 2022-12-31 0001811109 us-gaap:PatentsMember 2021-12-31 0001811109 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001811109 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-12-31 0001811109 us-gaap:TradeNamesMember 2022-01-01 2022-12-31 0001811109 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001811109 auvi:SecurityPurchaseAgreementMember 2022-10-01 2022-10-07 0001811109 auvi:SecurityPurchaseAgreementMember 2022-10-07 0001811109 us-gaap:DirectorsAndOfficersLiabilityInsuranceMember 2022-08-28 0001811109 2022-08-01 2022-08-28 0001811109 2022-09-01 2022-09-30 0001811109 auvi:LoanAndSecurityAgreementMember 2022-08-01 2022-08-28 0001811109 auvi:LoanAndSecurityAgreementMember 2022-01-01 2022-12-31 0001811109 srt:MaximumMember 2022-01-01 2022-12-31 0001811109 srt:MinimumMember 2022-01-01 2022-12-31 0001811109 auvi:StreetervilleNoteMember 2022-12-31 0001811109 auvi:FairValueMember 2022-12-31 0001811109 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001811109 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001811109 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001811109 auvi:FairValueMember 2021-12-31 0001811109 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001811109 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001811109 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001811109 auvi:AtTheMarketSalesAgreementMember 2022-06-28 2022-07-02 0001811109 auvi:MaximGroupLLCMember 2022-06-28 2022-07-02 0001811109 auvi:AtTheMarketSalesAgreementMember 2022-01-01 2022-12-31 0001811109 2022-06-28 2022-07-02 0001811109 us-gaap:SubsequentEventMember 2023-03-01 2023-03-31 0001811109 srt:BoardOfDirectorsChairmanMember 2022-07-01 2022-07-11 0001811109 us-gaap:PreferredStockMember 2022-12-31 0001811109 auvi:IncentivePlan2020Member 2020-03-01 2020-03-31 0001811109 auvi:IncentivePlan2020Member 2022-12-31 0001811109 auvi:OptionsMember 2022-01-01 2022-12-31 0001811109 auvi:OptionsMember 2021-01-01 2021-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2022-12-31 0001811109 2021-12-01 2021-12-28 0001811109 2021-12-28 0001811109 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-01-05 0001811109 us-gaap:OverAllotmentOptionMember 2022-01-05 0001811109 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001811109 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001811109 us-gaap:RestrictedStockMember 2022-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2020-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2021-12-31 0001811109 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001811109 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2022-12-31 0001811109 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-12-31 0001811109 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2021-12-31 0001811109 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2021-12-31 0001811109 auvi:DividendYieldMember 2022-01-01 2022-12-31 0001811109 auvi:DividendYieldMember 2021-01-01 2021-12-31 0001811109 us-gaap:MeasurementInputPriceVolatilityMember 2022-01-01 2022-12-31 0001811109 us-gaap:MeasurementInputPriceVolatilityMember 2021-01-01 2021-12-31 0001811109 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-01-01 2022-12-31 0001811109 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-01-01 2021-12-31 0001811109 us-gaap:MeasurementInputExpectedTermMember 2022-01-01 2022-12-31 0001811109 us-gaap:MeasurementInputExpectedTermMember 2021-01-01 2021-12-31 0001811109 us-gaap:WarrantMember 2020-12-31 0001811109 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001811109 us-gaap:WarrantMember 2021-12-31 0001811109 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001811109 us-gaap:WarrantMember 2022-12-31 0001811109 us-gaap:RestrictedStockMember 2020-12-31 0001811109 us-gaap:RestrictedStockMember 2021-12-31 0001811109 auvi:PayrollProtectionPlanLoanCaresActMember 2020-04-30 0001811109 auvi:PayrollProtectionPlanLoanCaresActMember 2020-04-01 2020-04-30 0001811109 auvi:RelatedPartyMember 2021-02-28 0001811109 2021-11-30 0001811109 auvi:HospitalitySegmentMember 2022-12-31 0001811109 auvi:DisinfectantSegmentMember 2022-12-31 0001811109 us-gaap:CorporateMember 2022-12-31 0001811109 auvi:HospitalitySegmentMember 2021-12-31 0001811109 auvi:DisinfectantSegmentMember 2021-12-31 0001811109 us-gaap:CorporateMember 2021-12-31 0001811109 auvi:HospitalitySegmentMember 2022-01-01 2022-12-31 0001811109 auvi:DisinfectantSegmentMember 2022-01-01 2022-12-31 0001811109 us-gaap:CorporateMember 2022-01-01 2022-12-31 0001811109 auvi:HospitalitySegmentMember 2021-01-01 2021-12-31 0001811109 auvi:DisinfectantSegmentMember 2021-01-01 2021-12-31 0001811109 us-gaap:CorporateMember 2021-01-01 2021-12-31 0001811109 auvi:AkidaKESVisionmarkAndSciAirMember 2022-01-01 2022-12-31 0001811109 auvi:AkidaKESVisionmarkAndSciAirMember 2021-01-01 2021-12-31 0001811109 us-gaap:SubsequentEventMember 2023-01-25 0001811109 us-gaap:SubsequentEventMember 2023-01-01 2023-01-25 0001811109 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-01-25 0001811109 us-gaap:SubsequentEventMember 2023-07-25 0001811109 us-gaap:SubsequentEventMember 2023-01-01 2023-01-26 0001811109 2022-02-01 2022-02-25 0001811109 us-gaap:SubsequentEventMember 2023-01-26 iso4217:USD shares iso4217:USD shares pure 0001811109 false 2022 FY 10-K true 2022-12-31 --12-31 false 001-39480 APPLIED UV, INC. DE 84-4373308 150 N. Macquesten Parkway Mount Vernon NY 10550 (914) 665-6100 Common Stock, par value $0.0001 per share AUVI NASDAQ 10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share AUVIP NASDAQ No No Yes Yes Non-accelerated Filer true true false false 17200000 19237273 Mazars USA LLP Fort Washington, PA 339 2734485 7922906 0 845250 1508239 986253 1306762 0 5508086 1646238 75548 992042 1187223 419710 12320343 12812399 1133468 196611 3722077 4809811 11354430 18976556 153000 0 4044109 1730615 32727427 38525992 2982760 1642108 0 1460000 4730299 788776 229234 0 9987 68263 33712 7671 1437308 389486 2098685 97500 11521985 4453804 393230 0 765144 60000 158070 0 2655103 1346428 3971547 1406428 15493532 5860232 0.0001 0.0001 19990000 19990000 552000 552000 552000 552000 55 55 0.0001 0.0001 10000 10000 10000 10000 2000 2000 1 1 0.0001 0.0001 150000000 150000000 13676450 13676450 12775674 12775674 1368 1278 45619670 42877622 113485 0 149686 -0 -28237513 -10213196 17233895 32665760 32727427 38525992 20139849 11667579 16101555 7569193 4038294 4098386 319167 53408 14804068 11341712 6993075 0 22116310 11395120 -18078016 -7296734 58276 66862 290341 -0 240000 574000 1700000 0 274764 24871 0 296827 1502699 -185440 -16575317 -7482174 0 -91819 -16575317 -7390355 1449000 603750 -18024317 -7994105 -1.41 -0.86 12754979 9273257 2000 1 7945034 795 11973051 -2219091 9754756 3000 21420 21420 -135125 -135125 17852 2 1155 1157 2075000 208 10195293 10195501 74500 7 1549781 1549788 2666667 267 6999661 6999928 552000 55 12272385 12272440 603750 603750 -6379 -1 1 -7390355 -7390355 552000 55 2000 1 12775674 1278 42877622 -10213196 32665760 400000 40 1091960 1092000 804811 80 929656 929736 -111535 -11 11 -400000 -40 40 113485 149686 149686 8000 207500 21 720381 720402 1449000 1449000 -16575317 -16575317 552000 55 10000 1 13676450 1368 113485 -149686 45619670 -28237513 17233895 -16575317 -7390355 720402 1549788 94714 -71003 -0 296827 58276 66862 -0 20000 240000 0 1700000 -574000 6993075 0 -52208 -140000 1213949 635540 1991798 946744 223643 0 -19850 -73189 1125610 -0 3633057 166126 -916494 951242 448680 -35273 0 -173716 1340655 -361569 1388838 -0 3941523 -544563 -279518 0 -1170949 -630241 -8736350 -6997970 682 14434 23017 14735 10 14560193 152571 -0 -176280 -14589362 6591 7217 0 1157 149686 -0 1449000 603750 -0 65000 2021736 19272368 2462500 0 2878959 18597558 -6033671 -2989774 8768156 11757930 2734485 8768156 57534 1022 0 16246 0 135125 190702 0 0 21420 0 10195501 0 886000 3527443 1884730 318833 0 <p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_z2XQRs62abHk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_821_zfv3alL2tuE9">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p id="xdx_840_ecustom--NatureOfBusinessPolicyTextBlock_zR1xJbOjU9Y1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zWpv2tHEZxQ1">Nature of Business</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applied UV, Inc. (the “Parent”) was formed and incorporated in the State of Delaware for the intended purpose of holding the equity of SteriLumen, Inc. (“SteriLumen”) and MunnWorks, LLC (“MunnWorks”), together “the Subsidiaries”, and other companies acquired or created by the Parent in the future. The Parent acquired the Subsidiaries pursuant to share exchanges whereby the equity holders of the Subsidiaries exchanged all of their equity interests in the Subsidiaries for shares of voting stock of the Parent. As a result of the share exchanges, each Subsidiary became a wholly-owned subsidiary of the Parent. The Parent and each Subsidiary are collectively referred to herein as (the “Company”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SteriLumen is engaged in the design, manufacture, assembly and distribution of (i) automated disinfecting mirror systems for use in hospitals and other healthcare facilities and (ii) air purification systems through its purchase of substantially all of the assets and certain liabilities of Akida Holdings, LLC, KES Science &amp; Technology, and Scientific Air Management LLC, as described below. MunnWorks, LLC is engaged in the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February of 2021, the Company acquired all the assets and assumed certain liabilities of Akida Holdings, LLC (“Akida”). At the time of this acquisition, Akida owned the Airocide™ system of air purification technologies, originally developed for NASA, with assistance from the University of Wisconsin at Madison, that uses a combination of UVC and a proprietary, titanium dioxide based photocatalyst (“PCO”) to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products, with applications in the hospitality, hotel, healthcare, nursing homes, grocer, wine, commercial buildings and retail sectors. The Airocide™ system has been used by brands and organizations such as NASA, Whole Foods, Dole, Chiquita, Opus One, Sub-Zero Refrigerators and Robert Mondavi Wines. Akida contracted KES Science &amp; Technology, Inc. (“KES”) to manufacture, warehouse and distribute the Airocide™ system and Akida’s contractual relationship with KES was assigned to and assumed by the Company as part of the acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2021, the Company acquired all the assets and assumed certain liabilities of KES. At the time of the acquisition, KES was principally engaged in the manufacturing and distribution of the Airocide™ system of air purification technologies and misting systems. KES also had the exclusive right to the sale and distribution of the Airocide™ system in certain markets. This acquisition consolidates all of manufacturing, sale and distribution of the Airocide™ system under the SteriLumen brand and expands the Company’s market presence in food distribution, post-harvest produce, wineries, and retail sectors. The Company sells its products throughout the United States, Canada, and Europe.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2021, the Company acquired all the assets and assumed certain liabilities of Scientific Air Management LLC, (“SciAir”). SciAir is a provider of whole-room, aerosol chamber and laboratory certified air disinfection machines that use a combination of UVC and a proprietary, patented system to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products. The units are well suited for larger spaces within a facility and are mobile with industrial grade casters allowing for movement throughout a facility to address increased bio burden from larger meetings or increased human traffic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2022, the Company acquired the assets and assumed certain liabilities of VisionMark, LLC, (“Visionmark”). Visionmark is engaged in the business of manufacturing customized furniture using wood and metal components for the hospitality and retail industries.</span></p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zsaiC95fwzi3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zMUtdESnyesj">Principles of Consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Applied UV, Inc., Munnworks, LLC and SteriLumen, Inc. All significant intercompany transactions and balances are eliminated in consolidation. </span></p> <p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zx3UWtiBQp71" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zuOEQZKTwFn6">Concentration of Credit and Business Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At times throughout the year, the Company maintains cash balances at various institutions, which may exceed the Federal Deposit Insurance Corporation limit. As of December 31, 2022, the Company was approximately $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zBc2y1OX1GU2">2,473,000</span> in excess of FDIC insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides credit in the normal course of business. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends and other information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, the Company had no major suppliers that accounted for over 10% of supplies and materials used by the Company. For the year ended December 31, 2021, the Company had two major suppliers that accounted for approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--TwoMajorSuppliersMember_zARrtibPwH9c">25.4</span>% of supplies and materials used by the Company. The amounts have been recorded as costs of sales in the consolidated statements of operations.</span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zpNWhpUBv2f4" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zPp28jLGj6Wi">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, as of the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation and accounting for equity awards related to warrants and stock-based compensation, determination of fair value for derivative instruments, the accounting for business combinations and allocating purchase price and estimating the useful life of intangible assets.</span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zXL4q1txhcm3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zuTt18zzr4U7">Cash, Restricted Cash and Cash Equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and equivalents include highly liquid investments that have original maturities less than 90 days at the time of their purchase. These investments are carried at cost, which approximates market value because of their short maturities. As of December 31, 2022 and 2021, the Company had approximately $<span id="xdx_90E_eus-gaap--CashEquivalentsAtCarryingValue_c20221231_pp0p0" title="Cash Equivalents, at Carrying Value">27,000</span> and $<span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_c20211231_pp0p0" title="Cash Equivalents, at Carrying Value">1,077,000</span>, respectively, in cash equivalents.</span></p> <p id="xdx_848_eus-gaap--ReceivablesPolicyTextBlock_zUrMobeSyCE6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zLHWpWIiHMV2">Accounts receivable</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An allowance for uncollectible accounts receivable is recorded when management believes the collectability of the accounts receivable is confirmed. Subsequent recoveries, if any, are credited to the allowance. The allowance is determined based on management’s review of the debtor’s ability to repay and repayment history, aging history, and estimated value of collateral, if any. The Company had an allowance for doubtful accounts approximating $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20221231_pp0p0" title="Accounts Receivable, Allowance for Credit Loss">35,000</span> and $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20211231_pp0p0" title="Accounts Receivable, Allowance for Credit Loss">9,000</span> as of December 31, 2022 and 2021 respectively.</span></p> <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zz7f6evoqOpe" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zNhbLjVN4Vu9">Inventory</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of raw materials, work-in-process, and finished goods. Raw materials and finished goods are valued at the lower of cost or net realizable value, using the first-in, first-out (“FIFO”) valuation method. Work-in-process and finished goods includes the cost of materials, freight and duty, direct labor and overhead. The Company writes down inventory for estimated obsolescence equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. The company had a reserve for inventory approximating $<span id="xdx_90D_eus-gaap--InventoryLIFOReserve_iI_pp0p0_do_c20221231_zNuPYDkGNjCa">88,000</span> and $<span id="xdx_909_eus-gaap--InventoryLIFOReserve_iI_pp0p0_do_c20211231_zTy8MJvhOjn">140,000</span> as of December 31, 2022 and 2021, respectively.</span></p> <p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zfPbdQWLQDs2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zVBiEbomrTT2">Property and Equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost. Depreciation of furniture and fixtures is provided using the straight-line method, generally over the terms of the lease. Repairs and maintenance expenditures, which do not extend the useful lives of the related assets, are expensed as incurred. Depreciation of machinery and equipment is based on the estimated useful lives of the assets.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zkpLjZYVDPmh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zzJZOXo8cV5a">Schedule of estimated useful lives</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 0.05in"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 45%; text-align: left">Machinery and equipment</td><td style="width: 10%"> </td> <td style="width: 45%; text-align: center; padding-left: 0.05in"><span id="xdx_905_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z8NxgE4Q9hPd" title="Estimated useful lives">5 to 7 years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: center; padding-left: 0.05in"><span id="xdx_903_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zYoVj2SB3kg6" title="Estimated useful lives">Lesser of term of lease or useful life</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: center; padding-left: 0.05in"><span id="xdx_908_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zOulKpHtqAZ9" title="Estimated useful lives">5 to 7 years</span></td></tr> </table> <p id="xdx_8A8_zh8f51IolKfi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_842_eus-gaap--BusinessCombinationsPolicy_z2uUqhoANpye" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zkxobroieeRa">Business Acquisition Accounting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies the acquisition method of accounting for those that meet the criteria of a business combination. The Company allocates the purchase price of its business acquisitions based on the fair value of identifiable tangible and intangible assets. The difference between the total cost of the acquisition and the sum of the fair values of acquired tangible and identifiable intangible assets less liabilities is recorded as goodwill. Transaction costs are expensed as incurred in general and administrative expenses.</span></p> <p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zkRMY3H2UUya" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zu1RIdLcHkjf">Goodwill and Intangible Assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recorded intangible assets, including goodwill, in connection with business combinations. Estimated useful lives of amortizable intangible assets are determined by management based on an assessment of the period over which the asset is expected to contribute to future cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with U.S. GAAP for goodwill and other indefinite-lived intangibles, the Company tests these assets for impairment annually and whenever events or circumstances make it more likely than not that impairment may have occurred. For the purposes of that assessment, the Company has determined to assign assets acquired in business combinations to a single reporting unit including all goodwill and indefinite-lived intangible assets acquired in business combinations. During the year ended December 31, 2022, we evaluated potential triggering events that might be indicators that our goodwill and definite lived intangibles were impaired. As a result of our evaluation, we determined that the fair value of our goodwill and certain intangible assets were less than the carrying amount as of December 31, 2022. This resulted in a total impairment charge of $<span id="xdx_90C_eus-gaap--AssetImpairmentCharges_c20220101__20221231_zgbcHMuzlhG" title="Impairment charges">6,993,075</span>. See note 2 for further information related to the impairment.</span></p> <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zt1NARoWqEy4" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zqDH5pxo6JG5">Income Taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company files income tax returns using the cash basis of accounting. Income taxes are accounted for under the asset and liability method. Current income taxes are based on the year’s income taxable for federal and state tax reporting purposes. Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable income will be available to allow all or part of the asset to be recovered.</span></p> <p id="xdx_845_eus-gaap--DerivativesPolicyTextBlock_zyg5VF3f12i2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zjuKbLPKkRBi">Derivative Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its warrants to determine if those contracts or embedded components of those contracts qualify as derivatives. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company has concluded that there are no such reclassifications required to be made as of and for the periods ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company utilizes the Black-Scholes valuation model to value the derivative warrants as stipulated in the agreement for the warrant holders to receive cash based on that value.</span></p> <p id="xdx_840_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zWe5utcvurXd" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zb8IYJn4dwLc">Fair Value of Financial Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts reported in the consolidated balance sheets for loans payable approximate fair value because of the immediate or short-term maturity of the financial instruments. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy.</span></p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_z9MAxj2guHn3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zdkL2DavJImi">Loss Per Share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share is computed by dividing net loss attributable to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential shares outstanding would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the number of potential shares of common stock that have been excluded from diluted net loss per share because their effect was anti-dilutive:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zrxq1VMEJe6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-dilutive shares)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zzHuJx33oAVa" style="display: none">Schedule of anti dilutive securities excluded from computation of earnings per share</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">As of December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Common stock options</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--OptionMember_pdd" style="width: 12%; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">1,000,028</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--OptionMember_pdd" style="width: 12%; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">644,314</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Common stock warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">192,419</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zgSzcHFpnIR6" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">192,419</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">1,192,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">836,733</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zVHifpf2uedf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zMH0k537pN2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zzLJZBUUXth3">Stock-Based Compensation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for its stock-based compensation awards in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 718 (“ASC”), Compensation-Stock Compensation (“ASC 718"). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock and modifications to existing stock options, to be recognized in the statements of operations based on their fair values over the requisite service period.</span></p> <p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zoiF37F8mjOk" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zWls1iU9RVa5">Research and Development</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10"). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, research and development costs are expensed as incurred.</span></p> <p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_ziEPbmm1Xpjb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zmSPrIvZ3Mbl">Revenue Recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue when the performance obligations in the client contract has been achieved. A performance obligation is a contractual promise to transfer product to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as, the customer receives the benefit of the performance obligation. Under ASC 606, revenue is recognized when a customer obtains control of goods in an amount that reflects the consideration the Company expects to receive in exchange for those goods. To achieve this core principle, the Company applies the following five steps:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the contract with a customer.</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0.1in; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the performance obligations in the contract.</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0.1in; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determine the transaction price.</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0.1in; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocate the transaction price to performance obligations in the contract.</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0.1in; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize revenue when or as the Company satisfies a performance obligation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MunnWorks projects, including those from the VisionMark acquisition, are completed within the Company’s facilities. For these projects, the company designs, manufactures and sells custom mirrors and furniture for the hospitality and retail industries through contractual agreements. These sales require the company to deliver the products within three to nine months from commencement of order acceptance. Revenue is recognized using the input method of accounting. Deferred revenue represents amounts billed in excess of revenues recognized. Revenues recognized in excess of amounts billed typically does not occur as the Company will not perform any work in excess of the amount the company bills to its customers. If work is performed in excess of amounts billed, the Company will record an unbilled receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company applied the five-step model to the sales of Akida’s and KES’s Airocide™ and misting system products, and SciAir’s whole-room aerosol chamber and laboratory certified air disinfection machines. At contract inception and once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company sells Airocide™ air sterilization units, misting systems, and whole-room aerosol chamber and laboratory certified disinfection machines to both consumer and commercial customers. These products are sold both domestically and internationally. The cycle from contract inception to shipment of products is typically one day to three months. The Company’s contracts for both its consumer and commercial customers each contain a single performance obligation (delivery of Airocide™, KES, and SciAir products), as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts and, therefore, not distinct. As a result, the entire transaction price is allocated to this single performance obligation. The Company recognizes revenues at a point in time when the customer obtains control of the Company’s product, which typically occurs upon shipment of the product by the Company or upon customer pick-up via third party common carrier.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue recognized over time and revenue recognized at a point in time for the years ended:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of revenue:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfRevenueTableTextBlock_zJx28La089d8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span id="xdx_8B2_zJAfnF0PXbye" style="display: none">Schedule of revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 0pt">Recognized over time</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Revenues">9,419,117</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20210101__20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Revenues">1,606,950</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Recognized at a point in time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">10,720,732</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">10,060,629</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">20,139,849</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">11,667,579</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue was comprised of the following as of:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 0pt">Recognized over time</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredRevenueCurrent_c20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Deferred revenue">3,581,195</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredRevenueCurrent_c20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Deferred revenue">94,867</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Recognized at a point in time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredRevenueCurrent_c20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">1,149,104</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredRevenueCurrent_c20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">693,908</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredRevenueCurrent_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue">4,730,299</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredRevenueCurrent_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue">788,775</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zVIrtpuvAdge" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue amounting to $<span id="xdx_90F_eus-gaap--DeferredRevenueNoncurrent_iI_pp0p0_c20211231_zKkgf4a15GSc" title="Deferred revenue">788,775</span> as of December 31, 2021 was recognized as revenue during the year ended December 31, 2022.</span></p> <p id="xdx_84F_ecustom--ShippingAndHandlingChargesPolicyTextBlock_zqhJcRw9VWKj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_za6hNWmLs9b1">Shipping and Handling Charges</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports shipping and handling fees charged to customers as part of net sales and the associated expense as part of cost of sales. Shipping charges amounted to $<span id="xdx_90A_ecustom--ShippingCharges_c20220101__20221231_pp0p0" title="Shipping charges">821,448</span> and $<span id="xdx_908_ecustom--ShippingCharges_c20210101__20211231_pp0p0" title="Shipping charges">963,385</span> for the years ended December 31, 2022 and 2021, respectively.</span></p> <p id="xdx_846_eus-gaap--AdvertisingCostsPolicyTextBlock_zSWyqEJso2qg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zpJ7bmPhyY12">Advertising</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs consist primarily of online search advertising and placement, trade shows, advertising fees, and other promotional expenses. Advertising costs are expensed as incurred and are included in sales and marketing on the consolidated statements of operations. Advertising expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20220101__20221231_pp0p0" title="Advertising Expense">1,109,207</span> and $<span id="xdx_903_eus-gaap--AdvertisingExpense_c20210101__20211231_pp0p0" title="Advertising Expense">799,799</span>, respectively.</span></p> <p id="xdx_848_eus-gaap--DepositContractsPolicy_zPoEt8Hpkha" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zd4JaH9JaPl8">Vendor deposits</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vendor payments to third manufactures are capitalized until completion of the project and are recorded as vendor deposits. As of December 31, 2022 and 2021, the vendor deposit balance was $<span id="xdx_901_eus-gaap--DepositsAssetsCurrent_c20221231_pp0p0" title="Deposits assets current">75,548</span> and $<span id="xdx_900_eus-gaap--DepositsAssetsCurrent_c20211231_pp0p0" title="Deposits assets current">992,042</span>, respectively.</span></p> <p id="xdx_84C_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z5PNh4pofMy8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zlzBkiPUbd2l">Patent Costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company capitalizes costs consisting principally of outside legal costs and filing fees related to obtaining and maintaining patents. The Company amortizes patent costs over the useful life of the patent which is typically 20 years, beginning with the date the patent is filed with the U.S. Patent and Trademark Office, or foreign equivalent. As of December 31, 2022 and 2021, capitalized patent costs net of accumulated amortization was $<span id="xdx_901_eus-gaap--FiniteLivedPatentsGross_c20221231_pp0p0" title="Patent cost">1,593,741</span> and $<span id="xdx_906_eus-gaap--FiniteLivedPatentsGross_c20211231_pp0p0" title="Patent cost">1,693,124</span>, respectively. For the years ended December 31, 2022 and 2021, the Company recorded $<span id="xdx_902_eus-gaap--AdjustmentForAmortization_c20220101__20221231_pp0p0" title="Amortization">100,065</span> and $<span id="xdx_90D_eus-gaap--AdjustmentForAmortization_c20210101__20211231_pp0p0" title="Amortization">32,398</span>, respectively, of amortization expense for these patents.</span></p> <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWTuMg9b2oyd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zTMJUMSJHGqc">Recently adopted accounting standards</span></span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (eTopic 326): Measurement of Credit Losses on Financial Instruments. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards replace the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measure at amortized cost to be presented at the net amount expected to be collected. The Company determined that this change does not have a material impact to the consolidated financial statements.</span></p> <p id="xdx_840_ecustom--NatureOfBusinessPolicyTextBlock_zR1xJbOjU9Y1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zWpv2tHEZxQ1">Nature of Business</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applied UV, Inc. (the “Parent”) was formed and incorporated in the State of Delaware for the intended purpose of holding the equity of SteriLumen, Inc. (“SteriLumen”) and MunnWorks, LLC (“MunnWorks”), together “the Subsidiaries”, and other companies acquired or created by the Parent in the future. The Parent acquired the Subsidiaries pursuant to share exchanges whereby the equity holders of the Subsidiaries exchanged all of their equity interests in the Subsidiaries for shares of voting stock of the Parent. As a result of the share exchanges, each Subsidiary became a wholly-owned subsidiary of the Parent. The Parent and each Subsidiary are collectively referred to herein as (the “Company”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SteriLumen is engaged in the design, manufacture, assembly and distribution of (i) automated disinfecting mirror systems for use in hospitals and other healthcare facilities and (ii) air purification systems through its purchase of substantially all of the assets and certain liabilities of Akida Holdings, LLC, KES Science &amp; Technology, and Scientific Air Management LLC, as described below. MunnWorks, LLC is engaged in the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February of 2021, the Company acquired all the assets and assumed certain liabilities of Akida Holdings, LLC (“Akida”). At the time of this acquisition, Akida owned the Airocide™ system of air purification technologies, originally developed for NASA, with assistance from the University of Wisconsin at Madison, that uses a combination of UVC and a proprietary, titanium dioxide based photocatalyst (“PCO”) to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products, with applications in the hospitality, hotel, healthcare, nursing homes, grocer, wine, commercial buildings and retail sectors. The Airocide™ system has been used by brands and organizations such as NASA, Whole Foods, Dole, Chiquita, Opus One, Sub-Zero Refrigerators and Robert Mondavi Wines. Akida contracted KES Science &amp; Technology, Inc. (“KES”) to manufacture, warehouse and distribute the Airocide™ system and Akida’s contractual relationship with KES was assigned to and assumed by the Company as part of the acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2021, the Company acquired all the assets and assumed certain liabilities of KES. At the time of the acquisition, KES was principally engaged in the manufacturing and distribution of the Airocide™ system of air purification technologies and misting systems. KES also had the exclusive right to the sale and distribution of the Airocide™ system in certain markets. This acquisition consolidates all of manufacturing, sale and distribution of the Airocide™ system under the SteriLumen brand and expands the Company’s market presence in food distribution, post-harvest produce, wineries, and retail sectors. The Company sells its products throughout the United States, Canada, and Europe.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2021, the Company acquired all the assets and assumed certain liabilities of Scientific Air Management LLC, (“SciAir”). SciAir is a provider of whole-room, aerosol chamber and laboratory certified air disinfection machines that use a combination of UVC and a proprietary, patented system to eliminate airborne bacteria, mold, fungi, viruses, volatile organic compounds, and many odors without producing any harmful by-products. The units are well suited for larger spaces within a facility and are mobile with industrial grade casters allowing for movement throughout a facility to address increased bio burden from larger meetings or increased human traffic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2022, the Company acquired the assets and assumed certain liabilities of VisionMark, LLC, (“Visionmark”). Visionmark is engaged in the business of manufacturing customized furniture using wood and metal components for the hospitality and retail industries.</span></p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zsaiC95fwzi3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zMUtdESnyesj">Principles of Consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of Applied UV, Inc., Munnworks, LLC and SteriLumen, Inc. All significant intercompany transactions and balances are eliminated in consolidation. </span></p> <p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zx3UWtiBQp71" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zuOEQZKTwFn6">Concentration of Credit and Business Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At times throughout the year, the Company maintains cash balances at various institutions, which may exceed the Federal Deposit Insurance Corporation limit. As of December 31, 2022, the Company was approximately $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zBc2y1OX1GU2">2,473,000</span> in excess of FDIC insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides credit in the normal course of business. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends and other information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, the Company had no major suppliers that accounted for over 10% of supplies and materials used by the Company. For the year ended December 31, 2021, the Company had two major suppliers that accounted for approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--TwoMajorSuppliersMember_zARrtibPwH9c">25.4</span>% of supplies and materials used by the Company. The amounts have been recorded as costs of sales in the consolidated statements of operations.</span></p> 2473000 0.254 <p id="xdx_841_eus-gaap--UseOfEstimates_zpNWhpUBv2f4" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zPp28jLGj6Wi">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, as of the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation and accounting for equity awards related to warrants and stock-based compensation, determination of fair value for derivative instruments, the accounting for business combinations and allocating purchase price and estimating the useful life of intangible assets.</span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zXL4q1txhcm3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zuTt18zzr4U7">Cash, Restricted Cash and Cash Equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and equivalents include highly liquid investments that have original maturities less than 90 days at the time of their purchase. These investments are carried at cost, which approximates market value because of their short maturities. As of December 31, 2022 and 2021, the Company had approximately $<span id="xdx_90E_eus-gaap--CashEquivalentsAtCarryingValue_c20221231_pp0p0" title="Cash Equivalents, at Carrying Value">27,000</span> and $<span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_c20211231_pp0p0" title="Cash Equivalents, at Carrying Value">1,077,000</span>, respectively, in cash equivalents.</span></p> 27000 1077000 <p id="xdx_848_eus-gaap--ReceivablesPolicyTextBlock_zUrMobeSyCE6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zLHWpWIiHMV2">Accounts receivable</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An allowance for uncollectible accounts receivable is recorded when management believes the collectability of the accounts receivable is confirmed. Subsequent recoveries, if any, are credited to the allowance. The allowance is determined based on management’s review of the debtor’s ability to repay and repayment history, aging history, and estimated value of collateral, if any. The Company had an allowance for doubtful accounts approximating $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20221231_pp0p0" title="Accounts Receivable, Allowance for Credit Loss">35,000</span> and $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20211231_pp0p0" title="Accounts Receivable, Allowance for Credit Loss">9,000</span> as of December 31, 2022 and 2021 respectively.</span></p> 35000 9000 <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zz7f6evoqOpe" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zNhbLjVN4Vu9">Inventory</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of raw materials, work-in-process, and finished goods. Raw materials and finished goods are valued at the lower of cost or net realizable value, using the first-in, first-out (“FIFO”) valuation method. Work-in-process and finished goods includes the cost of materials, freight and duty, direct labor and overhead. The Company writes down inventory for estimated obsolescence equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. The company had a reserve for inventory approximating $<span id="xdx_90D_eus-gaap--InventoryLIFOReserve_iI_pp0p0_do_c20221231_zNuPYDkGNjCa">88,000</span> and $<span id="xdx_909_eus-gaap--InventoryLIFOReserve_iI_pp0p0_do_c20211231_zTy8MJvhOjn">140,000</span> as of December 31, 2022 and 2021, respectively.</span></p> 88000 140000 <p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zfPbdQWLQDs2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zVBiEbomrTT2">Property and Equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost. Depreciation of furniture and fixtures is provided using the straight-line method, generally over the terms of the lease. Repairs and maintenance expenditures, which do not extend the useful lives of the related assets, are expensed as incurred. Depreciation of machinery and equipment is based on the estimated useful lives of the assets.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zkpLjZYVDPmh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zzJZOXo8cV5a">Schedule of estimated useful lives</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 0.05in"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 45%; text-align: left">Machinery and equipment</td><td style="width: 10%"> </td> <td style="width: 45%; text-align: center; padding-left: 0.05in"><span id="xdx_905_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z8NxgE4Q9hPd" title="Estimated useful lives">5 to 7 years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: center; padding-left: 0.05in"><span id="xdx_903_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zYoVj2SB3kg6" title="Estimated useful lives">Lesser of term of lease or useful life</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: center; padding-left: 0.05in"><span id="xdx_908_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zOulKpHtqAZ9" title="Estimated useful lives">5 to 7 years</span></td></tr> </table> <p id="xdx_8A8_zh8f51IolKfi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zkpLjZYVDPmh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zzJZOXo8cV5a">Schedule of estimated useful lives</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 0.05in"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 45%; text-align: left">Machinery and equipment</td><td style="width: 10%"> </td> <td style="width: 45%; text-align: center; padding-left: 0.05in"><span id="xdx_905_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z8NxgE4Q9hPd" title="Estimated useful lives">5 to 7 years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: center; padding-left: 0.05in"><span id="xdx_903_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zYoVj2SB3kg6" title="Estimated useful lives">Lesser of term of lease or useful life</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: center; padding-left: 0.05in"><span id="xdx_908_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zOulKpHtqAZ9" title="Estimated useful lives">5 to 7 years</span></td></tr> </table> 5 to 7 years Lesser of term of lease or useful life 5 to 7 years <p id="xdx_842_eus-gaap--BusinessCombinationsPolicy_z2uUqhoANpye" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zkxobroieeRa">Business Acquisition Accounting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies the acquisition method of accounting for those that meet the criteria of a business combination. The Company allocates the purchase price of its business acquisitions based on the fair value of identifiable tangible and intangible assets. The difference between the total cost of the acquisition and the sum of the fair values of acquired tangible and identifiable intangible assets less liabilities is recorded as goodwill. Transaction costs are expensed as incurred in general and administrative expenses.</span></p> <p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zkRMY3H2UUya" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zu1RIdLcHkjf">Goodwill and Intangible Assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recorded intangible assets, including goodwill, in connection with business combinations. Estimated useful lives of amortizable intangible assets are determined by management based on an assessment of the period over which the asset is expected to contribute to future cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with U.S. GAAP for goodwill and other indefinite-lived intangibles, the Company tests these assets for impairment annually and whenever events or circumstances make it more likely than not that impairment may have occurred. For the purposes of that assessment, the Company has determined to assign assets acquired in business combinations to a single reporting unit including all goodwill and indefinite-lived intangible assets acquired in business combinations. During the year ended December 31, 2022, we evaluated potential triggering events that might be indicators that our goodwill and definite lived intangibles were impaired. As a result of our evaluation, we determined that the fair value of our goodwill and certain intangible assets were less than the carrying amount as of December 31, 2022. This resulted in a total impairment charge of $<span id="xdx_90C_eus-gaap--AssetImpairmentCharges_c20220101__20221231_zgbcHMuzlhG" title="Impairment charges">6,993,075</span>. See note 2 for further information related to the impairment.</span></p> 6993075 <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zt1NARoWqEy4" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zqDH5pxo6JG5">Income Taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company files income tax returns using the cash basis of accounting. Income taxes are accounted for under the asset and liability method. Current income taxes are based on the year’s income taxable for federal and state tax reporting purposes. Deferred income tax assets and liabilities are computed annually for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable income will be available to allow all or part of the asset to be recovered.</span></p> <p id="xdx_845_eus-gaap--DerivativesPolicyTextBlock_zyg5VF3f12i2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zjuKbLPKkRBi">Derivative Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its warrants to determine if those contracts or embedded components of those contracts qualify as derivatives. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company has concluded that there are no such reclassifications required to be made as of and for the periods ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company utilizes the Black-Scholes valuation model to value the derivative warrants as stipulated in the agreement for the warrant holders to receive cash based on that value.</span></p> <p id="xdx_840_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zWe5utcvurXd" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zb8IYJn4dwLc">Fair Value of Financial Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts reported in the consolidated balance sheets for loans payable approximate fair value because of the immediate or short-term maturity of the financial instruments. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy.</span></p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_z9MAxj2guHn3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zdkL2DavJImi">Loss Per Share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share is computed by dividing net loss attributable to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential shares outstanding would be anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the number of potential shares of common stock that have been excluded from diluted net loss per share because their effect was anti-dilutive:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zrxq1VMEJe6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-dilutive shares)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zzHuJx33oAVa" style="display: none">Schedule of anti dilutive securities excluded from computation of earnings per share</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">As of December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Common stock options</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--OptionMember_pdd" style="width: 12%; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">1,000,028</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--OptionMember_pdd" style="width: 12%; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">644,314</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Common stock warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">192,419</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zgSzcHFpnIR6" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">192,419</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">1,192,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">836,733</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zVHifpf2uedf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zrxq1VMEJe6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-dilutive shares)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zzHuJx33oAVa" style="display: none">Schedule of anti dilutive securities excluded from computation of earnings per share</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">As of December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Common stock options</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--OptionMember_pdd" style="width: 12%; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">1,000,028</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--OptionMember_pdd" style="width: 12%; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">644,314</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Common stock warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">192,419</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zgSzcHFpnIR6" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">192,419</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">1,192,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">836,733</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1000028 644314 192419 192419 1192447 836733 <p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zMH0k537pN2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zzLJZBUUXth3">Stock-Based Compensation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for its stock-based compensation awards in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 718 (“ASC”), Compensation-Stock Compensation (“ASC 718"). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock and modifications to existing stock options, to be recognized in the statements of operations based on their fair values over the requisite service period.</span></p> <p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zoiF37F8mjOk" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zWls1iU9RVa5">Research and Development</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10"). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, research and development costs are expensed as incurred.</span></p> <p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_ziEPbmm1Xpjb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zmSPrIvZ3Mbl">Revenue Recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue when the performance obligations in the client contract has been achieved. A performance obligation is a contractual promise to transfer product to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as, the customer receives the benefit of the performance obligation. Under ASC 606, revenue is recognized when a customer obtains control of goods in an amount that reflects the consideration the Company expects to receive in exchange for those goods. To achieve this core principle, the Company applies the following five steps:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the contract with a customer.</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0.1in; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the performance obligations in the contract.</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0.1in; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determine the transaction price.</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0.1in; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocate the transaction price to performance obligations in the contract.</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0.1in; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize revenue when or as the Company satisfies a performance obligation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MunnWorks projects, including those from the VisionMark acquisition, are completed within the Company’s facilities. For these projects, the company designs, manufactures and sells custom mirrors and furniture for the hospitality and retail industries through contractual agreements. These sales require the company to deliver the products within three to nine months from commencement of order acceptance. Revenue is recognized using the input method of accounting. Deferred revenue represents amounts billed in excess of revenues recognized. Revenues recognized in excess of amounts billed typically does not occur as the Company will not perform any work in excess of the amount the company bills to its customers. If work is performed in excess of amounts billed, the Company will record an unbilled receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company applied the five-step model to the sales of Akida’s and KES’s Airocide™ and misting system products, and SciAir’s whole-room aerosol chamber and laboratory certified air disinfection machines. At contract inception and once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company sells Airocide™ air sterilization units, misting systems, and whole-room aerosol chamber and laboratory certified disinfection machines to both consumer and commercial customers. These products are sold both domestically and internationally. The cycle from contract inception to shipment of products is typically one day to three months. The Company’s contracts for both its consumer and commercial customers each contain a single performance obligation (delivery of Airocide™, KES, and SciAir products), as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts and, therefore, not distinct. As a result, the entire transaction price is allocated to this single performance obligation. The Company recognizes revenues at a point in time when the customer obtains control of the Company’s product, which typically occurs upon shipment of the product by the Company or upon customer pick-up via third party common carrier.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue recognized over time and revenue recognized at a point in time for the years ended:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of revenue:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfRevenueTableTextBlock_zJx28La089d8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span id="xdx_8B2_zJAfnF0PXbye" style="display: none">Schedule of revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 0pt">Recognized over time</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Revenues">9,419,117</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20210101__20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Revenues">1,606,950</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Recognized at a point in time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">10,720,732</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">10,060,629</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">20,139,849</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">11,667,579</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue was comprised of the following as of:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 0pt">Recognized over time</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredRevenueCurrent_c20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Deferred revenue">3,581,195</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredRevenueCurrent_c20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Deferred revenue">94,867</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Recognized at a point in time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredRevenueCurrent_c20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">1,149,104</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredRevenueCurrent_c20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">693,908</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredRevenueCurrent_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue">4,730,299</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredRevenueCurrent_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue">788,775</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zVIrtpuvAdge" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue amounting to $<span id="xdx_90F_eus-gaap--DeferredRevenueNoncurrent_iI_pp0p0_c20211231_zKkgf4a15GSc" title="Deferred revenue">788,775</span> as of December 31, 2021 was recognized as revenue during the year ended December 31, 2022.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfRevenueTableTextBlock_zJx28La089d8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span id="xdx_8B2_zJAfnF0PXbye" style="display: none">Schedule of revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 0pt">Recognized over time</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Revenues">9,419,117</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20210101__20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Revenues">1,606,950</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Recognized at a point in time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20220101__20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">10,720,732</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20210101__20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">10,060,629</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">20,139,849</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">11,667,579</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue was comprised of the following as of:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 0pt">Recognized over time</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--DeferredRevenueCurrent_c20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Deferred revenue">3,581,195</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredRevenueCurrent_c20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="width: 12%; text-align: right" title="Deferred revenue">94,867</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Recognized at a point in time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredRevenueCurrent_c20221231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">1,149,104</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredRevenueCurrent_c20211231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">693,908</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredRevenueCurrent_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue">4,730,299</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--DeferredRevenueCurrent_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue">788,775</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 9419117 1606950 10720732 10060629 20139849 11667579 3581195 94867 1149104 693908 4730299 788775 788775 <p id="xdx_84F_ecustom--ShippingAndHandlingChargesPolicyTextBlock_zqhJcRw9VWKj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_za6hNWmLs9b1">Shipping and Handling Charges</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports shipping and handling fees charged to customers as part of net sales and the associated expense as part of cost of sales. Shipping charges amounted to $<span id="xdx_90A_ecustom--ShippingCharges_c20220101__20221231_pp0p0" title="Shipping charges">821,448</span> and $<span id="xdx_908_ecustom--ShippingCharges_c20210101__20211231_pp0p0" title="Shipping charges">963,385</span> for the years ended December 31, 2022 and 2021, respectively.</span></p> 821448 963385 <p id="xdx_846_eus-gaap--AdvertisingCostsPolicyTextBlock_zSWyqEJso2qg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zpJ7bmPhyY12">Advertising</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs consist primarily of online search advertising and placement, trade shows, advertising fees, and other promotional expenses. Advertising costs are expensed as incurred and are included in sales and marketing on the consolidated statements of operations. Advertising expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20220101__20221231_pp0p0" title="Advertising Expense">1,109,207</span> and $<span id="xdx_903_eus-gaap--AdvertisingExpense_c20210101__20211231_pp0p0" title="Advertising Expense">799,799</span>, respectively.</span></p> 1109207 799799 <p id="xdx_848_eus-gaap--DepositContractsPolicy_zPoEt8Hpkha" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zd4JaH9JaPl8">Vendor deposits</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vendor payments to third manufactures are capitalized until completion of the project and are recorded as vendor deposits. As of December 31, 2022 and 2021, the vendor deposit balance was $<span id="xdx_901_eus-gaap--DepositsAssetsCurrent_c20221231_pp0p0" title="Deposits assets current">75,548</span> and $<span id="xdx_900_eus-gaap--DepositsAssetsCurrent_c20211231_pp0p0" title="Deposits assets current">992,042</span>, respectively.</span></p> 75548 992042 <p id="xdx_84C_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z5PNh4pofMy8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zlzBkiPUbd2l">Patent Costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company capitalizes costs consisting principally of outside legal costs and filing fees related to obtaining and maintaining patents. The Company amortizes patent costs over the useful life of the patent which is typically 20 years, beginning with the date the patent is filed with the U.S. Patent and Trademark Office, or foreign equivalent. As of December 31, 2022 and 2021, capitalized patent costs net of accumulated amortization was $<span id="xdx_901_eus-gaap--FiniteLivedPatentsGross_c20221231_pp0p0" title="Patent cost">1,593,741</span> and $<span id="xdx_906_eus-gaap--FiniteLivedPatentsGross_c20211231_pp0p0" title="Patent cost">1,693,124</span>, respectively. For the years ended December 31, 2022 and 2021, the Company recorded $<span id="xdx_902_eus-gaap--AdjustmentForAmortization_c20220101__20221231_pp0p0" title="Amortization">100,065</span> and $<span id="xdx_90D_eus-gaap--AdjustmentForAmortization_c20210101__20211231_pp0p0" title="Amortization">32,398</span>, respectively, of amortization expense for these patents.</span></p> 1593741 1693124 100065 32398 <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWTuMg9b2oyd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zTMJUMSJHGqc">Recently adopted accounting standards</span></span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (eTopic 326): Measurement of Credit Losses on Financial Instruments. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards replace the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measure at amortized cost to be presented at the net amount expected to be collected. The Company determined that this change does not have a material impact to the consolidated financial statements.</span></p> <p id="xdx_80A_eus-gaap--MergersAcquisitionsAndDispositionsDisclosuresTextBlock_zysDwISEFq86" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_82A_zX8bePhVA5q3">BUSINESS ACQUISITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounted for the acquisitions as a business combinations using the purchase method of accounting as prescribed in Accounting Standards Codification 805, Business Combinations (“ASC 805") and ASC 820 – Fair Value Measurements and Disclosures (“ASC 820"). In accordance with ASC 805 and ASC 820, the Company used its best estimates and assumptions to accurately assign fair value to the tangible assets acquired, identifiable intangible assets and liabilities assumed as of the acquisition dates. Goodwill as of the acquisition date is measured as the excess of purchase consideration over the fair value of tangible and identifiable intangible assets acquired and liabilities assumed. The results of operations of the acquired businesses since the date of acquisition are included in the consolidated financial statements of the Company years ended December 31, 2022 and 2021. The total purchase consideration was allocated to the assets acquired and liabilities assumed at their estimated fair values as of the date of acquisition, as determined by management. The excess of the purchase price over the amounts allocated to assets acquired and liabilities assumed has been recorded as goodwill. The value of the goodwill from the acquisitions described below can be attributed to a number of business factors including, but not limited to, cost synergies expected to be realized and a trained technical workforce.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In conjunction with acquisitions noted below, we used various valuation techniques to determine fair value of the assets acquired, with the primary techniques being discounted cash flow analysis, relief-from-royalty, a form of the multi-period excess earnings and the with-and-without valuation approaches, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Inputs to these valuation approaches require significant judgment including: (i) forecasted sales, growth rates and customer attrition rates, (ii) forecasted operating margins, (iii) royalty rates and discount rates used to present value future cash flows, (iv) the amount of synergies expected from the acquisition, (v) the economic useful life of assets and (vi) the evaluation of historical tax positions. In certain acquisitions, historical data is limited, therefore, we base our estimates and assumptions on budgets, business plans, economic projections, anticipated future cash flows and marketplace data.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Akida Holdings LLC</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 8, 2021 Applied UV, Inc. (the “Company”), entered into an asset purchase agreement (the “APA”) by and among the Company, SteriLumen, Inc., a New York corporation and wholly-owned subsidiary of the Company (the “Purchaser”) and Akida Holdings LLC, a Florida limited liability company (the “Seller”) pursuant to which the Purchaser acquired substantially all of the assets of the Seller and assumed certain of its current liabilities and contract obligations, as set forth in the APA (the “Acquisition”). In the Acquisition, the Purchaser acquired all the Seller’s assets and was assigned its contracts related to the manufacture and sale of the Airocide™ system, originally developed for NASA with assistance from the University of Wisconsin at Madison, that uses a combination of UV-C and a proprietary, titanium dioxide-based photocatalyst that has applications in the hospitality, hotel, healthcare, nursing homes, grocer, wine, commercial buildings, and retail sectors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price and purchase price allocation as of the acquisition completion date follows.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zYS2c3SezEM6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITION - Recognized Identified Assets Acquired and Liabilities Assumed (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span id="xdx_8B2_zCiROMGMl4Qb" style="display: none">Schedule of recognized identified assets acquired and liabilities assumed</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td>Purchase Price:</td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; padding-left: 10pt">Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--BusinessCombinationConsiderationTransferredOther_c20210208_pp0p0" style="width: 18%; text-align: right" title="Cash paid at closing">760,293</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Fair market value of common stock issued (1,375,000 shares)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--FairMarketValueOfCommonStockIssued1_c20210208_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Fair market value of common stock issued">7,122,500</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Purchase Price, Net of Cash Acquired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez_c20210208_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Purchase Price, net of cash acquired">7,882,793</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Assets Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20210208_pp0p0" style="text-align: right" title="Accounts receivable, net">233,241</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20210208_pp0p0" style="text-align: right" title="Inventory">211,105</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20210208_pp0p0" style="text-align: right" title="Prepaid expenses">285,490</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c20210208_pp0p0" style="text-align: right" title="Machinery and equipment">168,721</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_c20210208_pp0p0" style="text-align: right" title="Customer relationships">539,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Trade names</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradenames_c20210208_pp0p0" style="text-align: right" title="Trade names">1,156,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Technology and know how</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTechnologyAndKnowhow_c20210208_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Technology and know how">3,468,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Assets Acquired:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20210208_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets Acquired:">6,061,557</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Liabilities Assumed:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pp0p0_di_c20210208_zIdQG2tY9tr3" style="text-align: right" title="Accounts payable">(415,341</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Deferred revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pp0p0_di_c20210208_z1tNWVZMg9gd" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">(491,702</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Liabilities Assumed</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pp0p0_di_c20210208_z7dO4wqpd2Pa" style="border-bottom: Black 1pt solid; text-align: right" title="Total Liabilities Assumed">(907,043</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Assets Acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20210208_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets Acquired">5,154,514</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Excess Purchase Price “Goodwill”</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--ExcessPurchasePrice_c20210208_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right">2,728,279</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The excess purchase price has been recorded as goodwill in the amount of approximately $<span id="xdx_90C_ecustom--ExcessPurchasePrice_c20210208__us-gaap--BusinessAcquisitionAxis__custom--SteriLumenMember_pp0p0" title="Excess purchase price">2,728,279</span>. The estimated useful life of the identifiable intangible assets (see note 5) is seven to ten years. The goodwill is amortizable for tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">KES Science &amp; Technology, Inc.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2021, SteriLumen, Inc. completed an Asset Purchase Agreement with KES Science &amp; Technology, Inc. (“KES”), a Georgia corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price and purchase price allocation as of the acquisition completion date follows.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left">Purchase Price:</td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left; padding-left: 10pt">Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--BusinessCombinationConsiderationTransferredOther_c20210928_pp0p0" style="width: 18%; text-align: right" title="Cash paid at closing">4,299,900</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Fair market value of common stock issued (300,000 shares)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--FairMarketValueOfCommonStockIssued1_c20210928_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Fair market value of common stock issued">1,959,001</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Purchase Price, Net of Cash Acquired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez_c20210928_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Purchase Price, net of cash acquired">6,258,901</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Assets Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20210928_pp0p0" style="text-align: right" title="Accounts receivable, net">392,367</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in">Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20210928_pp0p0" style="text-align: right" title="Inventory">602,746</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20210928_pp0p0" style="text-align: right" title="Prepaid expenses">10,995</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.05in">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c20210928_pp0p0" style="text-align: right" title="Machinery and equipment">36,146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_iI_pp0p0_d0_c20210928_z7EVb4XM3vH3" style="text-align: right" title="Customer relationships">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.05in">Trade names</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradenames_c20210928_pp0p0" style="text-align: right" title="Trade names">914,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.05in">Technology and know how</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTechnologyAndKnowhow_c20210928_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Technology and know how">3,656,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Assets Acquired:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20210928_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets Acquired:">5,612,254</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.05in">Liabilities Assumed:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pp0p0_di_c20210928_z6eNwLIdfWmd" style="text-align: right" title="Accounts payable">(296,681</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.05in">Capital lease obligations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pp0p0_di0_c20210928_zpT7d0yqTuLc" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Liabilities Assumed</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pp0p0_di_c20210928_zcoIsWpOEsg" style="border-bottom: Black 1pt solid; text-align: right" title="Total Liabilities Assumed">(296,681</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Assets Acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20210928_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets Acquired">5,315,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Excess Purchase Price “Goodwill”</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--ExcessPurchasePrice_c20210928_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right">943,328</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">T</span>he excess purchase price has been recorded as goodwill in the amount of $<span id="xdx_90A_ecustom--ExcessPurchasePrice_iI_pp0p0_c20210928__us-gaap--BusinessAcquisitionAxis__custom--SteriLumenMember_zjukf2xtzdtg" title="Excess purchase price">943,328</span>. The estimated useful life of the identifiable intangible assets is ten years (see note 5). The goodwill is amortizable for tax purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Old SAM Partners (Scientific Air)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2021, the Company entered into an asset purchase agreement by and among the Company, SteriLumen, Inc., a New York corporation and wholly-owned subsidiary of the Company (the “Purchaser”) and Old SAM Partners, LLC, a Florida limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller, including the assignment of an exclusive distribution agreement. On October 13, 2021 the Seller received, as consideration for the Acquisition (i) $9,500,000 in cash; and (ii) 200,000 shares of the Company’s common stock and (iii) 200,000 unvested shares of the Company’s common stock, which are subject to cancellation if the earnout is not met. On the date of acquisition, the fair market value of the 200,000 vested shares was $5.57 for a total value of $1,114,000. An additional liability was recorded for $886,000 as a result of the agreement calling for additional cash consideration to the extent the share price is below $10 on the free trading date, as defined in the agreement. On December 31, 2021, the share price of our common stock was $2.70 per share and a loss on contingent consideration of  $574,000 was recorded in the consolidated statements of operations and increased the liability to $1,460,000.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price and purchase price allocation as of the acquisition completion date follows.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>Purchase Price:</td><td> </td> <td colspan="3" id="xdx_49B_20211013" style="text-align: center"> </td></tr> <tr id="xdx_402_ecustom--BusinessCombinationConsiderationTransferredOther_iI_pp0p0_zmbQfB6f8Tjd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; padding-left: 10pt">Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--BusinessCombinationConsiderationTransferredOther_c20211013_pp0p0" style="width: 18%; text-align: right" title="Cash paid at closing">9,500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Fair market value of common stock issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--FairMarketValueOfCommonStockIssued1_c20211013_pp0p0" style="text-align: right" title="Fair market value of common stock issued">1,114,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Contingent consideration based on stock price</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--ContingentConsiderationBasedOnStockPrice_c20211013_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Contingent consideration based on stock price">886,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Purchase Price, net of cash acquired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez_c20211013_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Purchase Price, net of cash acquired">11,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Assets Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20211013_pp0p0" style="text-align: right" title="Accounts receivable, net">129,845</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20211013_pp0p0" style="text-align: right" title="Inventory">369,970</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c20211013_pp0p0" style="text-align: right" title="Machinery and equipment">1,982</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_c20211013_pp0p0" style="text-align: right" title="Customer relationships">6,784,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Patents</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--Patents_c20211013_pp0p0" style="text-align: right" title="Patents">1,533,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Technology and know how</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--TechnologyAndKnowHow_c20211013_pp0p0" style="text-align: right" title="Technology and know how">1,217,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Trade names</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradenames_c20211013_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Trade names">326,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Assets Acquired:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20211013_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets Acquired:">10,361,797</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Assets Acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20211013_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets Acquired">10,361,797</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Excess Purchase Price “Goodwill”</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ExcessPurchasePrice_c20211013_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right">1,138,203</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The excess purchase price has been recorded as goodwill in the amount of approximately $<span id="xdx_901_ecustom--ExcessPurchasePrice_iI_pp0p0_c20211013__us-gaap--BusinessAcquisitionAxis__custom--SteriLumenMember_z2hEQDMzdA7g" title="[custom:ExcessPurchasePrice-0]">1,138,203</span>. The estimated useful life of the identifiable intangible assets (see note 5) is ten years. The goodwill is amortizable for tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2022, there was a settlement of a dispute that arose during the first quarter of 2022 between both parties regarding certain representations and warranties in the purchase agreement which resulted in a settlement and mutual release agreement where the seller agreed to relinquish any right, title, and interest in the previously issued <span id="xdx_904_eus-gaap--SharesIssued_iI_c20220331_zKuFUgIRvIek" title="Shares, Issued">400,000</span> shares. During the three months ended March 31, 2022, the company recorded a loss on change in fair market value of contingent consideration of $<span id="xdx_90E_ecustom--ChangeInFairMarketValue_c20220101__20220331_pp0p0" title="Change in fair market value">240,000</span> and, as a result of the settlement agreement, the company recorded a gain on settlement of contingent consideration of $<span id="xdx_908_eus-gaap--ContingentConsiderationClassifiedAsEquityFairValueDisclosure_c20220331_pp0p0" title="Contingent consideration">1,700,000</span>. The Company also determined that a triggering event had occurred as a result of the settlement agreement. A quantitative impairment test on the goodwill and intangible assets determined that the fair value was below the carrying value and as a result the Company recorded a full goodwill impairment charge of $<span id="xdx_909_ecustom--AssetImpairmentCharge_pp0p0_c20220101__20220331_zD3nGz3HJgsg" title="Asset Impairment Charge">1,138,203</span> in the first quarter of 2022. Subsequently, as of December 31, 2022, we evaluated potential triggering events that might be indicators that our definite lived intangibles were impaired. We saw a significant decrease in the number of orders and demand of certain product lines within our disinfectant business segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of our evaluation, we determined that the fair value of certain intangible assets were less than the carrying amount as of December 31, 2022. The Company recorded an impairment on intangibles of $<span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20220101__20221231_z8lXEFRlcDxf" title="Impairment on intangibles">5,854,872</span> in the Consolidated Statements of Operations during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2022, the Company entered into an asset purchase agreement by and among the Company, Munnworks, LLC., a New York Limited Liability Company and wholly-owned subsidiary of the Company (the “Purchaser”) and VisionMark LLC, a New York limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller in exchange for the assumption of obligations of buyer under the sublease and sublease guarantee.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price and purchase price allocation as of the acquisition completion date follows.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left">Purchase Price:</td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left; padding-left: 10pt">Cash paid at closing</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--BusinessCombinationConsiderationTransferredOther_c20220325_pp0p0" style="width: 18%; text-align: right" title="Cash paid at closing">10</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Due to landlord</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--DueToLandlord_c20220325_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Due to landlord">755,906</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Purchase Price, net of cash acquired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez_c20220325_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Purchase Price, net of cash acquired">755,916</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Assets Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Accounts receivable, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20220325_pp0p0" style="text-align: right" title="Accounts receivable, net">636,550</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20220325_pp0p0" style="text-align: right" title="Inventory">176,583</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Costs and estimated earnings in excess of billings</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--CostsAndEstimatedEarningsInExcessOfBillings_c20220325_pp0p0" style="text-align: right" title="Costs and estimated earnings in excess of billings">181,152</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Machinery and equipment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c20220325_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Machinery and equipment">1,100,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Assets Acquired:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20220325_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets Acquired:">2,094,285</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Liabilities Assumed:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Billings in excess of costs and earnings on uncompleted contracts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--BillingsInExcessOfCostsAndEarningsOnUncompletedContracts_iNI_pp0p0_di_c20220325_zTkGC7xfbNDa" style="border-bottom: Black 1pt solid; text-align: right" title="Billings in excess of costs and earnings on uncompleted contracts">(1,388,838</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Liabilities Assumed</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pp0p0_di_c20220325_zwT1Cq0TWxGj" style="border-bottom: Black 1pt solid; text-align: right" title="Total Liabilities Assumed">(1,388,838</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net Assets Acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20220325_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets Acquired">705,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Excess Purchase Price “Goodwill”</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--ExcessPurchasePrice_c20220325_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right">50,469</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zXgg90ynzenf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The excess purchase price has been recorded as goodwill in the amount of approximately $<span id="xdx_90D_ecustom--ExcessPurchasePrice_iI_pp0p0_c20220325__us-gaap--BusinessAcquisitionAxis__custom--SteriLumenMember_zSluMsoJLV81" title="Excess purchase price">50,469</span>. The goodwill is amortizable for tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the VisionMark LLC acquisition, the Company is obligated to repay $<span id="xdx_904_eus-gaap--OperatingLeasePayments_c20220101__20221231_pp0p0" title="Operating Lease, Payments">31,057</span> of past due lease payments per month for the next 36 months commencing on April 1, 2022. The Company recognized a discount and related liability equal to the present value of the past due lease liability, and amortizes the difference between such present value and the liability through interest expense using a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20221231_zLCWfkVrdTOf" title="Interest expense rate">38.7</span>% as per the effective interest rate method over the repayment period. Amortization of discount included in interest expenses was $<span id="xdx_908_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20220101__20221231_z192mszAPB4d" title="Amortization of discount in interest expenses">146,073</span> for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the future maturity of the lease liability as of December 31, is as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_zQPOuaWJFvTd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITION - Future Maturity of lease Liability (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span id="xdx_8BC_zJsSOrDlQVKg" style="display: none">Schedule of future maturity of the lease liability</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231_zUSLHaSk37Uc" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Years Ended December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left; padding-left: 10pt">2023</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">372,684</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">372,684</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">93,174</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--LesseeOperatingLeaseLiabilityPaymentDue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">838,542</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--LessUnamortizedDiscount_iNI_pp0p0_di_z7yUIitoXtXb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Unamortized discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(216,078</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_ecustom--TotalAmountDueToLandlord_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total amount due to landlord</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">622,464</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LessCurrentPortionOfAmountDueToLandlordNetOfDiscount_iNI_pp0p0_di_zE6PcEsDulI3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion of amount due to landlord, net of discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(229,235</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--TotalLongtermPortionOfAmountDueToLandlord_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total long-term portion of amount due to landlord</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">393,230</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zuy3MDwsHhzi" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zYS2c3SezEM6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITION - Recognized Identified Assets Acquired and Liabilities Assumed (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span id="xdx_8B2_zCiROMGMl4Qb" style="display: none">Schedule of recognized identified assets acquired and liabilities assumed</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td>Purchase Price:</td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; padding-left: 10pt">Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--BusinessCombinationConsiderationTransferredOther_c20210208_pp0p0" style="width: 18%; text-align: right" title="Cash paid at closing">760,293</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Fair market value of common stock issued (1,375,000 shares)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--FairMarketValueOfCommonStockIssued1_c20210208_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Fair market value of common stock issued">7,122,500</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Purchase Price, Net of Cash Acquired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez_c20210208_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Purchase Price, net of cash acquired">7,882,793</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Assets Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20210208_pp0p0" style="text-align: right" title="Accounts receivable, net">233,241</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20210208_pp0p0" style="text-align: right" title="Inventory">211,105</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20210208_pp0p0" style="text-align: right" title="Prepaid expenses">285,490</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c20210208_pp0p0" style="text-align: right" title="Machinery and equipment">168,721</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_c20210208_pp0p0" style="text-align: right" title="Customer relationships">539,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Trade names</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradenames_c20210208_pp0p0" style="text-align: right" title="Trade names">1,156,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Technology and know how</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTechnologyAndKnowhow_c20210208_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Technology and know how">3,468,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Assets Acquired:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20210208_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets Acquired:">6,061,557</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Liabilities Assumed:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pp0p0_di_c20210208_zIdQG2tY9tr3" style="text-align: right" title="Accounts payable">(415,341</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Deferred revenue</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pp0p0_di_c20210208_z1tNWVZMg9gd" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">(491,702</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Liabilities Assumed</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pp0p0_di_c20210208_z7dO4wqpd2Pa" style="border-bottom: Black 1pt solid; text-align: right" title="Total Liabilities Assumed">(907,043</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Assets Acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20210208_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets Acquired">5,154,514</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Excess Purchase Price “Goodwill”</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--ExcessPurchasePrice_c20210208_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right">2,728,279</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The excess purchase price has been recorded as goodwill in the amount of approximately $<span id="xdx_90C_ecustom--ExcessPurchasePrice_c20210208__us-gaap--BusinessAcquisitionAxis__custom--SteriLumenMember_pp0p0" title="Excess purchase price">2,728,279</span>. The estimated useful life of the identifiable intangible assets (see note 5) is seven to ten years. The goodwill is amortizable for tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">KES Science &amp; Technology, Inc.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2021, SteriLumen, Inc. completed an Asset Purchase Agreement with KES Science &amp; Technology, Inc. (“KES”), a Georgia corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price and purchase price allocation as of the acquisition completion date follows.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left">Purchase Price:</td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left; padding-left: 10pt">Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--BusinessCombinationConsiderationTransferredOther_c20210928_pp0p0" style="width: 18%; text-align: right" title="Cash paid at closing">4,299,900</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Fair market value of common stock issued (300,000 shares)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--FairMarketValueOfCommonStockIssued1_c20210928_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Fair market value of common stock issued">1,959,001</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Purchase Price, Net of Cash Acquired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez_c20210928_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Purchase Price, net of cash acquired">6,258,901</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Assets Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20210928_pp0p0" style="text-align: right" title="Accounts receivable, net">392,367</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in">Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20210928_pp0p0" style="text-align: right" title="Inventory">602,746</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20210928_pp0p0" style="text-align: right" title="Prepaid expenses">10,995</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.05in">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c20210928_pp0p0" style="text-align: right" title="Machinery and equipment">36,146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_iI_pp0p0_d0_c20210928_z7EVb4XM3vH3" style="text-align: right" title="Customer relationships">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.05in">Trade names</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradenames_c20210928_pp0p0" style="text-align: right" title="Trade names">914,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.05in">Technology and know how</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTechnologyAndKnowhow_c20210928_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Technology and know how">3,656,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Assets Acquired:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20210928_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets Acquired:">5,612,254</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.05in">Liabilities Assumed:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.05in">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pp0p0_di_c20210928_z6eNwLIdfWmd" style="text-align: right" title="Accounts payable">(296,681</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.05in">Capital lease obligations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pp0p0_di0_c20210928_zpT7d0yqTuLc" style="border-bottom: Black 1pt solid; text-align: right" title="Deferred revenue">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Liabilities Assumed</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pp0p0_di_c20210928_zcoIsWpOEsg" style="border-bottom: Black 1pt solid; text-align: right" title="Total Liabilities Assumed">(296,681</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Assets Acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20210928_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets Acquired">5,315,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Excess Purchase Price “Goodwill”</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--ExcessPurchasePrice_c20210928_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right">943,328</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">T</span>he excess purchase price has been recorded as goodwill in the amount of $<span id="xdx_90A_ecustom--ExcessPurchasePrice_iI_pp0p0_c20210928__us-gaap--BusinessAcquisitionAxis__custom--SteriLumenMember_zjukf2xtzdtg" title="Excess purchase price">943,328</span>. The estimated useful life of the identifiable intangible assets is ten years (see note 5). The goodwill is amortizable for tax purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Old SAM Partners (Scientific Air)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2021, the Company entered into an asset purchase agreement by and among the Company, SteriLumen, Inc., a New York corporation and wholly-owned subsidiary of the Company (the “Purchaser”) and Old SAM Partners, LLC, a Florida limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller, including the assignment of an exclusive distribution agreement. On October 13, 2021 the Seller received, as consideration for the Acquisition (i) $9,500,000 in cash; and (ii) 200,000 shares of the Company’s common stock and (iii) 200,000 unvested shares of the Company’s common stock, which are subject to cancellation if the earnout is not met. On the date of acquisition, the fair market value of the 200,000 vested shares was $5.57 for a total value of $1,114,000. An additional liability was recorded for $886,000 as a result of the agreement calling for additional cash consideration to the extent the share price is below $10 on the free trading date, as defined in the agreement. On December 31, 2021, the share price of our common stock was $2.70 per share and a loss on contingent consideration of  $574,000 was recorded in the consolidated statements of operations and increased the liability to $1,460,000.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price and purchase price allocation as of the acquisition completion date follows.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>Purchase Price:</td><td> </td> <td colspan="3" id="xdx_49B_20211013" style="text-align: center"> </td></tr> <tr id="xdx_402_ecustom--BusinessCombinationConsiderationTransferredOther_iI_pp0p0_zmbQfB6f8Tjd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; padding-left: 10pt">Cash</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--BusinessCombinationConsiderationTransferredOther_c20211013_pp0p0" style="width: 18%; text-align: right" title="Cash paid at closing">9,500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Fair market value of common stock issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--FairMarketValueOfCommonStockIssued1_c20211013_pp0p0" style="text-align: right" title="Fair market value of common stock issued">1,114,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Contingent consideration based on stock price</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--ContingentConsiderationBasedOnStockPrice_c20211013_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Contingent consideration based on stock price">886,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Purchase Price, net of cash acquired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez_c20211013_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Purchase Price, net of cash acquired">11,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Assets Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20211013_pp0p0" style="text-align: right" title="Accounts receivable, net">129,845</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20211013_pp0p0" style="text-align: right" title="Inventory">369,970</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c20211013_pp0p0" style="text-align: right" title="Machinery and equipment">1,982</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships_c20211013_pp0p0" style="text-align: right" title="Customer relationships">6,784,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Patents</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--Patents_c20211013_pp0p0" style="text-align: right" title="Patents">1,533,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Technology and know how</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--TechnologyAndKnowHow_c20211013_pp0p0" style="text-align: right" title="Technology and know how">1,217,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Trade names</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradenames_c20211013_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Trade names">326,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Assets Acquired:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20211013_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets Acquired:">10,361,797</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Assets Acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20211013_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets Acquired">10,361,797</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Excess Purchase Price “Goodwill”</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ExcessPurchasePrice_c20211013_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right">1,138,203</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The excess purchase price has been recorded as goodwill in the amount of approximately $<span id="xdx_901_ecustom--ExcessPurchasePrice_iI_pp0p0_c20211013__us-gaap--BusinessAcquisitionAxis__custom--SteriLumenMember_z2hEQDMzdA7g" title="[custom:ExcessPurchasePrice-0]">1,138,203</span>. The estimated useful life of the identifiable intangible assets (see note 5) is ten years. The goodwill is amortizable for tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2022, there was a settlement of a dispute that arose during the first quarter of 2022 between both parties regarding certain representations and warranties in the purchase agreement which resulted in a settlement and mutual release agreement where the seller agreed to relinquish any right, title, and interest in the previously issued <span id="xdx_904_eus-gaap--SharesIssued_iI_c20220331_zKuFUgIRvIek" title="Shares, Issued">400,000</span> shares. During the three months ended March 31, 2022, the company recorded a loss on change in fair market value of contingent consideration of $<span id="xdx_90E_ecustom--ChangeInFairMarketValue_c20220101__20220331_pp0p0" title="Change in fair market value">240,000</span> and, as a result of the settlement agreement, the company recorded a gain on settlement of contingent consideration of $<span id="xdx_908_eus-gaap--ContingentConsiderationClassifiedAsEquityFairValueDisclosure_c20220331_pp0p0" title="Contingent consideration">1,700,000</span>. The Company also determined that a triggering event had occurred as a result of the settlement agreement. A quantitative impairment test on the goodwill and intangible assets determined that the fair value was below the carrying value and as a result the Company recorded a full goodwill impairment charge of $<span id="xdx_909_ecustom--AssetImpairmentCharge_pp0p0_c20220101__20220331_zD3nGz3HJgsg" title="Asset Impairment Charge">1,138,203</span> in the first quarter of 2022. Subsequently, as of December 31, 2022, we evaluated potential triggering events that might be indicators that our definite lived intangibles were impaired. We saw a significant decrease in the number of orders and demand of certain product lines within our disinfectant business segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of our evaluation, we determined that the fair value of certain intangible assets were less than the carrying amount as of December 31, 2022. The Company recorded an impairment on intangibles of $<span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20220101__20221231_z8lXEFRlcDxf" title="Impairment on intangibles">5,854,872</span> in the Consolidated Statements of Operations during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2022, the Company entered into an asset purchase agreement by and among the Company, Munnworks, LLC., a New York Limited Liability Company and wholly-owned subsidiary of the Company (the “Purchaser”) and VisionMark LLC, a New York limited liability company (the “Seller”), pursuant to which the Purchaser acquired substantially all of the assets of the Seller in exchange for the assumption of obligations of buyer under the sublease and sublease guarantee.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price and purchase price allocation as of the acquisition completion date follows.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left">Purchase Price:</td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left; padding-left: 10pt">Cash paid at closing</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--BusinessCombinationConsiderationTransferredOther_c20220325_pp0p0" style="width: 18%; text-align: right" title="Cash paid at closing">10</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Due to landlord</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--DueToLandlord_c20220325_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Due to landlord">755,906</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Purchase Price, net of cash acquired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez_c20220325_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Purchase Price, net of cash acquired">755,916</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Assets Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Accounts receivable, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20220325_pp0p0" style="text-align: right" title="Accounts receivable, net">636,550</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20220325_pp0p0" style="text-align: right" title="Inventory">176,583</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Costs and estimated earnings in excess of billings</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--CostsAndEstimatedEarningsInExcessOfBillings_c20220325_pp0p0" style="text-align: right" title="Costs and estimated earnings in excess of billings">181,152</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Machinery and equipment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c20220325_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Machinery and equipment">1,100,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Assets Acquired:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20220325_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets Acquired:">2,094,285</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt">Liabilities Assumed:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Billings in excess of costs and earnings on uncompleted contracts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--BillingsInExcessOfCostsAndEarningsOnUncompletedContracts_iNI_pp0p0_di_c20220325_zTkGC7xfbNDa" style="border-bottom: Black 1pt solid; text-align: right" title="Billings in excess of costs and earnings on uncompleted contracts">(1,388,838</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total Liabilities Assumed</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pp0p0_di_c20220325_zwT1Cq0TWxGj" style="border-bottom: Black 1pt solid; text-align: right" title="Total Liabilities Assumed">(1,388,838</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net Assets Acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20220325_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Assets Acquired">705,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Excess Purchase Price “Goodwill”</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--ExcessPurchasePrice_c20220325_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right">50,469</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 760293 7122500 7882793 233241 211105 285490 168721 539000 1156000 3468000 6061557 415341 491702 907043 5154514 2728279 2728279 4299900 1959001 6258901 392367 602746 10995 36146 0 914000 3656000 5612254 296681 -0 296681 5315573 943328 943328 9500000 9500000 1114000 886000 11500000 129845 369970 1982 6784000 1533000 1217000 326000 10361797 10361797 1138203 1138203 400000 240000 1700000 1138203 5854872 10 755906 755916 636550 176583 181152 1100000 2094285 1388838 1388838 705447 50469 50469 31057 0.387 146073 <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_zQPOuaWJFvTd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITION - Future Maturity of lease Liability (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span id="xdx_8BC_zJsSOrDlQVKg" style="display: none">Schedule of future maturity of the lease liability</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231_zUSLHaSk37Uc" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Years Ended December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left; padding-left: 10pt">2023</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">372,684</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">372,684</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">93,174</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--LesseeOperatingLeaseLiabilityPaymentDue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">838,542</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--LessUnamortizedDiscount_iNI_pp0p0_di_z7yUIitoXtXb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Unamortized discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(216,078</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_ecustom--TotalAmountDueToLandlord_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total amount due to landlord</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">622,464</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LessCurrentPortionOfAmountDueToLandlordNetOfDiscount_iNI_pp0p0_di_zE6PcEsDulI3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion of amount due to landlord, net of discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(229,235</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--TotalLongtermPortionOfAmountDueToLandlord_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total long-term portion of amount due to landlord</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">393,230</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> 372684 372684 93174 838542 216078 622464 229235 393230 <p id="xdx_802_eus-gaap--InventoryDisclosureTextBlock_zB0MMnCRLZF4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_827_zJ24chDXnGv9">INVENTORY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consists of the following as of:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zbtaTQ5eg7bd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BA_zPG9NgEXHpH" style="display: none">Schedule of Inventory</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231_zT8XoyIUIRZk" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20211231_zpclzm6KLsO6" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Raw materials</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,485,040</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">356,759</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,110,838</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,429,479</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Inventory at cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,595,878</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,786,238</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_zs2NRbswGEIb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Reserve</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(87,792</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508,086</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,646,238</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zbtaTQ5eg7bd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BA_zPG9NgEXHpH" style="display: none">Schedule of Inventory</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231_zT8XoyIUIRZk" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20211231_zpclzm6KLsO6" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Raw materials</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,485,040</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">356,759</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,110,838</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,429,479</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Inventory at cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,595,878</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,786,238</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_zs2NRbswGEIb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Reserve</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(87,792</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,508,086</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,646,238</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3485040 356759 2110838 1429479 5595878 1786238 87792 140000 5508086 1646238 <p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ztHYkVTCaCDf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_82D_zhYy7B0vLUP6">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment (including machinery and equipment under capital leases) are summarized by major classifications as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_zhwN3W6wFHY7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BF_zQoXcZ2bvgI9" style="display: none">Schedule of property and equipment</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Machinery and Equipment</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and equipment, gross">1,266,189</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and equipment, gross">254,685</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and equipment, gross">67,549</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and equipment, gross">67,549</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Furniture and Fixtures</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">203,256</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">54,041</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="text-align: right" title="Property and equipment, gross">1,536,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross">376,275</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated Depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zix3B5PlC7xc" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation">(403,526</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zEa8WqRZ7TX3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation">(179,664</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">1,133,468</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">196,611</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif"/> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense, including amortization of assets under financing leases, for the year ended December 31, 2022 and 2021 was $<span id="xdx_90F_eus-gaap--Depreciation_c20220101__20221231_pp0p0" title="Depreciation">223,862</span> and $<span id="xdx_902_eus-gaap--Depreciation_c20210101__20211231_pp0p0" title="Depreciation">137,777</span>, respectively.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_zhwN3W6wFHY7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BF_zQoXcZ2bvgI9" style="display: none">Schedule of property and equipment</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Machinery and Equipment</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and equipment, gross">1,266,189</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="width: 12%; text-align: right" title="Property and equipment, gross">254,685</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and equipment, gross">67,549</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Property and equipment, gross">67,549</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Furniture and Fixtures</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">203,256</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">54,041</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="text-align: right" title="Property and equipment, gross">1,536,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross">376,275</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated Depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zix3B5PlC7xc" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation">(403,526</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zEa8WqRZ7TX3" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation">(179,664</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">1,133,468</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">196,611</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1266189 254685 67549 67549 203256 54041 1536994 376275 403526 179664 1133468 196611 223862 137777 <p id="xdx_80A_eus-gaap--IntangibleAssetsDisclosureTextBlock_zT2HSITKtj2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_82D_zMNHjRFlZOQ5">INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets as of December 31, 2022 and 2021 consist of the following:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zNCxaxT3FNZ8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B4_zZkfkg7hMzs1" style="display: none">Schedule of Intangible Assets</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intangible assets subject to amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: left">Customer Relationship (Note 2)</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 12%; text-align: right" title="Intangible assets gross">1,655,598</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 12%; text-align: right" title="Intangible assets gross">7,323,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Trade Names</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Intangible assets gross">2,208,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Intangible assets gross">2,396,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Patents</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Intangible assets gross">1,730,771</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Intangible assets gross">1,730,089</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Technology and Know How</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets gross">8,341,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets gross">8,341,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231_pp0p0" style="text-align: right" title="Intangible assets gross">13,935,899</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231_pp0p0" style="text-align: right" title="Intangible assets gross">19,790,089</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated Amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation">(2,581,469</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation">(813,533</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets net">11,354,430</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets net">18,976,556</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zxay65mVpEmc" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As described in Note 2 of the financial statements, a quantitative impairment test on the goodwill and intangible assets determined that the fair value was below the carrying value and as a result the Company recorded a full goodwill impairment charge of $<span id="xdx_90D_eus-gaap--AssetImpairmentCharges_pp0p0_c20220101__20220331_zC8NGCSNzRJ2" title="Asset Impairment Charges">1,138,203</span> in the first quarter of 2022. Subsequently, as of December 31, 2022, we evaluated potential triggering events that might be indicators that our definite lived intangibles were impaired. We saw a significant decrease in the number of orders and demand of certain product lines within our disinfectant business segment. As a result of our assessment, the Company recorded an additional impairment on trade name and customer relationship intangible assets of $<span id="xdx_903_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zmdoRbfxnqAf" title="Intangible assets">187,470</span> and $<span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqhduHKBhqc1" title="Intangible assets">5,667,402</span>, respectively, in the Consolidated Statements of Operations during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2022 and 2021, the Company recorded total amortization expense related to intangible assets of $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231_z9CjqAe0arH7">1,767,936</span> and $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_zlmfR4AiImBk">808,967</span>, respectively. The useful lives of tradenames ranges from 5 to 10 years, technology is 10 years, customer relationships ranges from 7 to 14 years, and patents range from 17 to 20 years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future amortization of intangible assets is as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_ztkT9N8o1Zk8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span id="xdx_8B2_zXBXuC0SK5f1" style="display: none">Future amortization of intangible assets</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20221231_zEDK6vh7Copb" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; text-align: left">For the years ending December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; width: 44%; text-align: left">2023</td><td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">1,256,948</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2024</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,256,948</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2025</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,256,948</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2026</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,242,192</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2027</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,197,925</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,143,468</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); vertical-align: top; text-align: left">Total </td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,354,430</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zlilv0ZxHIN9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zNCxaxT3FNZ8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B4_zZkfkg7hMzs1" style="display: none">Schedule of Intangible Assets</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intangible assets subject to amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: left">Customer Relationship (Note 2)</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 12%; text-align: right" title="Intangible assets gross">1,655,598</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 12%; text-align: right" title="Intangible assets gross">7,323,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Trade Names</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Intangible assets gross">2,208,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_pp0p0" style="text-align: right" title="Intangible assets gross">2,396,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Patents</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Intangible assets gross">1,730,771</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="text-align: right" title="Intangible assets gross">1,730,089</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Technology and Know How</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets gross">8,341,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets gross">8,341,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231_pp0p0" style="text-align: right" title="Intangible assets gross">13,935,899</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231_pp0p0" style="text-align: right" title="Intangible assets gross">19,790,089</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated Amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation">(2,581,469</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation">(813,533</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.05in"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets net">11,354,430</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets net">18,976,556</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1655598 7323000 2208530 2396000 1730771 1730089 8341000 8341000 13935899 19790089 -2581469 -813533 11354430 18976556 1138203 187470 5667402 1767936 808967 <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_ztkT9N8o1Zk8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span id="xdx_8B2_zXBXuC0SK5f1" style="display: none">Future amortization of intangible assets</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20221231_zEDK6vh7Copb" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; text-align: left">For the years ending December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; width: 44%; text-align: left">2023</td><td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">1,256,948</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2024</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,256,948</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2025</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,256,948</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2026</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,242,192</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2027</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,197,925</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,143,468</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); vertical-align: top; text-align: left">Total </td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,354,430</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1256948 1256948 1256948 1242192 1197925 5143468 11354430 <p id="xdx_801_eus-gaap--LesseeFinanceLeasesTextBlock_z2XGkYoGBadh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_824_z7qop8BpigY9">FINANCING LEASE OBLIGATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s future minimum principal and interest payments under a financing lease for machinery and equipment are as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--FinanceLeasesOfLesseeDisclosureTableTextBlock_zbeh1MQEtU6b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FINANCING LEASE OBLIGATION - Future minimum principal and interest payments under capital lease arrangements (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span id="xdx_8BF_zRQ60cDXaMW4" style="display: none">Schedule of future minimum principal and interest payments under capital lease arrangements</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20221231_zHsH7UFlZsjg" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; text-align: left">For the years ending December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_406_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_zlUclaNXAGF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; width: 44%; text-align: left">2023</td><td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">51,716</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2024</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">48,145</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_zX3cmuj3aLNl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2025</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">48,145</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_zZStrCfQJLA1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2026</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">48,145</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_zaWRxI70Ul5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2027</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">36,109</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--TotalLeasePayments_pp0p0_zcXxwilqN9ta" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">232,261</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zmf59goKNR2d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Amount representing interest</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(40,479</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_zF4PXowUy64f" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of future minimum lease payments</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">191,782</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FinanceLeaseLiability_iNI_pp0p0_di_zrgKlsoQHiBf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: current portion</span></td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(33,712</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing lease obligations, net of current</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">158,070</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--FinanceLeasesOfLesseeDisclosureTableTextBlock_zbeh1MQEtU6b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FINANCING LEASE OBLIGATION - Future minimum principal and interest payments under capital lease arrangements (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span id="xdx_8BF_zRQ60cDXaMW4" style="display: none">Schedule of future minimum principal and interest payments under capital lease arrangements</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20221231_zHsH7UFlZsjg" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; text-align: left">For the years ending December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_406_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_zlUclaNXAGF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; width: 44%; text-align: left">2023</td><td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">51,716</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2024</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">48,145</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_zX3cmuj3aLNl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2025</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">48,145</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_zZStrCfQJLA1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2026</td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">48,145</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_zaWRxI70Ul5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2027</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">36,109</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--TotalLeasePayments_pp0p0_zcXxwilqN9ta" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">232,261</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zmf59goKNR2d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Amount representing interest</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(40,479</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_zF4PXowUy64f" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of future minimum lease payments</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">191,782</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FinanceLeaseLiability_iNI_pp0p0_di_zrgKlsoQHiBf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: current portion</span></td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(33,712</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing lease obligations, net of current</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">158,070</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> 51716 48145 48145 48145 36109 232261 40479 191782 33712 158070 <p id="xdx_800_ecustom--NotesPayableDisclosureTextBlock_zaqMweOjOoRg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_828_zPW8v6r1eUS1">NOTES PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into a loan agreement in April of 2019 where the company was required to pay $<span id="xdx_902_eus-gaap--LongTermDebt_c20221231_pp0p0" title="Long term debt">157,500</span> in five payments in the amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_c20220101__20221231_pp0p0" title="Periodic payment">30,000</span> per year, with an additional $<span id="xdx_907_ecustom--DebtInstrumentAdditionalAmountPayableInYearTwo_c20220101__20221231_pp0p0" title="Debt instrument additional amount">7,500</span>, representing interest, in year two to a loan holder. As of December 31, 2022, the company has an outstanding balance of $<span id="xdx_902_eus-gaap--RepaymentsOfDebt_c20220101__20221231_pp0p0" title="Repayments of debt">157,500</span>, and no payments have been made as of year end.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum obligations under this loan agreement are as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zA4uKRaIztO3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE - Minimum obligations under this loan agreement (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span id="xdx_8BB_z6zeN2Jw2FXb" style="display: none">Schedule of minimum obligations under loan agreement</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20221231_zPbgKO45loQg" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; text-align: left">For the year ending December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; width: 44%; text-align: left">2023</td><td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">127,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2024</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">30,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); vertical-align: top; text-align: left">Total </td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">157,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z3T5me4J84j3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Applied UV, Inc. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Streeterville Note</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 7, 2022, the Company entered into a Security Purchase Agreement with Streeterville Capital, LLC whereby the Company issued an <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20221001__20221007__us-gaap--TransactionTypeAxis__custom--SecurityPurchaseAgreementMember_zUKCJQWgSEwe" title="Debt interest rate">8</span>% unsecured redeemable note in the principal amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20221007__us-gaap--TransactionTypeAxis__custom--SecurityPurchaseAgreementMember_zQggyW8NODlk" title="Principal amount">2,807,500</span>. The Company received net proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromNotesPayable_c20220101__20221231_zqzU7nUSvyKb" title="Proceeds from notes payable">2,462,500</span>, after the deduction of debt issuance costs of $<span id="xdx_90E_eus-gaap--PaymentsOfDebtIssuanceCosts_c20220101__20221231_z0mRDrExT2Fh" title="Debt issuance costs">345,000</span>. These fees were recorded as debt discounts, net of the carrying value of the debt, and are being amortized over the life of the loan using the effective interest rate method. The note has a maturity date of <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20220101__20221231_z2KzubSPQwrb" title="Maturity date">April 7, 2024</span>. At any time following the occurrence of any event of default, interest shall accrue on the outstanding balance beginning on the date the applicable event of default occurred at an interest rate equal to the lesser of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220101__20221231_z4u5gvlVvaNh" title="Interest rate">18</span>% per annum or the maximum rate permitted under applicable law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents the balance of the Streeterville Note, net of discount at December 31, 2022.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfNotePayableNetOfDiscountTableTextBlock_zTlznwijYDHb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE - net of discount (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B4_zkTpBNBILAP4" style="display: none">Schedule of note payable net of discount</span></td><td> </td> <td style="text-align: center"> </td><td id="xdx_492_20221231_zlz63TWoDLT4" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td></tr> <tr id="xdx_402_eus-gaap--DebtInstrumentFaceAmount_iI_z37nDc6IAH4e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Principle outstanding</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">2,807,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_z0Jm9vsoT7wj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(345,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--OtherNotesPayable_iI_pp0p0_z6WTqP43kb28" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,462,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_iI_zG71XwBkC86i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization of debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">77,600</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--StreetervilleNoteNetOfRelatedDiscount_iI_zEzFaROXqP2l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Streeterville note, net of related discount</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,540,100</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zdqJPnTPeiTg" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum obligations under this loan agreement are as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfMaturityOfLongTermDebtTableTextBlock_zbxhwPPyyMz5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE - Minimum obligations (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span id="xdx_8B0_zSRfudMdhghl" style="display: none">Schedule of minimum obligations</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20221231_zmbol0wKDp34" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left">For the years sending December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_hus-gaap--ShortTermDebtTypeAxis__custom--StreetervilleNoteMember_z8gCbHP7B2rd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 44%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">2,072,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_hus-gaap--ShortTermDebtTypeAxis__custom--StreetervilleNoteMember_zxLXkyg4bd1c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">2024</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">735,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LongTermDebt_iI_pp0p0_hus-gaap--ShortTermDebtTypeAxis__custom--StreetervilleNoteMember_zuMDgBSMzfr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); text-align: left">Total </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,807,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zEVePAJ4jSFk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lender has the right at any time 6 months after the effective date, at its election, to redeem all or part of the maximum redemption amount as set forth in the promissory note. Payments of each redemption amount may be made (a) in cash, or (b) in common stock per the following formula: the portion of the applicable Redemption amount being paid in common stock divided by the common stock redemption price, or (c) by any combination of the foregoing. Whereas common stock redemption price means <span id="xdx_904_eus-gaap--DebtInstrumentRedemptionPricePercentage_dp_c20220101__20221231_zOHk9VzRiJ0k" title="Redemption price">87.5</span>% multiplied by the Nasdaq minimum price. Whereas Nasdaq minimum price means the lower of: (i) the closing price on the trading day immediately preceding the date the common stock redemption price is measured; or (ii) the average closing price of the common stock for the five trading days immediately preceding the date the common stock redemption price is measured.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal amount of the Note may be prepaid in full, or any portion of the outstanding balance earlier than it is due; provided that in the event borrower elects to prepay all or any portion of the outstanding balance it shall pay to lender 120% of the portion of the outstanding balance borrower elects to prepay. The prepayment premium will not apply if borrower repays the Note in full on the anniversary date, which is one year from the purchase price date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If prior to the anniversary date all redemption amounts are paid as common stock redemptions, then each time after the anniversary date that borrower makes a common stock redemption, $<span id="xdx_907_ecustom--MonitoringFee_c20220101__20221231_zP2YTVWkARee" title="Monitoring fee">8,333</span> of the monitoring fee will be deducted from the outstanding balance, not to exceed $<span id="xdx_900_ecustom--OutstandingBalance_iI_c20221231_zANzQUozMVl4" title="Outstanding balance">50,000</span>. No interest will accrue on the monitoring fee.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, the Company recognized $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20221231_zrLy9XZPFB6k" title="Debt discount fee">345,000</span> as a debt discount relating to the fee and will be amortized using the effective interest method over the term of the note. The effective interest rate of the note is <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20221231_zQ1wRI6NYtdg" title="Effective interest rate">22.23</span>%. The Company recorded $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_iI_c20221231_z1Ds5wWS4oGd" title="Debt discount amortization to interest expense">77,600</span> due to debt discount amortization to interest expense in the accompanying Statement of Operations and as a result, at December 31, 2022, the remaining unamortized balance was $<span id="xdx_901_ecustom--DebtInstrumentUnamortizedDiscountRemainingBalance_iI_c20221231_zRPtj47M0xZd" title="Remaining unamortized balance">267,400</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense recorded in the accompanying Statements of Operations by the Company was $<span id="xdx_901_eus-gaap--InterestExpenseDebt_c20220101__20221231_zKw5hr6DZW51" title="Interest expense">53,031</span> for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Directors and Officers Liability Insurance Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 28, 2022, the Company entered into a one-year Directors and Officers Liability Insurance agreement for $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20220828__srt--TitleOfIndividualAxis__us-gaap--DirectorsAndOfficersLiabilityInsuranceMember_zIWThsW1Oyu3" title="Face amount">318,833</span>. Under the terms of the agreement, the Company made a down payment of $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPayment_c20220801__20220828_zNC0qCbve936" title="Down payment">41,730</span>, with the remaining balance financed over the remaining term at an annual percentage rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220801__20220828_zXuhcnxVB2pf" title="Annual percentage rate">5.05</span>%. Beginning in September 2022, the Company is making 10 monthly payments of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_c20220901__20220930_zOLmCS5FwH4h" title="Down payment">27,710</span>, with the last payment expected to be made in June 2023. At December 31, 2022, the outstanding balance on the note payable was $<span id="xdx_901_eus-gaap--NotesPayable_iI_c20221231_z2PU2QHNtorg" title="Note payable">166,262</span>. The interest expense for the year ended December 31, 2022 was immaterial to the consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pinnacle Note</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, the Company entered into a Loan and Security Agreement, or (the “Loan Agreement”), with Pinnacle Bank, which provides for a $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityAnnualPrincipalPayment_c20220801__20220828__srt--TitleOfIndividualAxis__custom--LoanAndSecurityAgreementMember_zVnH7gRC9VMg" title="Secured credit facility">5,000,000</span> secured revolving credit facility (the “Loan Facility”). <span id="xdx_907_eus-gaap--DebtInstrumentDescription_c20220101__20221231__srt--TitleOfIndividualAxis__custom--LoanAndSecurityAgreementMember_zWr3zPxYYXU9" title="Debt instrument description">The loan is subject to a maximum advance rate of up to 85% of net face amount of eligible accounts, plus the lessor a) of the sum of 20% of the aggregate eligible inventory value of raw materials and 35% of the aggregate eligible inventory value of finished goods, b) $1 million, c) 80% of the net orderly liquidation value of raw materials and finished goods, or d) 100% of the aggregate outstanding principal amount of advances. In no event shall the aggregate amount of the outstanding advances under the Loan Facility be greater than $5 million. The loan matures on December 9, 2024.</span> The principal amount of outstanding revolving loan, together with accrued and unpaid interest, is due on the maturity date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DebtInstrumentDescription_c20220101__20221231_zrttyBBO5JL4" title="Debt instrument description">The loan accrues interest at a 1.50% margin above the greater of the prime rate or 4.00%. The interest margin is increased to 2.00% in respect to the advances against eligible inventory. If the Company fails to perform any covenant, term or provision of the Loan Agreement, then interest shall accrue at the rate of 6.0% above the interest rate. If after the occurrence of an event of default and the loan is not paid in full by the maturity date, the loan shall bear interest at the rate of 18.0% above the interest rate.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations under the Loan Agreement are secured by all of the Company’s assets. On the effective date the Company paid a loan fee of <span id="xdx_906_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_ztUj15k4Xsck" title="Loan fee percentage">2</span>% of the amount of the Loan Facility and will be required to pay a loan fee of <span id="xdx_908_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zK0bOQHes4Nk" title="Loan fee percentage">1.5</span>% of the amount of the Loan Facility annually thereafter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Loan Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and the Subsidiaries, including, without limitation, restrictions on liens, indebtedness, fundamental changes, capital expenditures, consignments of inventory and distributions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Loan Agreement contains customary events of default, including, without limitation, payment defaults, covenant defaults, breaches of certain representations and warranties, certain events of bankruptcy and insolvency, certain events under ERISA and judgments. If an event of default occurs and is not cured within any applicable grace period or is not waived, the Lender is entitled to take various actions, including, without limitation, the acceleration of amounts due thereunder and termination of commitments under the Loan Facility.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no borrowings outstanding under the Loan Facility as of December 31, 2022.</span></p> 157500 30000 7500 157500 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zA4uKRaIztO3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE - Minimum obligations under this loan agreement (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span id="xdx_8BB_z6zeN2Jw2FXb" style="display: none">Schedule of minimum obligations under loan agreement</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20221231_zPbgKO45loQg" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; text-align: left">For the year ending December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; width: 44%; text-align: left">2023</td><td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">127,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left">2024</td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">30,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); vertical-align: top; text-align: left">Total </td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">157,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 127500 30000 157500 0.08 2807500 2462500 345000 2024-04-07 0.18 <table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfNotePayableNetOfDiscountTableTextBlock_zTlznwijYDHb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE - net of discount (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B4_zkTpBNBILAP4" style="display: none">Schedule of note payable net of discount</span></td><td> </td> <td style="text-align: center"> </td><td id="xdx_492_20221231_zlz63TWoDLT4" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="vertical-align: bottom; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td></tr> <tr id="xdx_402_eus-gaap--DebtInstrumentFaceAmount_iI_z37nDc6IAH4e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Principle outstanding</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">2,807,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_z0Jm9vsoT7wj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(345,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--OtherNotesPayable_iI_pp0p0_z6WTqP43kb28" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,462,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_iI_zG71XwBkC86i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization of debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">77,600</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--StreetervilleNoteNetOfRelatedDiscount_iI_zEzFaROXqP2l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Streeterville note, net of related discount</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,540,100</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2807500 345000 2462500 77600 2540100 <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfMaturityOfLongTermDebtTableTextBlock_zbxhwPPyyMz5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE - Minimum obligations (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span id="xdx_8B0_zSRfudMdhghl" style="display: none">Schedule of minimum obligations</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20221231_zmbol0wKDp34" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left">For the years sending December 31,</td><td> </td> <td colspan="3"> </td></tr> <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_hus-gaap--ShortTermDebtTypeAxis__custom--StreetervilleNoteMember_z8gCbHP7B2rd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 44%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">2,072,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_hus-gaap--ShortTermDebtTypeAxis__custom--StreetervilleNoteMember_zxLXkyg4bd1c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">2024</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">735,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LongTermDebt_iI_pp0p0_hus-gaap--ShortTermDebtTypeAxis__custom--StreetervilleNoteMember_zuMDgBSMzfr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); text-align: left">Total </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,807,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2072500 735000 2807500 0.875 8333 50000 345000 0.2223 77600 267400 53031 318833 41730 0.0505 27710 166262 5000000 The loan is subject to a maximum advance rate of up to 85% of net face amount of eligible accounts, plus the lessor a) of the sum of 20% of the aggregate eligible inventory value of raw materials and 35% of the aggregate eligible inventory value of finished goods, b) $1 million, c) 80% of the net orderly liquidation value of raw materials and finished goods, or d) 100% of the aggregate outstanding principal amount of advances. In no event shall the aggregate amount of the outstanding advances under the Loan Facility be greater than $5 million. The loan matures on December 9, 2024. The loan accrues interest at a 1.50% margin above the greater of the prime rate or 4.00%. The interest margin is increased to 2.00% in respect to the advances against eligible inventory. If the Company fails to perform any covenant, term or provision of the Loan Agreement, then interest shall accrue at the rate of 6.0% above the interest rate. If after the occurrence of an event of default and the loan is not paid in full by the maturity date, the loan shall bear interest at the rate of 18.0% above the interest rate. 0.02 0.015 <p id="xdx_80B_eus-gaap--FairValueDisclosuresTextBlock_zo9nUgXoAal" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_825_z7cGtkPNbS24">FAIR VALUE MEASUREMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting guidance on fair value measurements requires that financial assets and liabilities be classified and disclosed in one of the following categories of the fair value hierarchy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 1</i> – Based on unadjusted quoted prices for identical assets or liabilities in an active market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 2 </i>– Based on observable market-based inputs or unobservable inputs that are corroborated by market data.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Leve</i>l 3– Based on unobservable inputs that reflect the entity’s own assumptions about the assumptions that a market participant would use in pricing the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We did not have any transfers between levels during the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents assets and liabilities that were measured at fair value in the Consolidated Balance Sheets on a recurring basis as of December 31, 2022 and 2021:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zPemN0Vn9EI1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span id="xdx_8B1_zoGnbvJ6Mfyb" style="display: none">Fair Value, Assets Measured on Recurring Basis</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Carrying Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Quoted Priced active markets (Level 1)</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Significant other observable inputs (Level 2)</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Significant unobservable inputs (Level 3)</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="19" style="border-bottom: Black 1pt solid; text-align: center">As of December 31, 2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets</td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 35%; text-align: left; padding-bottom: 1pt">Money market funds</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--MoneyMarketFunds_c20221231_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">26,828</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--MoneyMarketFunds_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">26,828</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--MoneyMarketFunds_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">26,828</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--MoneyMarketFunds_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9OMpKe0HCR4" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">—  </td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--MoneyMarketFunds_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZIDyx0uwd4a" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">—  </td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherAssets_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">26,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--OtherAssets_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">26,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OtherAssets_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">26,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherAssets_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwzXkaKZtAr" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--OtherAssets_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbQKz6j0zZwk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Contingent consideration</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231_z43MYmtYJgDd" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zyctmDGsjZ8" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z7W4AqDBRv51" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZ0YZysFogmc" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrDRLdgo648h" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--WarrantLiability_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">9,987</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--WarrantLiability_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">9,987</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--WarrantLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdCyvli2fFC1" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--WarrantLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zR5jzNLXZJei" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--WarrantLiability_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">9,987</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherLiabilities_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">9,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilities_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">9,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OtherLiabilities_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zCm2ApfcX4xi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherLiabilities_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zsEhB381oSc8" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilities_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">9,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.05in"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td colspan="18" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Money market funds</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_ecustom--MoneyMarketFunds_iI_pp0p0_c20211231_zl9m9nOj1UA" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">1,076,664</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_ecustom--MoneyMarketFunds_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_z4FcO0tDEEE" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">1,076,664</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_ecustom--MoneyMarketFunds_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgkcYMzDCuf1" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">1,076,664</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_ecustom--MoneyMarketFunds_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlsIdrGKPjX3" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_ecustom--MoneyMarketFunds_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zk4oMtgu0Gg2" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherAssets_iI_pp0p0_c20211231_zS0jB1qsbLoe" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">1,076,664</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherAssets_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zkpHZA9vkDri" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">1,076,664</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherAssets_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ziDbQpmnCfoj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">1,076,664</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--OtherAssets_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zn2MIHOYtAcg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherAssets_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z39W6IhoWQI9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Contingent consideration</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_c20211231_zlEqh5TlJWW4" style="text-align: right" title="Contingent consideration">1,460,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zYFAjBuo6Yqk" style="text-align: right" title="Contingent consideration">1,460,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zBUmjuRNzTs7" style="text-align: right" title="Contingent consideration">1,460,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKZCISBihX48" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zht5hxuvwMUd" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--WarrantLiability_iI_pp0p0_c20211231_zZn2nhvC7tx2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">68,263</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--WarrantLiability_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zof11SwQgRh2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">68,263</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--WarrantLiability_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJmnjlKqenq5" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability"><span style="-sec-ix-hidden: xdx2ixbrl1368">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--WarrantLiability_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdM4F80K9xO6" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--WarrantLiability_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeIdLdwF5m6e" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">68,263</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherLiabilities_iI_pp0p0_c20211231_zpiXp8dDRhbl" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">1,528,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilities_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zxwzvKBTLWLj" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">1,528,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OtherLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuRzza19VFWd" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">1,460,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OtherLiabilities_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zK5VyAlcfvQ" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8L21zez26Tl" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">68,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of accounts receivable, accounts payable and short-term debt approximated fair values as of December 31, 2022 and 2021 because of the relatively short maturity of these instruments. There were no other level 3 or level 1 assets or liabilities as if December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Money market funds – Cash equivalents of $<span id="xdx_900_ecustom--MoneyMarketFunds_iI_c20221231_zMDfzpSCkjnc" title="Money market funds">26,828</span> and $<span id="xdx_906_ecustom--MoneyMarketFunds_iI_c20211231_znTf5DCbPlZe" title="Money market funds">1,076,664</span> as of December 31, 2022 and 2021, respectively, consisted of money market funds. Money market funds are classified as Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent consideration – The fair value of the contingent consideration is derived through the quoted market price of our stock, which represents a Level 1 measurement within the fair value hierarchy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant liability – The fair value of the warrant liability is derived through the Black scholes method and is based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Fair Value Measurements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to assets and liabilities that are recorded at fair value on a recurring basis, GAAP requires that, under certain circumstances, we also record assets and liabilities at fair value on a nonrecurring basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the acquisitions of SciAir, KES, and Akida during 2021, and VisionMark in 2022, as discussed in Note 2, we used various valuation techniques to determine fair value, with the primary techniques being discounted cash flow analysis and the relief-from-royalty, a form of the multi-period excess earnings, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zPemN0Vn9EI1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span id="xdx_8B1_zoGnbvJ6Mfyb" style="display: none">Fair Value, Assets Measured on Recurring Basis</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Carrying Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Quoted Priced active markets (Level 1)</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Significant other observable inputs (Level 2)</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Significant unobservable inputs (Level 3)</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="19" style="border-bottom: Black 1pt solid; text-align: center">As of December 31, 2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets</td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 35%; text-align: left; padding-bottom: 1pt">Money market funds</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--MoneyMarketFunds_c20221231_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">26,828</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--MoneyMarketFunds_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">26,828</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--MoneyMarketFunds_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">26,828</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--MoneyMarketFunds_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9OMpKe0HCR4" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">—  </td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--MoneyMarketFunds_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZIDyx0uwd4a" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Money market funds">—  </td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherAssets_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">26,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--OtherAssets_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">26,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OtherAssets_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">26,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherAssets_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwzXkaKZtAr" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--OtherAssets_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbQKz6j0zZwk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Contingent consideration</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231_z43MYmtYJgDd" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zyctmDGsjZ8" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z7W4AqDBRv51" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZ0YZysFogmc" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrDRLdgo648h" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--WarrantLiability_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">9,987</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--WarrantLiability_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">9,987</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--WarrantLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdCyvli2fFC1" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--WarrantLiability_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zR5jzNLXZJei" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--WarrantLiability_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">9,987</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherLiabilities_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">9,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilities_c20221231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">9,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OtherLiabilities_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zCm2ApfcX4xi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherLiabilities_iI_pp0p0_d0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zsEhB381oSc8" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilities_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">9,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.05in"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td colspan="18" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Money market funds</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_ecustom--MoneyMarketFunds_iI_pp0p0_c20211231_zl9m9nOj1UA" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">1,076,664</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_ecustom--MoneyMarketFunds_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_z4FcO0tDEEE" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">1,076,664</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_ecustom--MoneyMarketFunds_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgkcYMzDCuf1" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">1,076,664</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_ecustom--MoneyMarketFunds_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlsIdrGKPjX3" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_ecustom--MoneyMarketFunds_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zk4oMtgu0Gg2" style="border-bottom: Black 1pt solid; text-align: right" title="Money market funds">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherAssets_iI_pp0p0_c20211231_zS0jB1qsbLoe" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">1,076,664</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherAssets_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zkpHZA9vkDri" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">1,076,664</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherAssets_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ziDbQpmnCfoj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">1,076,664</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--OtherAssets_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zn2MIHOYtAcg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherAssets_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z39W6IhoWQI9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Contingent consideration</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_c20211231_zlEqh5TlJWW4" style="text-align: right" title="Contingent consideration">1,460,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zYFAjBuo6Yqk" style="text-align: right" title="Contingent consideration">1,460,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zBUmjuRNzTs7" style="text-align: right" title="Contingent consideration">1,460,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKZCISBihX48" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zht5hxuvwMUd" style="text-align: right" title="Contingent consideration">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--WarrantLiability_iI_pp0p0_c20211231_zZn2nhvC7tx2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">68,263</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--WarrantLiability_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zof11SwQgRh2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">68,263</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--WarrantLiability_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJmnjlKqenq5" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability"><span style="-sec-ix-hidden: xdx2ixbrl1368">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--WarrantLiability_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdM4F80K9xO6" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--WarrantLiability_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeIdLdwF5m6e" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liability">68,263</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherLiabilities_iI_pp0p0_c20211231_zpiXp8dDRhbl" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">1,528,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilities_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--FairValueMember_zxwzvKBTLWLj" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">1,528,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OtherLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuRzza19VFWd" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">1,460,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OtherLiabilities_iI_pp0p0_d0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zK5VyAlcfvQ" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--OtherLiabilities_iI_pp0p0_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8L21zez26Tl" style="border-bottom: Black 2.5pt double; text-align: right" title="Other liablities">68,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 26828 26828 26828 0 0 26828 26828 26828 0 0 0 0 0 0 0 9987 9987 0 0 9987 9987 9987 0 0 9987 1076664 1076664 1076664 0 0 1076664 1076664 1076664 0 0 1460000 1460000 1460000 0 0 68263 68263 0 68263 1528263 1528263 1460000 0 68263 26828 1076664 <p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z5bVg8HZDme" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_82A_ziym7Uio50o4">STOCKHOLDERS’ EQUITY</span></b><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">At the Market Sales Agreement</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2022, the Company filed a $<span id="xdx_90D_eus-gaap--StockholdersEquityAverageAmountOutstanding_c20220628__20220702__us-gaap--TransactionTypeAxis__custom--AtTheMarketSalesAgreementMember_zbrpFOq3VPj3" title="Stock holders equity">50,000,000</span> mixed use shelf registration (Form S-3) and entered into an At The Market sales agreement (ATM) with Maxim Group, LLC, for a total of $<span id="xdx_90E_eus-gaap--StockholdersEquityAverageAmountOutstanding_c20220628__20220702__us-gaap--TransactionTypeAxis__custom--MaximGroupLLCMember_zaxs2PEDWWfi" title="Stock holders equity">9,000,000</span>, as a readily available source of funding if needed. During the year ended December 31, 2022 the Company sold <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231__us-gaap--TransactionTypeAxis__custom--AtTheMarketSalesAgreementMember_zJsbzVFX4vn2" title="Sale of stock">804,811</span> ATM shares through the sales agent with gross proceeds of $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220101__20221231__us-gaap--TransactionTypeAxis__custom--AtTheMarketSalesAgreementMember_zPua9a9f0cX" title="Proceeds from sale of stock">964,083</span>. In connection with the sale of these ATM Shares, the compensation paid by the Company to the Sales Agent was $<span id="xdx_902_ecustom--CompensationPaid_c20220628__20220702_zLZGjsmHr7l2" title="Compensation paid">28,922</span>. As of March 31, 2023, an additional <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230301__20230331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3lcmJepFknf" title="Sale of stock">1,764,311</span> shares have been sold for gross proceeds of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230301__20230331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxdfpF2mrBI2" title="Proceeds from sale of stock">2,314,860</span>, leaving a balance of $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230301__20230331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zD2qp8w8FZQb" title="Balance of shares sold">5,721,057</span> on the ATM facility. The shelf registration statement will expire on <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220628__20220702_z3HjOPelqMb8" title="Expiration date">July 12, 2025</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Amendment of the Certificate of Designation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 17, 2021, the Company filed an amendment of the certificate of designation of Series A Preferred Stock. The Board of Directors, by unanimous written consent, duly adopted resolutions to amend the Series A Preferred Stock Certificate of Designations and changed the name from “Series A Preferred Stock” to “Series X Super Voting Preferred Stock”. All dividend, liquidation preference, voting, conversion, and redemption rights, did not change from the originally filed Certificate of Designation of Series A Preferred Stock. On July 11, 2022, the Board of Directors approved the reissuance of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesTreasuryStockReissued_c20220701__20220711__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zzNNxPifaYe1" title="Treasury stock reissued">8,000</span> shares of the Company’s Series X Super Voting Preferred Shares, which represent the remainder of the designated but unissued shares of Super Voting Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 9, 2022, the Board of Directors approved a resolution that authorized the senior management of the Company to purchase up to and limited to one million shares of common stock between March 10, 2022 and September 30, 2022. As of December 31, 2022, the Company has a total <span id="xdx_90F_eus-gaap--TreasuryStockSharesAcquired_c20220101__20221231_z3UR9r7IlLGh" title="Treasury stock, shares">113,485</span> of treasury shares, all of which have been purchased as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Company’s amended and restated certificate of incorporation, as amended, the Company is authorized to designate and issue up to <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zNW9YzTMrAlj" title="Preferred Stock, Shares Authorized">20,000,000</span> shares of preferred stock, par value $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zW8K1jXYcthc" title="Preferred Stock, Par or Stated Value Per Share">0.0001</span> per share, in one or more classes or series. During the year ended December 31, 2022, the Company had <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--SeriesXPreferredStockMember_zpEJlx8zYXX6" title="Preferred Stock, Shares Authorized">10,000</span> preferred shares designated as Series X Preferred Stock and <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zzUajKhsl8B" title="Preferred Stock, Shares Authorized">19,990,000</span> shares of preferred stock designated as 10.5% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). Upon certain events, the Company may, subject to certain conditions, at the Company’s option, redeem the Series A Preferred Stock. See below for a further description of the Series A Preferred Stock:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends: </i></b>Holders are entitled to receive cumulative cash dividends at the annual rate of 10.5% on $25.00 liquidation preference per share of the Series A Perpetual Preferred Stock. Dividends accrue and are payable in arrears beginning August 15, 2021, regardless of whether declared or there are sufficient earnings or funds available for payment. Sufficient net proceeds from the offering must be set aside to pay dividends for the first twelve months from issuance. The company has classified $<span id="xdx_908_eus-gaap--RestrictedCash_c20221231_pp0p0" title="Restricted cash">0</span> and $<span id="xdx_90F_eus-gaap--RestrictedCash_c20211231_pp0p0" title="Restricted cash">845,250</span> as restricted cash as of December 31, 2022 and 2021, respectively, as a reserve to pay the remaining required dividends for the first year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Redemption: </i></b>Company has an optional redemption right beginning July 16, 2022, which redemption price declines annually. The initial redemption price after year 1 is $30 and decreases annually over 5 years to $25 per share. The Company also has a special optional redemption right upon the occurrence of a Delisting Event or Change of Control, as defined, at $25 per share plus accrued and unpaid dividends.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting Rights:</i></b> The holders have no voting rights, except for voting on certain corporate decisions, or upon default in payment of dividends for any twelve periods, in which case the holders would have voting rights to elect two additional directors to serve on the Board of Directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conversion Rights</i></b>: Such shares are not convertible unless and until the occurrence of a Delisting Event or Change of Control and when the Company has not exercised its special optional redemption right. The conversion price would be the lesser of the amount converted based on the $25.00 liquidation preference plus accrued dividends divided by the common stock price of the Delisting Event or Change of Control (as defined) or $5.353319 (Share Cap). Effectively, the Share Cap limits the common stock price to no lower than $4.67.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">2020 Incentive Plan</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2020, the Company adopted the Applied UV, Inc. 2020 Omnibus Incentive Plan (the “Plan”) with <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200301__20200331__us-gaap--PlanNameAxis__custom--IncentivePlan2020Member_pdd" title="Number of share issued">600,000</span> shares of common stock available for issuance under the terms of the Plan. On May 17, 2022, the shareholders of the Company approved an amendment to the Plan, increasing the shares available for issuance to 2,500,000. The Plan permits the granting of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units and Other Awards. The objectives of the Plan are to optimize the profitability and growth of the Company through incentives that are consistent with the Company’s goals and that link the personal interests of Participants to those of the Company’s stockholders. The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract and retain the services of Participants who make or are expected to make significant contributions to the Company’s success and to allow Participants to share in the success of the Company. From time to time, the Company may issue Incentive Awards pursuant to the Plan. Each of the awards will be evidenced by and issued under a written agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If an incentive award granted under the Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered to the company in connection with an incentive award, the shares subject to such award and the surrendered shares will become available for future awards under the Plan. The number of shares subject to the Plan, and the number of shares and terms of any Incentive Award may be adjusted in the event of any change in our outstanding common stock by reason of any stock dividend, spin-off, stock split, reverse stock split, recapitalization, reclassification, merger, consolidation, liquidation, business combination or exchange of shares, or similar transaction. There are <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20221231__us-gaap--PlanNameAxis__custom--IncentivePlan2020Member_pdd" title="Number of shares available for grant">1,605,000</span> shares available for future grants under the plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s option activity and related information follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zXOCVTXHxLVg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt"><span id="xdx_8BF_zthO8TAETYy2" style="display: none">Schedule of the Company's option activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Number of Options</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Remaining Contractual Life (in years)</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Aggregate intrinsic value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: justify">Balances, January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkoZPiWrgnP1" style="width: 9%; text-align: right" title="Number of Option Outstanding, beginning">136,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zwEIAYOqs5p2" style="width: 9%; text-align: right" title="Weighted average exercise price, beginning">4.96</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zUzyH26jKFjb" style="width: 9%; text-align: right" title="Weighted average grant date fair value, beginning">2.27</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znSMzRo77Wgk" title="Weighted average remaining contractual life in years">9.95</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOptionsGrantedAvailableForGrant1_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Options granted">602,564</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, granted">7.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue1_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average grant date fair value, granted">5.43</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsgrantedWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zhF0rtf5Clij" title="Weighted average remaining contractual life, granted">10.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Options forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedAvailableForGrant_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Options forfeited/cancelled">(95,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, forfeited">4.96</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average grant date fair value, forfeited">3.73</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Options exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExerciseAvailableForGrant_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zQxffOUhvwyk" style="border-bottom: Black 1pt solid; text-align: right" title="Option exercised">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zRImHSS86MV7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, exercised">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balances, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5L4Uo0pQVPc" style="text-align: right" title="Number of Option Outstanding, beginning">644,314</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zirivfOKHib5" style="text-align: right" title="Weighted average exercise price, beginning">7.11</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zw34TuFpaFj9" style="text-align: right" title="Weighted average grant date fair value, beginning">5.03</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGzzRbp4aK5b" title="Weighted average remaining contractual life in years">8.47</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOptionsGrantedAvailableForGrant1_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Options granted">639,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, granted">1.66</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue1_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average grant date fair value, granted">1.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsgrantedWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zQypGcCoct2j" title="Weighted average remaining contractual life, granted">10.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Options forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedAvailableForGrant_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Options forfeited/cancelled">(283,286</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, forfeited">7.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average grant date fair value, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1482">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Options exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExerciseAvailableForGrant_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zeiLeXwBzNm7" style="border-bottom: Black 1pt solid; text-align: right" title="Option exercised">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zJsmWesmzr64" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, exercised">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Balances, December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHQO1ORkRAGc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Option Outstanding, ending">1,000,028</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zN4zfZYGP4r2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending">3.61</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zAUIiTNeIwq7" title="Weighted average remaining contractual life in years">9.03</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">Vested</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--VestedAndExercisables_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zlfluscNsF1b" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable">320,109</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--VestedAndExerciables_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zMUY5kBLnp42" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable">5.69</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_z6SZPIeRGPRk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation expense for options totaling $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--AwardTypeAxis__custom--OptionsMember_pp0p0" title="Share-Based Payment Arrangement, Expense">567,194</span> and $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20211231__us-gaap--AwardTypeAxis__custom--OptionsMember_z5scjDxMuOGc" title="Share-Based Payment Arrangement, Expense">721,783</span> was recognized for the years ended December 31, 2022 and 2021, respectively, based on requisite service periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation methodology used to determine the fair value of the options issued during the year was the Black-Scholes option-pricing model. The Black-Scholes model requires the use of a number of assumptions including volatility of the stock price, the average risk-free interest rate, and the weighted average expected life of the options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of the award. The Company’s calculation of estimated volatility is based on historical stock prices of peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 there was $<span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zG1XmUUFns11" title="Unrecognized compensation expenses">1,090,364</span> of total unrecognized compensation expense related to unvested employee options granted under the Company’s share-based compensation plans that is expected to be recognized over a weighted average period of approximately 2.19 years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average fair value of options granted, and the assumptions used in the Black-Scholes model during the years ended December 31, 2022 and 2021 are set forth in the table below.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zW4Fd8u0Ecf5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B1_zpYs2XBIDMt" style="display: none">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</span> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock Price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_900_eus-gaap--SharePrice_iI_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zwCCq7to9dDl" title="Stock Price">0.90</span> - $<span id="xdx_900_eus-gaap--SharePrice_iI_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ztVq0Ynxldpg" title="Stock Price">2.70</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_eus-gaap--SharePrice_iI_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPioJgEba4Qi" title="Stock Price">4.16</span> - $<span id="xdx_905_eus-gaap--SharePrice_iI_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zy3x0wkTeP4c" title="Stock Price">9.79</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercise Price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zqyKN7uNryqh" title="Exercise Price">1.07</span> - $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zYo4kSra31Xg" title="Exercise Price">2.70</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_z9KAyMQp492a" title="Exercise Price">4.16</span> - $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zzSNjdXcpLyh" title="Exercise Price">9.79</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify">Dividend Yield</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--WarrantsMeasurementInput_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__custom--DividendYieldMember_znS6VsTJAOz9" title="Dividend yield">0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_902_ecustom--WarrantsMeasurementInput_c20210101__20211231__us-gaap--MeasurementInputTypeAxis__custom--DividendYieldMember_z4I9mF4Gfry4" title="Dividend yield">0</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--WarrantsMeasurementInput_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zXWz4010aqO7" title="Dividend yield">78.95% - 92.96%</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--WarrantsMeasurementInput_c20210101__20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_ztH6hIDSHAd3" title="Dividend yield">75.04% - 89.96%</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Risk-Free Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--WarrantsMeasurementInput_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zthAw8PfRde7" title="Dividend yield">1.26% - 3.46%</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--WarrantsMeasurementInput_c20210101__20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zYrqWJrnwQOa" title="Dividend yield">1.02% - 1.40%</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected Life (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--WarrantsMeasurementInput_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zjI8s3EFc366" title="Dividend yield">5.31 - 6.08</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--WarrantsMeasurementInput_c20210101__20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zKrap3scWAU7" title="Dividend yield">5.36 - 6.25</span></span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A6_zniNnWgSMUBk" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Common Stock Warrants</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s warrant activity and related information follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zaWiLXj9PJP" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span id="xdx_8B5_zpsuiih7Yx48" style="display: none">Schedule of the Company's warrant activity</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; vertical-align: top"><p style="margin-top: 0; margin-bottom: 0"> </p> <p style="margin-top: 0; margin-bottom: 0"> </p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balances, January 1, 2021</span></td><td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zqjJ5VZigyWb" style="width: 26%; text-align: right" title="Options outstanding at the beginning">235,095</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zODIkZHBAzG5" style="width: 26%; text-align: right" title="Weighted average exercise price, beginning">5.89</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zLTQQY4BCqv1" title="Granted">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z9o8iEYVqc3e" title="Weighted average exercise price, Granted">—</span>  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zVxL1plJcHr4" title="Exercised">(42,676</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z29f6TDiKtRa" title="Weighted average exercise price, Exercised">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balances, December 31, 2021</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z8OltmQnjbai" style="text-align: right" title="Options outstanding at the beginning">192,419</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z7baZamzUIla" style="text-align: right" title="Weighted average exercise price, beginning">5.84</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zESpgjj0Iz53" title="Granted">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zV4OJ563629h" title="Weighted average exercise price, Granted">—</span>  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_d0_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zhtyArB79fM8" title="Exercised">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z0MGpOw7vZta" title="Weighted average exercise price, Exercised">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balances, December 31, 2022</span></td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zFBo8XpcydN6" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding at the ending">192,419</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zWG1v1SC21kl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending">5.84</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zrnkmDxEOGCg" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable">192,419</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zWZiStZcpJm4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price,Vested and Exercisable">5.84</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zAR4eORyHBX9" style="font: 10pt Times New Roman, Times, Serif"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022 and 2021, the Company recorded a gain on the change in fair value of warrant liability in the amount of $<span id="xdx_906_ecustom--GainLossOnChangeInFairValueOfWarrantLiability_pp0p0_c20220101__20221231_z9J2IOuqQKGe" title="Fair value of warrant liability">58,276</span> and $<span id="xdx_909_ecustom--GainLossOnChangeInFairValueOfWarrantLiability_pp0p0_c20210101__20211231_zb9qzjI69yW2" title="Fair value of warrant liability">66,862</span>, respectively. The Company valued the warrant using the Black-Scholes option pricing model with the following terms on December 31, 2022: (a) exercise price of $6.56, (b) volatility rate of 94.55%, (c) risk free rate of 4.22%, (d) term of 2.86 years, and (e) dividend rate of 0%. The Company valued the warrant using the Black-Scholes option pricing model with the following terms on December 31, 2021: (a) exercise price of $6.56, (b) volatility rate of 82.08%, (c) risk free rate of 0.98%, (d) term of 3.86 years, and (e) dividend rate of 0%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Preferred Stock Offering</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 13, 2021, Applied UV, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Ladenburg Thalmann &amp; Co. Inc. as representative (“Representative”) of the underwriters (“Underwriters”), related to the offering of 480,000 shares (the “Shares”) of the Company’s 10.5% Series A Cumulative Perpetual Preferred Stock [non-convertible], par value $0.0001 per share (“Series A Preferred Stock”), at a public offering price of $25.00 per share, which excludes 72,000 shares of Series A Cumulative Perpetual Preferred Stock that may be purchased by the Underwriters pursuant to their overallotment option granted to the Underwriters under the terms of the Underwriting Agreement. The Shares were offered and sold by the Company pursuant to the terms of the Underwriting Agreement and registered pursuant to the Company’s registration statement on (i) Form S-1 (File No. 333-257197), as amended, which was filed with the SEC and declared effective by the Commission on July 12, 2021 and (ii) the Company’s registration statement on Form S-1 (File No. 333-257862), which was filed with the Commission on July 13, 2021 and declared effective upon filing. The closing of the offering for the Shares took place on July 16, 2021 and were approved for listing on Nasdaq under the trading symbol “AUVIP”. On July 29, 2021, in connection with its offering of its 10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share, the Company closed the exercise of the underwriter’s overallotment option of 72,000 shares at $25.00 per share. Aggregate gross proceeds including the exercise of the underwriter’s overallotment option was $12,272,440 after deducting underwriting discounts and commissions and fees and other offering expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Common Stock Offering</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 28, 2021, the Company closed a common stock offering in which it issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211201__20211228_pdd" title="Number of share issued">2,666,667</span> common shares at a public offering price of $<span id="xdx_900_ecustom--SharePrice1_iI_c20211228_zNlgCf6j6j1d" title="Offering price">3.00</span> per share. In connection with the Offering, the Company (i) received $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20211201__20211228_pp0p0" title="Gross proceeds">8,000,000</span> less underwriting fees of $<span id="xdx_908_ecustom--UnderwritingFees_c20211201__20211228_pp0p0" title="Underwriting fees">560,000</span> and offering Costs in the amount of $<span id="xdx_90A_ecustom--OfferingCost_c20211201__20211228_pp0p0" title="Offering cost">440,073</span>, resulting in net proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20211201__20211228_pp0p0" title="Net proceeds">6,999,928</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 5, 2022, the underwriters fully exercised their over-allotment option to purchase an additional <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Number of share issued">400,000</span> shares of common stock at the public offering price of $<span id="xdx_90B_eus-gaap--SharePrice_c20220105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Offering price">3.00</span> per share. The Company received gross proceeds of $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220101__20220105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Gross proceeds">1,200,000</span> for the over-allotment, which resulted in net proceeds to us of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220101__20220105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Net proceeds">1,092,000</span>, after deducting underwriting discounts and commissions of $<span id="xdx_902_ecustom--UnderwritingDiscount_c20220101__20220105__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Underwriting discount">108,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Restricted Stock Awards</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records compensation expense for restricted stock awards based on the quoted market price of our stock at the grant date and the expense is amortized over the vesting period. These restricted stock awards are subject to time-based vesting conditions based on the continued service of the restricted stock award holder.</span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents the restricted stock units activity for the years ended December 31, 2021 and 2022:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_zRYU5GIKztYj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt"><span id="xdx_8BD_zdphox5tyocj" style="display: none">Schedule of Unvested Restricted Stock Units Activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Fair Market Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify">Unvested shares at January 1, 2021</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zXszI8jzmKxf" style="width: 12%; text-align: right" title="Number of unvested shares outstanding, at beginning">187,555</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zB54ZPG5P2Ch" style="width: 12%; text-align: right" title="Weighted average fair market value outstanding, at beginning">5.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Granted and unvested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z5uFFNLRW6C" style="text-align: right" title="Granted and unvested">274,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zVVH6L7O5bC3" style="text-align: right" title="Weighted average fair market value, granted and unvested">5.16</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zp2EhKqmOf0j" style="text-align: right" title="Vested">(163,176</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zc0XHmM2rHu4" style="text-align: right" title="Weighted average fair market value, vested">5.24</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zcHvGKXIqt1h" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited/Cancelled">(6,379</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBAPZ7K1mfXb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average fair market value, forfeited/Cancelled">5.00</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Unvested shares, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zx3K7quMbu1h" style="text-align: right" title="Number of unvested shares outstanding, at beginning">292,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z2FQYFya2mWa" style="text-align: right" title="Weighted average fair market value outstanding, at beginning">4.71</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Granted and unvested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zzebHcZp59Sf" style="text-align: right" title="Granted and unvested">207,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zd7RLBxJW8Tk" style="text-align: right" title="Weighted average fair market value, granted and unvested">2.10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zp77YNwvGP39" style="text-align: right" title="Vested">(100,966</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zFeAqKAT8lh4" style="text-align: right" title="Weighted average fair market value, vested">3.88</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z08TF9lrcI39" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited/Cancelled">(311,535</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPuOJbWKHU69" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average fair market value, forfeited/Cancelled">4.45</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Unvested shares, December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z6RLGKMtBzf1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of unvested shares outstanding, at ending">87,499</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z6qhDxIogfTc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average fair market value outstanding, at ending">2.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Vested as of December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zUyyTqxL5A53" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested">306,670</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zskSrzXA0hX8" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested">4.76</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zqboiwKjceGg" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon vesting, the restricted stock units are converted to common shares. Based on the terms of the restricted share and restricted stock unit grants, all forfeited shares revert back to the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the grant of restricted shares, the Company recognized $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_pp0p0" title="Share-Based Payment Arrangement, Expense">153,208</span> and $<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zvdPhEfVCPH5" title="Share-Based Payment Arrangement, Expense">550,138</span> of compensation expense within its statements of operations for the years ended December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unvested shares as of December 31, 2022 represent $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_pp0p0" title="Unrecognized stock based compensation">149,438</span> in unrecognized stock based compensation which will be recognized over a weighted average period of 2.10 years.</span></p> 50000000 9000000 804811 964083 28922 1764311 2314860 5721057 2025-07-12 8000 113485 20000000 0.0001 10000 19990000 0 845250 600000 1605000 <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zXOCVTXHxLVg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt"><span id="xdx_8BF_zthO8TAETYy2" style="display: none">Schedule of the Company's option activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Number of Options</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Remaining Contractual Life (in years)</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Aggregate intrinsic value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: justify">Balances, January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkoZPiWrgnP1" style="width: 9%; text-align: right" title="Number of Option Outstanding, beginning">136,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zwEIAYOqs5p2" style="width: 9%; text-align: right" title="Weighted average exercise price, beginning">4.96</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zUzyH26jKFjb" style="width: 9%; text-align: right" title="Weighted average grant date fair value, beginning">2.27</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znSMzRo77Wgk" title="Weighted average remaining contractual life in years">9.95</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOptionsGrantedAvailableForGrant1_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Options granted">602,564</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, granted">7.81</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue1_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average grant date fair value, granted">5.43</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsgrantedWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zhF0rtf5Clij" title="Weighted average remaining contractual life, granted">10.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Options forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedAvailableForGrant_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Options forfeited/cancelled">(95,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, forfeited">4.96</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average grant date fair value, forfeited">3.73</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Options exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExerciseAvailableForGrant_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zQxffOUhvwyk" style="border-bottom: Black 1pt solid; text-align: right" title="Option exercised">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zRImHSS86MV7" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, exercised">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balances, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5L4Uo0pQVPc" style="text-align: right" title="Number of Option Outstanding, beginning">644,314</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zirivfOKHib5" style="text-align: right" title="Weighted average exercise price, beginning">7.11</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zw34TuFpaFj9" style="text-align: right" title="Weighted average grant date fair value, beginning">5.03</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGzzRbp4aK5b" title="Weighted average remaining contractual life in years">8.47</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOptionsGrantedAvailableForGrant1_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Options granted">639,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, granted">1.66</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue1_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average grant date fair value, granted">1.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsgrantedWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zQypGcCoct2j" title="Weighted average remaining contractual life, granted">10.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Options forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedAvailableForGrant_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Options forfeited/cancelled">(283,286</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average exercise price, forfeited">7.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" style="text-align: right" title="Weighted average grant date fair value, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1482">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Options exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExerciseAvailableForGrant_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zeiLeXwBzNm7" style="border-bottom: Black 1pt solid; text-align: right" title="Option exercised">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zJsmWesmzr64" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, exercised">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Balances, December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHQO1ORkRAGc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Option Outstanding, ending">1,000,028</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zN4zfZYGP4r2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending">3.61</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zAUIiTNeIwq7" title="Weighted average remaining contractual life in years">9.03</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">Vested</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--VestedAndExercisables_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zlfluscNsF1b" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable">320,109</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--VestedAndExerciables_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zMUY5kBLnp42" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable">5.69</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 136750 4.96 2.27 P9Y11M12D 602564 7.81 5.43 P10Y -95000 4.96 3.73 0 0 644314 7.11 5.03 P8Y5M19D 639000 1.66 1.06 P10Y -283286 7.02 0 0 1000028 3.61 P9Y10D 320109 5.69 567194 721783 1090364 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zW4Fd8u0Ecf5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B1_zpYs2XBIDMt" style="display: none">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</span> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock Price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_900_eus-gaap--SharePrice_iI_c20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zwCCq7to9dDl" title="Stock Price">0.90</span> - $<span id="xdx_900_eus-gaap--SharePrice_iI_c20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ztVq0Ynxldpg" title="Stock Price">2.70</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_eus-gaap--SharePrice_iI_c20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zPioJgEba4Qi" title="Stock Price">4.16</span> - $<span id="xdx_905_eus-gaap--SharePrice_iI_c20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zy3x0wkTeP4c" title="Stock Price">9.79</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercise Price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zqyKN7uNryqh" title="Exercise Price">1.07</span> - $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zYo4kSra31Xg" title="Exercise Price">2.70</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_z9KAyMQp492a" title="Exercise Price">4.16</span> - $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zzSNjdXcpLyh" title="Exercise Price">9.79</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify">Dividend Yield</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--WarrantsMeasurementInput_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__custom--DividendYieldMember_znS6VsTJAOz9" title="Dividend yield">0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_902_ecustom--WarrantsMeasurementInput_c20210101__20211231__us-gaap--MeasurementInputTypeAxis__custom--DividendYieldMember_z4I9mF4Gfry4" title="Dividend yield">0</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--WarrantsMeasurementInput_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zXWz4010aqO7" title="Dividend yield">78.95% - 92.96%</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--WarrantsMeasurementInput_c20210101__20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_ztH6hIDSHAd3" title="Dividend yield">75.04% - 89.96%</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Risk-Free Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--WarrantsMeasurementInput_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zthAw8PfRde7" title="Dividend yield">1.26% - 3.46%</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--WarrantsMeasurementInput_c20210101__20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zYrqWJrnwQOa" title="Dividend yield">1.02% - 1.40%</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected Life (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--WarrantsMeasurementInput_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zjI8s3EFc366" title="Dividend yield">5.31 - 6.08</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--WarrantsMeasurementInput_c20210101__20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zKrap3scWAU7" title="Dividend yield">5.36 - 6.25</span></span></td><td style="text-align: left"> </td></tr> </table> 0.90 2.70 4.16 9.79 1.07 2.70 4.16 9.79 0 0 78.95% - 92.96% 75.04% - 89.96% 1.26% - 3.46% 1.02% - 1.40% 5.31 - 6.08 5.36 - 6.25 <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zaWiLXj9PJP" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span id="xdx_8B5_zpsuiih7Yx48" style="display: none">Schedule of the Company's warrant activity</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; vertical-align: top"><p style="margin-top: 0; margin-bottom: 0"> </p> <p style="margin-top: 0; margin-bottom: 0"> </p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balances, January 1, 2021</span></td><td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zqjJ5VZigyWb" style="width: 26%; text-align: right" title="Options outstanding at the beginning">235,095</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zODIkZHBAzG5" style="width: 26%; text-align: right" title="Weighted average exercise price, beginning">5.89</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zLTQQY4BCqv1" title="Granted">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z9o8iEYVqc3e" title="Weighted average exercise price, Granted">—</span>  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zVxL1plJcHr4" title="Exercised">(42,676</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z29f6TDiKtRa" title="Weighted average exercise price, Exercised">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balances, December 31, 2021</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z8OltmQnjbai" style="text-align: right" title="Options outstanding at the beginning">192,419</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z7baZamzUIla" style="text-align: right" title="Weighted average exercise price, beginning">5.84</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="vertical-align: top; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zESpgjj0Iz53" title="Granted">—</span>  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zV4OJ563629h" title="Weighted average exercise price, Granted">—</span>  </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="vertical-align: top; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_d0_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zhtyArB79fM8" title="Exercised">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_z0MGpOw7vZta" title="Weighted average exercise price, Exercised">—</span>  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balances, December 31, 2022</span></td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zFBo8XpcydN6" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding at the ending">192,419</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zWG1v1SC21kl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending">5.84</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="vertical-align: top; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zrnkmDxEOGCg" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable">192,419</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zWZiStZcpJm4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price,Vested and Exercisable">5.84</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 235095 5.89 0 0 42676 0 192419 5.84 0 0 0 0 192419 5.84 192419 5.84 58276 66862 2666667 3.00 8000000 560000 440073 6999928 400000 3.00 1200000 1092000 108000 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_zRYU5GIKztYj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt"><span id="xdx_8BD_zdphox5tyocj" style="display: none">Schedule of Unvested Restricted Stock Units Activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Fair Market Value</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify">Unvested shares at January 1, 2021</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zXszI8jzmKxf" style="width: 12%; text-align: right" title="Number of unvested shares outstanding, at beginning">187,555</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zB54ZPG5P2Ch" style="width: 12%; text-align: right" title="Weighted average fair market value outstanding, at beginning">5.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Granted and unvested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z5uFFNLRW6C" style="text-align: right" title="Granted and unvested">274,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zVVH6L7O5bC3" style="text-align: right" title="Weighted average fair market value, granted and unvested">5.16</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zp2EhKqmOf0j" style="text-align: right" title="Vested">(163,176</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zc0XHmM2rHu4" style="text-align: right" title="Weighted average fair market value, vested">5.24</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zcHvGKXIqt1h" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited/Cancelled">(6,379</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBAPZ7K1mfXb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average fair market value, forfeited/Cancelled">5.00</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Unvested shares, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zx3K7quMbu1h" style="text-align: right" title="Number of unvested shares outstanding, at beginning">292,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z2FQYFya2mWa" style="text-align: right" title="Weighted average fair market value outstanding, at beginning">4.71</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Granted and unvested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zzebHcZp59Sf" style="text-align: right" title="Granted and unvested">207,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zd7RLBxJW8Tk" style="text-align: right" title="Weighted average fair market value, granted and unvested">2.10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zp77YNwvGP39" style="text-align: right" title="Vested">(100,966</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zFeAqKAT8lh4" style="text-align: right" title="Weighted average fair market value, vested">3.88</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 10pt">Forfeited/Cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z08TF9lrcI39" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited/Cancelled">(311,535</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPuOJbWKHU69" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average fair market value, forfeited/Cancelled">4.45</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Unvested shares, December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z6RLGKMtBzf1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of unvested shares outstanding, at ending">87,499</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z6qhDxIogfTc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average fair market value outstanding, at ending">2.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Vested as of December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zUyyTqxL5A53" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested">306,670</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zskSrzXA0hX8" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested">4.76</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 187555 5.00 274500 5.16 163176 5.24 6379 5.00 292500 4.71 207500 2.10 100966 3.88 311535 4.45 87499 2.38 306670 4.76 153208 550138 149438 <p id="xdx_801_eus-gaap--LesseeOperatingLeasesTextBlock_zOTuCEZeFdJ5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 - <span id="xdx_829_zofvBmJ1Sc4j">LEASING ARRANGEMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines whether an arrangement qualifies as a lease under ASC 842 at inception. The Company has operating leases for office space and office equipment. The Company’s leases have remaining lease terms of one year to seven years, some of which include options to extend the lease term for up to five years. The Company considered these options to extend in determining the lease term used to establish the Company’s right-of use assets and lease liabilities once reasonably certain of exercise. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the lease term. The operating lease ROU asset also includes any lease payments made in advance of lease commencement and excludes lease incentives. The lease terms used in the calculations of the operating ROU assets and operating lease liabilities include options to extend or terminate the lease when the Company is reasonably certain that it will exercise those options. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate of <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20221231_zgrflypmQEnf" title="Operating Lease, Weighted Average Discount Rate, Percent">7.6</span>% based on the information available at commencement date in determining the present value of lease payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Munnworks, LLC entered into a lease agreement in Mount Vernon, New York for a term that commenced on April 1, 2019 and will expire on the 31st day of March 2024 at a monthly rate of $13,400. In March of 2021, the Company obtained additional lease space and the agreement was amended to increase rent expense to $15,000 per month. On July 1, 2021, the Company again obtained additional lease space and rent expense was increased to $27,500 per month through July 1, 2024 and $29,150 per month from July 1, 2024 through July 1, 2026.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2021, the Company entered into a lease agreement in Kennesaw, Georgia for office and production space for a term that commenced on September 29, 2021 and will expire on October 1, 2024, with a rate ranging from $14,729 to $15,626 per month.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 1, 2022, the Company entered into a lease agreement in Brooklyn, New York for office and production space that commenced on April 1, 2022 and will expire on June 1, 2023, with a rate ranging from $94,529 to $97,365 per month. On December 31, 2022, the Company exercised its option to renew the first renewal term, commencing on July 1, 2023 and ending on June 30, 2025. As a result of the extension of the lease, the Company recorded an additional $2,146,785 of ROU asset and liability on the balance sheet on December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_90B_eus-gaap--OperatingLeasesRentExpenseNet_c20220101__20221231_pp0p0" title="Rent expense">1,375,848</span> and $<span id="xdx_905_eus-gaap--OperatingLeasesRentExpenseNet_c20210101__20211231_pp0p0" title="Rent expense">249,100</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule maturities of operating lease liabilities outstanding as of December 31, 2022 are as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zsZfsm0GWe6h" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASING ARRANGEMENTS - Maturities of Operating lease laibilities (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span id="xdx_8B8_zNkZJgrOZUgh" style="display: none">Schedule of maturities of operating lease liabilities</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20221231_zeHAUIix37Dh" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzXEV_zDf02cn5Is19" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 44%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">1,699,318</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzXEV_zzqbXBy3qDj6" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,702,014</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzXEV_zTjfjGs8Tla9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">969,567</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzXEV_zKBZZlMO9p92" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left">2026</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">174,900</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzXEV_zARi2UcEug41" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,545,799</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zpjhCeloTEr" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Imputed Interest</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(453,388</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of future minimum lease payments</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,092,411</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consistent with ASC 842-20-50-4, the Company calculated its total lease cost based solely on its monthly rent obligation. The Company had no cash flows arising from its lease, no finance lease cost, short term lease cost, or variable lease costs. The Company’s lease does not produce any sublease income, or any net gain or loss recognized from sale and leaseback transactions. As a result, the Company did not need to segregate amounts between finance and operating leases for cash paid for amounts included in the measurement of lease liabilities, segregated between operating and financing cash flows; supplemental non-cash information on lease liabilities arising from obtaining right-of-use assets; weighted-average calculations for the remaining lease term; or the weighted-average discount rate.</span></p> 0.076 1375848 249100 <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zsZfsm0GWe6h" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASING ARRANGEMENTS - Maturities of Operating lease laibilities (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span id="xdx_8B8_zNkZJgrOZUgh" style="display: none">Schedule of maturities of operating lease liabilities</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20221231_zeHAUIix37Dh" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzXEV_zDf02cn5Is19" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 44%; text-align: left">2023</td><td style="width: 1%; text-align: left"> </td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 43%; text-align: right">1,699,318</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzXEV_zzqbXBy3qDj6" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left">2024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,702,014</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzXEV_zTjfjGs8Tla9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">969,567</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzXEV_zKBZZlMO9p92" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left">2026</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">174,900</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzXEV_zARi2UcEug41" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,545,799</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zpjhCeloTEr" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Imputed Interest</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(453,388</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of future minimum lease payments</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,092,411</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1699318 1702014 969567 174900 4545799 453388 4092411 <p id="xdx_80F_eus-gaap--LongTermDebtTextBlock_zsO38v01g6Fd" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 – <span id="xdx_826_zftX4pGtERR">PAYROLL PROTECTION PROGRAM</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April of 2020, the Company submitted a Paycheck Protection Program (“PPP”) application to Chase Bank for a loan amount equal to $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20200430__us-gaap--DebtInstrumentAxis__custom--PayrollProtectionPlanLoanCaresActMember_pp0p0" title="Face amount">296,827</span>. The amount was approved, and the Company has received the funds. The PPP Loan, which is in the form of a PPP promissory note and agreement, matures in April of 2025 and bears interest at a rate of 1.00% per annum. The Lender will have 90 days to review borrower’s forgiveness application and the SBA will have an additional 60 days to review the Lender’s decision as to whether the borrower’s loan may be forgiven. Under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, covered utilities, and certain covered mortgage interest payments during the twenty-four-week period beginning on the date of first disbursement of the PPP Loan. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee earning more than $<span id="xdx_90F_eus-gaap--AccruedPayrollTaxesCurrent_c20200430__us-gaap--DebtInstrumentAxis__custom--PayrollProtectionPlanLoanCaresActMember_pp0p0" title="Accrued payroll cost">100,000</span>, prorated annually. <span id="xdx_90F_eus-gaap--LongTermDebtDescription_c20200401__20200430__us-gaap--DebtInstrumentAxis__custom--PayrollProtectionPlanLoanCaresActMember" title="Long term debt, Description">Not more than 40% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. The loan was forgiven in July of 2021 and in accordance with ASC 470, the amount was recorded as other income.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the CARES Act, further economic relief was provided through the Employee Retention Tax Credit (ERTC). In the year ended December 31, 2022, the Company recorded non-operating income of $<span id="xdx_908_eus-gaap--OtherNonoperatingIncome_c20220101__20221231_zJViofGAZmGg" title="Non-operating income">205,052</span> related to the ERTC as a component of Other Income.</span></p> 296827 100000 Not more than 40% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. The loan was forgiven in July of 2021 and in accordance with ASC 470, the amount was recorded as other income. 205052 <p id="xdx_809_ecustom--NoteReceivableRelatedPartyDisclosureTextBlock_zuMhqgYJ5evj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 - <span id="xdx_82C_zlP9iLKrWoTi">NOTE RECEIVABLE- RELATED PARTY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company contemplated an acquisition with an entity where certain board members of the Company were also board members of the potential acquiree. In February of 2021, the Company entered into a non-interest bearing note receivable agreement whereby the Company loaned $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20210228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyMember_znSBjwG5TSGk" title="Face amount">500,000</span> to the entity. The note receivable was recorded at cost basis which approximates fair value because of the short-term maturity of the instrument. The loan matures on the earlier of (i) 180 days from the issuance date or (ii) the closing of the transactions set forth in a definitive acquisition entered into between the lender and the borrower. In the event the loan is paid in full on or before the maturity date, there shall be no interest accrued or payable on the outstanding principal amount. If an acquisition occurs, the $<span id="xdx_90C_ecustom--TotalAcquisitionPrice_iI_c20210228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyMember_z6b1wAtkJaq4" title="Acquisition price">500,000</span> will be applied against the total acquisition price. If the company decides not to execute a definitive agreement within 180 days from the issuance date, the maturity date shall be the one-year anniversary of the issuance date. The maturity date has since been extended to November 30, 2021. The acquisition did not occur and the full amount of $<span id="xdx_903_ecustom--NotesReceivableRelatedParty_iI_c20211130_zQXuZNPWnFPc" title="Note receivable, related party">500,000</span> was repaid on November 30, 2021.</span></p> 500000 500000 500000 <p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zzh6wdmXPaM1" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 - <span id="xdx_82E_zp7X7Q5TumAb">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for federal and state income taxes for the years ended is as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zH86zTvGZRS1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Federal and State Income Taxes (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_zsdUwSSB8mSc" style="display: none">Schedule of federal and state income</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20220101__20221231_z2cEexF1mNT1" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101__20211231_zoH6FMIsZEPe" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current provision:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_i01_pp0p0_d0_zCMw5yi6Gcpf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 56%">Federal</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(110,234</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_d0_z9VtaOjCmC0k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,415</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred provision (benefit):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_d0_z6fTVXNtrqjf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Federal</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pp0p0_d0_zr14RzcQyIUd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">State</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_d0_zlmRPMyVST97" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total Deferred</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--TotalProvisionForIncomeTaxes_d0_z6idPXoSF5zh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total provision for income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(91,819</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A1_zYp8o4vDh9N6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realization of future tax benefits related to the deferred tax assets is dependent on many factors, including the Company’s ability to generate taxable income within the net operating loss carryforward period. Management has considered these factors in reaching conclusion as to the valuation allowance for financial reporting purposes and has recorded a full valuation allowance against the deferred tax asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The income tax effect of temporary differences comprising the deferred tax assets and deferred tax liabilities is a result of the following at December 31:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zSJnR7Pn6Trh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred Tax Assets and Deferred Tax Liabilities (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_z5SFEmK56Iw3" style="display: none">Schedule of deferred tax assets and deferred tax liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231_zcX5KlpavQMb" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20211231_zuMB9RDJxQm6" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr id="xdx_408_eus-gaap--ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzoOH_zzfo9oG4ySld" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; width: 56%">Net operating loss</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,170,457</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,732,422</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzoOH_zvPagOy8dNHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fixed assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(51,573</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,493</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--DeferredTaxAssetsLease_iI_pp0p0_maDTAGzoOH_zj2ukjnqOunl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,340</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,201</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--LossOnContingency_iI_pp0p0_maDTAGzoOH_zWkoBMYuR702" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on contingency</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(193,398</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130,765</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGzoOH_zBe2M4xVZCl3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,663,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,707</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_pp0p0_maDTAGzoOH_zrMNUv3CLKQi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,189</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzoOH_zbHxRmFiB9tj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,908</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">284,468</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_pp0p0_maDTAGzoOH_z9zGCVEHWpkf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrual to cash conversion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,099,403</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">216,068</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzoOH_z6w2WW2ynK7d" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,900,370</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,381,124</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zYhGvJunLpV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,900,370</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,381,124</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_d0_zeX0MRa9oknb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zzKY8hIpPgJ1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The income tax provision differs from the expense that would result from applying federal statutory rates to income before income taxes because the Company is subject to state income taxes, deferred income taxes are based on average tax rates and a portion of gifts and meals and entertainment are not tax deductible. A valuation allowance has been provided to reduce deferred tax assets to an amount that is more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to the share exchange, Munn Works, LLC was taxed as a single member Limited Liability Company for federal and state income tax purposes. As such, the Company will not pay income taxes for earnings prior to the share exchange, as any income or loss will be included in the tax returns of the individual member. Accordingly, no provision is made for income taxes in the financial statements prior to the share exchange.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective tax rates differ from the federal statutory rate of <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zQqnmxsk3tTe" title="Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent">21</span>% applied to income before provision for income taxes due to the following:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zIwTJL3iocjd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Income Before Provision For Income Taxes (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zBvQxBOMuQfj" style="display: none">Schedule of income before provision for income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231_z5cZeuRIBUWi" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210101__20211231_zwqcMagkbiec" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Federal statutory rate times financial statement income</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,551,627</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,552,673</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitPermanentTaxBasisDifferences_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Permanent tax basis differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,268</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,997</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitDeferredTrueUp_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred true up</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">159,849</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--StateTaxableIncomeNet_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State taxable income, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(158,480</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(86,700</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--ValuationAllowanceDeferredTaxAssetExplanationOfChange_zXmGZbKIHYQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in Valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,519,246</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,524,637</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_d0_zRrsB8COHBUf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Rate change</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">154,179</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitTrueUp_d0_zxS9Llfsj9Cb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">True up</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(91,819</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitOther_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">33,280</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">19,643</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_d0_zSN6Mz0Sguqc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total provision for income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(91,819</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A7_zYrwKahfR7vl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has available net operating loss approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_c20221231_pp0p0" title="Operating Loss Carryforwards">16,757,643</span> for tax purposes to offset future taxable income. Pursuant to the Tax Reform Act of 1986, annual utilization of the Company’s net operating loss and contribution carryforwards may be limited if a cumulative change in ownership of more than <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductions_dp_c20220101__20221231_zJ5rTVdUjp84" title="Effective Income Tax Rate Reconciliation, Deduction, Percent">50</span>% is deemed to occur within any three-year period. The tax years 2018 through 2021 remain open to examination by federal agencies and other jurisdictions in which it operates.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zH86zTvGZRS1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Federal and State Income Taxes (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_zsdUwSSB8mSc" style="display: none">Schedule of federal and state income</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20220101__20221231_z2cEexF1mNT1" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101__20211231_zoH6FMIsZEPe" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current provision:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_i01_pp0p0_d0_zCMw5yi6Gcpf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 56%">Federal</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(110,234</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_d0_z9VtaOjCmC0k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,415</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred provision (benefit):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_d0_z6fTVXNtrqjf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Federal</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—  </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pp0p0_d0_zr14RzcQyIUd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">State</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_d0_zlmRPMyVST97" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total Deferred</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—  </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--TotalProvisionForIncomeTaxes_d0_z6idPXoSF5zh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total provision for income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(91,819</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 0 -110234 0 18415 0 0 0 0 0 0 0 -91819 <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zSJnR7Pn6Trh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred Tax Assets and Deferred Tax Liabilities (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_z5SFEmK56Iw3" style="display: none">Schedule of deferred tax assets and deferred tax liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231_zcX5KlpavQMb" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20211231_zuMB9RDJxQm6" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr id="xdx_408_eus-gaap--ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzoOH_zzfo9oG4ySld" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; width: 56%">Net operating loss</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,170,457</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,732,422</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzoOH_zvPagOy8dNHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fixed assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(51,573</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,493</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--DeferredTaxAssetsLease_iI_pp0p0_maDTAGzoOH_zj2ukjnqOunl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,340</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,201</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--LossOnContingency_iI_pp0p0_maDTAGzoOH_zWkoBMYuR702" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on contingency</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(193,398</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130,765</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGzoOH_zBe2M4xVZCl3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,663,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,707</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_pp0p0_maDTAGzoOH_zrMNUv3CLKQi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,189</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzoOH_zbHxRmFiB9tj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,908</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">284,468</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_iI_pp0p0_maDTAGzoOH_z9zGCVEHWpkf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrual to cash conversion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,099,403</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">216,068</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzoOH_z6w2WW2ynK7d" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,900,370</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,381,124</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zYhGvJunLpV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,900,370</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,381,124</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_d0_zeX0MRa9oknb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3170457 1732422 -51573 14493 52340 1201 -193398 130765 1663044 1707 64189 0 95908 284468 1099403 216068 5900370 2381124 5900370 2381124 0 0 0.21 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zIwTJL3iocjd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Income Before Provision For Income Taxes (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zBvQxBOMuQfj" style="display: none">Schedule of income before provision for income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231_z5cZeuRIBUWi" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20210101__20211231_zwqcMagkbiec" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2022</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom">2021</td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Federal statutory rate times financial statement income</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,551,627</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,552,673</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitPermanentTaxBasisDifferences_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Permanent tax basis differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,268</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(72,997</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitDeferredTrueUp_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred true up</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">159,849</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,911</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--StateTaxableIncomeNet_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State taxable income, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(158,480</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(86,700</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--ValuationAllowanceDeferredTaxAssetExplanationOfChange_zXmGZbKIHYQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in Valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,519,246</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,524,637</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_d0_zRrsB8COHBUf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Rate change</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">154,179</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitTrueUp_d0_zxS9Llfsj9Cb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">True up</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(91,819</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitOther_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">33,280</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">19,643</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_d0_zSN6Mz0Sguqc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total provision for income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">—  </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(91,819</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -3551627 -1552673 -2268 -72997 159849 13911 -158480 -86700 3,519,246 1,524,637 0 154179 0 -91819 33280 19643 0 -91819 16757643 0.50 <p id="xdx_802_eus-gaap--SegmentReportingDisclosureTextBlock_z98TWjy5zuXl" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 - <span id="xdx_828_zdTAeVuTAFh">SEGMENT REPORTING</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB Codification Topic 280, Segment Reporting, establishes standards for reporting financial and descriptive information about an enterprise’s reportable segments. The Company has three reportable segments: the design, manufacture, assembly and distribution of a suite of air (fixed and mobile) and surface disinfecting systems for use in healthcare, hospitality, food, wine, and commercial municipal and residential markets (Disinfection segment); the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries (Hospitality segment); and the Corporate segment, which includes expenses primarily related to corporate governance, such as board fees, legal expenses, audit fees, executive management, and listing costs. The segments are determined based on several factors, including the nature of products and services, the nature of production processes, customer base, delivery channels and similar economic characteristics.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net sales less cost of sales, segment selling, general and administrative expenses, research and development costs and stock-based compensation. It does not include other charges (income), or interest.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_ziDs03mgZZq6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span id="xdx_8BA_zHf2mobZjtPj" style="display: none">Schedule of segment reporting</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Hospitality</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Disinfectant</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Corporate</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance sheet at December 31, 2022</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="width: 16%; text-align: right" title="Total Assets">9,638,828</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="width: 16%; text-align: right" title="Total Assets">19,831,097</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="width: 15%; text-align: right" title="Total Assets">3,257,502</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_c20221231_pp0p0" style="width: 15%; text-align: right" title="Total Assets">32,727,427</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--TotalLiabilities_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Total Liabilities">10,666,643</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--TotalLiabilities_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Total Liabilities">1,545,217</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--TotalLiabilities_c20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="text-align: right" title="Total Liabilities">3,281,672</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--TotalLiabilities_c20221231_pp0p0" style="text-align: right" title="Total Liabilities">15,493,532</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance sheet at December 31, 2021</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsNet_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Total Assets">2,158,789</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsNet_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Total Assets">27,851,691</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsNet_c20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="text-align: right" title="Total Assets">8,515,512</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsNet_c20211231_pp0p0" style="text-align: right" title="Total Assets">38,525,992</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TotalLiabilities_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Total Liabilities">2,481,186</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--TotalLiabilities_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Total Liabilities">1,528,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--TotalLiabilities_c20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="text-align: right" title="Total Liabilities">1,850,340</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--TotalLiabilities_c20211231_pp0p0" style="text-align: right" title="Total Liabilities">5,860,232</td><td style="text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Hospitality</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Disinfectant</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Corporate</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Income Statement for the year ended December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; width: 40%">Net Sales</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="width: 10%; text-align: right" title="Net Sales">13,639,370</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="width: 10%; text-align: right" title="Net Sales">6,500,479</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_z1CiNuEh0X69" style="width: 10%; text-align: right" title="Net Sales">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231_pp0p0" style="width: 10%; text-align: right" title="Net Sales">20,139,849</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Cost of Goods Sold</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Cost of Goods Sold">12,375,645</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Cost of Goods Sold">3,725,910</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zWa9r31rsmc8" style="text-align: right" title="Cost of Goods Sold">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231_pp0p0" style="text-align: right" title="Cost of Goods Sold">16,101,555</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Research and development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_zf69WiHRTIjj" style="text-align: right" title="Research and development">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Research and development">319,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zE1Kf2MbLFq9" style="text-align: right" title="Research and development">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_pp0p0" style="text-align: right" title="Research and development">319,167</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Loss on impairment of goodwill</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_zrg4WOf07Kbc" style="text-align: right" title="Loss on impairment of goodwill">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--GoodwillImpairmentLoss_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Loss on impairment of goodwill">6,993,075</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_z53OVACgzW06" style="text-align: right" title="Loss on impairment of goodwill">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--GoodwillImpairmentLoss_c20220101__20221231_pp0p0" style="text-align: right" title="Loss on impairment of goodwill">6,993,075</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Selling, General and Administrative expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--SellingGeneralAndAdministrativeExpense_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">4,351,932</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SellingGeneralAndAdministrativeExpense_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">7,680,551</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SellingGeneralAndAdministrativeExpense_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">2,771,585</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SellingGeneralAndAdministrativeExpense_c20220101__20221231_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">14,804,068</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Income Statement for the year ended December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Net Sales</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Net Sales">5,943,664</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Net Sales">5,723,915</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zQx9buy4ezG1" style="text-align: right" title="Net Sales">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20211231_pp0p0" style="text-align: right" title="Net Sales">11,667,579</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Cost of Goods Sold</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Cost of Goods Sold">4,488,652</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Cost of Goods Sold">3,080,541</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_d0_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zQHQ3ebWpJ5i" style="text-align: right" title="Cost of Goods Sold">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231_pp0p0" style="text-align: right" title="Cost of Goods Sold">7,569,193</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Research and development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_d0_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_zWz5E5pnFvXc" style="text-align: right" title="Research and development">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Research and development">53,408</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_d0_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zwBcxLpMMXjl" style="text-align: right" title="Research and development">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_pp0p0" style="text-align: right" title="Research and development">53,408</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Selling, General and Administrative expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">2,281,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">6,110,206</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pdp0" style="text-align: right" title="Selling, General and Administrative Expenses">2,950,046</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20211231_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">11,341,712</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A2_z5HDg9dedEpa" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_ziDs03mgZZq6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span id="xdx_8BA_zHf2mobZjtPj" style="display: none">Schedule of segment reporting</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Hospitality</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Disinfectant</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Corporate</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance sheet at December 31, 2022</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; width: 17%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="width: 16%; text-align: right" title="Total Assets">9,638,828</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="width: 16%; text-align: right" title="Total Assets">19,831,097</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsNet_c20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="width: 15%; text-align: right" title="Total Assets">3,257,502</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsNet_c20221231_pp0p0" style="width: 15%; text-align: right" title="Total Assets">32,727,427</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--TotalLiabilities_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Total Liabilities">10,666,643</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--TotalLiabilities_c20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Total Liabilities">1,545,217</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--TotalLiabilities_c20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="text-align: right" title="Total Liabilities">3,281,672</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--TotalLiabilities_c20221231_pp0p0" style="text-align: right" title="Total Liabilities">15,493,532</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance sheet at December 31, 2021</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsNet_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Total Assets">2,158,789</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsNet_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Total Assets">27,851,691</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsNet_c20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="text-align: right" title="Total Assets">8,515,512</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsNet_c20211231_pp0p0" style="text-align: right" title="Total Assets">38,525,992</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--TotalLiabilities_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Total Liabilities">2,481,186</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--TotalLiabilities_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Total Liabilities">1,528,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--TotalLiabilities_c20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="text-align: right" title="Total Liabilities">1,850,340</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--TotalLiabilities_c20211231_pp0p0" style="text-align: right" title="Total Liabilities">5,860,232</td><td style="text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Hospitality</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Disinfectant</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Corporate</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Income Statement for the year ended December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt; width: 40%">Net Sales</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="width: 10%; text-align: right" title="Net Sales">13,639,370</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="width: 10%; text-align: right" title="Net Sales">6,500,479</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_z1CiNuEh0X69" style="width: 10%; text-align: right" title="Net Sales">—  </td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231_pp0p0" style="width: 10%; text-align: right" title="Net Sales">20,139,849</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Cost of Goods Sold</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Cost of Goods Sold">12,375,645</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Cost of Goods Sold">3,725,910</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zWa9r31rsmc8" style="text-align: right" title="Cost of Goods Sold">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231_pp0p0" style="text-align: right" title="Cost of Goods Sold">16,101,555</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Research and development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_zf69WiHRTIjj" style="text-align: right" title="Research and development">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Research and development">319,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zE1Kf2MbLFq9" style="text-align: right" title="Research and development">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_pp0p0" style="text-align: right" title="Research and development">319,167</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Loss on impairment of goodwill</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_zrg4WOf07Kbc" style="text-align: right" title="Loss on impairment of goodwill">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--GoodwillImpairmentLoss_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Loss on impairment of goodwill">6,993,075</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_z53OVACgzW06" style="text-align: right" title="Loss on impairment of goodwill">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--GoodwillImpairmentLoss_c20220101__20221231_pp0p0" style="text-align: right" title="Loss on impairment of goodwill">6,993,075</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Selling, General and Administrative expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--SellingGeneralAndAdministrativeExpense_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">4,351,932</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SellingGeneralAndAdministrativeExpense_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">7,680,551</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SellingGeneralAndAdministrativeExpense_c20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">2,771,585</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SellingGeneralAndAdministrativeExpense_c20220101__20221231_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">14,804,068</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Income Statement for the year ended December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Net Sales</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Net Sales">5,943,664</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Net Sales">5,723,915</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zQx9buy4ezG1" style="text-align: right" title="Net Sales">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20211231_pp0p0" style="text-align: right" title="Net Sales">11,667,579</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Cost of Goods Sold</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Cost of Goods Sold">4,488,652</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Cost of Goods Sold">3,080,541</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_d0_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zQHQ3ebWpJ5i" style="text-align: right" title="Cost of Goods Sold">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20210101__20211231_pp0p0" style="text-align: right" title="Cost of Goods Sold">7,569,193</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Research and development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_d0_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_zWz5E5pnFvXc" style="text-align: right" title="Research and development">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Research and development">53,408</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_d0_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_zwBcxLpMMXjl" style="text-align: right" title="Research and development">—  </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_pp0p0" style="text-align: right" title="Research and development">53,408</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Selling, General and Administrative expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--HospitalitySegmentMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">2,281,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DisinfectantSegmentMember_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">6,110,206</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--CorporateMember_pdp0" style="text-align: right" title="Selling, General and Administrative Expenses">2,950,046</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SellingGeneralAndAdministrativeExpense_c20210101__20211231_pp0p0" style="text-align: right" title="Selling, General and Administrative Expenses">11,341,712</td><td style="text-align: left"> </td></tr> </table> 9638828 19831097 3257502 32727427 10666643 1545217 3281672 15493532 2158789 27851691 8515512 38525992 2481186 1528706 1850340 5860232 13639370 6500479 0 20139849 12375645 3725910 0 16101555 0 319167 0 319167 0 6993075 0 6993075 4351932 7680551 2771585 14804068 5943664 5723915 0 11667579 4488652 3080541 0 7569193 0 53408 0 53408 2281460 6110206 2950046 11341712 <p id="xdx_80B_ecustom--ProformaFinancialStatementsTextBlock_z5VX9jdiIse4" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 – <span id="xdx_829_z81kHWSDA6w9">PROFORMA FINANCIAL STATEMENTS (UNAUDITED)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Unaudited Supplemental Pro Forma Data</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaudited pro forma results of operations for the years ended December 31, 2022 and 2021 as though the company acquired Akida, KES, Visionmark, and SciAir (the “Acquired Companies”) on January 1, 2021 is set forth below.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_z0cwjYBQ2Iq8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROFORMA FINANCIAL STATEMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span id="xdx_8B9_zgXBWu2H31Hj" style="display: none">Business Acquisition, Pro Forma Information</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20220101_20221231_us-gaap--BusinessAcquisitionAxis_custom--AkidaKESVisionmarkAndSciAirMember" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20210101_20211231_us-gaap--BusinessAcquisitionAxis_custom--AkidaKESVisionmarkAndSciAirMember" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center">Year Ended December 31,</td><td> </td> <td colspan="3" style="text-align: center">Year Ended December 31,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 0pt">Net Sales</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">22,248,183</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">22,072,379</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Net Loss</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(16,580,044</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(9,046,424</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; text-align: left; padding-left: 0pt">Net Loss attributable to common stockholders:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Dividends to preferred shareholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,449,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">603,750</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net Loss attributable to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(18,031,480</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,650,174</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--EarningPerShareBasicAndDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Basic and Diluted Loss Per Common Share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.41</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.98</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_404_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDiluted_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0pt">Weighted Average Shares Outstanding - basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12,754,979</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">9,799,627</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_z0cwjYBQ2Iq8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROFORMA FINANCIAL STATEMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"><span id="xdx_8B9_zgXBWu2H31Hj" style="display: none">Business Acquisition, Pro Forma Information</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20220101_20221231_us-gaap--BusinessAcquisitionAxis_custom--AkidaKESVisionmarkAndSciAirMember" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20210101_20211231_us-gaap--BusinessAcquisitionAxis_custom--AkidaKESVisionmarkAndSciAirMember" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3" style="text-align: center">Year Ended December 31,</td><td> </td> <td colspan="3" style="text-align: center">Year Ended December 31,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 0pt">Net Sales</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">22,248,183</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">22,072,379</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Net Loss</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(16,580,044</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(9,046,424</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.05in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; text-align: left; padding-left: 0pt">Net Loss attributable to common stockholders:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt">Dividends to preferred shareholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,449,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">603,750</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net Loss attributable to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(18,031,480</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,650,174</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--EarningPerShareBasicAndDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Basic and Diluted Loss Per Common Share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.41</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.98</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_404_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDiluted_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0pt">Weighted Average Shares Outstanding - basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12,754,979</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">9,799,627</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 22248183 22072379 -16580044 -9046424 -1449000 603750 -18031480 -9650174 -1.41 -0.98 12754979 9799627 <p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zhITAGgNYSIf" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 – <span id="xdx_82E_zWoVvHRNkTG7">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Streeterville Capital</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2023, (the “Execution Date”) the Company executed a Redeemable Promissory Note with Streeterville Capital, LLC (the “Investor”) in the amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20230125__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1DQB7pQ2MPi" title="Principal amount">2,807,500</span> (the “Note”). The Note matures eighteen (18) months from its issuance date of January 25, 2023 and bears interest at <span id="xdx_90C_ecustom--BearsInterestRate_dp_c20230101__20230125__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0XIQpRYKIg2" title="Bears interest rate">8</span>% per annum on the outstanding principal balance of the Note. The original principal balance of the Note is $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20230125__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zVW6ZkO3582l" title="Principal amount">2,500,000</span>, plus debt issuance costs of $<span id="xdx_906_eus-gaap--AmortizationOfFinancingCosts_c20230101__20230125__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUv1s6kfoLYk" title="Debt issuance costs">345,000</span>. Beginning on July 25, 2023, the Investor shall have the right in any month to cause the Company to redeem up to $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20230725__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNf7oyTxR022" title="Principal amount">247,500</span> of the principal amount of the Note in such month. The Company may elect, in its sole discretion, to redeem such portions of the Note in cash or in its common stock or in any combination thereof. If redemptions are made by the Company with its common stock, such stock will be valued at 87.5% of the Nasdaq Minimum Price. The Company may not redeem the Note with its common stock if at the time of such redemption there is an Equity Condition Failure. It is the intention of the Company to make all Note redemption payments in cash and not in stock. Beginning on July 25, 2023, all cash redemptions will be subject to a ten percent (10%) redemption premium. The Company may pay all or any portion of the outstanding balance on or before one hundred five (105) days from the Execution Date without a prepayment penalty; if paid after one hundred five (105) days, the Company will be subject to a 10% prepayment premium.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Acquisitions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The PURO Acquisition</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 26, 2023 (the “Closing Date”), prior to the effective time of the Puro Mergers (as defined below), the Company paid or issued, as applicable <span id="xdx_908_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20230101__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxf83IEccSYd" title="Acquisition description">(i) 2,497,220 shares of the Company’s common (based on a value of $2.00 per share), (ii) 251,108 shares of the Company’s 5% Series C Cumulative Perpetual Preferred Stock, par value $0.0001 per share (“Series C Preferred Stock”) (iii) $1,335,114 of PURO’s indebtedness to various creditors, (iv) $221,675 of the PURO’s transaction expenses and (v) $2,500,000 and 1,250,000 shares of the Company’s 2% Series B Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”) in repayment of a $5 million note issued by PURO and held by one of its vendor’s. As a result of these issuances and payments the Company and PURO agreed that the acquisition of PURO by the Company (the “PURO Acquisition”) was closed and the PURO Mergers could be affected as soon as possible. The Company financed the payments described above through a $2,807,500 Redeemable Promissory Note from Streeterville Capital, LLC (the “Redeemable Note”) and a $1,537,938 draw on a line of credit from Pinnacle Bank (the “Line of Credit Draw”). The shares described in clauses (i) and (ii) above are collectively referred to herein as the “PURO Equity Consideration”.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> On January 27, 2023 in connection with the prior closing of the PURO Acquisition, the Company caused a two-step merger to occur as follows: (i) a merger between PURO Lighting, LLC, a Colorado limited liability company (“Old PURO”) and PURO Acquisition Sub I, Inc., a Colorado corporation (“PURO Sub I”) and wholly owned subsidiary of the Company became effective (the “First PURO Merger), whereby PURO Sub I was the surviving entity of the merger and then (ii) a merger between PURO Sub I and PURO Acquisition Sub II, LLC, a Delaware limited liability corporation (“PURO Sub II”) and wholly owned subsidiary of the Company became effective (the “Second PURO Merger” and together with the First PURO Merger, the “PURO Mergers”), in each case, pursuant to a previously executed Agreement and Plan of Merger dated as of December 19, 2022, as amended on January 26, 2023 (the “PURO Merger Agreement”), by and between the Company, PURO Acquisition Sub I, PURO Acquisition Sub II, PURO, Brian Stern and Andrew Lawrence. In connection with the PURO Mergers, PURO Sub II was renamed Puro Lighting, LLC (“New PURO”) and New PURO is a wholly-owned subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the effective time of the First Puro Merger (i) all of the capital stock of PURO Merger Sub I that was outstanding immediately prior to the effective time of the First PURO Merger was converted into and became (i) 100% of the membership interests of Old PURO (and the membership interests of Old PURO into which the membership interests of PURO Merger Sub I were converted became the only outstanding membership interests of Old PURO) and (ii) the right of each holder of a membership interest or profit interest in Old PURO immediately prior to the effective time of the First PURO Merger to receive from the Company their ownership percentage of the following:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The PURO Equity Consideration; and</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The right to receive earnout payments subject to certain conditions, including achieving certain revenue targets and gross profit margins and payable as set forth in the PURO Merger Agreement and Schedule II thereto.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The LED Supply Acquisition</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the Closing Date, prior to the effective time of the Puro Mergers, the Company paid or issued, as applicable <span id="xdx_900_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20220101__20221231_z58YhK5TIf4l" title="Acquisition descrption">(i) 1,377,777 shares of the Company’s common stock; (ii) 148,888 shares of Series C Preferred Stock; (iii) $364,316 of Old LED Supply’s indebtedness to various creditors; and (iv) $221,674 of Old LED Supply’s transaction expenses. Part of Old LED Supply’s indebtedness on the Closing Date was $1,778,667 outstanding principal and interest on a line of credit from JP Morgan Chase Bank, N.A. (the “Chase Loan”). The Company has agreed to repay the Chase Loan 14 calendar days from the Closing Date As a result of these issuances, agreements and payments the Company and Old LED Supply agreed that the acquisition of Old LED Supply by the Company (the “LED Supply Acquisition”) was closed and the LED Supply Mergers could be effected as soon as possible. The Company financed the payments described above through the Line of Credit Draw. The shares described in clauses (i) and (ii) above are collectively referred to herein as the “LED Supply Equity Consideration”.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 27, 2023 in connection with the prior closing of the LED Supply Acquisition, the Company caused a two-step merger to occur as follows: (i) a merger between LED Supply Co. LLC, a Colorado limited liability company (“Old LED Supply”) and LED Supply Acquisition Sub I, Inc., a Colorado corporation (“LED Supply Sub I”) and wholly owned subsidiary of the Company became effective (the “First LED Supply Merger”), whereby LED Supply Acquisition Sub I was the surviving entity in the merger and then (ii) a merger between LED Supply Sub I and LED Supply Acquisition Sub II, LLC, a Delaware limited liability corporation (“LED Supply Sub II”) and wholly owned subsidiary of the Company became effective (the “Second LED Supply Merger” and together with the First LED Supply Merger, the “LED Supply Mergers”), pursuant to the previously executed Agreement and Plan of Merger dated as of December 19, 2022, as amended on January 26, 2023 (the “LED Supply Merger Agreement”), by and between the Company, LED Supply Acquisition Sub I, LED Supply Acquisition Sub II, LED Supply, Brian Stern and Andrew Lawrence. In connection with the LED Supply Mergers, LED Supply Sub II was renamed Led Supply Co. LLC (“New LED Supply”) and New LED Supply is a wholly-owned subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the effective time of the First LED Supply Merger (i) all of the capital stock of LED Supply Merger Sub I that was outstanding immediately prior to the effective time of the First LED Supply Merger was converted into and became (i) 100% of the membership interests of Old LED Supply (and the membership interests of Old LED Supply into which the membership interests of LED Supply Merger Sub I were converted became the only outstanding membership interests of Old LED Supply) and (ii) the right of each holder of a membership interest or profit interest in Old LED Supply immediately prior to the effective time of the First LED Supply Merger to receive from the Company their ownership percentage of the following:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The LED Supply Equity Consideration; and</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The right to receive earnout payments subject to certain conditions, including achieving certain revenue targets and gross profit margins and payable as set forth in the LED Supply Merger Agreement and Schedule II thereto.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing descriptions of the transactions consummated by the Merger Agreements (as amended) are not intended to be complete and is qualified in its entirety by reference to the full text of the Merger Agreements previously filed as Exhibits 10.1 and 10.2 to the Form 8-K filed on December 20, 2022, and the Amendments to the Merger Agreements filed hereto as Exhibits 10.1 and 10.2including its amendments, and the Note Cancellation Agreement, copies of which are filed herewith as Exhibits 10.1, 10.2, 10.3, 10.4 and 10.5, respectively, and incorporated by reference herein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal Settlement</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 25, 2022, James Doyle, a former Chief Operating Officer of the Company filed an arbitration claim against the Company for approximately $<span id="xdx_906_ecustom--AttorneysFees_pn3n3_dm_c20220201__20220225_zAHjRhzQdC67" title="Attorneys fees">1.5</span> million plus attorneys’ fees and other costs with the American Arbitration Association in the State of New York for severance pay and other claims after being terminated by the Company for cause. The arbitration proceeding was initiated pursuant to the arbitration provision in Mr. Doyle’s employment agreement with the Company. The evidentiary hearing was conducted at the American Arbitration Association’s midtown offices on November 7, 8, 9, and 10, 2022.  Afterwards, the parties submitted post-hearing briefs.  On January 24, 2023, the arbitration panel issued a Partial Final Award, whereby the Panel denied five of the seven counts asserted by Doyle, and awarded him only $<span id="xdx_904_ecustom--ArbitrationPanelIssuedAmount_pp0p0_c20220201__20220225_zAZCTu2cbDu8" title="Arbitration panel issued amount">100,000</span> in severance pay plus $21,153.84 in unused vacation time plus 6,379 additional shares in the Company pursuant to the terms of his Employment Agreement.  Because Mr. Doyle was determined to be the prevailing party, the Panel awarded him his reasonable attorneys’ fees and expenses, which amounts are currently the subject of post-hearing briefing.  The Company estimated additional legal fees of $<span id="xdx_907_eus-gaap--LegalFees_pp0p0_c20220201__20220225_zSi5Duf820D9" title="Legal fees">10,000</span>. The Company accrued a total of $131,153.83 in S,G&amp;A expense to cover severance pay, unused vacation time, and the legal fee estimate. An additional $<span id="xdx_90B_eus-gaap--InterestExpenseOther_pp0p0_c20220201__20220225_zIq6OcVydr7a" title="Accrued interest expense">5,000</span> was accrued for interest expense as per the Partial Final Award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered Sales of Equity Securities.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The issuance of the PURO Equity Consideration, the LED Supply Equity Consideration and the Series B Preferred Stock are exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material Modification to Rights of Security Holders.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Series B Preferred Stock</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2023, the Company filed the Certificate of Designations, Rights, and Preferences for the Series B Preferred Stock with the Secretary of State of the State of Delaware, which became effective upon acceptance for record. On January 26, 2023, the Company filed the Amendment to the Series B Certificate of Designation (together with the Certificate of Designations, Rights, and Preferences for the Series B Preferred Stock, the “Series B Certificate of Designation”), which became effective upon acceptance for record. The Series B Certificate of Designation classified a total of <span id="xdx_904_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20230125__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zOiUqxvVmMhf" title="Shares authorized">1,250,000</span> shares of the Company’s authorized shares of preferred stock, $<span id="xdx_907_ecustom--PreferredStockParValue_iI_c20230125__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6p20v40kMI3" title="Preferred stock, par value">0.0001</span> par value per share, as Series B Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As set forth in the Series B Certificate of Designation, the Series B Preferred Stock ranks, as to dividend rights and rights upon the Company’s liquidation, dissolution or winding up: (i) senior to all classes or series of Common Stock and to all other equity securities issued by the Company expressly designated as ranking junior to the Series B Preferred Stock; (ii) on parity with the Company’s 10.5% Series A Cumulative Perpetual Preferred Stock; (iii) at least on parity with any future class or series of the Company’s equity securities designated on or after January 25, 2023, including the Company’s 5% Series C Cumulative Perpetual Preferred Stock; and (iv) effectively junior to all the Company’s existing and future indebtedness (including indebtedness convertible into Common Stock or preferred stock) and to the indebtedness and other liabilities of the Company’s existing or future subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Series B Preferred Stock, when and as authorized by the Company’s Board of Directors, are entitled to cumulative cash dividends at the rate of 2% of the $6 per share liquidation preference per year (equivalent to $0.12 per share per year). Dividends will be payable quarterly in arrears, on or about the 15th day after the end of a quarterly period, beginning on April 15, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of Series B Preferred Stock, at his, her, or its option, can require the Company to redeem all or a portion of the Series B Preferred Stock at any time and from time to time held by such holder after 30 months from the original issue date at a redemption price of $2.00 per share, plus any accrued and unpaid dividends (whether or not authorized or declared), up to but not including the date fixed for redemption, without interest, to the extent the Company has funds legally available therefor; provided that if a holder requires the Company to redeem all or a portion of the Series B Preferred Stock at any time and from time to time held by such holder on or after the five (5) year anniversary of the original issue date, the redemption price will be $6.00 per share, plus any accrued and unpaid dividends (whether or not authorized or declared), up to but not including the date fixed for redemption, without interest, to the extent the Company has funds legally available therefor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series B Certificate of Designation provides for a special optional redemption by the Company upon a change of control, in whole or in part, for $6.00 per share, plus accrued but unpaid dividends to, but not including the redemption date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of Series B Preferred Stock neither have voting nor preemptive rights. Each share of Series B Preferred Stock is convertible, at any time and from time to time from and after the original issue date, at the option of the holder, into one share of Common Stock. The Series B Preferred Stock has no stated maturity and will not be subject to any sinking fund for the payment of the redemption price or mandatory redemption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Series C Preferred Stock</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2023, the Company filed the Certificate of Designations, Rights, and Preferences for the Series C Preferred Stock with the Secretary of State of the State of Delaware, which became effective upon acceptance for record. On January 26, 2023, the Company filed the Amendment to the Series C Certificate of Designation (together with the Certificate of Designations, Rights, and Preferences for the Series C Preferred Stock, the “Series C Certificate of Designation”), which became effective upon acceptance for record. The Series C Certificate of Designation classified a total of 2,500,000 shares of the Company’s authorized shares of preferred stock, $0.0001 par value per share, as Series C Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As set forth in the Series C Certificate of Designation, the Series C Preferred Stock will rank, as to dividend rights and rights upon the Company’s liquidation, dissolution or winding up: (i) senior to all classes or series of Common Stock and to all other equity securities issued by the Company expressly designated as ranking junior to the Series C Preferred Stock; (ii) on parity with any future class or series of the Company’s equity securities expressly designated as ranking on parity with the Series C Preferred Stock; (iii) junior to all equity securities issued by the Company with terms specifically providing that those equity securities rank senior to the Series C Preferred Stock with respect to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up; and (iv) effectively junior to all the Company’s existing and future indebtedness (including indebtedness convertible into Common Stock or preferred stock) and to the indebtedness and other liabilities of the Company’s existing or future subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Series C Preferred Stock, when and as authorized by the Company’s Board of Directors, are entitled to cumulative cash dividends at the rate of <span id="xdx_90D_ecustom--DividendsRatePercentage_dp_c20220101__20221231_zk06IK6NsF49" title="Dividends rate percentage">5</span>% of the $<span id="xdx_90A_eus-gaap--PreferredStockLiquidationPreference_iI_c20221231_zNJaEcl53Tyj" title="Per share liquidation preference">5.00</span> per share liquidation preference per year (equivalent to $<span id="xdx_90C_eus-gaap--DividendsPayableAmountPerShare_iI_c20221231_zj7lme0byCGh" title="Dividends per share">0.25</span> per share per year). Dividends will be payable quarterly in arrears, on or about the 15th day after the end of a quarterly period, beginning on April 15, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, to the extent it has legally available funds, must redeem all shares of Series C Preferred Stock on the date that is three years from January 26, 2023. The Series C Certificate of Designation provides for a special optional redemption by the Company upon a change of control, in whole or in part, for $<span id="xdx_904_eus-gaap--PreferredStockLiquidationPreference_iI_c20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zC4dMOChjQCj" title="Per share liquidation preference">5.00</span> per share, plus accrued but unpaid dividends to, but not including the redemption date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of Series C Preferred Stock neither have voting nor preemptive rights. Each share of Series C Preferred Stock will be convertible, at any time and from time to time from and after January 26, 2023, at the option of the holder, into one share of Common Stock. The Series C Preferred Stock has no stated maturity and will not be subject to any sinking fund for the payment of the redemption price or mandatory redemption.</span></p> 2807500 0.08 2500000 345000 247500 (i) 2,497,220 shares of the Company’s common (based on a value of $2.00 per share), (ii) 251,108 shares of the Company’s 5% Series C Cumulative Perpetual Preferred Stock, par value $0.0001 per share (“Series C Preferred Stock”) (iii) $1,335,114 of PURO’s indebtedness to various creditors, (iv) $221,675 of the PURO’s transaction expenses and (v) $2,500,000 and 1,250,000 shares of the Company’s 2% Series B Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”) in repayment of a $5 million note issued by PURO and held by one of its vendor’s. As a result of these issuances and payments the Company and PURO agreed that the acquisition of PURO by the Company (the “PURO Acquisition”) was closed and the PURO Mergers could be affected as soon as possible. The Company financed the payments described above through a $2,807,500 Redeemable Promissory Note from Streeterville Capital, LLC (the “Redeemable Note”) and a $1,537,938 draw on a line of credit from Pinnacle Bank (the “Line of Credit Draw”). The shares described in clauses (i) and (ii) above are collectively referred to herein as the “PURO Equity Consideration”. (i) 1,377,777 shares of the Company’s common stock; (ii) 148,888 shares of Series C Preferred Stock; (iii) $364,316 of Old LED Supply’s indebtedness to various creditors; and (iv) $221,674 of Old LED Supply’s transaction expenses. Part of Old LED Supply’s indebtedness on the Closing Date was $1,778,667 outstanding principal and interest on a line of credit from JP Morgan Chase Bank, N.A. (the “Chase Loan”). The Company has agreed to repay the Chase Loan 14 calendar days from the Closing Date As a result of these issuances, agreements and payments the Company and Old LED Supply agreed that the acquisition of Old LED Supply by the Company (the “LED Supply Acquisition”) was closed and the LED Supply Mergers could be effected as soon as possible. The Company financed the payments described above through the Line of Credit Draw. The shares described in clauses (i) and (ii) above are collectively referred to herein as the “LED Supply Equity Consideration”. 1500000 100000 10000 5000 1250000 0.0001 0.05 5.00 0.25 5.00 EXCEL 85 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

'R:E:"N8K[!JUBM>;R4$ZPLUXCY^,I+I?TV MDH.&@LF]L9^9GU,HW4'%C*/4FDD*"4-AK&;G! M'A>&;'"9;1#LM+.W-YJ BE3ZLR9D)XGN*MLU&"BY=248[ 76)ADZ%V!R(12^ M^C:4BZG+BKS\BT'.2N'^.S5)SRY/T]%HQ+OJ[W0X:5'T@#:<.58HL<*BB+0R MI_#V.8PD*]V@9$0B5?.:C55&T4]9V3FR20\#7L2,M6.,07$)HX)H#49;U-VT M!4H%0^(D@28 .##C).4TP#U?6W)S-M@ZY,0N.>QG)!Y.\9-R(4H8"1%T(,6< MDQ/"1-W21^JY54M+ZA:I"7"@SU;R@#=&SRC0L2;@T.3 GQ*%:._D,2 M=[[1*X.!GV*R9^YMOT,LD_J&3.-=F=KU'Q)J:"63\Y,S]8EW/'E-=HN?+=L+ M41)BN"'2_1%0P$U0+;"'(\.G$^*JO]S>P^5E;5V9 0D F1"7H0X]%$IQA2M\ MLKU%:T_VK5UF.R1A0XEXU;GE$1G4%7+H0L"^?PC?R+U,79#/^S0%=3FD+EV) MU9 F&HZ$9+*HN0;-G:B'"$![A<9 '3Q4U-Q7WF$5KJJ(&B_Y"J='D@/1#X1, M3E=<03P6_P1 TTIXQ#0I-%GT,F)&,] I3"DE8\([\Y2AOL?XV'1.;U$$\:*$ MP!AQ+6<:A!Q(-J H7Q,CTI4+87>KIJOLT.190)72S'@?@3Y$KZ:EC_84'PC! MT^1>(RYRNHH?>"C^\)I40@M@V\8/G)WKZ$>OW 7E+N1*)3)HQ"&P='$)=K]% M]J1#70:N3QO/=*+$(NF62EV/R-XV'$6VTCI)LGBI#,16)_$$7#JE'6+^VI+& M;.M#3N3G/LUP^X'R;6>C&>R"S"^2[&#,8>4P^B3;Z+,3?"XY\HS3T:5\Z 2BN%[J* 65*=(!\S3JGY8'$ MN3=]EKQO2%">F<%)R G7N6F7,1XF>G(IEIF!4J>B<8X_XA\\J%^#Q,I^20;% M47$,P+R/:[W((0\DC#!Z[8OSA9Y2] H7_1IH.H"R)W;TB9DWZG3<][F:_[_'=EHQ?F5 M_X0B--<4+1=-FFS=1\&43XZ/384TA7B!PU-"6F,7)/H M9N$]B98@&2$\ ^E"1S" >DI!3-N49>Y(\\K01 MJBAWBLMKB039,KZK*T&;LQ'_^Q$5BZ;=,&0#QU?L*(.?=?@99A,PQ:'H";@Y M_6CZ@!92,=G8+_ALX>*.41>1&>$ &SMY7/+1!EM(JHAZP.T('[&+:8?Z>/-O$M%E7[(=,'0J6(20614U])A8!_/)?()B#DB M0K[.=MGAP&UWU:X&XO:^UYF):/K0(O;-[R)N\I"3+W0EP]#^)RAGWS_A.=#O MDBFQ3=Y"43@[568)[3L&^I;<3MP=:L6_K%$E1W2>#21O]N]D/$/(#Y.;J'P8 M=2O$&57FF/U6%=9M.W/4(<,1\L;D *4,E],8A@&^?2\'&GJ\XT*D,3R]18=< M!A9&B:3:VK>(IN&A0JIPC(T]7^+F@!WZ]#A CB1&CK:6ZH3=5R /*$((X2_W M8@BG#\69@0RQ=#L",9U*XG)-3!7(R '!:U.6)'E?4V A[< A5.002&JQEC<\]5-@-BY4TF8V2G6?EGMWF2M$BV*Z@4 M?)[/?DE)N6-+? ;CSF[JQ(4$KJ3,*%3+@2V$YGT$O]18%1*XELN-N6GR;BFG MIU;25T->7-,R2O,9U)<)/3"9_3L:&C4@R05RC[8^T7<]- XOLS92\C;3'C!* M%$WYO"KLHG<<,IC]>10>48A399QWHB <&1X*^ -%;ZMXGP%]:VH*+GW*^_5R MRUK[@A(:C&H4TPU751[/WN>#'! HK=OP9G EP94F M=I3E3KE$5.FPR!S^1K9'P:&9LU#?J8OT^OJ4TK)S5%_KI4X>LR]Z"%$S4TKQ M@"X3!G]!%9F"IHT8CBM_$I\?!K@3-RH> C7 M@K<&&T0O6%'(DOI;.4!@KIFKLTKM A4=64PHMSB_ ^]Q+4?1HF5ODJTBD6M7 M6JXZ9E0.+R1)"M'0#HCTGI*1!$&:!.OY2AU+#)DCB[-&U&O=$KFN@F,=,257 M<1JTK?7Z(A(I*$R3EME:9FJD[";-#1STZPC2>:P>T:/E)3Y@>F#W13HGF6A1 M.,*V(=-:B]#@%=0LT1I)L)!P[CGK=XK+<9+VXO#3I]X)$U^/M1QNJIJRO@K' M1,0,I[(H7+4=SH4,WSV0DK4+^,B>,E-Z+7#Z*PU6S?"HGZV6[IAJ7R 0XNP+ M7,E=7^ :>)6'-#F)#84U&BI@"1)R88>^6X&C#ER^*%S1S1WXU+MW(JFA7Y_'S_0\XMHH)U/4N0#_H" MHPUT@JT":A=Z=R*G8B5";>AV8"O>7]/LXR@1"!Z2VV^B>U!Q0T5WJ@>+&IPU M-OA%RK*I+.186 &T)^I!RH=,:N@JOH;\N,4;R$ZX^E $_0*;&QS]B( DRF"- MUE?M"V?NRZS0+@[AT-L?.7JP.!#.0]'P9. -74M+_=VE3:_*+/]\3.DA*A1Q M;:4N-,H4;C^E-A:TWM>F2:.M675EW+N6 MS-4TB*.1.26_>D=X$Z!\V\NW8,[V1P'&EU.B$Y2!?P@++6O*2@AJ-@Q!43TU MMNAA[38QRZ4N#!]5N#+N,:>^KI8;RIY]!(JL<& B(8SVMQZ(2'S\3WEUU_B2 M!Y$.BH:V[R9L%Z1ZXC-/NK2[*9Y:&/(Z2EC)[]_6E+1])&MYX*;C5T0H\J2D M'V%5KA/9V#[>4EY2F"?#WE41LO"M62M)A<=N]-:AEW;!?6/28*^TC"Y,GN MP4?"& ;\ G3URZM==7.,BF,ZFERIB[.S]'1\-KPM8-3X>I*>C:_]O\DC<_1Q MRM_/+M75Z45Z>7JJ'OB,[14WRMY&9VS#DI.OPG/ZBH!RX&3.G^@A+=C*JWLH MB^I:#[ 1?N)53?_TM>^;AU>^]IWLO?^V+OKH^%BOR&(OQU=]1_3#;?_B1KRN M8U[PX*?X(0QRA!9J^=@?)!,U2^)5N],0YE-ZN2KKC=;#:HKL _;=7=[:22$H MX310+G(1-EJ:C/_%MS;**Q4KU^S1L\)YQ?T[^TB'BDA'G,V0L0_*8$\N3>(5 M6V2MJ(2CO.=1YEY;#1SE%.5G:??F@'?05!KWA,N&^R>D#+;'2KZ]U[:;MK+= MIZ/C\2@-8C%)B,4:;"O?C)W]Q EA_UO*K/L;DBX[RRF_)+:%; JS-36H9]_P M^1D> ?=5?U MI>-^3)[!%9I%QZ":!1L_7=TO5N*)OO.!;$LIS&S3@3">ADE(F^I*STQ<7MPS M2VPW%Z.+-,SA.+],GO",63]1/77=6UAAS0W _FB.BYN2HG+H:O0,!\@VD#=T ME[I6YXA:2Q9L540F317>GNKK_8D[Q7RL_=9*)I:C=KCR+7E;38K1R4(?F&<< MXUJ]LB^2\3-U)V5QZ4\/.R=O+?3;G4RV[OR67;J!3I+39X0M+C^5,ZMMHSE) MSIZABX_M9/\M4,\?GO'\F;KW6YCLVLY 18@8=L:\]*"EA/>1X"!_T_DP29,L M.G#7OL-SV%+ORSZEAB^XSMAV'X$.[WF% B\?S/B9Y>Q7I)1MIM#32 \Q=%D9I2RF!&/V7=MB0U<\8!!F(,7AJ:\1VLW+OHQ6UMESQY\+^ MMH%R=0E7G74R24>_PW!TSE@]^@3-)YB,L67044D)QLR-8?VX7QZ"E;I#RC1.SR I6$S3R)4+X(!FQ.O8P7X MB#1 ? 6PH"^+O@%^OL"+>:WS8G?*K1LYKL)OKGZ]R4OM MX6S'5O@];]>C@*S8ST1XUB-$7:&A=".^ JP4C-Q?@.GKN=P-"4'9^?Z&FG+T:PG)(D0 MDFUJRV3,'8P>(A*Q2^QR?N[?)!92&_?' ]#&&?* ;0J:1!1T'XUP*O>-/I$Q M(9P"B*_/1_'->^2CI/-R0O^=3O!Q=#%*+R;7R77UX'XM&3TTQJ> W#JJ]X!L;.-?,7@X4GZ%6M$Y5GB6 M7EUG9VI:XO3M/3 MJW-U4SPAX##EC#XG4A7P3:NTM\N,0AT#9LU_OT7YE9E0WA2X4Z#* M7Z\1!:/[9MJ_I- #7BV!)VHKVA7G8*>2?S//^%,>LH1>AW(VAXGK/:<1A^I3 M P'\M,D>;_[*J0_[!EQQ/+I.)Z-+=7E]G=)_ZE=ZLFZ20MZ!LOY[7,<3:!KF M1MPP)/D.9PIDJZ5/S*)7=5V^%=02G[,]\4S*S[ROW3T9MKOSD,/'PA&.K._R M/#V'35U/TM'91'WD-T#))^S6(7 ONU4# ^.CN^AU;6X@:5%T4*6>NW8ZWU7< MNU+TJH8$%F^$_H4K'I>EDD/;V^0JV"1D7/6%&O>)B^9FI#S?0-O[8#:(9AT[]$7?0ZOI=, MMJ+/N>[?[3#6=N$%,84B/!0AB.&'QA$-/S^MB] Q,L@]();MWVU*W MSP%(^ M74$]"7LT)#@AK76O5?0#H[$HES9^MW0O:+]<:6/CT^663*.-IN+L$P=#21:: MW\.8!VHJX:R"?8_]O FO1PUKZM)_7DA1GCL*_]H15D]&8Y>3L1J=P#?) M3&0<+!42U27/=F6=_L4..*\KE\1M2-/PWH_>ZH#8:M=SM5>IT<+2$]@I:W37 M*'WI_%NO0)[L^QMSSZ._#4@\9\Y_ 9%?Z:M:^3.!X=?P1Q9OY&\+]K?+7VA\ M1VP&Q>M2S^C1TN_8(+P MIR=_^C]02P,$% @ O8A_5N^5?=\-#P [RH !@ !X;"]W;W)KGIU6\DNNH.LD+F>')(B_748W+NRI?/\Z9.52:O2E$UZW54;E[)-+]]<> >M#=^4Z M>)>\.'!((9G*N"8)$?Z[D1#>541D&YKDL\ M59A7OWSU^?K=AS?7UV)V\??/[Z[??7KW\7YGI\_R1@_9V52X M4U7B(E_/51;IE,@2,:LJI/XL_J-1E>*[_YC-J[I$NOQSGR/T,O[^9:B$SJHB MBN6+ ]1()?#RQQ_=S[O!)T<\DS MBJ:,5Z@HL9;U*D]$OFC%T@B((/7B4LVQBLH0H_:9=5TC=%&94#@3M5"QCN?$ M"6VQ+]*5."3+/.=\=GU!PPZ.=/#IRG,ZL]]&JA1?HK21XE)&55-*X$]=\=C7 MJHK3G.YM2;,P_^#H1+S+6/DRB;)8HHCKE3!K#5>RV?#6B4U%ED'^7%:UP%\% MF)%ZN:@"3A9:^3HGV4V)A^F&GJAE)A:DZPWK6N<6B853EFJ>2AHA26N*2"D3 M6Z@$9L!/$3U5V;V!6"_%0Y4B?+0^K2U)!XK)3G!%0CJ>B)_R/+E5:;I_E$6C MA*H06_8C"Z,Q\BZFX&!&%_X8-D+#4@[=$):D2ITVBTY7&D65Y MJFAX8BV0C%FLHE14-6[HS#++M1FQD5%9"4D@*@"!*/0'>:P$$HJ@D\0:J29U^ M2Y.Q6HLVL[ATVD=B4>;K^W"6=#@T)QHCXBC#+_BIQMVFU4UD#<<+AG70MT ? MR1%2G1G +AO/:I'E-?1>*SW51O"JVJHVF2R79(:\*\!:M-@Y96J4JG\902*B^5N5RI>D1\$ 2NWDZP639;/J3D:C"F:&D/1Z][+ M&YD*O[O%Z;YH(R=644J&+,$GX/JR:R*:0"(E.5-Y,7YH0X ZL@82# (B-HC84F5Z M"%8Q_A\(;8-G;G'^($682^"N-GS1U$#]/KHL[^9H4-D4R2[CK2[C]Q4@YIJI MJ.8L7ZN85ETT*6IHH0&H;V2'-\J,[3V,$2L%5Y1<+75T)XK]7:EL"[%7L2HT_.ZZD^4C5%]E#2$Q0W%T(F9?T6RLG_,TX4)X__Y"?,RL MMW)>-E2($VXDKI@5!2HL$9^_V# ?3/N0'&9(C>E%?.6>'T$]%&K)38U0+M/. M[G$[6I:2T7U+RNQJUDJ@NJ!.C+@;YF>6L,4U)*OW@.Q,*T)E_@%;N=\ : #% MLLC+GJK?KO(TW1SGMU1K53-'NU-DU4X/'6IQ990L.UU($?:2&'J)UGV;(MBX MW^)RVU&S':O8A\GJIE9'(9*$5!0\8"( P[08C8 M)*L-69_]K5U<'3QV6(T/F$;&]+HSIQZ?5\/:9%;"]-40WU990KZ469*A*N , M#?5.RGJ:20C7^F:FRCP&U<$*P<0[!XH PM8$S@K(17X%(@.D@6EZ>_)A=CTS MG1"+D_M1,!W0?,X4.$=%@<8"OQ*Z@4D!#&IQ&0'LM,6X:H@$1L/=#$WX_.7X MPC1FE"]:GJR1E)BBL(YJUL#+_ [:'A-()*)8Y37Q&>IUM99+9"6BBHP-!S7Q M6>55 2&4@K:%:3(%)H$*U*LX(N#)D'.$V"M O$9_I BUWTP2HU@#^)ENSANE M,]UF/4LHJ$!")3,3)D/6#@FC8;NW- WC6MR[+: B266W0X#C4P*J$^L:G2UI M=/B(CJ&S$9=I.3QSLR>Q.JO-.7%%*IU9%P2'S\1XY-C>U+=X]Z8QL6H M!"2/OP+!JP;R#UW;'X>VXSBB6L&5U9$8VZ[GV:'C6)^85F\O90.4N&'QBK-6 MS[$]F7CV&$O/M 7MDS/+;%8IKV.I-(GP?-_V M=ZE]W ]!S(A4VG[3JA=57* M(E()\[Z,LLR;A'8P=:Q+T *$LV0 %40."D9:=S2QQYYK7;0-GLN'DF>EBDJ$ M_I2LLSZ542)%%B$_!%8*1_HNT;$\S9=:ZM<,Y&N%O[X=0*S3^6#7*('I(]<. MP['U?A"=F8[.P.8BVK#!AX$;VG[@BB/KM5S(DGQ6HC*SAIY-77OL>'BF5]LC M4AQ.G;'M!#X&40!V%!(A3 KLT VL-YH!;D>MA>IVIVI #1F#H'D3VQM/.?D- M?=Q)^$>W$&V)]E2&2=P=-W_@SW")O[VY1@TH2:#S8[0NSD4? --^T:.O95'K M[9YGNO3][MC6&)>(.;GJ3)YU;9B1#JN*;ZS:GF)@:-?LK4C\)'-PLFC8?O]Z MD'B@M ,4]M2>(B6?7MR^XVR5MFM/0RH']WM*>V1[X00+NT\K;7_JV?YH/"CM MD8,,"$;W2]MU[.DT?+"R_9'M8MH#A\OZ] >N1[L M#9Y:UMYT9(\F5-87$7XM[&OBV[TW$ MI^[7QS2QKF>7XBHJ:[B\$H=<&=1]8F(31U2 ']$.J?Q;I M1M(N5!^^,-BT[BPBDS=S"Y 6KH??R3I=B6]CJ=.L+%M&ND4,1$;5.- M&$)I,70LDC/+_KCC!VT98>M"IO*6P1KW\6GH1C=F)DCB:[ MB<_ /31(88>*:"4)+T6XT24=B>@Z+4EY-IDP:NEW"?JPMLN=KMRP.4\I6S## M&LCEC?)V>,W&0M[5-(]^LO*FNV9K67.; V*#%>BX^:FW$X)]I]W,G9$@1S5H_66(LTK/CN@C1+48).WC\OA MWG#,SMWRH;7G"'KGX'EPZLV'ZEE<2MZCT+P^,G < AB,'!W _Q$3Z(KPZ4R@ MRSKKXB'OZ3U9-U'K;A+O ;J0:;K &=:A''A\J]Z3^(+K3>U)$ [X@C\"SQD_ MPOCMZ<1[B!:,[/%$6WH5U1Q>Z(/=QF.TP+6!*O=V";[W*%4 >?&Q!1A/Q[MV M#A]]9\-&G'Q09*3W654,I*TAXT@ MAOK(=%"#MU%94K.4W2' 'HJAD5\CH@:B+;WY9+"I&\0/62)WYY*MC$G<$"U^ MQ >X=.J>48$BKT$M2OJ>@8\Q4FD;@" .5-6=:MC+T5L#>-A47&"Z@Q?H_VF' MU_YJ S"KK"&<\ZEI=U++IZF#MT?L]OLO ]NCL/NO_F[)O)02"%,- L*G&WZC MK--#X]$N4GOZK5!+K/HTPRJXI4J=$\,U6E?UO^9A/*+H@]R8.?7EDEV&OP_44E*4D )DF I M6VIG]0?RG'J#[0J_L]M@6I,EY@4DEC/5DR7]Q1+%#AVD_!]U0MY,HBCH6P1* M:F";8[WFCP!$BN7!ZA,Q#D/L74??T\%XBCMZ4OO2(D;8JH:A,^AA[AAW)C[R MKC('OOT+Y.[EG(Z+^08 :9+R77="YU/>(^W/-?WU@<[DVT50]1:++^G*4_H*9#P\G$GOB3QX^LAL/V[6O'3F@'P79& M,,#A[7[NBV=0=3N@9[?-G&]1[!.A.?P:]R4 $Z^N[>H!YZ M+OFBSR@3GV2GGD=P2S *C*CVS4]!\C24[9_7E?I@01!/SP^[!5.TF&-JM]^6 M1I;#0,]WQ+YOV4X''R&"H2[Y4TO:M$*4_AZQN]M]S3G3'S'VP_6GH)?Z%30" ML\!4YV0<'F@ZTE[4><&?-()A@0[SSY4$B2UI )XO\KQN+VB![AO7E_\&4$L# M!!0 ( +V(?U9,H87NN0( ,4% 8 >&PO=V]R:W-H965T&UL?53;;MLP#'W/5Q!N4;2 4;)+B.3HT30Y74KWJ M' >U4*/?(*8Q:#(-!9@173IW*! MPI[,I*J8L:Z:!WJAD.4UJ"H#2D@WJ!@7WGA8QQ[5>"B7IN0"'Q7H954Q]7&! MI5R-O-#;!"9\7A@7",;#!9OC$YH?BT=EO:!ER7F%0G,I0.%LY)V'@XO8Y=<) M+QQ7>LL&5\E4RE?GW.8CCSA!6&)F' .SKS>\Q+)T1%;&WS6GUU[I@-OVAOVF MKMW6,F4:+V7YD^>F&'FI!SG.V+(T$[GZANMZ$L>7R5+73U@UN1'U(%MJ(ZLU MV"JHN&C>['W]';8 *?D"0-< 6NMN+JI57C'#QD,E5Z!3+*GG*+,^/;^Y?K^^>'R:]A8"R="P;9&GK10.D7T)#"G12FT' MEU$N%\/M\ MJHVR?\.?724WA-%N0C$0(C].$Y_$Q-E)U^\E M_,P)CXA!$ZVB X=!4E]DG:M'?K=N":!72T, MMD:K0C6O%XBV0I;"-%/61ML===Z,YF=ZL^#NF)ISH:'$F862TU[B@6J61N,8 MN:@'=2J-'?O:+.R>1>42[/E,2K-QW 7MYA[_ U!+ P04 " "]B']6ZGQW MR5X# #\!@ &0 'AL+W=O=7#)@BL '"%"^B+I$$R+&,!J@=U79:%$4?5N1(W&;)97:7EI6O[RQ)R1)@ M"^@+N;.<.7/FRLE6JN\Z1S3P4HA23]WU5 4S)*J- MKRN%+&N,"N&'O5[B%XR7[FS2W"W5;")K(WB)2P6Z+@JF=MM/CJ#C60E MY7'CZ"^;W-[#X_=N7Y=WB_FGB&\*V&G[:X5RW..$[.$$(=[(TN89%F6%V M"N 3J0.S<,_L.CR+>(/I%42!!V$O#,_@18=(HP8O>2]219VLS,Z#I6"E 59F ML/A1\XI:S,#?\Y4VBGKDG[=B;Y&CMY'MW(QUQ5*G!0WHN>)F*.N/EAIHO MS0E:[>!4I::Z*TA9Q0T3()!&15\"4]@-//^)&:QV9/^O)#W!M.9KGC([G!J8 MAK44M"+TV'FDS9/5 D&NH>KXG#ISJ#FP6)$_VR#'@F.[Q;9,X-R=$'TM]2\0 M>&&2>,%P1.>P'WO)L._\9@GG4F3 "W+ZC%970S+P^O&H>SFWM2JYJ2DF"WG+ M7^Q9D[O("_L)$%0O#IS ZT>)-QK%$ T2+QQ8<*W',$_3NJ@%,Y2(&Z1627D3 M/5S$!- /$[B$BV P\I(DADO'\@RBR(N3H>4\2KPD"$X,'7RAY:S1@]?RL$(J MPW^VP)1 2C-2'&UUUKQD96K5VOIXE'0%)D?8(5. =G1/TMD,7Q.L32ELJ4R4 MLC#RADD(033P!H/!6SWN'VVD M6FV;L:4EF7IEU.A]O#:I^W&^U5O?TOW#&U MX=0A M=DVKL:]%U0[:YM!2.K9K^MI*%MV1QS^CVAL@KT?2VEV0O6P>&'-_L/ M4$L#!!0 ( +V(?U8LO&4P1@0 $8) 9 >&PO=V]R:W-H965TB!8A8%TN6TL2 ACW0 MTK'%52)=DJJ;_?H=4JYK+VZPA\0\),]WOG.ESC9*?S8-HH5O72O->=A8NSX= MC4S58,?-B5JCI).ETAVW).K5R*PU\MHK=>THB:)\U'$AP^F9W[O3TS/5VU9( MO--@^J[C^O$"6[4Y#^/P^\:]6#76;8RF9VN^P@>TOZWO-$FC'4HM.I1&* D: ME^?A+#Z]&+O[_L+O C=F;PW.DX52GYUP4Y^'D2.$+5;6(7#Z^8J7V+8.B&A\ MV6*&.Y-.<7_]'?VM]YU\67"#EZK]0]2V.0^+$&I<\KZU]VKS'K?^9 ZO4JWQ M_V$SW,W2$*K>6-5ME8E!)^3PR[]MX["G4$0_44BV"HGG/1CR+*^XY=,SK3:@ MW6U""].STYG8^NWUW<_'Q&F8/#]?SA[.1)5AW.*JV M$!<#1/(3B#B!3TK:QL"UK+$^!!@1GQVIY#NIB^19Q"NL3B"-&211DCR#E^Z< M3#U>_A.\=TK5&]&VP&4--])RN1*+%F%F#%H#5\)4K3*]1OASMC!64ZG\=2P. M@Y7TN!77/J=FS2L\#ZD_#.JO&$Y?OHCSZ,TS/HQW/HR?0_]_B7H6XCC!VU_G MUT$&+U\421R_@2=F]N(5\"%>W(!: B4)NP7J7:)\=&D10Z6H:8UUMVR#L%0M M];Z0J]/@@89*W5/HZ>A)(H(#R'TA\/@..]C3VM(Q_>)OZG&P"GBGM!7_<-?P MP:7O'@*XQ];OF$:LX=6ML@C):_@%8I9G&(]SR#@TD M+(D*EJ41K=(R]^=WW*(DLS&;I!&;3.+M*BK*8(Y5(U6K5H\^&!\DY?@]_14L M'<=.^\$C&G,*LZKJNYY88PVS/9_@5<*R(F;CO(37 M\*H@C"Q-X75 SL0LS<9L3%Q)*%@YR5F6Y13:H$93:;$@+"%A<'^7&B&YK 1O MP5BRUCG/&'#XTG-I!6W1R 31K;G0[@PLNK1*K[O:[RKQ)"TU6M0TLP;&J_^RJ4B&O*1MBJE:<[0 MZ;(GZSL:>S2KANN5+S*7Y3@M*(\I167"QI,(,I;GM(H2N.HU&?74'I%K ^@F MV#.ES8Y3LK#_ ;O9L&Z'-,+Z$&# Z==Z/_;<*GGEF0Y*\>%VQ@?BMFAF#MQ MG+"X3)PX<8$OR:\D"^8-T@?#DNJ!8A^/4ZK?(IC[F!T4[K$Q.=I[VZB95_X% M-S1B>FF'9VZWN_M(F UOXX_KPQ?&)RH*(0VTN"35Z&22A:"'5WL0K%K[EW*A M+$T.OVSH0P>UNT#G2T7-LQ6<@=VGT_1?4$L#!!0 ( +V(?U8[PY8W(0, M /0& 9 >&PO=V]R:W-H965TYTZYK+G!6U7\*S*;3X-1 M !EN>%W8+VKW%Q[RZ3N^5!7&?V'7^+)A &EMK"H/8%)0"MG\^??#/IP 1M$; M '8 ,*^[">15?N26SR9:[4 [;V)SAD_5HTFRE9(+E,AM_" =)3PN"[$EKOR M.)=MPY64]EJEO4OLOW@N%[G.*UT] MOMQU!O#^W8C%\0V\'0]>G-A#2 ;=.+KNO*@?@5M5+&%= M-H@[#VC,&.:EJBEKC?Z(I'4*VDP^]*)N;W@-?W:>FE5XY45];BM^BA%?D^ 1 M.\1(:ZT=N%+:M\0/24+I,**]_^E@5'LQ3!=/)?K@W[\%GKK="&A*T(6AT->P'H)L>VPRLJGQ? M6RM+7=*;.3U+J)T#K6^4LL>!"] ^=+/_ %!+ P04 " "]B']6#3E4$IP) M V& &0 'AL+W=O=7 MH#3>J;B**TN49&GB2Y5SF5I7.6M7G)FI?81(2,*$!#D :,7S]7NZ05*493O9 MAWV)11)H].7T.4WF?%O:KVZCE!??BMRXB\'&^^KMR8E+-ZJ0;EA6RN#)JK2% M]+BTZQ-7624SWE3D)\EH='I22&T&E^=\[\Y>GI>US[51=U:XNBBD?7RG\G)[ M,1@/VAN?]7KCZ<;)Y7DEU^I>^=^J.XNKD\Y*I@MEG"Z-L&IU,;@:OWTWI?6\ MX'>MMJ[W6U DR[+\2A?7V<5@1 ZI7*6>+$C\>5#O59Z3(;CQ5V-ST!U)&_N_ M6^N_E_F?^C,;RX&BX'(U$K6N?]<;O^EFGAF9"\M<\?_BFU8.YX. M1%H[7Q;-9GA0:!/^RF]-'GH;%J,7-B3-AH3]#@>QEQ^DEY?GMMP*2ZMAC7YP MJ+P;SFE#1;GW%D\U]OG+?]]^^7@O[J[^<_7NYN/YB8=)>G"2-MO?A>W)"]O' MB?A4&K]QXJ/)5+9OX 2^= XEK4/ODEW4$V]=)5-U,0#HG;(/:G#Y\T_CT]'9*\Y-.^>F MKUG_?O:_OSV:BY]_6B3C\9G8LR:^;)1X7Q:5-(^1,EY9E0EM?"FDR$N)?EA; MI=!>'G?%565U+LH5LC[^16PW6"T\#*3!@-A*AQ;\J]9D!38J^2B.Q'@VCV>C MD9B,XA'^A(OVYB=M=%$74;G,]5I2"SI1 R06AK5[ZH/$@3AC5>:@"?C M+Z67>2^FJZK*M%*'>Y765OM'<5?;= -N$5==0K;:;_:/$.]EI>%D+&YN MWH<:+1_WS&OG:EB7)EJ()%Z,0B1)/#U-0IVF,RY4J';P<"K&"\)*%%)/*?/4 M*H+A;KSC$Y8RER;E:M#EOE\4>BP,% 2/,^W2LJ:*^KW<W4UE+(J=.;3 M[='3NB71G=4FU17MK;WS,M3W:!"./R50JW28F3]XLPW59("P! MR4V_BJJ)J^N*B 8@0.9M<($P$_!"EY+((F4JFH*I74V<$IF7[0D$W1 M]/'>LUX,:-=4!5?3XPB+J1)8O-1&]MV BVI=XK2A^(/H =9('[0$1!C87R>D\GN+O-G>(YJ.9V[!$ VA/U%AFI6.Q&P2CR9C\0$3$R8"ZR*:'VY7*]0' M7'VCY5+G)/W7QM66T;73?HP15_4:P[](%C\P1@ /_^3T=(>)[QZV$QV0!N5I MO(@7R/IT',\G(S$;CF8"4])\C('N]#1.3A-QIXV1:3OJ7)N=1'_7PQO6.1J@ MVHFG"S;0&NVE,389G?':[C'?')\=QV$@:GT0[Z3YBGO4$E'#'XY#D91[*CF7 MG=J2119MX^KEGTB/8(]:Q9'9 ^4CLH14E+6NZ/EBQK1 "K^2E*V.#A745Q// M$S2H76)1Y75HXUR1* FH2\,ACO2:9NJ.9.0:@:WIK,Z0-L1T)&8/,J]51".% MW,)!9%#+/-1R,OL?3-#*%<8%O!5F8EV6&9R$Q!V-,43D.3=9>BP6.Z]XD@'N M+2@JUYCR,T9VU%D[=.BI?<2='0N,/,_XV2?DYR2FJ8$#91F094/]@:]A*=I9 MVI>EOMW61C==J0"Z7V4:H _I@A7I6_TYFK79&.Y0@AAK$ )Q< ?N7\*8/ RC M$0,Y36V-5;JA#YZ-Q'@X0_"%M&N0AUR6#^$-JCVT51E+;!G09L5TB(2%\SMC MC05-]E/2\/#&E=!2XB4LJ@#CJ&7U-G"YEMI@_R$J2 KVNG,E=1[42UD::YIY M LLE-20<*7A"H[YR/4W<;\V@ 5'G>"A82 ZEA&?'IJU.AW!^EY1NCVV4JJ/+8P_WVMLZ&O4GTE:0N9J4NW#2-IM"8XNB3'[)>S[ M.UZ\ZO!M;PA_ KBKO6G>$=^% 8\'EKTZ\'O[_ REYH,LA MC)5B5Q-"'H/SR?DI9G2"1/,9B?08,T=XJVN4BS*YE1:2X.F-EBYWBR7T@[Y[ MD2/TQ% /TD6+%->?>QLXME\4[\&.D<#@V\*'=R)"=H> TSP M#;##M&AX%[V3J:>[BF#+@]-JP9A.O M[GB2W,,+&TY;UGS<\ + Z@_?CY^OZ*E_Y99VM.4VC&7=-%;=-Q M6P8G0LN)@&P*F0@/X.RA86U)-D$ONLR(2IHM6PG\9*$5;\((CB @5PSZ(JDR;87.7XNBY%#>C&J9RV[T/M=,LWC#HN54A9,8E^*WWYD23J/9% M+R\'ZL'HL"K:TGW^RA^%;X%[Y:'+^J?6$D&ULG5A?4]LX$'_WI]A).YWK MC"&)0].4 C.!TKO.E98#2A]N[D&1-[$&6PJ23,BWOUW9C@--N0S1PV.1:W?[) MT5S,\!K]M_FEI;?NBDNJ"M1.&0T6I\>=@P(.0AZ/. 9YCDS(ACW-<_.2B03KJ\;[A^#[J3+1#@\,_EWE?KL MN#/J0(I34>;^RBS^P%J?-\Q/FMR%7UA49P<''9"E\Z:HB0E!H73U%(^U'=8( M1KTM!$E-D 3!%4#=0$3FEVRK6W]%41G3_Y./YT M!;?CS]_.X>)\?/WMZOSB_,O-]5'7$W,^TI4UH].*4;*%43^!"Z-]YN!^QV #U: M#W9Q_Q7?[&;TY>O->32"5R]&2;__'K;PA;&4IM1>Z5DT*U4JM$2@Q)FRW1Z" MW0H4;#1*2N\H)>]+Q1;TF? P59H(E,A!.(?T6>@4T:D)@LSIFYHJ M3,/7M/("O2E-@DC8E'@A3$U.M8)A2.%Q9BR3-]]:,)E"*ZS,EH?P&1\PC_KU M,PE/^(Y1JE+0QD,FZ%WH)9"CM9NB93A^@:@A9Q(':6E)8! Q1ZM,ZB!X5'M, M]^$FPVB%"KR8Y-A\=MOT#599H%U9C93VZ_A):19W9K0S.9F;),&IR(/9KSFA M'5M?D)UE:0,Z*C_*12(8@[(#BPG:588$ +3H'T9MI,":L7?+KN&#_PUJB_%4:AG5IE63\H812^;%WS/.W8&[HOX9K-=/D5RF(VI!2 M%LR$LR$82NEYV9Y.GIXN]=:3@]?1>+.J4:541 4'ES4UK_-^>89=FLUUJ/O97V^?6Z265%OMG)_IY7[<>_M,!X.#W:L_]/< M_X_)3]J]'Q\,>W&OU]NQ_AGK#T=Q,APTC^?VK[8W.J ?OTDJHN?K30!J_EQI M9)./(N1C\(ZH:C-778DJI$O<;L[%,B00EP"7&>OW/-J";B<3#V(^M^91%:&^ MM.6'Z];N.A)-4(K2KJ22:J#CA.8&JE96@/H6A2\0L5 M4)NZ+.159H-IEOTF&GAGS7P$3K7@H@;,0M]TE9#]PJ2_RH-C1J#WY- M[:\<46N]KNEQU>WD$[7.-%7LHU(!C^'T\OGQZ_8FI MD9$%0:+U- F!5%:6A?/'/\^LXB!K?T26CN>AP@E?;MXH'K MR#CN*DRSF[./+ M6>GJR]D7"F5(@AXE;ST(NB*5+F*D51)XE)E6]UQ7R-HI1F,M2$YS-%AL'Z;I+("?+9_$9 MM?&Y:0#HK@UJ!=I9&$<=!)VKF6VUNYIXQ]6@UQZOQF5RV(S*+971*9'V]M^^ MZ8"M1M#JQ9MY&/LFQM,0&9893>UH^0!]GQIR:OW" E;_ YS\"U!+ P04 M" "]B']6-%5(\L@. P)P &0 'AL+W=O&IODB45+>9IS$:=->+VE\SK73Z0=(A&0T)*'C MBWV^7]]G%R!%2K*33ML/MD026"P6N\\^N]2+.U-]J6^4:L2O15[6+T]NFF;[ M[/R\7MVH0M:!V:H23]:F*F2#RVIS7F\K)3.>5.3G<1BFYX74Y;NY4ETTMWXI#7$3/7D]H/ _XK-5=/?@N:"=+8[[0Q?OLY4E("JE7?WTX7GZZ^_]T\CF;/Q>5?K]__]/<7YPWDTZCSE9/UVLJ*'Y 5Q>(OIFQN:G%9 M9BH;"SB'8KUV<:?=Z_A1B6_5*A!)Y(LXC.-'Y"7];A.6ESX@[_*75C?WXA\7 MR[JIX!#_/+9)*R(Y+H*"Y%F]E2OU\@114*OJ5IV\^OYW41H^?T3!2:_@Y#'I M_^%Q/"[KQP\_77H+P6*BY^)AT>*B\9H;)?XBJR^ @2N9JUI<;"JE$'V-^%!Z M?VKS>^&.P1E-*CG%6M50BFO'DZ*BN@().I' B5V.1V4 D+J]4IFK<5=I9M&E6)ERAIK^B*C M_BTS?Z@SJ^R+7"+3,&G#+,U2Y M4KYWRT)\,L6MJ@C8?589\E2QY>$5P2A,F.E,E*9QN[%[(+,8#-"ES//N/!]Q MA\?.SOM0.D<;^?7A:0JYW5;FUAH4FNJZ;B5V0X/F[.3P.H3.Z@9^_XV2Y.#8 M,5@V0K;-#;;VFUL&CJ)-!: OD1F'GMKY,LYIVV)-)"31;MESRLS+=:')J7!I M$ :%SG-:H;Z16(]$K$Q1T UVI*5J[A00"%/8OU&YK!LXD_F4_&QK2.IR M9:JMJ?A@X33]K/'RNAY9TO2AK%@ZG9WRK+WB'5Z% ?Y'9 &ZBA;^8F&_OG4> M73_S@&63J1]/0_&I=]9GGHT*C[E,_0QJ='[M;I&%0N\]W*4D]B$^YK+<^8LS M83C>0X<,=.]BN\TUOE]_]@6D!#QNF&"\ZGH!3-C4C= M9M^O/8S5_51Y1WZZJ7! 6*B%32M>FD6J7[?P7H1CHRJP#]@1WV%D@.ROJEKI M&E/@I[@#?KA6Y'P^WU@+VHIS//P#ZT/PD7![+@1.J^[0&!M+Q]-8V4,-K8V< MP+I=_@O#25#=PI!V#](AYW I-^$.D0!_QXH0=RMU+I>Y(IW%NFW:2GDLH=[; MO@7XLF5_AQ,>KMZ-]/O%#T;S UB/HX>VNSNU"U:[D/=0#FA?"V0924&0'R.*+O$4"RMM#'!\"W=\!<;W5Y9M9KWSVIX5[( M2)4BMU6CFQY02VXU EG_YJ(.=W)9US8L^4ZAJHVJ&-"!9P[R1_B/9-C68"9U M3:HN=0?-%7S+[:JW%;M.#0S+)0X!'EE+]HG PSG A\B/(C\-I^S(%YZK)/:P ML<<5L]T1?Z)]%E]RAA==VH*&!JQ-CMH$,7Z%D@?)6>T)_/V!*._'_I0_;&WF M_9GYO\K.+F!*@+:X= &"S*.1+0Z>_X$B3KPE:'HG-1*LS-LCPSXI*JWHI $N M3%I;0.L/>JW$*=SA7LFJ?@JV!KJV(5D:@S1JII6X)8'>:YE3MH)M_R3+EJQE M00=PEZ3^#'CV1$R"18J/.(AG8A$LIOC.1HR?>]WV.GQ(P]B?IA,Q"^:1F :3 M!*@)]#P8W\.!.%W8XWIJETF"6=*-/IBU Y6]$0]]#K:WGY@BD4Z(8TZPFUD MJ@F*&H2)F >3V6,;3!8V"P1IBG]A^O4-QO/$C^=OX0!+ M=PN79MM150(&>"7$I#,_6L EP+=GX/B(58]\STXN%-)Q9G*SN1=MW25EFTX4 M1]F:O)^=M8N[;A%.UQGXK+V<(6D,%BYUTMD6TT>C" M9"IGX-@;QP^ T H@F<2!+T8, ?@#9AKBTZ-O:4D(R7)4ZW+#E8=.^5XS0Q!Y=:@(.!4VZZ1OS45U ,A2-:2>78SLC6Q M?N\8ZR>1.$$*Q2>$02#,"=(">>F!8X\#W(P!=Q<0PY!CI'!$Z%CX[D$"'((K MB*&:7E_,<#)@#JH: C'P2R>Z81JXI-9D,,K^ RP4'^4]5V 7EH;:(MR!N<]I MFYW%N]CI;]>F=3T[W'* )Z@T%B'R[,QFW2@%1L\6WAY5>$)Y9W8XK*M&Q-^U MRC,1BN_H#S5(?_ZS.;+W=^),+&+DVN_$#!EO0M?S!5VC* & O", ^43Q$@5Q M2D^38()/+!K3511,PN^@DW/)?:HQ#9((H](@G-/WE+_'4W)1$%&WWY]E1<=; M?YVDW=F1_Q.6MB]K0-.N+!G_"DM[A"W%"6@,4Z-I,%]X?W!T83]57_;)_702 M^^F,6,&W<)5H$?N3R&;E^>0;Q/]''&$LW!&!\5WQSF*Y]U \B5$\C4M6% :F MXA)>;"05*3:\=E7+& *Z<\JU7#I +8>9P*P]*#7W8Y@O3?UY&N_:-\[!/JQQ M21#0=R>3KN5W4#,/Z^*!^W%IK#@Q#NG;I)U$ MC^O7'R0"==E6&R"BS M9EN)[66R?PV*!50K 62GN()>-Y&KPU,G_-+K=:^J\ MO5<0!5L_Y7IPLYM !9R-(I< 3&(VO5;^XK+;%MESFJGGZ7EBM _2?QE @\!'LLV'WY5(! M]^]<$=_UY#)B,V2WX8?WW_LWPMT7?9XT<'SD6X? MD(,4W!,%+YX?>_/FS"W'W#P\!T+O37,,DWWX7@3IPSK%OFQNZ0ZR'I$%-I70Y] M9"' MFCX'7M@^,]5)8_+$[='C/9>J%^(,YYK5?0E*N_RE-32@L.]P^^1'[6(WJ>%Q MG%RHW%-=X>5U:U%M7J \XGHGLP6/@.@]98[5,#&\!GP9=9^<3_.:F0201 M$1T1+JHS!IG6Z_F&10#HL:]#?5C4;4H&@RL7N>? M#UBWKW-(SF3A3Y+YL9_*G ]^Q<3OE>BW6@2+2%CV!TW]W?[G8!?V5U"[X?:W M9 BCC0; Y&J-J6$PFY[8'Q9T%XW9\F^BEJ9I3,%?;Q1JMHH&X/G: $W=!2W0 M_TCNU;\!4$L#!!0 ( +V(?U;L=S\;- @ .@4 9 >&PO=V]R:W-H M965TS25HD MG5GL(RW1-E&)5$DJ3O;7[SF'DBR[CK<#%(TEGOOUHRXVVGRS:R$<>RMR92][ M:^?*L\' IFM1<-O7I5!PLM2FX X>S6I@2R-X1DQ%/DBB:#(HN%2]JPMZ]\5< M7>C*Y5*)+X;9JBBX>;\1N=Y<]N)>\^)9KM8.7PRN+DJ^$B_"_5%^,? T:*5D MLA#*2JV8$B+X4XJ-[?QFZ,E"ZV_X<)]=]B(T2.0B=2B!PY]7 M<2OR' 6!&=]KF;U6)3)V?S?2_T&^@R\+;L6MSO\M,[>^[,UZ+!-+7N7N66_^ M*6I_QB@OU;FE_]G&TR:@,:VLTT7-#,^%5/XO?ZOCT&&811\P)#5#0G9[163E M;]SQJPNC-\P@-4C#'^0J<8-Q4F%27IR!4PE\[NKA[OKE_ND3NWY^OG[Z=/=X M]_3UY6+@0#*>#]):RHV7DGP@)4[8HU9N;=F=RD2V*V )K5V)8U=-\E1B;^) MM,^&<E8(>16]JU]_B2?1^1$;1ZV-HV/2?SH7QZ4\??YZ%\01.V6'Y+&O:Q'< MZJ+DZAVJUPD#124LVZR%6PO#.#3*-D3L>\5SN91 P.$?RR&*@E608\.N7V[9 M;)0P[IA4J2BQR?HHGC7BU\ #T\-PAY$G7LM@CC"]7,I4!!1)T)C5+YCX7LD2 M]>[(^?6761)/SVTC8V*Z;*?!+B(@@7MO* M9%N94K6Q1I/W5%0668'8.K[(I5T'[H#W!N?+*3@ Y) -*YREV'E!N>0+F4N' MJ=*0#@@0MUJ!/#!0& ?!0N?%FS"IM.)(@!E?&>$;),@T4]JAAR0 O85!*(SD M.2@ KZ$\V"O/*\%6%8>R<0+UFQTJ9R2-7A #Z0 :B-_SYS^"V@_D[1I'X*3][\3PPVP8Q(WF*=4KY3\+Y0 =\'6DU07H#?U;9A!.&GY@#Q% MRAM??/ AL_AR6;G*_& X1'T_1#[]^Z:UE@<\M[II$4MIWY-9<.@=K(CLE6.U M@0$'S$;_Q5LMQ9_CJ%!8#743=;N7^D!Z_U*>IU7.?7/6[FWM_0LQWFOT3E-B MX5!+8G"W\8%)J+HEPJ3M-%/0-)-;X^!SL*[SO&TK>*NW Z#/'DBB> ,(!7^Q M5/?B2++; D"4PJ!?.+4Z#G9,NOP@A=?VX)RHIV3=NJ71KS"8R!9,A M5B+<<;&RE&8,EJ'40>LSPM#]ACY52A!C#X.'AE@$I#3ZI(*Y\ M?X!@,A]U!3_^%$9I%;(G@&G_ 7:*!??M2I%LZH:"<%T:F3-:_O&<,EQ'N910 MWG4'#&.+C?&.U?'(#<%0A&8/(UEI_$PW 417UVKVI:> GD\6X8 M] )3BYV891)3"&'P+FU7%=)O'=S@6H1? 'IPA5#\D-[@89-W.#B)QV$410P* MU1L'@N3?H4!U]3IU&FMJ_$,[!;^[K!E%0._!/XE$X M3>9-+B?)9#>70:=FD^2O.G]CX-J2O^\WR#'O/^B:H+;@D+>_5S!0_/GPF*OS M43BN79U/P^%DO%>V@,U]:(>'W:V'819(W#YELU2A4L$YVE/20._2,U0T9C!L M7$$K]$YG#/T:45E[!%X,(SH;XQ1$)X2%6UBS!FF^TZW1OP@HXKM&XM0U&;:6 MZG;721+&HTDXG8V1MUTS'E+46^6]F4 +GM/R\[=G?2 P '0@PT%W 2 C@4A& M4^-''M)%!8O#Y02B,)R.P]EHQI(1="@T\PO@WB2C RAYNZ/0L:-4C]TYH"RAA:/9G/PV$\"VAPQ.$T2L(H'N'C MF,TG\W \F>+#A,7343B/HN"K=NU\:Q^HI MJ**_C<;#<#B;L;\'7_8Q48V'$'475;$O^@2$1_,D',4QE 44C'68+.J+^G)S MFD2GX^ATM%L[#3;!EG:(*+9VIQI,\D#-ZESD5"M(U&XD-' +-O!3!4'@1M46VGP,.@-2%K=6_UH79O"3Z12LKD.02O+/,&7 $8.J5# MJ?R'-9I6ZN =H5,!'A 0)JMO@Z< W>J;U#G;T#FXYSUM'IPNZ5O60CNG"_JY%G 7,4@ YTNM7?. "MJ/FU?_ M U!+ P04 " "]B']6)PY8CZX# ".!P &0 'AL+W=OZY(X21/;@.-DVQ2;Q'"\+8JB M#[0TMHCPHB6I./[[#BE9ZP))@+[8)'7FS)D9SG"TU>;1EH@.GJ50=AR5SE7G M<6SS$B6S UVAHB]K;21SM#6;V%8&61&,I(BS)#F))>,JFHS"V=Q,1KIV@BN< M&["UE,SL+E'H[3A*H_W!@F]*YP_BR:AB&WQ ][V:&]K%'4O!)2K+M0*#ZW$T M3<\OCST^ /[@N+4':_"1K+1^])N;8APE7A *S)UG8/3WA#,4PA.1C!\M9]2Y M](:'ZSW[UQ [Q;)B%F=:_,D+5XZCLP@*7+-:N(7>_H9M/$//EVMAPR]L&VQV M&D%>6Z=E:TP*)%?-/WMN\W!@<):\8I"U!EG0W3@**J^88Y.1T5LP'DUL?A%" M#=8DCBM?E =GZ"LG.S>93_]:W'_[!O/%_?)ZMKRYO_/+7Q?3VU'LB-^CXKSE MNFRXLE>XT@QNM7*EA6M58/%?@IB$=>JRO;K+[$W&*\P'<)3V(4NR[ V^HR[: MH\!W\BK?RL$5M[G0MC8(?T]7UAFZ&?^\%&W#=?0RE^^6$/I<:?T^"WV_UF7M[GNB**7IO#QW5F6IA?P.C?&2?CD/67)Q7P^#ZOT MXC.PJA(\9P'G-,Q*:B6X9.H1:+(0G]",>E3J6CG 'S43/4*]A^R7D_Y9=@II MDO23)($[[4!J*ITK"7^BSBDLOH9U+<071W,'2IIQN>?J%9C[G-H^$!MA+!/,<+3 5 %; MFETV^$%9";U#VFVY*W^B2.'[O7Z"">^4*44QBATPBF7O?K4[B"T;?AC DB(+ MF=DRV^M"Y I^K\FV*5(:9' _X7)M"J9R; 1,'V9P?-K6L$T+\9 [C_-5)&WT MC6)2N98X@._4MZ872CY=7#_ -'=]RH@)(+)26G*Z<2@XK@-59?03]U2N-+K> ME,'5=9L'6*!#%2J^9,\PHS"Y@T_7B^7L\X"N6@#OD!&UGQ= W8YR19[V'=_O M'=Z^3K:O)[U*ABZ3VK3:0Y+):-A/AB].BOA@1DHTF_ 26 @%;L9E=]H]-M-F MQOZ$-R_5+:,Z*$N%7)-I,C@=1F":Z=]LG*["Q%UI1_,[+/UE0N,!]'VMJ67: MC7?0/<&3?P%02P,$% @ O8A_5M^]K,:H @ ^@4 !D !X;"]W;W)K M&ULG91?3]LP$,#?^12G;-H3-&D*#+&V4EN*A@1; M53JF/3K)M;'PGV"[A'[[G9V2E:ETTEYBW^7N=W>V[_JU-H^V1'3P(H6R@ZAT MKKJ,8YN7*)GMZ H5_5EJ(YDCT:QB6QED17"2(DZ3Y#R6C*MHV ^ZF1GV]=H) MKG!FP*ZE9&8S1J'K0=2-7A5SOBJ=5\3#?L56>(_N1S4S),4MI> 2E>5:@<'E M(!IU+\>GWCX8/'"L[?"69UH]>N"D&4>(30H&Y\P1&RS-.4 @/HC2>MLRH M#>D==_>O].M0.]62,8L3+7[RPI6#Z"*" I=L+=Q2)5?-REZVY[#C<)&\XY!N'=*0=Q,H9'G%'!OVC:[!>&NB^4TH M-7A3-\RQLWO/0=7C>%.ZU<:6&J"BS> F)*KLTP?@5[W&-(D30_P M>FW%O< [?Z]B[1#FF"-_9IE JA@%]IF>WJ(_A_W\V_>$5W2"1PFPZ)$R+6LF-H;U;1/1&3B2:<0>P1!U *X%!9 M!QDRP]6*E/0 3/L @*V(37/&-Y5JYIS5;;#K91T\]_S)NI>,?,BBL+ I?DFG0^GT5@FDG3"$Y7H;LS M[6A6A&U)PQF--Z#_2TWE;@4?H!WWP]]02P,$% @ O8A_5C=5&F+M!@ MYP\ !D !X;"]W;W)K&ULG5?;;N,X$GW75Q"> MQB -:&+=?$LG =))&MM TAUT,C,++.:!ELHVIR712U)QO%^_IRCYDHZ3P6)_V^S1=427NLEU3CRTR;2CK\-/.^ M71J2A5>JRGX21<-^)57=.S_U>W?F_%0WKE0UW1EAFZJ29OV12KTZZ\6]S<8W M-5\XWNB?GR[EG.[)_;J\,_C5WZ(4JJ+:*ET+0[.SWD5\\C%C>2_PFZ*5W5L+ M]F2J]7?^\;DXZT5L$)64.T:0^/=(EU26# 0S_MMA]K9'LN+^>H/^R?L.7Z;2 MTJ4N?U>%6YSUQCU1T$PVI?NF5_^BSI\!X^6ZM/ZO6+6R:=H3>6.=KCIE6%"I MNOTOG[HX["F,HU<4DDXA\7:W!WDKKZ23YZ=&KX1A::#QPKOJM6&.__\Y?+K[;5XN/CW]?UIWP&1]_MYI_VQU4Y>T8X3<:MKM[#BNBZH> [0 MARE;>Y*-/1^3-Q&O*#\6:1R*)$J2-_#2K7^IQQN^YE^=ZXK$@WP25\KFI;:- M(?&?BZEU!A7QQR&?6\3T,")WR8E=RIS.>F@#2^:1>N<__Q0/HP]OV)MM[ M0O_+?+RM_>7KPW40I^(7L8\C'A8DED8_*FZE )TL9E20D:60=2&LDXZ$:@/E MY!-9P2(.2FN2Q@KBW IEA>0O)?K8G@3WH(>B*4GHV:MH 2>1,QD'EXTQ5+N= M&2?!IT[KG?CYIW$2)Q^P.HKC*$S23+P/[CW0YE,\#K-X$%S1C !4['#$T91J MFBGW_C!BM_H!;K/[H!WDMZB'/^_.XK@\"]0SVR=Q.(XGXKWX1K)4_Y-,.P&' MIW%<=- 0G:T6?%;"GD(X[0-=;"Q@(6DM000!+VC)P4?<<'@EZ[68H6BUL2&; M43:%JN=>_U)72WSVQHP^(%-352JW9O@YCC0X*P"TG);;3*^46ZC::]<@?] \ MI!@//6)%+HU9P]V5- @V&:6+8W$K:Q!UQ?8L4 NY!C3K'/RL9VI&FN%F!M::N/-639FJ2UBS=7% MQQK*M>&*E(AL61X$DW/,(^M>B>TQ=T2P2Z2@V0Q3@DO9486#,9Y$H;")FLV) M/:V6!B701?M0MMBZ9_NE:I.@R*=2PFZ+4>$/65#72$ ,I$,!YE1-R8#YGG?6 MWSUIK^.N7JJ>!%]>9OJ=2,-X%(798(1U'([2),R2)/BDGCC&[9E'@S@"(B-+/.O_MI M7/CCYG?![_KF5!X%QK \PT8^UMV.7 MMN+ L497OD;HB3V#V (ULM)-66R*R(O(Y;)<\-ZUAG B MI? =C>^HZ[F:=95<@2O]*D"&R3CTK<\U(];:>1 T>X/;&TKF6%P<['?FA2E1 MW4:S:(G5L-KA;L57"?U*-[5KPPO/*X0H*-5W*M>\5[?G:P SG8'1"1QX!RHT M04?;=L%FTE,.Z3F%XK:I:_$[7ZA#<7-S*59,>;+M(P2 "01E7[6]?J,JQ2/@ M1FW8>I.%OYK06TX\#BXX8?DBW)\"H';0(AN_E.N7@QV]5<,0BU@IGO.'76&# MZZTVY#Q9>.0I==/'5P%K!S[5A#%7VPW!J;I02 6W7^LP/&'^S*L&VP77\=[AMV /RY3\// MN^CU^\ >_7XZC.WPHK&'W-G@@$32< "Z'2:CEE/ O.#9(;-O<$=XB=0L[F\3 MTBK[;%"!@)(AL^W1* DG$R#LS0'3D&B6(AY,PG$V 2&'DSCN+D;/+P>AOQ(< MQ0/=&X#* M1Y/@H;-IL[^]0P5?D2#,PS1,8 PAUGZ3Z]C3+B;UF"BD(]2E=[; Q7Q69N7]B\I4!U-*^P[:[VU?L1?MXVXFW M3^!;:>:XMHB29E"-CD>#GC#ML[+]X?32/^6FVN%AZ)<+O,3)L "^S[1VFQ]\ MP/9M?_Y_4$L#!!0 ( +V(?U;R-\4W= 8 #$. 9 >&PO=V]R:W-H M965T*7T-[,5PI+KIF[- MT6QK;?=R/C?E5C3<'*A.M-A9*]UPBZG>S$VG!:^\4E//61AF\X;+=G9\Z->^ MZN-#U=M:MN*K)J9O&JYO3D6MKHYFT6Q<.)>;K74+\^/#CF_$4MC?NZ\:L_ED MI9*-:(U4+=%B?30[B5Z>)D[>"_PAQ979&Q/GR4JI;V[RH3J:A0Z0J$5IG06. MGTOQ6M2U,P08_^QLSJ8CG>+^>+3^UOL.7U;J_E-6=GLT*V:D$FO>U_9< M7;T7.W]29Z]4M?'_R=4@RQ8S4O;&JF:G# 2-;(=??KWC84^A"'^@P'8*S.,> M#O(HWW#+CP^UNB+:2<.:&WA7O3; R=8%96DU=B7T[/'R[-VGL\\7Y/SLZY?S MBP^?WQW.+L1=/3L;>7O8C)\4&>63)N>B4MK+=D+].5L9JI,3?#_D[6(L? MMN;*Y*7I>"F.9J@#(_2EF!T_?1)EX:M'L"83UN0QZ[\6D$=-/ SP\Y>+LR!* MR MR[P3R]F1Y&KQ6E5S+DOMBN5"=+ DK0DKND4>),):O:HFL,P3#MN*Z,@0= M F4Z,KR6+6]+R6N"?=2)*;7L7 42V0Z]Q!?E"HT"$@0G"-UI:<33)P6+\ERTH MX<:(9E7?#,@D$D&N>@]'K0E'?Y)6^*'4Y-E:7HLJ<)*-6LE://=:IMVVW)W;%;93II>2WM#86,JBAJO75X8+!432.T MYZOI6UG*;L<< B@K.(2= &WSF["&/'LS'0O0.X^?O_(>[WGJ?$ 8L":U5MH, M!_F>0M:];J47,ITH?>!K,.*@.RM[6'R*W$)RP]3'2 M" FW4T#@[%:66Y@HZQYA(>(:%XO! %&'8Q*G:U%# P84^!CU-^I2:)=+8,KT ML("HKQ0RCJR%,#2HQ094C=; 9E]).^QA592]3SK0@CMF .(P(GM]S$IEQK0: M,X<@6D@/EGI"+((80\.B'\(CAJJ& 40.]OB'EEK>MJ'2NO"(EY8?DUN[>"T MJ50H0:;L##L>@/E@:A7#W-G&_>@X#!"S%B\,PVL$''_&$^]H\$MT,H7[NO8] M9B-:3[;SEU>(A*M3[F-Y&VO7W;AV.>%[S"7>&)TWX\,Z<&55^>V%]RP *J?I M6\\!^6!)I0"G57;,2J(0(^WIW&#GV>#(<^^L=!T*G>\@6.)E5/6UC^*(>VI\ MP7Y=3'7*(7);$A<*^\$IKWT(AL<7MP37'OH2SA^OON $20$_?B,+FL4%+5B! M<;2@!23"18Y)3%F:TS1D;LQHSG*:L#SX*#F:E;2H5!*%-,LRFB4QB6B:I!19 MX/2*B&8Y(U%*DT5,TYC]'%%TBXC1*"UH7BS<.*=%"FN+")."IC"91AX1)BRE MBP6[@XC1!(='1>8 ,5@)W:A(0QHG(4EID864 <\O4_EA2+BEQ9(/Q]C';H0K M$_8#=SW!RZ3,2I,9@>$'C/,0D Z$A37+GFZ\:]LIY&=(((D6RP%TY).\[ M='%#EJJN2,2@G(+E%-SFSNDHG)2CC$8A?$W3X/Q'*3O*QHAOE.7?SX./"E7C M:A.7G]1>!0@V0' EZWH2S\!V3,,\O;\2+,?B>K=77"E[Z&3X#+@5'SZF M/J&!R=:UVC54PX,\G1$]?* ,$ZLZ_U&P4A;WC1_BK5()[02PC_>)'2?N@.DK M\?A?4$L#!!0 ( +V(?U;L;.,=PP, (( 9 >&PO=V]R:W-H965T MY&0D:IWS M$A\DJ+HHF'R;82YV8R=P#@>/?)MI<^!-1A7;8HSZN7J0M/..+"DOL%1,;09ACH@T#H[]7O,$\-T0DX_N> MTSFZ-,#3]8']UL9.L:R9PAN1?^.ISL;.P($4-ZS.]:/8_8'[>+J&+Q&YLK^P M:VRCT(&D5EH4>S I*'C9_+,?^SR< ;^!X!P#PBM[L:153EGFDU&4NQ &FMB M,PL;JD63.%Z:CQ)K2;><<'KR\'A_>_]X-X7;Y6JZNEE.OT#\-'U:W"U63S%< M/*^FS_/ETV)^.?(TN3,@+]E3SQKJ\ /J((0[4>I,P:),,?V5P".=1['A0>PL M/,LXQZ0-G<"%T _#,WR=8_ =R]?[*'@I;%G#+2]9F7"60ZR91BHZK=X+N*'K MO$]G^N=*52S!L4,-HE"^HC/Y_"GH^==GQ$9'L=$Y]O_WI8.=(;PADPJ0%-,0*6 Q1KEL1R E:E9!, 468MZFUE0(HJ*E6_4 M_M]K+@DY?>$I<^&O1>S"5VZ&"TVC%[=E\''"IUS"A0&:N$/_>GK W5@BCLI> M!->70$/E3U;6-,N@$1$ 5Z!HDI)BG<':C+QV:U8KRK=28*D4-T&Y)]E8ELUL MI>/6WQ1BTRZ_1OC!>FYWX+M^%,$E7 QIT7.CD#8_;9C6DJ]KS=8Y@A8FD05%3!,I>3"]\E7S^^X_:[_G]P0P\#U*=QH MX#=R>UW?#?I&[HPIGMAO/^=Y3=74L#Y0?FX:IMAHH3Q0Q!2")$[[ ]AZ/:')"?LPWL= M[IW,Y0+EUKX^BD*L2]V,Z./I\8&;-G/]IWGS.MXQN>74"SEN".JW^UT'9//B M-!LM*COEUT+3FV&7&3W2*(T!W6^$T(>-<7!\]B?_ %!+ P04 " "]B']6 M_3$TW] 0 :/P &0 'AL+W=OQ]V-D'B(0L;"F")4C+OG_] M/1\@"4JDK#3>=O;%EDC@X'R?\P.@5RM;_.H66I?R89EF[O7>HBSS[X^.7+S0 M2^4.;:XS>#.WQ5*5\+6X.W)YH55"DY;IT60T.CU:*I/MO7E%SVZ*-Z]L5:8F MTS>%=-5RJ8K'MSJUJ]=[X[WZP<_F;E'B@Z,WKW)UIV]U^26_*>#;44,E,4N= M.6,S6>CYZ[W+\?=O3W \#?B'T2L7?)8HR+RG2K5FU>%7OCDH@BR^/8D_B+9.8#) 83^1'FY4+)Z^S1"== D? 3\/4I&;J[60K MQ77T/?YW\Y^7,E06XQ+_Z MY&5JQ_W4,$R^=[F*]>L]B .GBWN]]^9O?QF?CBZV\'K2\'JRC?IN!ME.XM/G M7Z[%^%3^[2_GD_'X0FZ0E# :' 8X-VFJQ97*3:E2^3D3/ZFL@MB4DRDI_SB2 M!^5"$Z7)Z.+Z0<<5!1/XFJ:'XXL7$D=I:8A.I)(_ZT1#!IFE6MX4 M=FFZ8+E$SC U HU0C[DRB0"*H+5*)Y&$X2K/4Q.3/@_,"Y#SY.59!!Q)MU#@ MA_4RG@(9_^S"R=@NER#6 >:N1&(BE/JB@%5O2QO_"DI2A5][ M?P0+C\;MTO+ J[EYJA025229J%3>F S\@<#J1$29,+1ADP?RDN0&R@[*'->,,>D5!9[G?A5';X4 MM0?C"U[G#N(\@7>JY, -@LW;#ED(O3\4?#U FSRP@IB((1@QV61)8\(ZQ$1L M*Q0.%J1PQ&%..HL1X&1NG3,02H>8!)IU(1Y1*B;62)5H%Q=FA@1F%H-Z4=CJ M;H$:;A//<+83<_B^)=MUI W(X-Q&6)10H==/C\^BE\?G,BG4BJ,9TS\JDOU; MTFHW)LM4#$3>JHS]2/@%/OC15SSZ'9"I%V%=>!]NA0;'BE-580!@WJ$@P!!D M96#L0A.2,ZBX!GN6CZ!X:.\27:C LH>=%'SF4S!R M8;/,-W-40,A(E'=CGY.#2 Y=IIM:8Y0%M5FN['>NU+E,19K@(GOT=S0/2@ M\'XMKT,?JYEWHE[5,L%AG;QGG8-.WNE4K= '^W2^34O/IR;19&APT"34DU^" M1;9W&@87K>MNJ#5:CY(ZE;5M!D2!5O$"?-AIJ*=5@6FX1,]5 IK1>RQT:="% M76+NI8I RDP5I5PF*Q/EDR(\@I9;+V?PW++"D GY0JT)#!C\4[_OS1:C6 M*' V=E^8"R(GW*IUXKOQH$^PRD;DU@^A+H)'LS-]1\XD!IT)*FLIAKM%[QUM MS\C)-TWK ;'OVAVU"G4A]6,Y@*CDHER QET)C&)0FB5(:,#TX"=UU_HT'P%M MJKL6NO*BI.J SD?6I=A +L>CT5_;J$>W<@N3XU!(&JXDAZLS('3"OGBW(T7_ M2%IJM3#Q8BOE33VL-!6IFF7/*=*P&49]H)T^HB)@(JA_.+] '\%%*2K![E#+ MN/GJ(21!UWEAYU!VFT<0T*U\/9;IX@FQW3(PO( X1A-2%Q"F+OAL"DIPS!1T MWC$$J;IKZ'') R5 T1N_H%Z B'.I%IU233E-'$QX&&NA75UH562@U;:%@BCX M-XB 8V(P@N)JGC .P[06IQ7I']1H-!6/>AQD-9T!9"@5R%ARPWE70/M6ZW() M+TS6=*+4.V&GITLQMP7$O0>,H::Z>?$V7NBD@FGO,6; ,*6E7DA\N'X'+@2X MZW$=(I)J R3XU0AP$^[)K7 /\,[9671V=M8%&6( [E%6N&!''9^<1^?GY\'$ M(9!%$Q!='9^>1,?CTSK\6CT,H2RQ@;(N?*2T2.MD"[D^O'4H;U11[LJ#S5@? M@5$H54'/?'9V'IV>GG4"'=C=':"7'ZQJ<,JA"!'& BWK 9%EP,:.T,P#]!;,J+=)&@RG_S,8CK31 M XG^("C42OR?!43]MOAZ6"1J6"1[85&PS!5DT-\'B[IQWK18_2*($"+))R!2 M0.)Y@9+H *4--VX;X1HU#=25)W"4KV-;<93HL46+IK:M^[[!L5^)J=97:O0J MG@N >F0UI-BM^ HFBG@^A!='3@]-ZQS>JWPVM#>FG%[.)G3';)D//C-R$1VZAQ$_BMYVL M]_M0G!A&<4]T&?^-6&Y+0MR.Z("*OK/($W=U.9\$>N4%*(0BB*XJE'QF@N_7 MU^)S/)_%7U #F%GV$GCYUC?PE6KHTEH4W'0\?(4- M?)IRF]$L$H$B<\, EO,*ZKM=F&K-^M(1K4M_C^GO2N1Q8-WA M@%8ZUN#^'>J0OE.IN-5EF;*[06_^@YX5X;$YK/<3".?D._N8:FRI\/8,*.P* M @+R4DZ1!UKX/)^;F/-.&.7>B%!A"Q#$MUL /,P2X!G$D2N[PR'3J!PBZ,$L MN7;LR_'A%),\G4J.^1\?AG_)( ",PR26B%O F:1/GQ>@T:H*"&3$WA@M-9SL M'*STY9!H/2K[!C4.-72620:%WFJ9>]#-K/)L4668HGE^S2;T*Q07XY?'QYV. M:JU]#(:WIUT?05G0SJ3BHTT@'F-F$OR7KB;YC1*:^BA_I (!:F'>Q2;OO;T-G[C+E\R.J@-"<8N])/IW<\7 7YRX= ** MHNP4Q1W(1]M=",K?KX[B",R5 /A,P'S<$G!-]A])T,#B]8Z<2 W$?>*72O 0 M/.4+0Q:-R>U:E?/V@=.9[Y&P?R:Y,1D5\*+P:?Z*-S-]8?F'./: M\.;M4[&V*Z4?\)X65L?$:X)+)$J+#/V[RH)F;4@Y?C,5V,D5I836.=>V8+&X MU%<]Q.5.5SWJC5? !*E6O \9+D-15945]L2HJ*Z:^IC84(X(A&>#J#GD/[F9 MM-HJW4?X:Z_]!/O 3:1 B6J5C@;ME> !PX%P;07M6LA%QU*^)Q]K=X"V:;QFE]8P;/;@$VJJ+Z&B'8#OB;J(CBCE'*'6C<&BE6;M'$ MM1-^B[?P>6+20,+]T^!F5A#37G/4$.& 1P '\@!=[1YWK"G+[T/7-0FFU^.@ MX+ZK5P:G!J//=-WC"VB) >85!!M!@ +&@R3>36<(/Y"M\11"(5&/WG,)6F4) MH[:6 BQH;!(!>8 2&1D$ND@ 9"D08!_G=,R@+SP0Z;$'Z&AA@)<%[ASA"0TV M!CDGN%@AI 'I"]U%:8B>\!X/)RL004)/66^A]R<9X9-<2;%..)'\GA @?D/_ MQ/_UE2U7M;B5]7$\DDN^B-O@1O >4 ($)65&VI&B)8B_9>YM:N+V-J!H+!?) M/*T"T\230D+%@-JF:5$R "8S)( M"K,,<38W#S")JV;-7B0P :('U,@[:F#U0TD^MW:\,J^0JQ3[=#S/N%84NYM3?HLYP_1,$) V1*!D/Z ]KWF46L;FB]M M-*#.@#/4[,ZY36;:D"T7"MSKWE+MRK@\$L%[OQL$I>L:-\DXGV^C:#K%-Q)/ MNS\]H7+7>'NO,_M2Q>:HPXZ%C+C(XQ76AL.PXO,!["#/Z$:9E:ZDS@@ - ,^ M.KO 8$&%SW2XZX4B.<.](SI@ \V"V[=]P8W;!E1NG,?_T:!R MDX'_)E!Y]2> R@V-]8'*;8P]%ZC<*GP_J&Q_*;']WGI0T-N!30_-1QV1:*[T M-Y?\@_P&,3:DL,-M6':;5-%3G@O!6] MC9WQ[,9MFC\7SXKVQOXWX]G^NSX; M>+8':(JO!)I/\M<#H9^ZD,0B":^N(>"_KB@FKXNEXWJ.;I32X0S6>JZ?5%BL MTSU$D=_ JBV?/8F:EO+[R[X$FN+%I9E5=S]!;:D_LN1!^P MEG\\L!:;P%K^R<"Z)RW_B'M'4WF5+*;H[EN\VM*:D9V40NU.5&69FF8QW#3+H&EF+?9W MMYNB?VMW.U!19OH;6]S-+N=;>MO 5#U9Z8_K;678VXJ@M^W[2>Q1\'MENK:$ MO\JFRWY9R3]=;IXV/_R^Y-\[M\/Y5^,?_8%QJNVK+_@ LW/X=_\/U!+ P04 " "]B']64) C;-(> M 17@ &0 'AL+W=OO MJ-!X-Z0(=(MDWY*MB%;+[>E9R5*H)3MV-_8!!(HD1B# P=$4_>LWO\RZ0(+L M]NP\[(,M-HFJRLK*X\NC\..ZJK\U"ZU;]7U9E,U/SQ9MNWKU\F63+O0R:8ZK ME2[IEUE5+Y.6_JSG+YM5K9.,!RV+EY/1Z/SE,LG+9V]^Y.\^U6]^K+JVR$O] MJ59-MUPF]>:M+JKU3\_&S^P7G_/YHL47+]_\N$KF^EZW7U>?:OKKI9LERY>Z M;/*J5+6>_?3L>OSJ[>0, _B)WW*];H+/"EN95M4W_'&7_?1L!(ITH=,64R3T MSX.^T46!F8B.?YA)G[DU,3#\;&>_Y3<3E)4[EOJWIUYS&M6_NOW[X_?E'7-S[77]2GC^_O;NY^OE?//U5%GN:Z M>?'CRY:6Q@0O4[/,6UEFLF>9\41]J,IVT:B?RTQG_0E>$LV.\(DE_.WDX(SO M='JL3L:QFHPFDP/SG3A&G/!\YWOFNT[3JBO;O)PKNT_UW]?3IJU)MLU]%O3#%'XE#FB8 YUO5H5N9E6]:JJDU;C#X6!]RW]!2+?Z2)9TW ,X%_RLM40 M!+7J:%###RVJ(@/[\;O^1Y>W&]!VW^HZ?]^1(; D&7+\#XXDT/&A*\O?8=-B M]?[]C7O:?6T?CE5;S36M5=O],<7=M,FS/*GI^,V3<81I*WXRK9:KI(1H)"E1 M6-,&:$,IF4/L>KIAVH5/E@>S#EP^5E_\+V[L]HK@1M,E]$A;J68!ANGOZ2(I MY[J)UD2 -DL(>YACNF[ O)VI[$ ZG:(P3^2U'0G^DU2VC3NJ<"Q.B9?GJ1\J MU@HR1>FWR"PE.SE6U\0),LX-V4!+Q1;=L=))NO#S;]14I\E2T[@UT5]LCJIU M250V_H&M-4+.T4E@NBB8#JN1%60S_Z"+#7R%KIF]E0+/:(&T[;;NHJVZ^4'G+,D5'(2H&)KE)@'_0%&.-[6 M8'\@D3F0X"! _XQLE^&KV0&[3=*\NLSYH6:E4V82=FU-D.4WU &C:DW;+N@D ML@ZGJ9MCLC?1K9[6G1%*\C3D;S#6")#79+!RBX_TL8-Q'."G&N:G,U;\FY?. MZS;"W"VA(3FOW-B?)L>IQV8NT2,\29RNTCS3-,7IY>2U$0N,W9&8UIY7#E6M MZGR>E\RF3),R$?C+F&&_7M]?Q]$Z;Q?85PXAHB.?U<1F+/BU)-6K&["2%OD] M;]**IJ1;QOB>,T@HZG MS+LE:5#UG;;#\"N+5HN*3!&!G8*VY7CVZ>:C\P.D^+K(EUA!8\O3JBXQ.H6: M)Z3)Q/68Y*.4E3KS*(&5@!$'< MB,C-NA1ZC=_(\"UG74%^X$A^:&FD\ Q^53CN+&X@?S']T>HB#O0]5B7Y LR\ MJ):@;DY'JFO,5]*/1-I2URGIL9IVND5AI0@9603]74U(*(,(L>[9:'U(5/.FT<'SQNG%T=<3R6A?"F46^D@,&J0!$4(YY M*;XG- +33=2S&V26D]JYS$"9C]7',KK7*R*">*0FE_&_UNP0H3 HJF]0=-^> MF-V0>!.JRU=L#[:P2/^N$_P_&")1-YJ/<8?XM.,(5)%[)*>>B)DCC%$0 M/#_$_ MM399&%T;O&QAB.BBX)WO*U;+0 "<4 JM$0<8T!(B?T9ZV5L]5@2PVR,R3@\$ M^)18)BV&I&:KO\]N6'&C&)I0"6,)8]8LP" ;:.T_*6S$>)\FO"$OGR4R\<\= MF73-8OV1YH90CT_^Q4+]",AP$4.:T\_.KT;R-P &.YZ''.= TP&7ZJ.ZJI:T M!;)@=.B*(!0K)*@IDFG%UFS#!-&ZH)IF\DBO@ARE"Q@VY_CV^KUHR^^MB(LE M#* 1D/\_[DSDHBLA"P"E:Y(,\@XX?(8)15*3H5<<]\JT $6NPK.PKAE-05E M;#HMX"*[.J^33$=I0KN&IR@(#H(8S+RL'N1$ \D+)H:YS;(:,2R9+(K'V*7E M%7G'.B-U8J1BJ%MJ#H MO^7(9M'$W^*^:,H/4&'+CK"KM=BB+<7"RX3R+7R':7@$2 M' 66/$/\0&@6\M? ?BV9(32^Z#)M?".GA@2V2X9$V0Q)S.'*VHBXHYS>>C3\.M'*L#AW'N#N/\ MX&$0FC@Y,S1$.@9$=O[+12=U7/"2: MH5D$R))F$;"J50])G1/,(S81<&C9]P%_+W+2XF6R 5S01F-O-9EZ.O!WFGPC M4717-EV-B:(;D\0",\!YR7%P"BL52&9SCGVZ&/RMR$Y^SQ'U$V#Z04WBTXN3 M>#0:L,0I?(,4,G"?8S*K,:WO?%*UTCZ48DE?.*U5UFT0]) MT1FX3H-AH,40:(.Y'>,BMJO"-:A]5G73%G;>B3F'6;0 S"MC=F).#<]ALW-F MS1I'AZR"":_]BA3)$ *A:))";K*IVH45G-4@'\D)=1;AVZJ.[%$KR0D^PFK MOQ(8_^](I'2LD+5QLV8/QAV1SR"T,?HW27WP@Y89[#H)U=C8I_4GQ#2I1V@: M[]+4KI]$5%]*)F?'IP>T^,)I\<5!5?LJ,O,S23XF'LP&/V6&R,W ,DL6E>(4 M9QJ>8C;Q$(X7'H3]^]=CBCA^N;[^1,Z$G29@JP-H'*Q](S/GUG5N="72#!9& MY)4)5C'+B:2J!@')TEGEP ,''C>V2#PMJL8DBQ#&D1AS,G'?()=0S4SZFF4^ MV'LTM'=9;1^%M7[096>V1Y!>E\B$9.*R_2#\12J>5QG9'1ML(KN* +0KL!OB M1,UXAM0&F7/'N6-U'[@8S]#0E3DK(6SV-0](ILD-(U-/^LI!KD2R] 591\,K MS@,?B8V "Z.=\(QQE&G2JF6 ;V< Q5A2$O]D<_.'!%E:MM%U9_@6^%A+BH,W M 6(VHD'6"R$C&&4SFP2=4PF[S*[I5S8JI-VP;$4^XW.$!220/"TL9CN$9BZ= MZET>]G+DAV+U60,?<=H"7S Q_.%G8BJQ #L=4LHGS!T]96[^@C- .OC2'OV" MXF,R-@6R-, 1B 1%8=E +9('[7)_,(XDE@Q9"QP!/5*JJQ%IPX;][%;J0 )Y M/@AV58V.P@4X/4_RPS%22^?9M-8I!Y;0AK)&6E BZ)I@A69!RA%0MM0G4=>E M=]M2-"AMS8.E>7==A+7T5U7#>ZT7N@RM[I10)1FDQE@VGD@LX,8GA(:F!'*> MY2CZ'7-)AX0-\V&A!Y--R&>('F,Y> 8*8D1X4KL' 35^2SGJ &(]X(\M /$D MNY0'&=)R\8P](FW+: $M,TYL^K^]):#UA419%]1 MP 024+2[ZF,Q$BK2.-4_F%TXY>4.B_Z@3LY8[JX>D;GQR)?P1P<%YH[4K<1. M!NOR3QRK["?4>SA]WW!^LD[6'B[%W&-QE)?("!" -$Z/W&'>+(AUZ)06@2/0/%CU^.C9Q+-=5\[IIB9+8?$+( M8*/IV[M;7PSP+H^BW@4$]>U\G@-64D(9N4D[ID88!0U=LSL3[ M\_=3W:Z1O!<-%@+]A!:*^$G[]I45K%L!!P10BV@G+DK%FE1K:5.09BQ)1<:9 MT.8X^L++!L95F>";]Q(0LB7\EY=B=$]'CXE_T,$R?B2=4!%D,@D+N,05E'U0 M%YXV4=2;2/6^UNYKR+ SL,:S'2.BI"]S#X%<"D:D[#L^-[!W)@[, IE&LPG$ MZJC@DB:+:ZP(K,(&D<^"2$DI4',(*#:PT.QZ/Y.9R\-@3Y=LE!AL9DR#"X>S MBB(HPHC?T86A>DCI0;N)+0(4K"06W4!7,GRL)!T*[;N[-KE/(XB>9WD07/;% M@]&H6="Y4MPW\0L[\D&B.T! M6_$O-HL'T=(X8O07K33;#S1)0 MM25-0;B!09G4!-A]>-S/K4K;80!3XXUK%!K7MI)<:3-4KG.&EHRH_=F3(;&I M2Q7W: BIVR&(@7<4)H]#-$>J!R^USHN"*/?90R:RZ:FI"M04P;FQ)1))94LX M/<[//;@A!V.BL>^F&Q]L?WOSBR&05[KS^[OF_0T*\=,FC 8G[,DP"MN.63N\ MC8USAP!;-L8F<5&:V@TG+@9CT&.78]FU613N4P3/>"7:/=*$?:K'N)L>(+=R MG+!'IE7Y:R-1DA&0=)88<&<>N3V&3BXU*)O+U*:\747&E7.J=$802WI:H,%U MQLYA*T,#A9Z')V<3=ID&0&KU$38;,K7IY\%:[BEK$07:?3,>6,(WB=LLRP[. MC,\1<8G&KI =:;DBD^9UVBVEP:21W%!.IJ6B;13Y-T1N'(_"?;'1":9&DE=" MV=0Z)IO),VV&QK4D;<#D[4"Q%XF@KL0E?7>*5IM)8(:3%!BBX-*+,*F#FED@ M>*AQ]AB]S>(A 7IL:?+#/I]T.)^ZUC9CC![,"O7&G%.U^7RN>0YS(IQ]6S+6 MG<)09:C75S:S675;\F(WH7;DA):D(Y33PLEL=0YB)I_#9@+#8P 5NR9^9WE; M=MME'J_NTQGLI9*ZWO!A<)K.Y/UVF&4: 814:4)+C%,(9(\\5CUGHGY0Y_'5 MU4D\NC@[9$E]I^_X<)ON'47Z2ZV^)-^'T[I/&A[Q\)Z5G.6%) YM\1ZV/ M($X3X%%38J%0L._X847L,%.FZN>X?4N#&*DPQ[JQ<5AT R7E:MC69#VO#D%V M ;Y_E!TGUIJ96H[D)I&QEA>?R3B787F2!A/4M-@EO*!,N"G;:UB7::^;: MR*?S: M=*C>Y_QTCTKF+BQ8\I#DA>4"9VZD#;;N-V2QU-(34VUS6V2S#JFSKWV/#Q>_ MW_DD^)U/@@\J]E,GBH*)>BIN3;PT[[@L/NW+V58DM@3"VP8W]L(P@5EF,ORF M1Z#:?1*YB7RVD39>2XZ!TR+*D6]8=6%#BWYY&P_RN>V:=HX.+1%AX0D6(U,)5G*7*1 EP8&(5Q-O@V#!9(T')UI;1&PA[F"P0![I;^>6J^%! M1D>#ZE@UBY!*L-6,QL$K%E&P73#XL30I%( >KD&.56JX@.)Q!0$JGI([-H-G MD$!'^6BJ>YOJM:?4^$9J0+%LY$A0$K@G[$&V $%X7V]MP>K+%HXB.>$L6N;X M"T=1H]8M!!(IO3TVMD28&=U;)IDV?AE]4K9+Q5JN/?#&U0".>]K0M;35/TQL M^[9(TF]']RE:O9HP1UAE&NDVY]JW5TB522W M[PT:7Q'-;<(R*"3W-%?BA:*BH)8L\H8M=5"X"76M7R2*\N529SE7;$V]Z(CS M.:9HY H;WE$'^M$37H$ M"-.HP%(K;6X*P6 XP$2Q;98_Y&R12K+&_&C22F!JG2]:V'%E9<'MV7*1B2_I ME'0DW%[YPMZH6G.RG6P^!78&![#N^!#NCTJ$6O#!KHQ5IS[+ME* M^\!K@/ZU-=BXKW/$5)'=$),VJVQOI+#3!MJM@#C'GH$59H[QJ.,']5^^"L M MU3"J++^6%>X,_<:,\D52GM6"#+D)*J3V52]WBY^4_0FMQK;,W%]5V.R<'L'_ MDMLUW>+1;NTW8KL/FP]S[[=7F#2Y5.>GI_')^+3_F+/KXZM)?#J^ MLO]&7SC.&\?\]^F%NCPYCR].3@XUWHU]X\#X<'7_GCLIWK(/N DZ*0;5]LE3 M1>%4_=RNK4AR2@:@8$\KAVT!0:B[E2OR1C]((-]#9GG$VXK^\76XZ_NWM@X7 M#3Y_4V4>X7RI5J1!%^-+?Q'J_L;?UPSW=<0;[GT5#L(DSW!S2C[ZSB/"^E&X M:U,99DRLEZNBVFC=SQ"*7$ .S<];DB4@TS5HR(]<@PFV)O-_MS<:Y";ERG0H M^C!C7G+;[A!P5 %P#,-C4KY>OOG!Q-V\XP:9&-APY-&-U3LDN;[-87RX1>$S M>0;NCL9&W\E-L;U%MZ=-%6U-M5]RZW#Q+!@AZ>\!H7U<])INVHKTG8R.QB/N MYW&+1"%9/2GCAR%H7SGAX;^+.:I\A-)EUW!637)'F<@(!P"J5UV[YNT@H[B) MHT?FW)?\/W3N$]]I,#G<+?!9NMB(.RRL^XS5TV:)@EEZI^U4H;%M<]+ 8GPW M-X_B;*MID<_[E^K2(A=>2(3J[[BA/DAS@9M[YI![(,$U+UR'6.:-Y$M099E) MO@')&)M#L1VO@A^#3FY?O/)S\@JFU"6GC3@J8ZM OPZ3%=DHUAB'9(LI'+;% M/6)LC"'88ZI+/&"6AE\8A73/Q"U=3T8F.'%5^(LOT3 M7,F09!!CC%K/T&74./R/VS;FZE<0-TJ^J5%!I)27[C:YKSA&IM7D2V6/5M(, M*0H%*]O^OW5I(ZAM>@0U8S#2ZE7S*AJ_4'=2F)/[>N[DY!:G/^YHLO7D8W)I M)CJ.3EZ0E3/)%ZGE;PO-<73Z C<&6$Z&'P%[GKSBV0NKKW_H:%=V>BR"*VUF M'-KLE11W/QL*\G>=]C,0DB)RX8^_\=*_8F@3K(6&+IB;0NU0#.;NO;MJ#I>& M[? 5&V=OUX950%_M+;TPCUQ!= M0L,M=)5 M]]FI;138#)_1Y^ATL)@?I,>MC-1:+A;"K9A GB+?0A *;E,T_=9FOZ(CI$=& M;]36C.UF9>[G9Y5NN+S'5;QM >4\+GXUTLG1%)K2^K-S.L9:'\?Y"(NQ;>G= MCZ!(<&;F:.R\A\F-=VF2M!JL7E>:/?G.29/0Z]FAS&0C'O01K(_//$EH602O M"?#]C27?BG9_;]\HW;TWJ_Q-=/,Z!G,%$N,C?]/Q7W#1D>\5>U]70BIMBP1N M O7,4K_C,Q(,')B!)B7 RPRP'JEGR24O*:(A'@=)'T&ZW%H%Q^WL"OM9M[( M)[-T$S2P<,%CGUDUUQ)D69MFY8G=:B DH(.W:)S[T(7:G<-#GS/Z9@IS\3[B MBY;Q]DUH.],I6B3%MJ:LQU9X??>F-XMI"_L2F3/O(6H2ES-V(BNP%:* MC1S.X?EB!=\K *&L_,.;#2Y-.:%)N.(K%?UH#W9\;@PZ9QFW#I;OTX?JY[;U M(K;F;0AJBKWF1!H\S(Z81[G8R4;NZ* UHM=5Q#PVB2:9?@<&M M$S2A%]J@2!^; D#+WLP#DD@ R3:T93!FNB#V 8E0)78Q/]\U(!12Y>9E2KAR MX.* ;0@:!1!T"$88EML&R$"8X&4:Z84-12_PS#8-:6E%@1N/.QIHKF]'W4H] MY GAM;S.N)BXL9DVN?Y0.Z<8^D0)V+$UP1K6\WJ\O\L$BU2XYU"*(*^43;1% MWB/WLV_FRVA/VNSS$$T_J"NDP>+Q^((^CV,8XJNS4?CP 'T4_EY,Z+^3"3Z. MSD?Q^>0J^H'6B<N+HV!A1\PT+K?ZG$9P#]6_]@0I90$YMH.2G&N%%F*= MA5D0^[SMO^0QQY';>VK($S[+@C\H4OKX]/1279V?Q">7!]GM^W(GA[MHK[,' M.-)F3P_NTT>KX',D61M[WX(D?ID0 & W4O$DRJ9[@@G LE612" 0PQIG*)]5 M:V"#X+F9MI<@O1NHQ!W[=L\!8?!:WT8];N7-38E&.XLB.%#9H#EXK8V)A=SAA@?^A3_O0M;FH M?VV.I^P/G/@>M\GA)K5/_,83E"CTW_=[V9I"W:L&=6,$=5AOM[7J>EZDQ M=V1\*F>HN.29 MF%=;R7B@1+3Z9?X)[OZ-"\ZI;O;@-50._I7T+=>AT^ M2QI=TN=4^RNT>=-T[DT%"H4U')*8=3LURL \?EIEKJVP%S:#K,9?<(_,FQO@ M/S5U&QEP;]1.C 3:5:X*6I890OUUIM^:NGY;$M@V6XL0)BL]1 MXB[7N3GWI -=_9%-$YO!VMV1[]?)Y'Y;)H4V[GS_6T<.=3(:FW0"L]$0?'W_ ME7\YPMNIAEM;F(CQ:_L:D_?<,*">:ZE;GDS.7[Q2'Z0;Q$81_4>)'#=SV+0G M[&9J&G>IUO,RH8%,)/RR,2YMARK#_/2'HN M33<-8W!C,C,!?Y(B,AE)?W$4AL5D^L)>U:F[UZRW.M.VVLI-V4#*"Y#T"'+* M'-T52EOU>>P]&(/5MI?!6[H)#L_Y7>3\7H>RE1=VNV_=^\ZOY2W?_G%Y6?H' M KVHNQ1Z1D-'QQ=DEVIY_[C\T58K?N?WM&H)>_-'W$75-1Z@WV=5U=H_L(![ M"_R;_P502P,$% @ O8A_5IRI\7[2 P +@D !D !X;"]W;W)K&ULM5;;;N,V$'WW5PS41=$"0G2U9*6V <>[V360&^*D M15'T@99&%K&4J"6I..G7=R@[W@1PO &*/MCB9>;,F1O)\4:JK[I"-/!8BT9/ MG,J8]M3S=%YAS?2);+&AG5*JFAF:JK6G6X6LZ)5JX86^GW@UXXTS'?=K-VHZ MEIT1O,$;!;JK:Z:>SE#(S<0)G.>%6[ZNC%WPIN.6K7&)YKZ]433S]B@%K['1 M7#:@L)PXL^#T++'RO<#O'#?ZQ1BL)RLIO]K)HI@XOB6$ G-C$1A]'G".0E@@ MHO%MA^GL35K%E^-G]//>=_)EQ33.I?B#%Z::.",'"BQ9)\RMW'S!G3]#BY=+ MH?M_V.QD?0?R3AM9[Y2)0&>I8?F6'3L9(;4%:: MT.R@=[77)G*\L4E9&D6[G/3,='E_>3F[_1.NSV&Y^'RU.%_,9U=W,)O/K^^O M[A97G^'F^F(Q7WQ:PB]W;"50_SKV#!FVZEZ^,W*V-1*^820(X5(VIM+PJ2FP M> W@$>,][?"9]EEX%/$CYB<0!2Z$?A@>P8OV88AZO.0-O%F>RZXQO%G#C10\ MYZCAK]E*&T5E\_J MX:93V)LH^:,=ZU<6CL1ON(_?\-V^,LHZ%%QT]G0 C7FGN+'IQ\=<=%2M4"I9 M0R[KMC.L/TELA!CQ;-8:6G)*5TSAH8@?97&X1OX/:H.9MAO4,UBO:)'Z9F#[ MQC9/,)C+NB9-.FGRKR!;"Z,A<'W?=_UP!$D1DJ#[W"NN+1WJK JA ME(+N67N.,9OTTU>.O%4";W@5N<.13>70>AB[HR3]D4MN$%,8_!B2+'(S?T3N MQ.2A[X:9]28=C=PT'1ZL!N_%'5:C6O6(-[)]( MTW\!4$L#!!0 ( +V(?U;2/(!=+@H %T< 9 >&PO=V]R:W-H965T M.MDBZ* MQ7X8D2-I-A3)#LDHWE^_Y\Z0%.7*C@-TT?V0F(^9^S[GWJ&>[RK]J=E(V;(O MVZ)L7IQLVK9^=G[>9!NY%YLFHDC9.KP?I;XSO\&4I&GE5%?]0>;MY M<9*>L%RN1%>TOU2[GV3OCS$PJXK&_,]V=FT2GK"L:]IJVV^&!5M5VK_B2Q^' MR8;4O6>#WV_PC=U6D;'RE6C%Y7-=[9BFU9!&%\95LQO&J9*2LF@UWBKL:R]? M?EQ<__QZL6#SJ[]_O%Y/C]OH8(6GF>]N)=6G'^/.,]G M[ZJRW33L=9G+_%# .6P;#?0' U_Z#TI\);,S%GB<^:[O/R O&!T.C+SX/H>[ M!D^:AEU5VZ4JA:V-,F?SI@$&YMGOG6J4>?K/^;)I->KF7\<"8=4$Q]40EIXU MM%@HL50%?),-O>^V=Q-D'7M0]7''_C1[G)M.9QN@ MC-UHE2.41OGK3TC59U%T1F-6;;=(%["2?6(*@B#_ MU.-!$G'7=5FS$3#T*4NXY_L\X8@[M.,6R//1Y% MB?-VDIVYS<[$YUK<&H=/0R_B0>BQI\XKN9*:8J8EG._HWOCG=5V1"0[ MG;D)=\, BR@!=PQB$5P*>>2%SNLO&<'V,&OL^^]2WW*PMQZ%Z@8 M),U/N9_,V(>-=*3=7 ^;:[,9EVPI96EJ5N>F3-FZ%\54R=J-9&)+'E-EB+K6 MU1>%5B"+VP,5?WN]TGO;QP=(^-$^Y(]B/ M$FU<"2C3=:5-59V9.-T)$-7.W4=%464]:S84%1.C"6OV#M!ECDBQ584=N^;L M/FB' /:,SU"2CP=WX+H'T/;X+"(X>-\"[9C[40K%WN.@'^:%7X%U/ #_.*PC'GL^_ T?"VM_ M%O,X)5A?B5J1S$)20*MEH=;6VKVE]X-[+^8XN .P1Y0$WPKN61CPP$_9A_'J M?9$[B_D[=B-TBY W[-0@@[I/QN9*/R4 OL_:BN#G!0/\J'@Q"-2BO&58+P2^$S+VI>_&,&WM-$',93KJ80_HIDS@=K;L=\PF4[!YM#^W0;(N/VAVI50 MVG3+1N4*<_& J<&L4[KI(S'$1P]@-H; =S;UG;.W;Z](]9NBTBH7:+1;18PR M--Q; U((=Z;"%QB-]Y(Y>=YT OXB'+N-RC;&K-&$?2\GVULL5."&6R*(D19L MOOL[*Y\COEG1Y:J/'=:H=4EQ=8AB2Z (KQN,ZBQ7&+_4LK-D,X2?J)3=S>1$ M08]9F7,BJ R%BC'$AAU2B.>2I?N]D&0ZFR.Y=MF6_.L:V]&(P^*#'!/8BAT]M'JZM"D?E(5XL_9*RI,1S>=<_6I S0TT3CN=FW MSPP"AP2&L6L3^!=- B,('S\)C%7G7-T7O:7Q=]QH;>\+[YYQH;3C@JFPD>4P MQP_F/6I>\/P93\-H,B\$,>:.AL<#C M8)4_G!("_\%1 <-+@"- ,DON^CE]]8T-&WD*,"J[P?]N&M^K0*=_)R!Z_&Q@ M$ J\[0S/P*>VL-1"8JC-U!W*L]V(%F1;P:"\TT-_6BG=M.SW#KT5.<$&$@@[ MVQV9NJPPA]=X1U./EFNA#9-D4K<"G02#(9V1RW:"P9W0FIHE-O0^'1DQ+/-; M1K1$=& WR=EV;8?\H4KDW;WDJ^$DTQ =\RHGD&.Q*@F@J&N,%IH^62$X"G)Y M3Q T \'AP32&M$>[#2%9),JU(D3UX\2.W"NH@+"U9T#$])8"WY>'Y:.[3.T; M9AL'JWV900L>*6UK8JK3R'F"037%*31-_'UM^=&DMO[,&?)=5Y;FFZP9XPY' MR+?](#?,VK?.H/A/'2A_5?3-%7Y^&B;)T8+_IU&2BA14@B)8RV&T<\R'I'KH MF]/C"FZ7W2VV=26:@P5(M^S14^;[FS7 #AND_(LZH3E, A09)@,J:G";Z[P" M+!"] NHQU>-OZ6!FBQ<_JGU9$3&.JE'D3GJ8E^!)&J#NFM;R&=C" MD'!NIE#8V_1Y(812S)49W]"O4OH^Y3_0_KR^O][3F7SNSD+NI]'Q0^S+0=&! M^FQOZ& >LM"5^^\L-'?15][&?#1,4YX&Z<.?K*;+CIUK$S?B8?C-33)R,8+- MV /?AZ/Q^W#TZ._#*_0)$"92A*;6CFQ@2WV$\;$/P0_J^/J'X,)I]DG]R^6^1WH!6#U<,X[$5EG=94GC7)LZQR?-^(NHE"S(!^ M$(T*"[#]#]3YOBZ-/(>#?N >+8CSR4\^&!;7YHLG0( )8% 9 >&PO=V]R M:W-H965TY#9 M4*QTR6M\D*!65<7DVQA+L1EY@;>;F/#Y0ML)/QLNV1P?4?]8/DAC^2VEX!76 MBHL:),Y&WD4P&,?6WSD\<]RHO3'83*9"O%CCMAAYU K"$G-M":D'!<[8JM03L?F*VWP2R\M% MJ=P7-HUO%'J0KY06U3;8**AXW?S9Z_8<]@)2^D% N T(G>YF(Z?RBFF6#:78 M@+3>AF8'+E47;<3QVE[*HY9FE9LXG=W>/U_?/WV?_(+3)S8M49T-?6VX=M7/ MMXQQPP@_8 0AW(E:+Q1Y4C<.CQ"O,SR$*"(0T#(_PHC;+ MR/&Z'V59K['60K[!%5=Y*=1*(OR^F"HMS;/XP/V&H+.A&W,R],H.2L5G$!$XC0A-*9VG'1)+^EW;GC-S6,L8"Y$H2 D M04!)&J40D#CLD[C7[[S?!=.0"Z4A(4D_(6G/>O72+@FCM/,-E1K I%$-IVF/ M]/HAG,%I$%-"*86S/=")1="4T+1KQ@'IQ@X"AZ["WZN5"N7<=01EA*QJW91- M.]LVG8NFUM[=FXYUQ^2MY+/)!-%V@,+9:N\J9"FSIVPX5IG"BM M@UF?":%WAMV@;<79/U!+ P04 " "]B']6-4V;/\P" #J!0 &0 'AL M+W=O74K[[^>[!,8FRK[D;)_]^'%\]G#+Q:-,$!6\ MY%DA1U:B5#EP'!DEF#-YP4LLZ&;-1NQTZ.4L+:SPT MMH48#WFELK3 A0!9Y3D3KU/,^'9DN=;.L$PWB=(&9SPLV0;O4#V4"T&:LT>) MTQP+F?("!*Y'UL0=3 /M;QR^I;B5!S+H2E:QBH963T+8ERS*E-+OOV$33T= MC1?Q3)HO;&O?@#)&E50\;X))S].B/ME+\Q\. GKM-P*\)L SO.M$AN454VP\ M%'P+0GL3FA9,J2::R*6%;LJ=$G2;4IP:+Y9?%K/E_0^8W%[![.O#S6(^N[V' MLWNVRE">#QU%2;2K$S6 TQK0>P/0]6#."Y5(F!4QQG\#.,1N3]';49QZ)Q&O M,+H W[7!:WO>"3Q_7[)O\,*W2A;TI(5ZM6&1L4(!*V*8/55I26]-P<_)2BI! MC^77L=IK9/\XLAZ@@2Q9A".+)D2B>$9K_.&=&[8_GN =['D'I]#'=S20<94A M\#6430V&/.[('V-\$O,XX_\G:E%/,%^A,'TY5%JZ2;I3;FO.HH32B==__O![ M<&TO#&VWUR?9ZP1VV.NT/B/-5L*S&-*5X-+.8!)%%5YE3&%,7&F>J.4 MF=5P%A! QPOA',[<;M\.PP#.6YJGZ_MV$/8TYWYHAZX+QQKI',Q?CF)CMHR$ MB%>%JD=Q;]TOLDD]OW_%)N)O;.M3)(OU_WUH^0TE^[28 ^)28G\^%&D MQ/%.R,^J0M3PM6TZ-7$KK;?7GJ>*"ENNKL06.]I9"]ER3:K<>&HKD9?6J6V\ MT/=3K^5UYT['=NU13L>BUTW=X:,$U;)\;>&OQ6XTX=R6 R60GQV2CWY<3U M#2%LL- &@=/G"]Y@TQ@@HO'W'M,]A#2.Q_(+^CN;.^6RX@IO1/-[7>IJXF8N ME+CF?:.?Q.X#[O.Q! O1*/L/N\$VB5PH>J5%NW\AD&5YRS6?CJ78@336A&8$FZKU)G)U9XJRT))V:_+3T_N'Y>SA_?W\ MXQW,%HN[Y0(NEGS5H+H<>YKPC957[+'F U;X!E80PB?1Z4K!75=B^1K (V(' M=N$+NWEX%O$6BRN( @:A'X9G\*)#MI'%2]_ >R]$N:N;!GA7PGVG>;>I*5F8 M*85:P6VMBD:H7B+\,5LI+:EG_CQU#D.4Z'04ECV1%NOO4SA%]BS<:;)G8SA4%6Q7*&UECA7'E,G4 M*G".O/APN*I?_457$;0 W@JIZW^XN9?.C6UR GC"QJZHJM["Q8/0".$E_ @! M2Y.$)7E&\HA%8<1\WW>6DI<(#[Q%!2$+_8PED4]2E*=V_Y%K["ALP$:1ST:C M8"_Y6>XLL:@ZT8C-LVV$7SJJP ?Z92R* ^/]37*"B.51PK(\AR!GHWQ ^(A* M7<.L*/JV)]98PNPH)[@(69(%+$YSN(2+C#"2*()+AY()6)3$+":NI&0L'Z4L M25(XTQC)H3&2LXWQKM>F33/?)_PSGT>H*N$)Z12P78 ME76W^:YM(EOH,$E9'F=F(7ZM)J_5U*AQR((\-.J(U" ?L3Q,G&6%-)W6FK 3 M%L0152%SED+S!EX=_ZD3]XX>4FK)C1T7"@K1=WIX4P^KAXDT&Q[B;^;#./O$ MY:;N%#2X)E?_:D1'+(<1,2A:;.VSO!*:^M^*%4U5E,: ]M>";L!>,0$.07:#I"@;T.BM&J[[;-)#K": MV)GME/;?[^Q RB:*]F5?DCO[[KGG<QIC+]< +O>W" U^NC%WPA_V2+?$1S??R7I'G-R@9+U!H+@4H7 R\47@^ M3FR\"_C!<:UW;+!*YE(^6V>2#;S $L(<4V,1&+U>\ +SW (1C5\;3*\I:1-W M[2WZM=-.6N9,XX7,?_+,K ;>J0<9+EB5FP>Y_H8;/1V+E\IL-[&!!VFE MC2PVR<2@X*)^L]?-.?Q+0K1)B!SONI!C>32*=CGEF>'U9#::74QF-S"]&CU>P=UX.KD9/4WN9G#TQ.8YZN.^;ZB0#??3 M#>BX!HT^ TCN)7"K#1P&WP]P#1IF":'T(>/= VS*D>0"UA4IE)HVX 750&EXJ2A9#DPD0$7!JF\ M@9*]T:TQ&BHZ? 4I*[FAF-P)94HQL407L$_J03+[I?Y'ABVZ>6!6"&_(E 84 MF?UDU Q8S"F1&J)%#1'#9^B$[5[8M5X"R6D[3#K6[NS8W1V[!W&W'09GK2?Y M7KAA%<51.^J&K2EJ?0ZC0E;"T !RBH6Q#!HE1TG03GIG<-RZKW?AA>75OJ/X MJT9X1H1/HTV-M%+*)I=2N5EU%,,>_A]:"^96K)A29""TH-3GH=#U0] M_&K'R-(-G+DT-+Z=77&5H BDBJ=.TB+656F#:I+%5P#;MT4UN6PLGSFR'PG[]KIT28"K9 MQ%X2?]QS?.Z'?4<;I6_,&M'"72%+,P[6UE8G462R-1;<'*D*2]I9*EUP2U.] MBDRED><>5,B(Q?$@*K@H@\G(K\WU9*1J*T6)-R'$Q[)[.!L_<&WP1NS),Q.$\6 M2MVXR<=\',1.$$K,K&/@]+O%4Y32$9&,GUO.H#W2 9^.']C?>]_)EP4W>*KD M=Y';]3@X#B#'):^EO52;#[CU)W5\F9+&?V'3V*9) %EMK"JV8%)0B++Y\[MM M')X CN,7 &P+8%YW<8MGXRTVH!VUL3F!MY5CR9QHG1)N;*:=@7A[.3S ME^OS*YA/?TQGG\[AX)HO))K#462)VUE$V99GUO"P%WAZ#"Y4:=<&SLL<\^<$ M$8EJE;$'93/6R7B&V1$DO1!8S%@'7])ZFGB^P4N>*HL&YOS>N;C+P0:>[(:[ MRW%B*I[A.*#J-ZAO,9B\?=,;Q.\ZQ/5;ZO>@(WQI&[[TG\-74IZA:M(, M)3UKM)8+DZEZ=\@ZF?\>LJ[C]OX,"=N;:U%FHG+8VAK+F]#M PN/XR949[BP M+0,<)/W410T.MW%C87_ O.$TR^JBEMQB#KQ0VHI?/F5>P3.2X3 <$(#\HF>" M7!#2:27AX8-BC0U/"W&*TGX<]KH3-&@3-/B?^MZ5ET["5Y7RLZHU8#KJEH7Q MD#U6[C!)GY5NFZV=L8F>/,<%ZI5O.@9\8)N7N5UM^]JT>,'U2M E ME+@D:'PTI&K53:-I)E95_G%?*$NMP@_7U)M1.P/:7RI*\W;B#FB[_>0W4$L# M!!0 ( +V(?U8F+P+S,@, (X( 9 >&PO=V]R:W-H965T;T9BE5Q@Q-U:+!A*YRCN=_<*IIY>Y:49YAK+G-0N!PZ<7 Q M[EG_TN&!XU8?V6 C64CY:"_I04> MVSOVZS)VBF7!-%Y*\86G9CUT^@ZDN&2%,#.Y_8!U/&>6+Y%"ET_85KZ]

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�Z9*13,*(5&(IVSC%3_/4O00"DX MX(/XJ6"*E;._!W.E)9R)/TWR*QJWF<842E?E)*9]"RI!4;FF5O3I0RMPOAPQ MX=8FW&/1(\B)VZ2I0GDERM3:.G+;. B]GKUN8/-J-N\4F]?$5J'\=[+Y-9M_ MBLUO8O/WV#INJWV +*C)@J-D#T(3WL06[+&%;NA[N)FN7=.UC])=P\'KHEE& M4B$U^TL3E# 5BR+331K:>QHN,!R@=M@L(JQ%A*<](Y M"@I*-("<:@ +F32 M)"/D8JXD)*"C-SD TH.[I!F8>P MZS=+;3G_+T#G'2GC(EM>:"K3TW(;[SMGOSH[+G:=-^KLG9O:O'HW1"Y9IN!R M70#0N6R#05D])-5 B[R\O.="PU-0=E?P^%)I-L#Z0@C].C#O0?V<1_\ 4$L# M!!0 ( +V(?U;R\" ^ZP0 .D? 9 >&PO=V]R:W-H965T]S[%\7B1Q--Q1]HUO"!'H+4TR/NILA,AO#(-' M&Y)B?DUSDLD[*\I2+.0I6QL\9P0O2U&:&+9I]HP4QUEG/"RO/;/QD&Y%$F?D MF2&^35/,?MR1A.Y&':OS?N%+O-Z(XH(Q'N9X3>9$O.3/3)X9#649IR3C,=E9Q:8DPE-_HZ78C/J]#MH259XFX@O=/<[J3M4 M/F!$$U[^1[NJ;5=&C+9ZZ@5PMZYPJ\6N"5R:K>;IF:*19X/&1TAUC16M**@S*_ MI5IF),X**\X%DW=CJ1/CNY?Y[-&?S]'MY(^7V7SVY^SI$7V:$H'CA*-'S!@N MO/(9_8I>YE/TZ>?/0T/(N(7:B.H8=U4,^T0,!SW03&PX\K,E62KT$[W>LC4 M0W:XZ;7]WNL[6TM\P.P:.=85LDW;5CV07CXED58^/2.ZW3TI]_7RITA<(\LI MY99"'NCE2L53F- I^3U3AEPR^45SM%M]'T;\[@< MH+[>RVMH)DC*_U'YK4(Z:F0Q>M_P'$=DU)'#,R?LE73&O_QD]!UW3;Q#8-8N_]O--M&$N?<.0,!\2%D#"0B!8 M*_&])O$];>(G&YRM"8HSM,(QDXL2]DTNG5]QLE5^&WO']G,5+M#&O-0%D# ? M$A9 PD(@6,L%7N,"3^\"N3*+I0\R@2(J?Z$L2;%BI)G* M[10&!YJI% &_%2 M#T#"?$A8 D+@6 M#_0;#_2U'KCE7'[S9VDNQX&T<((<&MA:.0KTSYO3)MJ MEUH $N9#P@)(6 @$:UE@T%A@H+7 0?+E^CW.A)P;XD5"N,H$6M2E"[/!\5JJ MWW7[GMUVU!0RJ \)"R!A(1"L90++W%<33*T-GO)R^,_6Z)[(M?D5>L8_"E,H M;:!G7>J#FG9H!,V\#6[\V2"D3\;_E MFA#1%5K&/*);.4W$Y331LHAZE-#R+[:'?;P <7NFYWST!V14'Y06@-)"*%K; M'_ORGZ6M%8WGT@(QNM_*60)]?2#I@C!ER4^/N=@&H$4_4)H/2@M :2$4K6V6 M?>7/<[%;0(N:->W_ MZL:*9NK"L:*ALG*L:*MRCYFCVOLFU>; MX ^8K>.,HX2LI-2\]N0SL&I?N3H1-"^W-1=4")J6AQN"EX05#>3]%:7B_:0( MT.SNC_\#4$L#!!0 ( +V(?U9'G&.'I0( &4' 9 >&PO=V]R:W-H M965T3?(!5)Z:V(>V_GYVD68" ^C >$MLYY_@<\]F.2\8?Q1) HN><%F)D+*5< M#4U3I$O(L3AG*RC4ESGC.9:JRQ>F6'' 647*J>E85F#FF!1&$E=CMSR)V5I2 M4L M1V*=YYB_7 )EY!*5DLI1XPDWB%%W '\GYURU7/;%4RDD,A""L0 MA_G(N+"'XU#C*\ #@5)TVD@GF3'VJ#O7V X#0$YZT$MR&X5=#:615K@B5.8LY* MQ#5:J>E&M3856Z4AA?X7[R177XGBR>3ZYN'SS8_OTU_H9 (2$RI.T1FZOYN@ MD_>GL2G5%!IHIHW<92WG')";0'J.7/LCV8'UJ2_M?Q+;RNZVV=UCZLD4EZI0)'""J>A+6M.]BJXW^R9QO1W;MB(WVO&WC[,] M9^"%!PSZK4'_J,%_M8,E2IF0?1[]O;E]?^!'X:['?9P=1H'3R;+E,6@]!D<] M?@4AAFA:UTZ?OV!OWK,H# ?.CKT>F.U9ZM=O+VSMA6];PCYKX5Y9^;X565&P MXVT?9P=>S]*9G4-07T#?,%^00B *<\6TSD,5C]>'>MV1;%6=BS,FU2E;-9?J M'@2N >K[G#'YVM%';7NS)G\!4$L#!!0 ( +V(?U8\(ZYN9P, )(. 9 M >&PO=V]R:W-H965T'?STY":-H0Z!2^M'9RS\DY-]?.=7]) MV3V? PCT&(4Q'VAS(9)#7>?^'"+"#V@"L;PSI2PB0D[93.<) S+)0%&HFX;A MZA$)8LWK9]?&S.O35(1!#&.&>!I%A#T=0TB7 PUKSQ>N@MER^OE@U MM1EG=5RSXY1A%;EV*==NE'L.G!^B(]]/HS0D B9H"#(K?D#4-E"G-^=S5G3L MVX;EF.Z:WIHXW.FYKETOV"D%._^5WQA$G5IG0P7&EF6[W36U-7%2*\;U8MU2 MK-LH]H+X$3IMI:(FLDH9N MF89NNQM"=[,435F*W=Y:R6[&F8XL[%QU\OV MS;"JWI?V S=^UKVSE,6!2!ED@L^"1S5N+MQFQJW?UT>T'?BE[\#61Y9N8U>S M=2I:8JNFXJ6GP@?")HDITA[JB0)Y)L.)>'1F J0-Z?4BJ>)^I84AY#O7]0 M2P,$% @ O8A_5I,:.)!I @ J 4 !D !X;"]W;W)K&ULK53?3]LP$/Y7+&^:F,1(DY2"6!NIOZ;Q ,L*;)JF/;C)M;%P M[&"[+?SW.SMI5EB+]K \)#[[ON_NN_BNOU'ZWA0 ECR60IH!+:RM+H+ 9 64 MS)RH"B2>+)0NF453+P-3:6"Y!Y4BB#J=7E R+FG2]WNI3OIJ9067D&IB5F7) M]-,(A-H,:$BW&S.^+*S;"))^Q99P _:N2C5:0Y+0;TG)(<%FPE[$QM/D.CY]3Q94H8_R:;VOZ%U9E[6A%F6]+7:$.V\D7:97T^M;ON\'%B,[?) U449UE.A E# B5TK:PI"IS"%_3A!@RFW> MT3;O4?0JXP2R$Q*'QR3J1-&>A,;_#@]?22=NRQA[OMZA,FKL*VV?CDDJF+2$ MR9Q,'U:\P@MOR<_AW%B--_;7OM+5S/%^9M?%%Z9B&0PHMJD!O0::O'L3]CH? M]\G^3V3/BM!MB]!]C1V+BJ099ZX_]PFMT5V/=M-EG411?-[#W[?>E?"W6QB? MX=.ZU^!+WTL\"03*VDK>]1N]N.FZ'OLA?[(QQ#]=3X0U//L"NFEUP: M(F"!E)V3LU-*=#T7:L.JRK?67%EL5+\L<)2"=@YXOE#*;@T7H!W.R6]02P,$ M% @ O8A_5G[ Q^JF P +1$ !D !X;"]W;W)K&ULM5A=CYLX%/TK%EM5K;0S8!R^I@E2)FEW(TU'H\ET]Z'J@T-N$E3 M6=N9M/]^;6 (3 AM)/*28+CW<,[UL;DPW#/^76P )/J1)ID8&1LIMS>F*:(- MI%11K4VPYT&6>E":F;5FNF=(X,\)A?NZ!AT.VDTFFE/^\A83M1P8V7DX\QNN-U"?,<+BE:YB#_+)]X&ID5BC+.(5,Q"Q#'%8C M8XQO)MC3"7G$/S'L1>T8:2D+QK[KP6PY,BS-"!*(I(:@ZN\9)I D&DGQ^*\$ M-:I[ZL3Z\0OZIUR\$K.@ B8L^3=>RLW(\ VTA!7=)?*1[?^&4I"C\2*6B/P7 M[8O8P#&?W3^/[OV:W=Q_1>#[_^#1'[Z8@ M:9R(]^@*?9E/T;LW[X>F5+?2"694PMX6L/8)V"E$UXC@/Y%MV79+^N3WTW$S MW50"*Y5VI=+.\=P3>)_B+)9P=:<M#F_*>P!IU(%4=2!=Z6)-."^EK MSH1HTUP #7(@O1<\AY@$Q/&@^U_6T! 9>8%G^(;#!=5!Q'71RO0,A;M X MBG;I+J%23=P45$FBF.KUWT:YP'-J3*YLQ\<#]S7EED ?$X>0=L9.Q=@YL[H9 MR#:BSM']L;K]8$"L5T1; OW X/59AY[ &G7PJSKX?>T%_K$-E0>=P']E MU^,XC]C$LJQVMP85TZ"3Z1.G2T#W-(5NBW:BG#LU/8$U!&/K\%2V+FG2$KVG M4O2%UJQ%K4/!?1FU1*H[T+8MWSG:6-L"2>">M"H^=!JX\P$>/JA'52:[C=H- M6 I.+6K6S8SF[%CVA-6MQ:%EP=\]RCE6/FQ#L$> M[*_PH5W!W?W*$T2;C"5L_?/J5KT)MEXL[T<^>N9[0FK4X-$38O:B+>VV/ M^D)KUN+0(.'.ON,L%WM'W;]/!KB^CY:2?AU8L#5K[[+Z0\)GRM=Q)E "*Y5I M77O*)[QX-R\&DFWSU]L%DZJGS0\WH!H&K@/4]15C\F6@WYBK+R3A_U!+ P04 M " "]B']6PL;LR\$" "("0 &0 'AL+W=OPPSDW>:&JYG9N"Q)!KD@+$<<5@-C:%V,0UU? M%GPG4(B],=))%HS=Z\ET.3!Z&@@H)%([8'78P1@HU48*XW?M:31+:N'^^-'] ML^ )U'D_[)8R*\A<55:WG&"C9"LFR M6JP(,I)71_Q0]V%/8+D'!'8ML%\K<&J!4P:MR,I8$RQQ''%6(*ZKE9L>E+TI MU2H-R?5=G$FNKA*ED_'T>CZ\OIJ.OEZBX6QV.9^ALPE(3*A UGOT$=W-)NCL M[?O(E&HQ+3&3VGA4&=L'C">0G"/'^H#LGFVWR,>OEUM/Y::*V.2TFYQVZ>I[86_">S)PUQFH8X7>ZQZJO3%K!2N:5* MOP)VL65[?NCV(W.WS][I?B*[V["[Q]C=-O9*Y1UE[W0_D=UKV+UC[%X;N_=* M]D[W$]G]AMT_QNZWL?LM[*YMA?8S]D[W$]F#ACTXQAZTL0L+> MZ7XB>[]A[W>RSU-0._1* F]+T'^1P+-J";R M:M^O)I)MRJUSP:3:B,MAJCZ5@.L"=7W%F'R&UL MM9A=;]LV%(;_"J$.0PNLT:Q"+%]R'/2_%()Y,]H5]9"L#1]R(OV=1(.:\N39.M4R@PNR 5 ME.+.AM "<]&D6Y-5%'"B1$5N.I;EFP7.2B.:J+Y[&DW(CN=9"?<4L5U18/KW M%>1D/S5LX[GC(=NF7':8T:3"6U@"_U3=4]$R6TJ2%5"RC)2(PF9JS.S+V':D M0(WX,X,].[A&,I05(5]E8Y%,#4NN"')8*#.56H2?E7+?EYR*NYG0\6AQ]SB[^[BXNKE&L^7R^G&) MWL; <98S=(3O1SO=YV- !31-N&[#R'?.5HB;>87B#7_@TYEN/T+4@OCV&ME.Q:P:@[+M:N['_& M/6KC'FGC/GA^L'I^^@+6(LY]9&K8Z,"543CRPL Y]L'4O_)D).AS2U"%A\4"PCJGC MUM3QCR)/N8LK2US]<$(%#U KM(52[-* M?VCUQ'-=&I06#T7KNGGP:6S_S)/;T(=R=DA:/!2MZZSSXJSSX\=7SSC;/^?D MW3CR_<"SCK\TAIJVML8\*,W$P=RJ$I>A-=F5O"Y9VMZVC)ZIXO&H?R[+:U7R MO6#JVES4,]NL9"B'C4!:%X%(4K0N=^L&)Y4J %>$B^R@+E,0KW0J!XC[&T+X M&PO=V]R M:W-H965TU2TX2:V SVR3;MY\-A-*$D@C=-PT&/X]_SWR8[+G[(#8!"O[*4 MR:FU42J_M&V9;" C\H+GP/23%1<947HHUK;,!9!E*\] MB'C""Y52!@\"R2++B/A]!2G?32UL[6]\I>N-,C?L>)*3-3R"^IX_"#VR&YN]^4X768)R)ASM/_Z%)MIM;(0DM8D2)57_GN,]2! M N.7\%26?]&NGNM8*"FDXEDMU@099=4G^547HB7 _BL"MQ:XYPJ\6N"502NR M,M8U422>"+Y#PLS6;N:BK$VIUFDH,]OXJ(1^2K5.Q3>+N]G=?''W"=U^G#U^ M1/=7MXM/LV^+^SOT =T4JA!@EJ59D:%<4);0G*2(L"6B3($ J5!.?NM]51(5 M; D")22G2L])05<7$2$(6T,UX>TU*$)3^4Y[?W^\1F__>C>QE4YA6.RD)KZJ MB-U7B*\AN4 >?H]5U>YFO[*7,20)32W\G)8@M6/'?;W#H_-,5]'\R>Q';:V)[ M?>ZQKI[7%;!2^:7*O$*V<8 C'$[L;9N\UWL@N=^0^Z?(_2[R2A6TR/T1]H,# M\E[O@>1!0QZ<(@^ZR(.SR'N]!Y*'#7EXBCSL(@_/(N_U'D@>->31*?*HBSPZ M(O="[(P/R'N]!Y*/&O)1+_DW_OP6WK^BNY*,CI*XGNN&^"!*[V(#HXR;*./> M*+<@Y26:9;Q@2O<.Y0I,F7?N_A#J"C8^"O;!=_SH<(]ZEQX8##O/QZ_3&^VA MRH*V)"T \15:O3QS3^]?O4 [)Q[C:.0>Y.P'&1JTU6?@,_8P*80P<7,N7CLB M:Y\7^^9Y$3[*T[O>T#S/QS[N/5Y;YWZU1;PY]^5[Q'3_K?>R3MN9TCTZ*'$P M+P( X% M 9 >&PO=V]R:W-H965T[;"[37+-J=\4WA 7[_*!"W0CZH M$D"C1\XJE7BEUO72]U56 B=J(FJHS,Q!2$ZT*67AJUH"R1V(,Q\'P=SGA%9> M&KNQK4QCT6A&*]A*I!K.B7Q: Q-MXDV]YX%;6I3:#OAI7),"=J#OZZTTE3^P MY)1#I:BHD(1#XJVFRW5DU[L%WRFTZJ2/;)*]$ ^V^)PG7F - 8-,6P9BFB-< M F.6R-CXU7-Z@Z0%GO:?V3^Y[";+GBBX%.P'S769>!\\E,.!-$S?BO8:^CS. M8":8].R+G<$$W26(H6 M2;O:L-F.B^K0QARM[$_9:6EFJ<'I].NWNZL=VJY^KM9?KM![=$,KRAN.Q)[1 M@MB-4ZBI=,#XCO(%L M@L+I.X0#C-'];H,N7O]!XYLL0R \!,*.=WXND-"@T)8\D3V#,5L=/!R'VSNP M5#7)(/',(5<@C^"E;UY-Y\''%\R%@[GP)?;49 W'/'6HF4/9:W1,IW@1!4'L M'T?49H/:[%]JLS&U#A6=J(5!<$XL&L2B_]^X.Z$)&]N]SDCT=^QH)+9_&ULA57K;YLP$/]7+#9-G=060GA4'4%*FDZ;M$?4M)OV MT8%+8M78S#9)N[]^9T-0M#SV!?SZ/0[?'=E6JF>]!C#DI>)"C[RU,?6M[^MB M#175U[(&@3M+J2IJ<*I6OJX5T-*!*NZ'09#X%67"RS.W-E-Y)AO#F8"9(KJI M*JI>)\#E=N0-O-W" UNMC5WP\ZRF*YB#>:IG"F=^SU*R"H1F4A %RY$W'MQ. M4GO>'?C!8*OWQL1&LI#RV4X^ER,OL(: 0V$L \77!NZ CR"-% MHXVL.C ZJ)AHW_2E^PY[@# \ 0@[0.A\MT+.Y90:FF=*;HFRIY'-#ERH#HWF MF+"7,C<*=QGB3/[M^^/]G,S&O\:3+_?DB@C, [DD)=.%;(0A%U,PE'']/O,- MREF07W34DY8Z/$$]A>*:# >7) S"D#S-I^3B[3\T/KKM+8>]Y=#Q)J#)/APQMRP-S<\QY[/%!,% MJSD0K !MJ"B96!TSV=)$CL96SB8/;X(T#H+,WQS1CWK]Z*S^%!:FO[UCNBT\ MWM.]&D8H>T(W[G7CL[J/TE!^3"\^T NC)#P99]+K)6?UQD715 VG!DI"*ZD, M^T-=F=OD_=\W2 X\I6ERRE':.TK/.L(Q%B&F$^-X^P*3]')730I:H^<\I8?Y M$$?!X,"5OU?KMFU^I6K%A"8L,P* ' MP7,]\C)CBA/?UVD&@NHC64!N9Y92"6IL5ZU\72B@BQ(DN$\P'OB"LMQ+XG)L MJI)8K@UG.4P5TFLAJ/HY!BZW(R_P'@>NV2HS;L!/XH*N8 ;FMI@JV_,;E@43 MD&LFN<+T8>=HZ 0VHFWT_'%!W2(+EG.Q%H@ M.>=L1=W&:70P 4,9UV]CWUA)!_33FGY0<=O+-,*G-X TJ@"I5:AP1ZV'<9=8V(B%_[YQ-])0WK9[E9'PB9$@[ Y[T#@9[ W; MMNT5L 88YX"NI %T=PEB#JHU'_:2/3,?HL9J]**Y&_T'K\/&Z_!9N3M\-G)>_Q$[FH%W9F;X!_%S_\XOE;4^[>6S+$+1GL[U1E]\)=4K5B MMIQR6%HD/HIL/*IZ-*J.D459J.?2V+)?-C/[T()R"^S\4MJTKCNN]C=/=_(+ M4$L#!!0 ( +V(?U8A?]UQV0D "1+ 9 >&PO=V]R:W-H965T(%GE.1'/GVG&GRX'_N#EQ'>V6BMS8G1U49(5?:#JM_)> MZ*/1AI*RG!:2\0()NKP<7/N?XN#)G#[\PL]MA>O+V9!)+WAV3]9JM:7@_D MI71)JDQ]YT^_TN:")H:7\$S:O^BI3CO! Y144O&\"=8ER%E1_T]^-A6Q%>"/ M#P3@)@#O!DP.! 1-0/#6',9-P'@G8.X=")@T 9.WYC!M J:V[NO*LC4=$D6N M+@1_0L*DUC3SPNOG[[$3V@^^M_77_^$J%?0JH( MRR3Z2H0@1O-3]#?TVT.(?OEP>C%2.D,3-DH:^$T-QP?@/KKCA5I+%!4I37OB MHU?BL0,PTE>ZN5S\6_>\KWN>8%_3S3AWZ2)4GHY4!WDI**1SJX^NM?_*GW]SZE(&$A)"R" MA,5 L(["XXW"8Q?]Z@O7VBHJY5R1A^KU&2O/O!LYN]41[B? M:NS/@IU449UJLI4J\+R]J@4J?J=JIYNJG;JK5O_X$2ND$I6I7432E)EA$7!?LS).%8M M2%@("8MF;^O'@/+LZ#7?Z#5WZG5=%)5N6"45B19-3VZ0'HC2/LVQ\JYJ]H3?Q)CL]7YW,]SKI_/F.&$ EZXAQOA'CW"E&K,&./LX9?*P"D+ 0 M$A:=[]_MYEY/LP'*M*.4[[43.<^IU;W@":6I1$O!(KW]6L2;@O=)NFJLC6]]M\P=I"R(H5N2@F72O:JX:0< MK08D+02E10UMNY*#\61_P >5:UN#NXXX_6C%(6@A* MBUZIJ>M2#)'U5(RQ,.Z;PT*5IZMEZU/XSDFR'@*F-"^MD5D*EO3+">I-@-)" M4%K4T+JCD_ELLMO^WL-X\%OGP7=;#W>\8(H+8RXM:;]BH-X#*"T$I47^OOTP M#X)@5[#WZRC?P][P6W_#=QLSH;[ROX'MX);KT3[/9.;M_0ZMR( M8T4#I86@M CO&R:3P O\'H%:*J"T".]; M*OYTBJ=X5[#WL%1P:ZE@MU&PNXR64ID(9N?EO?J!&BR@M!"4%KU2;S_6]"3C MQ.S"2D1%93M&(/H?\H<3[R/*B5@QG63!]:!0K2E:":I'A,(L>IG#4K"\7DI! M7*#QT/,^#I$FM["&P P_T<%2W\/T@ 2;I/H4THE*/>@\T><,D*2/YO8F$5D1 M(RJB&5LQW19UVD[??YMG=XUH;4!5U0(CH2;I?7G[L*W+OGYSV\-=QZ:]CMK=V1 MGRRO<[[:]8(Z=Z"T$)06@=)B*%I7VM;?PS/HKA?4Y@.EA:"T")060]&Z M0K=F(':;@6_M>D$=/U!:"$J+<._>*7]W=1(JTZYLK>.'W8Y?R(2>"G$A[9Q MMU:64'WPA9$%R\S(_[:0E;!;/IR],Z@/"$H+06D1*"V&HG4?>VC=PL #[IT# M4.\0E!:"TB)06@Q%ZPK=6HR!VV)\9?NC._IH54$=QJ!GFY4_G^_N&HA ^0'FM0.S,8T>R#-4 M9I6LUR>HE%P@J)3"O)DUC^H M8"2K9T?!Y B$2;ED!9-KW=Q7G*>ZD(M3],%'.E,M?)14I% M]HPR]F?%4KN5YF1#VR_0+E]?=WJ*?*_O4OG6KL92L")AY>:I/[M,U*R"#?6, M#Q6\63.J%WHTZ:0EM3%VL6F+NUE)JXJT68NR YFXZ>;0HEW-4VO]Q8?)2VW4 M2WCV5V(7G32$%RBDB1WKH'/[K/>X=]T(ZK?<[15:\S)PFY>;$=I])9(UD?2M M0S500Q.4%H+2(E!:#$7KRMT:F@&TH1F &IJ@M!"4%H'28BA:5^C6T R@'M\, M>A]_]'8>?[QQYW>T#_>M8S>.-3D#?N;(X6#-2&!*7% M4+1:L-'62WQR*E;V=4L2V:&:R63K[.:53M?V148[YV_\3Z'?!29^4-9WIL(.I7,M4'BI?V%4(+KA3/[<< MJY<#D\'FQ5A7_P-02P,$% @ O8A_5HS5"^3>! 6QT !D !X;"]W M;W)K&ULS5EA3^,X$/TK5NYTVI4X$CMMVG)M)198 M+1+=0["P'U;WP;0NC4CBGNW2Y=^?DX:XP>XDO>M)\($FZ0NEEB>^+Z<+EE)YS)BL2$H3GP1! MY*0J3:EX^<02OAYYV'L]L^O4&9QRC(9\PP)-A]YI_CD+.SF"47$?+U8AZH9&<\^1[/ MU&+D]3TT8W.Z2M0-7W]AY8(*@E.>R.(_6I>Q@8>F*ZEX6B9K!FF<;3[IS[(0 M6PFXLR.!E FD;4)8)H3%0C?,BF6=4T7'0\'72.31&BW?*&I39.O5Q%G^,]XJ MH;^-=9X:?SZ]O$'WIU=W%VAR<7I[=W,QN?CZ[19].&>*QHG\B'Y'=[?GZ,.O M'X>^TB?,T_QI"?YI TYV@)^SZ3$*\1$B 2&.]+/VZ;B>[NME5FLEU5I)@1?M M6BN-!;JGR8H=H5,IF9*(9C-T%=.'.(E5S"2:,"I7@LV0OL)NV'0E1)P]%E%? M>2:J Y^HC"7Z<:5/@"X52^5?KN)LV(1N-OG]>2*7=,I&GKX!)1//S!O_]@N. M@C]'&QBZQS#P;]WAN"=I N=12ZZ?4J>CV0WI]JP41!;G.KNMCUVK"S@W"7[.;7 MK_CU07[;XG*9+5=*'J$K]LP2A-&/"4L?F'"*!(BZKT@<"*Q6@$%5@,&[4M?! M(0MW(+!:X7!@/#@X@+Z6($T:Y@@#10QOM0KX/VELF=Y(T Z#"1I_QZ +[J6S M)10DM(X04&FQ\5,,&VHKK2TQ0(;@:=S7+8(N66.W&/;;-G*,;3NU%N!P7+#$ MQG(Q[+F[]9B >@S#[JLKAT*K%\%8.H[>E29CL,78NW@'0JL7SS0<&.XX6JJR MW4]8%SD44B=GN@T,MQN-6MQOI@6%U&F9'@"#3KF? @^:*4(A]1G0F"V!S;:5 M]A+;1-]R T/JW(S#$MAAVZ@JL>W3H@:%U*EMSDN6D 0^KD3+M X':A24])\UP. MAM1I&0,G\%"^CYX2>^ZV*$(A=8K&)@ELD^WTM-5H[H@"GAP08Y8$-LM6LFJ[ MH8NA'04Q-+Y)8-\TP@*+Z4&'WD.AU9\I&B,.@WR!TA MX#P;&O<,8?=L);.A[8P.$7-$ 2(6&@\-80]M([,E1*>!H1WE?DCK;[WYRE\[ M3JAXC#.)$C;7F<%Q3P.)S9N\S8[BR^)EV -7BJ?%YH)1_:OG ?K[.>?J=2=_ MOU:]3QW_ U!+ P04 " "]B']6EAOMO3," #!0 &0 'AL+W=OBU)SE M,)-(E5E&Y>L]<'$<8!^?#N9LN]/V@,110;>P +TL9M)8I&%)60:Y8B)'$C8# M//3[H[;U=PXK!D=UMD=6R5J(O36>T@'V;$+ (=&6@9KE "/@W!*9-'[7G+@) M:8'G^Q/[@]-NM*RI@I'@/UBJ=P/Z#F< _QH@J '!>P'M&N J1ZK,G*PQU32.I#@B:;T- MF]VXVCBT4<-R^Q<76II;9G Z?A@^S=%J^&TY0=/)<+&<3Z:3Y^\+=#,&31E7 MZ)E*26VI;]$7M%R,T%>[5IHTP-NNS-3"J1U,/<;(?3)L(W0S+WX#U!+ P04 M " "]B']6Y,#50ZL$ !5$P &0 'AL+W=O58EMR=A %JA*2+8FM9-)-IFCMJ;F@[ ;<(T/ M1A*0_/N5#VQL"R5D\P4?=#^]UU*KVQIM4_:#+P$$>HRCA(^-I1"K,\OB_A)B MRLUT!8G\9YZRF KYR!867S&@0>X41Q:Q;<^*:9@8DU'^[HY-1NE:1&$"=PSQ M=1Q3]G0!4;H=&]C8O;@/%TN1O; FHQ5=P .(SZL[)I^L"B4(8TAXF":(P7QL MG..S*BIE1#M,T^AH&8CDV!@8*8$[7D;A/M^^A%.1F>'X:\?P7 M;4M;VT#^FHLT+ITE@SA,BBM]+ .QYT#< PZD="!M!^^ @U,Z.+G0@EDNZY(* M.AFQ=(M89BW1LIL\-KFW5!,FV30^"";_#:6?F#Q\NIW^_?[VP^75_<-OZ.J? MS]>?_D6_7X*@8<3_0*?H84D9G%[(2 7HCC[)&13HG#&:+""[/T&WJWP^OMU M/ /V7;J\0Q;BF1L?64)RS$:R_)+/1<&''."#";I)$['DZ"H)(&@"6%)(E^"9R\ DB-B$*0M.7NV,-':<*N)/C>8<"OA?/:1K+=.0T#^!>4-'L M21WW+64!^O9!0J)K 3'_K@IP,;ZC'C_;%L[XBOHP-F3>7_-]PXY;W0#3.Z%"!Z!^2$' MM&*A#\]0+[ '>YSZ)L8MXEVCGCGTU+2]BK9W'.V%7) "!50 FM.0H0V-UL^Q M]SK$7--V6NR[1L0D?37[?L6^?QQ[!ED5DS21+S<4)NO%FD8H"N> P@0] 67* M[4D_RJ!P1"Z*BUT*#V6 GE1(4SW2L$3"N((B"JA&+ 95+ 9:[")=>#&![4VT MD#GH)H@SM&V[-5,*,YNX7D\]5\.*W_#_)8B&^+"S=K#I>2W:7:.^.\ M* MDKSN'4&JQ?)KXLF$\H(ITUOHI&3ADT)D=A>'0W<^=)N&Z,\#::OI\6E1* ME/P=Q:*W29M\U^IPYQ"=K.BUN!V%D=[3]6:-*G5I1L?6;O;2T=/N@#OZ4CK3)JDZXJ-]250W]]! M?E72[7?;-IE^-AFT27<-6VU@DWE=7[&^P#X?[L/D!XJUZ;7[.X55HPML\J[K M+CZR\+ZR27IFF*JWL0\V1WJ$5WY8D+J4$WTI_P(\#T,2H*MBZN@L I74$FA_ M#3G$QO:P-6/Z 5\KJ*[M1%\YCQ"$%Y8.=;> 44,;)&?VW"YYM:) M*+[DJ[?5V=!Y?B+2>G^!SZ;%"4\-4QPXW5 F/TLXBF N(6VS+V>,%6-00P0 .<6 9 >&PO=V]R:W-H965T&5 M&FC3?BB)N>?8]W"2G+BS9/Q!3 $D>DSB5'2MJ92S<\<1X102(FPV@U1],V8\ M(5*=\HDC9AQ(E(&2V/%N*63J=0#3J\S(Q,8@?PZN^'JS"E8(II *BA+$8=QU[K YP%N:4!6\8W" M4FP<(]W*/6,/^N0JZEJN7A'$$$I-0=3' BXACC636L=_*U*KF%,#-X^?V3]E MS:MF[HF 2Q;_32,Y[5HM"T4P)O-8WK+E9U@UU-!\(8M%]A\M\UI?%8=S(5FR M JL5)#3-/\GC2H@- /9? '@K@'AW. MEHCK:L6F#S(Q,[1JGZ;Z=Q])KKZE"B=[H[OKRS\_7W\)!K>C7]'@KZ]7=]_1 M;P%(0F.!\._H(_H9.4A,"0?1<:2:4@.=<$7?S^F]%^BQAX8LE5.!!FD$T3:! MH]9:+-A[7G#?,S(&$-JHAL^0YWI>R8(NCX?C$GAP/-PU=%,KY*]E?+67^.B" M1I!&Z#N%.$+_#"&Y!_YOF=!&(GU[.!_ +X J_?+3]AW_R@3J4JR MH"*R+0'KA8#UXP1\T@*6Z6;&NV7JG X)C)!7:M H-&@8%S0$(N8X;#7> H&'7 ML'*,;[NM,JD.H_T,[37*M#&C7RO.1D;&QM6-=/K]V%>O%Q&Z(4^9\RXX)^DD M<^$9NIYE+S$FXYFG.-5YE;(%5;%MR^NMY?6,\@X>@8=40)Y:2L7+"5H9@7Z5 M7?1JMJ_R^V)+E/VJIHUWJH*2JKIZOA95VTVL@SPV)_DA36DR7]]\T/^H$MM4 M&OLK90NJ8MM6?)W\L3F'CR0+'PR>R=$8;_S0KMW>]4Q)5=W&_JYIWB/?XW7 MQ^:$?\05TMCO0SW%F[OMEI25M?L>P1NODS7R7:ZFBN+R2LDJVH"JV M;<7761Z;P_RA:ZFY;QO/WC-7257;;K;:FW^[3GN/E(W7,1N;@^X1%U9K[W%1 MTOE^T<'&*XW0SL8.8 )\DNVD"A2R>2KSO;5BM-BMO,RE9DAU.@43 =8'Z?LR8?#[1 M$Q1[V[T?4$L#!!0 ( +V(?U;EM9"3: , ,L, 9 >&PO=V]R:W-H M965TT=+:$2J1*TG;V[4=2LOP0A7:;[8U-4G=__NXHDJ?1BHLO,@-0Z+$L MF!Q[F5+5F>_+)(.2RA-> =-/9ER45.FNF/NR$D!3ZU06/@F"R"]ISKQX9,=N M13SB"U7D#&X%DHNRI.*?%31.=R#^E#="MWS6Y4T M+X')G#,D8#;VWN"S"0Z-@[7XF,-*;K61"67*^1?3N4K'7F"(H(!$&0FJ_Y8P M@:(P2IKC:R/JM7,:Q^WV6OUW&[P.9DHE3'CQD*<2"- ]EW")]QZ#4. M/1MH36;#NJ"*QB/!5T@8:ZUF&C8WUEM'DS.SC/=*Z*>Y]E/Q_?N;R9]O;]Y= M7-[=_XPN__IP]?YO],L%*)H7$I%?T6OT0(6@3*%/UU!.07S60S\B'\F,"I C M7VD*H^4GS8SG]8SDF1DQ0=>022Y!%2)/(%7;O1:>[#%U#\9A'O@G4;#;NRH MQ8Z&U]7(CM, M'(G$6[<;_MZ#"&RODQO*)T6T(G9.S+%_\9?4Z'O1(D*F&G)X.14KZBH M*^>ZHWAEB\\I5[J4MZ8"=KOE_A?4$L#!!0 ( +V( M?U:GG:F"YP, 4. 9 >&PO=V]R:W-H965TVP!5;Y:, M9T2J*5_98L.!Q,8I2VW7<0([(PFU)B.S=L0LOW8 MPM;3PGVR6DN]8$]&&[*".<@/FSNN9G81)4XRH")A%'%8CJU+?#'#OG8P%A\3 MV(O2&&DJ"\8>].0F'EN.1@0I1%*'(.JQ@QFDJ8ZD?P4_;4A MK\@LB( 92S\EL5R/K8&%8EB2;2KOV?X-' @9@!%+A?E%^]PV'%HHV@K)LH.S M0I E-'^2KPW5]/_\-7?_[X>;]?^CW*Y D207R M_D#GZ!Z$Y$DD(49SR:(']/D6L@7P+^K=*V0CL28'U-,\M=N2 M&KOHEE&Y%NB:QA"?!K 5CX*,^T1FZG9&O(*HASQ\AES'=1L S9[OCCO@>(6V MGHD7M&FKA3F?JDT6HQG+U)$1ENSOR:)8O]X3'Z/-; M%1+=2,C$ER:!\_Q> 7'/Q.#I],R5#(R0ZX*H%H21*NOE7^ MH*KQCJ1;^#XR>;9!"66_%^(*E=RH7S)J81$4+().%G^IK6E(T+CX+YK0!76I MG; N=8-9V"^;G8 ,"Y#A"Z4^0ZMG$@EK,KN]JLIU&[^'@V8.@X+#H)/#QU9$ M@YIFY]AQAD%00=5D%W@X; $V+( -7RQNNYS#FE1>;S"H(*\;^3VWWPP;.\=6 MYG0"5WU]"8G"9<\(C=3)H!GA(X9 D5L2V5^'"U6B[O,I3G!5]:G^HYC#NK' M,/D%Z99PU?L%2F&I0CJ]4!'@^9TCGTBV,NP &0 'AL+W=OF]4ZF-'>8UN/D.'O@8.'W,B\_E MK925\64Q7Y9G1[=5=??J^+BNRS.3_/[:IXMY65AE/>+15I\?2/G^>/9D7GT[8GW MV5+HY#79T>OS5>)9S4-5DO\ MDCW^:M&CISZ; MAIO??].#U8NO7\RGM)07^?R?V:RZ/3N:'!DS>9W>SZOW^6,DVQ?D-MXTGY>K MOXW'];)NW>/TOJSR1=NX?KS(ENM_TR_M?\1& ]-YIH'5-K"V&[C/-+#;!O:A M/3AM ^?0'MRV@7MH#U[;P#NTP;AM,-YNX#W38-(VF!S:PTG;X.30!N;HVV]N MM*J@]:]\52]^6J7GIT7^:!3-\K77?+,JNE7[NDRR93,^KJJB_FE6MZO.KSZ\ MN_A[].XW7[R_^O&'B66.?S7$/S[&'_YM_.3+*LWFI?%[6A1I4\8_&[\8'Z]\ MXZ>__7QZ7-6]-\;QM.U)K'NRGNG)--[FR^JV-,1R)F<][:,][2T-<%R_[*?7 M;GU[[6\LK9C9"W_QM6KPT M[/7*VSW- WUS7TY?&M9DU=SL:1X>WONH[W=Y0._V\__S\>'-^U8^.;SY2%-' M]M,8LE>>]XQW,4_+TLBOC:LJGWXV_ORM_KD15W)1_J=GY=ZL,;L?:]X/7Y5W MZ52>'=5O>*4L'N31^8\_F-[HU[X2)3&?Q 2)!206DEA$8C&))1"F# GG:4@X M.OW\(E_4,[@R7[%"06 MD%A(8A&)Q2260)A2X>Y3A;O:"@^+O-[HWQ7Y5,I9V5?>VO9#RYO$?!(3)!:X M.Z-X,EI]J>,X)#N-2"PFL03"E +WG@KL-^"RM9%^%:X&A%:Y? MF_5IG4G?0- ZPP= "3FDY@@L8#$0A*+UIB[\>9CFK8S<=7WGICL,X$P MI/7"T.I%-1_5!*H%J!:B6M1JF[O$VYOF MGD4FCFNYVUMF:L74 MY(FDQM ?]^O_A4;WKSZ_6$VLC*\KY_BJ&'!M:MKN8M;99^RN99];6W^+7BX.(G-1_5!*H%J!:B6M1JFP/3G5AC;WM#OKN8YTT\ M:WL[#JV;6M-=VFEJDZ/S=]?U'#M;WAAW]72D=Q*M!P:7,)IQHII M:#5-M_( M[>TM-QI>HEJ,:@FEJ57>!9BF/L'\N)S)XK'(JJ;2KV7_\3^],;C023\R#]AJA6HQJ":6IU=Z%F:8^S7S:ID_SLNJM=#3-1#4?U02J!:VV M^9;N.*/1>&>[CB::J!:C6D)I:J5WJ::I#Q)_EY4VM=2?UE3;8K'4TP42U&M832U$KO4DQ3'V.^>Y#%+Z_G\[Q:R'JG\]W=*LO_ M\ZUL#L/T?C)1#PZN?3301#6!:@&JA:@6H5J,:@FEJ0.DBS_-=18%?6[71)-/ M5/-13:!:@&HAJD6H%J-:0FGJZ.BB5%.?I>[_@*,>&#P@T+2TU3:G(Z;5\TE" M@78;H%J(:A&JQ:B64)IZ'E"7K5KZ;/7P:$H/#:UY5/-;3=G7["MYM-< U4)4 MBU M1K6$TM22[])8:T\:NV<_6-]\<*&C&6RK*1OWT8G54^EHO(IJ(:I%J!:C M6D)I:J5W&:RESV#WYU5Z8'"MHY%KJVDR(8%V&*!:B&H1JL6HEE":6N5=*FOI M4UDEKYIEY32_7_8>R=<[@XL=#6>MW0#4'$UZMNMH[(IJ(:I%J!:C6D)I:L5W M":VE3VC7!S1+[1%-/3&XV-& %M4$J@6H%J):A&HQJB64I@Z)+L:U7/*(IH6& MNJCFHYI M0#50E2+4"U&M832U-'11;^6/OI=G?3QRYNTE#/C,OVZ2L5>-Y_( MO)'-]R\,\:6Y:$'_+@(:"Z.:CVH"U0)4"U$MLG8C:]<;FR?.ULY8;6^9X MLK4?EE!KIY9WE_=:^KQW;WD?D #KNQA[0 MLD4U']4$J@6H%J):9.^>&FN.3D:VMSW'1[M-*$T= EVV:^NSW??=J>+MQ$8S MY==;@\L>#7I13:!:@&HAJD6H%J-:0FGJV.C28-LBI_PV&@VCFH]J M4"5 M1 M+4*U&-422E-'Q\:5C/4I\O]SB%1/#QXJ:+",:@+5 E0+42UJ-666[MK6:'O6 M;^\&]ZX[,NVMY1)J[=3R[B)C>]])O=^[;X#FR*CFHYI M0#50E2+[-V3D$WG MQ-FNV1CM-:$T=01T";&M/]$W7D[K[7CV((W+>;I<70%?OW> 1L2HYJ.:0+4 MU4)4BU M1K6$TM3AT47$MH?N':"I,*KYJ"90+4"U$-4B5(M1+:$T=71T";.M M3Y@//TU&#PT>&&B.C&H"U0)4"^W=*QI[/2<$16BO,:HEE*:6?)<0V_IK)']O M!J9G!P\ -"I&-8%J :J%J!;9/== ]D;N[K62T6X32E-'0)<"VX.NJ:S?6T"3 M7U3S44V@6H!J(:I%J!:C6D)IZCVNNJC9&9%["PX:,*.:CVH"U0)4"U$M0K48 MU1)*4T='ET([^A3Z\KMN+Z%'!P\2-(Y&-8%J :J%J!8Y/=>E'O7=URM&^TTH M31T 7=3LZ$\\WAD @^]&H>]@\&! TV=4$Z@6H%J(:E&K[;TI!=IK0FGJ4.AR M96=/KBR+K-[T_\L8LC>A-P=7/QHHHYI M0#50E2+4"U&M832U#&R<LN<';TYR0#^PAH!HUJ/JH)5 M0+42UJ-7V[R,< MMEQ"K9U:Y%UN[.ASXS=Y6LR:F8V?%7):Y45I7-RF6;%(]61N]#W-[CBT7@9U0)4"U$M0K48U1)*4RK> M[>)E5W\F\]7]IU+^==^<@R,>FK]U;Y*YZL;#J^F M2KWC 0V64'NWE/7''N.;6X=(PG0;D-4BU M1K6$TM12[Y)E5Y\L7[;W M,#"NBWQAE'L+'\V44?_]F?3 X%I'$V)4$V[/_83'ECERQ]NUCH:_J!:A6HQJ":6IM=Z%OZX^ M_'U=&1]NI?$V+3[+RFAF-Z7Q^J:0JXM2Z'>+T0 8U7Q4$Z@6H%J(:A&JQ:B6 M4)HZ4+HXV47/7W;1[!C5?%03J!:@6HAJ$:K%J)90FCHZNAS:W7.%[-6@N,WG M,UF4AOSK/JN^]@X+-'=N-65RTOOI=Q_M5Z!:@&HAJD6H%J-:0FEJR7>9LJL_ M?WG_D2 T148U']4$J@6H%J):Y.Z>J#P9.9/M0UXQVFM":6JE=_FPN^\\Y6$' M@M!3E5'-1S6!:@&JA:@6N;LW?3[QG-'VC3IBM->$TI2Z][J4V-.GQ&_3+]G" M"(O\_L[XK?YSH=T?UF-#RQ[5?%03J!:@6HAJ$:K%J)90FCHXNIC80V-B#XV) M4Q\WG6P\:Q3RNAX1 MYJO7UM'QSO/"?!6:/<]'YJMX]?QQQY^?WJ4W\FU:W&3+TIC+Z[JKTW3P^J_.[LJ![?G_*JRA>K;V]E6H^T9H'ZY]=Y7GU[T'3PF!>?5R_G_']0 M2P,$% @ O8A_5G,!' 6N @ !@< !D !X;"]W;W)K&ULC95K;]HP%(;_BI5-4R>MS3TA+$2BI>N02H>@W3Z;< )6G3BS M'6C__>PDC5 )=%^(;^=]WF/LXWC/^+/8 DCTDM-"C(RME.70-$6ZA1R+*U9" MH68RQG,L59=O3%%RP.LZ**>F8UF!F6-2&$ER)CD4@K "<7D=Z?;W@ M-X&].&@CGYK+" &T;_D+7)ZM5+3C3K5.EJ9(X7^ M4Y:2JUFBXF1R?SM>3A_NT'BQ&#_=W,J9*I\O)Z7)R:MW@5$[*I#8[YAP7&U!'2(H^=XV*VZ^B;\-0E#B%D:&. MNP"^ R/Y\LD.K.]G/+J=1_><>J)2=OL\-5%>':4OU"ZQ@RAR[4%L[GIP7H?S M/L)Y?;@FRC_$A99CV5X_SN]P_D,''7YP%G\/0@S1-"\K"6LT M+22HPRG[# R.#%QZONL.3AREJ#,0G34PUY>AD&B':06Z.F25JA6@BQ/)J_P_ M=B8Z.N.>%3F>;;\S9AZ4-?U"S##?D$(H0J8BK2M=4WE3=9N.9&5=Z59,JKI9 M-[?JH0*N%ZCYC#'YUM'%LWOZDG]02P,$% @ O8A_5KSCSZJ2 @ @08 M !D !X;"]W;W)K&ULK57;;IM $/V5%:VJ1$K- MS9NRI.+G" J^'5JNM3M8Y&FF]($=!A5-80GJH9H+ MW-DM2Y*7P&3.&1&P&EJ1>SWNZ7@3\#V'K=Q;$^WDB?-GO;E+AI:C!4$!L=(, M%!\;&$-1:"*4\:/AM-J4&KB_WK'?&._HY8E*&//B,4]4-K0N+9+ BJX+M>#; MS]#X,0)C7DCS2[9U;&]@D7@M%2\;,"HH1,_XM+)? V1YP*OTRCY=WLED2+ M132[G=Y/9]^6Y&P"BN:%)#,J!-5U/BGP>VPKP:;<=-CE&=PSN2 MP_7(/6$]@HN%7M[52/O).,$X@[Q'Z[9WTNT"E1-XP<$IX9"# M&MW=<^#Z@]YE]_*-AS_CO.Z5ZSAM6*W.WNOF$D1JAIPDIIQUB[2G[1R-S/AX M$W H0. MP/L5YVJWT0G:KT[X"U!+ P04 " "]B']6! ,0TNP# "*# &0 'AL M+W=O>Z>XY$\#W=" M?E$QI1J^I8RKD1-KG9V[K@ICFA+5$AGE^&8C9$HT3N7659FD)+*@E+F!Y_7< ME"3<&0_MLX4<#T6N6<+I0H+*TY3(_05E8C=R?.?AP3+9QMH\<,?#C&SIBNK/ MV4+BS*U8HB2E7"6"@Z2;D3/QSZ>^9P#6XL^$[M3!&(R4M1!?S.0J&CF>B8@R M&FI#0?#GGDXI8X8)X_A:DCJ53P,\'#^P7UKQ*&9-%)T*]E<2Z7CD#!R(Z(;D M3"_%[@]:"NH:OE P9;]A5]AV^PZ$N=(B+<$809KPXI=\*Q-Q !AX+P""$A#\ M /![+P#:):!MA1:165DSHLEX*,4.I+%&-C.PN;%H5)-PLXPK+?%M@C@]7DS^ M7M[.Y[!8WMY]G-Y=W=Z8X>_+R36\GU%-$J;@ADA)3+8_P"E\7LW@_=L/0U>C M=\/AAJ6GB\)3\((G'ZX%U[&"CSRB40U^^A_XH(' 1=F5]N!!^T70R#C)9 O: MW@D$7N#5!=0,G]$0X;Z%!PWAM*NE:%N^W@M\JUA(?7I'90HSNM;PSQP-X$K3 M5/U;E^Z"K5W/9K;_N\W^JD'HGLB?!.);S3Q#Z^ M1&(@JO^OA^M_72.A6$KJ-$FX$/\6CU6P3 MOH6$AR*E=5H:65ZKI?M=8N&.$P%_@U M)1@73$*LSFN:KJFLK22R)[GH5[GH'W5+]H\I_$AD3X0/*N&#_[,E M!\\K[ZPW"/I5Y14*&GW\I(*S2L%9HX))&,J<1I"5Y1P*52OE[)D4WS.?'Z0T M.OM)*;[W>$E[C6+F D\5;\ M=R V.*: 7>$6KWE>KCSV&7M8V\? \8 [3*5JP65I396"1&%/%^4A)CS9P"9G M[%1CMP[1,>/ M5ACA6UR8$UP90\",4\)Y3AC; QY*E?OU_D!;T'W7@CM4QLSAM2/J324QX? I M1RP2X_WMVS 2TU:&0D:$8_G; ":K*73ZV".8_)1I01YT9^S0'XX%OI/EH=^J M;6P:U^.UU>,>='LIE5O;!"NP:2X:O^IIU6A/;'OI/IH77?HUP6QPA>G<(-1K M]?%*D47C6TRTR&SON!8:.U$[-$M*I3' ]QN!ET0Y,0ZJOQ_C[U!+ P04 M" "]B']6#PEV]>P" ;# &0 'AL+W=O[ MOE6W7@=F;+769L#V>C%=P0WHNW@JL6?G+@L60J28B(B$9=\:U,_]KEF?++AG ML%-[;6(RF0OQ:#J7B[[EF T!AT ;!XJ/+8R C2_O!\.K\1FVKP:W8Y],![/;'^3$ M!TT95V1"I:3F%7TF9^3NQBS6>+(@@PAPI8F M4TXCXC,5<*$V$LC#%4Z32PVA^EG$*G5O%+N;\WZN8AI W\(#K4!NP?(^?:BW MG2]%Y*HT\RLR.Z#:R*DVRMR]"S0F-!2;2!=!2\7-1&SNM*WG=IU.RW%Z]G:? M1VF08WE49'; HYGS:);RF @->,$&P+9TSN$4VYQJ_.QB*O5+$:)2OV._J^8? MO)&U\SMNOZ*8!X1:.:%6*:%9!F1J@)"':PCG( M/7*G/L62J-/,K,CO@U\[Y MM?_K/=:NDFJ59GY%9@=4.SG5SK_<8Z7B8Z%5:>9W_G;B#W!T&PO=V]R:W-H965TY]G5_S<6S7 HM$D3)@?.0JFLY[HR6D!*Y"7/@.DO,RY2HG17S%V9 M"2"Q!:6)ZWM>X*:$,B?LV[%[$?;Y4B64P;U 6+#%-@4G*&1(P&SA7N#?"G@'8B%\4UG*OC8R5*>?/ MIG,;#QS/*(($(F4HB'ZM8 1)8IBTCK\%J5/.:8#[[2W[C36OS4R)A!%/?M-8 M+09.QT$QS,@R40]\_1T*0RW#%_%$VB=:Y[%!X*!H*15/"[!6D%*6O\FF6(@] M #X&\ N _Q+0/ )H%("&-9HKL[;&1)&P+_@:"1.MV4S#KHU%:S>4F=\X44)_ MI1JGPML?HY]WU^CQZL_U!%V@&XA!D 01%J.)(@K0+8MX"NB1;$"BLS$H0A-Y MKD.?)F-T]OF\[RHMPY"Y43'E,)_2/S(E]M$=9VHAT36+(3XD<+7^TH2_-3'T M:QG'$%VB!OZ*?,_W*P2-W@['-7(:Y9HV+%]PA&^T% *80IG@*VKRO5>U2#E' MHYK#[-Z>S$@$ T=O3PEB!4[XY1,.O&]5!C^([,!NL[3;K&,/BYRI\I@#FQ9H M#I15Z/7=U;[PUQ$7&'M^HUG&'6AJE9I:M9IL[E8IRF&M&D6O(W"GB5O5>H)2 M3U";$F.8@4Z*>)<3Z&P*#&94G5=F1_"1V?%!9 ?.VZ7S]GNSHWWR7]1%'*CI ME&HZ[\N+SDDM=1$'6KJEEFZMED>N]$F[S8PJ4=V3HNHB#D1A;U<0O#?(VN6I MOBH@FA&PO=V]R:W-H965TXM+8]M(I3HDK2=OGU)25%LB];V8F]B49KY^0TGG)GQ M0U4R?-RN]4EJR$2C%1(0FKB7=#KJ[>)V.?&P M)0(.A;82U/SL80J<6R7#\:,5];H]K>/Q\[/ZQSIX$\R"*I@*_@];ZLW$&WEH M"2NZX_I>'#Y!&U!L]0K!5?T7'5I;[*%BI[0H6V=#4+*J^:5/[4$<.9#H@D/0 M.@2_ZQ"V#O7)^0U9'=:,:IJ/I3@@::V-FGVHSZ;V-M&PRJ9QKJ7YRHR?SF^_ M3O_^\@$]W/S[88[>H1FL0$I8H@?ZA&Z4 JT0K9:G[S\SNF"<:08*O9Z!IHRK M-\;YVWR&7O_Q9NQK V;E_:*%>-] !!<@9E!S]NU9;6L#$,Q=,@=R#E__YBB3X M+U>(_Y/827"% 9)-:O6B NE7.$V&E&M8:O#/@])BJ,X'?O[ MXTCZ=B0-@\AF=N^ C#K(:!#R(WLR*6G2X<)KO..C;=_%)$[#,[J^&8FB+'2S MQ1U;/,CV&4PE<4'%O=WB((SP&5/?B@28N)&2#BD91C)91*9.%J*R686J^.D" M3/JG1K(PS$9GB'T[$N(TB=V0:0>9#D+>5II6:[;@,)#8M+]UDH0XBLX0'78I M3MV HPYP- AX;^X:E<6F+H)+V)NVMS5-3+LX1[W]DXB,LC/*OA5V(V8=8C:( M.->B>*Q;V=(DNS3]75';(5V(66_S+,[P>:[[5L$HBI*1FY/@EU:#!TEOBD+N M*$=:H(*JC?W7W(-4%UA;L9-\XBR+\/F-=A@&IC!>Y#UJC620]T%HRIUHI'^M M,XS#]/QB.PR#<$1($%U@>VE19+ AY-\IW]%F$.)F%*-5X:P_K*'M2024/C'\T^=O#\0N6:50IQ6!D??)6:B&0SRS4++;;U M.+00V@Q7]>/&S+\@K8'YOA)"/R_LA-5-U/DO4$L#!!0 ( +V(?U;])5.Y MI , "T+ 9 >&PO=V]R:W-H965T=N*](ME%3$FE&O*- M*W8<:&:Y)=\ MLY5ZPIV,=G0#2Y!?=@NN1FZ'DN4E5")G%>*P'COW^&Z&B78P%E]S.(B3;Z2E MK!C[H0>/V=CQ-",H()4:@JJ_/R0IA?=&ALX\A!:2TD*UMGQ:#,J^:? MOK:).'' UQQ(ZT#.'8(K#G[KX!NA#3,C:TXEG8PX.R"NK16:_C"Y,=Y*35[I M;5Q*KE9SY2JY25@*:@#@B@!6?[W&R82MEQ[86^ M@D ?YB!I7HB/RNG+46K-&^7014&B7*3+5M.FD"! M":0+TWYRXXG>BV&. Q)%/N=X3LM8:E;[X?Q!B),!"2+; M;>UWQ8.0!(/(CWON9M*I2GJQGG7^4R/-IB&Y2.5YLB\M5A:3FP0/\35:)Z\D[J7U66Z!6TGABXB^3R[.IL4,)U%PI2IA M\L:+]*>+255"=]T[K9[M]CKIVV4O3"UDW^Y:3*QY=$\:CQ+XQO1C J6LKF3S M:'>S7<]W;SJ=L_FI[@5-0_,&TS223Y1O\DJ@ M8*TKN-50YYTYLU \EVIKU9 M,:F:)?.Y5?TL<&V@UM>,R>- !^@ZY,F_4$L#!!0 ( +V(?U;-Q24WD0( M X& 9 >&PO=V]R:W-H965TV#N2O MC[1()SLAG]4&4<-+P;@:>!NMRRO?5]D&"Z(ZHD1N=E9"%D2;J5S[JI1(FKBUF4P346E&.($% M0H:9M@K$O+8X1L:LD,'XW6AZ[9'6\7"\5[]VL9M8ED3A6+#O-->;@??9@QQ7 MI&)Z+G9?L8FG;_4RP91[PJZQ#3S(*J5%T3@;@H+R^DU>FCP<.$31.PY1XQ Y M[OH@1SDAFJ2)%#N0UMJHV8$+U7D;.,KM1UEH:7:I\=/IS?WXX6X*C\,?TP6< M35 3RA3<$RF)3==YXFMSBK7ULT9Q5"M&[RB&$=P)KC<*ICS'_%\!W^"UC-&> M<12=5)Q@UH%N> %1$$7PM)C V=PJ;0TM^77L=AKQ>YQ15M!5ZHD&0X\4R(*Y1:]]-.', Z^G.#MM;R]4^KI M=+5"=XGA@'Q.-,(<,\$SRBBQ5_T"B(9KS%$2!@M-=*6%?'WK= $SE!ER?2S, M&B0,'(DM[&T:=*(P\;='^/LM?_\D_T.)]E;Q-=P*I6!L+MFK:2L[(G-U#*)6 MZQTPA/%E_S+N=8]SQ"U'_)_R.,&\RNKAB63%QY+5?\/H']1H@7+M.I&"3%1< MU^7:KK;-;EC7^%_SNE/>$;FF7 '#E7$-.IH% !)'@ &0 M 'AL+W=OQ"L6E;J"1Z(A.W_WZ4K(B62#%VZN0BEN1S#M]#D>)Y MY92E0PRA/\SB)!^,1]6SVV(\X@\R37)V6P#QD&5Q\>.#T.I'8@5:);955:%[&,QZ.";T!16JMH MY475-Y6WRB;)R]_G7W^?K3%7ASP627N5=5I3',<$!#CP@,Z^I(K$J@^_ %9<^1[.Y@I9B9!% M7,(:7'Y7JP]A'^9U^-8 \D+H03_LY&FS1,1# >J9AF@'ALB9Q $.+>3'BM9.'NOD\2LBK0Y^K*XX4K1V5VBX(R9\!6QVC-56@K_X\TA5J6F(O1"CT M>X1J ",W@9UP0Q;T$I]$)(!=@1;V1AY1J?0(U/!%;OKNQS=DP2LF"EU>MPY; M+#TO#'W:5YXTB)&;Q(UX(UG;&;SA>)2/*%VCK'ZH7L0S9WO$/+ M^;&BM;/76,?H%ZM,A>%!,&HNSJV6.(@I$BM MY7M&J\8OW@>_S[ -FVA5NS:*D2'49HC# /:@#6L&8S>#G6C#)E%]"J$7=/=M M%D,:8!(AVJ-/HQ>[T;L?V;!)5A*HK3?JEF&;(0PA]?I>N$8P=B/X$+!A$Z_6 MW9O%SK%]PQK"V WAPPF'3<[:=W#NEE]:&S2[L9O=/\LY;)(\\-7XH*B;IVGH M(P1Q[XS4J,9N5$]XH4I\+-E^D#O2EKG.ZC4VX$0CGL#7_$7RJ+P_5K1V5VC> M$_ZM$H)I0&%W068Q5(13 [IG*4\TA\D^''X&<<1$+%'K03\P=%JH M'5*HREV/SIV?N=TH=B*.F&3M,L-ITM:DL4O19=;EB\9P5I8'Z?L&Y M?+HI&VA.C\?_ U!+ P04 " "]B']6>@S[PB $ ![#P &0 'AL+W=O MFO&7\2<$ F^ M%7DI^M98EE;2 MJ^8>>=)C2YG3DCQR()9%@?F_ER1GZ[Z%K->))SJ;2SUA)[T%GI$QD1\7CUR- M[!8EHP4I!64EX&3:MP;H8H@"[5!9?*)D+;:>@98R8>Q%#VZRO@4U(Y*35&H( MK/Y69$CR7",I'E\;4*M=4SMN/[^B7U?BE9@)%F3(\L\TD_.^%5D@(U.\S.43 M6_]%&D&^QDM9+JI?L*YM_< "Z5)(5C3.BD%!R_H??VL"L>6 CCDXC8.S[^ = M<7 ;![<26C.K9(VPQ$F/LS7@VEJAZ8 6C)\'SU=W5_?/8_!^1"2FN?@ SL#'\0B\?_>A9TNUK':V MTV:)RWH)Y\@2R %WK)1S :[*C&2[ +;BVY)V7DE?.IV((Y*> Q?] 1SH. 9" MP[>[HPXZ;AM#M\(+CN ]$2'Y,I5+3LL9&#(A 2XSH*8)7Q'PY5;9@QM)"O&/ M*7HUN&L&UY_QA5C@E/0M]9U6B%;R^V\H@'^:E)\(;"<.7AL'KPL]N5=99XQS M(DPJ:U>O[6MX- 0H2 (_7!CN,/.;]GY/V1WRX217.WI M;ZUYA@(_]%T4[K$S6(9N#%W?-[,+6G9!YQEZ90>PE)Q.EA)/<@(D RDK"I7N M5")(7^8LSP@7%R8)P2E/T8G =B(1MI$(W[1/;XF$*1#AP0XASXLAA'L[>6@7 M0#?TH7D?HY9]U,E^\$(S#/X&5V ,/E%]V:G;\04,5#X8IQ0,* =?[D@Q(=R8 M"SK!_^LNG@AL)PYQ&X?X5^;$^)1Q.!'83AP0W%RP\.>S8N.[?0H=Q_$B%+E[ MQ]5H"4/'/987T58)@'XZ,S:N^ZDQ@M#S]AD:3&/H!9[C'6'H;!@ZOS8[-O@G M.E"G0MN-QJ;<0)VW>#*B*YJ1,A,Z FJ%*>&<9$#,,2<=B;%!W=U*8VHT6';E M1K0I$-"/*X3_D]O187%PAB+H(B\ZT& PC0,?HO#8:=P4$JB[DKC$@J95.AO1 M?"E5Z"M-CX2K1%?I&.NM, JHD:,= ><>VB=O,(/G<72$^:;(0)TW=_*YZFH4 MX<&*<-6EU40%>%A*(94@G:O/=%O4Z,MJ?48EP>$]ZX2^%X?[!9W!4AG%@1/N MR;&WVIB"\%G5W0EU-I:EK)N#=K;M( =5W[0W?ZD[RZH]VL#4;>D=YC-:"I"3 MJ8*$YZ%BQ>M.KQY(MJB:I0F3JO6J'N>J.R9<&ZCW4\;DZT OT/;;R7=02P,$ M% @ O8A_5EQL9YWP" %#4 !D !X;"]W;W)K&ULO5M;H8J.FI=$^F/9E]V-H'V2@V MU8!H23B=K?WQ/;'[ M6YJ+.$K)$T,\3Q+,WAY(3%_ONDYW^^!KM%H+^:!_?YOA%9D3\9P],;CK5RAA ME)"41S1%C+S<=3\Z'P)W* 54C3\C\LIWKI'LRH+2;_+F4WC7M66+2$R60D)@ M^-N0&8ECB03M^%Z"=BN=4G#W>HL>J,Y#9Q:8DQF-_Q&%8GW7G7912%YP'HNO M]/474G9H)/&6-.;J%[T6=8=0>9ES09-2&%J01&GQCW^4AM@1F-I'!-Q2P-T3 M<(9'! :EP.!4@6$I,#RU2:-28'2JAG$I,%:V+XRE+.UA@>]O&7U%3-8&-'FA MZ%+28. HE2-K+AB41B G[N?/#W/_]V?_RQ_(_Q-^Y^C2(P)',4=?,&-8\GZ% M_HZ>YQZZO+BZ[0M0*D7[RU+!0Z' /:+ 09]I*M8<^6E(PA9Y_QUY5P/0A]Y6 M77:W77YPM8B_XK2'W+&%7-L=M#1H=HKXZ*BXIQ"=QN?QL<8W;#FHAL] X8V/#9]\P%=9(3MB'=^Y]_+;"*9JMP45$#SC]9J$OO8\]= EZD6R4 M:]\4A8\4I^J!!<"ZYZ"(K434?LM$86-&U; M-6Z-A=*)=Z;J 1-H4;:^Q-NUQ$ZMG>F^M4I'4K.$_H NV0HIN"/QF; 587(T MYZ!P01!Y>0$G7U;FB%/)$D<9Y3Q:Q*2'=BW\$J72 @7DMM?%*A,M),"";@@4 M,IJOULH:CR7=LX)NC^'7 K*<,+5LE$*;<0YC$\DY60QP>:$PH3(T.%:GD0V! M7E23"ZA>P_B*5+-;;=3QP43B#7H!IZ&02(^V,E:O;;$CDT">%MR[96_MQEVR28-S[8'AW8&^W][=$WJ30P!-8@:U*1-=&3Q1:1 M*,833(>4Q&J1D!/AJ*>D!3R7/9-@7@$VVF6OC3R3.@-#8 WRIA5Y4RUYCV0% M.]2Q6::5/9M)VG/9I,J@P,@35HNJYHNG['GUVRG.RX$:4+TT::%NE< MTDR">=<'2^/HD#.3&@-#8 W.'+N.*=E:UKQH UMM&G+$I$.5$;8$7P&O6FG3 M8YW+FU$TSRB:7Z+)OVH@V#U[M'=^-*6T2=Y.0-#1G_@)*_PS\-;!=0K+#4ZY M7 3\OU8.M9!G4;1?*-H@2FT)L]U#-;11Q5/B9GK(*%IA":])6AU<E;7HYQ-V^1@$ Z&AZ6Z]K-[ PZDIVYE&^9A$6R88/C7(6? M+]R>;=?>\)55Q);=D6,Y]C9[TSD"//I;G=29Y4D>JUI^>OOQU+$Z&#-)'5 M2!&-MH9K@+0EAXK@NY*T8.!;T(..?.18[DC=O<.$6QGLX22#-7(;E>0QNT1I MD=N1R0?9 HPN1BB)XEAV(:6";(.PBS?55=6;-8G5 UJD(R+!$?A?(67;1O?> M2?HT$CV[V4%54.C1IW=4'4U21Y6WI'-02SI'U2T3.9TJD8/_-XD<:6'7 F=" M#@;TE82$)!@@@2&:@($H>T-?P.X=E4R#Z4L([+,;8 04XBP2.+;0X^.LT=L= M&"E;=5;V$,M1/QI,K.O!%(4,OQY/'3Y%:8J7<9$S5 HZV_S/8>:I2AO^?S)0 MDJ1S<%_3@7:\JB?[>^F/:@QSC; ML[@^#-V[H\/@O6=4K6\4+3"%UGQQKPXLN_K _?]E7#W$VM2TOU;:]->095>L;10M,H16L]7<^ MYDCD(4]^=J->V$M%\9%#];3ZM.>C^J!E[_F#\\$K/M"I88KOA3YCMHI2CF+R M I!V;P).*2L^P2EN!,W4)R,+*@1-U.6:8#C!R I0_D+AU%;>2 75AU#W?P%0 M2P,$% @ O8A_5H6[^(\S P \!( T !X;"]S='EL97,N>&UL[5AM M;],P$/XKD^ZQ[SQ;'99F+=CM@C$3K'(ARQ%9&%.\"\-RMF Y+2]4P:1% M,J5S:FQ7S\.RT(RF)3CE(NQU.G&84R[)>"B7^75NRF"FEM*,2+\U!>[U,1V1 M;OR6!(YNHE(V(O=GK[\ME;EZ%;CWR9N3D\[]^=6^_:P"SDGH)>T?0'K1L0_* M7*$8?7P8_7/D&/7E+G4S_-1RM;ZGF// X[SQ=&YAG9;Q,%-RDYV(.(/EI3D+ M'J@8D0D5?*HY>&4TYV+MS#TPS)10.C"V+&R@+EC*1P=W70\JIN;)N52ZBNTB MN+_3>O@>T/1 (!>B%=@CSC >%M08IN6U[52#*^,3**C;=^O"*IQKNN[V^F3C M4+ULD*G2*=-MF"YI3..A8!G(T7R^@+=110B@,2JWC933N9*TTM!XU U+.V-" MW,)V^IKM<*^RK8QU(%^R;5I!==/1N [P;[,Y[FW:WF_Q!@5_4.;#TDY'5GTH M4':C6<9757^5M0(P]B[.3HM"K-\+/IYW?X;?C4Y;1I3!W+3@B MF_9GEO)EGK2C;F AZE&;]B>87C=N[X$V%IL''/:1 MZ^KQ(YB/P_P(8%@<3 'FX[RP./_2? ;H?!R&:1MXD0'J,T!]G)//#[9+HBA)_ A@?@51A"&P&W$$4P :,"2*JG-P[SP*FW,J MW/S&-?X!4$L#!!0 ( +V(?U:7BKL

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end XML 86 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 87 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 88 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 168 453 1 false 54 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://applieduvinc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://applieduvinc.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://applieduvinc.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://applieduvinc.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Statements of Changes in Stockholders' Equity Sheet http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://applieduvinc.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://applieduvinc.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - BUSINESS ACQUISITION Sheet http://applieduvinc.com/role/BusinessAcquisition BUSINESS ACQUISITION Notes 8 false false R9.htm 00000009 - Disclosure - INVENTORY Sheet http://applieduvinc.com/role/Inventory INVENTORY Notes 9 false false R10.htm 00000010 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://applieduvinc.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 10 false false R11.htm 00000011 - Disclosure - INTANGIBLE ASSETS Sheet http://applieduvinc.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 11 false false R12.htm 00000012 - Disclosure - FINANCING LEASE OBLIGATION Sheet http://applieduvinc.com/role/FinancingLeaseObligation FINANCING LEASE OBLIGATION Notes 12 false false R13.htm 00000013 - Disclosure - NOTES PAYABLE Notes http://applieduvinc.com/role/NotesPayable NOTES PAYABLE Notes 13 false false R14.htm 00000014 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://applieduvinc.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 14 false false R15.htm 00000015 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://applieduvinc.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 15 false false R16.htm 00000016 - Disclosure - LEASING ARRANGEMENTS Sheet http://applieduvinc.com/role/LeasingArrangements LEASING ARRANGEMENTS Notes 16 false false R17.htm 00000017 - Disclosure - PAYROLL PROTECTION PROGRAM Sheet http://applieduvinc.com/role/PayrollProtectionProgram PAYROLL PROTECTION PROGRAM Notes 17 false false R18.htm 00000018 - Disclosure - NOTE RECEIVABLE- RELATED PARTY Sheet http://applieduvinc.com/role/NoteReceivable-RelatedParty NOTE RECEIVABLE- RELATED PARTY Notes 18 false false R19.htm 00000019 - Disclosure - INCOME TAXES Sheet http://applieduvinc.com/role/IncomeTaxes INCOME TAXES Notes 19 false false R20.htm 00000020 - Disclosure - SEGMENT REPORTING Sheet http://applieduvinc.com/role/SegmentReporting SEGMENT REPORTING Notes 20 false false R21.htm 00000021 - Disclosure - PROFORMA FINANCIAL STATEMENTS (UNAUDITED) Sheet http://applieduvinc.com/role/ProformaFinancialStatements PROFORMA FINANCIAL STATEMENTS (UNAUDITED) Notes 21 false false R22.htm 00000022 - Disclosure - SUBSEQUENT EVENTS Sheet http://applieduvinc.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 22 false false R23.htm 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 23 false false R24.htm 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://applieduvinc.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - BUSINESS ACQUISITION (Tables) Sheet http://applieduvinc.com/role/BusinessAcquisitionTables BUSINESS ACQUISITION (Tables) Tables http://applieduvinc.com/role/BusinessAcquisition 25 false false R26.htm 00000026 - Disclosure - INVENTORY (Tables) Sheet http://applieduvinc.com/role/InventoryTables INVENTORY (Tables) Tables http://applieduvinc.com/role/Inventory 26 false false R27.htm 00000027 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://applieduvinc.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://applieduvinc.com/role/PropertyAndEquipment 27 false false R28.htm 00000028 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://applieduvinc.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://applieduvinc.com/role/IntangibleAssets 28 false false R29.htm 00000029 - Disclosure - FINANCING LEASE OBLIGATION (Tables) Sheet http://applieduvinc.com/role/FinancingLeaseObligationTables FINANCING LEASE OBLIGATION (Tables) Tables http://applieduvinc.com/role/FinancingLeaseObligation 29 false false R30.htm 00000030 - Disclosure - NOTES PAYABLE (Tables) Notes http://applieduvinc.com/role/NotesPayableTables NOTES PAYABLE (Tables) Tables http://applieduvinc.com/role/NotesPayable 30 false false R31.htm 00000031 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://applieduvinc.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://applieduvinc.com/role/FairValueMeasurements 31 false false R32.htm 00000032 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://applieduvinc.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://applieduvinc.com/role/StockholdersEquity 32 false false R33.htm 00000033 - Disclosure - LEASING ARRANGEMENTS (Tables) Sheet http://applieduvinc.com/role/LeasingArrangementsTables LEASING ARRANGEMENTS (Tables) Tables http://applieduvinc.com/role/LeasingArrangements 33 false false R34.htm 00000034 - Disclosure - INCOME TAXES (Tables) Sheet http://applieduvinc.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://applieduvinc.com/role/IncomeTaxes 34 false false R35.htm 00000035 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://applieduvinc.com/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://applieduvinc.com/role/SegmentReporting 35 false false R36.htm 00000036 - Disclosure - PROFORMA FINANCIAL STATEMENTS (UNAUDITED) (Tables) Sheet http://applieduvinc.com/role/ProformaFinancialStatementsTables PROFORMA FINANCIAL STATEMENTS (UNAUDITED) (Tables) Tables http://applieduvinc.com/role/ProformaFinancialStatements 36 false false R37.htm 00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesTables 37 false false R38.htm 00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-dilutive shares) Sheet http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Anti-dilutiveShares SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-dilutive shares) Details http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesTables 38 false false R39.htm 00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue) Sheet http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue) Details http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesTables 39 false false R40.htm 00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesTables 40 false false R41.htm 00000041 - Disclosure - BUSINESS ACQUISITION - Recognized Identified Assets Acquired and Liabilities Assumed (Details) Sheet http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails BUSINESS ACQUISITION - Recognized Identified Assets Acquired and Liabilities Assumed (Details) Details 41 false false R42.htm 00000042 - Disclosure - BUSINESS ACQUISITION - Future Maturity of lease Liability (Details) Sheet http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails BUSINESS ACQUISITION - Future Maturity of lease Liability (Details) Details 42 false false R43.htm 00000043 - Disclosure - BUSINESS ACQUISITION (Details Narrative) Sheet http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative BUSINESS ACQUISITION (Details Narrative) Details http://applieduvinc.com/role/BusinessAcquisitionTables 43 false false R44.htm 00000044 - Disclosure - INVENTORY (Details) Sheet http://applieduvinc.com/role/InventoryDetails INVENTORY (Details) Details http://applieduvinc.com/role/InventoryTables 44 false false R45.htm 00000045 - Disclosure - PROPERTY AND EQUIPMENT (Details) Sheet http://applieduvinc.com/role/PropertyAndEquipmentDetails PROPERTY AND EQUIPMENT (Details) Details http://applieduvinc.com/role/PropertyAndEquipmentTables 45 false false R46.htm 00000046 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://applieduvinc.com/role/PropertyAndEquipmentDetailsNarrative PROPERTY AND EQUIPMENT (Details Narrative) Details http://applieduvinc.com/role/PropertyAndEquipmentTables 46 false false R47.htm 00000047 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://applieduvinc.com/role/IntangibleAssetsDetails INTANGIBLE ASSETS (Details) Details http://applieduvinc.com/role/IntangibleAssetsTables 47 false false R48.htm 00000048 - Disclosure - INTANGIBLE ASSETS (Details 1) Sheet http://applieduvinc.com/role/IntangibleAssetsDetails1 INTANGIBLE ASSETS (Details 1) Details http://applieduvinc.com/role/IntangibleAssetsTables 48 false false R49.htm 00000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://applieduvinc.com/role/IntangibleAssetsTables 49 false false R50.htm 00000050 - Disclosure - FINANCING LEASE OBLIGATION - Future minimum principal and interest payments under capital lease arrangements (Details) Sheet http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails FINANCING LEASE OBLIGATION - Future minimum principal and interest payments under capital lease arrangements (Details) Details 50 false false R51.htm 00000051 - Disclosure - NOTES PAYABLE - Minimum obligations under this loan agreement (Details) Notes http://applieduvinc.com/role/NotesPayable-MinimumObligationsUnderThisLoanAgreementDetails NOTES PAYABLE - Minimum obligations under this loan agreement (Details) Details 51 false false R52.htm 00000052 - Disclosure - NOTES PAYABLE - net of discount (Details) Notes http://applieduvinc.com/role/NotesPayable-NetOfDiscountDetails NOTES PAYABLE - net of discount (Details) Details 52 false false R53.htm 00000053 - Disclosure - NOTES PAYABLE - Minimum obligations (Details) Notes http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails NOTES PAYABLE - Minimum obligations (Details) Details 53 false false R54.htm 00000054 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://applieduvinc.com/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) Details http://applieduvinc.com/role/NotesPayableTables 54 false false R55.htm 00000055 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://applieduvinc.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://applieduvinc.com/role/FairValueMeasurementsTables 55 false false R56.htm 00000056 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative) Sheet http://applieduvinc.com/role/FairValueMeasurementsDetailsNarrative FAIR VALUE MEASUREMENTS (Details Narrative) Details http://applieduvinc.com/role/FairValueMeasurementsTables 56 false false R57.htm 00000057 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://applieduvinc.com/role/StockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details 57 false false R58.htm 00000058 - Disclosure - STOCKHOLDERS' EQUITY (Details 1) Sheet http://applieduvinc.com/role/StockholdersEquityDetails1 STOCKHOLDERS' EQUITY (Details 1) Details 58 false false R59.htm 00000059 - Disclosure - STOCKHOLDERS' EQUITY (Details 2) Sheet http://applieduvinc.com/role/StockholdersEquityDetails2 STOCKHOLDERS' EQUITY (Details 2) Details 59 false false R60.htm 00000060 - Disclosure - STOCKHOLDERS' EQUITY (Details 3) Sheet http://applieduvinc.com/role/StockholdersEquityDetails3 STOCKHOLDERS' EQUITY (Details 3) Details 60 false false R61.htm 00000061 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://applieduvinc.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://applieduvinc.com/role/StockholdersEquityTables 61 false false R62.htm 00000062 - Disclosure - LEASING ARRANGEMENTS - Maturities of Operating lease laibilities (Details) Sheet http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails LEASING ARRANGEMENTS - Maturities of Operating lease laibilities (Details) Details 62 false false R63.htm 00000063 - Disclosure - LEASING ARRANGEMENTS (Details Narrative) Sheet http://applieduvinc.com/role/LeasingArrangementsDetailsNarrative LEASING ARRANGEMENTS (Details Narrative) Details http://applieduvinc.com/role/LeasingArrangementsTables 63 false false R64.htm 00000064 - Disclosure - PAYROLL PROTECTION PROGRAM (Details Narrative) Sheet http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative PAYROLL PROTECTION PROGRAM (Details Narrative) Details http://applieduvinc.com/role/PayrollProtectionProgram 64 false false R65.htm 00000065 - Disclosure - NOTE RECEIVABLE- RELATED PARTY (Details Narrative) Sheet http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative NOTE RECEIVABLE- RELATED PARTY (Details Narrative) Details http://applieduvinc.com/role/NoteReceivable-RelatedParty 65 false false R66.htm 00000066 - Disclosure - INCOME TAXES - Federal and State Income Taxes (Details) Sheet http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails INCOME TAXES - Federal and State Income Taxes (Details) Details 66 false false R67.htm 00000067 - Disclosure - INCOME TAXES - Deferred Tax Assets and Deferred Tax Liabilities (Details) Sheet http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails INCOME TAXES - Deferred Tax Assets and Deferred Tax Liabilities (Details) Details 67 false false R68.htm 00000068 - Disclosure - INCOME TAXES - Income Before Provision For Income Taxes (Details) Sheet http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails INCOME TAXES - Income Before Provision For Income Taxes (Details) Details 68 false false R69.htm 00000069 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://applieduvinc.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://applieduvinc.com/role/IncomeTaxesTables 69 false false R70.htm 00000070 - Disclosure - SEGMENT REPORTING (Details) Sheet http://applieduvinc.com/role/SegmentReportingDetails SEGMENT REPORTING (Details) Details http://applieduvinc.com/role/SegmentReportingTables 70 false false R71.htm 00000071 - Disclosure - PROFORMA FINANCIAL STATEMENTS (Details) Sheet http://applieduvinc.com/role/ProformaFinancialStatementsDetails PROFORMA FINANCIAL STATEMENTS (Details) Details http://applieduvinc.com/role/ProformaFinancialStatementsTables 71 false false R72.htm 00000072 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://applieduvinc.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://applieduvinc.com/role/SubsequentEvents 72 false false All Reports Book All Reports auvi123122form10k.htm auvi-20221231.xsd auvi-20221231_cal.xml auvi-20221231_def.xml auvi-20221231_lab.xml auvi-20221231_pre.xml ex21_1.htm ex31_1.htm ex31_2.htm ex32_1.htm ex32_2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 90 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "auvi123122form10k.htm": { "axisCustom": 0, "axisStandard": 22, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 763, "http://xbrl.sec.gov/dei/2022": 39 }, "contextCount": 168, "dts": { "calculationLink": { "local": [ "auvi-20221231_cal.xml" ] }, "definitionLink": { "local": [ "auvi-20221231_def.xml" ] }, "inline": { "local": [ "auvi123122form10k.htm" ] }, "labelLink": { "local": [ "auvi-20221231_lab.xml" ] }, "presentationLink": { "local": [ "auvi-20221231_pre.xml" ] }, "schema": { "local": [ "auvi-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 649, "entityCount": 1, "hidden": { "http://applieduvinc.com/20221231": 43, "http://fasb.org/us-gaap/2022": 51, "http://xbrl.sec.gov/dei/2022": 4, "total": 98 }, "keyCustom": 111, "keyStandard": 342, "memberCustom": 22, "memberStandard": 31, "nsprefix": "auvi", "nsuri": "http://applieduvinc.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://applieduvinc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - PROPERTY AND EQUIPMENT", "menuCat": "Notes", "order": "10", "role": "http://applieduvinc.com/role/PropertyAndEquipment", "shortName": "PROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - INTANGIBLE ASSETS", "menuCat": "Notes", "order": "11", "role": "http://applieduvinc.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - FINANCING LEASE OBLIGATION", "menuCat": "Notes", "order": "12", "role": "http://applieduvinc.com/role/FinancingLeaseObligation", "shortName": "FINANCING LEASE OBLIGATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:NotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - NOTES PAYABLE", "menuCat": "Notes", "order": "13", "role": "http://applieduvinc.com/role/NotesPayable", "shortName": "NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:NotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - FAIR VALUE MEASUREMENTS", "menuCat": "Notes", "order": "14", "role": "http://applieduvinc.com/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "15", "role": "http://applieduvinc.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - LEASING ARRANGEMENTS", "menuCat": "Notes", "order": "16", "role": "http://applieduvinc.com/role/LeasingArrangements", "shortName": "LEASING ARRANGEMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - PAYROLL PROTECTION PROGRAM", "menuCat": "Notes", "order": "17", "role": "http://applieduvinc.com/role/PayrollProtectionProgram", "shortName": "PAYROLL PROTECTION PROGRAM", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:NoteReceivableRelatedPartyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - NOTE RECEIVABLE- RELATED PARTY", "menuCat": "Notes", "order": "18", "role": "http://applieduvinc.com/role/NoteReceivable-RelatedParty", "shortName": "NOTE RECEIVABLE- RELATED PARTY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:NoteReceivableRelatedPartyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "19", "role": "http://applieduvinc.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://applieduvinc.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - SEGMENT REPORTING", "menuCat": "Notes", "order": "20", "role": "http://applieduvinc.com/role/SegmentReporting", "shortName": "SEGMENT REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:ProformaFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - PROFORMA FINANCIAL STATEMENTS (UNAUDITED)", "menuCat": "Notes", "order": "21", "role": "http://applieduvinc.com/role/ProformaFinancialStatements", "shortName": "PROFORMA FINANCIAL STATEMENTS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:ProformaFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "22", "role": "http://applieduvinc.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:NatureOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "23", "role": "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:NatureOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:ScheduleOfEstimatedUsefulLivesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "24", "role": "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:ScheduleOfEstimatedUsefulLivesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - BUSINESS ACQUISITION (Tables)", "menuCat": "Tables", "order": "25", "role": "http://applieduvinc.com/role/BusinessAcquisitionTables", "shortName": "BUSINESS ACQUISITION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - INVENTORY (Tables)", "menuCat": "Tables", "order": "26", "role": "http://applieduvinc.com/role/InventoryTables", "shortName": "INVENTORY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "menuCat": "Tables", "order": "27", "role": "http://applieduvinc.com/role/PropertyAndEquipmentTables", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "28", "role": "http://applieduvinc.com/role/IntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:FinanceLeasesOfLesseeDisclosureTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - FINANCING LEASE OBLIGATION (Tables)", "menuCat": "Tables", "order": "29", "role": "http://applieduvinc.com/role/FinancingLeaseObligationTables", "shortName": "FINANCING LEASE OBLIGATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:FinanceLeasesOfLesseeDisclosureTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://applieduvinc.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - NOTES PAYABLE (Tables)", "menuCat": "Tables", "order": "30", "role": "http://applieduvinc.com/role/NotesPayableTables", "shortName": "NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "menuCat": "Tables", "order": "31", "role": "http://applieduvinc.com/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "menuCat": "Tables", "order": "32", "role": "http://applieduvinc.com/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - LEASING ARRANGEMENTS (Tables)", "menuCat": "Tables", "order": "33", "role": "http://applieduvinc.com/role/LeasingArrangementsTables", "shortName": "LEASING ARRANGEMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://applieduvinc.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - SEGMENT REPORTING (Tables)", "menuCat": "Tables", "order": "35", "role": "http://applieduvinc.com/role/SegmentReportingTables", "shortName": "SEGMENT REPORTING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "auvi:ProformaFinancialStatementsTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - PROFORMA FINANCIAL STATEMENTS (UNAUDITED) (Tables)", "menuCat": "Tables", "order": "36", "role": "http://applieduvinc.com/role/ProformaFinancialStatementsTables", "shortName": "PROFORMA FINANCIAL STATEMENTS (UNAUDITED) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "auvi:ProformaFinancialStatementsTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "auvi:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_MachineryAndEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:PropertyPlantAndEquipmentEstimatedUsefulLive", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "menuCat": "Details", "order": "37", "role": "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "auvi:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_MachineryAndEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:PropertyPlantAndEquipmentEstimatedUsefulLive", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-dilutive shares)", "menuCat": "Details", "order": "38", "role": "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Anti-dilutiveShares", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Anti-dilutive shares)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "auvi:ScheduleOfRevenueTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)", "menuCat": "Details", "order": "39", "role": "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "auvi:ScheduleOfRevenueTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:DeferredRevenueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://applieduvinc.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "40", "role": "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-03-25", "decimals": "0", "first": true, "lang": null, "name": "auvi:BusinessCombinationConsiderationTransferredOther", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - BUSINESS ACQUISITION - Recognized Identified Assets Acquired and Liabilities Assumed (Details)", "menuCat": "Details", "order": "41", "role": "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "BUSINESS ACQUISITION - Recognized Identified Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-03-25", "decimals": "0", "first": true, "lang": null, "name": "auvi:BusinessCombinationConsiderationTransferredOther", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "auvi:LesseeOperatingLeasesLiabilityMaturityTableTextBlock", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - BUSINESS ACQUISITION - Future Maturity of lease Liability (Details)", "menuCat": "Details", "order": "42", "role": "http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails", "shortName": "BUSINESS ACQUISITION - Future Maturity of lease Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "auvi:LesseeOperatingLeasesLiabilityMaturityTableTextBlock", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-03-25", "decimals": "0", "first": true, "lang": null, "name": "auvi:ExcessPurchasePrice", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - BUSINESS ACQUISITION (Details Narrative)", "menuCat": "Details", "order": "43", "role": "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative", "shortName": "BUSINESS ACQUISITION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - INVENTORY (Details)", "menuCat": "Details", "order": "44", "role": "http://applieduvinc.com/role/InventoryDetails", "shortName": "INVENTORY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - PROPERTY AND EQUIPMENT (Details)", "menuCat": "Details", "order": "45", "role": "http://applieduvinc.com/role/PropertyAndEquipmentDetails", "shortName": "PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://applieduvinc.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "47", "role": "http://applieduvinc.com/role/IntangibleAssetsDetails", "shortName": "INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - INTANGIBLE ASSETS (Details 1)", "menuCat": "Details", "order": "48", "role": "http://applieduvinc.com/role/IntangibleAssetsDetails1", "shortName": "INTANGIBLE ASSETS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-012022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2020-12-31_custom_PreferredStockSeriesXMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Statements of Changes in Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2020-12-31_custom_PreferredStockSeriesXMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "auvi:FinanceLeasesOfLesseeDisclosureTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - FINANCING LEASE OBLIGATION - Future minimum principal and interest payments under capital lease arrangements (Details)", "menuCat": "Details", "order": "50", "role": "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails", "shortName": "FINANCING LEASE OBLIGATION - Future minimum principal and interest payments under capital lease arrangements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "auvi:FinanceLeasesOfLesseeDisclosureTableTextBlock", "us-gaap:LesseeFinanceLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - NOTES PAYABLE - Minimum obligations under this loan agreement (Details)", "menuCat": "Details", "order": "51", "role": "http://applieduvinc.com/role/NotesPayable-MinimumObligationsUnderThisLoanAgreementDetails", "shortName": "NOTES PAYABLE - Minimum obligations under this loan agreement (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "auvi:ScheduleOfNotePayableNetOfDiscountTableTextBlock", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - NOTES PAYABLE - net of discount (Details)", "menuCat": "Details", "order": "52", "role": "http://applieduvinc.com/role/NotesPayable-NetOfDiscountDetails", "shortName": "NOTES PAYABLE - net of discount (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "auvi:ScheduleOfNotePayableNetOfDiscountTableTextBlock", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:OtherNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - NOTES PAYABLE - Minimum obligations (Details)", "menuCat": "Details", "order": "53", "role": "http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails", "shortName": "NOTES PAYABLE - Minimum obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "auvi:ScheduleOfMaturityOfLongTermDebtTableTextBlock", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31_custom_StreetervilleNoteMember", "decimals": "0", "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "p", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - NOTES PAYABLE (Details Narrative)", "menuCat": "Details", "order": "54", "role": "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "shortName": "NOTES PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-09-012022-09-30", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentPeriodicPayment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "auvi:MoneyMarketFunds", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - FAIR VALUE MEASUREMENTS (Details)", "menuCat": "Details", "order": "55", "role": "http://applieduvinc.com/role/FairValueMeasurementsDetails", "shortName": "FAIR VALUE MEASUREMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:OtherAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "auvi:MoneyMarketFunds", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)", "menuCat": "Details", "order": "56", "role": "http://applieduvinc.com/role/FairValueMeasurementsDetailsNarrative", "shortName": "FAIR VALUE MEASUREMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2021-12-31_us-gaap_EmployeeStockOptionMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - STOCKHOLDERS' EQUITY (Details)", "menuCat": "Details", "order": "57", "role": "http://applieduvinc.com/role/StockholdersEquityDetails", "shortName": "STOCKHOLDERS' EQUITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2021-12-31_us-gaap_EmployeeStockOptionMember", "decimals": "INF", "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-012022-12-31_custom_DividendYieldMember", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:WarrantsMeasurementInput", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - STOCKHOLDERS' EQUITY (Details 1)", "menuCat": "Details", "order": "58", "role": "http://applieduvinc.com/role/StockholdersEquityDetails1", "shortName": "STOCKHOLDERS' EQUITY (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-012022-12-31_custom_DividendYieldMember", "decimals": null, "first": true, "lang": "en-US", "name": "auvi:WarrantsMeasurementInput", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2021-12-31_us-gaap_WarrantMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - STOCKHOLDERS' EQUITY (Details 2)", "menuCat": "Details", "order": "59", "role": "http://applieduvinc.com/role/StockholdersEquityDetails2", "shortName": "STOCKHOLDERS' EQUITY (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2020-12-31_us-gaap_WarrantMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://applieduvinc.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2021-12-31_us-gaap_RestrictedStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - STOCKHOLDERS' EQUITY (Details 3)", "menuCat": "Details", "order": "60", "role": "http://applieduvinc.com/role/StockholdersEquityDetails3", "shortName": "STOCKHOLDERS' EQUITY (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2020-12-31_us-gaap_RestrictedStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-06-282022-07-02", "decimals": "0", "first": true, "lang": null, "name": "auvi:CompensationPaid", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "61", "role": "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-06-282022-07-02", "decimals": "0", "first": true, "lang": null, "name": "auvi:CompensationPaid", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - LEASING ARRANGEMENTS - Maturities of Operating lease laibilities (Details)", "menuCat": "Details", "order": "62", "role": "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails", "shortName": "LEASING ARRANGEMENTS - Maturities of Operating lease laibilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - LEASING ARRANGEMENTS (Details Narrative)", "menuCat": "Details", "order": "63", "role": "http://applieduvinc.com/role/LeasingArrangementsDetailsNarrative", "shortName": "LEASING ARRANGEMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "auvi:ScheduleOfNotePayableNetOfDiscountTableTextBlock", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - PAYROLL PROTECTION PROGRAM (Details Narrative)", "menuCat": "Details", "order": "64", "role": "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative", "shortName": "PAYROLL PROTECTION PROGRAM (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:OtherNonoperatingIncome", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "auvi:ScheduleOfNotePayableNetOfDiscountTableTextBlock", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - NOTE RECEIVABLE- RELATED PARTY (Details Narrative)", "menuCat": "Details", "order": "65", "role": "http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative", "shortName": "NOTE RECEIVABLE- RELATED PARTY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "auvi:NoteReceivableRelatedPartyDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "lang": null, "name": "auvi:NotesReceivableRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - INCOME TAXES - Federal and State Income Taxes (Details)", "menuCat": "Details", "order": "66", "role": "http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails", "shortName": "INCOME TAXES - Federal and State Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - INCOME TAXES - Deferred Tax Assets and Deferred Tax Liabilities (Details)", "menuCat": "Details", "order": "67", "role": "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails", "shortName": "INCOME TAXES - Deferred Tax Assets and Deferred Tax Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - INCOME TAXES - Income Before Provision For Income Taxes (Details)", "menuCat": "Details", "order": "68", "role": "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails", "shortName": "INCOME TAXES - Income Before Provision For Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "69", "role": "http://applieduvinc.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "7", "role": "http://applieduvinc.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - SEGMENT REPORTING (Details)", "menuCat": "Details", "order": "70", "role": "http://applieduvinc.com/role/SegmentReportingDetails", "shortName": "SEGMENT REPORTING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "auvi:ScheduleOfRevenueTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - PROFORMA FINANCIAL STATEMENTS (Details)", "menuCat": "Details", "order": "71", "role": "http://applieduvinc.com/role/ProformaFinancialStatementsDetails", "shortName": "PROFORMA FINANCIAL STATEMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "auvi:ProformaFinancialStatementsTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-012022-12-31_custom_AkidaKESVisionmarkAndSciAirMember", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "auvi:ScheduleOfNotePayableNetOfDiscountTableTextBlock", "auvi:NotesPayableDisclosureTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "72", "role": "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - BUSINESS ACQUISITION", "menuCat": "Notes", "order": "8", "role": "http://applieduvinc.com/role/BusinessAcquisition", "shortName": "BUSINESS ACQUISITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - INVENTORY", "menuCat": "Notes", "order": "9", "role": "http://applieduvinc.com/role/Inventory", "shortName": "INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "auvi123122form10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 54, "tag": { "auvi_AkidaKESVisionmarkAndSciAirMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Akida K E S Visionmark And Sci Air [Member]" } } }, "localname": "AkidaKESVisionmarkAndSciAirMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "auvi_ArbitrationPanelIssuedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Arbitration panel issued amount" } } }, "localname": "ArbitrationPanelIssuedAmount", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_AssetImpairmentCharge": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Asset Impairment Charge" } } }, "localname": "AssetImpairmentCharge", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_AtTheMarketSalesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "At The Market Sales Agreement [Member]" } } }, "localname": "AtTheMarketSalesAgreementMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_AttorneysFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Attorneys fees" } } }, "localname": "AttorneysFees", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_BasicAndDilutedLossPerCommonShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and Diluted Loss Per Common Share" } } }, "localname": "BasicAndDilutedLossPerCommonShare", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "auvi_BearsInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bears interest rate" } } }, "localname": "BearsInterestRate", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "auvi_BillingsInExcessOfCostsAndEarningOnUncompletedContract": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "BillingsInExcessOfCostsAndEarningOnUncompletedContract", "negatedLabel": "Billings in excess of costs and earnings on uncompleted contracts" } } }, "localname": "BillingsInExcessOfCostsAndEarningOnUncompletedContract", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_BillingsInExcessOfCostsAndEarningsOnUncompletedContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "BillingsInExcessOfCostsAndEarningsOnUncompletedContracts", "negatedLabel": "Billings in excess of costs and earnings on uncompleted contracts" } } }, "localname": "BillingsInExcessOfCostsAndEarningsOnUncompletedContracts", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total Purchase Price, net of cash acquired" } } }, "localname": "BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncomez", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_BusinessCombinationConsiderationTransferredOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cash paid at closing" } } }, "localname": "BusinessCombinationConsiderationTransferredOther", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Customer relationships" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTechnologyAndKnowhow": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Technology and know how" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTechnologyAndKnowhow", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradenames": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Trade names" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradenames", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_CancellationOfRestrictedSharesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cancellation of restricted shares , shares" } } }, "localname": "CancellationOfRestrictedSharesShares", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "auvi_CancellationOfRestrictedSharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cancellation of restricted shares" } } }, "localname": "CancellationOfRestrictedSharesValue", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "auvi_CancellationOfRestrictedStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cancellation of restricted stock" } } }, "localname": "CancellationOfRestrictedStock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "auvi_CancellationOfRestrictedStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cancellation of Restricted Stock, shares" } } }, "localname": "CancellationOfRestrictedStockShares", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "auvi_ChangeInFairMarketValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Change in fair market value" } } }, "localname": "ChangeInFairMarketValue", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_ChangeInFairMarketValueOfWarrantLiability": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://applieduvinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Change in Fair Market Value of Warrant Liability", "negatedLabel": "Change in fair market value of warrant liability" } } }, "localname": "ChangeInFairMarketValueOfWarrantLiability", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "auvi_CommonStockIssuedInConnectionWithAcquisitions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued in connection with acquisitions" } } }, "localname": "CommonStockIssuedInConnectionWithAcquisitions", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_CommonStockIssuedInPublicOfferingAtmNetOfCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued in public offering (ATM), net of costs" } } }, "localname": "CommonStockIssuedInPublicOfferingAtmNetOfCosts", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "auvi_CommonStockIssuedInPublicOfferingAtmNetOfCostsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued in public offering (ATM), net of costs, shares" } } }, "localname": "CommonStockIssuedInPublicOfferingAtmNetOfCostsShares", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "auvi_CommonStockIssuedInPublicOfferingOverallotmentNetOfCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued in public offering (over-allotment), net of costs" } } }, "localname": "CommonStockIssuedInPublicOfferingOverallotmentNetOfCosts", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "auvi_CommonStockIssuedInPublicOfferingOverallotmentNetOfCostsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued in public offering (over-allotment), net of costs, shares" } } }, "localname": "CommonStockIssuedInPublicOfferingOverallotmentNetOfCostsShares", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "auvi_CommonStockParValue0.0001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.0001 per share" } } }, "localname": "CommonStockParValue0.0001PerShareMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "domainItemType" }, "auvi_CompensationPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Compensation paid" } } }, "localname": "CompensationPaid", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_ContingentConsiderationBasedOnStockPrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Contingent consideration based on stock price" } } }, "localname": "ContingentConsiderationBasedOnStockPrice", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_CostAndEstimatedEarningsExcessOfBillings": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "CostAndEstimatedEarningsExcessOfBillings", "negatedLabel": "Cost and estimated earnings excess of billings" } } }, "localname": "CostAndEstimatedEarningsExcessOfBillings", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_CostsAndEstimatedEarningsInExcessOfBillings": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Costs and estimated earnings in excess of billings" } } }, "localname": "CostsAndEstimatedEarningsInExcessOfBillings", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_DebtInstrumentAdditionalAmountPayableInYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of additional amount payable in year two under the debt instrument.", "label": "Debt instrument additional amount" } } }, "localname": "DebtInstrumentAdditionalAmountPayableInYearTwo", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_DebtInstrumentUnamortizedDiscountRemainingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Remaining unamortized balance" } } }, "localname": "DebtInstrumentUnamortizedDiscountRemainingBalance", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_DeferredTaxAssetsLease": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Lease" } } }, "localname": "DeferredTaxAssetsLease", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "auvi_DisclosureFinancingLeaseObligationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Lease Obligation", "verboseLabel": "Financing Lease Obligation - Future Minimum Principal And Interest Payments Under Capital Lease Arrangements" } } }, "localname": "DisclosureFinancingLeaseObligationAbstract", "nsuri": "http://applieduvinc.com/20221231", "xbrltype": "stringItemType" }, "auvi_DisclosureLeasingArrangementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leasing Arrangements", "verboseLabel": "Leasing Arrangements - Maturities Of Operating Lease Laibilities" } } }, "localname": "DisclosureLeasingArrangementsAbstract", "nsuri": "http://applieduvinc.com/20221231", "xbrltype": "stringItemType" }, "auvi_DisclosureNoteReceivableRelatedPartyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note Receivable- Related Party" } } }, "localname": "DisclosureNoteReceivableRelatedPartyAbstract", "nsuri": "http://applieduvinc.com/20221231", "xbrltype": "stringItemType" }, "auvi_DisclosureNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable", "terseLabel": "Notes Payable - Net Of Discount", "verboseLabel": "Notes Payable - Minimum Obligations Under This Loan Agreement" } } }, "localname": "DisclosureNotesPayableAbstract", "nsuri": "http://applieduvinc.com/20221231", "xbrltype": "stringItemType" }, "auvi_DisclosureProformaFinancialStatementsUnauditedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Proforma Financial Statements", "verboseLabel": "Proforma Financial Statements Unaudited" } } }, "localname": "DisclosureProformaFinancialStatementsUnauditedAbstract", "nsuri": "http://applieduvinc.com/20221231", "xbrltype": "stringItemType" }, "auvi_DisinfectantSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disinfectant Segment [Member]" } } }, "localname": "DisinfectantSegmentMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "auvi_DividendYieldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividend Yield [Member]" } } }, "localname": "DividendYieldMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "auvi_DividendsRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividends rate percentage" } } }, "localname": "DividendsRatePercentage", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "auvi_DueToLandlord": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Due to landlord (Note 2)", "verboseLabel": "Due to landlord" } } }, "localname": "DueToLandlord", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_DueToLandlordlessCurrentPortion": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Due to landlord-less current portion (Note 2)" } } }, "localname": "DueToLandlordlessCurrentPortion", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "auvi_EarningPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EarningPerShareBasicAndDiluted", "verboseLabel": "Basic and Diluted Loss Per Common Share" } } }, "localname": "EarningPerShareBasicAndDiluted", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails" ], "xbrltype": "perShareItemType" }, "auvi_ExcessPurchasePrice": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Excess Purchase Price \"Goodwill\"", "verboseLabel": "Excess purchase price" } } }, "localname": "ExcessPurchasePrice", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails", "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_FairMarketValueOfCommonStockIssued1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair market value of common stock issued" } } }, "localname": "FairMarketValueOfCommonStockIssued1", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_FairValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value [Member]" } } }, "localname": "FairValueMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "auvi_FinanceLeasesOfLesseeDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of future minimum principal and interest payments under capital lease arrangements" } } }, "localname": "FinanceLeasesOfLesseeDisclosureTableTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligationTables" ], "xbrltype": "textBlockItemType" }, "auvi_ForgivenessOfPaycheckProtectionProgramLoan": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://applieduvinc.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Forgiveness of paycheck protection program loan", "negatedLabel": "Forgiveness of paycheck protection program loan" } } }, "localname": "ForgivenessOfPaycheckProtectionProgramLoan", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "auvi_GainLossOnChangeInFairValueOfWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of warrant liability" } } }, "localname": "GainLossOnChangeInFairValueOfWarrantLiability", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_GainOnSettlementOfContingentConsideration": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Gain on Settlement of Contingent Consideration (Note 2)" } } }, "localname": "GainOnSettlementOfContingentConsideration", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "auvi_GainOnSettlementOfContingentConsiderations": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "GainOnSettlementOfContingentConsiderations", "negatedLabel": "Gain on settlement of contingent consideration" } } }, "localname": "GainOnSettlementOfContingentConsiderations", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_GainOnSettlementOfLoanPayable": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "GainOnSettlementOfLoanPayable", "negatedLabel": "Gain on settlement of loan payable" } } }, "localname": "GainOnSettlementOfLoanPayable", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_HospitalitySegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Hospitality Segment [Member]" } } }, "localname": "HospitalitySegmentMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "auvi_IncentivePlan2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incentive Plan 2020 [Member]" } } }, "localname": "IncentivePlan2020Member", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_IncomeTaxReconciliationIncomeTaxExpenseBenefitDeferredTrueUp": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred true up" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitDeferredTrueUp", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "auvi_IncomeTaxReconciliationIncomeTaxExpenseBenefitOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitOther", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "auvi_IncomeTaxReconciliationIncomeTaxExpenseBenefitPermanentTaxBasisDifferences": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Permanent tax basis differences" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitPermanentTaxBasisDifferences", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "auvi_IncomeTaxReconciliationIncomeTaxExpenseBenefitTrueUp": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "True up" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitTrueUp", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "auvi_IncreaseDecreaseInDueToLandlord": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Due to landlord" } } }, "localname": "IncreaseDecreaseInDueToLandlord", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_InitialRecognitionOfContingentConsiderationLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Initial recognition of contingent consideration liability" } } }, "localname": "InitialRecognitionOfContingentConsiderationLiability", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_InitialRecognitionOfWarrantLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Initial recognition of warrant liability" } } }, "localname": "InitialRecognitionOfWarrantLiability", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_IssuanceOfNotePayableForPaymentOfPrepaidExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of Note Payable for payment of prepaid expense" } } }, "localname": "IssuanceOfNotePayableForPaymentOfPrepaidExpense", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_LessCurrentPortionOfAmountDueToLandlordNetOfDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "LessCurrentPortionOfAmountDueToLandlordNetOfDiscount", "negatedLabel": "Less: current portion of amount due to landlord, net of discount" } } }, "localname": "LessCurrentPortionOfAmountDueToLandlordNetOfDiscount", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "auvi_LessUnamortizedDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "LessUnamortizedDiscount", "negatedLabel": "Less: Unamortized discount" } } }, "localname": "LessUnamortizedDiscount", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "auvi_LesseeOperatingLeaseLiabilityPaymentDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentDue", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "auvi_LesseeOperatingLeasesLiabilityMaturityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of future maturity of the lease liability" } } }, "localname": "LesseeOperatingLeasesLiabilityMaturityTableTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "auvi_LoanAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan And Security Agreement [Member]" } } }, "localname": "LoanAndSecurityAgreementMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_LossOnChangeInFairMarketValueOfContingentConsideration": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "LossOnChangeInFairMarketValueOfContingentConsideration", "negatedLabel": "Loss on change in Fair Market Value of Contingent Consideration" } } }, "localname": "LossOnChangeInFairMarketValueOfContingentConsideration", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "auvi_LossOnChangeInFairMarketValueOfContingentConsiderations": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loss on change in fair market value of contingent consideration (Note 2)" } } }, "localname": "LossOnChangeInFairMarketValueOfContingentConsiderations", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_LossOnContingency": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loss on contingency" } } }, "localname": "LossOnContingency", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "auvi_MaximGroupLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Maxim Group L L C [Member]" } } }, "localname": "MaximGroupLLCMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_MoneyMarketFunds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Money market funds" } } }, "localname": "MoneyMarketFunds", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails", "http://applieduvinc.com/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_MonitoringFee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Monitoring fee" } } }, "localname": "MonitoringFee", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_NatureOfBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Business" } } }, "localname": "NatureOfBusinessPolicyTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "auvi_NoteReceivableRelatedPartyDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTE RECEIVABLE- RELATED PARTY" } } }, "localname": "NoteReceivableRelatedPartyDisclosureTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NoteReceivable-RelatedParty" ], "xbrltype": "textBlockItemType" }, "auvi_NotesPayableDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTES PAYABLE" } } }, "localname": "NotesPayableDisclosureTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "auvi_NotesReceivableRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Note receivable, related party" } } }, "localname": "NotesReceivableRelatedParty", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_OfferingCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Offering cost" } } }, "localname": "OfferingCost", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_OptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options [Member]" } } }, "localname": "OptionsMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_OutstandingBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Outstanding balance" } } }, "localname": "OutstandingBalance", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_Patents": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Patents" } } }, "localname": "Patents", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_PayrollProtectionPlanLoanCaresActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Payroll Protection Plan Loan, CARES ACT [Member]", "label": "Payroll Protection Plan Loan Cares Act [Member]" } } }, "localname": "PayrollProtectionPlanLoanCaresActMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_PreferredStockIssuedInPublicOfferingNetOfCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Preferred stock issued in public offering, net of costs" } } }, "localname": "PreferredStockIssuedInPublicOfferingNetOfCosts", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "auvi_PreferredStockIssuedInPublicOfferingNetOfCostsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred stock issued in public offering, net of costs, shares" } } }, "localname": "PreferredStockIssuedInPublicOfferingNetOfCostsShares", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "auvi_PreferredStockParValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParValue", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "auvi_PreferredStockSeriesACumulativeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock Series A Cumulative [Member]" } } }, "localname": "PreferredStockSeriesACumulativeMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "auvi_PreferredStockSeriesXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock Series X [Member]" } } }, "localname": "PreferredStockSeriesXMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "auvi_ProformaFinancialStatementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PROFORMA FINANCIAL STATEMENTS (UNAUDITED)" } } }, "localname": "ProformaFinancialStatementsTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatements" ], "xbrltype": "textBlockItemType" }, "auvi_PropertyAndEquipmentObtainedInExchangeForFinancingLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Property and equipment obtained in exchange for financing lease liabilities" } } }, "localname": "PropertyAndEquipmentObtainedInExchangeForFinancingLeaseLiabilities", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_PropertyPlantAndEquipmentEstimatedUsefulLive": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLive", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "auvi_ReclassificationFromLiabilityToBeSettledInStockToAdditionalPaidInCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Reclassification from liability to be settled in stock to additional paid in capital" } } }, "localname": "ReclassificationFromLiabilityToBeSettledInStockToAdditionalPaidInCapital", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "auvi_ReissuanceOfPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Reissuance of preferred stock" } } }, "localname": "ReissuanceOfPreferredStock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "auvi_ReissuanceOfPreferredStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reissuance of preferred stock, shares" } } }, "localname": "ReissuanceOfPreferredStockShares", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "auvi_RelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party [Member]" } } }, "localname": "RelatedPartyMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_ScheduleOfEstimatedUsefulLivesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of estimated useful lives" } } }, "localname": "ScheduleOfEstimatedUsefulLivesTableTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "auvi_ScheduleOfMaturityOfLongTermDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of minimum obligations" } } }, "localname": "ScheduleOfMaturityOfLongTermDebtTableTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "auvi_ScheduleOfNotePayableNetOfDiscountTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of note payable net of discount" } } }, "localname": "ScheduleOfNotePayableNetOfDiscountTableTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "auvi_ScheduleOfRevenueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of revenue" } } }, "localname": "ScheduleOfRevenueTableTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "auvi_Sec10.5SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share" } } }, "localname": "Sec10.5SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "domainItemType" }, "auvi_SecurityPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Security Purchase Agreement [Member]" } } }, "localname": "SecurityPurchaseAgreementMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_SeriesXPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series X Preferred Stock [Member]" } } }, "localname": "SeriesXPreferredStockMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/BalanceSheetsParenthetical", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_SettlementOfStockInConnectionWithPriorAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Settlement of stock in connection with prior acquisition" } } }, "localname": "SettlementOfStockInConnectionWithPriorAcquisition", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "auvi_SettlementOfStockInConnectionWithPriorAcquisitionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Settlement of stock in connection with prior acquisition, shares" } } }, "localname": "SettlementOfStockInConnectionWithPriorAcquisitionShares", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "auvi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average grant date fair value, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue1", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "auvi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExerciseAvailableForGrant": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Option exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesExerciseAvailableForGrant", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "auvi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedAvailableForGrant": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options forfeited/cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedAvailableForGrant", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "auvi_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOptionsGrantedAvailableForGrant1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOptionsGrantedAvailableForGrant1", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "auvi_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average grant date fair value, forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice1", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "auvi_SharePrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offering price" } } }, "localname": "SharePrice1", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "auvi_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsgrantedWeightedAverageRemainingContractualTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life, granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsgrantedWeightedAverageRemainingContractualTerm2", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "auvi_SharesGrantedToSettlePreviouslyRecordedLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares granted to settle previously recorded liability" } } }, "localname": "SharesGrantedToSettlePreviouslyRecordedLiability", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "auvi_SharesGrantedToSettlePreviouslyRecordedLiabilityShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares granted to settle previously recorded liability , shares" } } }, "localname": "SharesGrantedToSettlePreviouslyRecordedLiabilityShares", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "auvi_ShippingAndHandlingChargesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shipping and Handling Charges" } } }, "localname": "ShippingAndHandlingChargesPolicyTextBlock", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "auvi_ShippingCharges": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Shipping charges" } } }, "localname": "ShippingCharges", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_StateTaxableIncomeNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "State taxable income, net" } } }, "localname": "StateTaxableIncomeNet", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "auvi_SteriLumenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Steri Lumen.", "label": "Steri Lumen [Member]" } } }, "localname": "SteriLumenMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_StreetervilleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Streeterville Note [Member]" } } }, "localname": "StreetervilleNoteMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails" ], "xbrltype": "domainItemType" }, "auvi_StreetervilleNoteNetOfRelatedDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Streeterville note, net of related discount" } } }, "localname": "StreetervilleNoteNetOfRelatedDiscount", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NotesPayable-NetOfDiscountDetails" ], "xbrltype": "monetaryItemType" }, "auvi_TechnologyAndKnowHow": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "TechnologyAndKnowHow", "verboseLabel": "Technology and know how" } } }, "localname": "TechnologyAndKnowHow", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "auvi_TotalAcquisitionPrice": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Acquisition price" } } }, "localname": "TotalAcquisitionPrice", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_TotalAmountDueToLandlord": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total amount due to landlord" } } }, "localname": "TotalAmountDueToLandlord", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "auvi_TotalLeasePayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total lease payments" } } }, "localname": "TotalLeasePayments", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "auvi_TotalLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total Liabilities" } } }, "localname": "TotalLiabilities", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "auvi_TotalLongtermPortionOfAmountDueToLandlord": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total long-term portion of amount due to landlord" } } }, "localname": "TotalLongtermPortionOfAmountDueToLandlord", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "auvi_TotalProvisionForIncomeTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total provision for income taxes" } } }, "localname": "TotalProvisionForIncomeTaxes", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "auvi_TreasuryStockShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury Stock, Shares" } } }, "localname": "TreasuryStockShare", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "auvi_TreasuryStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury Stocks [Member]" } } }, "localname": "TreasuryStocksMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "auvi_TwoMajorSuppliersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Major Suppliers [Member]" } } }, "localname": "TwoMajorSuppliersMember", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "auvi_UnderwritingDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Underwriting discount" } } }, "localname": "UnderwritingDiscount", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_UnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of underwriting fees incurred.", "label": "Underwriting fees" } } }, "localname": "UnderwritingFees", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "auvi_VestedAndExerciables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "VestedAndExerciables", "verboseLabel": "Vested and Exercisable" } } }, "localname": "VestedAndExerciables", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "auvi_VestedAndExercisables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vested and Exercisable" } } }, "localname": "VestedAndExercisables", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "auvi_WarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[custom:WarrantLiability-0]", "verboseLabel": "Warrant liability" } } }, "localname": "WarrantLiability", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "auvi_WarrantLiabilityRecognizedInConnectionWithInitialIssuanceOfNovemberOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Warrant liability recognized in connection with initial issuance of November offering (See Note 7)" } } }, "localname": "WarrantLiabilityRecognizedInConnectionWithInitialIssuanceOfNovemberOffering", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "auvi_WarrantsMeasurementInput": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividend yield" } } }, "localname": "WarrantsMeasurementInput", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "auvi_WeightedAverageNumberOfSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WeightedAverageNumberOfSharesOutstandingBasicAndDiluted", "verboseLabel": "Weighted Average Shares Outstanding - basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAndDiluted", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails" ], "xbrltype": "sharesItemType" }, "auvi_WeightedAverageSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Shares Outstanding - basic and diluted" } } }, "localname": "WeightedAverageSharesOutstandingBasicAndDiluted", "nsuri": "http://applieduvinc.com/20221231", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r589", "r591", "r592" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r589", "r591", "r592" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r589", "r591", "r592" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r589", "r591", "r592" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r584" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r585" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r586" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r587" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://applieduvinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r296", "r562", "r640", "r700" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r336", "r337", "r338", "r339", "r395", "r505", "r529", "r540", "r541", "r559", "r572", "r577", "r637", "r690", "r691", "r692", "r693", "r694", "r695" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r336", "r337", "r338", "r339", "r395", "r505", "r529", "r540", "r541", "r559", "r572", "r577", "r637", "r690", "r691", "r692", "r693", "r694", "r695" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r296", "r562", "r640", "r700" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r336", "r337", "r338", "r339", "r387", "r395", "r423", "r424", "r425", "r504", "r505", "r529", "r540", "r541", "r559", "r572", "r577", "r634", "r637", "r691", "r692", "r693", "r694", "r695" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r336", "r337", "r338", "r339", "r387", "r395", "r423", "r424", "r425", "r504", "r505", "r529", "r540", "r541", "r559", "r572", "r577", "r634", "r637", "r691", "r692", "r693", "r694", "r695" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r625", "r686" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r298", "r299" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net of allowance for doubtful accounts" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r26" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll cost" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r83", "r195" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated Depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r13", "r576" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r428", "r429", "r430", "r620", "r621", "r622", "r678" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r52", "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r434" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r203", "r300", "r303", "r304", "r306" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r42", "r52", "r151", "r364" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r36", "r364", "r483", "r614" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "verboseLabel": "Debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r364", "r483", "r557", "r558", "r614" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of discount in interest expenses" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r52", "r73", "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Anti-dilutiveShares" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Anti-dilutiveShares" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Anti-dilutiveShares" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Anti-dilutiveShares" ], "xbrltype": "domainItemType" }, "us-gaap_AssetAcquisitionContingentConsiderationLiability": { "auth_ref": [ "r677" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized from contingent consideration in asset acquisition.", "label": "Contingent Consideration", "verboseLabel": "Contingent consideration" } } }, "localname": "AssetAcquisitionContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r52", "r80" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Impairment charges", "verboseLabel": "Asset Impairment Charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r159", "r173", "r199", "r225", "r277", "r283", "r289", "r301", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r460", "r464", "r474", "r576", "r635", "r636", "r688" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r191", "r206", "r225", "r301", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r460", "r464", "r474", "r576", "r635", "r636", "r688" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r1", "r182", "r183", "r184", "r185" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Total Assets" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r398", "r399", "r400", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r422", "r423", "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails", "http://applieduvinc.com/role/StockholdersEquityDetails1", "http://applieduvinc.com/role/StockholdersEquityDetails3", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r458", "r570", "r571" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative", "http://applieduvinc.com/role/ProformaFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r126", "r127", "r458", "r570", "r571" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative", "http://applieduvinc.com/role/ProformaFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": { "auth_ref": [ "r125" ], "lang": { "en-us": { "role": { "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.", "label": "Acquisition descrption" } } }, "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r135", "r136", "r137" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "negatedLabel": "Acquisitions, net of cash acquired (Note 2)" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Total Assets Acquired:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Prepaid expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r129" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r129" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "negatedLabel": "Deferred revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment": { "auth_ref": [ "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.", "label": "Machinery and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r128", "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "verboseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r129" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedLabel": "Total Liabilities Assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r128", "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Net Assets Acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-RecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Acquisition Accounting" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r535", "r536", "r576", "r599" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r55", "r157" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash, Restricted Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r49", "r54", "r58" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, restricted cash, and cash equivalents at December 31,", "periodStartLabel": "Cash, restricted cash, and cash equivalents at January 1," } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r49", "r150" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net Decrease in Cash and equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r599" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r200", "r201", "r202", "r225", "r245", "r246", "r253", "r254", "r258", "r259", "r301", "r340", "r342", "r343", "r344", "r347", "r348", "r368", "r369", "r372", "r376", "r383", "r474", "r542", "r598", "r616", "r623" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/BalanceSheetsParenthetical", "http://applieduvinc.com/role/Cover", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r101", "r108" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r101", "r108" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r620", "r621", "r678" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r91" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12", "r576" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock $.0001 par value, 150,000,000 shares authorized; 13,676,450 shares issued and outstanding as of December 31, 2022 and 12,775,674 shares issued and outstanding as of December 31, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax assets:" } } }, "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r170", "r262" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration of Credit and Business Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r62", "r63", "r148", "r149", "r296" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r139", "r546" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": { "auth_ref": [ "r146" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.", "label": "Contingent consideration" } } }, "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateMember": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.", "label": "Corporate Segment [Member]" } } }, "localname": "CorporateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r38", "r510" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods Sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r671" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Federal" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current provision:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r619", "r671", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r133" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails", "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r6", "r7", "r8", "r160", "r161", "r171", "r229", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r484", "r554", "r555", "r556", "r557", "r558", "r617" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails", "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r6", "r8", "r92", "r160", "r161", "r167", "r171" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt instrument description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r152", "r155", "r349", "r484", "r555", "r556" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principle outstanding", "terseLabel": "Principal amount", "verboseLabel": "Face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative", "http://applieduvinc.com/role/NotesPayable-NetOfDiscountDetails", "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative", "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r28", "r152", "r361" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Annual percentage rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r28", "r152", "r366", "r484" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Interest expense rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r28", "r350" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r207", "r554", "r680" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r29", "r229", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r484", "r554", "r555", "r556", "r557", "r558", "r617" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails", "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r29", "r168" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Down payment" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Redemption price" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r151", "r155", "r638" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt discount fee", "negatedLabel": "Debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-NetOfDiscountDetails", "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r151", "r152", "r153", "r154", "r155", "r638" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Accumulated amortization of debt discount", "verboseLabel": "Debt discount amortization to interest expense" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-NetOfDiscountDetails", "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r619", "r672", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred provision (benefit):" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r123", "r619", "r672" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Total Deferred" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r603" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r601" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r603" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r619", "r672", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-FederalAndStateIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Intangible assets" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r443" ], "calculation": { "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r121", "r670" ], "calculation": { "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Deferred Tax Assets, in Process Research and Development", "verboseLabel": "Research and development" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r669" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Net" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r121", "r670" ], "calculation": { "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r121", "r670" ], "calculation": { "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Fixed assets" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r121", "r670" ], "calculation": { "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "verboseLabel": "Stock based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r121", "r670" ], "calculation": { "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Accrual to cash conversion" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-DeferredTaxAssetsAndDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DepositContractsPolicy": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer.", "label": "Deposit Contracts, Policy [Policy Text Block]", "verboseLabel": "Vendor deposits" } } }, "localname": "DepositContractsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepositsAssetsCurrent": { "auth_ref": [ "r608" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.", "label": "Vendor deposits", "verboseLabel": "Deposits assets current" } } }, "localname": "DepositsAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r52", "r81" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r52", "r272" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r141", "r142", "r143", "r144", "r145", "r228" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivative Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DirectorsAndOfficersLiabilityInsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Professional liability coverage for legal expenses and liability to shareholders, bondholders, creditors or others due to actions or omissions by a director or officer of a corporation or nonprofit organization.", "label": "Directors and Officers Liability Insurance [Member]" } } }, "localname": "DirectorsAndOfficersLiabilityInsuranceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r386", "r560", "r561", "r562", "r563", "r564", "r565", "r566" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue" ], "xbrltype": "stringItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends per share" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r226", "r439", "r452" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationDeductions": { "auth_ref": [ "r668", "r674" ], "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r667" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized stock based compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails", "http://applieduvinc.com/role/StockholdersEquityDetails1", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r91", "r188", "r211", "r212", "r213", "r230", "r231", "r232", "r234", "r239", "r241", "r257", "r302", "r384", "r428", "r429", "r430", "r448", "r449", "r467", "r475", "r476", "r477", "r478", "r479", "r480", "r495", "r530", "r531", "r532" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ExtendedProductWarrantyAccrualCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount at end of the reporting period of the aggregate extended product warranty liability that is expected to be paid within one year of the balance sheet date or normal operating cycle, if longer. Does not include the balance for the standard product warranty liability.", "label": "Warrant liability" } } }, "localname": "ExtendedProductWarrantyAccrualCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r469", "r470", "r473" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r146", "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r357", "r388", "r389", "r390", "r391", "r392", "r393", "r470", "r501", "r502", "r503", "r555", "r556", "r567", "r568", "r569" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r357", "r388", "r393", "r470", "r501", "r567", "r568", "r569" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r357", "r388", "r393", "r470", "r502", "r555", "r556", "r567", "r568", "r569" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r357", "r388", "r389", "r390", "r391", "r392", "r393", "r470", "r503", "r555", "r556", "r567", "r568", "r569" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r357", "r388", "r389", "r390", "r391", "r392", "r393", "r501", "r502", "r503", "r555", "r556", "r567", "r568", "r569" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r486", "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "negatedLabel": "Less: current portion" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r486" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Financing lease obligations" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r486" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Financing lease obligations-less current portion", "verboseLabel": "Financing lease obligations, net of current" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Present value of future minimum lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "verboseLabel": "2027" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "verboseLabel": "2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "verboseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Amount representing interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation-FutureMinimumPrincipalAndInterestPaymentsUnderCapitalLeaseArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r488", "r491" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedLabel": "Payments on financing leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r487", "r490", "r575" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Amortization of right-of-use asset" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r197", "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Less: Accumulated Depreciation" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "verboseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "verboseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "verboseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r323", "r324", "r325", "r326", "r511", "r512" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails", "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r77", "r512" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails", "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r74", "r76" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails", "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r77", "r511" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets net", "verboseLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails", "http://applieduvinc.com/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedPatentsGross": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.", "label": "Patent cost" } } }, "localname": "FiniteLivedPatentsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetails", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r196", "r311", "r525", "r553", "r576", "r631", "r632" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://applieduvinc.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.", "label": "Loss on impairment of goodwill and intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetImpairment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r72", "r75" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r52", "r312", "r317", "r322", "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Loss on impairment of goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r37", "r225", "r277", "r282", "r288", "r291", "r301", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r474", "r552", "r635" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r614", "r633" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment on intangibles", "verboseLabel": "Intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative", "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r34", "r156", "r164", "r179", "r277", "r282", "r288", "r291", "r526", "r552" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss Before Provision for Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r226", "r440", "r441", "r446", "r450", "r453", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r227", "r240", "r241", "r275", "r438", "r451", "r454", "r528" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Benefit from Income Taxes", "verboseLabel": "Total provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r210", "r436", "r437", "r441", "r442", "r445", "r447" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r435", "r439" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Rate change" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r439" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Federal statutory rate times financial statement income" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r51" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r51" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r51" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r545" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "verboseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "auth_ref": [ "r51" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.", "label": "Increase (Decrease) in Deposit Assets", "negatedLabel": "Vendor deposits" } } }, "localname": "IncreaseDecreaseInDepositOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r51" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities, net of effects of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r613", "r682" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease payments" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r51" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r76", "r507", "r508", "r509", "r511", "r547" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Patent Costs" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r153", "r166", "r214", "r271", "r482" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r42", "r362", "r367", "r557", "r558" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Accrued interest expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r218", "r221", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORY" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r604" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r607" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory at cost" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLIFOReserve": { "auth_ref": [ "r606" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.", "label": "Inventory, LIFO Reserve" } } }, "localname": "InventoryLIFOReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r205", "r543", "r576" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, net", "verboseLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r193", "r204", "r256", "r307", "r309", "r310", "r506", "r548" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r605" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r71", "r607" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Less: Reserve" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r308" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Change in reserve for Obsolescence inventory" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r684", "r685" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetails", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "FINANCING LEASE OBLIGATION" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FinancingLeaseObligation" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r683" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of maturities of operating lease liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r493" ], "calculation": { "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": { "auth_ref": [ "r683" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": { "auth_ref": [ "r683" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths": { "auth_ref": [ "r683" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition-FutureMaturityOfLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r493" ], "calculation": { "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r493" ], "calculation": { "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r493" ], "calculation": { "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r493" ], "calculation": { "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Imputed Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "LEASING ARRANGEMENTS" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r25", "r225", "r301", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r461", "r464", "r465", "r474", "r551", "r635", "r688", "r689" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r17", "r162", "r176", "r576", "r618", "r630", "r681" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r27", "r192", "r225", "r301", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r461", "r464", "r465", "r474", "r576", "r635", "r688", "r689" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r3", "r4", "r5", "r8", "r9", "r225", "r301", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r461", "r464", "r465", "r474", "r635", "r688", "r689" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Long-Term Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAnnualPrincipalPayment": { "auth_ref": [ "r600", "r602" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the total principal payments made during the annual reporting period.", "label": "Secured credit facility" } } }, "localname": "LineOfCreditFacilityAnnualPrincipalPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate during the reporting period.", "label": "Loan fee percentage" } } }, "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r8", "r161", "r174", "r356", "r365", "r555", "r556" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Total", "verboseLabel": "Long term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails", "http://applieduvinc.com/role/NotesPayable-MinimumObligationsUnderThisLoanAgreementDetails", "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtDescription": { "auth_ref": [ "r29", "r92" ], "lang": { "en-us": { "role": { "documentation": "Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment.", "label": "Long term debt, Description" } } }, "localname": "LongTermDebtDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r86", "r229", "r360" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "verboseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails", "http://applieduvinc.com/role/NotesPayable-MinimumObligationsUnderThisLoanAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r86", "r229", "r360" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "verboseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails", "http://applieduvinc.com/role/NotesPayable-MinimumObligationsUnderThisLoanAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "PAYROLL PROTECTION PROGRAM" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PayrollProtectionProgram" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermLoansPayable": { "auth_ref": [ "r29" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable- less current portion" } } }, "localname": "LongTermLoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetails", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r0", "r138" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "BUSINESS ACQUISITION" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisition" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r220" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r220" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used in Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r49", "r50", "r53" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Used in Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r35", "r53", "r165", "r178", "r190", "r208", "r209", "r213", "r225", "r233", "r235", "r236", "r237", "r238", "r240", "r241", "r251", "r277", "r282", "r288", "r291", "r301", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r468", "r474", "r552", "r635" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://applieduvinc.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net Loss", "verboseLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails", "http://applieduvinc.com/role/StatementsOfCashFlows", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r235", "r236", "r237", "r238", "r242", "r243", "r252", "r254", "r277", "r282", "r288", "r291", "r552" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "negatedLabel": "Dividends to preferred shareholders", "verboseLabel": "Net Loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Net Loss attributable to common stockholders:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r244", "r247", "r248", "r249", "r250", "r252", "r254" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Loss attributable to common stockholders:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": { "auth_ref": [ "r243", "r254" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.", "label": "Dividends to preferred shareholders" } } }, "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently adopted accounting standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r41" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other Income (Expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income (Expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r8", "r161", "r174" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Note payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Assets [Line Items]" } } }, "localname": "OffsettingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTable": { "auth_ref": [ "r32", "r33" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Assets [Table]" } } }, "localname": "OffsettingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses [Default Label]", "totalLabel": "Total Operating Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r277", "r282", "r288", "r291", "r552" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating Loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r486" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "verboseLabel": "Present value of future minimum lease payments" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangements-MaturitiesOfOperatingLeaseLaibilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r486" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r486" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability-less current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r489", "r491" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r485" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r614" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Recognition of right of use asset - operating lease" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r492", "r575" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeasesRentExpenseNet": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.", "label": "Rent expense" } } }, "localname": "OperatingLeasesRentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/LeasingArrangementsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r120" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OptionMember": { "auth_ref": [ "r140" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received).", "label": "Options Held [Member]" } } }, "localname": "OptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Anti-dilutiveShares" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r158", "r172", "r198" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Total assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r198" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r180" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsNet": { "auth_ref": [], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.", "label": "Other intangible assets, net of accumulated amortization" } } }, "localname": "OtherIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r163" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other liablities" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Schedule of Non-Cash Financing and Investing Activities:" } } }, "localname": "OtherNoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r217" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Non-operating income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNotesPayable": { "auth_ref": [ "r8", "r161", "r174" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes payable classified as other.", "label": "Other Notes Payable", "verboseLabel": "Total" } } }, "localname": "OtherNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-NetOfDiscountDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfEquity": { "auth_ref": [ "r46" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common and preferred stock.", "label": "Payments for Repurchase of Equity", "negatedLabel": "Shares repurchased" } } }, "localname": "PaymentsForRepurchaseOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r46" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Dividends to preferred shareholders" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r43" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Cash paid for patent costs" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMachineryAndEquipment": { "auth_ref": [ "r43" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of machinery and equipment.", "label": "Payments to Acquire Machinery and Equipment", "negatedLabel": "Purchase of machinery and equipment" } } }, "localname": "PaymentsToAcquireMachineryAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r11", "r92", "r93", "r616", "r639" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Per share liquidation preference" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r11", "r368" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheetsParenthetical", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheetsParenthetical", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r11", "r368" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r11", "r576" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r609" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expense and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Net proceeds" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r45" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from note payable, net", "verboseLabel": "Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherEquity": { "auth_ref": [ "r44" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the issuance of equity classified as other.", "label": "Proceeds from equity raises, net" } } }, "localname": "ProceedsFromOtherEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r611" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from warrant exercise" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r190", "r208", "r209", "r219", "r225", "r233", "r240", "r241", "r277", "r282", "r288", "r291", "r301", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r459", "r462", "r463", "r468", "r474", "r526", "r552", "r573", "r574", "r610", "r635" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetails", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r85", "r537", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r82", "r194" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetails", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r84", "r177", "r527", "r576" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net of accumulated depreciation", "verboseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r84", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetails", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r216", "r305" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Bad debt expense (recovery)" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r626", "r627", "r628", "r629" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Accounts receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r394", "r496", "r497" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative", "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r394", "r496", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r687" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative", "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfConstructionLoansPayable": { "auth_ref": [ "r47" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from repayment of borrowings to finance the cost of construction.", "label": "Repayments of Construction Loans Payable", "negatedLabel": "Payments on loan payable" } } }, "localname": "RepaymentsOfConstructionLoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r612" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r47" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Payments on note payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r117", "r186", "r696" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r599", "r615", "r697", "r698" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r14", "r98", "r175", "r533", "r534", "r576" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r188", "r230", "r231", "r232", "r234", "r239", "r241", "r302", "r428", "r429", "r430", "r448", "r449", "r467", "r530", "r532" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r268", "r269", "r281", "r286", "r287", "r293", "r294", "r296", "r385", "r386", "r510" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Net Sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r549", "r550" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r215", "r225", "r268", "r269", "r281", "r286", "r287", "r293", "r294", "r296", "r301", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r474", "r526", "r635" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "verboseLabel": "Net Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Proceeds from sale of stock" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.", "label": "Gross proceeds" } } }, "localname": "SaleOfStockConsiderationReceivedPerTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of stock" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Anti-dilutiveShares" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of anti dilutive securities excluded from computation of earnings per share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r126", "r127", "r458" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of income before provision for income taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of deferred tax assets and deferred tax liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r103", "r104", "r105", "r106", "r107" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NoteReceivable-RelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of federal and state income" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r74", "r76", "r511" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails", "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r74", "r76" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r2", "r18", "r19", "r20" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of minimum obligations under loan agreement" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/PropertyAndEquipmentDetails", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of recognized identified assets acquired and liabilities assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r329", "r330", "r331", "r332", "r333", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/ProformaFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r67", "r68", "r69", "r72" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r67", "r68", "r69", "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of segment reporting" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Schedule of Unvested Restricted Stock Units Activity" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r396", "r397", "r398", "r399", "r400", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r422", "r423", "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails", "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r109", "r111", "r113" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of the Company's option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails", "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r88", "r89", "r90", "r92", "r93", "r94", "r95", "r96", "r97", "r98", "r200", "r201", "r202", "r258", "r368", "r369", "r370", "r372", "r376", "r381", "r383", "r559", "r598", "r616" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r101", "r108" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of the Company's warrant activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Future amortization of intangible assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r265", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r291", "r296", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r332", "r335", "r553", "r699" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r265", "r266", "r267", "r277", "r280", "r285", "r289", "r290", "r291", "r292", "r293", "r295", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "SEGMENT REPORTING" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r40" ], "calculation": { "http://applieduvinc.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling general and administrative", "verboseLabel": "Selling, General and Administrative Expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails", "http://applieduvinc.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r51" ], "calculation": { "http://applieduvinc.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Granted and unvested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Weighted average fair market value, granted and unvested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r642" ], "lang": { "en-us": { "role": { "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.", "label": "Expiration date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments": { "auth_ref": [ "r424" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments", "negatedLabel": "Dividends paid to preferred shareholder" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails", "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Exercised", "negatedLabel": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Number of shares available for grant", "periodEndLabel": "Number of Option Outstanding, ending", "periodStartLabel": "Number of Option Outstanding, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "verboseLabel": "Vested and Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r647" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Weighted average exercise price, forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r402", "r403" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options outstanding at the ending", "periodStartLabel": "Options outstanding at the beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r402", "r403" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Exercise Price", "periodEndLabel": "Weighted average exercise price, ending", "periodStartLabel": "Weighted average exercise price, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails", "http://applieduvinc.com/role/StockholdersEquityDetails1", "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Weighted average exercise price,Vested and Exercisable", "verboseLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2", "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "periodEndLabel": "Number of unvested shares outstanding, at ending", "periodStartLabel": "Number of unvested shares outstanding, at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average fair market value outstanding, at ending", "periodStartLabel": "Weighted average fair market value outstanding, at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r398", "r399", "r400", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r422", "r423", "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails", "http://applieduvinc.com/role/StockholdersEquityDetails1", "http://applieduvinc.com/role/StockholdersEquityDetails3", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price, exercised", "verboseLabel": "Weighted average exercise price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails", "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted average exercise price, granted", "verboseLabel": "Weighted average exercise price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails", "http://applieduvinc.com/role/StockholdersEquityDetails2" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r401", "r420", "r421", "r422", "r423", "r426", "r431", "r432" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Stock Price", "verboseLabel": "Offering price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails1", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Forfeited/Cancelled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Weighted average fair market value, forfeited/Cancelled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodStartLabel": "Weighted average grant date fair value, beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life in years" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Weighted average remaining contractual life in years" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "negatedLabel": "Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Weighted average fair market value, vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails3" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails", "http://applieduvinc.com/role/PayrollProtectionProgramDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayable-MinimumObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r59", "r223" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r189", "r265", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r291", "r296", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r328", "r332", "r335", "r553", "r699" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SegmentReportingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r200", "r201", "r202", "r225", "r245", "r246", "r253", "r254", "r258", "r259", "r301", "r340", "r342", "r343", "r344", "r347", "r348", "r368", "r369", "r372", "r376", "r383", "r474", "r542", "r598", "r616", "r623" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/BalanceSheetsParenthetical", "http://applieduvinc.com/role/Cover", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r31", "r91", "r188", "r211", "r212", "r213", "r230", "r231", "r232", "r234", "r239", "r241", "r257", "r302", "r384", "r428", "r429", "r430", "r448", "r449", "r467", "r475", "r476", "r477", "r478", "r479", "r480", "r495", "r530", "r531", "r532" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/BalanceSheetsParenthetical", "http://applieduvinc.com/role/Cover", "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity", "http://applieduvinc.com/role/StockholdersEquityDetails1", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r230", "r231", "r232", "r257", "r510" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/BalanceSheetsParenthetical", "http://applieduvinc.com/role/Cover", "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity", "http://applieduvinc.com/role/StockholdersEquityDetails1", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r11", "r12", "r98" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Common stock issued for acquisition , shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r91", "r98" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common stock issued in public offering net of costs, shares", "verboseLabel": "Number of share issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r11", "r12", "r91", "r98" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Stock-based compensation , shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r11", "r12", "r91", "r98", "r407" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Exercise of warrants , shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": { "auth_ref": [ "r12", "r91", "r98" ], "lang": { "en-us": { "role": { "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.", "label": "Treasury stock reissued" } } }, "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r31", "r91", "r98" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Common stock issued for acquisition" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r11", "r12", "r91", "r98" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Common stock issued in public offering, net of costs" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r11", "r12", "r98", "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r31", "r91", "r98" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Exercise of warrants" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r11", "r12", "r91", "r98" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Common shares repurchased, shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r11", "r12", "r91", "r98" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Common shares repurchased" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r12", "r15", "r16", "r70", "r576", "r618", "r630", "r681" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets", "http://applieduvinc.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityAverageAmountOutstanding": { "auth_ref": [ "r701", "r702" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount outstanding of stockholders' equity.", "label": "Stock holders equity" } } }, "localname": "StockholdersEquityAverageAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r102", "r224", "r369", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r382", "r384", "r466" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r481", "r499" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative", "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r481", "r499" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r481", "r499" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative", "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r481", "r499" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative", "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r498", "r500" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosures of Cash Flow Information:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid during the year for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Shares authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r565", "r640" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing of Transfer of Good or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r565", "r640" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time." } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IntangibleAssetsDetails", "http://applieduvinc.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionDomain": { "auth_ref": [ "r544" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "localname": "TransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionTypeAxis": { "auth_ref": [ "r544" ], "lang": { "en-us": { "role": { "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction Type [Axis]" } } }, "localname": "TransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/NotesPayableDetailsNarrative", "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred at Point in Time [Member]" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred over Time [Member]" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Revenue" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r12", "r91", "r98" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury stock, shares" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r30", "r99", "r100" ], "calculation": { "http://applieduvinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock at cost, 113,485 and 0 shares, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r64", "r65", "r66", "r260", "r261", "r263", "r264" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetExplanationOfChange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of and reason for the change during the period in the valuation allowance for a specified deferred tax asset.", "label": "Change in Valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetExplanationOfChange", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/IncomeTaxes-IncomeBeforeProvisionForIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://applieduvinc.com/role/StockholdersEquityDetails2", "http://applieduvinc.com/role/SummaryOfSignificantAccountingPoliciesDetails-Anti-dilutiveShares" ], "xbrltype": "domainItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "83", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6487483&loc=d3e32239-158577", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r578": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r579": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r581": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r582": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r583": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r584": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r585": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r586": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r587": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r588": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r589": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r59": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r591": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r592": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r593": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r594": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r595": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r596": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r597": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 91 0001607062-23-000168-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001607062-23-000168-xbrl.zip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ˑ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Ð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�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end